Citrus Sinensis ID: 040826
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | 2.2.26 [Sep-21-2011] | |||||||
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.804 | 0.318 | 0.402 | 3e-48 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.870 | 0.611 | 0.374 | 2e-47 | |
| Q9SI06 | 892 | Putative leucine-rich rep | no | no | 0.855 | 0.332 | 0.376 | 3e-47 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.809 | 0.390 | 0.371 | 1e-46 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.896 | 0.358 | 0.376 | 1e-46 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.927 | 0.434 | 0.338 | 2e-46 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.786 | 0.422 | 0.376 | 2e-46 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.804 | 0.448 | 0.395 | 2e-46 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.806 | 0.353 | 0.368 | 2e-46 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.927 | 0.365 | 0.382 | 2e-46 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 192 bits (489), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 116/288 (40%), Positives = 170/288 (59%), Gaps = 9/288 (3%)
Query: 54 YRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--NTDSFSREV 111
Y++S EI NN R LG+G G VY GVL G+ VAIK + KS+ F EV
Sbjct: 559 YKYS--EIVEITNNF--ERVLGQGGFGKVYYGVL-RGEQVAIKMLSKSSAQGYKEFRAEV 613
Query: 112 EGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDS-VLTWERRVKILRDC 170
E L RV H NL+ L G C EG + L+YE+ G L +L K+S +L+WE R++I D
Sbjct: 614 ELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGKNSSILSWEERLQISLDA 673
Query: 171 ALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ESKVFTDVRGTI 229
A L YLH+ IVHRD+K TNIL+ EKL+ K++DFGL++ +E +S+V T+V GTI
Sbjct: 674 AQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTI 733
Query: 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289
GY+DPE+ + + + SD+YSFG+V L++++GQ VI ++ + + K I
Sbjct: 734 GYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDI 793
Query: 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
K DP+L N I ++A+ C ++S+K R T+ V E+ ++
Sbjct: 794 KSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELKES 841
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 116/310 (37%), Positives = 169/310 (54%), Gaps = 8/310 (2%)
Query: 27 GKNKGCMPKRKSP-KPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKG 85
G+ G P SP EI W + F+ ++E A N LG G G+VY+G
Sbjct: 143 GRQYGGGPVTASPLVGLPEISHLGWG--HWFTLRDLELATNRFAPVNVLGEGGYGVVYRG 200
Query: 86 VLPSGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143
L +G VA+K + + F EVE + VRH NLV L G C+EG + LVYE+
Sbjct: 201 KLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 260
Query: 144 AGNLAQHL---LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK 200
+GNL Q L +R+ LTWE R+KI+ A AL YLH I+ +VHRDIK +NIL+ ++
Sbjct: 261 SGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDE 320
Query: 201 LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
KLSDFGLAK+L ES + T V GT GY+ PEY L SDIYSFG++ L+ ++
Sbjct: 321 FNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAIT 380
Query: 261 GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKS 320
G+ ++ A + + + +G R ++ DPRL +++ + L +++ CV
Sbjct: 381 GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPE 440
Query: 321 SKGRPTIDVV 330
++ RP + V
Sbjct: 441 AEKRPRMSQV 450
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 118/313 (37%), Positives = 178/313 (56%), Gaps = 16/313 (5%)
Query: 35 KRKSPK-----PTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPS 89
KRK+P+ ++ + T + RF+ E+ NN + LG+G G+VY G +
Sbjct: 546 KRKTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMTNNF--EKILGKGGFGMVYHGTVND 603
Query: 90 GQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147
+ VA+K + S++ F EVE L RV H NLV L G C EG L+YE+ A G+L
Sbjct: 604 AEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLSLIYEYMAKGDL 663
Query: 148 AQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205
+H+L S+L W+ R+KI+ + A L YLH+ +VHRD+K TNILL E + KL
Sbjct: 664 KEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNILLDEHFQAKL 723
Query: 206 SDFGLAKMLGME-ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKV 264
+DFGL++ +E E++V T V GT GY+DPEY L SD+YSFGIV L++++ Q V
Sbjct: 724 ADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQHV 783
Query: 265 IELDFDARDQL-TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKG 323
I +R++ + V + K IK DP+ +G+ + +++A+ CV SS G
Sbjct: 784 IN---QSREKPHIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWRAVELAMSCVNPSSTG 840
Query: 324 RPTIDVVYEEIDK 336
RPT+ V E+++
Sbjct: 841 RPTMSQVVIELNE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 106/285 (37%), Positives = 169/285 (59%), Gaps = 4/285 (1%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKH--IYKSNNTDSFSREVEG 113
FS +++ENA + R LG+G G VYKG+L G +VA+K K N + F E+
Sbjct: 378 FSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIIL 437
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCA 171
LS++ H N+V + GCC+E LVYEF NL HL +D ++WE R+ I + A
Sbjct: 438 LSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVA 497
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
AL YLH + I HRD+K TNILL EK K+SDFG+++ + ++++ + T V+GTIGY
Sbjct: 498 DALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGY 557
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291
+DPEY+ + T SD+YSFG++ ++LL+G+K + L ++ +M + +
Sbjct: 558 VDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHE 617
Query: 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
D R+ +R + ++ K+A C++ +S+ RPT+ V+ E+D+
Sbjct: 618 ILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDR 662
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 127/337 (37%), Positives = 185/337 (54%), Gaps = 26/337 (7%)
Query: 5 IATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENA 64
+A +++L+L+ I KS RK +P+ E+ + RF E++
Sbjct: 518 VAVTIIVLVLIFIFRRRKSS----------TRKVIRPSLEMKNR------RFKYSEVKEM 561
Query: 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNL 122
NN LG+G G+VY G L + QV A+K + +S+ F EVE L RV H NL
Sbjct: 562 TNNF--EVVLGKGGFGVVYHGFLNNEQV-AVKVLSQSSTQGYKEFKTEVELLLRVHHVNL 618
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLL--RKDSVLTWERRVKILRDCALALRYLHHY 180
V L G C EG + L+YEF GNL +HL R SVL W R+KI + AL + YLH
Sbjct: 619 VSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYLHIG 678
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRGTIGYMDPEYMTN 239
+VHRD+K TNILL + E KL+DFGL++ L ++ V T+V GT+GY+DPEY
Sbjct: 679 CQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLK 738
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299
LT SD+YSFGIV L+ ++GQ VIE D + + A+ + + I+ DP L+
Sbjct: 739 NWLTEKSDVYSFGIVLLESITGQPVIEQSRD-KSYIVEWAKSM-LANGDIESIMDPNLHQ 796
Query: 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+ + + L++A+LC+ SS RP + V E+++
Sbjct: 797 DYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNE 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 120/355 (33%), Positives = 181/355 (50%), Gaps = 33/355 (9%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYR----- 55
+ ++I V++L + I+H K +RK K ++ + G+
Sbjct: 345 LVIIIGVLVLLLAAICIQHATK------------QRKYTKLRRQFFEQNGGGMLIQRLSG 392
Query: 56 ----------FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIK--HIYKSNN 103
F+++ ++ A N + R LG+G G VYKG+LP +VAIK + S
Sbjct: 393 AGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQ 452
Query: 104 TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK--DSVLTWE 161
D F EV LS++ H N+V + GCC+E LVYEF G L HL DS LTWE
Sbjct: 453 VDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWE 512
Query: 162 RRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
R++I + A L YLH I+HRDIK NILL E L K++DFG +K++ M++ ++
Sbjct: 513 HRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQL 572
Query: 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF-DARDQLTRKAR 280
T V+GT+GY+DPEY T L SD+YSFG+V ++LLSGQK + + A L
Sbjct: 573 TTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFV 632
Query: 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
+ R + +D LN + N + + +IA C + RP + V +++
Sbjct: 633 SATEENRLHEIIDDQVLNED-NLKEIQEAARIAAECTRLMGEERPRMKEVAAKLE 686
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 105/279 (37%), Positives = 163/279 (58%), Gaps = 6/279 (2%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TDSFSREVEG 113
FS + +E A + D+ LG+G +G VYKGVL +G+ VA+K ++ + D F EV
Sbjct: 311 FSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNL 370
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL-RKD-SVLTWERRVKILRDCA 171
+S+V H NLV L GC + G E LVYE+ A +L +L RKD L W +R KI+ A
Sbjct: 371 ISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTA 430
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
+ YLH + I+HRDIKL+NILL + P+++DFGLA++ +++ + T + GT+GY
Sbjct: 431 EGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGY 490
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291
M PEY+ KLT +D+YSFG++ +++++G++ DA L +++
Sbjct: 491 MAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSILQSVWSLYRTSN--VEE 548
Query: 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330
DP L N N+ + +L+I +LCV + RP + VV
Sbjct: 549 AVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVV 587
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 116/293 (39%), Positives = 166/293 (56%), Gaps = 14/293 (4%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEG 113
++ EIE A ++ D+ LG G+ G VY G P+ VAIK + + T D E++
Sbjct: 302 YTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKL 361
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL--RKDSVLTWERRVKILRDCA 171
LS V HPNLV L GCC GE +LVYEF G L QHL R L+W+ R+ I A
Sbjct: 362 LSSVSHPNLVRLLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPLSWQLRLAIACQTA 421
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM----EESKVFTDVRG 227
A+ +LH ++ I HRDIK +NILL + K+SDFGL++ LGM E S + T +G
Sbjct: 422 NAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSR-LGMSTDFEASHISTAPQG 480
Query: 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD-QLTRKARDVSMGK 286
T GY+DP+Y + +L+ SD+YSFG+V ++++SG KVI+ + L A D +G+
Sbjct: 481 TPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVD-RIGR 539
Query: 287 RPIKDFEDPRLNGNINRADFESILKIAVL---CVAKSSKGRPTIDVVYEEIDK 336
+ D DP LN IN F SI +A L C++ RPT+ + E++ +
Sbjct: 540 GRVVDIIDPCLNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHR 592
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 105/285 (36%), Positives = 160/285 (56%), Gaps = 5/285 (1%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKH--IYKSNNTDSFSREVEG 113
FS E+E A N R LG+G G VYKG+L G++VA+K + + + F EV
Sbjct: 435 FSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVI 494
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL---LRKDSVLTWERRVKILRDC 170
LS++ H N+V L GCC+E LVYEF GNL +HL ++ + TW R++I D
Sbjct: 495 LSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDI 554
Query: 171 ALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG 230
A AL YLH I HRD+K TNI+L EK K+SDFG ++ + ++ + + T V GT+G
Sbjct: 555 AGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVG 614
Query: 231 YMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290
YMDPEY +++ T SD+YSFG+V ++L++G+K I ++ ++M + +
Sbjct: 615 YMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLF 674
Query: 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
D D R+ + + K+A C+ + RP++ V E+D
Sbjct: 675 DIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELD 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 130/340 (38%), Positives = 184/340 (54%), Gaps = 18/340 (5%)
Query: 4 LIATFVMMLILVL-IKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIE 62
L+A+ V +L LVL I K + + G R P T + Y Y++S E+
Sbjct: 522 LVASVVGVLGLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRY-------YKYS--EVV 572
Query: 63 NAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHP 120
NN R LG+G G VY GVL QV A+K + +S+ F EVE L RV H
Sbjct: 573 KVTNNF--ERVLGQGGFGKVYHGVLNDDQV-AVKILSESSAQGYKEFRAEVELLLRVHHK 629
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHH 179
NL L G C EG + L+YEF A G L +L K VL+WE R++I D A L YLH+
Sbjct: 630 NLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHN 689
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ESKVFTDVRGTIGYMDPEYMT 238
IV RD+K NIL+ EKL+ K++DFGL++ + ++ ++ T V GTIGY+DPEY
Sbjct: 690 GCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHL 749
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR-DVSMGKRPIKDFEDPRL 297
KL+ SDIYSFG+V L+++SGQ VI + + R D+ + I+ DP+L
Sbjct: 750 TQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKL 809
Query: 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
+ I ++A+ C + SSK RPT+ V E+ ++
Sbjct: 810 GERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKES 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| 255569008 | 569 | serine-threonine protein kinase, plant-t | 0.968 | 0.590 | 0.771 | 1e-155 | |
| 359476546 | 585 | PREDICTED: probable LRR receptor-like se | 0.965 | 0.572 | 0.736 | 1e-147 | |
| 449449699 | 566 | PREDICTED: cysteine-rich receptor-like p | 0.855 | 0.524 | 0.791 | 1e-142 | |
| 147790217 | 684 | hypothetical protein VITISV_032293 [Viti | 0.916 | 0.464 | 0.746 | 1e-141 | |
| 356504137 | 478 | PREDICTED: probable receptor-like protei | 0.956 | 0.694 | 0.684 | 1e-139 | |
| 224145944 | 284 | predicted protein [Populus trichocarpa] | 0.818 | 1.0 | 0.835 | 1e-139 | |
| 356571206 | 567 | PREDICTED: probable receptor-like protei | 0.956 | 0.585 | 0.684 | 1e-137 | |
| 357512439 | 544 | Wall-associated receptor kinase-like pro | 0.890 | 0.568 | 0.733 | 1e-134 | |
| 62701712 | 408 | hypothetical protein LOC_Os11g26140 [Ory | 0.979 | 0.833 | 0.664 | 1e-124 | |
| 242067181 | 429 | hypothetical protein SORBIDRAFT_05g00059 | 0.858 | 0.694 | 0.711 | 1e-121 |
| >gi|255569008|ref|XP_002525474.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223535287|gb|EEF36964.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1430), Expect = e-155, Method: Compositional matrix adjust.
Identities = 267/346 (77%), Positives = 299/346 (86%), Gaps = 10/346 (2%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYST-TWSGLYRFSKD 59
A +A ++LIL+L +V KS+ K K PKP + WSGLYRFSK
Sbjct: 213 FATFMAVVALILILILTMYVTKSR---------RKNKPPKPVVQSKDMKAWSGLYRFSKA 263
Query: 60 EIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH 119
EIENAIN +R+ LGRGSAG VYKGVLPSGQVVA+KHI++S+ TDSF REVEGLSRVRH
Sbjct: 264 EIENAINYGNERKSLGRGSAGQVYKGVLPSGQVVAVKHIHQSSTTDSFQREVEGLSRVRH 323
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
PNLVCLFGCC EG ++YLVYE+C+AGNLAQHLLRKD++LTWERRVKILRDCAL LRYLHH
Sbjct: 324 PNLVCLFGCCSEGEDRYLVYEYCSAGNLAQHLLRKDTLLTWERRVKILRDCALGLRYLHH 383
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
YIDGCIVHRDIKLTNILLTE L+PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM+N
Sbjct: 384 YIDGCIVHRDIKLTNILLTENLDPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMSN 443
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299
AKLTCASDIYSFGIV LQLLSGQKVI+LD DARDQLTRKA+DVSMGKRP+ DFEDPRL+G
Sbjct: 444 AKLTCASDIYSFGIVILQLLSGQKVIDLDLDARDQLTRKAKDVSMGKRPVTDFEDPRLDG 503
Query: 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345
+NRADFE+IL+IAVLCVAKSSKGRPT+DVV+EE+DKAWKNT+ M
Sbjct: 504 QVNRADFEAILQIAVLCVAKSSKGRPTMDVVFEEMDKAWKNTIAYM 549
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476546|ref|XP_002267885.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g48740-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1361), Expect = e-147, Method: Compositional matrix adjust.
Identities = 254/345 (73%), Positives = 292/345 (84%), Gaps = 10/345 (2%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDE 60
+A+ +A+ +MLI++LIK VAK K K K +I TTWSGLYRFSK E
Sbjct: 228 LAIFVASASLMLIIMLIKFVAKDKQSAK----------AKEITKITETTWSGLYRFSKSE 277
Query: 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP 120
IE AI++ +R LG+GSAG V+KGVLPSGQ VAIKHIYK+N+ DSF+REVEGLSR+RHP
Sbjct: 278 IEKAISSANERSSLGQGSAGQVFKGVLPSGQAVAIKHIYKTNSHDSFTREVEGLSRIRHP 337
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
NLVCLFG CVE G+ YLVYEFC+AGNLA +L +K VLTWERRVKILRDCALALRYLH+Y
Sbjct: 338 NLVCLFGTCVEDGDMYLVYEFCSAGNLAYNLQKKHEVLTWERRVKILRDCALALRYLHNY 397
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
IDGCIVHRDIKLTNILLT+ LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA
Sbjct: 398 IDGCIVHRDIKLTNILLTDNLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 457
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
KLT ASDIYSFGIV LQLLSGQKVI+LD DARDQLTRKA+DV+MGKRP+KDFEDPRL G
Sbjct: 458 KLTAASDIYSFGIVTLQLLSGQKVIDLDLDARDQLTRKAKDVNMGKRPLKDFEDPRLKGE 517
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345
+ DF+SIL++AVLC AKS+KGRP+ID V++E+D+AWKNT+ M
Sbjct: 518 VVTEDFQSILQVAVLCAAKSNKGRPSIDQVFQEMDRAWKNTVAYM 562
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449699|ref|XP_004142602.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] gi|449479773|ref|XP_004155703.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1316), Expect = e-142, Method: Compositional matrix adjust.
Identities = 235/297 (79%), Positives = 273/297 (91%)
Query: 47 STTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS 106
++TWSGLYRF+K+EI+ A++ +R LGRGSAG VYKG+LPSGQ VAIK I++SN +DS
Sbjct: 246 TSTWSGLYRFAKEEIDRALDFGSERTSLGRGSAGQVYKGILPSGQQVAIKKIFQSNTSDS 305
Query: 107 FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI 166
F REVEGLSRVRH NLVCL GCC+E GEQYLVYE+C GNLAQHLLRKD+VL+W+ RV+I
Sbjct: 306 FIREVEGLSRVRHQNLVCLLGCCIENGEQYLVYEYCEQGNLAQHLLRKDTVLSWKSRVQI 365
Query: 167 LRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
LRDCALALRYLH +DGCIVHRDIKLTNILLTEK+EPKLSDFGLA+MLGM+E+KVFTDVR
Sbjct: 366 LRDCALALRYLHQRVDGCIVHRDIKLTNILLTEKMEPKLSDFGLARMLGMDETKVFTDVR 425
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286
GTIGYMDPEYM+NAKLTCASDIYSFGIVALQLLSGQKVI+LD DARDQLTRKA+DV+MG
Sbjct: 426 GTIGYMDPEYMSNAKLTCASDIYSFGIVALQLLSGQKVIDLDLDARDQLTRKAKDVNMGL 485
Query: 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343
R + DFEDP+L GN+N+ADFESIL++AVLCVAKSSKGRPTID+V+EE+DKAW+NT+V
Sbjct: 486 RALSDFEDPKLKGNVNKADFESILQVAVLCVAKSSKGRPTIDIVFEELDKAWQNTIV 542
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147790217|emb|CAN67880.1| hypothetical protein VITISV_032293 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-141, Method: Compositional matrix adjust.
Identities = 245/328 (74%), Positives = 277/328 (84%), Gaps = 10/328 (3%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDE 60
+A+ +A+ +MLI++LIK VAK K K K +I TTWSGLYRFSK E
Sbjct: 343 LAIFVASASLMLIIMLIKFVAKDKQSAK----------AKEITKITETTWSGLYRFSKSE 392
Query: 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP 120
IE AI++ +R LG+GSAG V+KGVLPSGQ VAIKHIYK+N+ DSF+REVEGLSR+RHP
Sbjct: 393 IEKAISSANERSSLGQGSAGQVFKGVLPSGQAVAIKHIYKTNSHDSFTREVEGLSRIRHP 452
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
NLVCLFG CVE G+ YLVYEFC+AGNLA L +K VLTWERRVKILRDCALALRYLH+Y
Sbjct: 453 NLVCLFGTCVEDGDMYLVYEFCSAGNLAYXLQKKHEVLTWERRVKILRDCALALRYLHNY 512
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
IDGCIVHRDIKLTNILLT+ LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA
Sbjct: 513 IDGCIVHRDIKLTNILLTDNLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 572
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
KLT ASDIYSFGIV LQLLSGQKVI+LD DARDQLTRKA+DV+MGKRP+KDFEDPRL G
Sbjct: 573 KLTAASDIYSFGIVTLQLLSGQKVIDLDLDARDQLTRKAKDVNMGKRPLKDFEDPRLKGE 632
Query: 301 INRADFESILKIAVLCVAKSSKGRPTID 328
+ DF+SIL++AVLC AKS+KGRP+ID
Sbjct: 633 VVTEDFQSILQVAVLCAAKSNKGRPSID 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504137|ref|XP_003520855.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1290), Expect = e-139, Method: Compositional matrix adjust.
Identities = 236/345 (68%), Positives = 291/345 (84%), Gaps = 13/345 (3%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDE 60
++V + ++L+++++K ++K K++ + KEI WSGLY F K E
Sbjct: 123 LSVPVVILAILLVVIMVKRLSKKKLRRQAN-----------LKEI--AAWSGLYWFCKRE 169
Query: 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP 120
IENA+N ++ LGRGSAG VY+G+LPSGQ+VAIKH+ KSN ++SF+REVEGLSR+RHP
Sbjct: 170 IENAMNYGGEKICLGRGSAGQVYRGILPSGQLVAIKHLTKSNTSESFTREVEGLSRLRHP 229
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
NLVCLFGCC+EG E+YLVYEFCA GNLAQHLLR+DS LTWE RV+ILRDC+ AL+YLHH+
Sbjct: 230 NLVCLFGCCIEGDERYLVYEFCANGNLAQHLLRRDSHLTWETRVRILRDCSYALKYLHHH 289
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+GC+VHRDIKLTNILL EK + KLSDFGLAK++G++ESKVFTDVRGTIGYMDPEYM+NA
Sbjct: 290 IEGCVVHRDIKLTNILLNEKYQAKLSDFGLAKVMGIKESKVFTDVRGTIGYMDPEYMSNA 349
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
KLTCASD+YSFGIVALQ+LSGQKVIELD DARDQLTRKARDVSMGKRP+ DFEDPRLNG
Sbjct: 350 KLTCASDVYSFGIVALQILSGQKVIELDLDARDQLTRKARDVSMGKRPLSDFEDPRLNGK 409
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345
+++ DFE+IL+IAVLCVAKSSKGRPTI++V+EE+DK ++T M
Sbjct: 410 VDKTDFEAILQIAVLCVAKSSKGRPTIELVFEELDKVCRDTETRM 454
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145944|ref|XP_002325821.1| predicted protein [Populus trichocarpa] gi|222862696|gb|EEF00203.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1287), Expect = e-139, Method: Compositional matrix adjust.
Identities = 238/285 (83%), Positives = 260/285 (91%), Gaps = 1/285 (0%)
Query: 60 EIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH 119
EIENAIN+ R+ LGRGSAG VYKGVLPSGQ VAIKHI+KSN+ DSF REVEGLSRVRH
Sbjct: 1 EIENAINHSKVRKSLGRGSAGEVYKGVLPSGQAVAIKHIHKSNSCDSFQREVEGLSRVRH 60
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
PNLVCLFGCC+EG ++YLVYE+CAAGNL+QHLL KD+VLTWERRVKILRDCAL LRYLHH
Sbjct: 61 PNLVCLFGCCIEGDDRYLVYEYCAAGNLSQHLLSKDTVLTWERRVKILRDCALGLRYLHH 120
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+IDGCIVHRDIKLTNILLTE LEPKLSDFGLAKMLGMEESKVFTDVRGT+GYMDPEYM+N
Sbjct: 121 FIDGCIVHRDIKLTNILLTENLEPKLSDFGLAKMLGMEESKVFTDVRGTMGYMDPEYMSN 180
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299
AKLTCASDIYSFGIV LQLLSGQKVIELD D+RDQLTRK + GKRP+ DFEDPRLNG
Sbjct: 181 AKLTCASDIYSFGIVTLQLLSGQKVIELDLDSRDQLTRKVSFFA-GKRPLTDFEDPRLNG 239
Query: 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344
+N DFE+IL+IAVLCVAKSSKGRPTID V+EEI+KAWKNT+ E
Sbjct: 240 KVNSVDFEAILQIAVLCVAKSSKGRPTIDDVFEEIEKAWKNTLAE 284
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571206|ref|XP_003553770.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1272), Expect = e-137, Method: Compositional matrix adjust.
Identities = 236/345 (68%), Positives = 288/345 (83%), Gaps = 13/345 (3%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDE 60
++V + ++L+++++K ++K K + + KEI + WSGLY F K E
Sbjct: 215 LSVPVVILAILLVVIMVKCLSKKKFRRQAN-----------LKEIVA--WSGLYWFCKRE 261
Query: 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP 120
IENA+N ++ LGRGS G VY+GVLPSGQ+VAIKH+ KSN ++SF+REVEGLSR+RHP
Sbjct: 262 IENAMNYGGEKICLGRGSTGQVYRGVLPSGQLVAIKHLTKSNTSESFTREVEGLSRLRHP 321
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
NLVCLFG C+EG E+YLVYEFCA GNLAQHLLR+DS LTWE RV+ILRDC+ AL+YLHH+
Sbjct: 322 NLVCLFGSCIEGDERYLVYEFCANGNLAQHLLRRDSHLTWETRVRILRDCSYALKYLHHH 381
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+GC+VHRDIKLTNILL EK + KLSDFGLAK++G+ ESKVFTDVRGTIGYMDPEYM+NA
Sbjct: 382 IEGCVVHRDIKLTNILLNEKYQAKLSDFGLAKVMGITESKVFTDVRGTIGYMDPEYMSNA 441
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
KLTCASD+YSFGIVALQ+LSGQKVIELD DARDQLTRKARDVSMGKRP+ DFEDPRLNG
Sbjct: 442 KLTCASDVYSFGIVALQILSGQKVIELDLDARDQLTRKARDVSMGKRPLSDFEDPRLNGK 501
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345
+++ADFE+IL+IAVLCVAKSSKGRPTI++V+EE+DK +T M
Sbjct: 502 VDKADFEAILQIAVLCVAKSSKGRPTIELVFEELDKVCGDTETRM 546
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512439|ref|XP_003626508.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355501523|gb|AES82726.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-134, Method: Compositional matrix adjust.
Identities = 229/312 (73%), Positives = 273/312 (87%), Gaps = 3/312 (0%)
Query: 32 CMPKRKSPKPTKEIYS-TTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSG 90
C+ K+K K ++ TWSGLY F+K EIENA+N + ++ LGRGSAG V++GVLPSG
Sbjct: 209 CVSKKKPVKKHVQLKQIATWSGLYWFTKTEIENAMNFENEKINLGRGSAGEVFRGVLPSG 268
Query: 91 QVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148
QVVAIKH+ KSN ++DSF+RE+ GLSR+RHPNLVCLFGCC+E GE+YLVYEFCA GNLA
Sbjct: 269 QVVAIKHLTKSNTSSSDSFTRELAGLSRLRHPNLVCLFGCCMEDGERYLVYEFCANGNLA 328
Query: 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208
QHLLR+DS LTWE RVKILR+C+ AL+YLHH+I+GC+VHRDIKLTNILLTEK E KLSDF
Sbjct: 329 QHLLRRDSHLTWEARVKILRECSFALKYLHHHIEGCVVHRDIKLTNILLTEKYEAKLSDF 388
Query: 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELD 268
GL++M+GMEESKVFTDVRGTIGYMDPEYM+NAKLTCASD+YSFGIVALQ+LSGQKVIELD
Sbjct: 389 GLSRMMGMEESKVFTDVRGTIGYMDPEYMSNAKLTCASDVYSFGIVALQILSGQKVIELD 448
Query: 269 FDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328
DARDQLTRKARDVSMGKRP+ DF D RL G +++ DF SIL+IAVLCVAKSS GRP I+
Sbjct: 449 LDARDQLTRKARDVSMGKRPLSDFVDSRLKGQVDKEDFGSILQIAVLCVAKSSTGRPPIE 508
Query: 329 VVYEEIDKAWKN 340
VV++E+DK +++
Sbjct: 509 VVFDELDKVYRD 520
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62701712|gb|AAX92785.1| hypothetical protein LOC_Os11g26140 [Oryza sativa Japonica Group] gi|62734060|gb|AAX96169.1| Protein kinase domain, putative [Oryza sativa Japonica Group] gi|77550532|gb|ABA93329.1| Protein kinase domain containing protein [Oryza sativa Japonica Group] gi|125547151|gb|EAY92973.1| hypothetical protein OsI_14768 [Oryza sativa Indica Group] gi|125589328|gb|EAZ29678.1| hypothetical protein OsJ_13739 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1155), Expect = e-124, Method: Compositional matrix adjust.
Identities = 228/343 (66%), Positives = 269/343 (78%), Gaps = 3/343 (0%)
Query: 1 MAVLIATFVMM--LILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSK 58
AV+I VM+ LI+ L+++++K + + K E+ + WSGLY+FSK
Sbjct: 39 FAVVIVFTVMLIALIIALMRYMSKKSKADETIDSTRSSQDNKVHGEVINR-WSGLYKFSK 97
Query: 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR 118
EIE AIN + LG GSAG VY+GVLPSGQ+VAIKHI+KS + SF REVEGLS+VR
Sbjct: 98 GEIEKAINYANSKICLGSGSAGQVYQGVLPSGQLVAIKHIHKSAMSGSFMREVEGLSKVR 157
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
HPNLVCLFG C +GG+QYLVYE+CA GNLAQ+LLR DSVL+W RVKILRDCA LR+LH
Sbjct: 158 HPNLVCLFGYCDDGGDQYLVYEYCANGNLAQNLLRSDSVLSWPARVKILRDCASVLRFLH 217
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ DGCIVHRDIKLTNILLTE +EPKLSDFGLAKML MEE+KVFTDVRGTIGYMDPEY+T
Sbjct: 218 THPDGCIVHRDIKLTNILLTESMEPKLSDFGLAKMLQMEETKVFTDVRGTIGYMDPEYIT 277
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
++KLTCASDIYSFG+VALQLLSG+KVIELD ARD LT+KARDV GK+P+ +F DPR+
Sbjct: 278 HSKLTCASDIYSFGVVALQLLSGRKVIELDTVARDSLTKKARDVVSGKKPLDEFIDPRVR 337
Query: 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341
+N DF ILKIAVLCVA SS GRPTI V+EE+DKA NT
Sbjct: 338 DEVNIEDFVLILKIAVLCVAHSSVGRPTIKDVFEEMDKALTNT 380
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242067181|ref|XP_002448867.1| hypothetical protein SORBIDRAFT_05g000590 [Sorghum bicolor] gi|241934710|gb|EES07855.1| hypothetical protein SORBIDRAFT_05g000590 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 212/298 (71%), Positives = 249/298 (83%)
Query: 47 STTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS 106
S+ WSGLY+F+K+EIE AIN R +LG GSAG VY+GVLPSGQ+VAIKHI+K+ + S
Sbjct: 110 SSKWSGLYKFTKEEIERAINYASSRIYLGSGSAGQVYQGVLPSGQLVAIKHIHKTAMSGS 169
Query: 107 FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI 166
F REVE LS+VRHPNLVCLFG C E G+QYLVYE+CA GNLAQ+LLR DS L WE RVKI
Sbjct: 170 FMREVEQLSKVRHPNLVCLFGYCDEEGDQYLVYEYCANGNLAQNLLRSDSALPWETRVKI 229
Query: 167 LRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
LRDCA LR+LH + DGCIVHRDIKLTNILLTE PKL+DFGLAKML MEE+KVFTDVR
Sbjct: 230 LRDCASVLRFLHTHPDGCIVHRDIKLTNILLTEDKVPKLADFGLAKMLEMEETKVFTDVR 289
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286
GTIGYMDPEY+T++KLTCASDIYSFG+VALQLLSG+KVIELD ARD LT+KA+DV GK
Sbjct: 290 GTIGYMDPEYITHSKLTCASDIYSFGVVALQLLSGRKVIELDIVARDSLTKKAKDVVSGK 349
Query: 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344
+P+++F DPR+ ++ DF ILKIAVLCVA SS GRPTI V+EE+DKA +NT ++
Sbjct: 350 KPLEEFIDPRVRDDVVIEDFVLILKIAVLCVASSSVGRPTIKDVFEEMDKALRNTTIK 407
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.945 | 0.494 | 0.372 | 3.2e-49 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.959 | 0.352 | 0.375 | 1.5e-48 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.870 | 0.611 | 0.374 | 2.9e-48 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.962 | 0.450 | 0.344 | 2.6e-46 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.945 | 0.367 | 0.356 | 2.8e-46 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.953 | 0.347 | 0.359 | 4.6e-46 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.936 | 0.503 | 0.332 | 4.8e-46 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.801 | 0.386 | 0.378 | 7.2e-46 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.927 | 0.365 | 0.382 | 1.2e-45 | |
| TAIR|locus:2017527 | 693 | AT1G51830 [Arabidopsis thalian | 0.945 | 0.473 | 0.355 | 1.7e-45 |
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 3.2e-49, P = 3.2e-49
Identities = 130/349 (37%), Positives = 193/349 (55%)
Query: 1 MAVLIATFVMMLIL-VLIKHVAKSKIQGKNKGCMPKRKSP--KPTKEIYSTTWSGLYRFS 57
+AV + VM+++L VLI+ + K+ C R SP +P I+ G +FS
Sbjct: 258 IAVTVFALVMVVVLIVLIQRKKRELDDSKSIACNLTRTSPSPRPRSMIHEGNSFGFRKFS 317
Query: 58 KDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEGLS 115
EI A D++ +GRG G VYK +G V A+K + KS+ D F RE+E L+
Sbjct: 318 YKEIRKA-TEDFNA-VIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREIELLA 375
Query: 116 RVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALAL 174
R+ H +LV L G C + E++LVYE+ G+L HL + S L+WE R+KI D A AL
Sbjct: 376 RLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDVANAL 435
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF----TDVRGTIG 230
YLH Y D + HRDIK +NILL E KL+DFGLA + S F TD+RGT G
Sbjct: 436 EYLHFYCDPPLCHRDIKSSNILLDEHFVAKLADFGLAHA-SRDGSICFEPVNTDIRGTPG 494
Query: 231 YMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290
Y+DPEY+ +LT SD+YS+G+V L++++G++ ++ + R+ L ++ + + +
Sbjct: 495 YVDPEYVVTHELTEKSDVYSYGVVLLEIITGKRAVD---EGRN-LVELSQPLLVSESRRI 550
Query: 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVV----YEEID 335
D DPR+ I+ E+++ + C K RP+I V YE D
Sbjct: 551 DLVDPRIKDCIDGEQLETVVAVVRWCTEKEGVARPSIKQVLRLLYESCD 599
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 1.5e-48, P = 1.5e-48
Identities = 129/344 (37%), Positives = 187/344 (54%)
Query: 1 MAVLIATFVMMLILVLIKHVA---KSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFS 57
+ V++ V++L+L L A K + Q P K E+ + G F+
Sbjct: 564 IGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFT 623
Query: 58 KDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFS--REVEGLS 115
+E+ NN D +G G G VYKG LP+GQV+AIK + + +F E+E LS
Sbjct: 624 FEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLS 683
Query: 116 RVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCALAL 174
RV H N+V L G C + EQ LVYE+ G+L L K+ V L W RR+KI L
Sbjct: 684 RVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGL 743
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG-MEESKVFTDVRGTIGYMD 233
YLH D I+HRD+K NILL E L K++DFGL+K++G E++ V T V+GT+GY+D
Sbjct: 744 AYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQVKGTMGYLD 803
Query: 234 PEY-MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
PEY MTN +LT SD+Y FG+V L+LL+G+ I+ ++ +K D S +++
Sbjct: 804 PEYYMTN-QLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKM-DKSRNLYDLQEL 861
Query: 293 EDPRLNGNI-NRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
D + N N FE + +A+ CV RPT+ V +E++
Sbjct: 862 LDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELE 905
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 2.9e-48, Sum P(2) = 2.9e-48
Identities = 116/310 (37%), Positives = 169/310 (54%)
Query: 27 GKNKGCMPKRKSPKP-TKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKG 85
G+ G P SP EI W + F+ ++E A N LG G G+VY+G
Sbjct: 143 GRQYGGGPVTASPLVGLPEISHLGWG--HWFTLRDLELATNRFAPVNVLGEGGYGVVYRG 200
Query: 86 VLPSGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143
L +G VA+K + + F EVE + VRH NLV L G C+EG + LVYE+
Sbjct: 201 KLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 260
Query: 144 AGNLAQHL---LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK 200
+GNL Q L +R+ LTWE R+KI+ A AL YLH I+ +VHRDIK +NIL+ ++
Sbjct: 261 SGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDE 320
Query: 201 LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
KLSDFGLAK+L ES + T V GT GY+ PEY L SDIYSFG++ L+ ++
Sbjct: 321 FNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAIT 380
Query: 261 GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKS 320
G+ ++ A + + + +G R ++ DPRL +++ + L +++ CV
Sbjct: 381 GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPE 440
Query: 321 SKGRPTIDVV 330
++ RP + V
Sbjct: 441 AEKRPRMSQV 450
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 2.6e-46, P = 2.6e-46
Identities = 118/343 (34%), Positives = 182/343 (53%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGK-NKGCMPKRKSPKPTKEIYSTTWSGL-YR-FS 57
+ ++I V++L + I+H K + K + + + + S + ++ F+
Sbjct: 345 LVIIIGVLVLLLAAICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFT 404
Query: 58 KDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIK--HIYKSNNTDSFSREVEGLS 115
++ ++ A N + R LG+G G VYKG+LP +VAIK + S D F EV LS
Sbjct: 405 EEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLS 464
Query: 116 RVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK--DSVLTWERRVKILRDCALA 173
++ H N+V + GCC+E LVYEF G L HL DS LTWE R++I + A
Sbjct: 465 QINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGT 524
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YLH I+HRDIK NILL E L K++DFG +K++ M++ ++ T V+GT+GY+D
Sbjct: 525 LAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLD 584
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF-DARDQLTRKARDVSMGKRPIKDF 292
PEY T L SD+YSFG+V ++LLSGQK + + A L + R +
Sbjct: 585 PEYYTTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEII 644
Query: 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
+D LN + N + + +IA C + RP + V +++
Sbjct: 645 DDQVLNED-NLKEIQEAARIAAECTRLMGEERPRMKEVAAKLE 686
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 2.8e-46, P = 2.8e-46
Identities = 121/339 (35%), Positives = 188/339 (55%)
Query: 3 VLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIE 62
V++ + L++VL +A + K K P+ + + ++ + T + RF+ E+
Sbjct: 521 VVLVVVSIALVVVLGSALALFLVFRKRK--TPRNEVSRTSRSLDPTITTKNRRFTYSEVV 578
Query: 63 NAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHP 120
NN + LG+G G+VY G + + VA+K + S++ F EVE L RV H
Sbjct: 579 KMTNNF--EKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHK 636
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLH 178
NLV L G C EG L+YE+ A G+L +H+L S+L W+ R+KI+ + A L YLH
Sbjct: 637 NLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLH 696
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ESKVFTDVRGTIGYMDPEYM 237
+ +VHRD+K TNILL E + KL+DFGL++ +E E++V T V GT GY+DPEY
Sbjct: 697 NGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYY 756
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297
L SD+YSFGIV L++++ Q VI + + + V + K IK DP+
Sbjct: 757 RTNWLNEKSDVYSFGIVLLEIITNQHVINQSRE-KPHIAEWV-GVMLTKGDIKSIIDPKF 814
Query: 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+G+ + +++A+ CV SS GRPT+ V E+++
Sbjct: 815 SGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVIELNE 853
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 4.6e-46, P = 4.6e-46
Identities = 125/348 (35%), Positives = 192/348 (55%)
Query: 2 AVLIATFVMMLILVLIKHVA-------KSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLY 54
++LI V +++L+L+ +A K + + P K I + G
Sbjct: 558 SILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAK 617
Query: 55 RFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS--FSREVE 112
F+ +E++ +N + +G G G VY+G+LP+GQ++AIK + + F E+E
Sbjct: 618 AFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIE 677
Query: 113 GLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCA 171
LSRV H N+V L G C + EQ LVYE+ + G+L L K + L W RR+KI
Sbjct: 678 LLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGSG 737
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG-MEESKVFTDVRGTIG 230
L YLH D I+HRDIK NILL E L K++DFGL+K++G E++ V T V+GT+G
Sbjct: 738 KGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQVKGTMG 797
Query: 231 YMDPEY-MTNAKLTCASDIYSFGIVALQLLSGQKVIELD-FDARDQLTRKARDVSM-GKR 287
Y+DPEY MTN +LT SD+Y FG+V L+LL+G+ IE + R+ T+ + S+ +
Sbjct: 798 YLDPEYYMTN-QLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSRSLYDLQ 856
Query: 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
+ D +GN+ FE + +A+ CV + RP++ V +EI+
Sbjct: 857 ELLDTTIIASSGNLK--GFEKYVDLALRCVEEEGVNRPSMGEVVKEIE 902
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 4.8e-46, P = 4.8e-46
Identities = 111/334 (33%), Positives = 187/334 (55%)
Query: 1 MAVLIATFVMMLILVLIKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDE 60
+ V++A ++ VL+ A ++ ++ K++ K ++ FS +
Sbjct: 259 LGVILAVTSSVVAFVLLVSAAGFLLKKRHA---KKQREKKQLGSLFMLANKSNLCFSYEN 315
Query: 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVR 118
+E A + D+ LG+G +G VYKGVL +G+ VA+K ++ + D F EV +S+V
Sbjct: 316 LERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVD 375
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL-LRKD-SVLTWERRVKILRDCALALRY 176
H NLV L GC + G E LVYE+ A +L +L +RKD L W +R KI+ A + Y
Sbjct: 376 HKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAY 435
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY 236
LH + I+HRDIKL+NILL + P+++DFGLA++ +++ + T + GT+GYM PEY
Sbjct: 436 LHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGYMAPEY 495
Query: 237 MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296
+ KLT +D+YSFG++ +++++G++ DA + + + +++ DP
Sbjct: 496 VVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDA-GSILQSVWSLYRTSN-VEEAVDPI 553
Query: 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330
L N N+ + +L+I +LCV + RP + VV
Sbjct: 554 LGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVV 587
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 7.2e-46, P = 7.2e-46
Identities = 109/288 (37%), Positives = 170/288 (59%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKH--IYKSNNTDSFSREVEG 113
FS +++ENA + R LG+G G VYKG+L G +VA+K K N + F E+
Sbjct: 378 FSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIIL 437
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCA 171
LS++ H N+V + GCC+E LVYEF NL HL +D ++WE R+ I + A
Sbjct: 438 LSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVA 497
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
AL YLH + I HRD+K TNILL EK K+SDFG+++ + ++++ + T V+GTIGY
Sbjct: 498 DALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGY 557
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV---SMGKRP 288
+DPEY+ + T SD+YSFG++ ++LL+G+K + L R Q R +M
Sbjct: 558 VDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSL---LRRQEVRMLGAYFLEAMRNDR 614
Query: 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+ + D R+ +R + ++ K+A C++ +S+ RPT+ V+ E+D+
Sbjct: 615 LHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDR 662
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.2e-45, P = 1.2e-45
Identities = 130/340 (38%), Positives = 184/340 (54%)
Query: 4 LIATFVMMLILVL-IKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIE 62
L+A+ V +L LVL I K + + G R P T + Y Y++S E+
Sbjct: 522 LVASVVGVLGLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRY-------YKYS--EVV 572
Query: 63 NAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHP 120
NN R LG+G G VY GVL QV A+K + +S+ F EVE L RV H
Sbjct: 573 KVTNNF--ERVLGQGGFGKVYHGVLNDDQV-AVKILSESSAQGYKEFRAEVELLLRVHHK 629
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHH 179
NL L G C EG + L+YEF A G L +L K VL+WE R++I D A L YLH+
Sbjct: 630 NLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHN 689
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ESKVFTDVRGTIGYMDPEYMT 238
IV RD+K NIL+ EKL+ K++DFGL++ + ++ ++ T V GTIGY+DPEY
Sbjct: 690 GCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHL 749
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR-DVSMGKRPIKDFEDPRL 297
KL+ SDIYSFG+V L+++SGQ VI + + R D+ + I+ DP+L
Sbjct: 750 TQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKL 809
Query: 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
+ I ++A+ C + SSK RPT+ V E+ ++
Sbjct: 810 GERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKES 849
|
|
| TAIR|locus:2017527 AT1G51830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.7e-45, P = 1.7e-45
Identities = 120/338 (35%), Positives = 186/338 (55%)
Query: 5 IATFVMMLILVLIKHVAKSKIQGKNK-GCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIEN 63
IA+ +++ +++ V K K Q K + + + + + RF+ E+
Sbjct: 324 IASIAILIGALVLFFVLKKKTQSKGPPAAYVQASNGRSRRSAEPAIVTKNKRFTYSEVMQ 383
Query: 64 AINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPN 121
NN +R LG+G G+VY G++ + VAIK + S++ F EVE L RV H N
Sbjct: 384 MTNNF--QRVLGKGGFGIVYHGLVNGTEQVAIKILSHSSSQGYKQFKAEVELLLRVHHKN 441
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCALALRYLHH 179
LV L G C EG L+YE+ A G+L +H+ R +L W R+KI+ + A L YLH+
Sbjct: 442 LVGLVGYCDEGENLALIYEYMANGDLKEHMSGTRNHFILNWGTRLKIVVESAQGLEYLHN 501
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ESKVFTDVRGTIGYMDPEYMT 238
+VHRDIK TNILL E+ + KL+DFGL++ +E E+ V T V GT GY+DPEY
Sbjct: 502 GCKPLMVHRDIKTTNILLNEQFDAKLADFGLSRSFPIEGETHVSTAVAGTPGYLDPEYYR 561
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
LT SD+YSFG+V L++++ Q VI+ + + + +V + K IK+ DP LN
Sbjct: 562 TNWLTEKSDVYSFGVVLLEIITNQPVIDPRRE-KPHIAEWVGEV-LTKGDIKNIMDPSLN 619
Query: 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
G+ + +++A+ C+ SS RP + V E+++
Sbjct: 620 GDYDSTSVWKAVELAMCCLNPSSARRPNMSQVVIELNE 657
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 347 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 68/199 (34%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCC 129
LG G G VY +G+ VAIK I K +++ + RE+E L ++ HPN+V L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ YLV E+C G+L L + L+ + ++IL L YLH I+HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 190 IKLTNILLTEK-LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASD 247
+K NILL + KL+DFGL+K+L + + + GT YM PE + + SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 248 IYSFGIVALQLLSGQKVIE 266
I+S G++ +L + +I
Sbjct: 177 IWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 79/228 (34%), Positives = 111/228 (48%), Gaps = 14/228 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFG 127
LG GS G VY +G++VAIK I K RE++ L +++HPN+V L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ + YLV E+C G+L L ++ L+ + LR AL YLH IVH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHSK---GIVH 120
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD+K NILL E KL+DFGLA+ L + + T GT YM PE + A D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295
I+S G++ +LL+G + F DQL + + K P E
Sbjct: 179 IWSLGVILYELLTG----KPPFPGDDQLLELFKKIGKPKPPFPPPEWD 222
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 84/267 (31%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
R LG GS G VYK G++VA+K + K + RE+ L R+ HPN+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
+ YLV E+C G+L +L R L+ + KI L YLH G I+
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSN--G-II 120
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE-YMTNAKLTCA 245
HRD+K NILL E K++DFGLAK L + S T GT YM PE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305
D++S G++ +LL+G + F + L + + P++ E +G+ D
Sbjct: 180 VDVWSLGVILYELLTG----KPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 306 FESILKIAVLCVAKSSKGRPTIDVVYE 332
I K +K RPT + + +
Sbjct: 236 L--IKKCLNKDPSK----RPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 71/207 (34%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 68 DWDR-RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPN 121
+W R LGRGS G VY + +G+++A+K + S ++ ++ RE+ LS ++HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 122 LVCLFGCCV-EGGEQYLVY-EFCAAGNLAQHLLRKDSVLTWERRVKIL-RDCALALRYLH 178
+V +G E ++ E+ + G+L+ LL+K L E ++ R L YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLS-SLLKKFGKLP-EPVIRKYTRQILEGLAYLH 118
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYM 237
IVHRDIK NIL+ KL+DFG AK LG E+ T VRGT +M PE +
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKV 264
+ A+DI+S G +++ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 7e-40
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 11/189 (5%)
Query: 74 LGRGSAGLVYKGVL-----PSGQVVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G VYKG L VA+K + F RE + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
G C E Y+V E+ G+L +L + L+ + A + YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+ N L+ E L K+SDFGL++ L ++ + I +M PE + K T
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 246 SDIYSFGIV 254
SD++SFG++
Sbjct: 184 SDVWSFGVL 192
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 74 LGRGSAGLVYKGVL-----PSGQVVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G VYKG L + VA+K + F E + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
G C +G Y+V E+ G+L L + LT + +++ A + YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
VHRD+ N L+TE L K+SDFGL++ + + + + I +M PE + + K T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 245 ASDIYSFGIV 254
SD++SFG++
Sbjct: 184 KSDVWSFGVL 193
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-38
Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 12/190 (6%)
Query: 74 LGRGSAGLVYKGVL-----PSGQVVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G VYKG L VA+K + F RE + ++ HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
G C E +V E+ G+L +L + L+ + A + YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
+HRD+ N L+ E L K+SDFGL++ L ++ + I +M PE + K T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 245 ASDIYSFGIV 254
SD++SFG++
Sbjct: 184 KSDVWSFGVL 193
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 70 DRRFLGRGSAGLVYKG-VLPSGQVVAIKHIY--KSNNTDSFSREVEGLSRVRHPNLVCLF 126
+G+G G VYK +G+ VAIK I + E++ L + +HPN+V +
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G ++ E ++V EFC+ G+L L + LT + + ++ L YLH I+
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMTNAKLTCA 245
HRDIK NILLT E KL DFGL+ L + GT +M PE +
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 246 SDIYSFGIVALQLLSGQ 262
+DI+S GI A++L G+
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 74 LGRGSAGLVYKGVL----PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCL 125
LG G+ G VYKG L VA+K + K + ++ F +E + ++ HPN+V L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCALALRY 176
G C E YLV E+ G+L LRK S L+ + + A + Y
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDL-LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRGTIGYMDPE 235
L VHRD+ N L+ E L K+SDFGL++ + + + T + I +M PE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 236 YMTNAKLTCASDIYSFGIV 254
+ + T SD++SFG++
Sbjct: 178 SLKDGIFTSKSDVWSFGVL 196
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 24/260 (9%)
Query: 73 FLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFGC 128
LG+GS+G+VYK P+G++ A+K I+ + + RE++ L P +V +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCALALRYLHHYIDGCIV 186
+ GE +V E+ G+LA LL+K V V I R L YLH I+
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD-LLKK--VGKIPEPVLAYIARQILKGLDYLHT--KRHII 122
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRDIK +N+L+ K E K++DFG++K+L + T V GT+ YM PE + + A+
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADF 306
DI+S G+ L+ G + F Q + + + I D P L +F
Sbjct: 182 DIWSLGLTLLECALG----KFPFLPPGQPSF----FEL-MQAICDGPPPSLPAEEFSPEF 232
Query: 307 ESILKIAVLCVAKSSKGRPT 326
+ C+ K K RP+
Sbjct: 233 RDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 1e-31
Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 25/284 (8%)
Query: 72 RFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFG 127
R LG GS G VY + +V+A K KS + F RE++ L+ + HP + L+
Sbjct: 6 RKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ G YLV E+ G+L L + + L+ + IL AL YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 186 VHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESKV-----FTDVRGTIGYMDPEYMT- 238
+HRDIK NILL KL DFGLAK+L S + GT GYM PE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 239 --NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296
A + +SDI+S GI +LL+G F+ + ++ + +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTG----LPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
L+ + ++ + +AK K R + ++
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSS---SDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 65/189 (34%), Positives = 98/189 (51%), Gaps = 5/189 (2%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG GS G VYK + +GQVVAIK + + +E+ L + P +V +G +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN 70
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
+ ++V E+C AG+++ + + LT E IL L YLH +HRDIK
Sbjct: 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKA 127
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
NILL E+ + KL+DFG++ L +K T V GT +M PE + +DI+S G
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 253 IVALQLLSG 261
I A+++ G
Sbjct: 187 ITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 68/195 (34%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
+GRG+ G+VYKG+ L +G VAIK I S +E++ L ++HPN+V G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYIDGCIVH 187
Y++ E+ G+L Q +++K E V + + L YLH + ++H
Sbjct: 68 IETSDSLYIILEYAENGSLRQ-IIKKFGPFP-ESLVAVYVYQVLQGLAYLH---EQGVIH 122
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RDIK NIL T+ KL+DFG+A L + SK V GT +M PE + + + ASD
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGASTASD 181
Query: 248 IYSFGIVALQLLSGQ 262
I+S G ++LL+G
Sbjct: 182 IWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSR----EVEGLSRVRHPNLVCLF 126
+ +G+GS G VY G++ +K I SN ++ EV+ L ++ HPN++ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLL--RKDSVLTWERRV-KILRDCALALRYLHHYIDG 183
E G+ +V E+ G+L+Q + +K+ E ++ LAL+YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
I+HRDIK NI LT KL DFG++K+L + V GT Y+ PE N
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARDQL 275
SDI+S G V +L + + F+ + L
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP----FEGENLL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 63/189 (33%), Positives = 100/189 (52%), Gaps = 10/189 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
+G+G G V G GQ VA+K + S +F E ++ +RHPNLV L G ++G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 133 GEQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191
Y+V E+ A G+L +L R +V+T +++ D + YL + VHRD+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLA 129
Query: 192 LTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
N+L++E L K+SDFGLAK E S+ + + + PE + K + SD++SF
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 252 GIVALQLLS 260
GI+ ++ S
Sbjct: 186 GILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 74/231 (32%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
LG+GS G V K +G++ A+K I K + E LSR+ HP +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDG 183
L + YLV E+ G L HL K+ + E R + + LAL YLH G
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFS-EERARFYAAEIVLALEYLHSL--G 113
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
I++RD+K NILL KL+DFGLAK L E S+ T GT Y+ PE +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 244 CASDIYSFGIVALQLLSG-------------QKVIELDFDARDQLTRKARD 281
A D +S G++ ++L+G +K+++ + L+ +ARD
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARD 222
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 69/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G+GS G VYK + + QVVAIK I + + +E++ LS+ R P + +G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
++G + +++ E+C G+ LL K L ILR+ L L YLH + +HRD
Sbjct: 69 LKGSKLWIIMEYCGGGSCL-DLL-KPGKLDETYIAFILREVLLGLEYLH---EEGKIHRD 123
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
IK NILL+E+ + KL+DFG++ L SK T V GT +M PE + + +DI+
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIW 182
Query: 250 SFGIVALQLLSG 261
S GI A++L G
Sbjct: 183 SLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI--YKSN-NTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G G+ +VY + LP+ + VAIK I K + D +EV+ +S+ HPN+V +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
V G E +LV + + G+L +++ L +L++ L YLH G I
Sbjct: 69 VVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--GQI- 124
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKML---GMEESKVFTDVRGTIGYMDPEYMT----- 238
HRDIK NILL E K++DFG++ L G KV GT +M PE M
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 239 NAKLTCASDIYSFGIVALQLLSG 261
+ K +DI+SFGI A++L +G
Sbjct: 185 DFK----ADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 76/300 (25%), Positives = 140/300 (46%), Gaps = 20/300 (6%)
Query: 49 TWSGLY---RFSKD-EIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT 104
TW + + SK I + +++ + + RG G YKG + + + + N+
Sbjct: 669 TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV--VKEINDV 726
Query: 105 DSF-SREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR 163
+S S E+ + +++HPN+V L G C YL++E+ NL++ L L+WERR
Sbjct: 727 NSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERR 782
Query: 164 VKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223
KI A ALR+LH +V ++ I++ K EP L L +L + +
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283
Y+ PE +T SDIY FG++ ++LL+G+ + +F + AR
Sbjct: 842 S-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR-YC 895
Query: 284 MGKRPIKDFEDPRLNGN--INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341
+ + DP + G+ +N+ + ++ +A+ C A RP + V + ++ A +++
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 84/271 (30%), Positives = 120/271 (44%), Gaps = 37/271 (13%)
Query: 73 FLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFG 127
+G+GS G V K G+++ K I N T EV L ++HPN+V +
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 128 CCVEGGEQ--YLVYEFCAAGNLAQHLLRK----DSVLTWERRVKILRDCALALRYLHHYI 181
++ Q Y+V E+C G+LAQ L++K + E +IL LAL H+
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 182 DG--CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
D ++HRD+K NI L KL DFGLAK+LG + S T V GT YM PE + +
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDAR--DQLTRKARDVSMGK-RPIKDFEDPR 296
SDI+S G + +L + F AR QL K ++ GK R I
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS----PPFTARNQLQLASKIKE---GKFRRIPYRYSSE 237
Query: 297 LNGNINRADFESILKIAVLCVAKSSKGRPTI 327
LN ++K + RP+
Sbjct: 238 LN---------EVIK---SMLNVDPDKRPST 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 6/191 (3%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE 131
+G G++G VYK +G+ VAIK + + N + E+ + +HPN+V + +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191
G E ++V E+ G+L + + + + + R+ L YLH I HRDIK
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ--NVI-HRDIK 143
Query: 192 LTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
NILL++ KL+DFG A L E+SK + V GT +M PE + DI+S
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 252 GIVALQLLSGQ 262
GI+ +++ G+
Sbjct: 203 GIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 69 WDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIY----KSNNTDSFSREVEGLSRVRHPNL 122
W R +G G+ G VY V L +G+++A+K I + E++ L ++HPNL
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYL 177
V +G V + Y+ E+C+ G L + LL +L E ++ +L L YL
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILD-EHVIRVYTLQLLE----GLAYL 115
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG---YMDP 234
H + IVHRDIK NI L KL DFG A L + + +V+ G YM P
Sbjct: 116 HSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 235 EYMTNAKLTC---ASDIYSFGIVALQLLSGQK 263
E +T K A+DI+S G V L++ +G++
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 70/197 (35%), Positives = 112/197 (56%), Gaps = 16/197 (8%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRH---PNLVCLF 126
+GRG+ G VY+G +P+G+VVA+K I D S REV LS++R PN+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCI 185
G ++G +++ E+ G++ + L++ + E+ + I+R+ +AL+Y+H G +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIA--EKYISVIIREVLVALKYIHK--VG-V 122
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TC 244
+HRDIK NIL+T KL DFG+A +L SK T V GT +M PE +T K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDT 181
Query: 245 ASDIYSFGIVALQLLSG 261
+DI+S GI ++ +G
Sbjct: 182 KADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 33/265 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGCC 129
LG G++G+V K + P+G+++A+K I N RE++ L + P +V +G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
G+ + E+ G+L + L + KI L YLH I+HRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
+K +NIL+ + + KL DFG++ L S T V GT YM PE + + SDI+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 250 SFGIVALQLLSGQ-------KVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
S G+ ++L +G+ + F + L I + PRL
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIF---ELLQY-----------IVNEPPPRLPSGKF 229
Query: 303 RADFESILKIAVLCVAKSSKGRPTI 327
DF+ + LC+ K + RP+
Sbjct: 230 SPDFQDFVN---LCLIKDPRERPSY 251
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 61/245 (24%)
Query: 74 LGRGSAGLVYKGVL-PSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLVCLF 126
+G GS V + + AIK + K E E L+R+ HP ++ L+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKIL-RDCA--------LALRYL 177
+ Y V E+ G L Q++ R+ L C LAL YL
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYI----------RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR----------- 226
H I+HRD+K NILL + + K++DFG AK+L S
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 227 --------GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG-------------QKVI 265
GT Y+ PE + +SD+++ G + Q+L+G QK++
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 266 ELDFD 270
+L++
Sbjct: 236 KLEYS 240
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRV-RHPNLVCLFGC-- 128
+G G+ G VYK +GQ+VAIK + + + E L + HPN+ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 129 ----CVEGGEQYLVYEFCAAG---NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
+ +LV E C G +L + L +K L E ILR+ L YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--- 130
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY-MTNA 240
+ ++HRDIK NILLT+ E KL DFG++ L + T + GT +M PE +
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACDE 189
Query: 241 KLTCA----SDIYSFGIVALQLLSGQ 262
+ + SD++S GI A++L G+
Sbjct: 190 QPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-25
Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 32/272 (11%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCC 129
+G+G+ G VYKGVL VA+K +S F +E E L + HPN+V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
V+ Y+V E G+L L +K + LT ++ +++ D A + YL CI HRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES--KNCI-HRD 118
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPEYMTNAKLTCA 245
+ N L+ E K+SDFG+++ EE ++T G I + PE + + T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD-VSMGKRPIKDFEDPRLNGNINRA 304
SD++S+GI+ + S D ++ R+ + G R P+L
Sbjct: 176 SDVWSYGILLWETFSLG-----DTPYPGMSNQQTRERIESGYR----MPAPQLCP----- 221
Query: 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
E I ++ + C A + RP+ +Y E+
Sbjct: 222 --EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 74/235 (31%), Positives = 110/235 (46%), Gaps = 50/235 (21%)
Query: 74 LGRGSAGLVYKG--VLPSG----QVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVC 124
LG G+ G VYKG P+ VAIK + ++ F +E E +S ++HPN+VC
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRD 169
L G C + +++E+ A G+L + L+R S L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 170 CALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-----SKVF 222
A + YL HH+ VHRD+ N L+ E L K+SDFGL++ + + SK
Sbjct: 133 IAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS----------GQKVIEL 267
VR +M PE + K T SDI+SFG+V ++ S Q+VIE+
Sbjct: 188 LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 71 RRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVC 124
R +G+G+ G V + ++ A+K++ K + + E L + HP LV
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC-ALALRYLHHYIDG 183
L+ + YLV + G+L HL +K V E +VK LAL YLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SK 119
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
I+HRDIK NILL E+ ++DF +A + + T GT GYM PE + +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 244 CASDIYSFGIVALQLLSG 261
A D +S G+ A + L G
Sbjct: 178 VAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGCC 129
+G G+ G VYK + +G++VAIK I K D F +E+ L RHPN+V FG
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ + ++V E+C G+L L+ + + R+ L YLH +HRD
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRD 126
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL---TCAS 246
IK NILLTE + KL+DFG++ L +K + + GT +M PE +
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKC 185
Query: 247 DIYSFGIVALQLLSGQ 262
DI++ GI A++L Q
Sbjct: 186 DIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-24
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 74 LGRGSAGLVYKGVL--PSGQV--VAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCL 125
+G G G V +G L P + VAIK + K+ ++D F E + + HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
G + ++ E+ G+L + L D T + V +LR A ++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNY 127
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG---TIGYMDPEYMTNAKL 242
VHRD+ NIL+ L K+SDFGL++ L E+ +G I + PE + K
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--TTKGGKIPIRWTAPEAIAYRKF 185
Query: 243 TCASDIYSFGIVALQLLS-GQK 263
T ASD++SFGIV +++S G++
Sbjct: 186 TSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 72 RFLGRGSAG--LVYKGVLPSGQVVAIKHIYKSNNTDSFSR----EVEGLSRVRHPNLVCL 125
R LG+G+ G +Y+ VV K + + ++ R E+ LS ++HPN++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+ ++ + E+ G L ++R+ L E V L A+ Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
I+HRDIK NI LT+ KL DFG++K+LG E S T V GT YM PE K
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNF 180
Query: 245 ASDIYSFGIVALQLLSGQKVIELDFDARDQL 275
SDI++ G V +LL+ ++ FDA + L
Sbjct: 181 KSDIWALGCVLYELLTLKRT----FDATNPL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-------FSREVEGLSRVRHPNLV 123
LG GS G VY+G+ L G A+K + +++ + +E+ LS+++HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
G E Y+ E G+LA+ LL+K R L L YLH D
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DR 121
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY-MTNAKL 242
VHRDIK NIL+ KL+DFG+AK + E +G+ +M PE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 243 TCASDIYSFGIVALQLLSGQ 262
A+DI+S G L++ +G+
Sbjct: 180 GLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G V K L +G + A+K I N D RE+E + P +V +G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 130 VE--GGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCAL-ALRYLHHYIDGC 184
++ + E+C G+L ++K E+ + + + L L YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRK 125
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
I+HRDIK +NILLT K + KL DFG++ L + FT GT YM PE + +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPYSI 182
Query: 245 ASDIYSFGIVALQLLSG 261
SD++S G+ L++
Sbjct: 183 TSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 19/262 (7%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG G G+V+ G VAIK I + + + D F E + + ++ HPNLV L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
++V E+ A G L +L + L E + + D A+ YL +HRD+
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAA 128
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
N L+ E K+SDFGLA+ + ++ + + + PE ++ + SD++SFG
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188
Query: 253 IVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKI 312
++ ++ S K + ++ + VS G R P+L + I
Sbjct: 189 VLMWEVFSEGK---MPYERFSN-SEVVESVSAGYR----LYRPKLAP-------TEVYTI 233
Query: 313 AVLCVAKSSKGRPTIDVVYEEI 334
C + + RP + ++
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 4e-23
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
LG G+ G+VYK +G++VA+K I N + RE+ L ++HPN+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVH 187
+ YLV+E+C +L ++L ++ L+ +K I+ L Y H I+H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAYCH---SHRILH 121
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCAS 246
RD+K NIL+ KL+DFGLA+ G+ +T T+ Y PE + +K + A
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHYSTAV 180
Query: 247 DIYSFGIVALQLLSGQ 262
DI+S G + ++++G+
Sbjct: 181 DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 36/275 (13%)
Query: 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFG 127
R LG G G V++G+ + VAIK I KS++ F +EV+ L R+RH +L+ LF
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
C G Y++ E G+L LR + VL + + A + YL +
Sbjct: 70 VCSVGEPVYIITELMEKGSL-LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNS 125
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY--MDPEYMTNAKLT 243
+HRD+ NIL+ E L K++DFGLA+++ + V+ I Y PE ++ +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 244 CASDIYSFGIVALQLLS-GQKVIE--LDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
SD++SFGI+ ++ + GQ + + DQ+T R K P
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP------------ 230
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
+ I KI + C A + RP+ + EE+D
Sbjct: 231 ------QEIYKIMLECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 19/200 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGC 128
+G G+ G+VY+ SG++VA+K + N D S RE+ L +RHPN+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 129 CVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDG 183
V G+ +LV E+C +LA L + + E +VK ++ L+YLH
Sbjct: 75 VV--GKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-ESQVKCLMLQLLRGLQYLHEN--- 127
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL- 242
I+HRD+K++N+LLT+K K++DFGLA+ G+ +K T T+ Y PE +
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 243 TCASDIYSFGIVALQLLSGQ 262
T A D+++ G + +LL+ +
Sbjct: 187 TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G G+ G+VYK +G++VAIK I ++ RE++ L + HPN++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G+ YLV+EF +L + + + L L L + H + I+
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCA 245
HRD+K N+L+ + KL+DFGLA+ G + +T T Y PE + K +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
DI+S G + +LLS + + + DQL +
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEI-DQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLF 126
+G G+ G VYK + P+G++ A+K IY N+ D+ RE+E L V HPN+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--HYIDGC 184
GE ++ EF G+L + + L + R + YLH H
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRH----- 188
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT- 243
IVHRDIK +N+L+ K++DFG++++L + V GTI YM PE + N L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERI-NTDLNH 246
Query: 244 -----CASDIYSFGIVALQLLSGQ 262
A DI+S G+ L+ G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 69 WDR-RFLGRGSAGLVYKGVLPSGQVVAIKHI-YKSNNTDSFSR-------EVEGLSRVRH 119
W + LG+G+ G VY G+ GQ++A+K + ++N + + EV+ L ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
N+V G C++ + EF G+++ L R + K + + YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLH- 119
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM-----EESKVFTDVRGTIGYMDP 234
+ C+VHRDIK N++L KL DFG A+ L S + + GT +M P
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 235 EYMTNAKLTCASDIYSFGIVALQLLSGQ 262
E + + SDI+S G ++ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 6e-22
Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIKHIYKSNNTDSFSR-EVEGL----------SRVR 118
LGRG G V YK +G++ AIK + K D +R EVE L + R
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKG---DIIARDEVESLMCEKRIFETANSER 60
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCA-LALRYL 177
HP LV LF C V E+ A G+L H+ V + E R C L L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFS-EPRAVFYAACVVLGLQYL 117
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H + IV+RD+KL N+LL + K++DFGL K GM + GT ++ PE +
Sbjct: 118 H---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAPEVL 173
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQ 262
T T A D + G++ ++L G+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 12/225 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
+G G GLV+ G + VAIK I + + + + F E + + ++ HP LV L+G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
LV+EF G L+ +L + + E + + D + YL ++HRD+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAA 128
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
N L+ E K+SDFG+ + + ++ T + + + PE + +K + SD++SFG
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188
Query: 253 IVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297
++ ++ S K ++ R + ++ G R K PRL
Sbjct: 189 VLMWEVFSEGKT---PYENRSN-SEVVETINAGFRLYK----PRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 74 LGRGSAGLVYK-GVLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+V+K +G+ VA+K + RE++ L +HP +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVH 187
G LV E+ + L++ L ++ L E +VK +R + Y+H I+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLP-EAQVKSYMRMLLKGVAYMH---ANGIMH 122
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCAS 246
RD+K N+L++ K++DFGLA++ EE ++++ T Y PE + A K
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 247 DIYSFGIVALQLLSGQ 262
D+++ G + +LL+G
Sbjct: 183 DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 74 LGRGSAGLVYKGVLPS-GQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
+G+GS G+V+K V + +V A+K I S + E L+++ ++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
++ G+ +V E+ G+L + L +++ L ++ + L L +LH I+H
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILH 124
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RDIK N+ L K+ D G+AK+L + T V GT Y+ PE + SD
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSD 183
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQ--LTRK 278
+++ G+V + +G+ FDA +Q L K
Sbjct: 184 VWALGVVLYECCTGKH----PFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 44/215 (20%)
Query: 72 RFLGRGSAGLVYKGVLPSGQ------VVAIKHIYKSNNTDS---FSREVEGLSRVRHPNL 122
R LG G+ G V+ G + +VA+K + ++ + D+ F RE E L+ +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD-------------SVLTWERRVKILRD 169
V +G C EG +V+E+ G+L + L LT + ++I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 170 CALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD--- 224
A + YL H+ VHRD+ N L+ L K+ DFG+++ V+T
Sbjct: 131 IASGMVYLASQHF-----VHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYY 178
Query: 225 -VRGT----IGYMDPEYMTNAKLTCASDIYSFGIV 254
V G I +M PE + K T SD++SFG+V
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 74 LGRGSAGLVYK------GVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
LG G+ G VYK G+ + +++ I+ + F E++ LS +HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ +++ EFC G L +L + LT + + R AL +LH ++H
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM-----TNAKL 242
RD+K NILLT + KL+DFG++ K T + GT +M PE + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 243 TCASDIYSFGIVALQL 258
+DI+S GI ++L
Sbjct: 186 DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-21
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS-----REVEGLSRV-RHPNLVCLF 126
LG G+ G VY +G++VAIK + K S+ REV+ L ++ HPN+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH--YIDG 183
E E Y V+E+ GNL Q + + E ++ I+ L ++H +
Sbjct: 65 EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF-- 121
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE-YMTNAKL 242
HRD+K N+L++ K++DFGLA+ + +TD T Y PE + +
Sbjct: 122 ---HRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRSTSY 176
Query: 243 TCASDIYSFGIVALQLLSGQ 262
+ DI++ G + +L + +
Sbjct: 177 SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 80/292 (27%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 72 RFLGRGSAGLVYKG----VLPSG---QVVAIKHIYKSNNTDSFS---REVEGLSRVRHPN 121
FLG G+ G VY+G +L G VA+K + K +E +S HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSV-------LTWERRVKILRDCALAL 174
+V L G C+ QY++ E G+L LR V LT + + I D A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLL-SYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 175 RYLH--HYIDGCIVHRDIKLTNILLTEKLEP-----KLSDFGLAKMLGMEESKVFTDVRG 227
YL H+I HRD+ N L++EK K+ DFGLA+ + + G
Sbjct: 120 VYLEQMHFI-----HRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEG 171
Query: 228 ----TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV 282
+ +M PE + + K T SD++SFG++ ++L+ GQ+ + A + V
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ----PYPALNNQEVLQH-V 226
Query: 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334
+ G R + P + I ++ C A+ RPT D + E +
Sbjct: 227 TAGGR----LQKPENCP-------DKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
R LG G G V++G+ + VA+K + + + F E + + ++RHP L+ L+ C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
Y+V E G+L ++L L + + + A + YL +YI H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI-----H 126
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD+ N+L+ E K++DFGLA+++ + + + I + PE + + SD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 248 IYSFGIVALQLLS 260
++SFGI+ ++++
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 41/274 (14%)
Query: 74 LGRGSAGLVYK--GVLPSGQVVAIKHIYKSNNTD---------SFSREVEGLS----RVR 118
LG G+ G VYK ++A+K I N S V ++ ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQH---LLRKDSVLTWERRVKILRDCALALR 175
HPN+V + +E Y+V + L +H L K T ER I LALR
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235
YLH + IVHRD+ NI+L E + ++DFGLAK ESK+ T V GTI Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKL-TSVVGTILYSCPE 183
Query: 236 YMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD--FE 293
+ N +D+++FG + Q+ + Q F + + L+ + V P+ + +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI 327
+ + I C+ ++ RP I
Sbjct: 240 E-DVTDVITS------------CLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 10/188 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG 133
+G G G V +G +GQ VA+K+I +F E ++++ H NLV L G + G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 134 EQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
Y+V E + GNL L R ++++ + ++ D A + YL +VHRD+
Sbjct: 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAA 128
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
NIL++E K+SDFGLA++ S + + + + PE + + K + SD++S+G
Sbjct: 129 RNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYG 184
Query: 253 IVALQLLS 260
++ ++ S
Sbjct: 185 VLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 9e-20
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 71 RRFLGRGSAGLVYKGVLP----SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLV 123
++ +G G G V++G+L VAIK + Y F E + + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G + ++ E+ G L ++L D + + V +LR A ++YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DM 126
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG--YMDPEYMTNAK 241
VHRD+ NIL+ LE K+SDFGL+++L + +T G I + PE + K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 242 LTCASDIYSFGIVALQLLS 260
T ASD++SFGIV +++S
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-19
Identities = 60/192 (31%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI--YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G+G++G V+ + + +GQ VAIK I K + E+ + +++PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V E+ A G+L + ++ + + + R+C AL +LH ++HRDI
Sbjct: 87 VGDELFVVMEYLAGGSLTD--VVTETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDI 141
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K N+LL KL+DFG + E+SK T V GT +M PE +T DI+S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 251 FGIVALQLLSGQ 262
GI+A++++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 72 RFLGRGSAGLVY--KGVLPSGQVVAIKHI----YKSNNTDSFSREVEGLSRVRHPNLVCL 125
+ +G GS G +Y K S V IK I ++ +EV L++++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRK-------DSVLTWERRVKILRDCALALRYLH 178
F E G ++V E+C G+L + + R+ D +L+W V+I +L L+++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQI----SLGLKHIH 118
Query: 179 HYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
D I+HRDIK NI L++ + KL DFG+A+ L +T V GT Y+ PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 238 TNAKLTCASDIYSFGIVALQL 258
N +DI+S G V +L
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 15/235 (6%)
Query: 74 LGRGSAGLVYKG-VLPSGQVVAIKHIYKSNNTDSFS-----REVEGLSRVRHPNLVCLFG 127
+G G+ G+V K +G++VAIK +K + D REV+ L ++RH N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
G YLV+E+ L + L L + + A+ Y H + I+H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIH 123
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCAS 246
RDIK NIL++E KL DFG A+ L + TD T Y PE +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV-SMGKRPIKDFE-DPRLNG 299
D+++ G + +LL G+ + D D DQL + + + + F +PR G
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 29/269 (10%)
Query: 74 LGRGSAGLVYKGVLPSGQV-VAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+GRG+ G V+ G L + VA+K ++ + F +E L + HPN+V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ Y+V E G+ L + L + ++++ + A + YL +HRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPEYMTNAKLTCA 245
+ N L+TEK K+SDFG+++ EE V+ G + + PE + + +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305
SD++SFGI+ + S V + +Q TR+A + G R P L
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLS--NQQTREA--IEQGVR----LPCPELCP------ 222
Query: 306 FESILKIAVLCVAKSSKGRPTIDVVYEEI 334
+++ ++ C RP+ V++E+
Sbjct: 223 -DAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 60 EIENAINNDWDRRFLGRGSAGLVYKGVLPSGQV-VAIKHIYKSNNTDS--FSREVEGLSR 116
E E + + +R LG+G+ G+VY S QV +AIK I + ++ E+ S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 117 VRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR--------KDSVLTWERRVKILR 168
++H N+V G E G + E G+L+ LLR + + + + +IL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTK-QILE 119
Query: 169 DCALALRYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLG----MEESKVFT 223
L+YLH D IVHRDIK N+L+ T K+SDFG +K L E+ FT
Sbjct: 120 ----GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FT 170
Query: 224 DVRGTIGYMDPEYMTNAK--LTCASDIYSFGIVALQLLSGQ 262
GT+ YM PE + +DI+S G +++ +G+
Sbjct: 171 ---GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 74 LGRGSAGLVYKGV--LPSGQV--VAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLF 126
LG G+ G V KGV + SG+ VA+K + + F RE ++++ HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 127 GCCVEGGEQY-LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC- 184
G C GE LV E G L ++L ++ + V L++ A + Y++
Sbjct: 63 GVCK--GEPLMLVMELAPLGPLLKYLKKRREI-----PVSDLKELAHQVAMGMAYLESKH 115
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM--EESKVFTDVRGTIGYMDPEYMTNAKL 242
VHRD+ N+LL + + K+SDFG+++ LG + + T R + + PE + K
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 243 TCASDIYSFGIVALQLLS-GQK 263
+ SD++S+G+ + S G K
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+VYKG +GQ+VA+K I + + RE+ L ++HPN+VCL
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCALALRYLHHYIDG--- 183
++ YL++EF + +L ++L L K + D L YL+ + G
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYM----------DAELVKSYLYQILQGILF 116
Query: 184 C----IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE-YMT 238
C ++HRD+K N+L+ K KL+DFGLA+ G+ +V+T T+ Y PE +
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLG 175
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280
+ + + DI+S G + ++ + + + D + DQL R R
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFR 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 74 LGRGSAGLVYKGV--LPSGQV-VAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLF 126
LG G+ G V KGV + Q+ VAIK + K+ N D RE E + ++ +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G C E LV E + G L + L K +T V+++ ++ ++YL V
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTNAKLTC 244
HRD+ N+LL + K+SDFGL+K LG ++S K + + + + PE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 245 ASDIYSFGIVALQLLS-GQK 263
SD++S+GI + S GQK
Sbjct: 178 RSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 90 GQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144
G + AIK I K+ N D E + LS+ + P +V L+ YLV E+
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77
Query: 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK 204
G+LA LL L + + + LAL YLH I+HRD+K NIL+ K
Sbjct: 78 GDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLK 133
Query: 205 LSDFGLAKMLGMEESKVFTDVR--------GTIGYMDPEYMTNAKLTCASDIYSFGIVAL 256
L+DFGL+K+ G+ ++ + GT Y+ PE + + D +S G +
Sbjct: 134 LTDFGLSKV-GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192
Query: 257 QLLSG 261
+ L G
Sbjct: 193 EFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 65/193 (33%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE-G 132
+G+G G V G G VA+K I +F E ++++RH NLV L G VE
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 133 GEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191
G Y+V E+ A G+L +L R SVL + +K D A+ YL VHRD+
Sbjct: 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLA 129
Query: 192 LTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
N+L++E K+SDFGL K E S + + + PE + K + SD++SF
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 252 GIVALQLLSGQKV 264
GI+ ++ S +V
Sbjct: 186 GILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G+GS G VYKG+ + +VVAIK I + + +E+ LS+ P + +G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
++G + +++ E+ G+ L K L ILR+ L YLH +HRD
Sbjct: 72 LKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERK---IHRD 126
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
IK N+LL+E+ + KL+DFG+A L + K T V GT +M PE + + +DI+
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIW 185
Query: 250 SFGIVALQLLSGQ 262
S GI A++L G+
Sbjct: 186 SLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-19
Identities = 60/192 (31%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIK--HIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G+G++G VY + + +GQ VAIK ++ + + E+ + ++PN+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V E+ A G+L + ++ + + + R+C AL +LH ++HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K NILL KL+DFG + E+SK T V GT +M PE +T DI+S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 251 FGIVALQLLSGQ 262
GI+A++++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 23/199 (11%)
Query: 72 RFLGRGSAG--LVYKGVLPSGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLF 126
R +G GS G L+ + V S Q A+K I S+ + +E L++++HPN+V
Sbjct: 6 RVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQ-------HLLRKDSVLTWERRVKILRDCALALRYLHH 179
G Y+V E+C G+L Q L +D++L W ++ C L ++++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW-----FVQMC-LGVQHIH- 117
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+ ++HRDIK NI LT+ + KL DFG A++L + T V GT Y+ PE N
Sbjct: 118 --EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWEN 174
Query: 240 AKLTCASDIYSFGIVALQL 258
SDI+S G + +L
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G VYK +G++VA+K I N + F RE++ L ++RHPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 129 CVE--GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCI 185
G Y+V+E+ +L L + T E ++K ++ L+YLH I
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFT-ESQIKCYMKQLLEGLQYLHS---NGI 121
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TC 244
+HRDIK +NIL+ KL+DFGLA+ S +T+ T+ Y PE + A
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181
Query: 245 ASDIYSFGIVALQLLSG 261
D++S G + +L G
Sbjct: 182 EVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 71/217 (32%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT-----DSFSR 109
FSKD+ E D R +G GS G VY + + +VVAIK + S +
Sbjct: 8 FSKDDPEKLFT---DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 110 EVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC---AAGNLAQHL--LRKDSVLTWERRV 164
EV L ++RHPN + GC + +LV E+C A+ L H L++ +
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI------A 118
Query: 165 KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224
I L YLH + +HRDIK NILLTE KL+DFG A ++ S V
Sbjct: 119 AICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV--- 172
Query: 225 VRGTIGYMDPEY---MTNAKLTCASDIYSFGIVALQL 258
GT +M PE M + D++S GI ++L
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-19
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI--YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G+G++G VY + + +GQ VAIK + + + E+ + +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V E+ A G+L + ++ + + + R+C AL +LH ++HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K NILL KL+DFG + E+SK T V GT +M PE +T DI+S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 251 FGIVALQLLSGQ 262
GI+A++++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQ--VVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVC 124
+ +G G G V G L P + VAIK + Y F E + + HPN++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
L G + +V E+ G+L L + D T + V +LR A ++YL D
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMG 126
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG--YMDPEYMTNAKL 242
VHRD+ NIL+ L K+SDFGL+++L + +T G I + PE + K
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 243 TCASDIYSFGIVALQLLS 260
T ASD++S+GIV +++S
Sbjct: 187 TSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 1e-18
Identities = 57/192 (29%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIK--HIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G+G++G VY + + +GQ VAI+ ++ + + E+ + ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V E+ A G+L + ++ + + + R+C AL +LH ++HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K NILL KL+DFG + E+SK + + GT +M PE +T DI+S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 251 FGIVALQLLSGQ 262
GI+A++++ G+
Sbjct: 202 LGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCV 130
R LG G G V+ G VA+K + + ++F +E + + ++RH LV L+ C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLH--HYIDGCIV 186
E Y+V E+ + G+L L + L + V + A + YL +YI
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI----- 125
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRD+ NIL+ E L K++DFGLA+++ +E + I + PE + T S
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 247 DIYSFGIV 254
D++SFGI+
Sbjct: 186 DVWSFGIL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 72 RFLGRGSAGLVYKGV--LPSGQV--VAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
R +G G G VY+GV P + VA+K K+ + S F +E + + HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G E ++V E G L +L L + + AL YL
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTNAK 241
VHRDI N+L++ KL DFGL++ +E+ + +G I +M PE + +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 242 LTCASDIYSFGIVALQLLS 260
T ASD++ FG+ ++L
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 74 LGRGSAGLVYKGVL----PSGQVVAIKHI----YKSNNTDSFSREVEGLSRVRHPNLVCL 125
+G GS G K +L G+ IK I + +EV LS ++HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQH-------LLRKDSVLTWERRVKILRDCALALRYLH 178
E G Y+V ++C G+L + L +D +L W ++ C LAL+++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-----FVQIC-LALKHVH 118
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
D I+HRDIK NI LT+ KL DFG+A++L T + GT Y+ PE
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIE 266
N SDI++ G V ++ + + E
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 74 LGRGSAGLVYKGV-LPSGQ----VVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G VYKGV +P G+ VAIK + + E ++ V HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 126 FGCCVEGGEQY-LVYEFCAAGNLAQHL------LRKDSVLTWERRVKILRDCALALRYLH 178
G C+ Q L+ + G L ++ + +L W ++ A + YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV-RGTIGYMDPEYM 237
+ +VHRD+ N+L+ K++DFGLAK+L ++E + + + I +M E +
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 238 TNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARD 273
+ T SD++S+G+ +L++ G K E A +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 38/285 (13%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDS----FSR 109
F KD+ E + D R +G GS G VY + + +VVAIK + Y ++ +
Sbjct: 8 FFKDDPEKLFS---DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 110 EVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD 169
EV L ++RHPN + GC + +LV E+C A LL E + +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTH 122
Query: 170 CAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228
AL L YLH + ++HRD+K NILL+E KL DFG A ++ V GT
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GT 174
Query: 229 IGYMDPEY---MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285
+M PE M + D++S GI ++ L+ +K + +A L A++
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQN---- 229
Query: 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330
E P L F + + C+ K + RPT +V+
Sbjct: 230 -------ESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 63/265 (23%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+ LG G G+V+ G + VAIK I + + + + F E + + ++ HP LV L+G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
+ Y+V EF G L +L ++ L+ + + + +D + YL +HRD+
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDL 126
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
N L++ K+SDFG+ + + +E + + + + PE +K + SD++S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 251 FGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESIL 310
FG++ ++ + K + F+ + +S G R + P+L ++
Sbjct: 187 FGVLMWEVFTEGK---MPFEKKSNY-EVVEMISRGFRLYR----PKLASM-------TVY 231
Query: 311 KIAVLCVAKSSKGRPTIDVVYEEID 335
++ C + +GRPT + I
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 72 RFLGRGSAGLV----YKGVLPSGQVVAIKHIYKS--NNTDSF-----SREVEGLSRVRHP 120
+ LG+GS G V KG + ++ A+K + K D + V L+ +HP
Sbjct: 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHP 56
Query: 121 NLVCLFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
L L C + ++ + V E+ G+L H+ R R + L L++LH
Sbjct: 57 FLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH- 113
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYM 237
+ I++RD+KL N+LL + K++DFG+ K +LG + F GT Y+ PE +
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEIL 168
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKVIELD 268
+ A D ++ G++ ++L+GQ E D
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 73/213 (34%), Positives = 113/213 (53%), Gaps = 19/213 (8%)
Query: 71 RRFLGRGSAG---LVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNL 122
+ LG+GS G LV K P +GQ+ A+K + K+ + E + L+ V HP +
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V L G+ YL+ +F G+L L ++ V+ E VK L + ALAL +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL- 117
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I++RD+K NILL E+ KL+DFGL+K E K ++ GT+ YM PE +
Sbjct: 118 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRG 174
Query: 242 LTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
T ++D +SFG++ ++L+G L F +D+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGS----LPFQGKDR 203
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 63/198 (31%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 74 LGRGSAGLVYKGVL-PSG---QVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLF 126
+G G G V +G L G VAIK + Y F E + + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G + ++ EF G L L + D T + V +LR A ++YL + V
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYV 128
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRG---TIGYMDPEYMTNAKL 242
HRD+ NIL+ L K+SDFGL++ L + S +T G I + PE + K
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 243 TCASDIYSFGIVALQLLS 260
T ASD++S+GIV +++S
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 72 RFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLV 123
+ LG G G V +G+ VA+K + S F RE+E L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 124 CLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--H 179
G C + G + L+ E+ +G+L +L R + +R + + YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPE 235
YI HRD+ NIL+ + K+SDFGLAK+L E K + V+ I + PE
Sbjct: 130 YI-----HRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYAPE 182
Query: 236 YMTNAKLTCASDIYSFGIVALQLLS 260
+ +K + ASD++SFG+ +L +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 36/201 (17%)
Query: 74 LGRGSAGLVYKG--VLPSGQV--VAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVCLF 126
LG GS G+V +G G+V VA+K S+ D F +E + + H NL+ L+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKD-------SVLTWERRVKILRDCALALRYLHH 179
G V +V E G+L L RKD S L + V+I A +RYL
Sbjct: 63 GV-VLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTL-CDYAVQI----ANGMRYLES 115
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG-------MEESKVFTDVRGTIGYM 232
+HRD+ NILL + K+ DFGL + L MEE + +
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL-----KVPFAWC 167
Query: 233 DPEYMTNAKLTCASDIYSFGI 253
PE + + ASD++ FG+
Sbjct: 168 APESLRTRTFSHASDVWMFGV 188
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFGCC 129
LG+G+ G V+KG L VA+K + + F E L + HPN+V L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ Y+V E G+ L +K L ++ VK D A + YL CI HRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--SKNCI-HRD 118
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV---RGTIGYMDPEYMTNAKLTCAS 246
+ N L+ E K+SDFG+++ E+ +++ + I + PE + + + S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 247 DIYSFGIVALQLLS 260
D++S+GI+ + S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 80/290 (27%), Positives = 121/290 (41%), Gaps = 53/290 (18%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIY---KSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G+V K + PSG ++A K I+ K + RE++ L P +V +G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCALA----LRYLHHYIDG 183
GE + E G+L D VL R+ IL ++A L YL
Sbjct: 69 YSDGEISICMEHMDGGSL-------DQVLKKAGRIPENILGKISIAVLRGLTYLREKHK- 120
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMTNAK 241
I+HRD+K +NIL+ + E KL DFG++ L M S V GT YM PE +
Sbjct: 121 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTH 174
Query: 242 LTCASDIYSFGIVALQLLSG--------QKVIELDFD-------ARDQLTRKARDVSMGK 286
T SDI+S G+ +++ G K +E F A++ +
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 287 RPIKDFE---------DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI 327
RP+ FE P+L +F+ + C+ K+ K R +
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK---CLKKNPKERADL 281
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 74 LGRGSAGLVYKG--VLPS---GQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCL 125
LG + G +YKG LP Q+VAIK + NN F +E ++ + HPN+VCL
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------------SVLTWERRVKILRD 169
G + +++E+ G+L + L+ + S L + I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 170 CALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRGT 228
A + YL + VH+D+ NIL+ E+L K+SD GL++ + + +V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 229 IGYMDPEYMTNAKLTCASDIYSFGIVALQL----------LSGQKVIEL 267
I +M PE + K + SDI+SFG+V ++ S Q+VIE+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-18
Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G+GS G V+KG+ + QVVAIK I + + +E+ LS+ P + +G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
++G + +++ E+ G+ A LLR ++ +L++ L YLH +HRD
Sbjct: 72 LKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQI-ATMLKEILKGLDYLHSEKK---IHRD 126
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
IK N+LL+E+ + KL+DFG+A L + K T V GT +M PE + + +DI+
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIW 185
Query: 250 SFGIVALQLLSGQ 262
S GI A++L G+
Sbjct: 186 SLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 74 LGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTD----SFSREVEGLSRV-RHPNL 122
LG G+ G V K VA+K + K + T+ E+E + + +H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-----------KILRDCA 171
+ L G C + G Y+V E+ A GNL L + + K L A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 172 LAL-RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTDVRGTI 229
+ R + +HRD+ N+L+TE K++DFGLA+ + ++ + T+ R +
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198
Query: 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
+M PE + + T SD++SFG++ ++ +
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G GS G+V+K +GQ+VAIK +S + RE+ L +++HPNLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 129 CVEGGEQYLVYEFC---AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ +LV+E+C L ++ L KI+ A+ + H + CI
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI----KKIIWQTLQAVNFCHKH--NCI 122
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT-NAKLTC 244
HRD+K NIL+T++ + KL DFG A++L +TD T Y PE + + +
Sbjct: 123 -HRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQYGP 180
Query: 245 ASDIYSFGIVALQLLSGQ 262
D+++ G V +LL+GQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-18
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNL 122
R LG G+ G VY+G+ VA+K + +S + F E +S+ H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD-------SVLTWERRVKILRDCALALR 175
V L G E ++++ E A G+L + LR++ S LT + + RD A +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 176 YLH--HYIDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGT- 228
YL H+I HRDI N LLT K P K++DFG+A+ D+
Sbjct: 131 YLEENHFI-----HRDIAARNCLLTCK-GPGRVAKIADFGMAR-----------DIYRAS 173
Query: 229 -----------IGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
I +M PE + T +D++SFG++ ++ S
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSR-----EVEGLSRVRHPNLVCLFG 127
+G+G +VYK + L G+VVA+K + D+ +R E++ L ++ HPN++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+E E +V E AG+L++ + +K L ER + K AL ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
I+HRDIK N+ +T KL D GL + + + + V GT YM PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 245 ASDIYSFGIVALQL 258
SDI+S G + ++
Sbjct: 186 KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 38/222 (17%)
Query: 72 RFLGRGSAGLVYK----GVLPSGQ--VVAIKHIYKSNNTD---SFSREVEGLSRVRHPNL 122
R +G+G+ G V++ G+LP +VA+K + + + D F RE ++ HPN+
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNL----------AQHLLRKDSV-----------LTWE 161
V L G C G L++E+ A G+L AQ L + L+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 162 RRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA-KMLGMEE 218
++ I + A + YL + VHRD+ N L+ E + K++DFGL+ + +
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
K + I +M PE + + T SD++++G+V ++ S
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-17
Identities = 84/289 (29%), Positives = 128/289 (44%), Gaps = 38/289 (13%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSR 109
F K++ E D R +G GS G VY + + +VVAIK + S + +
Sbjct: 18 FFKEDPEKLFT---DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 74
Query: 110 EVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD 169
EV+ L R++HPN + GC + +LV E+C A LL E + +
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITH 132
Query: 170 CAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228
AL L YLH + ++HRDIK NILLTE + KL+DFG A + S V GT
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184
Query: 229 IGYMDPEY---MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285
+M PE M + D++S GI ++ L+ +K + +A L A++
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQN---- 239
Query: 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334
E P L N F + + C+ K + RPT + + + +
Sbjct: 240 -------ESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 10/186 (5%)
Query: 74 LGRGSAGLVYKGVLPS-GQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVE 131
LG G G VY+GV VA+K + + + F +E + ++HPNLV L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 132 GGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLH--HYIDGCIVHR 188
Y++ EF GNL +L + + + + + A+ YL ++I HR
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI-----HR 128
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDI 248
D+ N L+ E K++DFGL++++ + + I + PE + K + SD+
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 249 YSFGIV 254
++FG++
Sbjct: 189 WAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 21/194 (10%)
Query: 89 SGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLVCLF--GCCVEGGEQYLVYEF 141
+G VAIK + + F RE +R+ HPN+V L G G + V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK- 200
L + +L D L +++ AL H + IVHRD+K NI++++
Sbjct: 61 VPGRTLRE-VLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 201 LEP--KLSDFGLAKML-GMEESKVFT-----DVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
+ P K+ DFG+ +L G+ ++ V T +V GT Y PE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 253 IVALQLLSGQKVIE 266
++ L+ L+GQ+V++
Sbjct: 177 LIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLF 126
R +GRG+ G+V+ ++V IK I T + E + L + HPN++ +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+E +V E+ G LA+++ R +S+L + + LAL ++H + I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---I 122
Query: 186 VHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
+HRD+K NILL + K+ K+ DFG++K+L +SK +T V GT Y+ PE
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT-VVGTPCYISPELCEGKPYNQ 180
Query: 245 ASDIYSFGIVALQLLSGQKVIE 266
SDI++ G V +L S ++ E
Sbjct: 181 KSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHI-----YKSNNTDSFS--REVEGLSRVRHPNLV 123
+ LG G+ +VYK +G++VAIK I ++ + +F+ RE++ L ++HPN++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYLH 178
L LV+EF +L + + K VLT +K LR L YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLT-PADIKSYMLMTLR----GLEYLH 119
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
I+HRD+K N+L+ KL+DFGLA+ G K+ V T Y PE +
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 239 NAKL-TCASDIYSFGIVALQLL 259
A+ D++S G + +LL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 6e-17
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 73 FLGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRV-RHPNLVCLFGCC 129
+G G+ G VYKG + +GQ+ AIK + + + +E+ L + H N+ +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 130 VEGG------EQYLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYID 182
++ + +LV EFC AG++ + K + L E I R+ L +LH +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 131
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT---- 238
++HRDIK N+LLTE E KL DFG++ L + T + GT +M PE +
Sbjct: 132 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 188
Query: 239 -NAKLTCASDIYSFGIVALQLLSG 261
+A SD++S GI A+++ G
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-17
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 16/181 (8%)
Query: 89 SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ--YLVYEFCA 143
+G++VA+K + + NT + +E+ L + H N+V GCC E G + L+ E+
Sbjct: 32 TGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--HYIDGCIVHRDIKLTNILLTEKL 201
G+L +L + L + + + + YLH HYI HRD+ N+LL
Sbjct: 92 LGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHYI-----HRDLAARNVLLDNDR 144
Query: 202 EPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259
K+ DFGLAK + G E +V D + + E + K + ASD++SFG+ +LL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
Query: 260 S 260
+
Sbjct: 205 T 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 72 RFLGRGSAGLVYK-GVLPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLF 126
+ LG+GS G VYK L Q A+K + + + E+ L+ V HPN++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSV-------LTWERRVKILRDCALALRYLHH 179
++G + +V E+ G+L++ + ++ W +++LR L+ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR----GLQALH- 120
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+ I+HRD+K NILL K+ D G++K+L +K GT YM PE
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKG 175
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273
+ SDI+S G + ++ + F+AR
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFA----PPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G GS G+V K +GQ+VAIK +S + RE+ L ++RH NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
YLV+EF + L + + L R K L + + H + I+HR
Sbjct: 69 FRRKKRLYLVFEF-VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHR 124
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT-NAKLTCASD 247
DIK NIL+++ KL DFG A+ L +V+TD T Y PE + + K A D
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQLTR 277
I++ G + ++L+G+ + D D DQL
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDI-DQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 74 LGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVC 124
LG G VYKG L Q VAIK + + F E SR++HPN+VC
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRD 169
L G + +++ +C+ +L + L+ + S L V I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 170 CALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVR 226
A + +L HH +VH+D+ N+L+ +KL K+SD GL + + + K+ +
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
I +M PE + K + SDI+S+G+V ++ S
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 9e-17
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
LG GS G V +K SG+ A+K I K + E L +RHP LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV---KILRDCALALRYLHHYI 181
L+G + YLV E+ G L HL + R +++ LAL YLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV----LALEYLHS-- 119
Query: 182 DGC-IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
IV+RD+K N+LL K++DFG AK + + + +T + GT Y+ PE + +
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPEIILSK 173
Query: 241 KLTCASDIYSFGIVALQLLSG-------------QKVIE--------LDFDARDQLTR 277
A D ++ GI+ ++L+G +K++E DA+D +
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 79/265 (29%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIY---KSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G V K +P+G V+A K ++ KS+ RE++ + R P +V +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL---HHYIDGCIV 186
+ + EF G+L + +K + E KI L YL H I+
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-----IM 126
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRDIK +NIL+ + + KL DFG++ L + F GT YM PE + K T S
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKYTVKS 183
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----KRPIKDFEDPRLNGNIN 302
D++S GI ++L G + F + +D MG + I PRL
Sbjct: 184 DVWSLGISIIELALG----KFPFAFSNIDD-DGQDDPMGILDLLQQIVQEPPPRL----P 234
Query: 303 RADFESILKIAV-LCVAKSSKGRPT 326
+DF L+ V C+ K RPT
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQ-VVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G+GS G V+KG+ Q VVAIK I + + +E+ LS+ P + +G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
++ + +++ E+ G+ L + L + ILR+ L YLH +HRD
Sbjct: 72 LKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK---IHRD 126
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
IK N+LL+E E KL+DFG+A L + K T V GT +M PE + + +DI+
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIW 185
Query: 250 SFGIVALQLLSGQ 262
S GI A++L G+
Sbjct: 186 SLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 74 LGRGSAGLVYKGVL---PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLF 126
LG G+ G V KG+ S + VA+K + NN D RE + ++ +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G C E LV E G L + L+K+ +T + +++ ++ ++YL + V
Sbjct: 63 GIC-EAESWMLVMELAELGPLNK-FLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTNAKLTC 244
HRD+ N+LL + K+SDFGL+K LG +E+ K T + + + PE M K +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 245 ASDIYSFGIVALQLLS-GQK 263
SD++SFG++ + S GQK
Sbjct: 178 KSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 21/257 (8%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG+G G V+ G VAIK + + ++F +E + + ++RH LV L+ E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC-IVHRDIK 191
Y+V E+ + G+L L + R+ L D A + Y++ VHRD++
Sbjct: 74 -PIYIVTEYMSKGSLLDFLKGEMGKYL---RLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 192 LTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
NIL+ E L K++DFGLA+++ E + I + PE + T SD++SF
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 252 GIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILK 311
GI+ +L + +V R+ L + R M P E P ES+
Sbjct: 190 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----ECP-----------ESLHD 234
Query: 312 IAVLCVAKSSKGRPTID 328
+ C K + RPT +
Sbjct: 235 LMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 74 LGRGSAGLVYK------GVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
LG G+ G VYK G L + +V+ K + + E+E L+ HP +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
G+ +++ EFC G + +L D LT + I R AL+YLH I+H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIH 133
Query: 188 RDIKLTNILLTEKLEPKLSDFGLA----KMLGMEESKVFTDVRGTIGYMDPEY-----MT 238
RD+K N+LLT + KL+DFG++ K L +S + GT +M PE M
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 239 NAKLTCASDIYSFGIVALQL 258
+ +DI+S GI +++
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDS----FSREVEGLSRVRHPNLVCLFG 127
+G GS G VY + +VVA+K + Y T+ +EV+ L +++HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-ALRYLHHYIDGCIV 186
C ++ +LV E+C A LL E + + AL L YLH + ++
Sbjct: 89 CYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMI 143
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY---MTNAKLT 243
HRDIK NILLTE + KL+DFG A S V GT +M PE M +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYD 198
Query: 244 CASDIYSFGIVALQL 258
D++S GI ++L
Sbjct: 199 GKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 30/252 (11%)
Query: 71 RRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKS----NNTDSFSREVEG--LSRVRHP 120
+ LG+G G V++ +G++ A+K + K+ N D+ + E L V+HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
+V L GG+ YL+ E+ + G L HL R + + + L + +LAL +LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I++RD+K NILL + KL+DFGL K + E V GTI YM PE + +
Sbjct: 120 ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 241 KLTCASDIYSFGIVALQLLSGQ---------KVIELDFDAR----DQLTRKARDVSMGKR 287
A D +S G + +L+G K I+ + LT +ARD+ K+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL--KK 233
Query: 288 PIKDFEDPRLNG 299
+K RL
Sbjct: 234 LLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQV----VAIKHIYKSNNTDSFSREVE---GLSRVRHPNLV 123
+ LG G G V+KG+ +P G VAIK I + +F + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G C G LV + G+L H+ + L +R + A + YL +
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKL 242
+VHR++ NILL +++DFG+A +L ++ K +++ + I +M E + +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 243 TCASDIYSFGIVALQLLS 260
T SD++S+G+ +++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-----------YKSNNTDSFSREVEGLSRVRHPN 121
+G GS G VY G+ SG+++A+K + K + D+ +RE+ L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHY 180
+V G ++ + E+ G++A L + E V+ +R L YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETLVRNFVRQILKGLNYLH-- 123
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-----MLGMEESKVFTDVRGTIGYMDPE 235
+ I+HRDIK NIL+ K K+SDFG++K L + + ++G++ +M PE
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 236 YMTNAKLTCASDIYSFGIVALQLLSG 261
+ T +DI+S G + +++L+G
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 63/195 (32%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 74 LGRGSAGLVYK-GVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
LG G G V V + A+K HI ++ + E E L HP +V L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCA-LALRYLHHYIDGCIV 186
+ Y++ E+C G L +LR D L E + C LA YLH+ I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL-WTILR-DRGLFDEYTARFYIACVVLAFEYLHNR---GII 115
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
+RD+K N+LL KL DFG AK L + K +T GT Y+ PE + N +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFSV 173
Query: 247 DIYSFGIVALQLLSG 261
D +S GI+ +LL+G
Sbjct: 174 DYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 67 NDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREV-------EGLSRV 117
+W R + LG+G+ G VY + +G+ +A+K + ++ +EV + L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL 177
+H +V +GC + + E+ G++ L + LT K R + YL
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYL 120
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--FTDVRGTIGYMDPE 235
H IVHRDIK NIL KL DFG +K L S V GT +M PE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 236 YMTNAKLTCASDIYSFGIVALQLLS 260
++ +D++S G +++L+
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 74 LGRGSAGLVYKG-VLPSGQVVAIK--HIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G GS G+V +G+ VA+K + K + EV + +HPN+V ++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 131 EGGEQYLVYEFCAAGNL----AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G E ++V EF G L + ++ + T + AL +LH ++
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLHAQ---GVI 137
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRDIK +ILLT KLSDFG + E + + V GT +M PE ++
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEV 196
Query: 247 DIYSFGIVALQLLSGQ 262
DI+S GI+ ++++ G+
Sbjct: 197 DIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG+G G V+ G VAIK + ++F +E + + ++RH LV L+ E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 133 GEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLH--HYIDGCIVHRD 189
Y+V EF G+L L D L + V + A + Y+ +YI HRD
Sbjct: 74 -PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI-----HRD 127
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
++ NIL+ + L K++DFGLA+++ E + I + PE + T SD++
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 250 SFGIVALQLLSGQKV 264
SFGI+ +L++ +V
Sbjct: 188 SFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVR---HPNLVCL 125
+G G+ G VYK L +G+ VA+K + + + S RE+ L ++ HPN+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 126 FGCC--VEGGEQ---YLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHH 179
C + LV+E +LA +L + L E ++R + +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+ IVHRD+K NIL+T + K++DFGLA++ E + T V T+ Y PE +
Sbjct: 126 H---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQ 180
Query: 240 AKLTCASDIYSFG-IVA 255
+ D++S G I A
Sbjct: 181 SSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 72 RFLGRGSAGLVYK----GVLPSGQV--VAIKHI---YKSNNTDSFSREVEGLSRV-RHPN 121
+ LG G+ G V + G+ S V VA+K + S+ ++ E++ +S + H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHY 180
+V L G C GG ++ E+C G+L L RK +S LT E + A + +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS- 159
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK--VFTDVRGTIGYMDPEYMT 238
CI HRD+ N+LLT K+ DFGLA+ + M +S V + R + +M PE +
Sbjct: 160 -KNCI-HRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGNARLPVKWMAPESIF 216
Query: 239 NAKLTCASDIYSFGIVALQLLS 260
N T SD++S+GI+ ++ S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 10/215 (4%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG G G V+ G VA+K + + +SF E + + ++RH LV L+ E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDS-VLTWERRVKILRDCALALRYLH--HYIDGCIVHRD 189
Y+V E+ + G+L L + L V + A + Y+ +YI HRD
Sbjct: 74 -PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI-----HRD 127
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
++ NIL+ + L K++DFGLA+++ E + I + PE + T SD++
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 250 SFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284
SFGI+ +L++ +V + R+ L + R M
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCV 130
+G G+ G VYKG + +GQ+ AIK + + + E+ L + H N+ +G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 131 EGG------EQYLVYEFCAAG-------NLAQHLLRKDSVLTWERRVKILRDCALALRYL 177
+ + +LV EFC AG N + L++D + R +ILR LA +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR--EILR--GLAHLHA 139
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H ++HRDIK N+LLTE E KL DFG++ L + T + GT +M PE +
Sbjct: 140 HK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193
Query: 238 T-----NAKLTCASDIYSFGIVALQLLSG 261
+A SDI+S GI A+++ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKH--------IYKSNNTDSFSREVEG-------LSR 116
R +G+GS G+V ++H I K N ++ RE + LS+
Sbjct: 6 RVVGKGS----------YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ 55
Query: 117 VRHPNLVCLFGCCVEG--GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALA 173
++HPN+V + EG G Y+V FC G+L L + L E +V + A+A
Sbjct: 56 LKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L+YLH + I+HRD+K N+ LT K+ D G+A++L + T + GT YM
Sbjct: 115 LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMS 170
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273
PE +N SD+++ G ++ + ++ F+A+D
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMAT----LKHAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 68/298 (22%)
Query: 54 YRFSKDEIENAINNDWDRRFLGRGSAGLVYKG-VLPSGQVVAIKHIYKSNNTDSFSREVE 112
Y +++EN +G G+ G VYK +G V+A+K + ++ N + R +
Sbjct: 10 YPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM 62
Query: 113 GLSRV--RH--PNLVCLFGCCVEGGEQYLVYEFCAA----------GNLAQHLLRKDSVL 158
L V H P +V +G + + ++ E + G + + +L K +V
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVA 122
Query: 159 TWERRVKILRDCALALRYL---HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215
VK AL YL H ++HRD+K +NILL KL DFG++ L
Sbjct: 123 I----VK-------ALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRL- 165
Query: 216 MEESKVFTDVRGTIGYMDPEYMT----NAKLTCASDIYSFGIVALQLLSGQ---KVIELD 268
+SK T G YM PE + N K +D++S GI ++L +GQ K + +
Sbjct: 166 -VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
Query: 269 FDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN-RADFESILKIAVLCVAKSSKGRP 325
F+ LT+ I E P L N DF S + LC+ K + RP
Sbjct: 225 FEV---LTK-----------ILQEEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 74 LGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLF 126
+G G+ G V + ++ + + +K N+ F+ E+E L ++ HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------------SVLTWERRVKILRDC 170
G C G Y+ E+ GNL LRK S LT ++ ++ D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLD-FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 171 ALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG 230
A ++YL + +HRD+ N+L+ E L K++DFGL++ G E T R +
Sbjct: 129 ATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVR 183
Query: 231 YMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
+M E + + T SD++SFG++ +++S
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 8/190 (4%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG G G+V G VAIK I + S + D F E + + ++ H LV L+G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDI 190
Y+V E+ + G L +L + +++ +D + YL +I HRD+
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI-----HRDL 126
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
N L+ ++ K+SDFGL++ + +E + + + PE + +K + SD+++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 251 FGIVALQLLS 260
FG++ ++ S
Sbjct: 187 FGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 71 RRFLGRGSAGLVY----KGVLPSGQ--VVAIKHIYKS--NNTDSFSREVEGLSRVRHPNL 122
+R LG G+ G V+ + P +VA+K + + N F RE E L+ ++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK--DSV----------LTWERRVKILRDC 170
V +G CVEG +V+E+ G+L + L D+V LT + + I +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 171 ALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRG 227
A + YL H+ VHRD+ N L+ E L K+ DFG+++ + + +V
Sbjct: 130 AAGMVYLASQHF-----VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
I +M PE + K T SD++S G+V ++ +
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 26/268 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSR-----EVEGLSRVRHPNLVCLFG 127
+GRG VY+ L G VA+K + + D+ +R E++ L ++ HPN++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+E E +V E AG+L++ + +K L E+ V K AL ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--- 126
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
++HRDIK N+ +T KL D GL + + + + V GT YM PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 245 ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304
SDI+S G + ++ + Q D L +K P +
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS----------- 234
Query: 305 DFESILKIAVLCVAKSSKGRPTIDVVYE 332
E + ++ +C+ + RP I VY+
Sbjct: 235 --EELRQLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 20/188 (10%)
Query: 89 SGQVVAIKHIYKSNNT--------DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140
+G ++A+K + NT ++ +E+ ++R+ HP+++ + G E L E
Sbjct: 24 TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83
Query: 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL-TE 199
+ A G+++ HLL K + L YLH + I+HRD+K N+L+ +
Sbjct: 84 WMAGGSVS-HLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDST 139
Query: 200 KLEPKLSDFGLA-----KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
+++DFG A K G E + + GTI +M PE + + + D++S G V
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQ--GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCV 197
Query: 255 ALQLLSGQ 262
+++ + +
Sbjct: 198 IIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 31/263 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGCC 129
+G G+ G VYK L +G++ A+K I K D FS +E+ + +H N+V FG
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ + ++ E+C G+L Q + L+ + + R+ L YLH +HRD
Sbjct: 76 LSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 190 IKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMT---NAKLTC 244
IK NILLT+ + KL+DFG+A + + + K F GT +M PE N
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEVAAVEKNGGYNQ 188
Query: 245 ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN-R 303
DI++ GI A++L Q + D L ++ +F+ P+L
Sbjct: 189 LCDIWAVGITAIELAELQPPM-FDLHPMRALFLMSK---------SNFQPPKLKDKTKWS 238
Query: 304 ADFESILKIAVLCVAKSSKGRPT 326
+ F + +KI++ K+ K RPT
Sbjct: 239 STFHNFVKISLT---KNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G+G+ G V+K + Q+VA+K + N + F RE++ L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 129 CVEGGEQ--------YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
C YLV+EFC +LA L K+ T K+++ L Y+H
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR- 137
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212
I+HRD+K NIL+T+ KL+DFGLA+
Sbjct: 138 --NKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 74 LGRGSAGLVY----KGVLPSG--QVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVC 124
LGRG G V+ KG+ G +V +K + K+ + + F RE++ ++ H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLL--------RKDSVLTWERRVKILRDCALALRY 176
L G C E Y++ E+ G+L Q L K L+ +++V + AL + +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 177 L--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDP 234
L + VHRD+ N L++ + E K+S L+K + E + + ++ P
Sbjct: 133 LSNARF-----VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 235 EYMTNAKLTCASDIYSFGIVALQLLS 260
E + + SD++SFG++ ++ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 73/290 (25%), Positives = 113/290 (38%), Gaps = 44/290 (15%)
Query: 73 FLGRGSAGLVYKGVL---PSGQVVAIKHIYKSNNT-DSFS----REVEGLSRVRHPNLVC 124
+GRG+ G VYK G+ AIK S RE+ L ++H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 125 LFGCCVEGGEQ--YLVYEFCA--AGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH 179
L +E ++ YL++++ + + + V VK +L + YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125
Query: 180 YIDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRG---TIGYM 232
++HRD+K NIL+ + K+ D GLA+ L K D+ TI Y
Sbjct: 126 --SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAPLKPLADLDPVVVTIWYR 182
Query: 233 DPEYMTNAK-LTCASDIYSFGIVALQLLSGQ---KVIELDFDA-----RDQLTRKARDVS 283
PE + A+ T A DI++ G + +LL+ + K E RDQL R
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE--V 240
Query: 284 MGKRPIKDFED-------PRLNGNI--NRADFESILKIAVLCVAKSSKGR 324
+G KD+ D L + S+ K S+G
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 71/262 (27%), Positives = 122/262 (46%), Gaps = 25/262 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIY--KSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G G+ G VYK + +G++ AIK I + +E+ + +H N+V FG +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
+ ++ EFC G+L Q + L+ + + R+ L YLH +HRDI
Sbjct: 77 RRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT---NAKLTCASD 247
K NILLT+ KL+DFG++ + +K + + GT +M PE D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCD 191
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD-F 306
I++ GI A++L Q + FD R + + + +F+ P+L + ++ F
Sbjct: 192 IWAVGITAIELAELQPPM---FD-----LHPMRALFLMTK--SNFQPPKLKDKMKWSNSF 241
Query: 307 ESILKIAVLCVAKSSKGRPTID 328
+K+A + K+ K RPT +
Sbjct: 242 HHFVKMA---LTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSR-----EVEGLSRVRHPNLVCLFG 127
+GRG VY+ L + VA+K + D+ +R E++ L ++ HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+E E +V E AG+L+Q + +K L ER V K A+ ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--- 126
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
++HRDIK N+ +T KL D GL + + + + V GT YM PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 245 ASDIYSFGIVALQL 258
SDI+S G + ++
Sbjct: 186 KSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 19/159 (11%)
Query: 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWER 162
+H N++ L G C + G Y++ E+ + GNL ++L + D +T++
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 163 RVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKV 221
V A + YL CI HRD+ N+L+TE K++DFGLA+ + ++ K
Sbjct: 139 LVSCTYQVARGMEYLAS--QKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
T+ R + +M PE + + T SD++SFG++ ++ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 74/253 (29%), Positives = 112/253 (44%), Gaps = 41/253 (16%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTD----SFSREVEGLSRVR---HPNLVCL 125
+G G+ G VYK P SG VA+K + N D S REV L R+ HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 126 FGCCVEGGEQY-----LVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHH 179
C LV+E +L +L + L E ++R L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
CIVHRD+K NIL+T + KL+DFGLA++ + + T V T+ Y PE +
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQ 181
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRK------------ARDVSM--- 284
+ D++S G + ++ + + + +A DQL + RDV++
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPRDVTLPRG 240
Query: 285 -----GKRPIKDF 292
G RP++
Sbjct: 241 AFSPRGPRPVQSV 253
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 46/284 (16%)
Query: 74 LGRGSAGLVYKGVLPSGQVVA---IKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFG 127
+G G G V G G A +K + S D F +EV+ + HPN++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI-- 185
C+E LV EFC G+L + LR + + V + + R G +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNY-LRSNRGM-----VAQMAQKDVLQRMACEVASGLLWL 116
Query: 186 -----VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT-IGYMDPEYMTN 239
+H D+ L N LT L K+ D+GLA E+ + D + ++ PE +
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 240 -------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD- 291
T S+I+S G+ +L F A DQ D + K+ +++
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL----------FTAADQPYPDLSDEQVLKQVVREQ 226
Query: 292 ---FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332
P+L+ + +E + C RPT + V+E
Sbjct: 227 DIKLPKPQLDLKYSDRWYE----VMQFCWLDPET-RPTAEEVHE 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG G G V+ G VAIK + + S + ++F E + +++HP LV L+ V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQ 72
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLH--HYIDGCIVHRD 189
Y++ E+ G+L L + + LT + + + A + ++ +YI HRD
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI-----HRD 127
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
++ NIL++E L K++DFGLA+++ E + I + PE + T SD++
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 250 SFGIVALQLLS 260
SFGI+ ++++
Sbjct: 188 SFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 73 FLGRGSAGLVYK------GVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCL 125
+G G+ G V K G+ + +K ++ F+ E+E L ++ HPN++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------------SVLTWERRVKILRD 169
G C G YL E+ GNL LRK S L+ ++ + D
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 170 CALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTI 229
A + YL +HRD+ NIL+ E K++DFGL++ G E T R +
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175
Query: 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
+M E + + T SD++S+G++ +++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 18/231 (7%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIKHIYKSN-----NTDSFSR-EVEGLSRVRH-P 120
R LG G+ G V+ G +G++ A+K + K+ T +R E + L VR P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
LV L + +L+ ++ G L HL +++ E RV I + LAL +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI-AEIVLALDHLHQL 124
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I++RDIKL NILL + L+DFGL+K EE + GTI YM PE +
Sbjct: 125 ---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 241 KL--TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289
A D +S G++ +LL+G +D ++ + +R + K P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVD-GEQNSQSEISRRILKSKPPF 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 74 LGRGSAGLVY----KGVLPSGQ--VVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCL 125
LG G+ G V+ +LP +VA+K + +++ + F RE E L+ ++H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQ---------HLLRKDSV-----LTWERRVKILRDCA 171
+G C EG +V+E+ G+L + +L LT + + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 172 LALRYLH--HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRGT 228
+ YL H+ VHRD+ N L+ + L K+ DFG+++ + + +V
Sbjct: 133 SGMVYLASLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 229 IGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
I +M PE + K T SDI+SFG+V ++ +
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G VYK +G++VA+K + N + F RE++ L ++ H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 129 CV----------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYL 177
+ G YLV+E+ + LL V E +K ++ L Y
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H +HRDIK +NILL K + KL+DFGLA++ EES+ +T+ T+ Y PE +
Sbjct: 133 H---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL 189
Query: 238 T-NAKLTCASDIYSFGIVALQLLS 260
+ A D++S G + +L +
Sbjct: 190 LGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-----RHPNLVCLFG 127
+G+G+ G VYK G + A+K + ++ D E+E + HPN+V +G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD---EEIEAEYNILQSLPNHPNVVKFYG 86
Query: 128 C------CVEGGEQYLVYEFCAAGN---LAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
V GG+ +LV E C G+ L + LL L IL L L++LH
Sbjct: 87 MFYKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ I+HRD+K NILLT + KL DFG++ L + T V GT +M PE +
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 239 -----NAKLTCASDIYSFGIVALQLLSG 261
+ D++S GI A++L G
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 28/202 (13%)
Query: 74 LGRGSAGLVYK-GVLPSGQVVAIKHIY---KSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G+V K PSG ++A K I+ K + RE++ L P +V +G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCALA-------LRYLHHY 180
GE + E G+L D VL +R+ +IL ++A LR H
Sbjct: 73 YSDGEISICMEHMDGGSL-------DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ- 124
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+HRD+K +NIL+ + E KL DFG++ L + F GT YM PE +
Sbjct: 125 ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGT 177
Query: 241 KLTCASDIYSFGIVALQLLSGQ 262
+ SDI+S G+ ++L G+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+VYK +G+VVA+K I T+ RE+ L + HPN+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCA--------LALRYLHHY 180
+ YLV+EF L Q L K D + L YL
Sbjct: 68 IHTENKLYLVFEF-----LHQDL-------------KKFMDASPLSGIPLPLIKSYLFQL 109
Query: 181 IDG---C----IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
+ G C ++HRD+K N+L+ + KL+DFGLA+ G+ + +T T+ Y
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRA 168
Query: 234 PEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280
PE + K + A DI+S G + ++++ + + D + DQL R R
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 89 SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ--YLVYEFCA 143
+G+ VA+K + N+ +E+E L + H N+V G C E G L+ EF
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKL 201
+G+L ++L R + + ++++K + YL Y VHRD+ N+L+ +
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY-----VHRDLAARNVLVESEH 146
Query: 202 EPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259
+ K+ DFGL K + ++ V D+ + + PE + +K ASD++SFG+ +LL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 260 S 260
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI----YKSNNTDSFSR--------EVEGLSRVRHP 120
+G+G+ G VY + + +G+++A+K + + DS + E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 121 NLVCLFGCCVEGGEQYL--VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-ALRYL 177
N+V G E E+YL E+ G++ LR E+ V+ + L L YL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGS-CLRTYGRFE-EQLVRFFTEQVLEGLAYL 124
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTDVRGTIGYMDPEY 236
H I+HRD+K N+L+ K+SDFG++K + ++ ++G++ +M PE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 237 MTN------AKLTCASDIYSFGIVALQLLSGQK 263
+ + AK+ DI+S G V L++ +G++
Sbjct: 182 IHSYSQGYSAKV----DIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIY---KSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G+V+K PSG ++A K I+ K + RE++ L P +V +G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA----LRYLHHYIDGCI 185
GE + E G+L Q L + + +IL ++A L YL I
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHK--I 125
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+K +NIL+ + E KL DFG++ L + F GT YM PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 182
Query: 246 SDIYSFGIVALQLLSGQKVI------ELDFDARDQLTRKARDVSMGKRP 288
SDI+S G+ +++ G+ I EL+ + + RP
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 24/192 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+VYK +G++VA+K I + RE+ L + HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG---C- 184
+ YLV+EF +L +++ +K YL+ + G C
Sbjct: 67 VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK---------SYLYQLLQGIAYCH 116
Query: 185 ---IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
++HRD+K N+L+ + KL+DFGLA+ G+ + +T T+ Y PE + ++
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGSR 175
Query: 242 L-TCASDIYSFG 252
+ DI+S G
Sbjct: 176 QYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 43/217 (19%)
Query: 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYK--SNNTDS---FSREVEGLSRVR-HPNLV 123
+ LG+G+ G+V+K + + +VVA+K I+ N TD+ F RE+ L + HPN+V
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 124 CLFGCCVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD---------C 170
L V E YLV+E+ ++ L R IL D
Sbjct: 71 KLLN--VIKAENDKDIYLVFEYM------------ETDLHAVIRANILEDVHKRYIMYQL 116
Query: 171 ALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML----GMEESKVFTDVR 226
AL+Y+H G ++HRD+K +NILL KL+DFGLA+ L E+ V TD
Sbjct: 117 LKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 227 GTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQ 262
T Y PE + + T D++S G + ++L G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 53/189 (28%), Positives = 95/189 (50%), Gaps = 25/189 (13%)
Query: 93 VAIKHIYKSNNTDS----FSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147
VA+K + K + TD E+E + + +H N++ L G C + G Y++ E+ + GNL
Sbjct: 47 VAVK-MLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 148 AQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
++L + + LT++ V A + YL CI HRD+
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCI-HRDLAA 162
Query: 193 TNILLTEKLEPKLSDFGLAK-MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
N+L+TE K++DFGLA+ + ++ K T+ R + +M PE + + T SD++SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 252 GIVALQLLS 260
G++ ++ +
Sbjct: 223 GVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 76 RGSAGLVY--KGVLPSGQVVAIKHIYKSNN------TDSFSREVEGLSRVRHPNLVCLFG 127
+G+ G VY K +G AIK + KS+ T+ + + + P + L+
Sbjct: 6 KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
YLV E+ G+ A L++ L + + + + L + LH G I+H
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ--RG-IIH 120
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RDIK N+L+ + KL+DFGL++ G+E K GT Y+ PE + SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-GLENKKFV----GTPDYLAPETILGVGDDKMSD 175
Query: 248 IYSFGIVALQLLSG 261
+S G V + L G
Sbjct: 176 WWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 77 GSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGCCVE 131
G+ G+VY+ +G++VA+K + + F RE+ L +++HPN+V + V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV- 74
Query: 132 GGEQ---YLVYEFCAAGNLAQHLLR------KDSVLTWERRVK-ILRDCALALRYLHHYI 181
G Y+V E+ +H L+ K L E VK ++ + +LH
Sbjct: 75 GSNLDKIYMVMEY------VEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLH--- 123
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
D I+HRD+K +N+LL + K+ DFGLA+ G K +T + T+ Y PE + AK
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 242 L-TCASDIYSFG------IVALQLLSGQKVIELDFDARDQLTR 277
+ A D++S G + L G+ I DQL +
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-------DQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 89 SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG--EQYLVYEFCAA 144
+G+VVA+K + S + F RE+E L ++H N+V G C G LV E+
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLE 202
G+L +L + L + + + YL Y VHRD+ NIL+ +
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRY-----VHRDLATRNILVESENR 146
Query: 203 PKLSDFGLAKMLGMEESKVFTDVR----GTIGYMDPEYMTNAKLTCASDIYSFGIVALQL 258
K+ DFGL K+L + K + VR I + PE +T +K + ASD++SFG+V +L
Sbjct: 147 VKIGDFGLTKVL--PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
Query: 259 LS 260
+
Sbjct: 205 FT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 72 RFLGRGSAGLVYKGV---LPSGQV---VAIKHIYKSNNTDSFSREVEGLS------RVRH 119
R LG+GS G+VY+G+ + G+ VAIK + N S +E L+
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLNEASVMKEFNC 68
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL--LRKD-------SVLTWERRVKILRDC 170
++V L G G +V E A G+L +L R + T ++ +++ +
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 171 ALALRYLH--HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-----SKVFT 223
A + YL + VHRD+ N ++ E L K+ DFG+ + + + K
Sbjct: 129 ADGMAYLAAKKF-----VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
VR +M PE + + T SD++SFG+V
Sbjct: 184 PVR----WMAPESLKDGVFTTKSDVWSFGVV 210
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKH--IYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G GS G+V +G+ VA+K + K + EV + H N+V ++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V EF G L + + + E+ + AL YLH + ++HRDI
Sbjct: 90 VGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K +ILLT KLSDFG + E K + V GT +M PE ++ DI+S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWS 203
Query: 251 FGIVALQLLSGQ 262
GI+ ++++ G+
Sbjct: 204 LGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 51/216 (23%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---------REVEGLSRVRH 119
+ +G G+ G+V V +G+ VAIK I ++ F RE++ L +RH
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 120 PNLVCL-----------FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK--- 165
N++ L F + Y+V E +L + +++ LT + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFN------DVYIVTELMET-DLHK-VIKSPQPLT-DDHIQYFL 109
Query: 166 --ILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK--V 221
ILR L+YLH ++HRD+K +NIL+ + K+ DFGLA+ + +E +
Sbjct: 110 YQILR----GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 222 FTDVRGTIGYMDPEYMTNAK-LTCASDIYSFG-IVA 255
T+ T Y PE + ++ T A DI+S G I A
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIK--HIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G GS G+V SG+ VA+K + K + EV + +H N+V ++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E +++ EF G L + + L E+ + AL YLH ++HRDI
Sbjct: 89 VGEELWVLMEFLQGGALTD--IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K +ILLT KLSDFG + + K + V GT +M PE ++ DI+S
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWS 202
Query: 251 FGIVALQLLSGQ 262
GI+ ++++ G+
Sbjct: 203 LGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 54/261 (20%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G G+ G V +G+ VAIK + + + + RE+ L + H N++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 127 GC-----CVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALR 175
+E + YLV A +L + K L+ + ++ ILR L+
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGA-DLNNIV--KCQKLS-DDHIQFLVYQILR----GLK 132
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235
Y+H I+HRD+K +NI + E E K+ DFGLA+ E T T Y PE
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPE 185
Query: 236 YMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR----------------- 277
M N DI+S G + +LL+G K + D DQL R
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 278 --KARDV--SMGKRPIKDFED 294
AR+ S+ + P KDF++
Sbjct: 245 SESARNYIQSLPQMPKKDFKE 265
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 62/268 (23%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+ LG G G V+ G + VA+K + + + +F E + ++H LV L+
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLH--HYIDGCIVH 187
+ Y++ E+ A G+L L + + + + A + Y+ +YI H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI-----H 126
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD++ N+L++E L K++DFGLA+++ E + I + PE + T SD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307
++SFGI+ ++++ K+ D ++ R M PR+ +
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------PRMENCP-----D 231
Query: 308 SILKIAVLCVAKSSKGRPTIDVVYEEID 335
+ I C + ++ RPT D + +D
Sbjct: 232 ELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 68 DW-DRRF---LGRGSAGLVYK------GVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV 117
+W D +F +G G+ G V K G+ + +K ++ F+ E+E L ++
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 118 -RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALAL-- 174
HPN++ L G C G YL E+ GNL LRK VL + I A L
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSS 123
Query: 175 -RYLHHYIDGC----------IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223
+ LH D +HRD+ NIL+ E K++DFGL++ G E T
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 181
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
R + +M E + + T SD++S+G++ +++S
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 74 LGRGSAGLVYK----GVLPSGQ----VVAIKHIYKSNNTDS----FSREVEGLSRV-RHP 120
LG G G V + G+ S VA+K + K N TD E+E + + +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVK 165
N++ L G C + G Y++ E+ A GNL + L + + L+++ V
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 166 ILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTD 224
A + YL CI HRD+ N+L+TE K++DFGLA+ + ++ K ++
Sbjct: 139 CAYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
R + +M PE + + T SD++SFGI+ ++ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 74 LGRGSAGLV-YKGVLPSGQVVAIKH--IYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G GS G+V V SG++VA+K + K + EV + +H N+V ++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWER--RVKILRDCALALRYLHHYIDGCIVHR 188
G E ++V EF G L ++T R +I C L+ L ++HR
Sbjct: 88 VGDELWVVMEFLEGGALT-------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDI 248
DIK +ILLT KLSDFG + E + + V GT +M PE ++ DI
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 249 YSFGIVALQLLSGQ 262
+S GI+ ++++ G+
Sbjct: 200 WSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 74 LGRGSAGLVYK------GVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
LG G+ G VYK GVL + +V+ K + + E++ L+ HPN+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKIL-RDCALALRYLHHYIDGCIV 186
+++ EFCA G + +L + LT E +++++ + AL YLH + I+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLT-EPQIRVVCKQTLEALNYLH---ENKII 125
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLA----KMLGMEESKVFTDVRGTIGYMDPEYM----- 237
HRD+K NIL T + KL+DFG++ + + +S + GT +M PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETS 180
Query: 238 TNAKLTCASDIYSFGIVALQL 258
+ +D++S GI +++
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 72 RFLGRGSAGLVY---------KGVLPSGQVVAIKHIYKSNNTDSFSR-EVEGLSRVRH-P 120
+ LG G+ G V+ G L + +V+ + + T +R E L VR P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
LV L + +L+ ++ + G + HL ++D+ E R + LAL +LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS-GEIILALEHLHKL 124
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM-TN 239
IV+RDIKL NILL + L+DFGL+K EE + GTI YM PE +
Sbjct: 125 ---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
A D +S GI+ +LL+G L+ + Q
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK-----------DSVLTWERRVKI 166
+H N++ L G C + G Y++ E+ + GNL ++L + V + K
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 167 LRDCALAL-RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTD 224
L CA + R + + +HRD+ N+L+TE K++DFGLA+ + ++ K T+
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
R + +M PE + + T SD++SFG++ ++ +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 74 LGRGSAGLVYKGVL--PSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGC 128
LG+G+ G VYK VL P+G +A+K I + F+ E++ L + P +V +G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA----LRYLHHYIDGC 184
G Y+ E+ AG+L + L V T +LR A L++L +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK--LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT------ 238
I+HRD+K TN+L+ + KL DFG++ L +K T++ G YM PE +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNI-GCQSYMAPERIKSGGPNQ 180
Query: 239 NAKLTCASDIYSFGIVALQLLSG 261
N T SD++S G+ L++ G
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 6e-13
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKH-----IYKSNNTDSFSREVEGLSRVR-HPNLVC 124
R LG+GS G V L SG++ A+K I + ++ + E LS R HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 125 LFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC------ALALRYL 177
L+ CC + ++ + V EF G+L H+ + RR R AL +L
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEITSALMFL 112
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H D I++RD+KL N+LL + KL+DFG+ K G+ K + GT Y+ PE +
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEIL 168
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKVIE 266
+ D ++ G++ ++L G E
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVC 124
D + +G G+ GLV +GQ VAIK I K +T + RE++ L +RH N++
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIIS 73
Query: 125 LFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRV----------KILRDCALA 173
L + E Y V E L L R L R + +ILR
Sbjct: 74 LSDIFISPLEDIYFVTEL-----LGTDLHR----LLTSRPLEKQFIQYFLYQILR----G 120
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L+Y+H +VHRD+K +NIL+ E + K+ DFGLA+ +++ ++ T T Y
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQM-TGYVSTRYYRA 173
Query: 234 PEYM-TNAKLTCASDIYSFGIVALQLLSGQ 262
PE M T K DI+S G + ++L G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGC 128
+G G+ G V+K + ++VA+K + ++ + S RE+ L ++H N+V L+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 129 CVEGGEQYLVYEFC----------AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
+ LV+E+C G++ +++ S + ++L+ LA + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFM-----FQLLK--GLAFCHSH 118
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ ++HRD+K N+L+ + E KL+DFGLA+ G+ + ++ T+ Y P+ +
Sbjct: 119 N-----VLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 172
Query: 239 NAKLTCAS-DIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
AKL S D++S G + +L + + + D DQL R
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVC 124
+ LG+GS G V+ L + Q AIK + K ++ + E LS HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 125 LFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L+ C + E + V E+ G+L H+ + R + L++LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLH---SK 115
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
IV+RD+KL NILL K++DFG+ K MLG ++ F GT Y+ PE + K
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPEILLGQK 172
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
+ D +SFG++ ++L GQ
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 74 LGRGSAGL----VYKGVLPSGQVVAIKHIY-KSNNTDSFSR---EVEGLSRVRHPNLVCL 125
+G+ L + K P+ +VA+K I S + + E+ +++HPN++
Sbjct: 6 IGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLR-------KDSVLTWERRVKILRDCALALRYLH 178
+ E Y+V A G+ + LL+ + + + IL+D AL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH 118
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-----KVFTDVRGTIG--- 230
G I HR +K ++ILL+ + LS GL + M + V + ++
Sbjct: 119 S--KGFI-HRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 231 YMDPEYMT------NAKLTCASDIYSFGIVALQLLSGQ 262
++ PE + N K SDIYS GI A +L +G
Sbjct: 174 WLSPEVLQQNLQGYNEK----SDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 64/236 (27%), Positives = 94/236 (39%), Gaps = 60/236 (25%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNL 122
+ LG+G G V+ KG +G++ A+K + K N E E L+ + HP L
Sbjct: 7 KLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCA---------LA 173
L+ LV ++C G L L + + K L + LA
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGEL--FRLLQ------RQPGKCLSEEVARFYAAEVLLA 115
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR------- 226
L YLH + G IV+RD+K NILL E LSDF L+K +E V +R
Sbjct: 116 LEYLH--LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 227 ---------------------GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
GT Y+ PE ++ A D ++ GI+ ++L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-------FSREVEGLSRVRHPNLV 123
+ LG G+ G VYKG+ +P G+ V I K N + F E ++ + HP+LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLR-KDSV-----LTWERRVKILRDCALALRYL 177
L G C+ Q LV + G L ++ KD++ L W C + +
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW---------CVQIAKGM 122
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPEY 236
+ + +VHRD+ N+L+ K++DFGLA++L +E + D + I +M E
Sbjct: 123 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 237 MTNAKLTCASDIYSFGIVALQLLS 260
+ K T SD++S+G+ +L++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 10/209 (4%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIY-KSNNTDSFS--REVEGLSRVRHPNLVCLFGCC 129
LG GS VYKG+ +GQ+VA+K I K+ F+ RE L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
V+E+ +LAQ++++ L + L Y+H I+HRD
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRD 128
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDI 248
+K N+L++ E KL+DFGLA+ + S+ ++ T+ Y P+ + A + A DI
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 249 YSFGIVALQLLSGQKVIELDFDARDQLTR 277
+ G + +++L GQ D +QL +
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 74 LGRGSAGLVYKGVL--PSGQVVAIKHIYKSNNTDSFSREVEGLSRV-----RHPNLVCLF 126
+G+G+ G V+K VL +G A+K + ++ D E+E + HPN+V +
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID---EEIEAEYNILKALSDHPNVVKFY 81
Query: 127 GC-----CVEGGEQYLVYEFCAAG---NLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
G G + +LV E C G +L + L++ + IL + + L++LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+HRD+K NILLT + KL DFG++ L + T V GT +M PE +
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 239 -----NAKLTCASDIYSFGIVALQLLSG 261
++ D++S GI A++L G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 39/237 (16%)
Query: 73 FLGRGSAGLVYKGV-LPSGQVVAIKHI----YKSNNTDSFS------------REVEGLS 115
LG G+ G V K +G++VAIK + ++ T RE++ ++
Sbjct: 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 116 RVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALAL 174
++H N++ L VEG LV + A +L + + RK + E +VK IL L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDI-MASDLKKVVDRK--IRLTESQVKCILLQILNGL 132
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-----MLGMEESKVFTDVRG-- 227
LH + +HRD+ NI + K K++DFGLA+ SK T R
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 228 ------TIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
T+ Y PE + A K A D++S G + +LL+G+ + + + DQL R
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE-NEIDQLGR 245
|
Length = 335 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 68 DWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLS-------RVR 118
+W R + LG+G+ G VY + +G+ +A K + + S+EV L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 119 HPNLVCLFGCCVEGGEQYLV--YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRY 176
H +V +GC + E+ L E+ G++ L + LT K R + Y
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSY 121
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG---MEESKVFTDVRGTIGYMD 233
LH + IVHRDIK NIL KL DFG +K L M + + V GT +M
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI-RSVTGTPYWMS 177
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLS 260
PE ++ +D++S G +++L+
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 66/286 (23%), Positives = 124/286 (43%), Gaps = 52/286 (18%)
Query: 73 FLGRGSAGLVYKGVLPSGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
FLG G+ + VL VA+K + + F +E++ +SR+++PN++ L G C
Sbjct: 32 FLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI---- 185
V ++ E+ G+L Q L +++ T+ I L Y+ I +
Sbjct: 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA 146
Query: 186 ----VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG----TIGYMDPEYM 237
VHRD+ N L+ K++DFG+++ L S + ++G I +M E +
Sbjct: 147 SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMAWESI 203
Query: 238 TNAKLTCASDIYSFGIVALQ-----------LLSGQKVIELDFDARDQLTRKARDVSMGK 286
K T ASD+++FG+ + LLS ++VIE + + + R + + +
Sbjct: 204 LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE---NTGEFFRNQGRQIYLSQ 260
Query: 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332
P+ + K+ + C ++ K RPT + ++
Sbjct: 261 TPLCP---------------SPVFKLMMRCWSRDIKDRPTFNKIHH 291
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 74 LGRGSAGLVYKGV------LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVC 124
LG G G V K VA+K + ++ ++ E L +V HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTW--ERRVKIL 167
L+G C + G L+ E+ G+L L R S L ER + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 168 RDCALAL---RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV-FT 223
+ A R + + + +VHRD+ N+L+ E + K+SDFGL++ + E+S V +
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
R + +M E + + T SD++SFG++ ++++
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-PNLVCLFGCC 129
R+ G S L VL +V K+ T+ E + L +R P LV L
Sbjct: 20 RKVSGHDSGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYIDGCIVHR 188
+ +L+ ++ G L HL +++ E+ V+I + LAL +LH I++R
Sbjct: 75 QTDTKLHLILDYINGGELFTHLSQRERFK--EQEVQIYSGEIVLALEHLHKL---GIIYR 129
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL--TCAS 246
DIKL NILL L+DFGL+K +E + GTI YM P+ + A
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV 189
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQ 274
D +S G++ +LL+G +D + Q
Sbjct: 190 DWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 74 LGRGSAGLVYKG----VLPSGQV----VAIKHIYKS--NNTDSFSREVEGLSRVRHPNLV 123
LG+G+ ++KG V G++ V +K + KS N ++SF +S++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
+G CV G E +V E+ G+L +L + +++ ++++ + A AL +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 184 CIVHRDIKLTNILLTEKLEP--------KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235
+ H ++ N+LL + + KLSD G++ + +E + + I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE--ILLE---RIPWVPPE 174
Query: 236 YMTNAK-LTCASDIYSFGIVALQLLSG 261
+ N + L+ A+D +SFG ++ SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 71 RRFLGRGSAGLVY----KGVLPSGQ--VVAIKHIYKSNNT--DSFSREVEGLSRVRHPNL 122
+R LG G+ G V+ + P+ +VA+K + F RE E L+ ++H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTWERRVKIL 167
V +G C +G +V+E+ G+L + L + L + + I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 168 RDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVFTD 224
A + YL H+ VHRD+ N L+ L K+ DFG+++ + + +V
Sbjct: 130 SQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
I +M PE + K T SD++SFG++ ++ +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 57/213 (26%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQ----VVAIKHIYKSNNTDSFSREVEG----LSRVRHPNL 122
+ LG G+ G VYKG+ +P G+ VAIK + + N + ++E+ ++ V P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIK-VLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
L G C+ Q LV + G L ++ + + + A + YL +
Sbjct: 72 CRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---E 127
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPEYMTNAK 241
+VHRD+ N+L+ K++DFGLA++L ++E++ D + I +M E + + +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 242 LTCASDIYSFGIVALQLLS-GQKVIELDFDARD 273
T SD++S+G+ +L++ G K + AR+
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 60/234 (25%)
Query: 74 LGRGSAG---LVYKGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCL 125
+GRG+ G LV +GQV A+K + KS N E + L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 126 FGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR----DCALALRYLH-- 178
+ + E YLV E+ G+L L+RKD + R + LAL +H
Sbjct: 67 Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF-----PEETARFYIAELVLALDSVHKL 120
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR------------ 226
+I HRDIK NIL+ KL+DFGL K M ++K
Sbjct: 121 GFI-----HRDIKPDNILIDADGHIKLADFGLCK--KMNKAKDREYYLNDSHNLLFRDNV 173
Query: 227 ------------------GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
GT Y+ PE + D +S G++ ++L G
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 16/228 (7%)
Query: 72 RFLGRGS-AGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH--------PNL 122
R +GRGS A ++ + + Q+ A+K + K D +++ + +H P L
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD--EDIDWVQTEKHVFEQASSNPFL 58
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
V L C +LV E+ G+L H+ R+ + R C +AL +LH +
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEIC-IALNFLH---E 114
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+KL N+LL KL+D+G+ K G+ + GT Y+ PE + +
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290
+ D ++ G++ ++++G+ ++ D D T + ++PI+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 62/196 (31%), Positives = 86/196 (43%), Gaps = 14/196 (7%)
Query: 74 LGRGSAGLVY------KGVLPSGQVVAIKHIYKSNNTDSFSREVEGL-SRVRHPNLVCLF 126
+G+GS G V G + +V+ K I K E L V+HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCALALRYLHHYIDGCI 185
+ Y V ++ G L HL R+ S E R + + A AL YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP--EPRARFYAAEIASALGYLHSL---NI 117
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
++RD+K NILL + L+DFGL K G+E SK + GT Y+ PE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 246 SDIYSFGIVALQLLSG 261
D + G V ++L G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDS--FSREVEGLSRVRHPNLVCL 125
LG+GS G V L + + AIK + K ++ + R V L+ HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 126 FGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCALALRYLHHYIDG 183
F C + E + V E+ G+L H+ + S E R + + L++LH
Sbjct: 62 F-CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I++RD+KL N+LL + K++DFG+ K M G ++ F GT Y+ PE + K
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC---GTPDYIAPEILKGQK 172
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
+ D +SFG++ ++L GQ
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI-YKSNNTDSFS--REVEGLSRVRHPNLVCLFGCC 129
LG GS VYKG +GQ+VA+K I + F+ RE L ++H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-----LRDCALALRYLHHYIDGC 184
LV+E+ +L Q++ L+ V++ LR L Y H
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLS-MHNVRLFLFQLLR----GLAYCHQRR--- 123
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
++HRD+K N+L++E+ E KL+DFGLA+ + SK +++ T+ Y P+ + + T
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVVTLWYRPPDVLLGS--TE 180
Query: 245 AS---DIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
S D++ G + ++ +G+ + D DQL +
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIKHI----YKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG+GS G VY K + ++ +K I N T ++E + LS++ HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 126 FGCCVEGGEQYLVYEFCAAGNL---AQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
+E ++ E+C +L + L L+ + + L + Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR- 126
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I+HRD+K NI L L K+ DFG++++L M + T GT YM PE + +
Sbjct: 127 --ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 243 TCASDIYSFGIV 254
SDI+S G +
Sbjct: 183 DSKSDIWSLGCI 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 72 RFLGRGS-AGLVYKGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVC 124
R +GRGS A ++ + + ++ A+K + K + D E + HP LV
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
L C + V E+ G+L H+ R+ L E + +LAL YLH +
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERG 116
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
I++RD+KL N+LL + KL+D+G+ K G+ + GT Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 245 ASDIYSFGIVALQLLSGQKVIEL 267
+ D ++ G++ ++++G+ ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 70/227 (30%), Positives = 112/227 (49%), Gaps = 31/227 (13%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
LG G+ G VYK + +G+VVA+K I N D F RE++ L +++HPN+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 129 CVEGGEQ--------YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH 179
VE ++ Y+V + +L+ LL SV E ++K + + YLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSG-LLENPSVKLTESQIKCYMLQLLEGINYLH- 132
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA----------KMLGMEESKVFTDVRGTI 229
+ I+HRDIK NIL+ + K++DFGLA K G ++ +T++ T
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 230 GYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQKVIELDFDARDQL 275
Y PE + + T A DI+ G V ++ + + +++ D DQL
Sbjct: 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQL 236
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQ----VVAIKHIYKSNNTDSFSR---EVEGLSRVRHPNLV 123
+ LG G+ G VYKG+ +P G+ VAIK + ++ + + E ++ V +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLR-KDSV-----LTWERRVKILRDCALALRYL 177
L G C+ Q L+ + G L ++ KD++ L W C + +
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW---------CVQIAKGM 122
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPEY 236
++ + +VHRD+ N+L+ K++DFGLAK+LG +E + + + I +M E
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 237 MTNAKLTCASDIYSFGIVALQLLS 260
+ + T SD++S+G+ +L++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIK--HIYKSNNTDSFS-REVEGLSRVRHPNLVCLFGCC 129
LG G+ VYKG +G++VA+K H+ T S + RE+ + ++H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG---C-- 184
+ LV+E+ +L +++ D+ V+ D + + + G C
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYM---DT-----HGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 185 --IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
++HRD+K N+L+ ++ E KL+DFGLA+ G+ + +V T+ Y P+ + ++
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRT 177
Query: 243 TCAS-DIYSFGIVALQLLSG 261
S DI+S G + ++++G
Sbjct: 178 YSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVC 124
R +G+G G VY G L A+K + + + + F +E + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 125 LFGCCV-EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-ALRYLHHYID 182
L G C+ G +V + G+L ++ +R + T VK L L + + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL-RNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVF--TDVRGTIGYMDPEYMTN 239
VHRD+ N +L E K++DFGLA+ + E V T + + +M E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 240 AKLTCASDIYSFGIVALQLLS 260
K T SD++SFG++ +L++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIK-----HIYKSNNTDS--FSREVEGLSRVRHPNLV 123
+ LG+GS G V L + +V AIK I + ++ D + + L+ +HP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCALALRYLHHYID 182
L C + V E+ G+L + R E R + + LAL +LH +
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD--EPRSRFYAAEVTLALMFLHRH-- 115
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
+++RD+KL NILL + KL+DFG+ K G+ T GT Y+ PE + +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 243 TCASDIYSFGIVALQLLSGQKVIELD 268
+ D ++ G++ ++++GQ E D
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 27/192 (14%)
Query: 91 QVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL--VYEFCA 143
Q A+K I K N E + L+ +P +V +F C E +++L V E+
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSFET-KRHLCMVMEYVE 84
Query: 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203
G+ A LL+ L + + LAL YLH+Y IVHRD+K N+L+T
Sbjct: 85 GGDCAT-LLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHI 140
Query: 204 KLSDFGLAKMLGM------------EESKVFTD--VRGTIGYMDPEYMTNAKLTCASDIY 249
KL+DFGL+K+ M ++++ F D V GT Y+ PE + D +
Sbjct: 141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200
Query: 250 SFGIVALQLLSG 261
+ GI+ + L G
Sbjct: 201 AMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 76 RGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCC 129
RG+ G VY G + ++ A+K + K+ N E + L+ + P +V L+
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
YLV E+ G++ + LL E VK + + ALAL YLH + I+HRD
Sbjct: 74 QSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 190 IKLTNILLTEKLEPKLSDFGLAKM 213
+K N+L++ + KL+DFGL+K+
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 33/274 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLS---RVRH-PNLVCLFGC 128
LGRG+ G+V K +P+G ++A+K I + N+ R + L R P V +G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 129 CVEGGEQYLVYEF--CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G+ ++ E + + + K + + KI AL YLH + ++
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VI 126
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM---TNAK-L 242
HRD+K +N+L+ + KL DFG++ L +S T G YM PE + N K
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKGY 184
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
SD++S GI ++L +G+ + QL + + S P+L
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-----------PQLPAEKF 233
Query: 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+F+ + C+ K+ K RP Y E+ +
Sbjct: 234 SPEFQDFVNK---CLKKNYKERPN----YPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI-YKSNNTDSFS--REVEGLSRVRHPNLVCLFGCC 129
LG GS VYKG +G++VA+K I + F+ RE L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
LV+E+ +L Q++ + L E L L Y+H I+HRD
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDI 248
+K N+L+++ E KL+DFGLA+ + S +++ T+ Y P+ + + + + D+
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 249 YSFGIVALQLLSGQKVIELDFDARDQLTR 277
+ G + ++++ G D +DQL R
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLER 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 72 RFLGRGSAGLV----YKGVLPSGQVVAIKHIYKSNNTDSFS---------REVEGLSRVR 118
+ LG+G+ G+V + VAIK I T+ FS RE++ L R
Sbjct: 6 KELGQGAYGIVCSARNAETSE-EETVAIKKI-----TNVFSKKILAKRALRELKLLRHFR 59
Query: 119 -HPNLVCLFGC-CVEGG---EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
H N+ CL+ V G E YL YE +L Q ++R LT +
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQ-IIRSGQPLTDAHFQSFIYQILCG 117
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV-----FTDVRGT 228
L+Y+H ++HRD+K N+L+ E K+ DFGLA+ G E+ T+ T
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR--GFSENPGENAGFMTEYVAT 172
Query: 229 IGYMDPEYM-TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLT 276
Y PE M + T A D++S G + +LL + V + D DQL
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK-DYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 28/181 (15%)
Query: 102 NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ-----HLLRKDS 156
N + F +EV+ LSR++ PN++ L G CV+ ++ E+ G+L Q HL K+
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 157 -------------VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203
+++ + + A ++YL VHRD+ N L+ E L
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTI 177
Query: 204 KLSDFGLAKMLGMEESKVFTDVRG----TIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259
K++DFG+++ L + + ++G I +M E + K T ASD+++FG+ ++L
Sbjct: 178 KIADFGMSRNLYAGD---YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 260 S 260
Sbjct: 235 M 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 72 RFLGRGSAGLVYKGVLPSGQV--VAIKH-----IYKSNNTDSFSREVEGLSRVRHPNLVC 124
R LG GS G V + VAIK I K D E + L+ + HP V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
L+G + YLV EF G LR++ + L YL
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---N 151
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
IV+RD+K N+LL + K++DFG AK++ +++ +T + GT Y+ PE + N
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHGK 207
Query: 245 ASDIYSFGIVALQLLSG 261
A+D ++ GI ++L G
Sbjct: 208 AADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 71 RRFLGRGSAGLVYKG-VLPSGQVVAIKHIYKSNNTDSFSR----EVEGLSRVRHPNLVCL 125
+ LG G+ G VYK L + +++A+K I + T + E+E L + P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+G + EF G+L + + VL +I L YL I
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---I 116
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+K +N+L+ + + KL DFG++ L +K + GT YM PE ++ +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYGIH 173
Query: 246 SDIYSFGIVALQLLSGQ 262
SD++S GI ++L G+
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVC 124
+ ++G G+ G+V P+G VAIK I + +F RE++ L R +H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRTLREIKILRRFKHENIIG 67
Query: 125 LF-----GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWER----RVKILRDCALALR 175
+ + Y+V E +L + L K L+ + +ILR L+
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMET-DL--YKLIKTQHLSNDHIQYFLYQILR----GLK 120
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE--SKVFTDVRGTIGYMD 233
Y+H ++HRD+K +N+LL + K+ DFGLA++ E + T+ T Y
Sbjct: 121 YIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 234 PEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLT 276
PE M N+K T A DI+S G + ++LS + + D QL
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYLHQLN 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYK--SNNT---DSFSREVEGLSRVRHPNLVCL 125
R +G+G G VY P + VA+K I + S N F RE + + + HP +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLR----KDSV---LTWERRVKIL-----RDCALA 173
+ C +G Y + L + LL+ K+S+ L + V + CA
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA-T 125
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVR------ 226
+ Y+H ++HRD+K NILL E + D+G A +EE + DV
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 227 ----------GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
GT YM PE + + ++DIY+ G++ Q+L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 24/231 (10%)
Query: 74 LGRGSAGLVYK-GVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
+G+GS G V + + ++ A+K HI + E L++V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ YLV F G L HL R+ R + AL LH + +++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT-AELLCALENLHKF---NVIY 116
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD+K NILL + L DFGL K L M++ GT Y+ PE + T A D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 248 IYSFGIVALQLLSG-------------QKVIELDFDARDQLTRKARDVSMG 285
++ G++ ++L+G +K+++ D R A+D+ +G
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIG 226
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 50/237 (21%), Positives = 95/237 (40%), Gaps = 35/237 (14%)
Query: 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPN 121
I N W G+ +Y V +K + + ++ + F ++ + ++HPN
Sbjct: 3 IGNGW----FGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPN 56
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHL-----LRKDSVLTWERRVKILRDCALALRY 176
++ G CVE LV+E+C G+L +L R++S L +R+ + +
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-----ESKVFTDVRGTIGY 231
H++ +H D+ L N LT L K+ D+G+ E E +R +
Sbjct: 117 KHNF-----LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----W 167
Query: 232 MDPEYMTN-------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD 281
+ PE + A+ T S++++ G+ +L R+ L +D
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 72 RFLGRGS-AGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-----------H 119
R +GRGS A ++ + + ++ A+K I K D E + V+ H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-----EDIDWVQTEKHVFETASNH 55
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
P LV L C + V EF + G+L H+ R+ L E + +LAL +LH
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISLALNFLH- 113
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+ I++RD+KL N+LL + KL+D+G+ K G+ + GT Y+ PE +
Sbjct: 114 --ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIEL--DFDARDQLT 276
+ D ++ G++ ++++G+ ++ D DQ T
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKS--NNTDSFS--REVEGLSRVRHPNLVCLFGC 128
+GRG+ G+V + + VAIK I + N D+ RE++ L + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 129 CVEGGEQ-----YLVYEFCAAGNLAQHLLRKDSVLTWER----RVKILRDCALALRYLHH 179
+ Y+VYE +L Q ++R L+ + ++LR L+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-DLHQ-IIRSSQTLSDDHCQYFLYQLLR----GLKYIH- 125
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
++HRD+K +N+LL + K+ DFGLA+ E+ T+ T Y PE + N
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 240 -AKLTCASDIYSFGIVALQLLSGQ 262
++ T A D++S G + +LL +
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS------REVEGLSRVRHPNLVCLF 126
+G+GS G+V + +G+ VAIK I ++ + S RE++ L +RHP++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 127 GCCV-----EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
+ E + Y+V+E + +L Q +++ + LT E L AL+Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMES-DLHQ-VIKANDDLTPEHHQFFLYQLLRALKYIH--- 120
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAK-MLGMEESKVF-TDVRGTIGYMDPEYMTN 239
+ HRD+K NIL + K+ DFGLA+ + +F TD T Y PE +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 240 --AKLTCASDIYSFGIVALQLLSGQ 262
+K T A DI+S G + ++L+G+
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 72 RFLGRGSAG-LVYKGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCL 125
+ LG+G+ G ++ SG+ A+K + K + E L RHP L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
V E+ G L HL R + V + +R + AL YLH G I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH---SGKI 116
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
V+RD+KL N++L + K++DFGL K G+ ++ GT Y+ PE + + A
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 246 SDIYSFGIVALQLLSGQ 262
D + G+V +++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLS-------RVRHPNLV 123
+ LGRG+ G VY +G+ +A+K + ++ S+EV L +RH +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 124 CLFGCCVEGGEQYL--VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
+GC + E+ L E+ G++ L + LT + R + YLH +
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG---MEESKVFTDVRGTIGYMDPEYMT 238
IVHRDIK NIL KL DFG +K + M + + V GT +M PE ++
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI-KSVTGTPYWMSPEVIS 182
Query: 239 NAKLTCASDIYSFGIVALQLLS 260
+D++S +++L+
Sbjct: 183 GEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 51 SGLYRFSKDEIENAINNDWD-RRFLGRGSAGLV----YKGVLPSGQVVAIK-----HIYK 100
Y F+K + + +D++ LG GS G V +KG +G+ AIK I K
Sbjct: 2 KAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILK 58
Query: 101 SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW 160
++E L + HP +V + + Y + EF G L HL RK
Sbjct: 59 MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAG---- 113
Query: 161 ERRVKILRDCA--------LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212
+ D A LA YLH I++RD+K N+LL K K++DFG AK
Sbjct: 114 ----RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
Query: 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
+ + FT + GT Y+ PE + + A D ++ G++ + ++G
Sbjct: 167 KV---PDRTFT-LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 7/149 (4%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCAL 172
L ++HP LV L + Y V ++ G L HL R+ L E R + + A
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL--EPRARFYAAEVAS 107
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYM 232
A+ YLH I++RD+K NILL + L+DFGL K G+E + + GT Y+
Sbjct: 108 AIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYL 163
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLSG 261
PE + D + G V ++L G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 52/149 (34%), Positives = 69/149 (46%), Gaps = 7/149 (4%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCAL 172
L V+HP LV L + Y V +F G L HL R+ S E R + + A
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAAEIAS 107
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYM 232
AL YLH IV+RD+K NILL + L+DFGL K G+ +S T GT Y+
Sbjct: 108 ALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYL 163
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLSG 261
PE + D + G V ++L G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 44/266 (16%)
Query: 42 TKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYK 100
+E+ T W R+ D + +G G+ G V + +G VAIK +Y+
Sbjct: 3 RQEVNKTIWEVPDRYR------------DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR 50
Query: 101 SNNTDSFS----REVEGLSRVRHPNLVCLFGCCV------EGGEQYLVYEFCAA--GNLA 148
++ F+ RE+ L ++H N++ L + YLV F G L
Sbjct: 51 PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM 110
Query: 149 QHLLRKDSVLTWERRVKILRDCAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207
+H K S E R++ L L L+Y+H I+HRD+K N+ + E E K+ D
Sbjct: 111 KH--EKLS----EDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD 161
Query: 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIE 266
FGLA+ E T T Y PE + N T DI+S G + ++L+G+ +
Sbjct: 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL-- 215
Query: 267 LDFDARDQLTRKARDVSMGKRPIKDF 292
F D L + + + P K+F
Sbjct: 216 --FKGHDHLDQLMEIMKVTGTPSKEF 239
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLS-------RVRHPNLV 123
+ LG+G+ G VY +G+ +A+K + + S+EV L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 124 CLFGCCVEGGEQYL--VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
+GC + E+ L E G++ L + LT K R + YLH +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML--------GMEESKVFTDVRGTIGYMD 233
IVHRDIK NIL KL DFG +K L GM+ V GT +M
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS------VTGTPYWMS 177
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA 271
PE ++ +DI+S G +++L+ +K +F+A
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQ--VVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
R LG G G + +G L PS + VAI H ++ +D F E L + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G G +V E+ + G L L + + L + + +L A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM--- 126
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG--TIGYMDPEYMTNAK 241
VH+ + +L+ L K+S F + E ++T + G + + PE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE--AIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 242 LTCASDIYSFGIVALQLLS 260
+ ASD++SFGIV +++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
+ LG G G V +G L S VA+K + +T S F E + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 124 CLFGCCVEGGEQ------YLVYEFCAAGNLAQHLLRK-----DSVLTWERRVKILRDCAL 172
L G C E ++ F G+L LL L + +K + D AL
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD---VRGTI 229
+ YL + +HRD+ N +L E + ++DFGL+K K+++ +G I
Sbjct: 125 GMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSK-------KIYSGDYYRQGRI 174
Query: 230 GYMDPEYMTNAKL-----TCASDIYSFGIVALQLLS-GQ 262
M +++ L T SD+++FG+ ++ + GQ
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 74 LGRGSAGLVYKGVL----------PSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPN 121
LG+G+ +YKGVL P +V + + S++ DS F +S++ H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
LV L+G CV +V E+ G L L R+ + ++ ++ + + A AL YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 182 DGCIVHRDIKLTNILLTEKLEP--------KLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
D +VH ++ NIL+ + KLSD G+ + E +V I ++
Sbjct: 119 DKKLVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIPITVLSREERV-----ERIPWIA 172
Query: 234 PEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273
PE + N A LT A+D +SFG L++ S E
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNG---EEPLSTLS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 72 RFLGRGSAGLVYKGVLPSGQV-------VAIKHIYKSNNTDS---FSREVEGLSRVRHPN 121
R LG+GS G+VY+G+ G V VAIK + ++ + F E + +
Sbjct: 12 RELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHL--LRKD-------SVLTWERRVKILRDCAL 172
+V L G +G ++ E G+L +L LR + + + ++ +++ + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-----SKVFTDVRG 227
+ YL+ VHRD+ N ++ E K+ DFG+ + + + K VR
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 228 TIGYMDPEYMTNAKLTCASDIYSFGIV 254
+M PE + + T SD++SFG+V
Sbjct: 187 ---WMSPESLKDGVFTTYSDVWSFGVV 210
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYK-SNNTDSFSREVEGLSRVRHPNLVCLFGC 128
+++ LG G G V+ VA+K + S + ++F E + ++H LV L
Sbjct: 11 EKK-LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLH--HYIDGCI 185
V Y++ EF A G+L L + S + + A + ++ +YI
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI---- 124
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
HRD++ NIL++ L K++DFGLA+++ E + I + PE + T
Sbjct: 125 -HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 246 SDIYSFGIVALQLLS 260
SD++SFGI+ +++++
Sbjct: 184 SDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 165 KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224
+ILR L+YLH I+HRDIK N+L+ K+ DFGLA++ +ESK T
Sbjct: 111 QILR----GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163
Query: 225 VRGTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQ 262
T Y PE + ++ T A DI+S G + +LL +
Sbjct: 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 26/196 (13%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCL--- 125
+G G+ G+V + SG+ VAIK I + + + + RE++ L +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 126 FGCCV-EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWER----RVKILRDCALALRYLHHY 180
+ + Y+V + +L H++ D LT E ++LR L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDL-MESDL-HHIIHSDQPLTEEHIRYFLYQLLR----GLKYIH-- 124
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG---MEESKVFTDVRGTIGYMDPEYM 237
++HRD+K +N+L+ E E ++ DFG+A+ L E T+ T Y PE +
Sbjct: 125 -SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 238 -TNAKLTCASDIYSFG 252
+ + T A D++S G
Sbjct: 184 LSLPEYTTAIDMWSVG 199
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 8/171 (4%)
Query: 91 QVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQH 150
+V+AI + + E L V HP ++ LF + Y++ E+ G L +
Sbjct: 32 KVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY 91
Query: 151 LLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210
L R + + + AL YLH IV+RD+K NILL ++ KL+DFG
Sbjct: 92 L-RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147
Query: 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
AK L + +T + GT Y+ PE + + A D ++ GI+ ++L G
Sbjct: 148 AKKL---RDRTWT-LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
L RHP L L V E+ G L HL ++ V + +R + A
Sbjct: 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA 107
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YLH +V+RD+KL N++L + K++DFGL K G+ + GT Y+
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLA 163
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273
PE + + A D + G+V +++ G+ L F +D
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR----LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/149 (31%), Positives = 68/149 (45%), Gaps = 5/149 (3%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
L RHP L L V E+ G L HL R + V T ER + A
Sbjct: 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSA 107
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YLH +V+RDIKL N++L + K++DFGL K G+ + GT Y+
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLA 163
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
PE + + A D + G+V +++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 74 LGRGSAGLVYKG--VLPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVR---HPNLVC 124
+G G+ G V+K + G+ VA+K + + S REV L + HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 125 LFGCCV-----EGGEQYLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLH 178
LF C + LV+E +L +L + + + E ++ L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ +VHRD+K NIL+T + KL+DFGLA++ + T V T+ Y PE +
Sbjct: 128 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLL 182
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
+ D++S G + ++ + + D DQL +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 74 LGRGSAGLVYKGVLPSG----QVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCLF 126
+G G G V G + SG QVV +K + S + F E + ++H NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
G C E LV EFC G+L +L RK ++T + C +AL LH + +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT-IGYMDPEYMTN---- 239
+H D+ L N LLT L K+ D+GL+ E+ V D + ++ PE +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 240 ---AKLTCASDIYSFGIVALQL----------LSGQKVIELDFDARDQLTRKAR 280
T S+++S G+ +L LS ++V L + R+Q + +
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 4/149 (2%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
L RHP L L V E+ G L HL R + V + +R + A
Sbjct: 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSA 107
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YLH + +V+RD+KL N++L + K++DFGL K G+++ GT Y+
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLA 164
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
PE + + A D + G+V +++ G+
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+V K + ++VAIK S + RE++ L ++ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
G+ YLV+E+ N+ + L + + E+ + A+ + H IVHR
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHR 124
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDI 248
DIK N+L++ KL DFG A+ L + +T+ T Y PE + A A D+
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDM 184
Query: 249 YSFGIVALQLLSGQ 262
+S G + +L GQ
Sbjct: 185 WSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 45/186 (24%), Positives = 92/186 (49%), Gaps = 23/186 (12%)
Query: 92 VVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148
+VA+K + + N ++ F +E++ +SR++ PN++ L C+ ++ E+ G+L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 149 QHLLRKD----------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198
Q L R + +++ + + A ++YL VHRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 199 EKLEPKLSDFGLAKMLGMEESKVFTDVRG----TIGYMDPEYMTNAKLTCASDIYSFGIV 254
+ K++DFG+++ L S + ++G I +M E + K T ASD+++FG+
Sbjct: 165 KNYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 255 ALQLLS 260
++L+
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRV-----RHPNL 122
+ LG+GS G V L G+ A+K + K + D VE RV +P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVE--KRVLALAWENPFL 58
Query: 123 VCLFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
L+ C + E + V EF G+L H+ K + R + L++LH
Sbjct: 59 THLY-CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY-RATFYAAEIVCGLQFLH--- 113
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I++RD+KL N++L K++DFG+ K +++ T GT Y+ PE + K
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
T + D +SFG++ ++L GQ
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 74 LGRGSAGLVYKGVL------------PSGQVVAIKHIYKSNNTD---SFSREVEGLSRVR 118
LGRG+ +Y G+L ++ I + ++ D +F + +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
H ++V L+G CV E +V EF G L + RK VLT + K+ + A AL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 179 HYIDGCIVHRDIKLTNILLT-EKLEP------KLSDFGLAKMLGMEESKVFTDVRGTIGY 231
D +VH ++ NILL E ++ KLSD G+ + + V I +
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV-----ERIPW 174
Query: 232 MDPEYMTNAK-LTCASDIYSFG 252
+ PE + ++K L+ A+D +SFG
Sbjct: 175 IAPECVEDSKNLSIAADKWSFG 196
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 50/282 (17%)
Query: 74 LGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRH-PNLVCLFGC 128
+GRG+ G V K + PSG ++A+K I + + +++ + R P +V +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 129 ---------CVEGGEQYL------VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
C+E + L VYE + + +L K +V T VK A
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVAT----VK-------A 119
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YL + I+HRD+K +NILL KL DFG++ L +S T G YM
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMA 175
Query: 234 PEYM---TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290
PE + SD++S GI ++ +G + + + + + V G
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATG----KFPYPKWNSVFDQLTQVVKG----- 226
Query: 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332
+ P L+ + R S + LC+ K RP + E
Sbjct: 227 --DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 50/194 (25%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ V+KG + +VA+K I ++ + REV L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
LV+E+ +L Q++ ++++ L L Y H ++HRD
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRD 129
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT-NAKLTCASDI 248
+K N+L+ E+ E KL+DFGLA+ + +K +++ T+ Y P+ + +++ + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 249 YSFGIVALQLLSGQ 262
+ G + ++ SG+
Sbjct: 189 WGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ V+KG + +VA+K I ++ + REV L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-ALRYLHHYIDGCIVHR 188
LV+E+ + +L Q+L ++++ VKI L L Y H I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHN-VKIFMFQLLRGLSYCHKRK---ILHR 127
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASD 247
D+K N+L+ EK E KL+DFGLA+ + +K +++ T+ Y P+ + + + + D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 248 IYSFGIVALQLLSGQ 262
++ G + ++ +G+
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 49/149 (32%), Positives = 68/149 (45%), Gaps = 7/149 (4%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCAL 172
L V+HP LV L + Y V ++ G L HL R+ L E R + + A
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL--EPRARFYAAEIAS 107
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYM 232
AL YLH IV+RD+K NILL + L+DFGL K +E + + GT Y+
Sbjct: 108 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYL 163
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLSG 261
PE + D + G V ++L G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 45/191 (23%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 82 VYKGVLPSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136
+YKG+ + + V I+ K + D E++ L R+ N++ ++G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 137 ----LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
L+ E+C G L + +L K+ L+++ ++ + DC L L+ Y + ++++
Sbjct: 95 PRLSLILEYCTRGYL-REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK--PYKNLTS 151
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYS 250
+ L+TE + K+ GL K+L S F +V + Y + + + ++ T DIYS
Sbjct: 152 VSFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 251 FGIVALQLLSG 261
G+V ++ +G
Sbjct: 208 LGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
L V HP+++ + V G +V ++ +L +L ++ L ++ + I +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEG 169
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
LRYLH I+HRD+K NI + + + + D G A+ + + F + GT+
Sbjct: 170 LRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--FLGLAGTVETNA 224
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA 271
PE + K +DI+S GIV ++L+ I D +
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 40/205 (19%)
Query: 93 VAIKHIYK---SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149
VA+K + N + F +EV+ LSR+ PN+ L G C ++ E+ G+L Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 150 HLLRKDSV----------LTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILL 197
L + + L++ + + A +RYL ++ VHRD+ N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF-----VHRDLATRNCLV 163
Query: 198 TEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPEYMTNAKLTCASDIYSFGI 253
+ K++DFG+++ L S + V+G I +M E + K T SD+++FG
Sbjct: 164 GKNYTIKIADFGMSRNL---YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG- 219
Query: 254 VAL------------QLLSGQKVIE 266
V L + L+ Q+VIE
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIKHIYKS---NNTDSFSREVEGLSRV-----RHPN 121
LG+GS G V KG + ++ AIK + K + D VE RV + P
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVE--KRVLALPGKPPF 62
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
L L C Y V E+ G+L H+ ++ V + A+ L +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLH--- 118
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYMTN 239
I++RD+KL N++L + K++DFG+ K + G + ++ F GT Y+ PE +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEIIAY 175
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
+ D ++FG++ ++L+GQ FD D+
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQP----PFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 67/298 (22%)
Query: 74 LGRGSAGLVYKGVLPSGQV---VAIK----HIYKSNNTDSFSREVEGLSRVRHPNLVCLF 126
LG G G V +G L VA+K I + + F E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 127 GCCVEGGEQ------YLVYEFCAAGNLAQHLLRK-----DSVLTWERRVKILRDCALALR 175
G C++ E ++ F G+L LL L + VK + D A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD---VRGTIGYM 232
YL +HRD+ N +L E + ++DFGL+K K++ +G I M
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSK-------KIYNGDYYRQGRIAKM 176
Query: 233 DPEYMTNAKL-----TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287
+++ L T SD++SFG+ ++ + G+
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEI-----------------------ATRGQT 213
Query: 288 PIKDFEDPRLNGNINRAD--------FESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
P E+ + + + + + + + C + K RP+ + + E++KA
Sbjct: 214 PYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 20/221 (9%)
Query: 67 NDWD-RRFLGRGSAG---LVYKGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRV 117
D+D + +GRG G +V + +G + A+K + KS F E + LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL 177
P + L + YLV E+ G+L L R + + L + LA+ +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H VHRDIK N+L+ KL+DFG A L + GT Y+ PE +
Sbjct: 119 HQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 238 T--NAKLTCASDI----YSFGIVALQLLSGQKVIELDFDAR 272
T N + +S G++A +++ G+ A+
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 12/196 (6%)
Query: 74 LGRGSAGLVYK-GVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
LG+G G V V +G++ A K + K E + L +V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR-DCALALRYLHHYIDGCIV 186
+ LV G+L H+ E R L +LH IV
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
+RD+K N+LL + ++SD GLA + ++ K GT GYM PE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 247 DIYSFGIVALQLLSGQ 262
D ++ G ++++G+
Sbjct: 176 DWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 26/247 (10%)
Query: 74 LGRGSAGLVYKGVLPSGQ---VVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+GRG+ G VYK G+ A+K I + + S RE+ L ++HPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRY-----LHHYIDGC 184
++ + F A + H+++ ++ +++ R +L Y +H+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 185 IVHRDIKLTNILLT----EKLEPKLSDFGLAKMLG--MEESKVFTDVRGTIGYMDPEYMT 238
++HRD+K NIL+ E+ K++D G A++ ++ V T Y PE +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 239 NAK-LTCASDIYSFGIVALQLLSGQKVIELDFD--------ARDQLTRKARDVSMGKRPI 289
A+ T A DI++ G + +LL+ + + + DQL R MG
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS--VMGFPAD 246
Query: 290 KDFEDPR 296
KD+ED R
Sbjct: 247 KDWEDIR 253
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 88 PSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143
P+G +V ++ N T+ + EV RHPN++ + G +++ F A
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 144 AGNLAQHLLRK--DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201
G+ A LL+ ++ IL L YLH +G I HR+IK ++IL++
Sbjct: 83 YGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYI-HRNIKASHILISGDG 138
Query: 202 EPKLSDFGLAKMLGM----EESKVFTDV----RGTIGYMDPE------YMTNAKLTCASD 247
LS GL+ + + +++KV D + ++ PE Y N K SD
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK----SD 192
Query: 248 IYSFGIVALQLLSGQ 262
IYS GI A +L +G+
Sbjct: 193 IYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 6/129 (4%)
Query: 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193
+ YLV ++ + G L HL +K+ + +R + + LAL +LH Y IV+RD+K
Sbjct: 70 DLYLVTDYMSGGELFWHL-QKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPE 125
Query: 194 NILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK-LTCASDIYSFG 252
NILL L DFGL+K + ++K GT Y+ PE + + K T D +S G
Sbjct: 126 NILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 253 IVALQLLSG 261
++ ++ G
Sbjct: 185 VLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 28/78 (35%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
IV+RD+K NILL + ++SD GLA + + E + GT+GYM PE + N + T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 245 ASDIYSFGIVALQLLSGQ 262
+ D ++ G + ++++GQ
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 74 LGRGSAGLVYKGVLPSGQV---VAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+GRG+ G VYK G+ A+K I + + S RE+ L ++HPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRY-----LHHYIDGC 184
++ + F A + H+++ ++ V++ R +L Y +H+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 185 IVHRDIKLTNILLT----EKLEPKLSDFGLAKMLG--MEESKVFTDVRGTIGYMDPEYMT 238
++HRD+K NIL+ E+ K++D G A++ ++ V T Y PE +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 239 NAK-LTCASDIYSFGIVALQLLSGQKV 264
A+ T A DI++ G + +LL+ + +
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 56 FSKDEIENAINNDWD--RRF-----LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSF 107
F ++E+ + W+ R+ +G G+ G V + +G+ VAIK + + ++ F
Sbjct: 1 FYREEVNKTV---WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIF 57
Query: 108 S----REVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW-ER 162
+ RE+ L ++H N++ L +F Q L+K E
Sbjct: 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 163 RVKILRDCAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
+V+ L L L+Y+H I+HRD+K N+ + E E K+ DFGLA+ E
Sbjct: 118 KVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170
Query: 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
T T Y PE + N DI+S G + ++L+G+ + + D DQLT+
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQ 226
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ VYKG + +VA+K I ++ + REV L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
LV+E+ +L Q+L + + L L Y H ++HRD
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRD 129
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDI 248
+K N+L+ E+ E KL+DFGLA+ + +K +++ T+ Y P+ + + + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 249 YSFGIVALQLLSGQ 262
+ G + ++ +G+
Sbjct: 189 WGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
IV+RD+K NILL ++ ++SD GLA + + E + GT+GYM PE + N K T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 245 ASDIYSFGIVALQLLSGQ 262
+ D + G + +++ GQ
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 117 VRHPNLVCLFGCCVEGGEQYLV-YEFCAAGNLAQHL-------LRKDSVLTWERRVKILR 168
+ H N++ + C+E GE V Y + GNL L L+ ++ V +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 169 DCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK--------MLGMEESK 220
A + YLH ++H+DI N ++ E+L+ K++D L++ LG E++
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQL--LSGQKVIELD 268
+ +M E + N + + ASD++SFG++ +L L +E+D
Sbjct: 182 -------PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 72 RFLGRGSAGLVYKGV---LPSGQV---VAIKHIYKSNNTDSFSREVEGLSRVR------- 118
R LG+GS G+VY+G + G+ VA+K + N + S +E L+
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFLNEASVMKGFTC 68
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL--LRKDS-------VLTWERRVKILRD 169
H ++V L G +G +V E A G+L +L LR ++ T + +++ +
Sbjct: 69 H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 170 CALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-----SKVFTD 224
A + YL+ VHRD+ N ++ K+ DFG+ + + + K
Sbjct: 128 IADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260
VR M PE + + T +SD++SFG+V ++ S
Sbjct: 185 VRW----MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 72 RFLGRGSAG---LVYKGVLPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLV 123
+ +GRG+ G LV K +G + A+K + KS E + L+ +P +V
Sbjct: 7 KVIGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH--YI 181
L+ + YL+ E+ G++ L++KD+ E R I + LA+ +H YI
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI-AETILAIDSIHKLGYI 123
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214
HRDIK N+LL K KLSDFGL L
Sbjct: 124 -----HRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G+VYK + + +A+K I + RE+ L ++H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG---C- 184
YLV+E+ +L +H+ DS + + ++++ YL+ + G C
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHM---DSSPDFAKNPRLIKT------YLYQILRGIAYCH 119
Query: 185 ---IVHRDIKLTNILLTEKLEP-KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
++HRD+K N+L+ + KL+DFGLA+ G+ + FT T+ Y PE + +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRAPEILLGS 178
Query: 241 K-LTCASDIYSFGIVALQLLS 260
+ + DI+S G + ++++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
R L GS G V++ P Q V +K + + S E L R+ HP ++ L V
Sbjct: 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWYA----SSVHEARLLRRLSHPAVLALLDVRV 230
Query: 131 EGGEQYLV---YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
GG LV Y +L +L + L + + R A+ Y+H +G I+H
Sbjct: 231 VGGLTCLVLPKYR----SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG--EG-IIH 283
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKML-GMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
RDIK N+L+ + L DFG A G + + GT+ PE + T +
Sbjct: 284 RDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV 343
Query: 247 DIYSFGIV 254
DI+S G+V
Sbjct: 344 DIWSAGLV 351
|
Length = 461 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 74 LGRGSAGLVYKG-VLPSGQVVAIKH---IYKSNNTDSFSREVEGLSRVR-HPNLVCLFGC 128
+G G+ V K +G+ AIK +KS + RE++ L R+ HPN++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 129 CVE--GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCI 185
+ G LV+E NL + L++ E+RVK + +L ++H +G I
Sbjct: 67 LFDRKTGRLALVFEL-MDMNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--NG-I 121
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM-TNAKLTC 244
HRDIK NIL+ + + KL+DFG + G+ +T+ T Y PE + T+
Sbjct: 122 FHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178
Query: 245 ASDIYSFGIVALQLLS 260
DI++ G V ++LS
Sbjct: 179 KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-08
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
+S+V H +L + G CV G E +V EF G L L ++ + ++ + + A A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASA 129
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLT-----EKLEP--KLSDFGLAKMLGMEESKVFTDVR 226
L YL D +VH ++ NILL E P KLSD G++ E +V
Sbjct: 130 LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV----- 181
Query: 227 GTIGYMDPEYMTN-AKLTCASDIYSFGIVALQL 258
I ++ PE + L+ A+D +SFG L++
Sbjct: 182 ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
V+RD+K NILL + ++SD GLA + + E + GT+GYM PE + N + T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 245 ASDIYSFGIVALQLLSGQ 262
+ D + G + +++ GQ
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 37/126 (29%), Positives = 54/126 (42%), Gaps = 8/126 (6%)
Query: 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTN 194
+ +Y F KD L + R I++ A+ Y+H D ++HRDIKL N
Sbjct: 246 DFDLYSFMYDEAFDW----KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 195 ILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
I L + L DFG A E GT+ PE + +DI+S G++
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 255 ALQLLS 260
L +LS
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
P L L C Y V E+ G+L H+ + + V + ++ L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHR 119
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYM 237
I++RD+KL N++L + K++DFG+ K M+ ++ F GT Y+ PE +
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEII 173
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
+ D +++G++ ++L+GQ FD D+
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQP----PFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
P L L C Y V E+ G+L + ++ V + A+ L +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLH- 118
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK--MLGMEESKVFTDVRGTIGYMDPEYM 237
I++RD+KL N++L + K++DFG+ K M +K F GT Y+ PE +
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAPEII 173
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
+ D ++FG++ ++L+GQ F+ D+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ----APFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 20/158 (12%)
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
+PN + L+ L+ ++ G+L LL+K+ L+ KI+R AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEP-KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
+ I+H DIKL N+L + L D+GL K++G GT+ Y PE
Sbjct: 127 KHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPE-- 176
Query: 238 TNAKLTCASDIYSF-----GIVALQLLSGQKVIELDFD 270
K+ + SF G++ +LL+G+ + D D
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 110 EVEGLSRVRHPNLVCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSV---LTWERRV 164
EV + ++H N+V + Q Y++ EFC AG+L++++ + + + V
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 165 KILRDCALALRYLHHYIDGC----IVHRDIKLTNILLTEKLE-----------------P 203
I R AL Y H+ DG ++HRD+K NI L+ +
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC--ASDIYSFGIVALQLLSG 261
K+ DFGL+K +G+ ES + V GT Y PE + + + SD+++ G + +L SG
Sbjct: 182 KIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 262 Q 262
+
Sbjct: 240 K 240
|
Length = 1021 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 27/78 (34%), Positives = 45/78 (57%), Gaps = 2/78 (2%)
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
IV+RD+K NILL + ++SD GLA + + E + GT+GYM PE + N + T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 245 ASDIYSFGIVALQLLSGQ 262
+ D + G + +++ G+
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 2/78 (2%)
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKL 242
CI HRD+ NILLT K+ DFGLA+ + + + V + R + +M PE + N
Sbjct: 235 CI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY 293
Query: 243 TCASDIYSFGIVALQLLS 260
T SD++S+GI+ ++ S
Sbjct: 294 TFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 72 RFLGRGSAGLVYKGVLP----SGQVVAIK----HIYKSNNTDSFSREVEGLSRVRHPNLV 123
R LG+G G V + L S Q VA+K I+ S++ + F RE + HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 124 CLFGCCVEGGEQ------YLVYEFCAAGNLAQHLL-----RKDSVLTWERRVKILRDCAL 172
L G + + ++ F G+L LL + L + V+ + D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA-KMLGMEESKVFTDVRGTIGY 231
+ YL +HRD+ N +L E + ++DFGL+ K+ + + + + +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLS-GQ 262
+ E + + T SD+++FG+ ++++ GQ
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 109 REVEGLSRVRHPNLVCLFGCCV------EGGEQYLVYEFCAA--GNLAQ-HLLRKDSV-- 157
RE+ L ++H N++ L E + YLV A N+ + L D V
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 158 LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217
L ++ ILR L+Y+H I+HRD+K +N+ + E E K+ DFGLA+ E
Sbjct: 125 LIYQ----ILR----GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173
Query: 218 ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQ 262
T T Y PE M N DI+S G + +LL+G+
Sbjct: 174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 72 RFLGRGSAGLV---YKGVLPSGQVVAIKHIYK--SNNTDSFS--REVEGLSRVRHPNLVC 124
+ +G G+ G+V Y V GQ VAIK + + N T + RE+ + V H N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 125 LFGCCV------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
L E + YLV E A NL Q + L ER +L +++LH
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH 135
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
I+HRD+K +NI++ K+ DFGLA+ G S + T T Y PE +
Sbjct: 136 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 190
Query: 239 NAKLTCASDIYSFGIVALQLLSGQ 262
DI+S G + +++ G
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 72 RFLGRGSAG---LVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLV----- 123
+ +GRG+ G LV K +G V A+K + K+ D +E G R LV
Sbjct: 7 KVIGRGAFGEVRLVQKK--DTGHVYAMKILRKA---DMLEKEQVGHIRAERDILVEADSL 61
Query: 124 ---CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
+F + YL+ EF G++ L++KD+ LT E + + LA+ +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQL 120
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214
+HRDIK N+LL K KLSDFGL L
Sbjct: 121 ---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKLTC 244
+HRD+ NILL+E K+ DFGLA+ + + V D R + +M PE + + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 245 ASDIYSFGIVALQLLS 260
SD++SFG++ ++ S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L+Y+H I+HRD+K +N+ + E E ++ DFGLA+ E T T Y
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRA 183
Query: 234 PEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
PE M N DI+S G + +LL G+ + + D DQL R
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-DYIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 110 EVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD 169
E E L +V P +V L LV G+L H+ RV I
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV-IHYS 101
Query: 170 CALALRYLH-HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228
+ LH H +D IV+RD+K N+LL ++ +LSD GLA + +++ K T GT
Sbjct: 102 AQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 229 IGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
GYM PE + + D ++ G ++++G+
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 78 SAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSR-EVEGLSRVRHPNLVCLFGCCVEGGEQY 136
+A + +G P +VVA + +++R E+ L+ H +V F +
Sbjct: 82 AAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141
Query: 137 LVYEFCAAGNLAQHLLR--KDSVLTWERRVKIL-RDCALALRYLHHYIDGCIVHRDIKLT 193
L+ E+ + G+L + + + K+ + E V +L LAL +H ++HRD+K
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSA 198
Query: 194 NILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
NI L KL DFG +K S V + GT Y+ PE + + +D++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 253 IVALQLLS 260
++ +LL+
Sbjct: 259 VILYELLT 266
|
Length = 478 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLF 126
D R LG GS GLV+ V + VA+K I ++ + RE++ + R+ H N+V ++
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 127 GCCVEGGEQ--------------YLVYEFCAAGNLAQHLLRKDSVLTWERRV---KILRD 169
G Y+V E +LA +L + + R+ ++LR
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLAN-VLEQGPLSEEHARLFMYQLLR- 125
Query: 170 CALALRYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESK--VFTDVR 226
L+Y+H ++HRD+K N+ + TE L K+ DFGLA+++ S ++
Sbjct: 126 ---GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 227 GTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQ 262
T Y P + + T A D+++ G + ++L+G+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 28/232 (12%)
Query: 74 LGRGSAGLV---YKGVLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G G+ G+V Y VL VAIK + + + + RE+ + V H N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 127 GCCV------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
E + YLV E A NL Q + + L ER +L +++LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH-- 136
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+HRD+K +NI++ K+ DFGLA+ G S + T T Y PE +
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
DI+S G + +++ K++ F RD + + + + P +F
Sbjct: 194 GYKENVDIWSVGCIMGEMVR-HKIL---FPGRDYIDQWNKVIEQLGTPCPEF 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 29/79 (36%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK--VFTDVRGTIGYMDPEYMTNAK 241
CI HRD+ N+LLT+ K+ DFGLA+ + M +S V + R + +M PE + +
Sbjct: 233 CI-HRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNARLPVKWMAPESIFDCV 290
Query: 242 LTCASDIYSFGIVALQLLS 260
T SD++S+GI+ ++ S
Sbjct: 291 YTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 2/78 (2%)
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKL 242
CI HRD+ NILL+E K+ DFGLA+ + + V D R + +M PE + +
Sbjct: 194 CI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 243 TCASDIYSFGIVALQLLS 260
T SD++SFG++ ++ S
Sbjct: 253 TTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR----GTIGYM 232
+HH ++HRDIK NILL KL DFG +KM + V DV GT Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYV 212
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLS 260
PE + +D++S G++ +LL+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 72 RFLGRGSAG---LVYKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLV 123
+ +G+G+ G LV K +G++ A+K ++K + E + L+ P +V
Sbjct: 7 KVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L+ + YL+ EF G+L L++ D+ R + +C LA+ +H G
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYM-AECVLAIEAVHKL--G 121
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLA 211
I HRDIK NIL+ KLSDFGL+
Sbjct: 122 FI-HRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 20/150 (13%)
Query: 72 RFLGRGSAG---LVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGC 128
+ +GRG+ G LV K +G + A+K + K+ D +E R LV G
Sbjct: 7 KVIGRGAFGEVRLVQKK--DTGHIYAMKILRKA---DMLEKEQVAHIRAERDILVEADGA 61
Query: 129 CV--------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
V + YL+ EF G++ L++KD+ L+ E + + LA+ +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQL 120
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210
+HRDIK N+LL K KLSDFGL
Sbjct: 121 ---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 61 IENAINNDWDRRF-----LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGL 114
I+N IN ++ + +G GS G+VY+ + + + + VAIK + + + RE+ +
Sbjct: 56 IDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIM 113
Query: 115 SRVRHPNLVCL----FGCCVEGGEQYL----VYEFC--AAGNLAQHLLRKDSVLTWERRV 164
+ H N++ L + C + E+ + V EF +H R + L V
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL-FLV 172
Query: 165 KILR-DCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP-KLSDFGLAK-MLGMEESKV 221
K+ AL Y+H I HRD+K N+L+ KL DFG AK +L + S
Sbjct: 173 KLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 222 FTDVRGTIGYMDPEYMTNA-KLTCASDIYSFG------IVALQLLSGQKVIELDFDARDQ 274
+ R Y PE M A T D++S G I+ + SGQ + DQ
Sbjct: 230 YICSR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-------DQ 279
Query: 275 LTR 277
L R
Sbjct: 280 LVR 282
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 72 RFLGRGSAGLV---YKGVLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVC 124
+ +G G+ G+V + VL G VA+K + + + + RE+ L V H N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84
Query: 125 LFGCCV------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
L E + YLV E A NL Q ++ + L ER +L +++LH
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ-VIHME--LDHERMSYLLYQMLCGIKHLH 140
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
I+HRD+K +NI++ K+ DFGLA+ + + T T Y PE +
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVIL 195
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIE 266
DI+S G + +L+ G + +
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKL 242
CI HRD+ NILL+E K+ DFGLA+ + + V R + +M PE + +
Sbjct: 195 CI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 243 TCASDIYSFGIVALQLLS 260
T SD++SFG++ ++ S
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 166 ILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225
I R A++YLH + I+HRDIK NI + + L DFG A + +
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
GTI PE + A DI+S GIV ++ +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 46/274 (16%)
Query: 35 KRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLV---YKGVLPSGQ 91
KR + + EI +T++ L R+ + + +G G+ G+V Y +L
Sbjct: 5 KRDNNFYSVEIGDSTFTVLKRYQ------------NLKPIGSGAQGIVCAAYDAILERN- 51
Query: 92 VVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGCCV------EGGEQYLVYEF 141
VAIK + + + + RE+ + V H N++ L E + Y+V E
Sbjct: 52 -VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201
A NL Q + + L ER +L +++LH I+HRD+K +NI++
Sbjct: 111 MDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDC 163
Query: 202 EPKLSDFGLAKMLG---MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQL 258
K+ DFGLA+ G M V T Y PE + DI+S G + ++
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 259 LSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
+ G + F D + + + + P +F
Sbjct: 219 IKGGVL----FPGTDHIDQWNKVIEQLGTPCPEF 248
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
L L ++H+ +V+RD+K NILL E ++SD GLA + K V GT GY
Sbjct: 108 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGY 161
Query: 232 MDPEYMTNA-KLTCASDIYSFGIVALQLLSGQ 262
M PE + ++D +S G + +LL G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
L L ++H+ +V+RD+K NILL E ++SD GLA + K V GT GY
Sbjct: 108 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGY 161
Query: 232 MDPEYMTNAK-LTCASDIYSFGIVALQLLSGQ 262
M PE + ++D +S G + +LL G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 7/79 (8%)
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPEYMTNAK 241
VHRD+ N+L+ E K+ DFGLA+ + M +S + +G+ + +M PE + N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYIS--KGSTFLPLKWMAPESIFNNL 317
Query: 242 LTCASDIYSFGIVALQLLS 260
T SD++SFGI+ ++ +
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSG-QVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
+ +GRG+ G V L + +V A+K + K T F E + L + + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--HYIDG 183
+ YLV ++ G+L L + + L + L + +A+ +H HY
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMT---- 238
VHRDIK NIL+ +L+DFG L ME+ V + V GT Y+ PE +
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 239 -NAKLTCASDIYSFGIVALQLLSGQ 262
K D +S G+ ++L G+
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 68 DWDR-RFLGRGSAGLVYKGVLPSGQ-VVAIK-----HIYKSNNTDSFSREVEGLSRVRHP 120
D+D + +GRG+ G V S Q V A+K + K +++ F E + ++ P
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
+V LF + Y+V E+ G+L + D W + + LAL +H
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSM 161
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVR-GTIGYMDPEYMT 238
++HRD+K N+LL + KL+DFG + M+E+ V D GT Y+ PE +
Sbjct: 162 ---GLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 239 ----NAKLTCASDIYSFGIVALQLLSG 261
+ D +S G+ ++L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 89 SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143
+G++VA+K + KS N E + L+ + LV L + YL E+
Sbjct: 25 TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84
Query: 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203
G+ + LL VL+ + + + A+ LH +HRD+K N L+
Sbjct: 85 GGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHI 140
Query: 204 KLSDFGLAK-MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
KL+DFGL+K ++ S V G+ YM PE + D +S G + + L G
Sbjct: 141 KLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 28/194 (14%)
Query: 88 PSGQVVAIKHI---YKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCA 143
P+G+ V ++ I +N +F + +S++ HPN+V + E ++V F A
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 144 AGN----LAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199
G+ + H + S L IL+ AL Y+HH VHR +K ++IL++
Sbjct: 83 YGSAKDLICTHFMDGMSELAI---AYILQGVLKALDYIHHM---GYVHRSVKASHILIS- 135
Query: 200 KLEPKLSDFGLAKMLGM----EESKVFTD-----VRGTIGYMDPEYMTN--AKLTCASDI 248
++ K+ GL L M + +V D V+ + ++ PE + SDI
Sbjct: 136 -VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK-VLPWLSPEVLQQNLQGYDAKSDI 193
Query: 249 YSFGIVALQLLSGQ 262
YS GI A +L +G
Sbjct: 194 YSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTI 229
L +LH I++RD+K N+LL ++SD GLA L G ++K + GT
Sbjct: 108 SGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---GTP 161
Query: 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
G+M PE + + + D ++ G+ ++++ +
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 26/79 (32%), Positives = 46/79 (58%), Gaps = 7/79 (8%)
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT----IGYMDPEYMTNAK 241
VHRD+ N+LL + K+ DFGLA+ + M +S + +G+ + +M PE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVS--KGSTFLPVKWMAPESIFDNL 315
Query: 242 LTCASDIYSFGIVALQLLS 260
T SD++S+GI+ ++ S
Sbjct: 316 YTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 18/137 (13%)
Query: 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--HYIDGCIVHRDIKLT 193
YLV ++ G+L L + + L + L + LA+ +H Y VHRDIK
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY-----VHRDIKPD 131
Query: 194 NILLTEKLEPKLSDFG-LAKML--GMEESKVFTDVRGTIGYMDPEYMT-----NAKLTCA 245
N+LL + +L+DFG ++L G +S V GT Y+ PE + +
Sbjct: 132 NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV---GTPDYISPEILQAMEDGKGRYGPE 188
Query: 246 SDIYSFGIVALQLLSGQ 262
D +S G+ ++L G+
Sbjct: 189 CDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH--HYIDGCIVHRDIKLT 193
YLV ++ G+L L + + L + + + LA+ +H HY VHRDIK
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY-----VHRDIKPD 131
Query: 194 NILLTEKLEPKLSDFG-LAKMLGMEESKVFTDVR-GTIGYMDPEYMTN-----AKLTCAS 246
N+LL +L+DFG KM ++ V + V GT Y+ PE + K
Sbjct: 132 NVLLDMNGHIRLADFGSCLKM--NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189
Query: 247 DIYSFGIVALQLLSGQ 262
D +S G+ ++L G+
Sbjct: 190 DWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 29/90 (32%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYM 232
AL YLH I+HRD+K NI L E L DFG A L G G +
Sbjct: 197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT--PQCYGWSGTL 251
Query: 233 D---PEYMTNAKLTCASDIYSFGIVALQLL 259
+ PE + +DI+S G+V ++
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 72 RFLGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
+ +GRG+ G V +K + +V A+K + K +++ F E + ++ P +
Sbjct: 49 KVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
V LF + Y+V E+ G+L + D W R + LAL +H
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--EVVLALDAIHSM-- 161
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT---- 238
+HRD+K N+LL + KL+DFG + E GT Y+ PE +
Sbjct: 162 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 239 NAKLTCASDIYSFGIVALQLLSG 261
+ D +S G+ ++L G
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 18/152 (11%)
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL-----RKDSVLTWERRVKILRDCALAL 174
PN+VCL V +LV + G L H+ ++ V W + + AL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------AL 98
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDP 234
LH +G IV RD+ NILL ++ +L+ F + +E+S V Y P
Sbjct: 99 DALHR--EG-IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAP 151
Query: 235 EYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266
E ++ T A D +S G + +LL+G+ ++E
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRH-PNLVCLFG 127
+G G+ G VYK +G++VA+K + + RE+ L + +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 128 CCVEGGEQ-------YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
VE E+ YLV+E+ L L K + + R +++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEY-----LDSDL--KKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 181 IDGC-------IVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYM 232
+ G ++HRD+K N+L+ +K K++D GL + + K +T T+ Y
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIVTLWYR 178
Query: 233 DPEYMTNAK-LTCASDIYSFGIVALQLLSGQ 262
PE + + + DI+S G + ++ Q
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 35/132 (26%), Positives = 54/132 (40%), Gaps = 13/132 (9%)
Query: 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNI 195
Y+V E+ G+L + D W R + LAL +H +HRD+K N+
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTA--EVVLALDAIHSM---GFIHRDVKPDNM 173
Query: 196 LLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT------CASDIY 249
LL + KL+DFG + GT Y+ PE + + C D +
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC--DWW 231
Query: 250 SFGIVALQLLSG 261
S G+ ++L G
Sbjct: 232 SVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 10/92 (10%)
Query: 72 RFLGRGSAGLVYKGV---LPSGQ------VVAIKHIYKSNNTDSFSREVEGLSRV-RHPN 121
R LG G+ G V + L Q V +K +S+ + E++ +S + H N
Sbjct: 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR 153
+V L G C +GG Y++ E+C G+L +L R
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 65/206 (31%)
Query: 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYIDGCIVHRDIKLTN 194
Y V ++ G++ L+R + E + + + A+ +H +HRDIK N
Sbjct: 77 YFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDN 131
Query: 195 ILLTEKLEPKLSDFGL------------------AKMLGMEESKVFTDVR---------- 226
IL+ KL+DFGL + ME S+ ++++
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 227 --------------GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ---------- 262
GT Y+ PE + T D +S G++ ++L GQ
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
Query: 263 ---KVI----ELDFDARDQLTRKARD 281
KVI L ++ +L+R+A D
Sbjct: 252 TQLKVINWETTLHIPSQAKLSREASD 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.36 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.14 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.54 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.41 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.37 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.33 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.28 | |
| PLN02236 | 344 | choline kinase | 97.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.01 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.97 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.97 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.8 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.13 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.03 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.01 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 95.85 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.72 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-56 Score=397.85 Aligned_cols=285 Identities=41% Similarity=0.670 Sum_probs=246.9
Q ss_pred CcccccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEE
Q 040826 52 GLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCC 129 (347)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~ 129 (347)
....|+++++..+|++|...+.||+|+||.||+|.+.+|..||||++..... ..+|.+|+.++.+++|||+++++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5677999999999999999999999999999999999999999998887655 46799999999999999999999999
Q ss_pred EeCC-eEEEEEeecCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 130 VEGG-EQYLVYEFCAAGNLAQHLLRKDS-VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 130 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
.+.+ ..+|||||+++|+|.++++.... .++|..+++|+.++|+||+|||..+...|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999987665 899999999999999999999987777899999999999999999999999
Q ss_pred cccceecCCCccceeecc-cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCCh-hhhhHHHHHHhhhcCC
Q 040826 208 FGLAKMLGMEESKVFTDV-RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF-DARDQLTRKARDVSMG 285 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~-~~~~~~~~~~~~~~~~ 285 (347)
||++...... ....... .||.+|+|||++..+..+.++||||||++++||+||+++..... .....+..|+......
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999764321 1111222 79999999999999999999999999999999999998887543 2223355555444333
Q ss_pred CCCcccccCCCCC-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLN-GNINR-ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 286 ~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
. .+.+++||.+. +.... +....+.+++.+|++.+|.+||+|.+|++.|+.+.
T Consensus 300 ~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 G-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred c-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 2 68899999987 56664 68889999999999999999999999999997664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-52 Score=368.17 Aligned_cols=264 Identities=25% Similarity=0.449 Sum_probs=229.3
Q ss_pred CcccccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEE
Q 040826 52 GLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCV 130 (347)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~ 130 (347)
+...+..+++... +.||+|.||.||.|.++....||+|.+.... ..+.|.+|+++|++|+|+|||+++++|.
T Consensus 199 d~wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 199 DPWEIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred CCeeecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 3455666666544 5699999999999999877799999998754 4578999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
.++.++||||||+.|+|.++|+. .+..++..+.+.++.|||+|++||+ ++++|||||.+.||||++++.+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccc
Confidence 98899999999999999999986 6678999999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
+++....+......+..-+..|.|||.+....++.+|||||||++||||+|-...+...+...+.+..+.+..+...
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--- 425 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--- 425 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---
Confidence 99976655555666667788999999999999999999999999999999966655556666666666666655443
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+..|+.+++++|..||+.+|++|||++.+...|+++...
T Consensus 426 ------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 ------------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 335778999999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=355.87 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=211.2
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCC-eEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGG-EQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 142 (347)
......||+|..|+||++.++ +++.+|+|++.-..+ .+++.+|++++++.+||+||.++|.|.+.. ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344577999999999999954 789999999954433 457899999999999999999999999988 599999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++|+|.+++... +.+++....+++.++++||.|||+ .++|+||||||+|+|++..|.+||||||.+..+... ..
T Consensus 161 DgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 161 DGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999988654 569999999999999999999995 479999999999999999999999999999986433 45
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
.+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+..+........+....+..+..+ .+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP-------~lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP-------RLPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC-------CCCcc--
Confidence 667899999999999999999999999999999999999999987633333444444444444332 11111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.++++.++..||++||.+|||+.|++++
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 355789999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=362.69 Aligned_cols=252 Identities=32% Similarity=0.483 Sum_probs=211.0
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC-eEEEEEeecCCC
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG-EQYLVYEFCAAG 145 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g 145 (347)
.+.+|+|+||+||+|.+.....||+|.+..... ...|.+|+.+|.+++||||++++|++.+.. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999996555599999976431 348999999999999999999999999887 799999999999
Q ss_pred ChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-ceeCCCCCCCEEecCCC-ceEEeecccceecCCCcccee
Q 040826 146 NLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGC-IVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 146 sL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~-i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|.+++.. ....+++..+++++.|+|+||.||| +.+ |+||||||+|+|++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999987 4678999999999999999999999 777 99999999999999998 99999999998764322 334
Q ss_pred ecccCCCCcccccccc--CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMT--NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
+...||+.|||||++. ...|+.++||||||+++|||+||+.||..... .......+ ..+.++ .
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~---~~~~Rp-----------~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVV---VGGLRP-----------P 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHH---hcCCCC-----------C
Confidence 4468999999999999 56999999999999999999999999985443 22222221 122222 2
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
++..+...+..|+.+||+.||..||++.+|+..|+.+.+..
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 23335678999999999999999999999999999987644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=363.72 Aligned_cols=246 Identities=27% Similarity=0.450 Sum_probs=214.2
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.+|...+.||+|||+.||.++. .+|+.||+|++.+. ...+...+|+++.+.|+|||||+++++|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3577788999999999999996 89999999999763 34567889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|+|+.++|..+++ ....+++.+++.+++||+.||.||| +.+|+|||||..|+|++++.++||+|||+|..+..+ .
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence 9999999999886 5567999999999999999999999 889999999999999999999999999999998643 3
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......+||+.|.|||++....++..+||||+||++|-||.|++||+ .+.+.+..+.+......++.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe-----tk~vkety~~Ik~~~Y~~P~-------- 239 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE-----TKTVKETYNKIKLNEYSMPS-------- 239 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----cchHHHHHHHHHhcCccccc--------
Confidence 34456789999999999999999999999999999999999999998 44444455555544433332
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....+..+|+..+|++||.+|||+.+|+..
T Consensus 240 ----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 ----HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 233578999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=333.28 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=210.8
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeee-EEEeCC-eEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFG-CCVEGG-EQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~lv~ 139 (347)
+|...++||+|.||.||++. ..+|..+|.|.+.-.. ..+.+..|+.+|++|+||||+++++ .+..++ ..++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45556789999999999998 6789999999987432 2457889999999999999999998 344444 489999
Q ss_pred eecCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 140 EFCAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 140 e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|+|+.|+|...++ +....+++..+|+++.|++.||.++|+... .-+.||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999885 345779999999999999999999996322 238999999999999999999999999999876
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. .....+.+||+.||+||.+.+.+|+.+|||||+||++|||+...+||.+. .+.+..+.+..++.+
T Consensus 180 s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~------- 246 (375)
T KOG0591|consen 180 SK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYP------- 246 (375)
T ss_pred ch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCC-------
Confidence 43 33345678999999999999999999999999999999999999999854 455566666666432
Q ss_pred CCCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 296 RLNGNIN-RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 296 ~l~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+++ ...++.+.+++..|+..||+.||+...++..+..-
T Consensus 247 ----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 247 ----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 222 45668899999999999999999976666665553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=342.16 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=206.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC---------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN---------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGG 133 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 133 (347)
..+.|...+.||+|+||.|-+|. .++|+.||||.+.+.. ......+|+++|++++|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567778899999999999999 5689999999997642 1123569999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC---CceEEeeccc
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK---LEPKLSDFGL 210 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~---~~~kl~dfg~ 210 (347)
..|+||||++||.|.+.+..+. .+.+..-..+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999997654 3677777889999999999999 8999999999999999866 7799999999
Q ss_pred ceecCCCccceeecccCCCCccccccccCCc---cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAK---LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
|...+ ...-+...+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.....+.. ..+.+..|..
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----l~eQI~~G~y 399 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----LKEQILKGRY 399 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----HHHHHhcCcc
Confidence 99865 344567789999999999998654 33488999999999999999999985433321 2222333433
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... ..-....++..+|+.++|..||++|||+.|++++
T Consensus 400 ~f~p--------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 AFGP--------LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccC--------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2221 1123455789999999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=336.01 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=197.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
..+|...+.||+|+||.||+|++ .++..||||.+.... ..+.+..|+.+|+.++|||||.+++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35677778899999999999995 468999999998764 3456789999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC------CceEEeeccccee
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK------LEPKLSDFGLAKM 213 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~------~~~kl~dfg~~~~ 213 (347)
|||+||+|.++++..+ .+++..+..++.|++.||++|| +++|+||||||.|||++.. -.+||+|||+++.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999997665 5899999999999999999999 8999999999999999864 4589999999998
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
+. ........+|++.|||||++...+|+.|+|+||+|+++|++++|+.||...... +....+..+...+.
T Consensus 165 L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-----eL~~~~~k~~~~~~--- 234 (429)
T KOG0595|consen 165 LQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-----ELLLYIKKGNEIVP--- 234 (429)
T ss_pred CC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHHHhccccccC---
Confidence 75 344456688999999999999999999999999999999999999999843322 22222222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
.+.......+.+|....++.+|.+|-++.+-
T Consensus 235 ------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 235 ------VLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred ------chhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 1111222234466666667777777665543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=322.67 Aligned_cols=260 Identities=27% Similarity=0.327 Sum_probs=211.8
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.|+...++|+|+||.||+|+.+ +|+.||||++..+.+. .-..+|+.+|++++|+|+|.++++|.....++|||||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4566678999999999999954 7999999999876653 3578999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
|+. ++.+-+.....-.+.....+++.|++.|+.|+| +++++||||||+||||+.+|.+||||||.|+.+.. +...
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 998 777778777777899999999999999999999 89999999999999999999999999999998753 4445
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----------CCC--
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----------KRP-- 288 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~-- 288 (347)
.+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+.. +.+++..+......- ..-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 667789999999999987 689999999999999999999999887543 345554444432211 111
Q ss_pred ---cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 ---IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ---~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+++..+++--....++...-+.+++..||+.||++|+|.++++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111221111122344567899999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=328.50 Aligned_cols=240 Identities=28% Similarity=0.353 Sum_probs=202.4
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||.++ .++++.+|+|++.+. .+.+...+|..+|.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3567788999999999999999 457999999999764 3456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+||+.||.|..++.+. +.+++..+.-++..|+.||.||| +.||+||||||+|||+|.+|.++|+|||+++... ..
T Consensus 104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-KD 178 (357)
T ss_pred EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc-cC
Confidence 9999999999999654 45999999999999999999999 8999999999999999999999999999999643 23
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......+||+.|||||++.+.+|+.++|+||||+++|+|++|.+||.... ...+.+.+..+...
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k~~---------- 243 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGKLP---------- 243 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCcCC----------
Confidence 344556799999999999999999999999999999999999999998543 22233333333311
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP 325 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp 325 (347)
..+.-...+..+++...|..||++|.
T Consensus 244 -~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 01111235788999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=332.41 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=214.8
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 137 (347)
.+.|...++||+|.||+||+|+ ..+|+.||+|++..+.. .....+|+.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3446666889999999999999 66899999999976543 34677999999999999999999998876 68999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|||||+. +|..++...+-.|++.++..+++|+++||.|+| .+|+.|||||.+|||||.+|.+||+|||+|+.+...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999 999988777778999999999999999999999 899999999999999999999999999999998777
Q ss_pred ccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC------cc
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP------IK 290 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~ 290 (347)
.....+..+.|.+|.|||.+.|. .|+.++|+||.||||.||++|++.+.+ ....+++..+.+..-..... ++
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-RTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-ccHHHHHHHHHHHhCCCChhccccccCC
Confidence 76667888899999999999875 699999999999999999999998874 34455666655543322211 11
Q ss_pred --cccCCCCC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 --DFEDPRLN-----GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 --~~~~~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.+.-. .+.-....+...+|+..+|..||++|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111100 0001123357888999999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=354.52 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=214.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
.+....+.||+|+||.||+|... +...||||.++...+. .+|.+|++++..++|||||+++|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455677999999999999832 3457999999876654 58999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcC---------CC----CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 137 LVYEFCAAGNLAQHLLRK---------DS----VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~---------~~----~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
+|||||..|+|.++|... +. +++..+.+.|+.|||.|+.||. ++.++||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 999999999999999531 22 3889999999999999999999 7889999999999999999999
Q ss_pred EEeecccceecCCCccceee-cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhh
Q 040826 204 KLSDFGLAKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 281 (347)
||+|||+++..=..++.... ...-+.+|||||.+..++||.+||||||||+|||+++ |+.|+. +....+-+..+...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-GLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-ccchHHHHHHHHcC
Confidence 99999999875444444433 4556889999999999999999999999999999998 555554 33333333333322
Q ss_pred hcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
... +.++.++.+++.||..||+.+|.+|||+.||-..|++..+++
T Consensus 722 ~lL---------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 722 QLL---------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred Ccc---------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 211 445577889999999999999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=333.15 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=211.6
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC-hh--HHHHHHHHhhcCC-CCcceeeeeEEEeCC-eEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN-TD--SFSREVEGLSRVR-HPNLVCLFGCCVEGG-EQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~--~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 138 (347)
-++|...++||.|.||+||+|+ ..+|+.||||++...-. .+ .=.+|+..|++++ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4677788899999999999999 45799999999876422 22 3458999999999 999999999998877 99999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
||||+. +|+++++..+..+++..++.|+.||++||+|+| .+|++|||+||+|||+..+..+||+|||+|+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc--
Confidence 999988 999999888899999999999999999999999 89999999999999999999999999999998743
Q ss_pred cceeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC---------
Q 040826 219 SKVFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP--------- 288 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 288 (347)
....+..+.|.+|.|||++. ...|+.+.|+||+||+++|+.+.++.|.+. ...|++..+...+......
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 34456678999999999875 568999999999999999999999988643 3344555444443222100
Q ss_pred ------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 ------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 ------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+......+..-+ ..+..+..+|+.+|++.||++|||+.|.++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111112 2356789999999999999999999998863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=324.27 Aligned_cols=252 Identities=31% Similarity=0.418 Sum_probs=201.3
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCC--eEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGG--EQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 141 (347)
++...+.||+|+||.||++... +|+..|||.+..... .+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3445678999999999999965 589999998865421 456889999999999999999999855544 68999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCC--Cc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGM--EE 218 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~--~~ 218 (347)
+++|+|.+++...++.+++..+..+.+|+++||.||| ++|++||||||+|||++. ++.+||+|||++..... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999876657999999999999999999999 899999999999999999 79999999999987652 12
Q ss_pred cceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........||+.|||||++.++ ....++|||||||++.||+||++|+..... .............. |
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~~~-------P-- 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGREDSL-------P-- 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccCCC-------C--
Confidence 2224456799999999999953 334599999999999999999999874211 11111222211111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.++...+.+..+++..|+..||.+|||+.+++++--
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 223334467999999999999999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=302.52 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=215.0
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.+|...+.+|+|.||.||+|+ ..+|+.||+|++.-... .....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356667889999999999999 56899999999975432 3478899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|++. +|...++.+.-.++..++..++.+++.|++||| .+.|.||||||.|+|++.+|.+|++|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9998 999999888889999999999999999999999 889999999999999999999999999999998754433
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-------Cc---
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-------PI--- 289 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~--- 289 (347)
. ...+.|.+|.|||.+.| ..|+..+|+||.||++.||+-|.+.|. +..+-+++..+.+....... .+
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3 33378999999999887 579999999999999999998876665 44556777777666533211 11
Q ss_pred ---ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 290 ---KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 290 ---~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+..+.++. +-.....+..+|+..+|..||.+|+|+.|.+++
T Consensus 236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111222222 223445677999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=330.95 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=209.4
Q ss_pred HHhcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 135 (347)
.-..+|.+.+.||.|+|++|++|+ ..+++.+|+|++.+. ........|-++|.+| +||.|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678899999999999999999 558999999998764 2344677889999999 799999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|+|+||+++|.|.+++.+. +.+++...+.++++|+.||+||| +.|||||||||+|||+|+|+.++|+|||.+..+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999765 45999999999999999999999 8999999999999999999999999999998874
Q ss_pred CCccc---------e---eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 216 MEESK---------V---FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 216 ~~~~~---------~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
..... . ...++||..|.+||++.+...+..+|+|+|||++|+|+.|.+||....... ..+.+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----iFqkI~ 300 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----IFQKIQ 300 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----HHHHHH
Confidence 32111 1 145789999999999999999999999999999999999999998654321 122222
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... .+++...+.+.+|+.+.|..||.+|+|.++|-++
T Consensus 301 ~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 ALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred Hhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111 2223344689999999999999999999888654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=337.65 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=213.5
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
++++...++......||+|.||+||+|.|. | .||||++....- .+.|.+|+.++++-+|.||+-+.|++.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 455555666667788999999999999985 3 489999976432 3579999999999999999999999988766
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.+|+.+|+|-+|+.+++.....|.....++|++|+++|+.||| .++|+|+|||..||++.++++|||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999999887778999999999999999999999 899999999999999999999999999998753
Q ss_pred C-CCccceeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 215 G-MEESKVFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 215 ~-~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
. ...........|...|||||++.. .+|++.+||||||+++|||+||..|+. ....+.-+..+-++...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~------ 611 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLM------ 611 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccC------
Confidence 2 122233444568899999999863 579999999999999999999999998 22222211111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
+.+. -...++..++.+|+..||..++++||.+.+|+..|+.++.
T Consensus 612 ----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 ----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111 1233566799999999999999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=329.41 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=210.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----C---ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----N---NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 134 (347)
...+|...+.||+|+||.|+.|.. .+|+.||+|.+... . ......+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356788889999999999999984 47899999976553 1 2345668999999998 9999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~ 213 (347)
.++||||+.||.|.+++.+ .+++.+..+.++++|++.|++|+| ++||+||||||+|++++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999987 667999999999999999999999 8999999999999999999 9999999999997
Q ss_pred cCCCccceeecccCCCCccccccccCCc-cC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAK-LT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.. .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||.. .......+.+..+...++.
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCCccCCC
Confidence 63 2334456678999999999999877 76 789999999999999999999985 2222333335555544443
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~ 331 (347)
.+. ..++..|+.+|+..||.+|+|+.+|+
T Consensus 245 ~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 245 YLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 331 35799999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=317.54 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=208.7
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
...|...+.||.|..++||+|. .+.++.||||++.-+. +-+.+.+|+..|+.++||||++++..|..+..+|+||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3567777889999999999999 6788999999996543 34678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||.+||+.+.+... ..-+++..+..++++++.||.||| .+|.+|||+|+.||||+.+|.++|+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999652 344899999999999999999999 89999999999999999999999999998876543222
Q ss_pred ce---eecccCCCCcccccccc--CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 220 KV---FTDVRGTIGYMDPEYMT--NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 220 ~~---~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. +....|+++|||||++. ...|+.|+||||||++..||.+|..||.... ..+.+.... .+.++... -
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-PmkvLl~tL----qn~pp~~~--t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-PMKVLLLTL----QNDPPTLL--T 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-hHHHHHHHh----cCCCCCcc--c
Confidence 21 25568999999999953 3579999999999999999999999997432 222222222 22222111 2
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+..+........+.+++..||++||++|||+.++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22333334455568999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=330.61 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=203.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeC-C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEG-G 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 133 (347)
.++|...+.||+|+||.||+|.. .++..||+|.+..... ...+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35678889999999999999973 2356899999875432 34688999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCChHHHhhcCC----------------------------------------------------------
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKD---------------------------------------------------------- 155 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 155 (347)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc-eeecccCCCCc
Q 040826 156 ---SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGY 231 (347)
Q Consensus 156 ---~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y 231 (347)
..+++..+..++.|+++||.||| +++++||||||+||+++.++.++|+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999 889999999999999999999999999999865322211 12233456789
Q ss_pred cccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHH
Q 040826 232 MDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESIL 310 (347)
Q Consensus 232 ~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 310 (347)
+|||.+.+..++.++||||||+++|+|++ |..||........ .. .....+... . .+....+.+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~---~~~~~~~~~-------~----~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC---QRLKDGTRM-------R----APENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH---HHHhcCCCC-------C----CCCCCCHHHH
Confidence 99999999899999999999999999997 8888875332211 11 111111110 0 1112335799
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 311 KIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 311 ~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+++.+||+.||.+|||+.++++.|++++++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=329.85 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=208.0
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..|..-.+||+|+.|.||.+. ..+++.||+|++..... .+-+.+|+.+|+..+|+|||.+++.|...+..++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 446677889999999999999 56789999999976544 456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+||+|.|.+.. ..+++.++..+++.+++||+||| .+||+|||||.+|||++.+|.+||+|||.+..+..... ..
T Consensus 353 ~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 99999998844 34899999999999999999999 89999999999999999999999999999998764333 45
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...+||+.|||||++....|+.++||||||++++||+.|++||-...+.. .+..+ ...+.+++. -.
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-AlyLI---a~ng~P~lk----------~~ 492 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLI---ATNGTPKLK----------NP 492 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-HHHHH---hhcCCCCcC----------Cc
Confidence 66789999999999999999999999999999999999999997432221 11111 112221111 12
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....++.+++.+||..|+++|||+.|++++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2344689999999999999999999999863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=342.96 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=218.8
Q ss_pred ccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 69 WDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
...+.||.|.||.|++|.++- ...||||.++.. +...+|+.|..+|-+..||||+++.|+........+|.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 345789999999999999652 347999999875 3456899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
|++|+|+.+|+++++.+++.++.-++++|+.|+.||. +.+++||||..+|||++.+..+|++|||+++.+.++....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999999889999999999999999999999 7899999999999999999999999999999876544333
Q ss_pred eec--ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 222 FTD--VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 222 ~~~--~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.+. -.-+.+|.|||.+...+++.+|||||+|+++||.++ |.+|+= ++...+-+..+.++.+..
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLP------------- 854 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLP------------- 854 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCC-------------
Confidence 222 234679999999999999999999999999999876 777763 444455555555554433
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
-+.+|+..|++||++||++|..+||.+.+|+..|++++++..
T Consensus 855 --pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 855 --PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 334778899999999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.26 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=214.1
Q ss_pred ccCCeeeecCCeeEEEEEeC--CCC----EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLP--SGQ----VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
...+.||+|+||.||.|... .|. .||+|.+.+... ..+|.+|..+|+.++||||++++|++.+....++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 34577999999999999954 243 499999987654 347999999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 140 EFCAAGNLAQHLLRK------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 140 e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
|||++|+|..++++. ...++....+.++.|+|+|+.||+ ++++|||||..+|+|+++...+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999876 677999999999999999999999 88999999999999999999999999999995
Q ss_pred cCCCccceeecc-cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 214 LGMEESKVFTDV-RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 214 ~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+...+....... .-+..|||||.+....++.++|||||||++||++|...+++......+-+..+...-+.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL-------- 923 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL-------- 923 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc--------
Confidence 443333333322 45679999999999999999999999999999999665555454444444433333211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
+.+..|++.+++||.+||+.+|++||++..|+++++++.++..
T Consensus 924 -------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 924 -------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 3344677899999999999999999999999999999976654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=314.08 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=203.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|.++ .+..||+|.+..... ...+.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45677888999999999999853 356899999876533 24688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999776667899999999999999999999 8899999999999999999999999999876532221
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........++..|+|||.+.+..++.++||||||+++|++++ |..||...... +. ...+..+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~----~~~~~~~~~~--------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DV----IKAVEDGFRL--------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HH----HHHHHCCCCC---------
Confidence 111112235678999999999999999999999999999875 99888643221 11 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
..+..++..+.+++.+||+.+|.+|||+.+|.+.|+++
T Consensus 228 --~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=299.02 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=202.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.+|...+.||.|+||.|.+++.+ +|..+|+|++.+.. ..+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45667788999999999999954 68899999997753 3456788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||.+||.|..++++.+ .+++..++-+++|++.|++||| +.+|++|||||+|||+|.+|.+||+|||.+......
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 9999999999996654 5999999999999999999999 899999999999999999999999999999986422
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
+-..+||+.|+|||.++..+|+.++|.||||+++|||+.|.+||..... ...-..+..+....+..++
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v~fP~~fs----- 265 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKVKFPSYFS----- 265 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCcccCCcccC-----
Confidence 4567899999999999999999999999999999999999999986544 2334445555554444433
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 300 NINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
.++.+|+...|+.|-++|
T Consensus 266 -------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 -------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------HHHHHHHHHHHhhhhHhh
Confidence 468888999999999888
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=309.52 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=203.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||++.++++..+++|.+.... ....+.+|+..+++++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 3466678899999999999998888899999886543 356788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998765556899999999999999999999 8899999999999999999999999999988654322222223
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... .+... .+..+.... .+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~----~i~~~~~~~----~~~------- 224 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVE----MISRGFRLY----RPK------- 224 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHH----HHHCCCCCC----CCC-------
Confidence 345678999999988889999999999999999999 8888864321 11112 222221110 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
....++.+++.+||+.+|++|||+.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1225799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.49 Aligned_cols=259 Identities=19% Similarity=0.320 Sum_probs=204.7
Q ss_pred CcccccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeee
Q 040826 52 GLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLF 126 (347)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~ 126 (347)
++..++.+++ +......+|+|++|.||+|.+ +|+.||+|.+..... .+.+.+|+.++++++||||++++
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3455555555 222335799999999999998 689999999876432 24577999999999999999999
Q ss_pred eEEEe----CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc
Q 040826 127 GCCVE----GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 127 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
+++.+ ....+++|||+++|+|.+++... ..+++....+++.|++.|+.|||+ ..+++||||||+||++++++.
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCc
Confidence 99876 34789999999999999998654 468899999999999999999994 248889999999999999999
Q ss_pred eEEeecccceecCCCccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh
Q 040826 203 PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~ 280 (347)
+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.......
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~~~i~~ 236 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIIN 236 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh
Confidence 9999999988653221 22357889999999976 6789999999999999999999999974322 111111111
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
. +... ..+..+.+++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 237 ~---~~~~-----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 K---NNSL-----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred c---CCCC-----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1110 111134467999999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=327.05 Aligned_cols=241 Identities=27% Similarity=0.446 Sum_probs=202.7
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
..+-||.|+.|-||+|++ .++.||||++..-.+ .++..|++|+|+||+.+.|+|.....+|+|||||..|.|..
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-----TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-----TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhhh-----hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 345699999999999999 468899998854332 47889999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCC
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTI 229 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 229 (347)
.|+. +..+.......|..+||.|+.||| .+.|||||||.-||||+.+..+||+|||.++..... ...-.+.||.
T Consensus 202 VLka-~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTV 275 (904)
T KOG4721|consen 202 VLKA-GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTV 275 (904)
T ss_pred HHhc-cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhH
Confidence 8855 456888999999999999999999 788999999999999999999999999999876432 2233478999
Q ss_pred CccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHH
Q 040826 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESI 309 (347)
Q Consensus 230 ~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 309 (347)
.|||||++.+.+.+.|+|||||||+|||||||..|+.. .++ ..+...+ -...|...++..+++-+
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd----Vds-sAIIwGV----------GsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD----VDS-SAIIWGV----------GSNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc----cch-heeEEec----------cCCcccccCcccCchHH
Confidence 99999999999999999999999999999999999862 111 1111111 12233345566777889
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 310 LKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 310 ~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.-|+++||+..|.+|||+.+|+.+|+-.
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=318.19 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=212.3
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.....++||+|-||.|.+|...++..||||+++.... ..+|.+|+.+|.+++||||++++|+|..++.+++++||++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 3445688999999999999998889999999988654 3589999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce-
Q 040826 144 AGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV- 221 (347)
Q Consensus 144 ~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~- 221 (347)
+|+|.+++..+..+ +.......|+.||+.|++||. +.+++||||.+.|+|++.++++||+|||+++.+-..++..
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999776433 355667789999999999999 8899999999999999999999999999999654444443
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh--CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS--GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
....+-+.+|||||.+..++++.++|+|+||+++||+++ ...|+.. ..+++..+-............-+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~--lt~e~vven~~~~~~~~~~~~~l------- 766 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ--LTDEQVVENAGEFFRDQGRQVVL------- 766 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh--hhHHHHHHhhhhhcCCCCcceec-------
Confidence 334567899999999999999999999999999999865 5666652 22333344333333333221111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
..+..|+..+++|+.+||..+..+|||++++...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 23345667899999999999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=328.22 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=210.1
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEeC--CC--CE-EEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVLP--SG--QV-VAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCV 130 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~ 130 (347)
++-..++....++||+|+||.||+|.+. ++ .. ||+|...... ...++.+|.++|+.++||||++++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3333455555688999999999999954 22 23 8999887522 2347999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccc
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
....+++|||+|+||+|.++|...+..++..+...++.+.|.||+||| +++++||||..+|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999999888778999999999999999999999 88999999999999999999999999999
Q ss_pred ceecCCCccceee-cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhh-cCCCC
Q 040826 211 AKMLGMEESKVFT-DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV-SMGKR 287 (347)
Q Consensus 211 ~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 287 (347)
++... ...... ...-+..|+|||.+....|+.++||||||+++||+++ |..|+..-... .....+ ..+-+
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~~~~~r 381 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIVKNGYR 381 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHHhcCcc
Confidence 88642 111122 2246789999999999999999999999999999999 77777643222 122222 11111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
. ..+...+.++..++.+||..+|++||||.++.+.++.+....
T Consensus 382 ~-----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 382 M-----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred C-----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1 222244578999999999999999999999999999997653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=313.85 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=198.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC-----------------CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS-----------------GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~ 125 (347)
++|...+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999997532 33699998876433 2468899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCcee
Q 040826 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKD------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVH 187 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 187 (347)
++++.+.+..+++|||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999885321 24678889999999999999999 789999
Q ss_pred CCCCCCCEEecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhC--CCC
Q 040826 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG--QKV 264 (347)
Q Consensus 188 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg--~~p 264 (347)
+||||+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865432221 12234457889999999888899999999999999999974 455
Q ss_pred cCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 265 IELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+.... ..+.................. ..+..++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 242 ~~~~~-~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELT-DEQVIENAGEFFRDQGRQVYL--------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCC-HHHHHHHHHHHhhhccccccc--------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 54321 122222111111111111100 011123467999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.98 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=209.3
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+-||.|+.|.|-+|+. .+|+.+|||.+.+.. ....+.+|+-+|+-+.|||++.+++++++...+|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 34456799999999999994 589999999997652 234678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++|.|++++..++. +++.++.++++||+.|+.|+| ..+|+||||||+|+|+|..+++||+|||+|..- .....
T Consensus 94 v~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~gkl 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE--VPGKL 167 (786)
T ss_pred cCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc--cCCcc
Confidence 999999999977655 889999999999999999999 889999999999999999999999999999874 34455
Q ss_pred eecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
....+|++.|.+||++.|.+|. .++||||.|+|||.||||+.||. ++.+......+..|...++.++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~~G~f~MPs~I------- 235 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQRGVFEMPSNI------- 235 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHHcCcccCCCcC-------
Confidence 6777899999999999999875 79999999999999999999998 3444445555555554444322
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+..+|+.+|+..||..|.|++||+++
T Consensus 236 -----s~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 -----SSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----CHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2468999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=319.98 Aligned_cols=244 Identities=30% Similarity=0.391 Sum_probs=211.6
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|.||.||||+ ..+.+.||+|.+.+.... ..+.+|++++++++||||+.++++|++..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 456666789999999999999 447899999999765432 368899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+.| +|..++.+.+ .++++.+..++.|+..||.||| +.+|.|||+||.|||++.+|.+|+||||+++.+.. ...
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9988 9999886654 5999999999999999999999 89999999999999999999999999999998753 333
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
..+...||+-|||||.+.+.+|+..+|.||+||++||+.+|++||. ...+....+.+...+.+.+.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-----a~si~~Lv~~I~~d~v~~p~--------- 221 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-----ARSITQLVKSILKDPVKPPS--------- 221 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----HHHHHHHHHHHhcCCCCCcc---------
Confidence 4566789999999999999999999999999999999999999998 55666666666655443222
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........++...|.+||..|.|..+++.
T Consensus 222 ---~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 ---TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 34467899999999999999999998875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.88 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=200.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|.. .++..||+|++..... .+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34677789999999999999973 2456899999875432 34688999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------------------------------------------------
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD----------------------------------------------------------- 155 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 155 (347)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 156 ---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 156 ---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
..+++..+.+++.|++.||.||| +.+++||||||+||++++++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24678889999999999999999 889999999999999999999999999999865432221
Q ss_pred e-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 221 V-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 221 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... .+.... .+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~---~~~~~~----~~--- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIK---EGYRML----SP--- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHH---hCccCC----CC---
Confidence 1 122335678999999999999999999999999999998 777775432221 1111111 111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.....++.+++.+||+.||++|||+.+|++.|++.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11235799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=287.45 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=208.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...++||+|-||.||.|+. +++-.||+|++.++ ....++.+|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45677889999999999999994 57889999999765 3345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 139 YEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
+||...|++...+.. ....+++...+.+..|+|.|+.|+| .++++||||||+|+|++..+.+|++|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 999999999999974 3456999999999999999999999 899999999999999999999999999998863
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
+.......+||..|.|||...+..++..+|+|++|++.||++.|.+||.... ..+.+. .+..-+..++
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYk----rI~k~~~~~p------- 242 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYK----RIRKVDLKFP------- 242 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHH----HHHHccccCC-------
Confidence 3455667789999999999999999999999999999999999999998544 222222 2222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..++ ....+++.+|+.++|.+|.+..|+.+.
T Consensus 243 -~~is----~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -STIS----GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -cccC----hhHHHHHHHHhccCccccccHHHHhhh
Confidence 1222 468999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=310.40 Aligned_cols=248 Identities=24% Similarity=0.288 Sum_probs=199.4
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|+.++++++|+|++++++++.+++..++++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55668899999999999995 578999999886432 223577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GE 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CC
Confidence 9999999887543 346899999999999999999999 88999999999999999999999999999987532 12
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ............. .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~------------~ 223 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKEDQE------------E 223 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhcccc------------c
Confidence 23345689999999999999999999999999999999999999975432111 1111111111110 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPT-----IDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~~ 333 (347)
+......++.+|+.+||+.||.+||+ ++++++.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12223457899999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=289.47 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=207.5
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEe-----CCeEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVE-----GGEQY 136 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~ 136 (347)
.++|+..+.||+|||+-||++. ..++..+|+|++.... +.+...+|++..++++|||+++++++... ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678889999999999999999 6688999999997654 45578899999999999999999987653 33589
Q ss_pred EEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 137 LVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
++++|...|||.+.+.. ++..+++.+.+.|+.++++||.+||.. ..+++||||||.||++.+.+.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999854 566899999999999999999999943 23499999999999999999999999999886
Q ss_pred cCCCcc--------ceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh
Q 040826 214 LGMEES--------KVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 214 ~~~~~~--------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 282 (347)
..-.-. ........|..|.|||.+. +...+.++|||||||+||.|+.|..||.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence 531111 0111234689999999884 56788999999999999999999999973222
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
+|..-.....++.+..+-....++.+.+++.+|++.||.+||++.+++..+++++
T Consensus 247 -~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1211111222222222222235688999999999999999999999999999874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=304.76 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=205.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|++|.||+|...+++.|++|.+.... ....+.+|+..+++++|||++++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34577788999999999999998778889999987543 34678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||++++++.++|+|||++...........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999986543 56899999999999999999999 78999999999999999999999999999987652222222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ..... +...... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~----~~~~~~~-----------~~ 225 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQ----VDQGYRM-----------PC 225 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH----HHcCCCC-----------CC
Confidence 22233568999999998889999999999999999999 88887643211 11111 1111100 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
.....+.+.+++.+||+.+|.+||++.++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11233679999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=304.86 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+|...+.||+|+||.||++...++..+|+|.+.... ....+.+|+..+++++||||+++++++......+++|||+.++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 466678899999999999998777789999887543 3457899999999999999999999999888899999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+..............
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 999999765557899999999999999999999 88999999999999999999999999999886543322222233
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
.++..|+|||...+..++.++|+||||+++|+|++ |..||..... ...... ...+.... ....
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~----~~~~~~~~-----------~~~~ 225 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEK----VSQGLRLY-----------RPHL 225 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHH----HhcCCCCC-----------CCCC
Confidence 45678999999988889999999999999999998 8888763322 111111 11111110 0001
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
..+.+.+++.+||+.+|++|||+.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2367999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=306.48 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=205.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...++||+|+||.||+|...++..|++|.+.... ..+.+.+|+.++++++|+|++++++.+...+..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 5677789999999999999998888899999886543 346788999999999999999999999998999999999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++............
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 9999998653 456889999999999999999999 789999999999999999999999999999876432222222
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +....... +.. . +. .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~----~~~-~-----~~-----~ 226 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSALQR----GYR-M-----PR-----M 226 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHHHHc----CCC-C-----CC-----C
Confidence 3345678999999988889999999999999999998 88888643211 11111111 110 0 00 1
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
.....++.+++.+||+.+|++|||++++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=321.01 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=201.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 135 (347)
++|...+.||+|+||.||+|... ++..||+|.+..... ...+.+|+.+++.+ +|+||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46777889999999999998832 335799999976433 24578899999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC------------------------------------------------------------
Q 040826 136 YLVYEFCAAGNLAQHLLRKD------------------------------------------------------------ 155 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 155 (347)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce-eecc
Q 040826 156 ---------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV-FTDV 225 (347)
Q Consensus 156 ---------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 225 (347)
..+++..+++++.|++.||.||| ++|++||||||+||++++++.++|+|||++.......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 24678889999999999999999 8899999999999999999999999999987653222111 1223
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
.++..|+|||++.+..++.++||||||+++|+|++ |+.||....... ........ +... ..+ ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~---~~~~----~~~---~~---- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR---GYQM----SRP---DF---- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc---ccCc----cCC---CC----
Confidence 35678999999998899999999999999999997 999986433222 11111111 1000 000 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
...++.+++.+||+.||.+|||+.+|++.|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1357999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=297.87 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=210.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChh----HHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 137 (347)
.++|...+.|++|.||.||+|+. .+++.||+|+++.+.+.. ...+|+.+|.+++|||||.+-.+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34566678899999999999994 478999999998876544 57799999999999999999988764 457999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|||||+. +|..++....+++...++..++.|++.|++||| .+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999998 999999887888999999999999999999999 889999999999999999999999999999998743
Q ss_pred ccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cccccc--
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIKDFE-- 293 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 293 (347)
....+..+.|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+.. .-+++..+.+....+.. ..+.+.
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCccccCCCcccc
Confidence 445677789999999999887 469999999999999999999999887543 33445555444322110 000000
Q ss_pred ------------CCCCCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 ------------DPRLNGNINRA-DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ------------~~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
-..+.+.+... ..+.-++|+...|..||.+|.|+.+.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00111111111 3367889999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=305.28 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=204.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.+|...+.||+|++|.||+|... +++.+++|.+.... ....+.+|++.+++++|+|++++++++..++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 34667788999999999999954 58899999886543 24568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++... ...+++..++.++.|+++||+||| +++++|+||||+||++++++.++|+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999998653 346899999999999999999999 88999999999999999999999999999887643322222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....+..|+|||.+.+..++.++||||||+++|+|++ |..|+.... ..+.... ...+... ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~----~~~~~~~-----------~~ 226 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYEL----LEKGYRM-----------ER 226 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH----HHCCCCC-----------CC
Confidence 22334668999999998899999999999999999998 888876432 1111111 1111100 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122346799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=303.66 Aligned_cols=253 Identities=28% Similarity=0.388 Sum_probs=204.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|.+.. ...|++|.+..... ...+.+|+..+++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 467788899999999999998642 35799998865433 24678899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..++.++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999776667999999999999999999999 7899999999999999999999999999998764211
Q ss_pred cc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 219 SK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 219 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ....+..+...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~----~~~~~~~~~~~-------- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-D----VIKAVEDGYRL-------- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-H----HHHHHHcCCCC--------
Confidence 11 1122335678999999998889999999999999999998 88887532211 1 11111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+.....++.+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112346799999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.00 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=197.4
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|.....||+|+||.||+|+ ..+|..+|+|++.++. .......|-.+|....+|.||+++..|++...+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 5678888999999999999999 5579999999998753 445788899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC--
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM-- 216 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~-- 216 (347)
|||.+||++..+|... +.+++..+..++++++.|+..|| +.|++||||||+|+|||..|.+||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999988654 46999999999999999999999 89999999999999999999999999999853311
Q ss_pred --------------------Cccc-----e-------------------eecccCCCCccccccccCCccCCcccHHHHH
Q 040826 217 --------------------EESK-----V-------------------FTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252 (347)
Q Consensus 217 --------------------~~~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 252 (347)
.... . ....+||+.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0 0113699999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 040826 253 IVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT 326 (347)
Q Consensus 253 ~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps 326 (347)
||+||||.|.+||..+.+... .+.+......+.- +-......+..+||.+|+. ||++|.-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T-----~rkI~nwr~~l~f--------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQET-----YRKIVNWRETLKF--------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhhhccC--------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999986554432 1222111100000 0111222678999999997 9999965
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=307.94 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=201.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46778889999999999999954 78899999886432 234677999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++...+..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 986 999988766667899999999999999999999 8899999999999999999999999999987643221 12
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC----------Ccc
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----------PIK 290 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 290 (347)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...... +.+....+....... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccchhhh
Confidence 233467899999998865 56889999999999999999999999754322 222222221111100 001
Q ss_pred cccCCCCCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNGN----INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+..... .......+..+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111000 00112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=302.72 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=201.5
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+|...+.||+|+||.||++...++..+++|.+.... ....+.+|+++++.++|||++++++++...+..++++||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 456678899999999999998777889999886543 3457889999999999999999999999888999999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999766667899999999999999999999 88999999999999999999999999999886542222222222
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+.... ...+... ..+..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~----~~~~~~~-----------~~~~~ 225 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVES----VSAGYRL-----------YRPKL 225 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHH----HHcCCcC-----------CCCCC
Confidence 34568999999998889999999999999999999 7888764322 111111 1111110 01112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.+.++.+++.+||+.+|++|||+.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 345799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.85 Aligned_cols=266 Identities=28% Similarity=0.493 Sum_probs=213.0
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.....+...+.||+|+||.||+|.. .+|..||+|++...... ...|++.+++++||||+++++++.+.+..++||||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3445677788999999999999996 57899999988654332 23568899999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++|+|.+++.. ++|..+.+++.|+++|++|||+.++.+++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999842 8899999999999999999997767899999999999999999888775 655443211
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC--
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG-- 299 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-- 299 (347)
.....++..|+|||++.+..++.++||||||+++|||+||+.|+............+.+..... .......++.+..
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDV 913 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCC
Confidence 1123578899999999999999999999999999999999999865444333444444332221 1233344555433
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
....+...++.+++.+||+.||++||||.||++.|+++.+..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 345566778999999999999999999999999999997754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=308.10 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=201.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888899999999999999965 78999999986532 23457789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++ +|.+++......+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++...... ..
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 158 (303)
T cd07869 84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SH 158 (303)
T ss_pred CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Cc
Confidence 9965 888888766667899999999999999999999 889999999999999999999999999998754322 12
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-------Ccccc
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-------PIKDF 292 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 292 (347)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||....+....+............ ....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234567899999998865 457889999999999999999999997654433333333222111000 00000
Q ss_pred cCCCCC--CC--CC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 EDPRLN--GN--IN-----RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 ~~~~l~--~~--~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...... .. .. ......+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 00 011246889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=315.53 Aligned_cols=243 Identities=23% Similarity=0.283 Sum_probs=199.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.++++++||||+++++++.+++..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46777889999999999999964 6899999998653 22346889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999988654 45889999999999999999999 889999999999999999999999999999875322
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+..+..+...
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~~~~~p~-------- 236 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKILAGRLKFPN-------- 236 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHHhcCCcCCCC--------
Confidence 12346899999999999988999999999999999999999999743221 111222222211111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPT-----IDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~~ 333 (347)
.+ ...+.+|+.+||+.||.+||+ +.+++++
T Consensus 237 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 WF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12 246889999999999999997 6777644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=307.97 Aligned_cols=262 Identities=24% Similarity=0.281 Sum_probs=200.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|... +++.+|+|++.... ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36778889999999999999965 68899999986542 23467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|++++++.. +......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999866654 4344456899999999999999999999 889999999999999999999999999999875433222
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC----------CCCCcc
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM----------GKRPIK 290 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~ 290 (347)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||...... +........... ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 333456899999999999888999999999999999999999999754322 111111111000 000000
Q ss_pred cccCCCCCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNG------NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.... ........++.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000011000 011123457999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=305.29 Aligned_cols=245 Identities=31% Similarity=0.534 Sum_probs=191.9
Q ss_pred CCeeeecCCeeEEEEEeC-----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+.||.|.||.||+|.+. .+..|+||.+..... ...+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 457999999999999975 356899999965433 357899999999999999999999999888899999999
Q ss_pred CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-c
Q 040826 143 AAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-K 220 (347)
Q Consensus 143 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 220 (347)
++|+|.+++... ...+++..+..++.|++.||.||| +.+++|++|+++||++++++.+||+|||++........ .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 999999999876 667999999999999999999999 77899999999999999999999999999987632212 2
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
..........|+|||.+.+..++.++||||||+++||+++ |+.|+... ...+..... .. +...
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~---~~~~----------- 224 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQ---GQRL----------- 224 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HT---TEET-----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cc---cccc-----------
Confidence 2333457789999999998889999999999999999999 56776533 222222222 11 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
..+..+...+.+++.+||+.+|++|||+.+|++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112346799999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=320.11 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=229.5
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEeCC-CCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|+.-..+....++||-|.||.||.|.|+. ...||||.+..+. ...+|..|..+|+.++|||+|+++|+|..+..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 4444445556667899999999999999864 6689999998764 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 137 LVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
+|+|||..|+|.+|++.. ....+.-..+.++.||+.|+.||. .+++|||||...|+|+.++..+|++|||+++.+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999874 345777788899999999999999 8899999999999999999999999999999987
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.+.+....+..-+..|.|||.+....++.++|||+||++|||+.|-....+.+.+....+....+++++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~---------- 486 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD---------- 486 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc----------
Confidence 6666666667778899999999999999999999999999999986554444555555555555555443
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~ 344 (347)
.+..|++.+++||..||+.+|.+||+++||-+.+|.++.++.++
T Consensus 487 -----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 487 -----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred -----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 23467789999999999999999999999999999999887653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=301.90 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=204.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...++||+|+||.||+|...++..|++|.+.... ....+.+|++++++++||||+++++.+. ....+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 4577888999999999999997777789999987643 3457889999999999999999999875 4567999999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
|+|.+++... +..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||.+............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 9999999653 346899999999999999999999 889999999999999999999999999999866433322223
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||...+..++.++|+||||+++|+|++ |..||...... .... ....+... ...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~----~~~~~~~~-----------~~~ 225 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLD----QVERGYRM-----------PCP 225 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHH----HHhcCCCC-----------CCc
Confidence 3446778999999988889999999999999999999 77777643221 1111 11111100 112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.+.+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 234467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.05 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=202.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC-C-----CEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS-G-----QVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|...+ + ..+++|.+..... ...+.+|+..+++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356677889999999999998532 2 5799998875443 246889999999999999999999999888999
Q ss_pred EEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 137 LVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
++|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999986431 45788999999999999999999 88999999999999999999
Q ss_pred ceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHH
Q 040826 202 EPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 202 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~ 279 (347)
.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... + ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~-~~--- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-E-VI--- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-H-HH---
Confidence 999999999886533222 12233456788999999988889999999999999999998 99888643221 1 11
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
..+..+... ..+..++.++.+|+.+||+.||.+|||+.+|++.|++
T Consensus 237 ~~i~~~~~~-----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIRSRQLL-----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcC-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111111 1122445789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.94 Aligned_cols=243 Identities=24% Similarity=0.236 Sum_probs=199.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 35777889999999999999964 68999999986432 2346788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999998654 35899999999999999999999 889999999999999999999999999998865321
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+..+....
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~---------- 217 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAGKLEF---------- 217 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCcCC----------
Confidence 22346899999999999988999999999999999999999999754321 1112222222111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPT-----IDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~~ 333 (347)
+......+.+|+.+||+.||.+||+ +.++++.
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112357899999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=314.61 Aligned_cols=246 Identities=30% Similarity=0.449 Sum_probs=205.3
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.|...+.||+|.||.||+|. ..+++.||+|++.-. .+.+++.+|+.++..++++||.++++.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 34445779999999999999 457899999998644 33457889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
.||++.+.+... ..+.+..+.-+++++..|+.||| ..+.+|||||+.||++..+|.+|++|||++..+...... .
T Consensus 94 ~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred cCcchhhhhccC-CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 999999988543 34578888889999999999999 889999999999999999999999999999887543333 3
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...+||+.|||||++....|+.++||||||++++||.+|.+|+..-.+. .+.-. +..-..|.+.+.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rvlfl-------Ipk~~PP~L~~~~- 235 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RVLFL-------IPKSAPPRLDGDF- 235 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eEEEe-------ccCCCCCcccccc-
Confidence 7789999999999999989999999999999999999999998743321 11111 2222234555433
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...+.+++..||.+||+.|||+.+++++
T Consensus 236 ---S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 ---SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3569999999999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=302.46 Aligned_cols=257 Identities=25% Similarity=0.283 Sum_probs=205.2
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCC-----eEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG-----EQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e 140 (347)
.|...+++|+|+||.||.|.. .+++.||||+...+..... +|+++|+.+.|||||++.-+|.... ...+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn--rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN--RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc--HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 455678899999999999994 4578999999987665443 7999999999999999998887532 2358999
Q ss_pred ecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeecccceecCC
Q 040826 141 FCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKMLGM 216 (347)
Q Consensus 141 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~ 216 (347)
|++. ||.+.++. .+..++...+.-+..|+++||.||| +.||+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9998 99998864 3556777888889999999999999 8899999999999999976 8999999999998753
Q ss_pred CccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC--------C
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK--------R 287 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~ 287 (347)
. ........|..|.|||.+.| ..|+.+.||||.||++.||+-|++.|.+ ....+++..+.+...... .
T Consensus 179 ~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 179 G--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred C--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 3 22345567889999999987 5799999999999999999999999975 556677777776543321 2
Q ss_pred CcccccCCCCCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKDFEDPRLNG-----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...++..|.+.. ........+..+|+.++++.+|++|.++.|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 222223333322 123345578999999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=313.68 Aligned_cols=239 Identities=25% Similarity=0.297 Sum_probs=194.9
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+.||+|+||.||++.. .+|+.+|+|.+.... ....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999995 478999999987532 2245778999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... ........
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccce
Confidence 999988654 46899999999999999999999 88999999999999999999999999999875321 12223345
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
.|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+..+.... +...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~------------p~~~ 218 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEIRF------------PRTL 218 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCCCC------------CCCC
Confidence 6899999999999999999999999999999999999999743221 1111121111111 1123
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 306 FESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
..++.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 35789999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=311.14 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=204.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC----EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ----VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|+||.||+|.+. +|+ .||+|.+..... ...+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45777889999999999999853 344 389999865432 35688899999999999999999998764 5779
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++......+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999877667899999999999999999999 889999999999999999999999999999876432
Q ss_pred ccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ....... .+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~---~~~~~------- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE---KGERL------- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHh---CCCCC-------
Confidence 2211 122334678999999999999999999999999999998 88888643211 1111111 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.....+..++.+++.+||+.+|.+|||+.+++..+.++.++..
T Consensus 231 ----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 231 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0011123568999999999999999999999999999977654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=305.08 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=206.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..+|...+.||.|+||.||+|...++..+++|.+..... ...+.+|+..++.++|+|++++++++.+....+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456777888999999999999988899999999876543 457889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++|.+++... +..+++..+..++.|++.|+.||| +++++|+||+|+||++++++.++|+|||.+........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 999999999753 456899999999999999999999 78999999999999999999999999999876542211 1
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ......... .+... .
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~----~~~~~-----------~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQIT----AGYRM-----------P 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHH----hCCcC-----------C
Confidence 223346778999999998889999999999999999998 788886432 111112111 11110 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
....+.+.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112334679999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=309.21 Aligned_cols=261 Identities=25% Similarity=0.292 Sum_probs=202.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||++... +|..+|+|.+..... ...+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888889999999999999954 688999998875432 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++..... .
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 157 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---c
Confidence 99999999988654 358999999999999999999994 24699999999999999999999999999876532 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhh-hcCCCCCccc--------
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD-VSMGKRPIKD-------- 291 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------- 291 (347)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .+...... ...+......
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccccc
Confidence 223446899999999999989999999999999999999999999643321 11111110 0000000000
Q ss_pred ------------------------ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 292 ------------------------FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 292 ------------------------~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
................++.+|+.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000011234679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=316.54 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=203.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 134 (347)
.++|...++||+|+||.||+|... .+..||+|++..... .+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457778899999999999999842 234699999975432 346889999999996 9999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------------------------------------------------
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD----------------------------------------------------------- 155 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 155 (347)
.++||||+++|+|.+++.+..
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999875321
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 156 ------------------------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 156 ------------------------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
..+++..+..++.|++.||.||| +.+++|+||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 23677888999999999999999 889999999999999999
Q ss_pred CCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHH
Q 040826 200 KLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTR 277 (347)
Q Consensus 200 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~ 277 (347)
++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~- 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN- 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence 99999999999986532221 11223346778999999998889999999999999999997 8888864322222111
Q ss_pred HHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 278 KARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
....+... ........++.+++.+||+.||++|||+.+|.+.|+.+++
T Consensus 352 ---~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 ---KIKSGYRM-----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHhcCCCC-----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111110 1112334679999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=299.78 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=202.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|...++..+++|.+.... ....+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 4677788999999999999998888889999987643 3457889999999999999999999875 4568899999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 9999998653 345899999999999999999999 789999999999999999999999999999875433222222
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+.... +..+... ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~----~~~~~~~-----------~~~ 225 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQ----VERGYRM-----------PCP 225 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH----HHcCCCC-----------CCC
Confidence 3345678999999988889999999999999999999 788876432 2222222 1111110 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
......+.+++.+||.++|++|||++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=310.55 Aligned_cols=235 Identities=23% Similarity=0.259 Sum_probs=190.7
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||++... +++.||+|.+... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999954 6889999998643 2234577899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccC
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG 227 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 227 (347)
.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ........|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccC
Confidence 9998654 45899999999999999999999 889999999999999999999999999998754221 222334568
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............. +.....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~------------~~~~~~ 218 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEPLRF------------PDGFDR 218 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCCC------------CCcCCH
Confidence 99999999999999999999999999999999999999743221 1222222221111 112235
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH
Q 040826 308 SILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
++.+++.+||+.||.+||++..+
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCH
Confidence 78999999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=310.35 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=202.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEe-CCe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVE-GGE 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~~ 134 (347)
++|...+.||+|+||.||+|.. .+++.||+|++...... ..+.+|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4677789999999999999963 23578999998754332 3577899999999 79999999998765 457
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------------------------------------------------
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD----------------------------------------------------------- 155 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 155 (347)
.++++||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-ceeecccCCCCccc
Q 040826 156 -SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMD 233 (347)
Q Consensus 156 -~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~a 233 (347)
..+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++..+..... .......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25789999999999999999999 88999999999999999999999999999987532221 12223446778999
Q ss_pred cccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHH
Q 040826 234 PEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKI 312 (347)
Q Consensus 234 PE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 312 (347)
||++.+..++.++|||||||++|+|++ |..||....... .+.... ..+... ..+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~---~~~~~~-----------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRL---KEGTRM-----------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHH---hccCCC-----------CCCccCCHHHHHH
Confidence 999999999999999999999999998 888886432211 111111 111111 0111233679999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 313 AVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 313 ~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+.+||+.+|++|||+.|+++.|+++++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.90 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=201.3
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+|...+.||+|+||.||+|... +|+.||+|++... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5777889999999999999965 6899999998653 223467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 99999999998654 45889999999999999999999 88999999999999999999999999999886432
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... +.............. ....++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~--~~~~~~----- 225 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETLQR--PVYDDP----- 225 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHhccccccC--CCCCcc-----
Confidence 223456899999999999989999999999999999999999999753322 111111110000000 000000
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......++.+++.+||+.+|.+|||+.++++.
T Consensus 226 -~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 -RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.43 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=201.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|... ++..|++|.+...... ..+.+|++++++++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 34666788999999999999853 3478999998765433 57889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 137 LVYEFCAAGNLAQHLLRKD-------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
++|||+++++|.+++...+ ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 34788899999999999999999 8899999999999999999999
Q ss_pred EEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhh
Q 040826 204 KLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 281 (347)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +. ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~----~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EV----IEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HH----HHH
Confidence 99999998765322211 1223345778999999999999999999999999999998 99988643221 11 112
Q ss_pred hcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
+..+... .........+.+++.+||+.||++|||+.||++.|++
T Consensus 237 ~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQGRLL-----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCcC-----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2222111 0111233579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=302.97 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=209.1
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCCh--h---HHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT--D---SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.-+|...+.||+|.||.|-++. ...|+.||||.+.++.-. + .+.+|+++|..|+||||+.++.+|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4467777889999999999999 578999999999876432 2 478999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||..+|.|+||+...+ .+++.+++.+++||..|+.|+| .++++|||||.+|||+|.|+++||+|||++..+. +
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~--~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--D 205 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc--c
Confidence 99999999999996654 5999999999999999999999 8999999999999999999999999999998874 3
Q ss_pred cceeecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
..-.+.++|++-|.+||++.|.+|. +.+|.||||++||-|+.|.-||.+ .+. ...++.+..|... +-
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dh----k~lvrQIs~GaYr--EP----- 273 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDH----KRLVRQISRGAYR--EP----- 273 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chH----HHHHHHhhccccc--CC-----
Confidence 4446678999999999999999885 789999999999999999999973 222 2334444444321 11
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
..+....-|+.|||..||++|.|+.+|..+.
T Consensus 274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1124578899999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=304.51 Aligned_cols=254 Identities=27% Similarity=0.349 Sum_probs=201.7
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----------------ChhHHHHHHHHhhcCCCCcc
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----------------NTDSFSREVEGLSRVRHPNL 122 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------~~~~~~~e~~~l~~l~h~ni 122 (347)
+-....++|.....||+|.||.|-+|+. .+++.||+|++.+.. ..+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3344578899999999999999999994 478999999996542 12367899999999999999
Q ss_pred eeeeeEEEe--CCeEEEEEeecCCCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 123 VCLFGCCVE--GGEQYLVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 123 v~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
|+++++..+ .+.+|||+|||..|.+...= ...+ ++..+++++++++..||.||| .+||+||||||+|+|+++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence 999999876 46899999999998875422 2333 899999999999999999999 899999999999999999
Q ss_pred CCceEEeecccceecCCC----ccceeecccCCCCccccccccCC----ccCCcccHHHHHHHHHHHHhCCCCcCCChhh
Q 040826 200 KLEPKLSDFGLAKMLGME----ESKVFTDVRGTIGYMDPEYMTNA----KLTCASDIYSFGIVALQLLSGQKVIELDFDA 271 (347)
Q Consensus 200 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~lltg~~p~~~~~~~ 271 (347)
+|.+||+|||.+...... .........||+.|+|||...++ ..+.+.||||+|++||-|+.|+.||..++..
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999866221 11223447899999999988763 2457899999999999999999999854332
Q ss_pred hhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....+....... +..++..+++.+|+.++|.+||+.|.+..+|..+
T Consensus 326 -----~l~~KIvn~pL~f----------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 -----ELFDKIVNDPLEF----------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -----HHHHHHhcCcccC----------CCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 2222222222111 1222445789999999999999999999998654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=298.07 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=205.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.++++++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4677888999999999999995 478999999875422 1235788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988743 3455889999999999999999999 88999999999999999999999999999887542
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........... ..+.....+ .
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-------~ 227 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC---QKIEQCDYP-------P 227 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH---HHHhcCCCC-------C
Confidence 22 122234578899999999888889999999999999999999999865432222222 222111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.........+.+++.+||+.+|++|||+.+|++.++.+
T Consensus 228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11123346799999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=310.09 Aligned_cols=240 Identities=26% Similarity=0.303 Sum_probs=194.3
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+.||+|+||.||++.. .+|..||+|.+.... ....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999995 478999999986531 2345678999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||++..... ........
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccccc
Confidence 999888554 45899999999999999999999 88999999999999999999999999999875321 12223345
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+...... ++...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~----~~~~~~~~~~~------------~p~~~ 218 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-R----LFELILMEEIR------------FPRTL 218 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-H----HHHHHhcCCCC------------CCCCC
Confidence 6899999999999989999999999999999999999999743221 1 11111111111 11122
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 306 FESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
..++.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 35789999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=312.22 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=211.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe-EEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE-QYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 139 (347)
++|...+.+|+|+||.++.+..+ ++..+++|.+.-. ...+...+|+.+++++.||||+.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999999854 6788999988643 234467899999999999999999999998887 99999
Q ss_pred eecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 140 EFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 140 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+|++||++.+.+... +..++++.+.+|+.|++.|+.||| ++.|.|||||+.||+++.++.++|+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999654 478999999999999999999999 8899999999999999999999999999999886443
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||+.|+.||.+.+.+|+.++|||||||.+|||++-+++|.... +......+..+. .
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~-----------~ 223 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL-----------Y 223 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc-----------C
Confidence 23456789999999999999999999999999999999999999998432 222333332222 1
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+++.....++..|+..|++++|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 13444566789999999999999999999999987
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=298.20 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...++||+|+||.||+|...+++.+|+|.+.... ....+.+|+.++++++|+|++++++++. .+..++++||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 34677788999999999999998889999999887643 3457889999999999999999999864 457899999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++... +..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999988653 456899999999999999999999 88999999999999999999999999999987643222222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...... ...... ..+... ..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~----~~~~~~-----------~~ 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNL----ERGYRM-----------PR 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHH----HcCCCC-----------CC
Confidence 33446778999999988889999999999999999999 89888643321 111111 111100 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
......++.+++.+||+.+|++|||++++++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11223579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=295.07 Aligned_cols=244 Identities=26% Similarity=0.378 Sum_probs=197.7
Q ss_pred eeeecCCeeEEEEEeCCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
+||+|+||.||+|...++..+++|.+..... ...+.+|++.+++++|||++++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999987889999998876543 2357889999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCC
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTI 229 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 229 (347)
++......+++..++.++.|++.+|.|+| +++++|+||+|+||+++.++.++|+|||++...............++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 98766667899999999999999999999 889999999999999999999999999998764322221112223466
Q ss_pred CccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHH
Q 040826 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFES 308 (347)
Q Consensus 230 ~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 308 (347)
.|+|||++.+..++.++|+||||+++|++++ |..||...... ... .....+... .........
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~----~~~~~~~~~-----------~~~~~~~~~ 222 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAR----EQVEKGYRM-----------SCPQKCPDD 222 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH----HHHHcCCCC-----------CCCCCCCHH
Confidence 7999999988889999999999999999998 88888643221 111 111111110 011123357
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 309 ILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 309 l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=315.88 Aligned_cols=259 Identities=20% Similarity=0.192 Sum_probs=197.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
..+|...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++++|++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 35799999999999999999995 478999999653 2346789999999999999999999999999999999996
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++............
T Consensus 167 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 5888888654 35889999999999999999999 789999999999999999999999999998754322222233
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh------hhhHHHHHHhhhcCCCCCcc-------
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD------ARDQLTRKARDVSMGKRPIK------- 290 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~------- 290 (347)
...||..|+|||++.+..++.++||||||+++|+|++|..|+..... ....+...............
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 45799999999999998999999999999999999999987653211 11122222111100000000
Q ss_pred ----------cccCCCCCCC--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 ----------DFEDPRLNGN--INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ----------~~~~~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+..... .......++.+|+.+||+.||.+|||+.|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00123457899999999999999999999985
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=302.16 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=204.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|+||.||++... ++..+++|.+..... ...+.+|++++++++|||++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 45677788999999999999842 345689998865433 3468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 138 VYEFCAAGNLAQHLLRKD------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
++||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 34899999999999999999999 889999999999999999999999
Q ss_pred eecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhc
Q 040826 206 SDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 206 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +... .+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~----~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIE----CIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHH
Confidence 99999876532221 11222345778999999998889999999999999999998 88887643221 1111 122
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.+... .... ....++.+++.+||+.||.+|||+.++.+.|+++.+..
T Consensus 237 ~~~~~-------~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVL-------QRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcC-------CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 22111 0011 12356999999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=313.13 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=192.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34455678999999999999954 789999999865433 34688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+. ....+..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++...... ...
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 224 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDP 224 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-ccc
Confidence 999998653 23567778899999999999999 889999999999999999999999999999875422 112
Q ss_pred eecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 222 FTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||...... ..............+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~-------- 294 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQPP-------- 294 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccCCC--------
Confidence 234568999999998743 23456899999999999999999999732211 111111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........++.+|+.+||+.||++|||+.|++++
T Consensus 295 ---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111233579999999999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=308.57 Aligned_cols=240 Identities=25% Similarity=0.304 Sum_probs=195.2
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999995 468999999987532 2346778999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence 999888554 45899999999999999999999 889999999999999999999999999998753221 2223345
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+....... +...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~------------p~~~ 218 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEDIKF------------PRTL 218 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCCccC------------CCCC
Confidence 6899999999999889999999999999999999999999743221 1111221111111 1122
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 306 FESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
..++.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 35789999999999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.24 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=200.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC----EEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ----VVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|+||.||+|.+. +|+ .+++|.+...... ..+..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35666788999999999999953 454 4778877544332 35667777889999999999999875 456788
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++......+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||++......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876677999999999999999999999 789999999999999999999999999999865322
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...... ....... .+.... .+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~---~~~~~~----~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE---KGERLA----QP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---CCCcCC----CC
Confidence 211 1223456778999999998889999999999999999998 88888643221 1111111 111110 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
. .+...+.+++.+||+.||.+|||+.|+++.|+.+.++.
T Consensus 234 ~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 Q-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1 12356888999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=296.47 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=201.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|++|.||++...++..+++|.+.... ....+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 4567778899999999999998777789999886543 3457889999999999999999999875 4568899999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 9999999653 345899999999999999999999 789999999999999999999999999999865433222222
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||...+..++.++|+||||+++|+|++ |..||...... ...... ..+... ...
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~-----------~~~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQV----ERGYRM-----------PCP 225 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HcCCCC-----------CCC
Confidence 3346678999999988889999999999999999999 88887643221 111111 111100 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
...+..+.+++.+||++||.+||++++|++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2334679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=310.06 Aligned_cols=243 Identities=26% Similarity=0.264 Sum_probs=198.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-C-CCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-S-GQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... + +..||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46777889999999999999854 3 368999988643 2334678899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999998654 35899999999999999999999 889999999999999999999999999999865321
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||...... .....+..+.....
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~i~~~~~~~p-------- 248 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQKILEGIIYFP-------- 248 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHHHhcCCCCCC--------
Confidence 22346899999999999988999999999999999999999999754221 11122222221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
... ...+.+++.+||+.||.+|+ |++++++.
T Consensus 249 ~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112 24678999999999999995 88888764
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=295.99 Aligned_cols=250 Identities=25% Similarity=0.439 Sum_probs=202.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
.+|...+.||+|+||.||++.+.++..+++|.+.... ....+.+|++++++++|||++++++++......++++||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3566678899999999999998778899999887543 346788999999999999999999999998999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++......+++..+..++.|++.++++|| +.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999766667899999999999999999999 7899999999999999999999999999988654322222223
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... . .......+... ..+.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~----~~~~~~~~~~~----~~~~------- 224 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-E----VVETINAGFRL----YKPR------- 224 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-H----HHHHHhCCCCC----CCCC-------
Confidence 345678999999998889999999999999999998 88888643211 1 11111111110 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.....+.+++.+||+.+|++|||+.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.70 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=195.0
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
+.||+|+||.||+|... +|+.+++|.+..... ...+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 35999999999999964 789999998765432 34688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee-eccc
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF-TDVR 226 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~ 226 (347)
.+++......+++..++.++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766667899999999999999999999 88999999999999999999999999999875432111111 1112
Q ss_pred CCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 227 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
.+..|+|||.+.+..++.++|+||||+++|+|++ |..|+...... ....... ..... ..+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~~~~~~~----~~~~~-----------~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREAIE----QGVRL-----------PCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-HHHHHHH----cCCCC-----------CCcccC
Confidence 3457999999998889999999999999999998 77777532211 1111111 11100 111123
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 306 FESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=296.72 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=206.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccC-CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS-NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||++..+++..+++|.+... .....+.+|+..+++++|+|++++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4567788899999999999999888889999998764 335678999999999999999999999998889999999999
Q ss_pred CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++.... ..+++..+..++.|++.|+.||| +++++|+||+|+||++++++.++++|||.+...........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999999997643 56899999999999999999999 78999999999999999999999999999887643222222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....+..|+|||.+.+..++.++|+||||++++++++ |+.||.... ............. . ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~~~~---~------------~~ 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQVERGYR---M------------PR 225 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC---C------------CC
Confidence 23335678999999998889999999999999999998 888885432 2222222211110 0 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
+...+.++.+++.+||+.+|.+||+++++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11123579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=301.34 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=204.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|+||.||+|... ++..+++|.+..... ...+.+|+..+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35666788999999999999732 345688998865443 2468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc
Q 040826 138 VYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
||||+++++|.+++.... ..+++..++.++.|++.|++||| +++++|+||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999986432 34789999999999999999999 889999999999999999999
Q ss_pred eEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHh
Q 040826 203 PKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~ 280 (347)
++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH
Confidence 999999998765332211 1223446788999999998899999999999999999999 888876432211 111
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
....+... ......+..+.+++.+||+.+|++|||+.+|++.|+++.+.
T Consensus 237 ~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQGRVL-----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCC-----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 12211111 00112335799999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.19 Aligned_cols=245 Identities=28% Similarity=0.431 Sum_probs=195.7
Q ss_pred eeecCCeeEEEEEeC---CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP---SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||+|.+. ++..||+|.+..... .+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 355799998876533 245889999999999999999999875 4578999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce--eecc
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--FTDV 225 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~ 225 (347)
.+++......+++..+++++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999766667999999999999999999999 7899999999999999999999999999987654322211 1112
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||...... + ....+..+... ..+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~----~~~~~~~~~~~-----------~~~~~ 222 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-E----VMSFIEQGKRL-----------DCPAE 222 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-H----HHHHHHCCCCC-----------CCCCC
Confidence 23578999999988889999999999999999996 88888643221 1 11222222111 11123
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
+.+++.+++.+||+.+|++||++.+|.+.|+.++
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 3468999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=310.18 Aligned_cols=250 Identities=27% Similarity=0.312 Sum_probs=196.7
Q ss_pred CcccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccC------CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKS------NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 135 (347)
+|...+.||+|+||.||++.. .+|+.||+|.+... .....+..|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 366778899999999999874 36889999998642 1234577899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999988654 35899999999999999999999 8899999999999999999999999999988654
Q ss_pred CCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...........||..|+|||.+.+. .++.++||||||+++|+|++|+.||........ .......+.....+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~------ 229 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKCDPP------ 229 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcCCCC------
Confidence 3333333345689999999999865 478899999999999999999999964322111 11111222111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
+... ....+.+++.+||+.||++|| ++.++++.
T Consensus 230 --~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 --FPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1112 235688999999999999999 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=292.38 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=205.9
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCc-ceeeeeEEEeCC------e
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPN-LVCLFGCCVEGG------E 134 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~ 134 (347)
.|...++||+|.||.||+|. ..+|+.||+|++.-..+ .....+|+.++++++|+| |+.+++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 34455679999999999999 55789999999875433 346789999999999999 999999998877 8
Q ss_pred EEEEEeecCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD---SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.++||||++. +|.+++.... ..++...+..++.|++.||+||| +++|+||||||.||+|+++|.+||+|||++
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999988 9999997654 35777889999999999999999 899999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PI 289 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 289 (347)
+.... +....+..++|..|.|||++.+. .|+...|+||+|||+.||+++++.|.+..+ .+++..+.+....... ..
T Consensus 168 ra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCC
Confidence 96542 23335566789999999999876 799999999999999999999988876554 5555555554432210 00
Q ss_pred c---cc-----cCCCCC--CCCCH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 290 K---DF-----EDPRLN--GNINR---ADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 290 ~---~~-----~~~~l~--~~~~~---~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+ .+ ..+... ..... ....+..+++.+||+.+|.+|.|+..++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00 001111 00111 111478899999999999999999999875
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.25 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=205.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC--------CCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
++|...+.||+|+||.||++... ++..+|+|.+..... ...+.+|+.+++++ +|||++++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56778889999999999999742 235799999876432 23577899999999 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
..+++|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999996432 34888999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLT 276 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~ 276 (347)
.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... . ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-~-~~-- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-V-EE-- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-H-HH--
Confidence 9999999999998765321111 1111234568999999998889999999999999999998 777775322 1 11
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~~ 345 (347)
.......+... ..+.....++.+++.+||+.+|++|||+.+|++.|++++....++|
T Consensus 251 -~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~~~ 307 (307)
T cd05098 251 -LFKLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQE 307 (307)
T ss_pred -HHHHHHcCCCC-----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhcCC
Confidence 11111111110 1111233579999999999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.78 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=171.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||++... +|..+++|.+..... ...+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888899999999999999965 688899998765432 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++..... .
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 157 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---h
Confidence 99999999998654 358899999999999999999994 24799999999999999999999999999875432 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELD 268 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~ 268 (347)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 223346889999999999888999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=320.59 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=198.5
Q ss_pred cccCCeeeecCCeeEEEEEeC-C-CCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-S-GQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
|...+.||+|++|.||++... + ++.|++|.+..... ...+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999843 3 67888887654432 2357789999999999999999999999999999999999
Q ss_pred CCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 144 AGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 144 ~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
+|+|.+++.+ ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998753 2456899999999999999999999 88999999999999999999999999999987643222
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........+...
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~~~----------- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLYGKYD----------- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC-----------
Confidence 1233456899999999999989999999999999999999999998743221 111122111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.....++.+++.+||+.||++|||+.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122357999999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=301.04 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=194.7
Q ss_pred CcccCCeeeecCCeeEEEEEe-C-CCCEEEEEEcccCCC----hhHHHHHHHHhhcC---CCCcceeeeeEEEe-----C
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-P-SGQVVAIKHIYKSNN----TDSFSREVEGLSRV---RHPNLVCLFGCCVE-----G 132 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 132 (347)
+|...+.||+|+||.||+|.. . +|+.||+|.+..... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 677888999999999999985 2 468899998865322 23566777777665 69999999998852 4
Q ss_pred CeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
...+++|||+++ +|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 568999999975 999988653 345899999999999999999999 889999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Ccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIK 290 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 290 (347)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|++||...... +.+............ ...
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhch
Confidence 875422 2233456899999999998888999999999999999999999999754332 222222222111000 000
Q ss_pred c-------ccCCCCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 D-------FEDPRLN---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~-------~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ...+... ..+.....+.+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000 0011123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=300.03 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=199.7
Q ss_pred ccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEEE
Q 040826 69 WDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYLV 138 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 138 (347)
...+.||+|+||.||++.. .++..||+|.+..... ...+.+|++++++++|||++++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778899999999988753 3577899999876432 45678999999999999999999987653 468999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++... .+++..+..++.|++.|+.||| +++++|+||||+||++++++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999998543 4899999999999999999999 8899999999999999999999999999988654222
Q ss_pred cc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 219 SK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 219 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..|+................ ...........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG-QMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc-ccchhhhhhhhhcC
Confidence 11 1122235667999999988889999999999999999999999876432111110000000 00000011111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.....+.....++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111222234468999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.43 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=200.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++... +|+.+|+|.+.... ....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 35777889999999999999954 78999999987532 2345778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999776567999999999999999999999 88999999999999999999999999999987643333
Q ss_pred ceeecccCCCCcccccccc------CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 220 KVFTDVRGTIGYMDPEYMT------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.......|+..|+|||.+. +..++.++||||||+++|+|++|+.||...... ..+.. +....... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~----i~~~~~~~-~~- 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNN----IMNFQRFL-KF- 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHH----HHcCCCcc-CC-
Confidence 2333456899999999986 456788999999999999999999999754322 11111 11111100 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+ .......++.+|+..||+ +|.+|||+.+++.
T Consensus 231 -~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 -P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 001123568899999997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=300.48 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=199.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|... ++..+|+|.+..... ...+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998742 356799998865432 2357889999999999999999999998899
Q ss_pred EEEEEeecCCCChHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD---------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 23577889999999999999999 789999999999999999999999
Q ss_pred eecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhc
Q 040826 206 SDFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~~~--- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVME--- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc---
Confidence 9999987543222211 112345778999999998889999999999999999999 6777753321 121111111
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.... ..+......+.+++.+||+.||++|||+.|+++.|+
T Consensus 237 -~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 -GGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -CCcC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1100 011123357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.34 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=200.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEE-eCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV-EGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~ 144 (347)
.+|...+.||+|+||.||++.. .|..+++|.+......+.+.+|+..+++++|+|++++++++. .++..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 4567778899999999999987 478899999877666778999999999999999999999764 45678999999999
Q ss_pred CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++.+.. ..+++..+..++.|++.||+||| ++|++|+||||+||++++++.++|+|||.+....... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~ 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence 99999987543 45889999999999999999999 8899999999999999999999999999987643211 2
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....+..|+|||.+.+..++.++||||||+++|+|++ |+.|+..... ......+..+..+ ...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~-----------~~~ 221 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKM-----------DAP 221 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCC-----------CCC
Confidence 2334668999999998889999999999999999998 8888763211 1111111111110 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12346799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.13 Aligned_cols=239 Identities=28% Similarity=0.382 Sum_probs=193.5
Q ss_pred CeeeecCCeeEEEEEe----CCCCEEEEEEcccC------CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKS------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+.||+|+||.||++.. .+++.||+|.+... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 35789999998643 1234567899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTV 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCc
Confidence 9999999988654 45788899999999999999999 889999999999999999999999999998754221 122
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+..+.....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~----~~~~~~~~~~~~~----------- 220 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-K----TIDKILKGKLNLP----------- 220 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-H----HHHHHHcCCCCCC-----------
Confidence 23356899999999999888999999999999999999999999753321 1 1122222221111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
.....++.+++.+||+.+|++|| ++.++++
T Consensus 221 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 -PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11235689999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=300.27 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC--EEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ--VVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... ++. .+++|.+..... ...+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46778889999999999999864 343 468887764322 34688899999999 799999999999998999999
Q ss_pred EeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 139 YEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
+||+++++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999985422 34888999999999999999999 8899999999999999999999
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhh
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~ 282 (347)
+|+|||++..... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||...... +... ..
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~~~----~~ 231 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-ELYE----KL 231 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HH
Confidence 9999999864221 111111223567999999998889999999999999999997 98988643221 1111 11
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+... ..+......+.+++.+||+.+|.+|||+.++++.|+++++..
T Consensus 232 ~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRM-----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111100 111123357899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=311.56 Aligned_cols=251 Identities=20% Similarity=0.228 Sum_probs=199.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +++.+|+|.+... .....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 567888899999999999999954 6889999998642 2234577899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999988543 4788899999999999999999 8899999999999999999999999999998754322
Q ss_pred cceeecccCCCCccccccccCC----ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNA----KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
........||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...... ..+ ..+........ .
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~----~~i~~~~~~~~---~ 268 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTY----SKIMDHKNSLT---F 268 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHH----HHHHcCCCcCC---C
Confidence 2223345689999999988653 4788999999999999999999999754321 111 22211111100 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~~ 333 (347)
+. ......++.+++.+||+.+|.+ |||+.++++.
T Consensus 269 ~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 PD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0112357899999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.27 Aligned_cols=243 Identities=20% Similarity=0.241 Sum_probs=193.6
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||++... +|+.+|+|.+.... ....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999954 78899999986532 123567899999999999999999999999999999999999999
Q ss_pred HHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 148 AQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 148 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 887743 3456899999999999999999999 8899999999999999999999999999987654222 22234
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ............. .++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~------------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDSV------------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccCC------------CCccc
Confidence 5689999999999999999999999999999999999999975322111 1111111111110 11223
Q ss_pred HHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
....+.+++.+||+.||++|| |+++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 446789999999999999999 66777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.15 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=202.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC---EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ---VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... ++. .+++|.+..... .+.+.+|++++++++|||++++.+++...+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45677789999999999999964 333 799998865432 34688899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..+..++.|++.|+.||| +.+++|+||||+||++++++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999776677999999999999999999999 7899999999999999999999999999988654322
Q ss_pred cceee--cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKVFT--DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+ ....+..+...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~----~~~~i~~~~~~------- 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HE----VMKAINDGFRL------- 229 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HH----HHHHHhcCCCC-------
Confidence 21111 1223457999999988889999999999999999997 9999864322 11 11222111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+...+...++.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112336789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=296.35 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=199.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEe-----CCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVE-----GGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 134 (347)
...|...+.||+|+||.|+.+.. .+|+.||+|++... .......+|+.+|++++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34555568899999999999994 57999999999743 234568899999999999999999998765 457
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.|+|+|+|+. +|...++. ++.++.....-++.|++.||.|+| +.+++||||||+|++++.+..+||+|||+|+..
T Consensus 101 vYiV~elMet-DL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHHhh-HHHHHHHc-CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence 8999999966 88887754 344999999999999999999999 899999999999999999999999999999987
Q ss_pred CCC-ccceeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc-
Q 040826 215 GME-ESKVFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD- 291 (347)
Q Consensus 215 ~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 291 (347)
... ....++..+.|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+. +...++..+..-...+......
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK-DYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC-chHHHHHHHHHhcCCCCHHHHHH
Confidence 532 122346678899999999875 468999999999999999999999999743 2222222222221111000000
Q ss_pred --------ccC-------CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 292 --------FED-------PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 292 --------~~~-------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+. ..+. ..-+.......+|+.+||..||.+|+|++|.+++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~-~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFS-SIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHH-HHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000 0001223578899999999999999999998863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.25 Aligned_cols=250 Identities=25% Similarity=0.314 Sum_probs=202.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36778889999999999999965 7899999998653 23346888999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc-
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE- 218 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 218 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998665 56899999999999999999999 8899999999999999999999999999988654322
Q ss_pred ---------------------------cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh
Q 040826 219 ---------------------------SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA 271 (347)
Q Consensus 219 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~ 271 (347)
........||..|+|||.+.+..++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223356899999999999999999999999999999999999999754422
Q ss_pred hhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 040826 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT-IDVVYEE 333 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~ei~~~ 333 (347)
. ... .+...... ...|.. ....+++.+++.+|++ +|.+||+ +.++++.
T Consensus 237 ~-~~~----~i~~~~~~---~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E-TYN----KIINWKES---LRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHH----HHhccCCc---ccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111 11110000 000110 0133578999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=301.46 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=202.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||++... +...+++|.+...... ..+.+|+++++++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456777789999999999999853 2367999988764332 3577899999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHhhc---------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 135 QYLVYEFCAAGNLAQHLLR---------------KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~---------------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
.+++|||+++|+|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 9999999999999999853 2356889999999999999999999 889999999999999999
Q ss_pred CCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHH
Q 040826 200 KLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTR 277 (347)
Q Consensus 200 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~ 277 (347)
++.++|+|||.+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... +
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~---- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-E---- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-H----
Confidence 999999999999875432211 1222335678999999998899999999999999999998 88887633211 1
Q ss_pred HHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 278 KARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.......+... ..+......+.+|+.+||+.||++|||+.++++.|++++
T Consensus 243 ~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGYRM-----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111110 111123357999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.17 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=205.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|++|.||++.. .+|..+++|.+.... ....+.+|+.+++.++|+|++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3566778899999999999994 578999999876432 2246788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
||+++++|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 2456899999999999999999999 88999999999999999999999999999876542
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .+....... +.
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~-------~~ 227 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEQCDY-------PP 227 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---hhhhhcCCC-------CC
Confidence 22 11233458889999999988889999999999999999999999986432221111 111111110 10
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
. ......+.+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 11124467999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.43 Aligned_cols=234 Identities=26% Similarity=0.361 Sum_probs=189.2
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +++.||+|.+... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 6889999998653 2234567788888776 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence 9999888654 45899999999999999999999 889999999999999999999999999998754221 122334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . ....+..+..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~----~~~~i~~~~~~~~------------~~ 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-D----LFEAILNDEVVYP------------TW 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-H----HHHHHhcCCCCCC------------CC
Confidence 56899999999999989999999999999999999999999744321 1 1122222211111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
...++.+++.+||+.||.+||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 23578999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=320.70 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=202.2
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC-
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG- 133 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 133 (347)
+.....++|...+.||+|+||.||++.. .+|+.||+|.+..... ...+.+|+..+..++|+|++++.+.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344456888999999999999999984 5789999999865422 235778999999999999999887765322
Q ss_pred -------eEEEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 134 -------EQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 134 -------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence 36899999999999998854 2356899999999999999999999 8899999999999999999999
Q ss_pred EEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh
Q 040826 204 KLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 282 (347)
||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~~ 257 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHKT 257 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHH
Confidence 9999999987543211 1223456899999999999999999999999999999999999999743221 122222
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+... ..+.....++.+++.+||+.||.+|||+.++++.
T Consensus 258 ~~~~~~-----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYD-----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222111 1112233579999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.24 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=200.7
Q ss_pred cccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
|...+.||+|+||.||+|... +...+++|.+..... ...+.+|+..++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 556788999999999999842 235788888865443 24688899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCE
Q 040826 139 YEFCAAGNLAQHLLRK-----------------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNI 195 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Ni 195 (347)
+||+.+++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheE
Confidence 9999999999987531 134788999999999999999999 88999999999999
Q ss_pred EecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhh
Q 040826 196 LLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARD 273 (347)
Q Consensus 196 li~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~ 273 (347)
++++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||...... .
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-R 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-H
Confidence 9999999999999998765322211 1222345678999999988889999999999999999998 88888643211 1
Q ss_pred HHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 274 QLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+..... .+... ........++.+++.+||+.+|.+||++.++++.|++++..
T Consensus 238 -~~~~~~---~~~~~-----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 -LFNLLK---TGYRM-----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHh---CCCCC-----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111111 11000 11112335799999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.56 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=201.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCC----EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQ----VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.+ .+|. .||+|.+..... ...+.+|...++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4566778999999999999984 3454 489998865433 3467789999999999999999998875 45789
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++......+++..++.++.|++.||.||| +++++|+||||+||++++++.++|+|||++......
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999776667999999999999999999999 889999999999999999999999999999876432
Q ss_pred ccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... .....++..|+|||...+..++.++||||||+++|||++ |..||..... ......... +...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~---~~~~------- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEK---GERL------- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC---CCcC-------
Confidence 2211 122335678999999998889999999999999999998 8888763321 112222211 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
........++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 ----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00112335789999999999999999999999999988554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=310.90 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=201.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 136 (347)
..++|....+||+|+||.|+++..+ +++.+|||.+.+. .+.+....|..++...+ ||.++.++.++.+.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4577888999999999999999955 6889999999875 45567888888887775 999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+.||++. ..+..+.+++..+.-+++.++.||+||| ++||++||||.+|||+|.+|.+||+|||+++...
T Consensus 446 fvmey~~Ggdm~--~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLM--HHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEEecCCCcEE--EEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC-
Confidence 999999999832 2234567999999999999999999999 8999999999999999999999999999999753
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....+++.+||+.|+|||++.+..|+.++|+|||||+|||||.|..||.++..+ + ....+...+..
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e----~FdsI~~d~~~-------- 586 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-E----VFDSIVNDEVR-------- 586 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-H----HHHHHhcCCCC--------
Confidence 2334567789999999999999999999999999999999999999999854322 2 22222222211
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
++.-.+.+...++.+.|.+||++|.-+
T Consensus 587 ----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 ----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 222334678899999999999999876
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.87 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=201.4
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||++... +|+.+++|.+... .....+.+|+.++++++|||++++++++...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3566788999999999999964 6889999988643 2345688899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 9999999998764 467899999999999999999999 8899999999999999999999999999988654322 2
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||+..+..++.++|+||||+++++|++|+.||...... . .......+..+ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~-----------~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-A----LILKIIRGVFP-----------P 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHcCCCC-----------C
Confidence 223345788999999999988999999999999999999999999754321 1 11111111111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+.......+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111233579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.91 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=204.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe--------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL--------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEG 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||++.. .++..+++|.+..... ...+.+|+..++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45667778999999999999973 1245799998865432 34688999999999 799999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
...+++|||+++|+|.+++.+. ...+++..+..++.|++.||.||| ++|++|+||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 9999999999999999998643 134788889999999999999999 8899999999999999
Q ss_pred cCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
++++.++|+|||.+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..|+.... ..+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~-- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE-- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHH--
Confidence 99999999999999876432221 1222345678999999988889999999999999999998 667665321 111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
.......+... .....+...+.+++.+||+.+|.+|||+.++++.|++++.-..+
T Consensus 248 --~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 248 --LFKLLKEGHRM-----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred --HHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 12222111111 01113346799999999999999999999999999999765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=291.76 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=207.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|++|.||+|... +|+.+++|.+... .....+.+|++++++++|+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56788899999999999999965 7899999987532 12456889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
||+++++|.+++.. ....+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 2456899999999999999999999 88999999999999999999999999999876542
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .......+..+ +
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~------~- 227 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEKCDYP------P- 227 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH---HHhhhhcCCCC------C-
Confidence 22 1122345788999999999888999999999999999999999998644322111 11111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.........+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001133457999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=294.57 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=202.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-C---CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-S---GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.+|...+.||+|+||.||+|... + +..+++|.+..... ...+.+|+.++++++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677789999999999999853 2 33799998865432 34688899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999776667899999999999999999999 8899999999999999999999999999998764322
Q ss_pred cceee--cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKVFT--DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ...++..|+|||.+.+..++.++|+||||+++|++++ |..||..... .+...... .+...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~----~~~~~------- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIE----EGYRL------- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHHHh----CCCcC-------
Confidence 21111 1223568999999998889999999999999999886 9988864321 11111111 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
......++.+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112335789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.48 Aligned_cols=248 Identities=24% Similarity=0.277 Sum_probs=199.7
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+|+.++++++||||+++++.+.+++..+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 56678899999999999995 478999999986532 123567899999999999999999999998999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++|+|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999999888653 346899999999999999999999 789999999999999999999999999998875322 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .........+..... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~------------~ 223 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKEDQE------------E 223 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhccc------------c
Confidence 223346899999999999888999999999999999999999999753221 111222222211111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
+.......+.+|+.+||+.||.+|| +++++++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1223346789999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.56 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=198.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.. .++..+++|.+...... ..+.+|+.++++++|||++++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3556678899999999999984 24578999998754332 457889999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 138 VYEFCAAGNLAQHLLRK----------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
+|||+++++|.+++... ...+++.....++.|++.||.||| +++++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998422 134788899999999999999999 78999999999999999999
Q ss_pred ceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHH
Q 040826 202 EPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 202 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~ 279 (347)
.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .. .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~-~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QE-VIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HH-HHHHH
Confidence 999999999986532221 11223345678999999988889999999999999999998 8888754321 11 11111
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
. ..... ..+......+.+++.+||+.||.+||++.+|.++|.+
T Consensus 240 ~---~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R---KRQLL-----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H---cCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11100 0111223579999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=293.13 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=194.2
Q ss_pred eeeecCCeeEEEEEe---CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 73 FLGRGSAGLVYKGVL---PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
.||+|+||.||+|.+ .++..+|+|.+..... .+.+.+|+.+++.++||||+++++++. ....+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3578899998865432 246788999999999999999999875 45678999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce--ee
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--FT 223 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~ 223 (347)
+|.+++... ..+++..+..++.|++.|+.||| +++++|+||||.||++++++.++|+|||++.......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999988643 45899999999999999999999 8899999999999999999999999999998764332211 11
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .... .+..+..+ ..+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~----~i~~~~~~-----------~~~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQ----MIESGERM-----------ECP 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHCCCCC-----------CCC
Confidence 2234578999999988889999999999999999998 88888643221 1111 11111111 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
....+++.+++.+||+.||.+|||+.+|.+.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12346799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.46 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=200.8
Q ss_pred cccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYL 137 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 137 (347)
|...+.||+|+||.||.+.. .++..|++|.+..... ...+.+|+++++.++|||++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 45678899999999999973 3578899999875432 34688999999999999999999998775 56899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
+|||+++++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++......
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999998765556899999999999999999999 889999999999999999999999999998865432
Q ss_pred ccc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh----------hhHHHHHHhhhcCC
Q 040826 218 ESK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA----------RDQLTRKARDVSMG 285 (347)
Q Consensus 218 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----------~~~~~~~~~~~~~~ 285 (347)
... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|...+... .............+
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 221 122345677899999998888999999999999999999987765432110 00011111111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.. .+........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 243 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KR-----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cc-----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10 011112346799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.17 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=198.4
Q ss_pred CcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
+|...+.||+|+||.||+|... ++..||+|++...... ..+.+|..++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3445677999999999999853 2468999999755432 457889999999999999999999999899999
Q ss_pred EEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc
Q 040826 138 VYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
++||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998421 134788889999999999999999 889999999999999999999
Q ss_pred eEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHh
Q 040826 203 PKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~ 280 (347)
+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..|+.... ..+. ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~----~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDV----IE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHH----HH
Confidence 99999999876532221 11223345778999999988889999999999999999998 777765332 2221 22
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
.+..+... ....+++..+.+++.+||+.+|.+||++++|+..|+.
T Consensus 238 ~i~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222111 1122345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.14 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=198.2
Q ss_pred CcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYL 137 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 137 (347)
.|...+.||+|+||.||++.. .++..|++|.+..... ...+.+|++++++++|||++++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 456678899999999999974 2578999999865443 3468899999999999999999998754 346899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|+||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||++++++.++|+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999766667899999999999999999999 889999999999999999999999999999875432
Q ss_pred ccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC---cccc
Q 040826 218 ESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP---IKDF 292 (347)
Q Consensus 218 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 292 (347)
.... .....++..|+|||.+.+..++.++|+||||+++++|++|..++...... ..........+... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHHH
Confidence 2111 11122345699999999888999999999999999999987765432110 00000000000000 0000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
......-........++.+++.+||+.+|++|||+.+|++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000011122345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.40 Aligned_cols=260 Identities=26% Similarity=0.332 Sum_probs=192.8
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeC-----CeEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GEQY 136 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 136 (347)
+|...+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 466778999999999999995 47899999988643 2234578999999999999999999987543 2579
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+. ++|.+++... ..+++..+..++.|+++||.||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 4898888544 45899999999999999999999 88999999999999999999999999999876432
Q ss_pred Ccc--ceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-----
Q 040826 217 EES--KVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----- 287 (347)
Q Consensus 217 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 287 (347)
... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+............
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHH
Confidence 111 11234568999999999875 67889999999999999999999999653221 111111000000000
Q ss_pred ----C-------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 ----P-------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ----~-------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
. ........+... .......+.+++.+||+.||++|||+.|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000 00123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=292.36 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=200.0
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|++|.||.+.. .+++.+++|.+..... ...+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4677889999999999999995 4689999998864321 2357789999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++++|.+++... ..+++.....++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988654 45889999999999999999999 889999999999999999999999999998765322
Q ss_pred cccee--ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKVF--TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .......... +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~-------~ 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQPTN-------P 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----HHHHhccCCC-------C
Confidence 11111 234577899999999998899999999999999999999999864322211 1111111110 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+......+.+++.+||+.+|.+|||+.++++.
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1122233578999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=318.92 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=201.6
Q ss_pred CcccCCeeeecCCeeEEEEEeCCC-CEEEEEEcccCCC--hhHHHHHHHHhhcCC-CCcceeeee-EEEe------CCeE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSG-QVVAIKHIYKSNN--TDSFSREVEGLSRVR-HPNLVCLFG-CCVE------GGEQ 135 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~-~~~~------~~~~ 135 (347)
+....+.|.+|||+.||++....+ ..+|+|++..... .+.+.+|+++|+.|+ |+|||.+++ .... .-++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 455667899999999999996655 9999999876633 246889999999997 999999999 3322 1367
Q ss_pred EEEEeecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 136 YLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
+|+||||.||.|.|++.+ ....|++.++++|+.|+++|+++||.. ..++||||||-+||||+.+|..||||||.+...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 899999999999999964 234499999999999999999999965 567999999999999999999999999988753
Q ss_pred CCCccce--e------ecccCCCCccccccc---cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 215 GMEESKV--F------TDVRGTIGYMDPEYM---TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 215 ~~~~~~~--~------~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
....... . -....|+.|++||.+ .+.++++|+|||+|||+||-|+...+||+.... ..+.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------laIl 267 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------LAIL 267 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------eeEE
Confidence 2222110 0 112469999999966 678999999999999999999999999984311 1122
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.+. +.-+-.+.....+..||..||+.||++||++-++++.+-++.
T Consensus 268 ng~----------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 268 NGN----------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ecc----------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 222 211222466789999999999999999999999999998874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=306.86 Aligned_cols=240 Identities=24% Similarity=0.294 Sum_probs=193.7
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+.||+|+||.||++.. .+|..||+|.+.... ....+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999995 478999999986531 2345678999999999999999999999999999999999999
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
+|.+++... ..+++..+..++.|++.||.||| + .|++||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKT 155 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccc
Confidence 999888544 45899999999999999999999 5 69999999999999999999999999998753211 222234
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||++.+..++.++||||||+++|+|++|..||...... .....+....... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~~~------------p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEIRF------------PRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCCCC------------CCC
Confidence 56899999999999989999999999999999999999999743221 1111111111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
...++.+++.+||+.||.+|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 235789999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=282.87 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=209.9
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC------Ch----hHHHHHHHHhhcCC-CCcceeeeeE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN------NT----DSFSREVEGLSRVR-HPNLVCLFGC 128 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~----~~~~~e~~~l~~l~-h~niv~~~~~ 128 (347)
-....+.|...+.+|.|..+.|-++.. .+|...|+|++.-.. .. +...+|+.+|+++. ||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 344567888889999999999999984 578899999884321 11 24668999999995 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 129 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
++++...++|+|.|+.|.|.|++... -.+++...++|++|+.+|++||| .++|+||||||+|||++++.+++|+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999999543 45899999999999999999999 899999999999999999999999999
Q ss_pred ccceecCCCccceeecccCCCCcccccccc------CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh
Q 040826 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMT------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 282 (347)
|.+..+. ........+||++|+|||.+. ...|+..+|.||+|+++|-|+.|.+||-. ..++ ...+.+
T Consensus 168 GFa~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQm-lMLR~I 240 (411)
T KOG0599|consen 168 GFACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQM-LMLRMI 240 (411)
T ss_pred ceeeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHH-HHHHHH
Confidence 9999874 445566789999999999874 34689999999999999999999999862 2332 234445
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..|.. ++.+|.+. +.+++..+|+.+||+.||++|.|++|.+.
T Consensus 241 meGky---qF~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGKY---QFRSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhccc---ccCCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 55543 34445443 34467999999999999999999999986
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.23 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC--EEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ--VVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... +|. .+++|.+..... ...+.+|+.++.++ +|+|++++++++..++..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46677788999999999999954 454 457777654322 24678899999999 899999999999999999999
Q ss_pred EeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 139 YEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
+||+++++|.+++.... ..+++..++.++.|++.|++||| ++|++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999986432 35789999999999999999999 8899999999999999999999
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhh
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~ 282 (347)
+|+|||++..... .........+..|+|||.+.+..++.++||||||+++|+|+| |..||...... + .....
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~----~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-E----LYEKL 236 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-H----HHHHH
Confidence 9999999864211 111111234667999999988889999999999999999998 89888633221 1 11111
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+... ........++.+++.+||+.+|++|||+.+++..|+.++.+..
T Consensus 237 ~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 PQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred hcCCcC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111100 0011123568999999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=298.33 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=202.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||++... ++..+|+|.+..... ...+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456888899999999999999731 345799998875432 34688999999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+++|||+++|+|.+++.... ..+++.++..++.|++.|+.||| +++++|+||||+||+++.++.++++|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999986533 34899999999999999999999 78999999999999999999999999999886
Q ss_pred cCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 214 LGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 214 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ..... ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~---~~~~~~--- 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLI---KEGYRM--- 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHH---HcCCcC---
Confidence 5422211 1222345778999999998889999999999999999998 8888764332211 11111 111100
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.. ......++.+++.+||+.+|++|||+.++++.|+++
T Consensus 264 ----~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ----AQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 011235799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=293.62 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=202.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...++||+|+||.||++...++..+++|.+..... ...+.+|+.++++++|+|++++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 356778899999999999999987788899998876443 4578899999999999999999999877 77899999999
Q ss_pred CCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9999999865 3456888999999999999999999 78999999999999999999999999999876543222222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||...... +... ....+.. . ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~----~~~~~~~-~----------~~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR----ALERGYR-M----------PR 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHH----HHhCCCC-C----------CC
Confidence 33345678999999998889999999999999999999 88887643211 1111 1111110 0 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
......++.+++.+||+.+|++||++.++.+.|++
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11233579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.71 Aligned_cols=240 Identities=26% Similarity=0.362 Sum_probs=192.3
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +|+.||+|.+... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999954 6889999998653 2234566788888766 799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccc
Confidence 9999888654 45889999999999999999999 889999999999999999999999999998764322 222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ..+..+..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~----~~i~~~~~~~p--------~~---- 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLF----ESILHDDVLYP--------VW---- 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHH----HHHHcCCCCCC--------CC----
Confidence 56899999999999989999999999999999999999999754321 111 22222211111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRP-------TIDVVYEE 333 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rp-------s~~ei~~~ 333 (347)
...++.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 225788999999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.68 Aligned_cols=242 Identities=27% Similarity=0.354 Sum_probs=191.0
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHh---hcCCCCcceeeeeEEEeCCeEEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGL---SRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
|...+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 445678999999999999954 68999999986432 223455665554 567899999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|...+.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... .
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-F 154 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-C
Confidence 999999999887743 46899999999999999999999 88999999999999999999999999999875321 1
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... +... .+.......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~----~i~~~~~~~--------- 220 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFD----SIVNDEVRY--------- 220 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHhCCCCC---------
Confidence 22233456899999999999989999999999999999999999999754322 1111 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
+......+.+++.+||+.||.+|| ++.++++
T Consensus 221 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 ---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112235688999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=300.83 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=188.8
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhc-CCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSR-VRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +++.||+|.+... ........|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999954 6889999988653 223345566666654 4799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999988654 35899999999999999999999 7899999999999999999999999999997643222 22334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ..+...... ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~~~~~------------~~~~ 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELF----DSILNDRPH------------FPRW 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHH----HHHHcCCCC------------CCCC
Confidence 56899999999999989999999999999999999999999753321 111 111111111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTID-VVY 331 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~-ei~ 331 (347)
...++.+++.+||+.||.+||++. +++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 235688999999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=301.99 Aligned_cols=239 Identities=23% Similarity=0.302 Sum_probs=191.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCC-CcceeeeeEEEeCCeEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRH-PNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 139 (347)
+|...+.||+|+||.||+|... +++.||+|.+... .....+..|..++..+.| ++|+.+++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3667788999999999999954 6789999998653 233467788899998876 46888999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++...... .
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-G 155 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-C
Confidence 999999999988654 45899999999999999999999 889999999999999999999999999998753221 1
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... ... ..+.......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~----~~i~~~~~~~---------- 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELF----QSIMEHNVSY---------- 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHH----HHHHcCCCCC----------
Confidence 2233456899999999999999999999999999999999999999744321 111 1121111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
+.....++.+++.+||+.||.+|++.
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 --PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11223568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=301.32 Aligned_cols=238 Identities=24% Similarity=0.326 Sum_probs=190.4
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +|+.||+|.+... ........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 6889999998653 2334566777777654 899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 9999988654 45899999999999999999999 889999999999999999999999999998753211 122334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+....... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~---~~~~~~~~~~~~--------~~~---- 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--E---LFESIRVDTPHY--------PRW---- 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--H---HHHHHHhCCCCC--------CCC----
Confidence 56899999999999999999999999999999999999999743321 1 112221111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTID-VVY 331 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~-ei~ 331 (347)
...++.+++.+||+.||++||++. +++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 224688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=292.00 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=200.0
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||+|+||.||++... ++..+++|.+.... ..+.+.+|+.+++.++|+|++++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3566788999999999999954 68899999875432 3456788999999999999999999999999999999999
Q ss_pred CCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++|.+++.. ....+++.....++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+...... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccc
Confidence 99999998864 3456899999999999999999999 889999999999999999999999999998765322 222
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . .......+... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~-----------~~ 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-N----LILKVCQGSYK-----------PL 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-H----HHHHHhcCCCC-----------CC
Confidence 23356888999999999888999999999999999999999999743221 1 11111111111 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+......+.+++.+||+.||++|||+.+|+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.94 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=194.1
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.|...+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 466778899999999999984 578899999986532 23467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
|+++|+|.+++.+. ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998654 35889999999999999999999 88999999999999999999999999998753210000
Q ss_pred ---------------------------------------------ceeecccCCCCccccccccCCccCCcccHHHHHHH
Q 040826 220 ---------------------------------------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254 (347)
Q Consensus 220 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 254 (347)
.......||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00122468999999999998889999999999999
Q ss_pred HHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHH--hccCCCCCCCCHHHHHH
Q 040826 255 ALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVL--CVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 255 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~--cl~~~p~~Rps~~ei~~ 332 (347)
+|+|++|..||........... .... ....... . ...++ .++.+|+.+ |+..+|..||++.+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~-i~~~--~~~~~~~-----~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLK-VINW--ENTLHIP-----P-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHH-HHcc--ccccCCC-----C-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999975443222211 1100 0000000 0 00122 456677766 56677777999999986
Q ss_pred H
Q 040826 333 E 333 (347)
Q Consensus 333 ~ 333 (347)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.44 Aligned_cols=238 Identities=26% Similarity=0.349 Sum_probs=190.2
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +++.||+|.+... ........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 5789999998653 2234566677777754 899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceee
Confidence 9999988653 45889999999999999999999 889999999999999999999999999998753221 122334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+....... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~----~~~~i~~~~~~~------------~~~ 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-E----LFQSIRMDNPCY------------PRW 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHhCCCCC------------Ccc
Confidence 56899999999999989999999999999999999999999753221 1 111111111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTID-VVY 331 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~-ei~ 331 (347)
...++.+++.+||+.||.+||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 235688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=306.39 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=193.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|..++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3677888999999999999985 468999999986532 2245778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++.+. ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999998654 45899999999999999999999 88999999999999999999999999999875421100
Q ss_pred ----------------------------------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCc
Q 040826 220 ----------------------------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 220 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
.......||..|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346899999999999999999999999999999999999999
Q ss_pred CCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhc--cCCCCCCCCHHHHHHH
Q 040826 266 ELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCV--AKSSKGRPTIDVVYEE 333 (347)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl--~~~p~~Rps~~ei~~~ 333 (347)
...... +.... +....... ..|.. ..++ +++.+++.+++ ..++..||++.||++.
T Consensus 237 ~~~~~~-~~~~~----i~~~~~~~---~~p~~-~~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQ-ETYKK----VMNWKETL---IFPPE-VPIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHH-HHHHH----HHcCcCcc---cCCCc-CCCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 754322 11111 11111000 00100 0122 34566666533 3344567999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=293.38 Aligned_cols=242 Identities=25% Similarity=0.283 Sum_probs=192.6
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||++... +|+.+|+|.+.... .......|++++++++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 68999999886422 223456799999999999999999999999999999999999999
Q ss_pred HHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeeccc
Q 040826 148 AQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226 (347)
Q Consensus 148 ~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 226 (347)
.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 9888543 345889999999999999999999 889999999999999999999999999998865422 2223456
Q ss_pred CCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHH
Q 040826 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADF 306 (347)
Q Consensus 227 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 306 (347)
++..|+|||++.+..++.++|+||+|+++|+|++|+.||........ .....+......... ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~-----------~~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLEDEVKF-----------EHQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhcccccc-----------ccccCC
Confidence 89999999999988899999999999999999999999874322111 111222221111110 001223
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 307 ESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 307 ~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++.+|+.+||+.||.+||+++|+++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchh
Confidence 57899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.27 Aligned_cols=244 Identities=24% Similarity=0.324 Sum_probs=191.8
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||++... +++.||+|.+.... ....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999954 68899999987532 223577889999888 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..... .......
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence 9999888544 46899999999999999999999 88999999999999999999999999999874321 1222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh----hhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD----ARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
..|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... .........+.+.......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 224 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----------- 224 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC-----------
Confidence 5689999999999999999999999999999999999999963111 0011111111121111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPT------IDVVYE 332 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps------~~ei~~ 332 (347)
+.....++.+++.+||+.||.+||| +.++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122356899999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.70 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=196.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36777889999999999999954 68999999986532 2345778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999998654 35899999999999999999999 88999999999999999999999999999875421110
Q ss_pred c-------------------------------------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCC
Q 040826 220 K-------------------------------------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262 (347)
Q Consensus 220 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~ 262 (347)
. ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 040826 263 KVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT---IDVVYE 332 (347)
Q Consensus 263 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~ei~~ 332 (347)
.||....... .. ..+........ .+. .....+++.+++.+|+. +|.+|++ +.++++
T Consensus 237 ~Pf~~~~~~~-~~----~~i~~~~~~~~---~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE-TY----RKIINWKETLQ---FPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH-HH----HHHHcCCCccC---CCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997543221 11 11111111100 000 00123568888888996 9999998 888776
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=307.36 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=201.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|.+. ++..||+|++..... ...+.+|+.++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345667788999999999999853 346899999976432 236888999999997 9999999999999889
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------------------------------------------------
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD----------------------------------------------------------- 155 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 155 (347)
.++|+||+++|+|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999985421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 156 --------------------------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 156 --------------------------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
..+++...+.++.|++.||.||| +.+++|+||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 23567788899999999999999 8899999999999999
Q ss_pred cCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
++++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|||++ |..||...... +..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-EQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-HHH
Confidence 9999999999999986532211 11223356788999999998889999999999999999998 78887532211 111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
. ..+..+... ..+.....++.+++.+||+.+|.+||++.+|++.|++++
T Consensus 352 ~---~~~~~~~~~-----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 Y---NAIKRGYRM-----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H---HHHHcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 111111110 011122367999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=290.58 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=193.6
Q ss_pred CeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEE-eCCeEEEEEeecC
Q 040826 72 RFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCV-EGGEQYLVYEFCA 143 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 143 (347)
+.||+|+||.||+|... ++..+|+|.+..... ...+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999853 235799998865332 346778999999999999999999765 4556899999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc---c
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES---K 220 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~ 220 (347)
+++|.+++.+.....++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766556788888999999999999999 78999999999999999999999999999875432111 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||.+.+..++.++||||||+++|+|++|..|+........ .......+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~~~~~----------- 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQGRRLL----------- 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcCCCCC-----------
Confidence 11223457789999999888899999999999999999996554332222211 111121111110
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.+...+..+.+++.+||+.+|++||++.+|++.|++++.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011223579999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=290.49 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=195.2
Q ss_pred CeeeecCCeeEEEEEeC-C---CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-S---GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|.+. . +..+++|.+..... ...+.+|+++++.++|+|++++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999843 2 26899999876554 346889999999999999999999876 4568999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee-
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT- 223 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~- 223 (347)
++|.+++.... .+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++|+|||++............
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 6899999999999999999999 789999999999999999999999999998866432221111
Q ss_pred -cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 224 -DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 224 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
...++..|+|||.+.+..++.++|+||||+++|++++ |..||..... . ..... +...... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~-~~~~~---~~~~~~~-----------~~ 219 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-A-EVIAM---LESGERL-----------PR 219 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-H-HHHHH---HHcCCcC-----------CC
Confidence 1223567999999998889999999999999999998 8888864322 1 11111 1111110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.......+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1123357999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=292.89 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=203.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|...+ ...+++|....... .+.+.+|+..+++++|||++++++++.+ +..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346677889999999999998543 24689998866543 3468899999999999999999998875 457899
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999766666899999999999999999999 8899999999999999999999999999988754332
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........++..|+|||.+.+..++.++|+||||+++|++++ |..||...... ...... ..+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~----~~~~~~--------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRI----ENGERL--------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH----HcCCcC---------
Confidence 222222334568999999988889999999999999999986 99998644322 111111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
........++.+++.+||..+|++|||+.++++.|+++.++.
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011123457999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=295.99 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=198.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
+++...++||+|+||.||++... ++..+++|.+..... ...+.+|++.++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45667788999999999999632 356789998765432 3478899999999999999999999999899999
Q ss_pred EEeecCCCChHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 138 VYEFCAAGNLAQHLLRKD--------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
++||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999986532 34789999999999999999999 8899999999999999999999
Q ss_pred EEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhh
Q 040826 204 KLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 281 (347)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +.. ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~----~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EAI----EC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HHH----HH
Confidence 99999998765322211 1222335678999999998899999999999999999998 88887533221 111 11
Q ss_pred hcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
...+... ..+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 237 ~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGREL-----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccC-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111 011123357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.84 Aligned_cols=239 Identities=24% Similarity=0.341 Sum_probs=187.9
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||++... +++.+|+|.+.... ....+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999954 68899999987532 223466788888776 799999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCcccc
Confidence 9999887544 45899999999999999999999 88999999999999999999999999999875321 1122234
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh----hhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD----ARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ...........+......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------------ 223 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------------ 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC------------
Confidence 5689999999999999999999999999999999999999952110 011111111111111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
++......+.+++.+||+.||.+|||+
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112233568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=294.39 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=203.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC-----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS-----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 135 (347)
.++|...+.||+|+||.||+|...+ +..|++|.+..... ...+.+|+..+++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567788899999999999999654 68899998865433 3457889999999999999999998766 4678
Q ss_pred EEEEeecCCCChHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 136 YLVYEFCAAGNLAQHLLRKD-------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
+++++|+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999985421 45899999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 209 GLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 209 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
|+++.+....... .....++..|+|||.+.+..++.++||||||+++|++++ |+.||..... .... .....+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~---~~~~~~~ 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMA---AYLKDGY 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHH---HHHHcCC
Confidence 9998654322221 122345678999999998889999999999999999999 9988864321 1111 1111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.. . ....+.+++.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 237 ~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 RL-A----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC-C----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 0 011223579999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.92 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=200.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CC---CEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SG---QVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.|...+.||+|+||.||+|... ++ ..|++|.+..... ...+..|+..++.++||||+++++++.++...++++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4566788999999999999954 33 3699999875432 347889999999999999999999999989999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++......+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999776667899999999999999999999 88999999999999999999999999999876532221
Q ss_pred ce-eec-cc--CCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 220 KV-FTD-VR--GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 220 ~~-~~~-~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ... .. .+..|+|||.+.+..++.++||||||+++||+++ |..||...... +... .+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~----~i~~~~-~~----- 230 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIN----AIEQDY-RL----- 230 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHH----HHHcCC-cC-----
Confidence 11 111 11 2457999999998899999999999999999886 88888643221 1111 111110 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
....+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11123346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.58 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=198.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
..++|...+.||+|+||.||++... +++.+|+|.+... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3577888999999999999999964 6889999988642 223457789999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999988543 4788999999999999999999 889999999999999999999999999999876433
Q ss_pred ccceeecccCCCCccccccccCC----ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNA----KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.........||..|+|||.+.+. .++.++|+||+|+++|+|++|..||...... .... .+........
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~----~i~~~~~~~~--- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYS----KIMDHKNSLN--- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHH----HHHhCCcccC---
Confidence 22223455799999999998754 3788999999999999999999999754321 1112 1211111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYEE 333 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~~ 333 (347)
.|. .......+.+++.+|+..++.+ |||+.+++++
T Consensus 268 ~p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 FPE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0122356888888899755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=307.85 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=215.2
Q ss_pred ccCCeeeecCCeeEEEEEeC---CCC--EEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 69 WDRRFLGRGSAGLVYKGVLP---SGQ--VVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
...++||.|-||.||+|.+. .|+ .||||.-+.+. +.+.|..|..+|+.+.||||++++|+|.+. ..++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 34577999999999999953 233 68888877643 356799999999999999999999998864 6889999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
.++.|.|..+++.+...++......++.|++.||+||| +..++||||..+|||+....-+||+|||+++.+..+...
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 99999999999988888999999999999999999999 889999999999999999999999999999998877766
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
..+...-+..|||||.+.-..++.+||||.||+.+||++. |.+||.+-... + +.-.+..|+ +.
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-D----VI~~iEnGe-----------Rl 611 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-D----VIGHIENGE-----------RL 611 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-c----eEEEecCCC-----------CC
Confidence 6666667889999999999999999999999999999876 88888742111 1 011111222 22
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
+.++.|+..++.|+.+||+.+|.+||++.+|...|++++++..
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 5667888999999999999999999999999999999988543
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=290.42 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=201.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|... |+.|++|.+..... ...+.+|+.++++++|+|++++++++.+.+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 45677788999999999999974 78899999976654 56788999999999999999999999988899999999999
Q ss_pred CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----~~ 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QD 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc----cc
Confidence 99999986543 36899999999999999999999 889999999999999999999999999998865211 11
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....+..|+|||.+.+..++.++|+||||++++++++ |..||..... .+ +..... ..... ..+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~~---~~~~~-----------~~~ 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD-VVPHVE---KGYRM-----------EAP 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHHh---cCCCC-----------CCc
Confidence 2335678999999988889999999999999999997 8888764321 11 111111 11000 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
...++.+.+++.+||..+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1233679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=302.93 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEe-CC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVE-GG 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~ 133 (347)
.++|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.++.++ +|||++++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35678889999999999999973 3577899999975432 24577899999999 68999999998765 45
Q ss_pred eEEEEEeecCCCChHHHhhcCC----------------------------------------------------------
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKD---------------------------------------------------------- 155 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 155 (347)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999885421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-ceeeccc
Q 040826 156 --------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVR 226 (347)
Q Consensus 156 --------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 226 (347)
..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23677888999999999999999 88999999999999999999999999999876532211 1122234
Q ss_pred CCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 227 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
++..|+|||.+.+..++.++|+||||+++|+|++ |..|+........ ... ....+... ..+. . .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~---~~~~~~~~----~~~~---~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR---RLKEGTRM----RAPD---Y----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHH---HHhccCCC----CCCC---C----C
Confidence 5678999999988889999999999999999997 8888754322111 111 11111110 0011 1 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 306 FESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.+++.+++.+||+.+|.+|||+.+|++.|+.++++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 24689999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=306.10 Aligned_cols=236 Identities=28% Similarity=0.348 Sum_probs=191.6
Q ss_pred CeeeecCCeeEEEEEe----CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
+.||+|+||.||++.. .+|+.+|+|.+.... ....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 367899999986532 23456789999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... .....
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCcee
Confidence 99999988543 45899999999999999999999 889999999999999999999999999998765322 12233
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... +...... ++.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~----i~~~~~~------------~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTM----ILKAKLG------------MPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHH----HHcCCCC------------CCC
Confidence 45689999999999988899999999999999999999999974322 111111 1111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDV 329 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~e 329 (347)
.....+.+|+.+||+.||.+|||+.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22357889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=300.66 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=192.6
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||++... +++.||+|.+... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 5789999998753 2234567788888877 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccc
Confidence 9999888654 35899999999999999999999 889999999999999999999999999998753211 122233
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . ....+...... .+..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~----~~~~i~~~~~~------------~~~~ 218 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-E----LFQSILEDEVR------------YPRW 218 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-H----HHHHHHcCCCC------------CCCc
Confidence 46899999999999999999999999999999999999999743321 1 11122111111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTI-----DVVYE 332 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~-----~ei~~ 332 (347)
....+.+++.+||+.||.+|||+ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 23578999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=313.70 Aligned_cols=259 Identities=21% Similarity=0.234 Sum_probs=194.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeC--------CeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG--------GEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~ 135 (347)
..+|...+.||+|+||.||+|.. .+++.||+|++.... ....+|+.+++.++||||+++++++... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 45788999999999999999995 478999999886543 3345799999999999999998876432 246
Q ss_pred EEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~ 211 (347)
++||||+++ +|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999986 78776642 4466899999999999999999999 88999999999999999665 6999999999
Q ss_pred eecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC----
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK---- 286 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 286 (347)
+..... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...... +.+....+......
T Consensus 219 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 219 KNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Confidence 865322 12233467899999998876 46899999999999999999999999754322 22222222211100
Q ss_pred ----CCcccc-----cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 ----RPIKDF-----EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ----~~~~~~-----~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...... ....+...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 0011111122233468999999999999999999999984
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=289.92 Aligned_cols=245 Identities=27% Similarity=0.443 Sum_probs=200.8
Q ss_pred CeeeecCCeeEEEEEeCC----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|.... +..+++|.+..... ...+.+|+..++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999653 78899999977544 45788999999999999999999999999999999999999
Q ss_pred CChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 145 GNLAQHLLRK--------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 145 gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
++|.+++... ...+++..+..++.|++.|+.||| +++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 467999999999999999999999 89999999999999999999999999999987643
Q ss_pred Ccc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 217 EES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 217 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+ .......+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~----~~~~~~~~~~~------ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EE----VLEYLRKGYRL------ 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HH----HHHHHHcCCCC------
Confidence 221 22333457889999999988889999999999999999999 5888865421 11 11222111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
........++.+++.+||+.+|.+|||+.++++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122467999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=299.64 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=199.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|... +++.+|+|.+.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46777889999999999999954 67889999886432 234577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++...+..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 986 898888766667899999999999999999999 8899999999999999999999999999987643221 12
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-c---------c
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-I---------K 290 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~---------~ 290 (347)
.....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||...... +......+........ . .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 233457889999998865 56889999999999999999999999754322 2222222111100000 0 0
Q ss_pred cccCCCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.... ........++.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 001123357889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=295.67 Aligned_cols=257 Identities=22% Similarity=0.286 Sum_probs=201.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|... .+..||+|.+...... ..+.+|+..++.++|||++++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888899999999999999743 2457999988654332 357789999999999999999999998889
Q ss_pred EEEEEeecCCCChHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 135 QYLVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
.+++|||+++|+|.+++... ....+...+..++.|++.||.||| +++++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999642 134567788999999999999999 889999999999999999999999
Q ss_pred eecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhc
Q 040826 206 SDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+ ......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~----~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQ----VLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHH
Confidence 999998765322211 1122335678999999998889999999999999999998 6777753221 11 111111
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.+... .........+.+++.+||+.+|.+|||+.++++.|++.+.
T Consensus 236 ~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 236 DGGYL-----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred cCCCC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11110 0111223679999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=290.13 Aligned_cols=249 Identities=28% Similarity=0.378 Sum_probs=204.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|... ++..+++|.+......+.+.+|++.+++++|+|++++++.+.+....++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 46777888999999999999965 47899999987665567899999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++....... .....
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 158 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRNT 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-ccccc
Confidence 9999999766677999999999999999999999 7899999999999999999999999999988754222 12233
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... . ....... +.+ ..+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~-------~~~--~~~~~ 224 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-F----MIPNKPP-------PTL--SDPEK 224 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-h----hhccCCC-------CCC--Cchhh
Confidence 45788999999999889999999999999999999999998743222111 1 0100000 000 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...++.+++.+||+.||++|||+.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3357999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.63 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=196.7
Q ss_pred cccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe-----
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE----- 134 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 134 (347)
|...+.||+|+||.||+|... .+..||+|.+..... ...+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 345678999999999999853 236799999875432 2467889999999999999999998866543
Q ss_pred -EEEEEeecCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 135 -QYLVYEFCAAGNLAQHLLRK-----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 135 -~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
.++++||+++|+|.+++... ...+++.....++.|++.||.||| +.+++|+||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988432 246899999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 209 GLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 209 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
|+++......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+.. .....+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~----~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIY----DYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHcCC
Confidence 9998754322211 122335678999999988889999999999999999999 7777754322 1111 1111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.. ..+.....++.+++.+||+.||.+|||+.++++.|+++
T Consensus 233 ~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 11112345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.70 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=193.3
Q ss_pred cCCeeeecCCeeEEEEEeCC-CC--EEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------CeEE
Q 040826 70 DRRFLGRGSAGLVYKGVLPS-GQ--VVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------GEQY 136 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 136 (347)
..+.||+|+||.||+|.+.+ +. .+|+|.+.... ....+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45779999999999999654 33 58999886532 234678899999999999999999987432 2468
Q ss_pred EEEeecCCCChHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 137 LVYEFCAAGNLAQHLLR-----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
+++||+++|+|.+++.. ....+++.....++.|++.||.||| +++++|+||||+||++++++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 2345889999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 212 KMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
.......... .....++..|++||...+..++.++|+||||+++|+|++ |..||..... .. .. .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~-~~---~~~~~~~~~- 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SE-IY---DYLRQGNRL- 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HH-HH---HHHHcCCCC-
Confidence 8754322111 122345678999999999899999999999999999999 7778754221 11 11 111111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 234 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112335689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.22 Aligned_cols=235 Identities=27% Similarity=0.291 Sum_probs=187.4
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHH-HhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVE-GLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +|+.||+|.+.... ....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 78999999986532 2233445544 56788999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||++..... .......
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTST 155 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccc
Confidence 9999988654 45899999999999999999999 88999999999999999999999999999875321 1222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+...... +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~--------~~~~---- 218 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKPLR--------LKPN---- 218 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCCC--------CCCC----
Confidence 56899999999999989999999999999999999999999743211 111222211111 1111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
....+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 235789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=293.29 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=197.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|++|.||+|... ++..|++|.+..... ...+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 356777889999999999999964 356789998865432 24688899999999999999999999988899
Q ss_pred EEEEeecCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceEEe
Q 040826 136 YLVYEFCAAGNLAQHLLRKD------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPKLS 206 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~ 206 (347)
+++|||+++++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999986532 35899999999999999999999 78999999999999998765 58999
Q ss_pred ecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcC
Q 040826 207 DFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 207 dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
|||++.......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...... . .. ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~-~~---~~~~~ 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-E-VM---EFVTG 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H-HH---HHHHc
Confidence 999988653221111 112233568999999998899999999999999999997 88888643221 1 11 11111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.... ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 237 ~~~~-----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRL-----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 111122357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=292.13 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=192.7
Q ss_pred eeeecCCeeEEEEEeC-CCC--EEEEEEcccCC---ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 73 FLGRGSAGLVYKGVLP-SGQ--VVAIKHIYKSN---NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
.||+|+||.||+|... +|. .+++|.+.... ....+.+|++++.++ +|||++++++++...+..+++|||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999964 444 46888876432 234688899999999 7999999999999999999999999999
Q ss_pred ChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccc
Q 040826 146 NLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 146 sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
+|.+++.... ..+++..+..++.|++.|++||| +.+++|+||||+||++++++.++++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999986432 24789999999999999999999 78999999999999999999999999999
Q ss_pred ceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
+..... .........+..|+|||++.+..++.++|+||||+++|+|++ |..||..... .+ .......+...
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~----~~~~~~~~~~~- 230 (270)
T cd05047 159 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE----LYEKLPQGYRL- 230 (270)
T ss_pred ccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HH----HHHHHhCCCCC-
Confidence 863211 111111234567999999988889999999999999999997 8888853221 11 11111111100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
........++.+++.+||+.+|.+|||+.+++..|+.++
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011122357899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=300.91 Aligned_cols=239 Identities=22% Similarity=0.284 Sum_probs=191.2
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 139 (347)
+|...+.||+|+||.||+|... +++.+|+|.+.... .......|..++..+ +|++++.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3666788999999999999954 67899999987532 223456677777777 5899999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++...... .
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 999999999988654 45899999999999999999999 889999999999999999999999999998754321 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... .. ...+......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~----~~~i~~~~~~----------- 219 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-EL----FQSIMEHNVA----------- 219 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCCCC-----------
Confidence 2233456899999999999999999999999999999999999999754321 11 1112111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
++.....++.+++.+||+.+|.+|++.
T Consensus 220 -~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 -YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111223578999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=295.17 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||++... ++..+++|.+..... ...+.+|+.++++++|||++++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356778889999999999999853 467899998875433 34688899999999999999999999998899
Q ss_pred EEEEeecCCCChHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCC
Q 040826 136 YLVYEFCAAGNLAQHLLRKD---------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTN 194 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~N 194 (347)
++++||+++++|.+++.... ..+++..++.++.|++.||.||| +++++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999985321 24778889999999999999999 7899999999999
Q ss_pred EEecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhh
Q 040826 195 ILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDAR 272 (347)
Q Consensus 195 ili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~ 272 (347)
|++++++.++|+|||.+........ ........+..|+|||.+.+..++.++||||||+++|+|++ |..||..... .
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-E 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H
Confidence 9999999999999999876532221 11222234667999999998889999999999999999998 7777753221 1
Q ss_pred hHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 273 DQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
+ ....+..+... ........++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 240 ~----~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E----VIYYVRDGNVL-----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----HHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11222111110 0111233679999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=291.36 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=198.4
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+|...+.||+|+||.||+|.. .+|+.+++|++.... ....+.+|+..+++++|||++++++.+...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4677889999999999999995 578899999886543 3346778999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++...... ....
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IAKR 163 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc-cccc
Confidence 999999988654 45899999999999999999999 789999999999999999999999999999865322 1122
Q ss_pred ecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
....++..|+|||.+. ...++.++|+||||+++|+|++|+.|+........ .. ...... +..+....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~----~~~~~~-----~~~~~~~~ 233 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF----LMSKSN-----FQPPKLKD 233 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-he----eeecCC-----CCCCCCcc
Confidence 3346788999999874 34577899999999999999999998853321111 00 000000 00111110
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
......++.+++.+||+.+|++|||+++|++.+
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112335799999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.10 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=194.6
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+|...+.||+|+||.||++.. .+|+.||+|.+... .....+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577888999999999999995 46899999998643 223467789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc--
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-- 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 218 (347)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999998654 45888999999999999999999 8899999999999999999999999999875321000
Q ss_pred ----------------------------------------cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHH
Q 040826 219 ----------------------------------------SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQL 258 (347)
Q Consensus 219 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 258 (347)
........||..|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001124689999999999999999999999999999999
Q ss_pred HhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 040826 259 LSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRP---TIDVVYEE 333 (347)
Q Consensus 259 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp---s~~ei~~~ 333 (347)
++|+.||.......... . +....... ..+. ...+ ..++.+++.+|+ .+|.+|+ |+.++++.
T Consensus 238 l~G~~Pf~~~~~~~~~~-~----i~~~~~~~---~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQL-K----VINWETTL---HIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHH-H----HhccCccc---cCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999997544322111 1 11110000 0000 1122 345777777776 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.40 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=203.8
Q ss_pred CcccCCeeeecCCeeEEEEEeC-----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQY 136 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 136 (347)
.|...+.||+|+||.||++.+. ++..+|+|.+..... ...+.+|++.++.++|+|++++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4555678999999999999853 367899999976554 4578999999999999999999999877 55789
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
++|||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999776667999999999999999999999 78999999999999999999999999999987642
Q ss_pred Cccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh----------HHHHHHhhhcC
Q 040826 217 EESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD----------QLTRKARDVSM 284 (347)
Q Consensus 217 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~----------~~~~~~~~~~~ 284 (347)
..... .....++..|+|||...+..++.++|+||||+++++|++|..|+........ ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 21111 1123345679999999888899999999999999999999998764322110 01111111111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
... ......+..++.+++.+||+.+|.+|||+.||++.|+++
T Consensus 242 ~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GER-----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCc-----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 110 011122346799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.39 Aligned_cols=250 Identities=30% Similarity=0.373 Sum_probs=211.5
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 136 (347)
....|...+.||+|.||.||++..+ +|+.+|+|.+.+... .....+|+.+|+++. ||||+.+.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456777789999999999999965 599999999976532 357899999999998 999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC----CceEEeecccce
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK----LEPKLSDFGLAK 212 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~----~~~kl~dfg~~~ 212 (347)
+|||++.||.|.+.+... .+++..+..++.|+++++.||| +.|++||||||+|+|+... +.++++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999766 3999999999999999999999 8999999999999999643 479999999999
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
.... .......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.......... .+..+.. .+
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~---~f 257 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF---DF 257 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC---CC
Confidence 8764 455677899999999999999999999999999999999999999998654333322 3333322 22
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.++.+. ...+.+.+++..++..||.+|+|+.+++++
T Consensus 258 ~~~~w~-----~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 TSEPWD-----DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCcc-----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 222222 234579999999999999999999999984
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=292.83 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|... ++..+++|.+..... ...+.+|+.+++.++|||++++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46777889999999999999853 236899999865543 236788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 137 LVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
++|||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 999999999999998542 234788899999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 208 FGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 208 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
||+++....... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...... ... +....+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~---~~~~~~ 237 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVL---KFVIDG 237 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHH---HHHhcC
Confidence 999876532221 11223346788999999988889999999999999999998 88887532211 111 111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
... ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHL-----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC-----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 110 011112467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=308.90 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=192.1
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.|...+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999999999995 468899999986532 23467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc--
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-- 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 218 (347)
|+++|+|.+++.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999988654 45889999999999999999999 8899999999999999999999999999975321000
Q ss_pred --------------------------------------------cceeecccCCCCccccccccCCccCCcccHHHHHHH
Q 040826 219 --------------------------------------------SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254 (347)
Q Consensus 219 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 254 (347)
........||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112468999999999999899999999999999
Q ss_pred HHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 040826 255 ALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT---IDVVY 331 (347)
Q Consensus 255 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~ei~ 331 (347)
+|+|++|+.||.......... .... ...... .|. ...+ .++..+++.+++ .+|.+|++ +.+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~-~i~~----~~~~~~---~p~-~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQM-KVIN----WQTSLH---IPP-QAKL----SPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHH-HHHc----cCCCcC---CCC-cccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999997543322111 1111 000000 000 0112 245677777665 59999987 77776
Q ss_pred H
Q 040826 332 E 332 (347)
Q Consensus 332 ~ 332 (347)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.63 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=204.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC----EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ----VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|+||.||+|... +|. .+++|....... ...+.+|+..+++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45667788999999999999854 343 589998876543 2467889999999999999999999887 78899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++.+....+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999875422
Q ss_pred ccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...... ... ..+..+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~---~~~~~~~~~------- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIP---DLLEKGERL------- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHH---HHHhCCCCC-------
Confidence 2111 112224568999999988889999999999999999998 99998643221 111 111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+..+...+.+++.+||..+|.+|||+.++++.|+++.++..
T Consensus 231 ----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 231 ----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 0011122468899999999999999999999999999977653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=289.23 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=199.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
.+|...+.||+|+||.||++.. +++.+++|.+........+.+|+.++++++|||++++++++..+ ..+++|||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4567788999999999999975 67889999987766667889999999999999999999998654 579999999999
Q ss_pred ChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 146 NLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 146 sL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
+|.+++.... ..+++..++.++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+...... ...
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDN 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----CCC
Confidence 9999996543 45889999999999999999999 889999999999999999999999999998764321 112
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .. ......+... ....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~----~~~~~~~~~~-----------~~~~ 220 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EV----KECVEKGYRM-----------EPPE 220 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HH----HHHHhCCCCC-----------CCCC
Confidence 234568999999988889999999999999999998 88888643221 11 1111111100 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
..++.+.+++.+||+.+|++|||+.++++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.05 Aligned_cols=245 Identities=29% Similarity=0.437 Sum_probs=197.1
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
++||+|++|.||++...+++.|++|.+..... ...+.+|++++++++|+||+++++++.+....++++||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999976799999998876433 346889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee-ecccC
Q 040826 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF-TDVRG 227 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~ 227 (347)
+++......+++.....++.|+++++.||| +++++|+||+|+||+++.++.++|+|||.+........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667899999999999999999999 88999999999999999999999999999876532111111 11223
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADF 306 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 306 (347)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ..... ...+... ..+...+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~----~~~~~~~-----------~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRER----IESGYRM-----------PAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHH----HhcCCCC-----------CCCccCC
Confidence 567999999988889999999999999999999 77777543221 11111 1111000 1111234
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 307 ESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 307 ~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 57999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=304.63 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=198.2
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
...++|...+.||+|+||.||++... +++.+|+|.+... .....+.+|..+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34678999999999999999999955 6889999988642 12345778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++|+|.+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999988543 4788899999999999999999 88999999999999999999999999999987643
Q ss_pred CccceeecccCCCCccccccccCC----ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNA----KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||...... . ....+........ +
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~----~~~~i~~~~~~~~-~ 268 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-G----TYSKIMNHKNSLT-F 268 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-H----HHHHHHcCCCccc-C
Confidence 322223345699999999998753 3788999999999999999999999754321 1 1122211111000 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYEE 333 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~~ 333 (347)
+ .......++.+++.+|+..++.+ ||++.+|++.
T Consensus 269 --~-----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 269 --P-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --C-----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 01123357889999999844433 7899888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.63 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=196.4
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-CChhHHHHHHHHhhcC-CCCcceeeeeEEEeC------Ce
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEG------GE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~ 134 (347)
+.+.|...+.||+|+||.||+|... +++.+|+|.+... .....+.+|+..++++ +|+|++++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3456777788999999999999954 6889999988654 3345688999999998 699999999998753 46
Q ss_pred EEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+++|||+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 89999999999999998753 456899999999999999999999 78999999999999999999999999999886
Q ss_pred cCCCccceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 288 (347)
.... ........|+..|+|||++. +..++.++|+||||+++|+|++|+.||........... . .....
T Consensus 161 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-~---~~~~~-- 233 (272)
T cd06637 161 LDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-I---PRNPA-- 233 (272)
T ss_pred cccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-H---hcCCC--
Confidence 5321 12223356888999999886 34578899999999999999999999864322211111 1 00000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... .......++.+|+.+||+.+|.+|||+.++++
T Consensus 234 -~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 -PRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 01122357899999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.08 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=202.0
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||.|+||.||.+. ..+++.+++|.+.... ....+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 46778899999999999998 4468899999876432 234688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++... ...+++..+..++.|++.++.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999764 456899999999999999999999 78999999999999999999999999999887643221
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||...+..++.++|+||||+++|+|++|..||...... .....+..+..+.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~----------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQGNYTP----------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCCC-----------
Confidence 223456889999999998888899999999999999999999998643221 1112222222110
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.......++.+++.+||+.+|.+|||+.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112233579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.43 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=200.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeC--------CCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
++|...+.||+|+||.||++... .+..+|+|.+..... ...+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46667889999999999999731 245789998875433 23577899999999 5999999999999888
Q ss_pred eEEEEEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
..++++||+++|+|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999998542 235888999999999999999999 88999999999999999
Q ss_pred CCCceEEeecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLT 276 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~ 276 (347)
+++.++|+|||.++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 99999999999998653221111 112234467999999998889999999999999999999 777775321 111111
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
....+... .....+..++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 248 ----~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 ----LLREGHRM-----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHcCCCC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111100 11112335788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.73 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=196.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC---------------CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS---------------GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFG 127 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~ 127 (347)
++|...+.||+|+||.||++.... ...||+|.+..... ...+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788899999999999987532 23589999876432 246889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEE
Q 040826 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKD-----------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNIL 196 (347)
Q Consensus 128 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nil 196 (347)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999885422 23688899999999999999999 889999999999999
Q ss_pred ecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh--CCCCcCCChhhhh
Q 040826 197 LTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS--GQKVIELDFDARD 273 (347)
Q Consensus 197 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt--g~~p~~~~~~~~~ 273 (347)
+++++.++|+|||++......... ......++..|+|||...+..++.++|+||||+++++|++ +..||..... .+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence 999999999999998765322211 1222345778999999988889999999999999999998 4455543221 11
Q ss_pred HHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 274 QLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.................. ......+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYL--------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111100000000 001112357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.50 Aligned_cols=248 Identities=24% Similarity=0.269 Sum_probs=198.0
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||++.. .+|+.+|+|.+.... ....+.+|++++++++|+|++.+.+.+..++..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999995 478899999886532 123467899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888653 346999999999999999999999 889999999999999999999999999998764322 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .............. .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~~------------~ 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETEE------------V 223 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhcccc------------c
Confidence 2233468999999999998889999999999999999999999997543221 11222222211111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPT-----IDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~~ 333 (347)
+......++.+|+..||+.||.+||| +.++++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11223356899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.93 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=195.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36777889999999999999954 6899999998642 22345788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++.+....+++..+..++.|++.||.||| +++++||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999766667899999999999999999999 88999999999999999999999999999876543222
Q ss_pred ceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...... +...... ...... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~~~~i~----~~~~~~-~~-- 229 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIM----NHKEHF-QF-- 229 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-HHHHHHH----cCCCcc-cC--
Confidence 22233468999999999863 45788999999999999999999999743221 1111111 111000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAK--SSKGRPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~ei~~~ 333 (347)
+... ....+.+.+++.+|+.. ++..||++.++++.
T Consensus 230 ~~~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCcc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 11335678888877654 34447899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=280.38 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=203.1
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEccc----CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYK----SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|.|+.|+++. .++|+.+|+|.+.- ..+.+.+.+|+.+.+.++||||+++...+.+....++|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 345555679999999999998 55899888887743 3456788999999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~ 217 (347)
+++|+.|..-+-+. ..+++..+....+||+++|.|+| .++|+|||+||+|+++.. ..-+||+|||++..+.
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999987766443 45788889999999999999999 899999999999999963 3459999999999876
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
+.....+..||+.|||||++...+|+..+|||+.|++||-|+.|.+||... +.......+..+...+. .|.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----~~~rlye~I~~g~yd~~---~~~w 236 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYEQIKAGAYDYP---SPEW 236 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhccccCCC---Cccc
Confidence 455566788999999999999999999999999999999999999999742 11222333333432221 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. ..++..+|+.+||..||.+|.|+.|.+++
T Consensus 237 -~~----is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 237 -DT----VTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -Cc----CCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12 33579999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.25 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=194.9
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhh--cCCCCcceeeeeEEEeCC----eEEEEEeecCC
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLS--RVRHPNLVCLFGCCVEGG----EQYLVYEFCAA 144 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e~~~~ 144 (347)
.+++|+|.||.||+|.+ +++.||||++. ..+.+.|.+|-++.+ .+.|+||+.+++.-...+ .++||++|.+.
T Consensus 215 ~eli~~Grfg~V~KaqL-~~~~VAVKifp-~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQL-DNRLVAVKIFP-EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHHhhcCccceeehhhc-cCceeEEEecC-HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 35699999999999999 45999999884 444566777776655 457999999999866544 88999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc------CCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|+|.++|.. ..++|....+++..+++||+|||+.. +.+|+|||||++|||+..|++..|+|||++..+....
T Consensus 293 GsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~ 370 (534)
T KOG3653|consen 293 GSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK 370 (534)
T ss_pred CcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence 999999954 56999999999999999999999754 4579999999999999999999999999999876432
Q ss_pred c-ceeecccCCCCccccccccCC-ccC-----CcccHHHHHHHHHHHHhCCCCcC--------CChh----hhhHHHHHH
Q 040826 219 S-KVFTDVRGTIGYMDPEYMTNA-KLT-----CASDIYSFGIVALQLLSGQKVIE--------LDFD----ARDQLTRKA 279 (347)
Q Consensus 219 ~-~~~~~~~~~~~y~aPE~~~~~-~~~-----~~~Dv~slG~il~~lltg~~p~~--------~~~~----~~~~~~~~~ 279 (347)
. ...-..+||.+|||||++.+. .+. .+.||||+|.+|||+++.-+-+. .++. ....+....
T Consensus 371 ~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq 450 (534)
T KOG3653|consen 371 PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQ 450 (534)
T ss_pred CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHH
Confidence 2 223447899999999999763 222 46899999999999998643332 1111 111122222
Q ss_pred hhhcCCCCCcccccCCCCCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 280 RDVSMGKRPIKDFEDPRLNG-NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
..+... ...|.+.. ......+..+++.+..||+.||+.|.|+.=+.+++..+.
T Consensus 451 ~~VV~k------K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 451 ELVVRK------KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHhh------ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 222111 11222221 122245578999999999999999999999999988874
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.16 Aligned_cols=191 Identities=26% Similarity=0.356 Sum_probs=166.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
..+|...+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|+|++.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 457999999999999999999964 5778999975433 23568999999999999999999999999999999996
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+ +|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..... .....
T Consensus 141 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~~ 214 (357)
T PHA03209 141 S-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--APAFL 214 (357)
T ss_pred C-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc--Ccccc
Confidence 5 899988776677999999999999999999999 88999999999999999999999999999875321 12223
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCc
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
...||..|+|||.+.+..++.++||||||+++|+|+++..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 456899999999999989999999999999999999876555
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=301.86 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=196.3
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCC-----
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG----- 133 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 133 (347)
..++|...+.||+|+||.||++.. .+|..||+|.+... .....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457888899999999999999995 46899999998643 22346778999999999999999999886543
Q ss_pred -eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 134 -EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 134 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999986 67666532 3788899999999999999999 8899999999999999999999999999987
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhh-----------
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD----------- 281 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~----------- 281 (347)
.... ........+|..|+|||.+.+..++.++||||||+++|+|++|+.||...... +........
T Consensus 172 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHH
Confidence 5432 12233456899999999999999999999999999999999999999754221 111111111
Q ss_pred -------hcCCCCCccccc----CCCC----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 282 -------VSMGKRPIKDFE----DPRL----NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 282 -------~~~~~~~~~~~~----~~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
............ .+.+ ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 100000000000 0000 001111223578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.22 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=197.0
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCC-----eEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGG-----EQY 136 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 136 (347)
+|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 356678899999999999995 478999999886532 2246788999999999999999999988766 789
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+|+||+.+ +|.+.+.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeecccc-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999975 88887754 346899999999999999999999 88999999999999999999999999999987543
Q ss_pred CccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh-------------
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV------------- 282 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~------------- 282 (347)
..........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... +.+..+....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhH
Confidence 333333445678899999998874 5789999999999999999999999754321 1221111110
Q ss_pred ------cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 283 ------SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 283 ------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.......... . .+ ........+++.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~-~-~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSL-P-VL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCch-H-Hh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0 00 01111224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=294.40 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=202.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC----EEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ----VVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.+. +|. .+++|.+...... ..+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 35566788999999999999853 454 4788888655432 3678899999999999999999988654 5679
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++......+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999776667899999999999999999999 889999999999999999999999999999865422
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......... +... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~---~~~~-~----- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK---GERL-P----- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC---CCCC-C-----
Confidence 211 1222345678999999998899999999999999999997 8888864321 112222211 1110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
....+...+.+++.+||..+|++||++.++++.|+++.++.-
T Consensus 232 -----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 232 -----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 011123568999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=291.53 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=199.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC-----------------CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS-----------------GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~ 125 (347)
.+|...+.||+|+||.||++.... +..|++|.+..... ...+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467788899999999999998532 24589998876543 3468889999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCE
Q 040826 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNI 195 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Ni 195 (347)
++++..++..++++|++++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999986533 26899999999999999999999 78999999999999
Q ss_pred EecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh--CCCCcCCChhhh
Q 040826 196 LLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS--GQKVIELDFDAR 272 (347)
Q Consensus 196 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt--g~~p~~~~~~~~ 272 (347)
+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ +..|+.... ..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-hH
Confidence 999999999999999876532221 11233446778999999988889999999999999999998 556664322 11
Q ss_pred hHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 273 DQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+.+............... . ......++++.+++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIY-L-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcccccccccc-C-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111110000 0 111123367999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.33 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=189.1
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +++.+|+|.+.... ....+.+|..++.++ +||||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999954 67899999997542 223577888888888 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 9999888543 45899999999999999999999 889999999999999999999999999998753211 122334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........+....... +
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------p 223 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI------------P 223 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC------------C
Confidence 56899999999999999999999999999999999999999632111 011111111111111111 1
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
......+.+++.+||+.||.+||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11225688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.20 Aligned_cols=239 Identities=21% Similarity=0.286 Sum_probs=190.7
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 140 (347)
|...+.||+|+||.||+|.. .+|+.||+|.+... .....+..|..++..+. |++++++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 55678899999999999995 46899999998653 22345677888888875 5778889999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ..
T Consensus 82 y~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GV 156 (323)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Cc
Confidence 99999999988654 45899999999999999999999 889999999999999999999999999998754322 12
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... . ....+.......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~----~~~~i~~~~~~~----------- 220 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-E----LFQSIMEHNVSY----------- 220 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-H----HHHHHHhCCCCC-----------
Confidence 233456899999999999989999999999999999999999999754321 1 111221111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
+.....++.+++.+||+++|.+|++..
T Consensus 221 -p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 221 -PKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 112235688999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.88 Aligned_cols=260 Identities=23% Similarity=0.234 Sum_probs=196.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
.+|...+.||+|+||.||++... +++.||+|... ...+.+|++++++++|+||+++++++..++..+++||++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 35888899999999999999965 57889999542 2346789999999999999999999999999999999996
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc-eee
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFT 223 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 223 (347)
++|.+++......+++..++.++.|++.||.||| +.||+||||||+|||++.++.++|+|||+++........ ...
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 5999988766667999999999999999999999 889999999999999999999999999999865322211 122
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCCh------hhhhHHHHHHhhhcCCCCCccccc----
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF------DARDQLTRKARDVSMGKRPIKDFE---- 293 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~---- 293 (347)
...||..|+|||++.+..++.++|||||||++|||++|..++.... ....++....+.............
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 3568999999999999999999999999999999999886553211 111222222221110000000000
Q ss_pred ------------CCCCCC-CCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 294 ------------DPRLNG-NIN--RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 294 ------------~~~l~~-~~~--~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.... ... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000 0112468899999999999999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=295.37 Aligned_cols=194 Identities=25% Similarity=0.386 Sum_probs=162.1
Q ss_pred CCeeeecCCeeEEEEEeC---CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEEeecCCC
Q 040826 71 RRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVYEFCAAG 145 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g 145 (347)
.++||+|+||.||+|... +++.+|+|.+..........+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 467999999999999854 5678999999776666678899999999999999999998864 4568999999876
Q ss_pred ChHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe----cCCCceEEeeccccee
Q 040826 146 NLAQHLLRK--------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----TEKLEPKLSDFGLAKM 213 (347)
Q Consensus 146 sL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----~~~~~~kl~dfg~~~~ 213 (347)
+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888876421 235889999999999999999999 8899999999999999 4567899999999987
Q ss_pred cCCCcc--ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCC
Q 040826 214 LGMEES--KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELD 268 (347)
Q Consensus 214 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~ 268 (347)
...... .......+|..|+|||++.+ ..++.++|+||+||++|+|++|++||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 543211 12234568999999999876 46889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=287.26 Aligned_cols=237 Identities=27% Similarity=0.404 Sum_probs=186.3
Q ss_pred CeeeecCCeeEEEEEeCC-------------CCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 72 RFLGRGSAGLVYKGVLPS-------------GQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
+.||+|+||.||+|+..+ ...+++|.+..... ...+..|+..++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 22588898765432 346778899999999999999999999888999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc-------eEEeecc
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE-------PKLSDFG 209 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~-------~kl~dfg 209 (347)
++|||+++++|..++......+++..++.++.|+++|++||| +++++|+||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999888766667999999999999999999999 889999999999999987664 8999999
Q ss_pred cceecCCCccceeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHH-hCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLL-SGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
++..... .....++..|+|||.+. +..++.++||||||+++|+|+ +|..|+........ .. ...+..
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~~ 226 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ER----FYEGQC 226 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HH----HHhcCc
Confidence 8875432 12345778899999886 467889999999999999998 47776653221110 11 001110
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
. . ......++.+|+.+||+.||++||++.+|++.|
T Consensus 227 ~---~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 M---L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c---C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0 001235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=306.08 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=194.2
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677788999999999999985 478999999886432 2245778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999988654 45889999999999999999999 88999999999999999999999999999863211000
Q ss_pred -------------c---------------------------------eeecccCCCCccccccccCCccCCcccHHHHHH
Q 040826 220 -------------K---------------------------------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGI 253 (347)
Q Consensus 220 -------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 253 (347)
. ......||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001245899999999999989999999999999
Q ss_pred HHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHH
Q 040826 254 VALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR---PTIDVV 330 (347)
Q Consensus 254 il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~ei 330 (347)
++|+|++|..||...... +.+.... ...... ..|. ......++.+++.+|+. +|.+| +|+.++
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~----~~~~~~---~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ETYRKII----NWRETL---YFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HHHHHHH----ccCCcc---CCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999754322 1111111 111000 0010 00122568889999997 66665 599888
Q ss_pred HHH
Q 040826 331 YEE 333 (347)
Q Consensus 331 ~~~ 333 (347)
+.+
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=291.99 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=198.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-----------------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-----------------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~ 125 (347)
++|...+.||+|+||.||++... ++..+|+|.+..... ...+.+|+..++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46778889999999999998532 234689999875432 3468899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCE
Q 040826 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNI 195 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Ni 195 (347)
++++...+..+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999986432 24678899999999999999999 88999999999999
Q ss_pred EecCCCceEEeecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh--CCCCcCCChhhh
Q 040826 196 LLTEKLEPKLSDFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS--GQKVIELDFDAR 272 (347)
Q Consensus 196 li~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt--g~~p~~~~~~~~ 272 (347)
+++.++.++|+|||++.......... .....++..|++||...+..++.++|+||||+++|+|++ |..|+..... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence 99999999999999987653322211 122334678999999888889999999999999999998 6677753221 1
Q ss_pred hHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 273 DQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
+................ .. .....+...+.+++.+||+.||.+|||+.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQV---YL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccccc---cC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111110000000 00 0111233679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.80 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+|+..+++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56778889999999999999854 68899999886432 234577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++......+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 985 999988766667899999999999999999999 8899999999999999999999999999987643221 12
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC----------CCcc
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK----------RPIK 290 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 290 (347)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+............. ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 223456889999998865 4578899999999999999999999975432 222221111111000 0000
Q ss_pred cccCCCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000111100 011122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=291.19 Aligned_cols=250 Identities=36% Similarity=0.477 Sum_probs=199.0
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChh----HHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||+|+||.||++... +++.+|+|.+....... ...+|+..+++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456678999999999999965 56689999998765433 2345899999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++. ....+++..+..++.|+++||.+|| +.+++|+||||+||++++++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred cccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999997 3455899999999999999999999 7899999999999999999999999999988641 223344
Q ss_pred ecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+. +..++.++|+||+|+++++|++|..|+...... +......+...... .. +. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~-~~-----~~---~~ 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPL-PS-----SS---QQ 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHH-HH-----HT---TS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhcccccc-cc-----cc---cc
Confidence 5567899999999998 888999999999999999999999999865111 11111111111000 00 00 00
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011268999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=292.27 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=200.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+|...+.||+|++|.||+|.. .+++.+++|.+.... ....+.+|+.+++.++|+|++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677778899999999999995 478899999886543 3456888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++.+ ..+++.++..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-ccc
Confidence 99999998854 35789999999999999999999 8899999999999999999999999999887643221 112
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .... ..+.... ...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~~~---~~~~~~~----------~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIA---TNGTPEL----------QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HHHh---cCCCCCC----------CCc
Confidence 2346788999999999888899999999999999999999999754332211 1111 1111110 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......+.+++.+||..+|.+|||+.+|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1233568999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=285.31 Aligned_cols=251 Identities=28% Similarity=0.373 Sum_probs=202.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
++|...+.||.|+||.||++... +++.+++|.+.... ....+.+|++++++++|||++++++.+.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46777889999999999999954 67889999887543 3457889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh-hhcc
Confidence 999999988766567999999999999999999999 889999999999999999999999999998765321 1122
Q ss_pred ecccCCCCccccccccCC---ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNA---KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+......... ........ . .+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~----~-----~~~~-- 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNF----P-----PPKL-- 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC----C-----Cccc--
Confidence 334678899999999776 7889999999999999999999998753322211 11111100 0 0010
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........++.+++.+||+.+|.+|||+.+|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=300.70 Aligned_cols=238 Identities=25% Similarity=0.272 Sum_probs=187.4
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHH-HHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREV-EGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +++.+|+|.+.... ....+..|. ..++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 67889999986532 222344444 356788999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|+++||.||| +.|++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 9999988654 45788889999999999999999 889999999999999999999999999998753211 222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .... .+...... . ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~----~i~~~~~~--------~----~~~ 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYD----NILNKPLQ--------L----KPN 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHH----HHHhCCcC--------C----CCC
Confidence 56899999999999999999999999999999999999999743322 1111 11111111 1 112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~ 331 (347)
....+.+++.+||+.||.+||++.+.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 235689999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=292.40 Aligned_cols=256 Identities=26% Similarity=0.327 Sum_probs=198.9
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||+|+||.||++... +|..+++|.+..... ...+.+|++++++++||||+++++++.+++..++++||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5778889999999999999954 688899998865432 245788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++... ..+++..+..++.|+++||.|||+ ..+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 999999998654 458999999999999999999994 258999999999999999999999999988754221 12
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC-CCCCcc-----------
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM-GKRPIK----------- 290 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~----------- 290 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... ...+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCc
Confidence 3346889999999998888999999999999999999999998643211 11111110000 000000
Q ss_pred --------------cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 --------------DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 --------------~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.-..+.+. ......++.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 01134579999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.62 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=195.3
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...++||+|+||.||+|.. .+++.+|+|.+..... ...+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 456678899999999999984 5788999998865432 346888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|..+. .+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999986542 4688889999999999999999 889999999999999999999999999998765321 22
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH--HHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ--LTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ............. +.+.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-- 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------PVLP-- 221 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------CCCC--
Confidence 3356889999999999888999999999999999999999998643221111 1111111111110 0110
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......++.+++.+||+.+|.+||+++++++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123568999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=288.25 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=197.3
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++++.....||+|+||.||+|.. .++..|++|.+..... ...+.+|+.++++++|+||+++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 455555667899999999999994 4678899998865533 3468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLRKDSVL--TWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~ 217 (347)
|+++++|.+++......+ ++..+..++.|++.|+.||| +.+++|+||+|+||+++. ++.++|+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999997654445 78888999999999999999 889999999999999986 679999999998765321
Q ss_pred ccceeecccCCCCccccccccCC--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+.......... ....... . .+
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~~-~-------~~ 231 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMFK-I-------HP 231 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhhc-c-------CC
Confidence 1 122234578899999998654 37889999999999999999999986422111111 1000000 0 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.++....+++.+++.+||+.+|.+|||+.++++.
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 ----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1222334679999999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=286.76 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=198.4
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
+|...+.||+|+||.||+|...+|+.+|+|.+..... ...+.+|++.+++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3566788999999999999988899999998864321 23578899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC-
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME- 217 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 217 (347)
+||+++++|.+++.+. ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999998654 35789999999999999999999 789999999999999999999999999988754211
Q ss_pred ----ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 218 ----ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 218 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~~~~~----~~~~----- 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-FYIGA----HRGL----- 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-HHhhh----ccCC-----
Confidence 111123345888999999999888999999999999999999999999643222111 11110 0000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+.+ .....+++.+++.+||+.+|.+|||+.++++
T Consensus 227 ~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 1123357899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=285.56 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=196.3
Q ss_pred CeeeecCCeeEEEEEeCC--CC--EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLPS--GQ--VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|++|.||+|.+.+ ++ .+++|.+..... ...+.+|+..+++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999998543 33 689999876544 3468899999999999999999999888 889999999999
Q ss_pred CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc--e
Q 040826 145 GNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK--V 221 (347)
Q Consensus 145 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 221 (347)
++|.+++.+.. ..+++...+.++.|+++||.||| +++++|+||+|+||+++.++.++|+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 56899999999999999999999 889999999999999999999999999998876432211 1
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..|+...... +....... ..... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~---~~~~~-----------~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDK---EGERL-----------E 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh---cCCcC-----------C
Confidence 112346788999999998889999999999999999998 99988643221 11111111 11100 0
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123367999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.84 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=199.7
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|+||.||+|... +|+.+++|.+..... ...+.+|+.++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3666788999999999999964 789999998865322 24577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++......+++..++.++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 975 888888665667999999999999999999999 7899999999999999999999999999988654221 22
Q ss_pred eecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-------Ccccc-
Q 040826 222 FTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-------PIKDF- 292 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~- 292 (347)
.....++..|+|||.+.+. .++.++||||||+++|+|+||..|+.........+....+....... .....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2334578899999988764 47889999999999999999999875544433333332222111000 00000
Q ss_pred cCCCCCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 EDPRLNG-----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 ~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.... .......+++.+++.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 111123467899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=291.69 Aligned_cols=259 Identities=27% Similarity=0.336 Sum_probs=193.3
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcC---CCCcceeeeeEEEe-----CC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRV---RHPNLVCLFGCCVE-----GG 133 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 133 (347)
+|...+.||+|+||.||+|... +|+.||+|.+.... ......+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4667788999999999999954 78999999886532 123456777777665 69999999998764 34
Q ss_pred eEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 134 EQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
..++++||+++ +|.+++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999986 898888653 345899999999999999999999 8899999999999999999999999999988
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-CCcc-
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK-RPIK- 290 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~- 290 (347)
..... .......++..|+|||.+.+..++.++||||+|+++|+|++|.+||...... +.+........... ....
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCcc
Confidence 65322 1223346789999999999889999999999999999999999998644322 22222222111000 0000
Q ss_pred ------cccCCCC---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 ------DFEDPRL---NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ------~~~~~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.. .....++..+++.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 00111233467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.28 Aligned_cols=237 Identities=27% Similarity=0.284 Sum_probs=187.6
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHH-HhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVE-GLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||++.. .+|+.+|+|.+.... ....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999995 478999999986531 2234455554 46778999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++.. ...+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 999988854 346899999999999999999999 889999999999999999999999999998753211 122334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||...... . ........... + .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~----~~~~~~~~~~~--------~----~~~ 218 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-E----MYDNILHKPLV--------L----RPG 218 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-H----HHHHHHcCCcc--------C----CCC
Confidence 56899999999999999999999999999999999999999753221 1 11222111111 0 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
....+.+++.+|++.+|.+||++.+.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 23568899999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.87 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=202.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...++||+|+||.||+|... +|+.||+|++..... ...+.+|++++++++|||++++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46788899999999999999954 689999999875422 246889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 140 EFCAAGNLAQHLLRK----------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 140 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
||++||+|.+++... ....++..++.++.|+++||+||| +.|++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 133566788899999999999999 8899999999999999999999999999
Q ss_pred cceecCCCcc-----------------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh
Q 040826 210 LAKMLGMEES-----------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR 272 (347)
Q Consensus 210 ~~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~ 272 (347)
++........ .......||+.|+|||.+.+..++.++|||||||++|+|+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01122468999999999999999999999999999999999999997422111
Q ss_pred hHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHh
Q 040826 273 DQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR-PTIDVVYEEIDKAWKN 340 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~ei~~~l~~~~~~ 340 (347)
.. ........... .+ ..+.+..+.+++.+||+.||++| ++++++.+.|+..++.
T Consensus 239 i~----~~~~i~~P~~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS----YRDVILSPIEV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh----hhhhccChhhc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 10 00100000000 00 11233578899999999999999 5678888888887664
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=286.77 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=188.8
Q ss_pred eeeecCCeeEEEEEeC---CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 73 FLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
.||+|+||.||+|... ++..+++|.+..... ...+.+|+..+++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5999999999999854 345789998865433 2367889999999999999999999998889999999999999
Q ss_pred hHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce-
Q 040826 147 LAQHLLRK----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV- 221 (347)
Q Consensus 147 L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~- 221 (347)
|.+++... ....++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.+..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998642 224567788899999999999999 8899999999999999999999999999987543222111
Q ss_pred eecccCCCCccccccccCC-------ccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 222 FTDVRGTIGYMDPEYMTNA-------KLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.....++..|+|||++.+. .++.++|+||||+++|+|++ |+.||........ ....... . .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~---~---~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE---Q---QLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc---c---cCCCC
Confidence 1234567889999988642 35789999999999999996 9988864332221 1111111 1 11112
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.+.+... ..+.+.+++..|| .+|++|||+++|...|+
T Consensus 232 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222212 2246888999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=289.60 Aligned_cols=249 Identities=26% Similarity=0.320 Sum_probs=198.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+.|...+.||+|+||.||+|... ++..+++|.+..... ...+.+|+..++.++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777888999999999999964 588999999865433 346788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|..++.+....+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence 999999888766667899999999999999999999 889999999999999999999999999988754221 1122
Q ss_pred ecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 223 TDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
....++..|+|||.+. ...++.++|+||||+++|+|++|..||...... ... ........+ ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~----~~~~~~~~~--~~----- 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVL----LKIAKSEPP--TL----- 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHH----HHHhcCCCc--cC-----
Confidence 3345788999999884 345788999999999999999999998643211 111 111111111 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........++.+++.+||+.+|++||++.++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011122346889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=288.34 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=202.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||+|++|.||++... +++.+++|.+..... ...+.+|++.+++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566678999999999999965 689999998876533 346888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++|.+++......+++.....++.|++.|+.||| + .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999998765567899999999999999999999 7 8999999999999999999999999998876532111
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..............+.......+ .+...
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~- 227 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-------RLPSG- 227 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-------CCChh-
Confidence 125688899999999988999999999999999999999999875432222222222222222111 11001
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....++.+++.+||..||++|||+.+++.
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13457999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=284.96 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=197.7
Q ss_pred cCCeeeecCCeeEEEEEeCC-----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 70 DRRFLGRGSAGLVYKGVLPS-----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
..+.||.|+||.||++.... +..+|+|.+..... ...+.+|+..++.++|+|++++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45779999999999999643 37899999976543 45788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++...... +++..+..++.|++.|+++|| +.+++|+||+|+||++++++.++++|||.+.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999765444 899999999999999999999 889999999999999999999999999999876433222
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......++..|+|||.+.+..++.++|+||+|+++++|++ |..|+... ....... ........
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~----~~~~~~~~----------- 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLE----YLKKGYRL----------- 223 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHhcCCCC-----------
Confidence 2212346789999999988889999999999999999998 67776532 1111111 11111110
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
........++.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111345799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.06 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=185.6
Q ss_pred eeeecCCeeEEEEEeCC-------------------------CCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceee
Q 040826 73 FLGRGSAGLVYKGVLPS-------------------------GQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~ 125 (347)
+||+|+||.||+|.... ...|++|.+..... ...+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588888865432 2467788999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----
Q 040826 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---- 201 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---- 201 (347)
++++.+....++||||+++|+|..++......+++..+..++.|++.||+||| +++++||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999988766667899999999999999999999 88999999999999998644
Q ss_pred ---ceEEeecccceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHH-hCCCCcCCChhhhhHHH
Q 040826 202 ---EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLL-SGQKVIELDFDARDQLT 276 (347)
Q Consensus 202 ---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~ll-tg~~p~~~~~~~~~~~~ 276 (347)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..|+....... ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~ 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KE 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HH
Confidence 3799999987643211 22346788999998865 56889999999999999995 6888876432211 11
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
..... ..... .. ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 232 ~~~~~----~~~~~--------~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RFYEK----KHRLP--------EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHh----ccCCC--------CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 00000 01 1246899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=301.46 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=197.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------ 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 132 (347)
..++|...+.||+|+||.||++.. .+++.+|+|.+.... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457888899999999999999985 468899999987542 224577899999999999999999988643
Q ss_pred CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
...+++|||+++ +|.+.+.. .+++..+..++.|+++||.||| +.|++||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999976 67766632 4788999999999999999999 8899999999999999999999999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC--------
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM-------- 284 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------- 284 (347)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... +...........
T Consensus 168 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 6532 22233456899999999999989999999999999999999999999754321 111111111100
Q ss_pred ----------CCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 285 ----------GKRPIKDFEDPRL--------NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 285 ----------~~~~~~~~~~~~l--------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..........+.. ..........++.+|+.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000 001111223578999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=289.85 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=195.8
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||+|... +|..|++|.+.... ....+.+|+.++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3566788999999999999964 68999999886432 234678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRK--DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
++ ++|.+++... +..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 98 4898888543 356899999999999999999999 889999999999999999999999999998765422 1
Q ss_pred ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-C----------
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK-R---------- 287 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~---------- 287 (347)
.......++..|+|||.+.+ ..++.++|+||||+++|+|+||+.||........ ............ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhHH
Confidence 22223356889999998865 4578899999999999999999999975432211 111111110000 0
Q ss_pred ---CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 ---PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ---~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........... ........++.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 001113357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=289.85 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=196.0
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
|...+.||+|+||.||++... ++..+++|.+..... ...+.+|+++++.++|||++++++.+...+..++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 344567999999999999965 577889998865432 34678899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|..++.+....+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++++|||++...... ......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccccc
Confidence 9999988665667999999999999999999999 889999999999999999999999999998764321 112233
Q ss_pred ccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 225 VRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 225 ~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
..++..|+|||.+. +..++.++|+||||+++|+|++|+.||...... ........ ...+ ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~----~~~~--~~~------ 229 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAK----SEPP--TLA------ 229 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhh----cCCC--CCC------
Confidence 45888999999874 345778999999999999999999998643221 11111111 1110 000
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.....++.+++.+||+.||.+|||+.++++.
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223579999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.10 Aligned_cols=253 Identities=20% Similarity=0.235 Sum_probs=196.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+|..++..++|+||+.+++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46778889999999999999954 6889999988642 12335778899999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999775667899999999999999999999 88999999999999999999999999999987643322
Q ss_pred ceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +... .+........ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~----~i~~~~~~~~--~- 229 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYG----KIMNHEERFQ--F- 229 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHH----HHHcCCCccc--C-
Confidence 22333568999999998875 46788999999999999999999999743321 1111 1111110000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~~ 333 (347)
+.... +..+++.+++.+|+..++.+ |+++++++++
T Consensus 230 p~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11001 22357888999988765544 4678877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.55 Aligned_cols=235 Identities=24% Similarity=0.289 Sum_probs=186.4
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHH-HhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVE-GLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|... +|+.+|+|.+.... ....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 68899999986432 2233445544 67889999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+.+... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCcccc
Confidence 9998887543 45888999999999999999999 88999999999999999999999999999875321 1222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||...... . ....+...... ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~----~~~~i~~~~~~------------~~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-Q----MYDNILHKPLQ------------LPGG 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-H----HHHHHhcCCCC------------CCCC
Confidence 56899999999999889999999999999999999999999754211 1 11222111111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
...++.+++.+||+.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 235789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=296.86 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=201.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC--------CCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
.+|...+.||+|+||.||++... ++..+++|.+..... ...+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46777889999999999999742 123689998875432 34688999999999 7999999999999988
Q ss_pred eEEEEEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
..++++||+++|+|.+++... ...+++..++.++.|++.||.||| ++|++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 999999999999999998642 234788899999999999999999 88999999999999999
Q ss_pred CCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLT 276 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~ 276 (347)
.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~--- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE--- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-HHH---
Confidence 9999999999998865422111 1122234567999999999899999999999999999998 777775322 111
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
....+..+... ........++.+++.+||+.+|++|||+.++++.|+++....
T Consensus 245 -~~~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -LFKLLKEGHRM-----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHHHcCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111110 111123357999999999999999999999999999997544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=284.56 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=198.0
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 140 (347)
+|...+.||+|++|.||++... +++.+++|.+.... ..+.+.+|++++++++|+|++++++.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4667789999999999999954 57889999986432 23467889999999999999999988764 446899999
Q ss_pred ecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|+++++|.+++... ...+++.++..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-C 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc-C
Confidence 99999999988653 456899999999999999999999 889999999999999999999999999998865422 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......++..|+|||...+..++.++|+||||+++++|++|+.||...... .. ......+..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~----~~~~~~~~~~----------- 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-SL----VYRIIEGKLP----------- 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HH----HHHHHhcCCC-----------
Confidence 2233446788999999999988999999999999999999999998643221 11 1111111110
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+.....++.+++.+||+.+|++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112333579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=284.93 Aligned_cols=237 Identities=25% Similarity=0.386 Sum_probs=188.7
Q ss_pred CeeeecCCeeEEEEEeCC-C----------CEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 72 RFLGRGSAGLVYKGVLPS-G----------QVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
+.||+|+||.||+|...+ + ..+++|.+..... ...+.+|+.+++.++|||++++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 359999999999999653 3 2578887765443 5678899999999999999999999887 7789999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-------ceEEeecccce
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-------EPKLSDFGLAK 212 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-------~~kl~dfg~~~ 212 (347)
||+++|+|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++ .++++|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999776657899999999999999999999 88999999999999999887 79999999988
Q ss_pred ecCCCccceeecccCCCCccccccccCC--ccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++| ..|+..... ......+ . .....+
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~-~--~~~~~~- 226 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFY-Q--DQHRLP- 226 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHH-h--cCCCCC-
Confidence 6532 2233467789999999876 788999999999999999995 555543221 1111111 1 000000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
. .....+.+++.+||..+|++|||+.+|++.|+
T Consensus 227 ----~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 ----M---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----C---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01167999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.77 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=196.7
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||++... +++.+|+|.+..... ...+.+|+.++++++|++++++++.+.+.+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 455678999999999999954 788999998865321 23467899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++...... .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--c
Confidence 9999999988543 345899999999999999999999 889999999999999999999999999998764322 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh--hHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR--DQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ............
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-------------- 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--------------
Confidence 2233468999999999998899999999999999999999999997532211 111111111100
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
........++.+|+.+||+.||++||| +.|+++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011122356899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.64 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=196.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++... +++.+|+|.+... .....+..|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 35777889999999999999965 5788999988642 22335778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++.+....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999776667899999999999999999999 88999999999999999999999999999876533323
Q ss_pred ceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 220 KVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.......||..|+|||++. ...++.++||||||+++|+|++|+.||...... ..... +....... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~----i~~~~~~~---~~ 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGK----IMNHKERF---QF 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHH----HhCCCccc---cC
Confidence 2333456899999999886 346788999999999999999999999743221 11111 11111100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCC--CCCCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSS--KGRPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p--~~Rps~~ei~~~ 333 (347)
|... .....++.+|+.+|+..++ ..|+++.+++++
T Consensus 230 p~~~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQV----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCcc----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1101 1223568888888775544 447899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=285.35 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=200.1
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|+||.+|++.. .+|+.+++|.+... .....+.+|+..+++++|||++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 466778999999999999994 46889999988643 2234688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|.+++... ...+++..+++++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 9999999988653 345889999999999999999999 7899999999999999999999999999988654221 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||...+..++.++|+||||+++++|++|+.|+...... + .......+..+ .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~----~~~~~~~~~~~-----------~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-N----LVLKIIRGSYP-----------P 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-H----HHHHHhcCCCC-----------C
Confidence 122345788999999999888999999999999999999999998743221 1 11122122111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.....++.+++.+||+.+|++||++.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112234579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=287.56 Aligned_cols=245 Identities=29% Similarity=0.455 Sum_probs=193.8
Q ss_pred eeeecCCeeEEEEEeCC-------CCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 73 FLGRGSAGLVYKGVLPS-------GQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.||+|+||.||+|...+ +..+++|.+.... ....+.+|+..++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998532 2578999886543 3457889999999999999999999999888999999999
Q ss_pred CCCChHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-----ceEEeecccc
Q 040826 143 AAGNLAQHLLRK------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-----EPKLSDFGLA 211 (347)
Q Consensus 143 ~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-----~~kl~dfg~~ 211 (347)
++++|.+++... ...+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999998642 234788999999999999999999 78999999999999999887 8999999998
Q ss_pred eecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 212 KMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 212 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... + ....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~----~~~~~~~~~~~- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-E----VLQHVTAGGRL- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-H----HHHHHhcCCcc-
Confidence 765322111 1122345678999999998899999999999999999998 88888633221 1 11111111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
......+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 233 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1112234678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=287.55 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=199.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|... +...+++|.+...... ..+.+|++++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45677788999999999999953 2457999988665443 56889999999999999999999999888999
Q ss_pred EEEeecCCCChHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 137 LVYEFCAAGNLAQHLLRKD--------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
+||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986433 25899999999999999999999 889999999999999999999999999
Q ss_pred ccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
|.+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~----~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVL----NRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHH----HHHHcCCc
Confidence 9887543222223333456778999999988888999999999999999999 6777753221 1111 11111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.. .........+.+++.+||+.+|.+|||+.++++.|+
T Consensus 237 ~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 EL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 011123357999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=289.64 Aligned_cols=251 Identities=26% Similarity=0.337 Sum_probs=200.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||.|++|.||++... ++..+++|.+..... ...+.+|+.++++++|||++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456777788999999999999964 688999998865432 34688899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++...+..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc-ccc
Confidence 9999999998776667999999999999999999999 889999999999999999999999999988754322 112
Q ss_pred eecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 222 FTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....++..|+|||.+. +..++.++|+||||+++|+|++|+.||...... ..... ...+..+ .+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~--~~~--- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLK----ILKSEPP--TLD--- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHH----HhcCCCC--CcC---
Confidence 23345788999999875 345778999999999999999999998643221 11111 1111111 000
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.....++.+++.+||+.+|.+|||+.++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111233578899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.06 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=196.7
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------ 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 132 (347)
..++|...+.||+|+||.||++... +++.||+|.+.... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578888999999999999999954 68899999986532 234677899999999999999999987543
Q ss_pred CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999976 77776643 3788899999999999999999 8899999999999999999999999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC--------
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM-------- 284 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------- 284 (347)
..... .......++..|+|||++.+..++.++||||||+++|+|++|+.||...... +...........
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHh
Confidence 65321 2223456899999999999999999999999999999999999999753221 111111111100
Q ss_pred ----------CCCCccccc----CCCC----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 285 ----------GKRPIKDFE----DPRL----NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 285 ----------~~~~~~~~~----~~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......... .+.. ..........++.+|+.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 0000 001111223578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.52 Aligned_cols=245 Identities=25% Similarity=0.399 Sum_probs=196.5
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh-----------hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT-----------DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
|.....||+|++|.||+|.. .+++.+++|.+...... ..+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 45667899999999999985 46889999988653211 3577899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++++||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999998654 45888999999999999999999 7899999999999999999999999999988664
Q ss_pred CCcc-----ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 216 MEES-----KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 216 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~---- 228 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFK----IGENA---- 228 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHH----HhccC----
Confidence 2111 1112235788999999999888999999999999999999999999743221 11111 11111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+ ..+....+.+.+++.+||+.+|.+||++.+|++
T Consensus 229 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 ---SP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 111233467999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=286.76 Aligned_cols=245 Identities=30% Similarity=0.433 Sum_probs=199.4
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||.|++|.||+|... +++.+++|.+.... ....+.+|+++++.++|+|++++++++.++...++++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5667788999999999999954 68899999886543 2346788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++++|||++....... ...
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 999999998654 6899999999999999999999 8899999999999999999999999999998764321 222
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . ....+..... +.+...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~----~~~~~~~~~~-------~~~~~~-- 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-R----VLFLIPKNNP-------PSLEGN-- 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-H----HHHHhhhcCC-------CCCccc--
Confidence 3346788899999999888999999999999999999999998643321 1 1111111110 111111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+++.+++.+||..+|++|||++++++
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13357899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.81 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=186.1
Q ss_pred eeeecCCeeEEEEEeCC---CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 73 FLGRGSAGLVYKGVLPS---GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
.||+|+||.||+|...+ ...+++|.+..... ...+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997433 34788887764432 2357889999999999999999999999999999999999999
Q ss_pred hHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc-e
Q 040826 147 LAQHLLRKD----SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-V 221 (347)
Q Consensus 147 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 221 (347)
|.+++.... ...++...+.++.|++.|++||| +.+++||||||+||++++++.++|+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986532 23467788899999999999999 889999999999999999999999999998653222111 1
Q ss_pred eecccCCCCccccccccC-------CccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 222 FTDVRGTIGYMDPEYMTN-------AKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||..... .+.+...... ... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~---~~~---~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVRE---QDI---KLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhhc---cCc---cCC
Confidence 122345678999998742 356789999999999999999 6667653322 1212211111 111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
.+.+. ......+.+++..|| .||++|||+++|++.|.
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12222 223356778888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=283.30 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=203.5
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhc--CCCCcceeeeeEEEeC----CeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSR--VRHPNLVCLFGCCVEG----GEQYL 137 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~l 137 (347)
+..+....+.||+|.||.||+|.| -|+.||||++.. .+++.+.+|.++... |+|+||+.+++.-..+ ...+|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s-rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS-RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc-cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 355666778899999999999999 588999998854 445567777777665 4999999999875433 26799
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI-----DGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
|++|.+.|||.|||.. ..++....++++..+|.||++||... ...|.|||||++|||+..++...|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999955 56899999999999999999999653 4579999999999999999999999999998
Q ss_pred ecCCCcc---ceeecccCCCCccccccccCC----ccC--CcccHHHHHHHHHHHHhC----------CCCcCCChhhhh
Q 040826 213 MLGMEES---KVFTDVRGTIGYMDPEYMTNA----KLT--CASDIYSFGIVALQLLSG----------QKVIELDFDARD 273 (347)
Q Consensus 213 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~----~~~--~~~Dv~slG~il~~lltg----------~~p~~~~~~~~~ 273 (347)
....... ...+..+||.+|||||++... .+. ..+||||||.++||+... +.||..--+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 7653322 224556899999999998642 121 368999999999999753 355543222222
Q ss_pred HHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 274 QLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
+.+.. ++...-. .+....+++ ..+.+.+..+.++|..||..||.-|.|+--|-+.|.++.+
T Consensus 445 s~eeM-rkVVCv~-~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEM-RKVVCVQ-KLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHH-hcceeec-ccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22322 2222211 111122222 3345778899999999999999999999999999999963
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=285.66 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=196.5
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
++|...+.||+|+||.||+|.. .+++.+++|.+..... ...+.+|+.+++.++|||++++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3556667899999999999995 4688999998865432 345778999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++... ..+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 999999988654 35899999999999999999999 789999999999999999999999999998765322 2223
Q ss_pred ecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
....|+..|+|||.+. ...++.++|+||||+++|+|++|..|+......... ...... ... .+....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~----~~~-----~~~~~~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKS----NFQ-----PPKLKD 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhhcc----CCC-----CCcccc
Confidence 3456889999999874 456888999999999999999999998643221111 111110 000 011100
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ....+.+.+++.+||+.+|++|||+.+|++
T Consensus 234 ~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 K--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 012356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=288.33 Aligned_cols=239 Identities=24% Similarity=0.421 Sum_probs=187.0
Q ss_pred CeeeecCCeeEEEEEeCC-C-------CEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 72 RFLGRGSAGLVYKGVLPS-G-------QVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+.||+|+||.||+|.... + ..+++|.+..... .+.+..|..+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 359999999999998532 2 3478887754322 34678899999999999999999999998899999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc--------eEEeeccccee
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE--------PKLSDFGLAKM 213 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~--------~kl~dfg~~~~ 213 (347)
+++|+|.+++......+++..+..++.|++.|+.||| +.+++||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776667899999999999999999999 889999999999999987765 69999998765
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..++........... ... ....
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~----~~~~---- 223 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE----DRHQ---- 223 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH----cccc----
Confidence 432 122457888999999986 4578999999999999999999644332221111111 111 0111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
++.....++.+++.+||+.+|++|||+++|++.|+
T Consensus 224 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 --------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11112256899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=282.77 Aligned_cols=259 Identities=26% Similarity=0.357 Sum_probs=217.5
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
|+...+||+|+||+||++... +|+.+|+|.+.-+.+-+++..|+.+|.++..|++|++||.|.....+++|||||-.|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 344567999999999999954 7999999999989999999999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeeccc
Q 040826 147 LAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226 (347)
Q Consensus 147 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 226 (347)
..|.++....++++.++..+++..+.||+||| ...-+|||||..|||++.+|..||+|||++..+... -...+...
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCccc
Confidence 99999888889999999999999999999999 556799999999999999999999999999876422 22345678
Q ss_pred CCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC-CCCCcccccCCCCCCCCCHHH
Q 040826 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM-GKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 227 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~ 305 (347)
||+.|||||++..-.|+.++||||||++..||..|++|+..-.+. +.+.. .-.+.+.|.. +...
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------RAIFMIPT~PPPTF~K-------PE~W 255 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------RAIFMIPTKPPPTFKK-------PEEW 255 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------ceeEeccCCCCCCCCC-------hHhh
Confidence 999999999999999999999999999999999999998743222 11211 1112222332 3345
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHH-----------HHHHHHhhhhhh
Q 040826 306 FESILKIAVLCVAKSSKGRPTIDVVYEE-----------IDKAWKNTMVEM 345 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rps~~ei~~~-----------l~~~~~~~~~~~ 345 (347)
..++.+++.+||-++|++|.|+.+++++ ++.++++.+-..
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~~A~e~~ 306 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQLMIQDAQEKA 306 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHHHHHHHHHHHH
Confidence 6789999999999999999999999864 566666655443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.78 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=200.0
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+|...+.||.|++|.||+|.. .+|+.|++|.+.... ....+.+|+..++.++|||++++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4577788999999999999984 578999999886533 3456788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++.. ..+++.++..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99999998854 35899999999999999999999 88999999999999999999999999998876532221 12
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ...... .... . ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~---~~~~---~-------~~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATN---GTPE---L-------QNP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc---CCcc---c-------CCc
Confidence 2346788999999999888999999999999999999999999765432221 111111 1100 0 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......+.+++.+||..+|.+|||+.+|++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122356889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.88 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=197.8
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||+|+||.||++... +|..+|+|.+..... ...+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5667788999999999999965 789999998865422 346888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 143 AAGNLAQHLLRK--DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 143 ~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
++++|..++... ...+++..+..++.|++.|+.|||+ +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999888653 2368999999999999999999994 358999999999999999999999999998765321
Q ss_pred eeecccCCCCccccccccCC------ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 221 VFTDVRGTIGYMDPEYMTNA------KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... .......+..+..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~------ 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIVDGDPP------ 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHhhcCCC------
Confidence 12234578899999988543 35789999999999999999999986432211 11111222111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........++.+++.+||+.+|.+||++.+++..
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1122344678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=300.09 Aligned_cols=261 Identities=21% Similarity=0.201 Sum_probs=199.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC---CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
..+|...+.||+|+||.||++... ++..|++|.+... ....+|+.++++++||||+++++++......+++||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 456888999999999999999743 4578999988653 2345899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-c
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-K 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 220 (347)
+.+ +|.+++. ....+++..++.++.|++.||.||| +.|++||||||+|||++.++.++|+|||++........ .
T Consensus 168 ~~~-~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 168 YKC-DLFTYVD-RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred cCC-CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 965 8888883 3456899999999999999999999 88999999999999999999999999999876543222 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCcccc------
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKDF------ 292 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~------ 292 (347)
......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+....+............
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 223456899999999999999999999999999999999999999654321 222222222211111000000
Q ss_pred ---------cCCCCC--CCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 293 ---------EDPRLN--GNI-NRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 293 ---------~~~~l~--~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+... ..+ ......++.+++.+||..||++|||+.|++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000 01123568889999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.61 Aligned_cols=243 Identities=28% Similarity=0.388 Sum_probs=195.8
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
|...+.||+|+||.||+|... ++..||+|.+..... ...+.+|+..+++++|||++++++++...+..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344567999999999999854 678899998864432 3468899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++.. ..+++..+..++.|+++|+.||| +++++|+||+|+||++++++.++++|||++....... ....
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 9999998843 45889999999999999999999 8899999999999999999999999999987654221 1122
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ........ .+. ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~-------~~~----~~~ 223 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFLIPKNS-------PPT----LEG 223 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----HhhhhcCC-------CCC----CCc
Confidence 34578899999999988899999999999999999999999863322111 11111111 111 112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+.+++.+||+.+|++|||+.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23457899999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.51 Aligned_cols=250 Identities=30% Similarity=0.391 Sum_probs=197.6
Q ss_pred cccCCeeeecCCeeEEEEEeCC--CCEEEEEEcccCC------------ChhHHHHHHHHhhc-CCCCcceeeeeEEEeC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLPS--GQVVAIKHIYKSN------------NTDSFSREVEGLSR-VRHPNLVCLFGCCVEG 132 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~------------~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 132 (347)
|...+.||+|+||.||+|.... ++.+++|.+.... ....+.+|+.++.+ ++|||++++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5567789999999999999654 6889999875321 11246678887764 7999999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 133 GEQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
+..+++|||+++++|.+++.. ....+++..++.++.|++.|+.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988743 44568999999999999999999993 3689999999999999999999999999
Q ss_pred cceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......+...
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~- 231 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKIVEAVYE- 231 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHHhhccCC-
Confidence 998754322 3344568899999999998889999999999999999999999986432211 11111111100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
+.. .......+.+++.+||+.||++|||+.|+..++++
T Consensus 232 -----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 -----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000 01123579999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.16 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=202.4
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCC-C-----CcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVR-H-----PNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l 137 (347)
.+|...+.||+|.||+|-+|. ..+++.||||+++.... ..+...|+.+|..++ | -|+|++++++...++.||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 367788999999999999999 56799999999987644 356678999999886 3 389999999999999999
Q ss_pred EEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC--CceEEeecccceec
Q 040826 138 VYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK--LEPKLSDFGLAKML 214 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~--~~~kl~dfg~~~~~ 214 (347)
|+|.+.. +|.++++++ ...++...++.++.|++.||.+|| ..+|||+||||+|||+.+- ..+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999977 999999764 356999999999999999999999 8999999999999999753 47999999999875
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-------C
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK-------R 287 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 287 (347)
... .-....+..|.|||++.|.+|+.+.|+||||||+.||++|.+.|.+. ...+++..+..-..... .
T Consensus 342 ~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~-ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD-NEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC-CHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 322 12556888999999999999999999999999999999997777643 33344444433322110 0
Q ss_pred Cccccc------------------------------------CC-CCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 288 PIKDFE------------------------------------DP-RLN---GNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 288 ~~~~~~------------------------------------~~-~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
....+. .| ... .......-..+.+++.+||..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 000000 01 000 00111223578999999999999999999
Q ss_pred HHHHHH
Q 040826 328 DVVYEE 333 (347)
Q Consensus 328 ~ei~~~ 333 (347)
.+++++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 998863
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.51 Aligned_cols=193 Identities=26% Similarity=0.395 Sum_probs=161.1
Q ss_pred CCeeeecCCeeEEEEEeC---CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEEeecCCC
Q 040826 71 RRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVYEFCAAG 145 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g 145 (347)
..+||+|+||.||+|... ++..+|+|.+........+.+|+.++++++||||+++++++.. +...++++||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 457999999999999954 4578999998776666678899999999999999999998854 5578999999876
Q ss_pred ChHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe----cCCCceEEeeccccee
Q 040826 146 NLAQHLLR--------KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----TEKLEPKLSDFGLAKM 213 (347)
Q Consensus 146 sL~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----~~~~~~kl~dfg~~~~ 213 (347)
+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||++ +.++.++|+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 78777642 1235888999999999999999999 8899999999999999 5667899999999987
Q ss_pred cCCCcc--ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCC
Q 040826 214 LGMEES--KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIEL 267 (347)
Q Consensus 214 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~ 267 (347)
...... .......+|..|+|||.+.+ ..++.++||||||+++|+|+||++||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 543221 12234567899999999876 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.67 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=198.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+|+..++.++|+|++++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566788999999999999965 78999999886533 234688899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998654 35889999999999999999999 8899999999999999999999999999988653222
Q ss_pred cceeecccCCCCccccccccCCc-cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||..... ......... .... +
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~---~~~~-------~-- 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGR---SKEL-------P-- 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHHHHHHh---cccC-------C--
Confidence 233456888999999987766 88999999999999999999999864431 111111111 0110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++....+.+.+++.+||+.+|.+|||+.++++
T Consensus 222 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122357899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=283.32 Aligned_cols=248 Identities=24% Similarity=0.252 Sum_probs=198.9
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.|...+.||+|.-|+||++... ++...|+|++.+..- ......|-++|..+.||-+..+|..++.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4555678999999999999965 468999999976532 2356678899999999999999999999999999999
Q ss_pred ecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC--
Q 040826 141 FCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-- 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 217 (347)
||+||+|..+.++ .+..+++..++-+++.++-||+||| ..||++|||||+||||.++|.+.|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999998864 4578999999999999999999999 899999999999999999999999999887543110
Q ss_pred ------------------------------c-c----------------------ceeecccCCCCccccccccCCccCC
Q 040826 218 ------------------------------E-S----------------------KVFTDVRGTIGYMDPEYMTNAKLTC 244 (347)
Q Consensus 218 ------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 244 (347)
. . ......+||-.|+|||++.|...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0012246899999999999999999
Q ss_pred cccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 245 ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 245 ~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
++|+|+||+++|||+.|.+||.+...... +. .+......... .........+||.+.|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~----NIv~~~l~Fp~----------~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-LR----NIVGQPLKFPE----------EPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh-HH----HHhcCCCcCCC----------CCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999986544322 12 12111111110 11334579999999999999999
Q ss_pred CC----HHHHHH
Q 040826 325 PT----IDVVYE 332 (347)
Q Consensus 325 ps----~~ei~~ 332 (347)
.. +.||-+
T Consensus 380 lg~~rGA~eIK~ 391 (459)
T KOG0610|consen 380 LGSKRGAAEIKR 391 (459)
T ss_pred hccccchHHhhc
Confidence 88 666643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=300.22 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=192.7
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+|...+.||+|+||.||++... +++.||+|.+... .....+.+|..++..++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5777889999999999999954 6899999998642 223467789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
|+++|+|.+++.+. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999998654 45899999999999999999999 88999999999999999999999999999865421100
Q ss_pred ---------------------------------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 220 ---------------------------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 220 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
.......||..|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113468999999999999999999999999999999999999997
Q ss_pred CChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 040826 267 LDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT---IDVVYE 332 (347)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~ei~~ 332 (347)
...... .. ..+....... ..|.. .. ..+++.+++.+++ .||.+|++ +.++++
T Consensus 238 ~~~~~~-~~----~~i~~~~~~~---~~p~~-~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 238 SETPQE-TY----RKVMNWKETL---VFPPE-VP----ISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCHHH-HH----HHHHcCCCce---ecCCC-CC----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 543221 11 1111111000 00000 01 2246788888776 59999986 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.74 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.|...+.||.|+||.||+|... ++..+|+|.+..... ...+.+|+.+++++.|+|++++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3555678999999999999964 688999998865432 346888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++.. ..+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++....... ...
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 99999998854 35889999999999999999999 8899999999999999999999999999987654322 122
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ ......... ....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~-----------~~~~ 222 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPKNNP-----------PTLT 222 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhhhhcCCC-----------CCCc
Confidence 334578899999999888899999999999999999999999864322111 111111111 1233
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......+.+++.+||+.+|.+||++.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3456789999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.58 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=191.2
Q ss_pred CCeeeec--CCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 71 RRFLGRG--SAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 71 ~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++||+| +|++||++.. .+|+.||+|.+..... ...+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3569999 7899999985 5789999999865422 2357789999999999999999999999999999999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-c-
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-K- 220 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~- 220 (347)
+|+|.+++... ...+++..++.++.|++.||.||| +.+++||||||+||+++.++.++++||+.......... .
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999998653 345899999999999999999999 88999999999999999999999999986543221110 0
Q ss_pred ----eeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----CCCcc
Q 040826 221 ----VFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----KRPIK 290 (347)
Q Consensus 221 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 290 (347)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.................... ..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111246678999999875 4688999999999999999999999964322111111100000000 00000
Q ss_pred --------cccC-----------------CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 --------DFED-----------------PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 --------~~~~-----------------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+ ..............+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00001122233467999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.82 Aligned_cols=242 Identities=29% Similarity=0.398 Sum_probs=202.8
Q ss_pred cccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||.|+||-||-+. ..+.+.||||++.-+. ...++..|+..|++++|||++.+-|||..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4455779999999999999 4578899999986543 235788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
|-| |-.|++.-...++-+..+..|+.+.++||+||| +.+.||||||..|||+++.|.|||+|||.+....+
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 976 888888777778999999999999999999999 88999999999999999999999999999987543
Q ss_pred eecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.+.++||+.|||||++. .+.|+-++||||||++..||...++|.... .....+..++.. + .|.+.
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQN----e-------sPtLq 246 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN----E-------SPTLQ 246 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhc----C-------CCCCC
Confidence 34568999999999885 468999999999999999999999887532 222223332222 2 22332
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+..+.+++++..||++-|.+|||.++++++
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34667889999999999999999999998764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=289.85 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
..+|...+.||+|++|.||++.. .+|+.|++|.+.... ....+.+|+.+++.++|+|++++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46778889999999999999995 578999999886533 335678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++.+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 999999998854 34788999999999999999999 78999999999999999999999999999876532221 1
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||......... . .....+... + ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-~---~~~~~~~~~--------~--~~ 237 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y---LIATNGTPE--------L--QN 237 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-e---eeccCCCCC--------C--CC
Confidence 22345788999999999888999999999999999999999999643221110 0 000001000 0 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.01 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=199.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|++|.||+|... +++.|++|.+..... ...+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56778889999999999999965 688999999865322 24567899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+.+ +|.+++......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 986 999988766667899999999999999999999 8899999999999999999999999999987543211 11
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc-------cccc
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI-------KDFE 293 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 293 (347)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......+......+......... ....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346788999998865 56888999999999999999999999755433333333322221110000 0000
Q ss_pred --------CCCCCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 --------DPRLNGNI-NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 --------~~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+.... .......+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.08 Aligned_cols=252 Identities=26% Similarity=0.323 Sum_probs=200.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||++... +|..+++|.+.... ....+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666788999999999999954 68899999876542 235788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++... ..+++.....++.|++.++.|||+ ..+++|+||+|+||++++++.++|+|||++..... ..
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SI 158 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---hc
Confidence 9999999887553 458999999999999999999994 35899999999999999999999999998865421 11
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh------hHHHHHHhhhcCCCCCcccccCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR------DQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...............+
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------- 231 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-------
Confidence 223468999999999988889999999999999999999999997543221 1111122222211111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+ .......++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 011234679999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=296.49 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=194.6
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC-----
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG----- 132 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 132 (347)
...++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3567888899999999999999995 478899999986532 234577899999999999999999887543
Q ss_pred -CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 133 -GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 133 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
...+++++++ +++|.+++. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3568999988 669988774 345899999999999999999999 889999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC--
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-- 288 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 288 (347)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+.............
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 865321 234468999999999877 57889999999999999999999998643221 1111111111000000
Q ss_pred --------------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 --------------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 --------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........+. .......+.+.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.43 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=197.5
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+|++++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 466778899999999999985 468899999886542 234688899999999999999999999989999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~ 219 (347)
+++++|.+++... ...+++..+..++.|++.++.||| +++++|+||+|+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9999999999764 345899999999999999999999 88999999999999998654 5799999999876422
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . .......+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~----~~~~~~~~~~~----------- 219 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-A----LVLKIMSGTFA----------- 219 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-H----HHHHHHhcCCC-----------
Confidence 1222345788999999999888999999999999999999999998643221 1 11111111100
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.........+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011123357999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=281.64 Aligned_cols=261 Identities=26% Similarity=0.328 Sum_probs=198.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|++|.||+|... +|+.|++|++.... ....+.+|+.++++++|+|++++++++......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777889999999999999965 68999999886432 23457889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|..+... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999877776543 345899999999999999999999 78999999999999999999999999999987643221
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC----------CCCCc
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM----------GKRPI 289 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~ 289 (347)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +........... .....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223457889999999876 56788999999999999999999998754322 222111111100 00000
Q ss_pred ccccCCCCCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 290 KDFEDPRLNGNI-----NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 290 ~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+...... .......+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000011110000 0122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.52 Aligned_cols=259 Identities=25% Similarity=0.339 Sum_probs=202.0
Q ss_pred cHHHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-ChhHHHHHHHHhhcC-CCCcceeeeeEEEeC-
Q 040826 57 SKDEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-NTDSFSREVEGLSRV-RHPNLVCLFGCCVEG- 132 (347)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~- 132 (347)
+.+.++.+.++|...+.||+|+||.||++.. .+++.+++|.+.... ....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3455566678899999999999999999995 468899999886543 345677899999998 799999999998753
Q ss_pred ----CeEEEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 133 ----GEQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 133 ----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
+..++|+||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998753 3456899999999999999999999 789999999999999999999999
Q ss_pred eecccceecCCCccceeecccCCCCccccccccCC-----ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh
Q 040826 206 SDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-----KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~ 280 (347)
+|||.+........ ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...... .......
T Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~- 246 (291)
T cd06639 170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP- 246 (291)
T ss_pred eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh-
Confidence 99999876532211 12234578899999987643 3678999999999999999999998743221 1111111
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... ....+ ..+....+.+++.+||+.+|++|||+.++++.
T Consensus 247 ---~~~~--~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 ---RNPP--PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---cCCC--CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 11111 11233579999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=280.04 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=203.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||+|++|.||++... +|+.+++|.+..... ...+.+|+..+.+++|+|++++++++...+..++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5677789999999999999965 589999999876643 567889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++|.+++... ..+++...+.++.|+++|+.||| + .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 999999998654 56899999999999999999999 7 9999999999999999999999999999887642222 1
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..|+...... ........+..... + ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~-------~----~~ 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPP-------P----SL 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCC-------C----CC
Confidence 22345788999999999888999999999999999999999998754310 11111111111111 1 11
Q ss_pred CHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 302 NRA-DFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 302 ~~~-~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
... ..+.+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=279.22 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=185.5
Q ss_pred eeeecCCeeEEEEEeCCC---CEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 73 FLGRGSAGLVYKGVLPSG---QVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
.||+|+||.||++...++ ..+++|.+.... ....+.+|+..++.++|||++++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999974333 346677665432 23578899999999999999999999999889999999999999
Q ss_pred hHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-cee
Q 040826 147 LAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVF 222 (347)
Q Consensus 147 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 222 (347)
|.+++.+. ....+...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998653 234667778899999999999999 78999999999999999999999999998764321111 112
Q ss_pred ecccCCCCccccccccC-------CccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 223 TDVRGTIGYMDPEYMTN-------AKLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....++..|+|||++.. ..++.++||||||+++|+|+++ ..|+.. ....+.+....... .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~------~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH-LSDREVLNHVIKDQ------QVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhhc------ccccCC
Confidence 33457889999998743 2457799999999999999975 455542 22222222222111 111222
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+.+...+ .+.+.+++..|| .+|++|||+++|++.|.
T Consensus 232 ~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3332222 256888999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=283.16 Aligned_cols=263 Identities=24% Similarity=0.281 Sum_probs=198.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+++|...+.||+|+||.||+|.. .+|..+++|.+..... ...+.+|+..++.++|+||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788889999999999999985 4688999999865422 2357789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+. ++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-Q 158 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-C
Confidence 996 5888777655556888899999999999999999 7899999999999999999999999999987643211 1
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC----------C-
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----------P- 288 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~- 288 (347)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......+.+............ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 1223356889999999875 457889999999999999999999997554433333333221110000 0
Q ss_pred cccccCC----CCCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 IKDFEDP----RLNGNI-NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ~~~~~~~----~l~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....... .+.... .......+.+++.+|+..||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 000000 0011357889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.31 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=206.4
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
-|+..+.||+|.|+.|-+++ .-+|+.||||++.+.. ....+.+|+..|+.++|||||++|++......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35556679999999999998 3489999999997753 245788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
-++|+|.||+.++..-+++..+.++++||+.|+.|+| +..++||||||+|+.+- +-|-+||+|||.+-.+. +..
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--PGK 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC--Ccc
Confidence 9999999999888888999999999999999999999 67799999999999865 67889999999988763 455
Q ss_pred eeecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
..+..+|+..|.|||++.|..|+ +++||||||+|||.|+.|+.||+...+. +.+..+. ....
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETLTmIm----DCKY------------ 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETLTMIM----DCKY------------ 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-hhhhhhh----cccc------------
Confidence 66778899999999999998887 6899999999999999999999843222 2222221 1121
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++.....+..+|+..||..||.+|.|.+||..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 334455678999999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=285.27 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=201.6
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||+|... +|+.+++|.+.... ....+.+|+.++++++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3666788999999999999954 78999999986543 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+ +++|.+++......+++..++.++.|+++||.||| +.+++|+||+|+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 89999998766677999999999999999999999 7899999999999999999999999999988764333222
Q ss_pred eecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC----------Ccc
Q 040826 222 FTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----------PIK 290 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 290 (347)
.....++..|+|||.+.+. .++.++||||+|+++++|++|.++|..... ................ ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 3345688999999988654 568899999999999999999777754332 2222222221111000 000
Q ss_pred cccCCCCC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLN----GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....+.-. .....+....+.+++.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00111233789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=280.97 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=192.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-------ChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-------NTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 135 (347)
.+|...+.||+|+||.||++.. .+|..+++|.+.... ....+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3677888999999999999995 468899999886432 12357789999999999999999998875 3578
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++++||+++++|.+++.... .+++...+.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999886543 4889999999999999999999 8899999999999999999999999999987643
Q ss_pred CCc--cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 216 MEE--SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 216 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~~~~~~------- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKIATQPT------- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHHhcCCC-------
Confidence 211 11122345788999999999888999999999999999999999998743211 11111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+. ++....+.+..++ +||..+|++|||+++|++
T Consensus 227 ~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1222234566666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.32 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=199.6
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-hhHHHHHHHHhhcC-CCCcceeeeeEEE-----
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-TDSFSREVEGLSRV-RHPNLVCLFGCCV----- 130 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~----- 130 (347)
+.+..+.++|...+.||+|+||.||++.. .+++.+++|.+..... ...+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 44556678888899999999999999985 4688999998865433 35678899999999 6999999999874
Q ss_pred eCCeEEEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
.++..+++|||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEcc
Confidence 34578999999999999998742 3456889999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCccceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh
Q 040826 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 282 (347)
||++....... .......++..|+|||.+.. ..++.++|+||+|+++|+|++|+.|+...... ..... .
T Consensus 168 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~~~----~ 241 (286)
T cd06638 168 FGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RALFK----I 241 (286)
T ss_pred CCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHHhh----c
Confidence 99988653221 12233468899999998753 45788999999999999999999998643221 11111 1
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..... ....++ ......+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~--~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRNPP--PTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCC--CcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11110 001111 1123469999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.91 Aligned_cols=261 Identities=28% Similarity=0.342 Sum_probs=199.2
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+|++++++++|+||+++++++..++..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5777889999999999999965 68899999886532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++.+..+. .....+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++|+|||.+..........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9986665544 34455899999999999999999999 7899999999999999999999999999988765333223
Q ss_pred eecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC----------CCcc
Q 040826 222 FTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK----------RPIK 290 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 290 (347)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... +.+........... ....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 3345678899999999887 8899999999999999999999988754322 11111111110000 0000
Q ss_pred c--ccCCC----CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 D--FEDPR----LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~--~~~~~----l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. +.... ...........++.+++.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00000 000111123578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.29 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=195.3
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQY 136 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 136 (347)
..++|...+.||+|+||.||++... ++..+++|.+.... ....+..|+.+++.++||||+++++++.. ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3567888899999999999999954 67789999886432 23468899999999999999999998865 35789
Q ss_pred EEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcc----CCCceeCCCCCCCEEecCC---------
Q 040826 137 LVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYI----DGCIVHRDIKLTNILLTEK--------- 200 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----~~~i~H~dl~p~Nili~~~--------- 200 (347)
+||||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.. ..+|+|+||||+|||++.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999998864 2356999999999999999999999531 1469999999999999642
Q ss_pred --------CceEEeecccceecCCCccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChh
Q 040826 201 --------LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFD 270 (347)
Q Consensus 201 --------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~ 270 (347)
+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 34899999999865322 12234568999999999864 4588999999999999999999999974332
Q ss_pred hhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 271 ARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... ....+..... .. . .....++.+|+.+||+.+|.+|||+.+++.
T Consensus 249 ~~q----li~~lk~~p~-lp------i-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQ----LISELKRGPD-LP------I-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHH----HHHHHhcCCC-CC------c-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 2222211110 00 0 012357999999999999999999999984
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.27 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=198.6
Q ss_pred cHHHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-ChhHHHHHHHHhhcC-CCCcceeeeeEEEe--
Q 040826 57 SKDEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-NTDSFSREVEGLSRV-RHPNLVCLFGCCVE-- 131 (347)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-- 131 (347)
+..++....+.|...+.||+|+||.||+|.. .+++.+++|.+.... ....+..|+.+++++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344444566788888999999999999995 468899999886543 345678899999988 69999999998853
Q ss_pred ----CCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 132 ----GGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 132 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
....+++|||+++|+|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999988653 345888889999999999999999 8899999999999999999999999
Q ss_pred ecccceecCCCccceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhh
Q 040826 207 DFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 207 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 281 (347)
|||++....... .......++..|+|||.+. +..++.++|+||||+++|+|++|..||........ ... .
T Consensus 164 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~---~ 238 (282)
T cd06636 164 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LFL---I 238 (282)
T ss_pred eCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hhh---H
Confidence 999987543211 1223345888999999875 34678899999999999999999999864322111 111 0
Q ss_pred hcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..... +. ........++.+++.+||+.||.+|||+.||++
T Consensus 239 ~~~~~--------~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PRNPP--------PK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhCCC--------CC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 00 111123457999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=280.56 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=201.4
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||.|+||.||+|.. .++..+++|.+.... ....+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3677888999999999999995 467899999886533 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRK--DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
+++++|.+++... ...+++..+..++.|++.|+.+|| +.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998653 246899999999999999999999 88999999999999999999999999999876543222
Q ss_pred c---eeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 220 K---VFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 220 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...... ........ ... +
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~----~~~-------~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQ----NDP-------P 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhc----CCC-------C
Confidence 2 12234578899999998776 7889999999999999999999998643222 11111111 111 0
Q ss_pred CCCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNI-NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+.... .......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1233467899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=285.04 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=198.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
+|...+.||+|++|.||+|... +|+.|++|.+..... ...+..|++++++++|+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3566778999999999999954 689999999875432 23467899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+ +++|.+++......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999998765557999999999999999999999 8899999999999999999999999999998764321
Q ss_pred cceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-------Ccc
Q 040826 219 SKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-------PIK 290 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 290 (347)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|.++|....+ .+.............. ...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccc
Confidence 12223346778999998854 4678899999999999999999777754332 1222222211110000 000
Q ss_pred cccCCCCCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNG-----NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......... .........+.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 0112234689999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=279.89 Aligned_cols=250 Identities=28% Similarity=0.367 Sum_probs=199.5
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 139 (347)
+|...+.||.|+||.||++.. .+|..+++|.+.... ....+.+|++.+++++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 356678899999999999984 468899999886432 23457789999999999999999997754 45689999
Q ss_pred eecCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 140 EFCAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYI--DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 140 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998642 467899999999999999999999543 578999999999999999999999999998876
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..... ......++..|+|||.+.+..++.++|+||||+++++|++|..|+.... . .. .......+..+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~-~~---~~~~~~~~~~~------ 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-Q-LQ---LASKIKEGKFR------ 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-H-HH---HHHHHhcCCCC------
Confidence 43221 1233468899999999998889999999999999999999999987543 1 11 11222211110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222334679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.84 Aligned_cols=238 Identities=24% Similarity=0.305 Sum_probs=185.0
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC---CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV---RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
||+|+||.||+|... +|+.||+|.+.... .......|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999954 68999999986432 122344566666555 699999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++... ..+++..+..++.|+++||+||| +.+++||||||+|||++.++.++|+|||++...... ......
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccC
Confidence 9999888654 45899999999999999999999 889999999999999999999999999998753221 222334
Q ss_pred ccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..||..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ...+.+..+..... . ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~---~----~~--- 220 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGKVRFP---K----NV--- 220 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCCCCCC---C----cc---
Confidence 5689999999998754 5889999999999999999999999753221 11222222221111 0 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPT----IDVVYE 332 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps----~~ei~~ 332 (347)
..+++.+++.+||+.||.+||+ +.++++
T Consensus 221 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 -LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 2356889999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=287.59 Aligned_cols=261 Identities=28% Similarity=0.372 Sum_probs=197.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+|+++++.++|||++++++++..+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35677789999999999999965 689999998865432 3467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|.++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 99998887766443 34899999999999999999999 7899999999999999999999999999988654322 2
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC---C-------CCCc
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM---G-------KRPI 289 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~---~-------~~~~ 289 (347)
......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...... +........... . ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2233457889999998875 45778999999999999999999888644321 111111111000 0 0000
Q ss_pred ccccCCCCCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 290 KDFEDPRLNG-----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 290 ~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+.... .........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000010000 001123467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=280.64 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=198.4
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
+|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+|+..+++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366678899999999999984 578999999886533 12468889999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGM 216 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~ 216 (347)
++||+++++|.+++.+. ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999988654 35889999999999999999999 88999999999999998776 599999999876543
Q ss_pred Ccc---ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 217 EES---KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 217 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~------- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFKIASATT------- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHHHhccCC-------
Confidence 211 1122345788999999998888999999999999999999999998643221 11111111110000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.....++.+++.+||+.+|++|||+.++++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01223334467999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=303.04 Aligned_cols=263 Identities=16% Similarity=0.209 Sum_probs=191.3
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-CChhHHHHHHHHhhcCC------CCcceeeeeEEEe
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-NNTDSFSREVEGLSRVR------HPNLVCLFGCCVE 131 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~ 131 (347)
++....++|...+.||+|+||.||+|.. .+++.||||++... ........|+.+++.++ |.+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444567899999999999999999995 46889999998643 22334566777777665 4458888888876
Q ss_pred C-CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCC--------
Q 040826 132 G-GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKL-------- 201 (347)
Q Consensus 132 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~-------- 201 (347)
. ...++|||++ +++|.+++.+. ..+++..+..++.|++.||.||| . .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 66899888654 45899999999999999999999 5 5999999999999998765
Q ss_pred --------ceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh
Q 040826 202 --------EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273 (347)
Q Consensus 202 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~ 273 (347)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... +
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-E 352 (467)
T ss_pred cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-H
Confidence 49999999876421 2233457899999999999999999999999999999999999999753321 2
Q ss_pred HHHHHHhhhcCCC-------------------CCcccccCCC----C-CC--CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 274 QLTRKARDVSMGK-------------------RPIKDFEDPR----L-NG--NINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 274 ~~~~~~~~~~~~~-------------------~~~~~~~~~~----l-~~--~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
.+..+........ .......++. + .. .........+.+|+.+||+.||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 1111111100000 0000000000 0 00 0000112567899999999999999999
Q ss_pred HHHHH
Q 040826 328 DVVYE 332 (347)
Q Consensus 328 ~ei~~ 332 (347)
.|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.41 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=198.9
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCC------e
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGG------E 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~ 134 (347)
.+++|...+.||+|++|.||+|... +++.+++|.+.... ....+.+|+.+++++ .|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4578888999999999999999964 67899999887644 345788999999999 6999999999987644 4
Q ss_pred EEEEEeecCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 135 QYLVYEFCAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.+++|||+++++|.+++... +..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 89999999999999988542 467899999999999999999999 889999999999999999999999999998
Q ss_pred eecCCCccceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
...... ........++..|+|||.+.. ..++.++||||||+++++|++|..||...... ........ ..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~ 234 (275)
T cd06608 161 AQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR----NP 234 (275)
T ss_pred eecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhc----cC
Confidence 765322 222233458889999998753 34678999999999999999999998643221 11111111 11
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. . .+ ........++.+++.+||+.||++|||+.++++
T Consensus 235 ~--~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 P--P-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C--C-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0 01 111234467999999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=280.18 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=195.9
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----C--------hhHHHHHHHHhhcCCCCcceeeeeEEEeCC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----N--------TDSFSREVEGLSRVRHPNLVCLFGCCVEGG 133 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 133 (347)
+|...+.||+|+||.||+|.. .+|+.+|+|.+.... . .+.+.+|+..++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 355678899999999999985 468899999875321 0 124678999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++|+||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998665 46899999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCccc-eeecccCCCCccccccccCCc--cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 214 LGMEESK-VFTDVRGTIGYMDPEYMTNAK--LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 214 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
....... ......++..|+|||.+.+.. ++.++|+||||+++|++++|..|+...... ........... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~---~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFKLGNKRS---A 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHHhhcccc---C
Confidence 4321111 122345788999999987654 788999999999999999999998632211 11111111110 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....+ ........++.+++.+||+.+|++|||+.+|++.
T Consensus 231 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111 1112234679999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=281.49 Aligned_cols=255 Identities=26% Similarity=0.327 Sum_probs=197.9
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 140 (347)
+|...+.||.|++|.||++... +++.+++|.+..... ...+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5677789999999999999964 688999998875433 3468899999999999999999998865 347899999
Q ss_pred ecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|+++++|.+++.. ....++...+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999887643 3456889999999999999999999 889999999999999999999999999998754321
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+......................+ .+.+. .
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~ 232 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP--ELKDE-P 232 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch--hhccC-C
Confidence 1 1234578899999999988999999999999999999999999875422101111111111111100 00000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.+.+++.+||+.+|.+|||+.|+++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 --GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111123467999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=277.92 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=198.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|+||.||+|... +++.+++|.+..... ...+.+|++++++++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4667789999999999999954 788999999875433 35688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999988654 44789999999999999999999 8899999999999999999999999999988764332221
Q ss_pred e---ecccCCCCccccccccCCc---cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 222 F---TDVRGTIGYMDPEYMTNAK---LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 222 ~---~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ....++..|+|||.+.+.. ++.++||||||++++++++|+.||............ ...+..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~------- 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH----VGAGHKP------- 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH----HhcCCCC-------
Confidence 1 1345788999999998765 889999999999999999999998643221111111 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+... ......+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 112356889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=281.71 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=203.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
..+.|...+.||+|++|.||++... ++..+++|.+..... ...+.+|++.++.++|+|++++++.+...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3556777788999999999999976 688999999876543 55788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SK 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hh
Confidence 9999999999765557999999999999999999999 8999999999999999999999999999877543221 11
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..|+....... ....... ..... ...
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~---~~~~~---~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITT---KGIPP---LKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh---cCCCC---Ccc-------
Confidence 223457889999999988889999999999999999999999986432221 1111111 11100 000
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.+++.+||+.+|.+|||+.+|++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113357999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.30 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=197.0
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
|...+.||+|+||.||+|.. .++..+|+|.+..... ...+.+|+..+++++|||++++++++..++..++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 45567899999999999985 4688999998764332 3468889999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++.. ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||++....... ....
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 9999998853 35899999999999999999999 8899999999999999999999999999987654221 1122
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+...... ... ..+..... +.+ ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~----~~~~~~~~-------~~~----~~ 223 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVL----FLIPKNNP-------PTL----EG 223 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHH----HHHhcCCC-------CCC----Cc
Confidence 345788999999998888899999999999999999999998643211 111 11111111 111 12
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....++.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233578999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=286.85 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=198.6
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+|...+.||+|++|.||+|... +++.+++|.+..... ...+..|++.++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777788999999999999965 589999999876432 2457889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|+.+++|.+++... ...+++.....++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999988653 356899999999999999999999 88999999999999999999999999998875432111
Q ss_pred c----------------------------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh
Q 040826 220 K----------------------------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA 271 (347)
Q Consensus 220 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~ 271 (347)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788899999999888999999999999999999999998744322
Q ss_pred hhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 040826 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT----IDVVYE 332 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps----~~ei~~ 332 (347)
..+.... ....... ........+.+++.+||+.||++||| +++++.
T Consensus 239 -~~~~~~~----~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 -ETFSNIL----KKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -HHHHHHh----cCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111111 1111110 01113468999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.54 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=195.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
..|...+.||+|+||.||+|... +|+.|++|.+..... ...+.+|+.+++.++|||++++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34667788999999999999954 689999998864321 235788999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++ ++.+.+......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99975 888877655567999999999999999999999 889999999999999999999999999998764321
Q ss_pred ceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
....++..|+|||.+. ...++.++||||||+++|+|++|+.|+.......... .......+ .
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~-------~ 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNDSP-------T 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-----HHhcCCCC-------C
Confidence 2345788999999874 3568889999999999999999999986433221111 11111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+ ........+.+++.+||+.+|++|||+.+|+..
T Consensus 234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 112244679999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.83 Aligned_cols=243 Identities=27% Similarity=0.471 Sum_probs=200.3
Q ss_pred CeeeecCCeeEEEEEeC--CCC--EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP--SGQ--VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++||+|.||.|++|.|. +|+ .||||.+..... ..+|.+|+.+|.+|+|+|++++||+..+ ....+|||.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 57999999999999975 455 589999987643 4689999999999999999999999887 678899999999
Q ss_pred CChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-cee
Q 040826 145 GNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVF 222 (347)
Q Consensus 145 gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 222 (347)
|+|.+.|.. ....|.......++.|||.|++||. .+++|||||...|+++-....+||+|||+.+.++.... ..+
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999987 5567888899999999999999999 88999999999999999999999999999998764322 222
Q ss_pred -ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 223 -TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 223 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
....-+..|+|||.+....++.++|||+|||++|||+|+ ..|+.+- ...+ +.+.+..++ +-.
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~q----IL~~iD~~e-----------rLp 335 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQ----ILKNIDAGE-----------RLP 335 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHH----HHHhccccc-----------cCC
Confidence 334567899999999999999999999999999999985 5565432 1111 222222111 123
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
-++.|.+++++++..||.++|.+|||+..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 4557889999999999999999999999998544
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=282.85 Aligned_cols=242 Identities=26% Similarity=0.291 Sum_probs=198.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|++|.||++... +++.+++|.+... .....+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777889999999999999954 6899999988653 23356888999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998654 46899999999999999999999 789999999999999999999999999998875432
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . .......+..+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~~~--------- 218 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-Q----IYEKILEGKVRFP--------- 218 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHhcCCccCC---------
Confidence 23345888999999998888899999999999999999999998744311 1 1111112221111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
......+.+++.+||+.||.+|| +++++++
T Consensus 219 ---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 ---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11235789999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=274.38 Aligned_cols=246 Identities=30% Similarity=0.438 Sum_probs=202.0
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
|...+.||+|++|.||++... ++..+++|++.... ....+.+|++.++.++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 566788999999999999965 68899999997765 456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++......+++..+..++.|+++|+.+|| ..+++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 9999998765567899999999999999999999 88999999999999999999999999999887643221 334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..++..|+|||.+.+..++.++|+||||+++++|++|+.|+........ ...... .. ...... . ..
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---~~---~~~~~~-----~--~~ 222 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIAT---NG---PPGLRN-----P--EK 222 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh---cC---CCCcCc-----c--cc
Confidence 5688899999999888889999999999999999999999874322111 111111 00 000100 0 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1357999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=281.70 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=191.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHH-hhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEG-LSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||++... +|+.||+|.+..... ...+..|+.. ++..+|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 35777888999999999999964 689999998875432 2345556664 566789999999999999999999999
Q ss_pred ecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 141 FCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 141 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
|+++ +|.+++.. ....+++..++.++.|++.||.||| ++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9975 88887743 3356899999999999999999999 65 899999999999999999999999999876532
Q ss_pred CccceeecccCCCCccccccccC----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTN----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......+.+...... ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~----- 225 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----PS----- 225 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----CC-----
Confidence 1 11223457889999998864 456889999999999999999999986432222222222111 10
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.+. ....++++.+++.+||+.+|.+|||+.++++
T Consensus 226 --~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 --PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0113357999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=279.23 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=198.0
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|+||.||++... +|..+++|.+... .....+.+|+.+++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3566788999999999999964 5889999988653 3445678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc-eEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE-PKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~ 219 (347)
+++++|.+++... ...+++..+..++.|+++|+.||| +.+++|+||+|+||++++++. ++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 9999999988653 345899999999999999999999 789999999999999998864 6999999887654221
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......++..|+|||...+..++.++|+||||+++++|++|..|+...... +.... ...+...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~----------- 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-QLVLK----ICQGYFA----------- 220 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH----HhcccCC-----------
Confidence 1222345888999999998888999999999999999999999998643322 11111 1111100
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.........+.+++.+||+.+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111223579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=282.39 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=198.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 138 (347)
++|...+.||.|+||.||+|... +++.+++|.+..... ...+.+|+..+++++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777788999999999999965 688999999865432 22467899999999999999999998877 889999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+||+++ +|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999986 999988765567999999999999999999999 7899999999999999999999999999988764321
Q ss_pred cceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC-------------
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM------------- 284 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~------------- 284 (347)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... +...........
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhccc
Confidence 222334578899999988754 4688999999999999999999998754322 111111111000
Q ss_pred -CC-CCcccccCCCCCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 285 -GK-RPIKDFEDPRLNGNINRA-DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 285 -~~-~~~~~~~~~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ..........+...++.. ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000000111111111111 3467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=284.93 Aligned_cols=253 Identities=24% Similarity=0.256 Sum_probs=198.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||++... +++.|++|.+.... ....+.+|+.+++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 35777889999999999999954 67899999886542 2345778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999998654 45899999999999999999999 78999999999999999999999999998864211100
Q ss_pred --------------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 220 --------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 220 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~----~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-E----LFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHhc
Confidence 0011234678899999998888999999999999999999999998643221 1 11111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
... .+.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~~~-----~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE-----WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC-----CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 011111 233568999999999999999998777777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.78 Aligned_cols=244 Identities=28% Similarity=0.458 Sum_probs=195.8
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 140 (347)
|...+.||+|+||.||+|.. .+++.+++|.+.... ....+.+|+.++++++ |||++++++++..+...+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 55667899999999999995 578999999886532 2346778999999986 9999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|.+++... .+++..++.++.|++.|+.||| +.+++|+||+|+||++++++.++++|||.+....... .
T Consensus 83 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 83 YAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred cCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 99999999988543 6899999999999999999999 8899999999999999999999999999998765332 2
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ....... ..+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~~~~~-------~~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKS-------KPPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhccccC-------CCCCCCc
Confidence 2233468889999998865 4578899999999999999999999864322111 1111000 1111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ....++.+++.+||+.||++||++.++++
T Consensus 225 ~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 N---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 13357999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.29 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=194.1
Q ss_pred cccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC------
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG------ 133 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 133 (347)
|...+.||+|+||.||+|... ++..+|+|.+..... .+.+.+|++.+++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999843 468899998875432 345788999999999999999999876532
Q ss_pred eEEEEEeecCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRK-----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
..++++||+++|+|.+++... ...+++.....++.|++.|++||| +.+++|+||||+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887421 235788999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 209 GLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 209 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
|.+......... ......++..|++||...+..++.++||||||+++|+|++ |..||..... .. .. .....+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~-~~---~~~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SE-IY---NYLIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HH-HH---HHHHcCC
Confidence 998865322211 1222345678999999988889999999999999999999 7787764322 11 11 1111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.. .........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00112335799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.60 Aligned_cols=269 Identities=28% Similarity=0.396 Sum_probs=216.7
Q ss_pred CCeeeecCCeeEEEEE-eCCCCEEEEEEccc---CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCC------eEEEEEe
Q 040826 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYK---SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG------EQYLVYE 140 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e 140 (347)
.+.||+|+||.||+|+ ..+|+.||||.... ....+.+.+|+++|++++|+|||++++.-++.. ...++||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3569999999999999 56899999999987 345678899999999999999999999865533 5689999
Q ss_pred ecCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--CCCc--eEEeecccceec
Q 040826 141 FCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLE--PKLSDFGLAKML 214 (347)
Q Consensus 141 ~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~~--~kl~dfg~~~~~ 214 (347)
||.||+|...+.+ +..-+++.+.+.++.+++.||.||| .+||+||||||.||++- ++|+ -||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999999975 3355999999999999999999999 89999999999999984 3343 699999999987
Q ss_pred CCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
. +.....+.+||..|++||.+.. ..|+..+|.|||||++|+..||..||.+..................+..+....
T Consensus 175 ~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 175 D--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred C--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 5 3447788999999999999984 889999999999999999999999998654443333333333333332233333
Q ss_pred CCCCCC------------CCCHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHhhhhh
Q 040826 294 DPRLNG------------NINRADFESILKIAVLCVAKSSKGRP--TIDVVYEEIDKAWKNTMVE 344 (347)
Q Consensus 294 ~~~l~~------------~~~~~~~~~l~~l~~~cl~~~p~~Rp--s~~ei~~~l~~~~~~~~~~ 344 (347)
.+..++ ...+.....+.+.+..+|..+|.+|- .+.+....+.++++...+.
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvh 317 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVH 317 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeE
Confidence 333322 22345567888888889999999998 9999999999999876653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=281.88 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=195.9
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||.|++|.||+|... +|+.|++|.+..... ...+.+|++.+++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3667788999999999999854 689999998864322 24688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+. ++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 96 4898888543 456899999999999999999999 7899999999999999999999999999987653221 1
Q ss_pred eeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-----------
Q 040826 221 VFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP----------- 288 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 288 (347)
......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||....... ...............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 12223467889999988764 46889999999999999999999987543322 222222111111000
Q ss_pred ---cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 ---IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ---~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........+ .........++.+++.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 0001122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=283.54 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=194.2
Q ss_pred CCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 71 RRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
...||+|+||.||++... ++..|++|.+.... ....+.+|+..++.++|+|++++++.+...+..+++|||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999854 68899999885433 234678999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccC
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG 227 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 227 (347)
.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++...... ........+
T Consensus 107 ~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~ 180 (292)
T cd06658 107 TDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKSLVG 180 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-cccCceeec
Confidence 998743 35889999999999999999999 789999999999999999999999999998754321 122233457
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .......... . +... .......
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~-~----------~~~~--~~~~~~~ 246 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRRIRDNL-P----------PRVK--DSHKVSS 246 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcC-C----------Cccc--cccccCH
Confidence 88999999998888999999999999999999999998743221 1111111110 0 0000 0112235
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 308 SILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.+++.+||..||.+|||++++++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 78899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.00 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=199.2
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC----
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG---- 133 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 133 (347)
...++|...+.||+|+||.||+|... +|+.|++|.+..... ...+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45677888899999999999999965 688999999865422 245778999999999999999999887654
Q ss_pred ------eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 134 ------EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 134 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
..++++||+++ ++.+.+......+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999987 787877665567999999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
||.+...............++..|+|||.+.+ ..++.++||||||+++++|++|++||..... ...+...........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence 99988654332222223345778999998864 4578899999999999999999999875432 222222222111110
Q ss_pred C-Cccccc--------CC------CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 R-PIKDFE--------DP------RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~-~~~~~~--------~~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ..+... ++ ..... .......+.+++.+||+.+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000000 00 00000 0012467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=281.53 Aligned_cols=243 Identities=28% Similarity=0.369 Sum_probs=194.4
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||++.. .+|..+++|.+..... ...+.+|++.+++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55567899999999999995 4688999998864321 23578899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+.+ +|.+.+......+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 975 888887665667899999999999999999999 88999999999999999999999999998875432
Q ss_pred eecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....++..|+|||.+. +..++.++|+||||+++|+|++|+.||...... ......... +...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~---~~~~---------- 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN---ESPT---------- 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhc---cCCC----------
Confidence 22345788999999874 456888999999999999999999998643211 111111111 1100
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.........+.+++.+||+.+|.+||++.++++..
T Consensus 244 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 -LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00112335789999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.64 Aligned_cols=247 Identities=23% Similarity=0.275 Sum_probs=193.9
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---C----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---N----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 135 (347)
.+|...+.||+|+||.||.+.. .+|..|++|.+.... . ...+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4677788999999999999995 468999999875321 1 23577899999999999999999988663 467
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++++||+++++|.+++... ..+++....+++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999988654 34788999999999999999999 8899999999999999999999999999987643
Q ss_pred CCcc--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 216 MEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 216 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . ...+......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~---~~~~~~~~~~------- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-A---AIFKIATQPT------- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-H---HHHHHhcCCC-------
Confidence 2111 1122345788999999998888999999999999999999999998743211 1 1111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ...+......+.+++.+|| .+|.+||++++|++
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 0 1223344467888888898 49999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=279.58 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=195.9
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 33446899999999999995 478899999875432 234578899999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+...... ......
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-~~~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-Cccccc
Confidence 999998865 45899999999999999999999 889999999999999999999999999987754322 112233
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..++..|+|||...+..++.++|+||||+++|+|++|+.||...... ...........+ .... ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~~~~~-------~~~~--~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRDNLPP-------KLKN--LHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHhcCCC-------CCcc--ccc
Confidence 45888999999998888999999999999999999999998643221 111111111110 0000 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2357999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=282.71 Aligned_cols=263 Identities=28% Similarity=0.378 Sum_probs=197.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 137 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 456788889999999999999954 689999998864322 22466899999999999999999998754 56899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+.+ +|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999976 898888765567999999999999999999999 889999999999999999999999999999876432
Q ss_pred ccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc-------
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI------- 289 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 289 (347)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ..+..............
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhhhcc
Confidence 2 12223345778999998865 56789999999999999999999999754322 22222221111000000
Q ss_pred ---ccccC--CCCCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 290 ---KDFED--PRLNG--NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 290 ---~~~~~--~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+.. ..+.. ........++.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000 0001124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=272.30 Aligned_cols=247 Identities=30% Similarity=0.393 Sum_probs=202.2
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 140 (347)
|...+.||+|++|.||+|... ++..+++|.+..... .+.+.+|+..+++++|+|++++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 566788999999999999965 788999999876543 55788999999999999999999999888 89999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++++|.+++.+.. .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999987654 7899999999999999999999 789999999999999999999999999998876533221
Q ss_pred -eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 -VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......++..|+|||...+..++.++|+||||+++++|++|..||.......... ........ . .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-~---------~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL----YKIGSSGE-P---------P 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----HhccccCC-C---------c
Confidence 1234568889999999988889999999999999999999999987543111111 11111000 0 0
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++......+.+++.+|++.+|++||++.+++.
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122223468999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=281.65 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=194.5
Q ss_pred CCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 71 RRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
...||+|+||.||++... +++.|++|.+.... ....+.+|+..++.++|||++++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 356999999999999854 68999999986432 345688899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccC
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG 227 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 227 (347)
.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ........+
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~ 179 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVG 179 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-cccccceec
Confidence 987743 45889999999999999999999 889999999999999999999999999998754322 112233458
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
+..|+|||.+.+..++.++|+||||+++++|++|+.||...... ..+.. ........ .. .......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~----~~~~~~~~--~~-------~~~~~~~ 245 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKR----LRDSPPPK--LK-------NAHKISP 245 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH----HhccCCCC--cc-------ccCCCCH
Confidence 89999999999888999999999999999999999998743221 11111 11111000 00 0112235
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 308 SILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.+++.+||+.+|.+|||+.++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 68899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.51 Aligned_cols=261 Identities=18% Similarity=0.198 Sum_probs=193.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCe-----
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGE----- 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 134 (347)
++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++ |||++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35777889999999999999954 68999999876532 2346788999999995 6999999999887655
Q ss_pred EEEEEeecCCCChHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecc
Q 040826 135 QYLVYEFCAAGNLAQHLLRK----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFG 209 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg 209 (347)
.+++|||+++ +|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 888887542 345899999999999999999999 889999999999999998 8899999999
Q ss_pred cceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR- 287 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 287 (347)
.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ............
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHhCCCChh
Confidence 9886532211 1122346788999998865 46789999999999999999999998754332221 111111110000
Q ss_pred Cccccc-------CCCC----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKDFE-------DPRL----NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~~~-------~~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...... .+.. .....+....++.+++.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 00011223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.38 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred CeeeecCCeeEEEEEeCC-CCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
..||-|+||.||++..++ +-..|-|.+.... .-++|.-|+++|..+.||+|+++++.|...+.++++.|||.||-+.
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 459999999999999764 4445667765433 3468999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCC
Q 040826 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 228 (347)
..+..-+..+.+.++.-+++|++.||.||| +++|+|||||..|||++-+|.++|+|||++.... ........+.||
T Consensus 118 aimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRDsFIGT 193 (1187)
T KOG0579|consen 118 AIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRDSFIGT 193 (1187)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch-hHHhhhccccCC
Confidence 988887888999999999999999999999 8999999999999999999999999999987643 222335567899
Q ss_pred CCccccccc-----cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 229 IGYMDPEYM-----TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 229 ~~y~aPE~~-----~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
+.|||||++ ...+|+.++||||||++|.+|..+.+|...-.+. ....+.....++ .++.| .
T Consensus 194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKiaKSePP---TLlqP-------S 259 (1187)
T KOG0579|consen 194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPP---TLLQP-------S 259 (1187)
T ss_pred cccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHhhcCCC---cccCc-------c
Confidence 999999977 3568999999999999999999999887522211 112222222221 12222 2
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....+.+++.+||.+||..||++.+++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 444678899999999999999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=267.41 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=199.7
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhH---HHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDS---FSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
..||.|..|+||++.. .+|..+|||.+....+.++ +...+.++...+ +|+||+.+|+|..+...++.||.|.. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 4589999999999995 4689999999988766554 555666665555 89999999999999999999999965 6
Q ss_pred hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeeccc
Q 040826 147 LAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226 (347)
Q Consensus 147 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 226 (347)
+..++.....++++..+-++...+..||.||.. .++++|||+||+|||+|+.|++|+||||.+..+- ++...+...
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSkAhtrsA 252 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKAHTRSA 252 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee--ccccccccc
Confidence 777776666779999999999999999999987 5699999999999999999999999999998763 455556677
Q ss_pred CCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 227 GTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 227 ~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
|.+.|||||.+.- ..|+..+||||||++++||.||+.||.....+-+.+..+..+.. |.|.+..
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-----------P~L~~~~-- 319 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-----------PLLPGHM-- 319 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-----------CCCCccc--
Confidence 9999999998863 46889999999999999999999999875555555555544321 2222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....+.+++..||++|+.+||...+++++
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 144579999999999999999999998764
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.57 Aligned_cols=260 Identities=26% Similarity=0.327 Sum_probs=198.5
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 140 (347)
|...+.||.|++|.||+|... +|+.+++|.+.... ....+.+|+++++.++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345678999999999999965 58899999997653 234678899999999999999999999887 79999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++ +|.+++......+++..++.++.|+++|+.||| +.+++|+||+|+||++++++.++++|||.+.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9986 899888766567999999999999999999999 789999999999999999999999999999876543322
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-CcccccC----
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIKDFED---- 294 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---- 294 (347)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ................ ......+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhh
Confidence 2333456788999997765 4678999999999999999999999875432 2222222211110000 0000000
Q ss_pred ----------CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 ----------PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ----------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.......+...+.+++.+||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000011112567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=278.02 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=199.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+|...+.||.|+||.||+|... ++..+++|.+.... ....+.+|++.+++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4667788999999999999965 68999999886532 34578899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+.+++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998655 56899999999999999999999 7899999999999999999999999999988654321
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||.+.+..++.++|+||||+++|+|++|..|+...... .............. .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~------------~ 220 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADV------------L 220 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccccc------------c
Confidence 223456788999999998888999999999999999999999998754321 11111111111111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTI--DVVY 331 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~--~ei~ 331 (347)
.+......+.+++.+||+.||.+||++ .|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112233679999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.43 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=206.3
Q ss_pred CCeeeecCCeeEEEEE-eCCCC----EEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGV-LPSGQ----VVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..+||+|+||+||+|. .+.|+ +||+|++..... ..++..|...|.++.|||++++++++.... ..||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 4679999999999999 45554 688998876433 467999999999999999999999998765 88999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc-e
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-V 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 221 (347)
+.|+|.|+++.+...+.....+.|..|||+||.||| .+.++||||..+|||+..-..+|++|||+++....+... .
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999988888999999999999999999999 899999999999999999999999999999987543222 2
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....-++.|||=|.+....|+.++|||||||++||++| |..|+.. ...++ +... +..+++ -.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~e-I~dl---le~geR-----------Ls 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEE-IPDL---LEKGER-----------LS 920 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHH-hhHH---Hhcccc-----------CC
Confidence 233345778999999999999999999999999999998 6666653 22211 1111 111211 13
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.++.+.-+++.++.+||..|++.||+++++...+..+.++.
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 34456678999999999999999999999999999887653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=273.03 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=190.4
Q ss_pred HHHhcCcccCCee--eecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 62 ENAINNDWDRRFL--GRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 62 ~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
....++|...+.+ |+|+||.||++.. .++..+++|.+....... .|......+ +|||++++++.+...+..++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 3345566666666 9999999999995 468889999886542221 122222222 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGM 216 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~ 216 (347)
||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++++|||.+.....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999986554 7899999999999999999999 78999999999999999998 999999999876532
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......-....+.... ....
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--------- 227 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL--------- 227 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC---------
Confidence 2 223578899999999988899999999999999999999999974432221222222221 1110
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPT-IDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~ei~~ 332 (347)
.........+.+++.+||+.+|.+||+ ++++++
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 ---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011133457999999999999999996 688874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.61 Aligned_cols=246 Identities=29% Similarity=0.403 Sum_probs=201.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||++... ++..+++|.+.... ....+.+|++.++.++|||++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4666788999999999999964 68899999987543 335688899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 142 CAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 142 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+++++|.+++... +..+++..+..++.|++.|+.+|| +.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998654 467999999999999999999999 7899999999999999999999999999988764322
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......++..|+|||...+..++.++|+||+|+++++|++|..|+..... ............+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~---------- 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYP---------- 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCC----------
Confidence 223334678899999999888899999999999999999999999864321 1111111111110
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+......+.+++.+||..+|++|||+.++++
T Consensus 222 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 -PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111123357899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.53 Aligned_cols=250 Identities=27% Similarity=0.359 Sum_probs=192.1
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||+|+||.||++.. .+|+.+|+|.+..... ...+.+|+..+.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 34456799999999999995 4689999998875432 346788999999996 999999999999888999999998
Q ss_pred CCCChHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 143 AAGNLAQHLL----RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 143 ~~gsL~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
.. ++.++.. .....+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 161 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS- 161 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC-
Confidence 75 6655432 233568999999999999999999994 358999999999999999999999999998764322
Q ss_pred cceeecccCCCCccccccccCC---ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNA---KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .........+.. +
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~-------~ 229 (288)
T cd06616 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVKGDP-------P 229 (288)
T ss_pred -CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcCCCC-------C
Confidence 112233578899999998765 6889999999999999999999998643211 111111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+..........++.+|+.+||+.+|.+|||+.+|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112344679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=276.93 Aligned_cols=257 Identities=23% Similarity=0.255 Sum_probs=192.5
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCC-CCcceeeeeEEEeC--CeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVR-HPNLVCLFGCCVEG--GEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 140 (347)
|...+.||+|+||.||+|.. .+++.+|+|.+.... ......+|+..++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 34567899999999999995 468899999886532 2224457888888885 99999999999887 88999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++ +|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 9975 888888765567899999999999999999999 789999999999999999 999999999998653221
Q ss_pred eeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC---------Ccc
Q 040826 221 VFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR---------PIK 290 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 290 (347)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||....... .............. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhcccccc
Confidence 122345788999999764 4567889999999999999999999996543211 11111111000000 000
Q ss_pred cccCCCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+..+...+ .........+.+++.+||+++|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111111000 011233578999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=277.73 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=200.5
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||+|++|.||++... +|+.+++|.+..... ...+.+|++.+++++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999964 788999998865432 346788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++ +|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 86 898888766567999999999999999999999 8899999999999999999999999999988765332 122
Q ss_pred ecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-cccccC------
Q 040826 223 TDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IKDFED------ 294 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------ 294 (347)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+.+............. ...+.+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334578889999998876 788999999999999999999998865432 22222222211111000 000000
Q ss_pred ---CCCC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 ---PRLN----GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ---~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+... .........++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0112234578999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.19 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||.|++|.||+|... +|..|++|++.... ....+.+|++.+++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 445678999999999999954 78999999886542 2246788999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+ ++|.+++.... ..+++..++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cc
Confidence 6 59999886543 46899999999999999999999 7899999999999999999999999999987653221 11
Q ss_pred eecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-------------
Q 040826 222 FTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR------------- 287 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 287 (347)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ .....+.......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2223468899999988654 578899999999999999999999875433221 1111111100000
Q ss_pred -CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 -PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 -~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.. ..........+.+++.+||+.+|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0111122357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.80 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=200.9
Q ss_pred eeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
.||+|.||+||.|+.. +...+|||-+.... ..+-+..|+.+.++++|.|||+++|.+..++.+-+.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999954 56689999987543 34567889999999999999999999999999999999999999999
Q ss_pred HhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCccceeeccc
Q 040826 150 HLLRKDSVL--TWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEESKVFTDVR 226 (347)
Q Consensus 150 ~l~~~~~~~--~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~ 226 (347)
++..+=+++ ++...--+.+||++||.||| .+.|+|||||.+|+||+. .|.+||+|||.++.+. .-...+..+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccccc
Confidence 998765566 77888889999999999999 889999999999999974 7899999999988764 3345566788
Q ss_pred CCCCccccccccCC--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 227 GTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 227 ~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
||..|||||++..+ .|..++|||||||++.||.||++||.--.. .+.....-++.. .. .+++.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMFkVGmyK--------vH----P~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMFKVGMYK--------VH----PPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhhhhccee--------cC----CCCcHH
Confidence 99999999999754 689999999999999999999999963211 111111111111 11 256778
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..++...++.+|+.+||.+||++.+++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8889999999999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.21 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=199.1
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+|...+.||+|+||.||++.. .++..+++|.+.... ..+.+.+|+..++.++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5677788999999999999985 468899999885432 3456888999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++.+. .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 999999988543 4788999999999999999999 88999999999999999999999999998876542221 22
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++|+||||+++|++++|+.||........ ... ......+ .. ...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~----~~~~~~~-------~~--~~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IATNGTP-------EL--QNP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee----hhcCCCC-------CC--CCc
Confidence 334578899999999888899999999999999999999999974322111 110 0001100 00 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......+.+++.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1233578899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=284.12 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=194.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccC-CC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS-NN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 140 (347)
..|...++||+||.+.||++...+.+.+|+|++... .+ ...|.+|+..|.+++ |.+|+.++++-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 456677889999999999999888888888877542 22 346999999999995 9999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|-+. +|...|.+.....+.-.+..+..|+++++.++| ..||||.||||.|+|+-+ |.+||+|||.|.....+...
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 9876 999999876655554478889999999999999 889999999999999885 59999999999877544332
Q ss_pred -eeecccCCCCccccccccCC-----------ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC
Q 040826 221 -VFTDVRGTIGYMDPEYMTNA-----------KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP 288 (347)
Q Consensus 221 -~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 288 (347)
.....+||..||+||.+... +.+.++||||||||||+|+.|++||..-... ......+....
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----~aKl~aI~~P~-- 589 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----IAKLHAITDPN-- 589 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----HHHHHhhcCCC--
Confidence 24557899999999988432 2668999999999999999999999732211 11111222111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++..|..... .++.++|+.||+.||.+|||+.|+++
T Consensus 590 -~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 590 -HEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -ccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11122222111 23999999999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=284.87 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=197.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------ 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 132 (347)
..++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457788889999999999999995 478999999986432 234577899999999999999999987643
Q ss_pred CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
...++|+||+.+ +|.+.+... ++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999976 888877432 888999999999999999999 7899999999999999999999999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC--------
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM-------- 284 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------- 284 (347)
..... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .............
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHH
Confidence 75422 112334578899999999999999999999999999999999999864321 1111111111000
Q ss_pred ----------CC-----CCccccc----CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 285 ----------GK-----RPIKDFE----DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 285 ----------~~-----~~~~~~~----~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. .+..... .+...........+.+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000 0000111112335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=276.40 Aligned_cols=241 Identities=22% Similarity=0.261 Sum_probs=190.8
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||++... +|+.+++|.+.... ....+..|+.+++.++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886432 233567899999999999999999999999999999999999999
Q ss_pred HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeeccc
Q 040826 148 AQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226 (347)
Q Consensus 148 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 226 (347)
.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99986543 46899999999999999999999 88999999999999999999999999998876432 22223345
Q ss_pred CCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHH
Q 040826 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADF 306 (347)
Q Consensus 227 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 306 (347)
++..|+|||.+.+..++.++|+||||+++++|++|+.||........ ............. ..+....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~------------~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLEMAV------------EYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccccccc------------cCCccCC
Confidence 78899999999888899999999999999999999999865432111 1111111111110 1111224
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 307 ESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 307 ~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 5789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=276.31 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=197.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+|...+.||.|++|.||+|... +|..|++|.+.... ....+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4667789999999999999964 68899999886542 2346778999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 143 AAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 143 ~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
++ +|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++...... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC-cc
Confidence 86 8988886543 56899999999999999999999 789999999999999999999999999998754322 11
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cc------ccc
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PI------KDF 292 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~ 292 (347)
......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...... +.............. .. ..+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 2223456889999998865 45788999999999999999999998754322 222221111100000 00 000
Q ss_pred c--CCCC----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 E--DPRL----NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 ~--~~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. .+.. ...+.......+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000 00111123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=278.81 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=193.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|++|.||+|... +++.||+|.+..... ...+..|+..+.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 355677789999999999999976 489999999875432 234666777666665 999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+.+ +|.+++......+++..+..++.|++.|++|||+ ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 99865 7877776655678999999999999999999994 2589999999999999999999999999987653221
Q ss_pred ceeecccCCCCccccccccCCc----cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAK----LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.......+.+...... ..+. ...
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~--~~~- 241 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE----EPPS--LPP- 241 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC----CCCC--CCC-
Confidence 122335778999999987543 7889999999999999999999986432222222222111 1110 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....+++.+++.+||+.||.+|||+.++++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 ------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00223579999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=272.70 Aligned_cols=240 Identities=25% Similarity=0.309 Sum_probs=193.2
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||.|++|.||++... +++.+++|.+.... ....+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 58899999986532 234688899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccC
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG 227 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 227 (347)
.+++.+. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9998654 34899999999999999999999 8899999999999999999999999999988764321 2223457
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
+..|++||.+.+..++.++|+||||+++|+|++|..||....... .........+... ...+.....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~----------~~~~~~~~~ 221 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGK----------LEFPNYIDK 221 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccCCC----------CCCCcccCH
Confidence 889999999988889999999999999999999999997543211 1111111111100 011111246
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 308 SILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
++.+++.+||+.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=279.21 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=193.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG------ 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 133 (347)
.++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457888899999999999999954 689999998864322 224568999999999999999999887543
Q ss_pred --eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 134 --EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 134 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
..++||||+.+ +|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999976 888888666557899999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccc---eeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 212 KMLGMEESK---VFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 212 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ...............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCh
Confidence 865422211 12234567889999988664 4788999999999999999999988754322 111111110000000
Q ss_pred C-ccc------------------ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 P-IKD------------------FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~-~~~------------------~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ... .....+... .....+.+++.+||+.||.+|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000 000000000 11246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.20 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=194.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC---CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQY 136 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 136 (347)
+|...+.||+|++|.||+|... ++..||+|.+... .....+.+|+.++++++|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3666788999999999999964 4789999998763 2345678899999999999999999999987 7899
Q ss_pred EEEeecCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC----CCceEEeec
Q 040826 137 LVYEFCAAGNLAQHLLR----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE----KLEPKLSDF 208 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~----~~~~kl~df 208 (347)
+||||+++ +|.+.+.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 77776642 1236899999999999999999999 889999999999999999 999999999
Q ss_pred ccceecCCCcc--ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhh--------hHHHH
Q 040826 209 GLAKMLGMEES--KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDAR--------DQLTR 277 (347)
Q Consensus 209 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~--------~~~~~ 277 (347)
|++........ .......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543221 11223457888999998876 457889999999999999999999997543221 11111
Q ss_pred HHhhhcCCCC----------Cccc----ccCCCCC-----CCCCH--HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 278 KARDVSMGKR----------PIKD----FEDPRLN-----GNINR--ADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 278 ~~~~~~~~~~----------~~~~----~~~~~l~-----~~~~~--~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......... .... ....... ..... ....++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111110000 0000 0000000 00000 23357899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=271.51 Aligned_cols=244 Identities=26% Similarity=0.348 Sum_probs=199.2
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||++... +++.+++|.+.... ....+.+|+..++.++|+||+++.+++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3666788999999999999844 78899999886532 234677899999999999999999999999999999999
Q ss_pred cCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 142 CAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 142 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+++++|.+++.+ ....+++..++.++.|++.|+.||| +.|++|+||+|+||++++++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998854 2356899999999999999999999 889999999999999999999999999998876432
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......++..|+|||...+..++.++|+||||+++++|++|+.||....... .. .....+..+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~---~~~~~~~~~---------- 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LR---YKVQRGKYP---------- 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHhcCCCC----------
Confidence 2223457889999999999889999999999999999999999987543211 11 111111110
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........++.+++.+||+.+|++|||+.++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.81 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=194.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|++|.||+|... +|+.|++|.+.... ....+.+|++.+++++|||++++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46777889999999999999964 78899999886532 23467889999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCc
Q 040826 141 FCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~ 218 (347)
|+++ +|.+++.... ..+++..+..++.|++.||.||| +++++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 9975 8888775433 34678888999999999999999 789999999999999985 557999999999765322
Q ss_pred cceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-------cc
Q 040826 219 SKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-------IK 290 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 290 (347)
........++..|+|||.+.+ ..++.++|+||+|+++|+|+||..||...... +............... ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccch
Confidence 111223456889999998865 46788999999999999999999998754322 2222211111110000 00
Q ss_pred ccc--CCCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFE--DPRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~--~~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... .+.... .......+++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 001122356899999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=285.06 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=194.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeC-----CeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 135 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788889999999999999984 478999999986432 234577899999999999999999887643 357
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++++||+.+ +|.+.+. ...+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999976 8887774 345899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCccc--eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cccc
Q 040826 216 MEESK--VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIKD 291 (347)
Q Consensus 216 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 291 (347)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ................ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHH
Confidence 22111 1123457889999998754 5688999999999999999999999864321 1111111111100000 0000
Q ss_pred ccCC---------CCCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 292 FEDP---------RLNGN-----INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 292 ~~~~---------~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+. ..... .......++.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000 001123578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.57 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=202.1
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
+.|..-+.||+||||.||-+. -.+|+.+|.|++.+. .......+|-.+|.+++.+.||.+--.|++.+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 456677899999999999998 458999999887543 45566889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 140 EFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
..|.||+|.-++.+.+ +.+++..++-++++|+.||.+|| +.+|++|||||+|||+|+.|+++|+|.|+|..+. .
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP--E 339 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC--C
Confidence 9999999999887644 56999999999999999999999 8899999999999999999999999999999874 3
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....+.+||.+|||||++.+..|+...|+|||||++|+|+.|..||......... .++-+.......
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~~~~~----------- 407 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTLEDPE----------- 407 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHhcchh-----------
Confidence 34445568999999999999999999999999999999999999999753221111 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
.++...+++...++...|++||.+|....
T Consensus 408 -ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 -EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 33445567889999999999999997554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=266.69 Aligned_cols=245 Identities=29% Similarity=0.401 Sum_probs=199.5
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+|...+.||+|++|.||++... +++.+++|.+..... ...+.+|++.+++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3566788999999999999855 678999999876542 34688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++... ..+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence 9999999988654 56899999999999999999999 88999999999999999999999999999987643222 1
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||...+..++.++|+||+|+++++|++|..|+...... .... ... .... +. .
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~---~~~-~~~~-------~~----~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALF---RIV-QDDH-------PP----L 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHH---HHh-ccCC-------CC----C
Confidence 23346788999999998878889999999999999999999998643321 1111 111 1111 01 1
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+......+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122357899999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=296.93 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=189.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC--CCCEEEEE------------------EcccC-CChhHHHHHHHHhhcCCCCcc
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP--SGQVVAIK------------------HIYKS-NNTDSFSREVEGLSRVRHPNL 122 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------~~~~~-~~~~~~~~e~~~l~~l~h~ni 122 (347)
..++|...+.||+|+||.||+|... ++...+.| .+... .....+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4678999999999999999998743 22222222 11111 122357789999999999999
Q ss_pred eeeeeEEEeCCeEEEEEeecCCCChHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 123 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
+++++++...+..+++++++.+ +|.+++.... .......+..++.|++.||.||| +++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 9999999999999999999865 7877774321 22345677889999999999999 88999999999999999
Q ss_pred CCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCCh--hhhhHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF--DARDQLT 276 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~--~~~~~~~ 276 (347)
.++.+||+|||++...............|+..|+|||++.+..++.++|||||||++|+|++|..++.... ....++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765332222334568999999999999999999999999999999999986543221 1222222
Q ss_pred HHHhhhcCCCCCccc-------ccCC-CC---CCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 277 RKARDVSMGKRPIKD-------FEDP-RL---NGNIN-----RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~-------~~~~-~l---~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
............... +.+. .+ ...+. .....++.+++.+||+.||.+|||+.|++..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222221111000000 0000 00 00000 0112457778899999999999999999863
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.86 Aligned_cols=248 Identities=26% Similarity=0.318 Sum_probs=194.6
Q ss_pred cccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccCC------ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN------NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 136 (347)
|...+.||.|+||.||++.. .+|..||+|.+.... ..+.+.+|+.+++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56678899999999999985 368899999986532 234677899999999 5999999999999989999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999998654 45889999999999999999999 88999999999999999999999999999887543
Q ss_pred CccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..........++..|+|||.+.+ ..++.++||||||+++|+|++|..|+...... ...............+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~------ 230 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPP------ 230 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccCCC------
Confidence 32222334558889999999875 34678999999999999999999998642211 1112222222211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
.+......+.+++.+||+.+|++|| ++.++++
T Consensus 231 ------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 ------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1112335789999999999999997 6677655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=299.49 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=206.8
Q ss_pred ccCCeeeecCCeeEEEEEeC----C----CCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLP----S----GQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 136 (347)
...+.||+|+||.|++|... . ...||||.+..... ...+..|+++|+.+ +|+|++.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 33458999999999999832 1 35799999986544 46789999999999 5999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 137 LVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
+|.||+..|+|.++++... ..++....+.++.|||.|++||+ +.+++||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999997665 34899999999999999999999 88899999999999999999
Q ss_pred ceEEeecccceecCCCccceeeccc--CCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHH
Q 040826 202 EPKLSDFGLAKMLGMEESKVFTDVR--GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 202 ~~kl~dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~ 279 (347)
.+||+|||+++.............. -+..|||||.+....|+.++||||||++|||++|...++..+......+.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~--- 532 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL--- 532 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH---
Confidence 9999999999975444444323222 45679999999999999999999999999999996544443332122222
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+.+..|.+. ..+..+..+++++|..||+.+|++||++.++.+.++..+.+
T Consensus 533 ~~l~~G~r~-----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 533 EFLKEGNRM-----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHhcCCCC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 222333221 23335568999999999999999999999999999998765
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.94 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=184.9
Q ss_pred eeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHh---hcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 73 FLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGL---SRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.||+|+||.||++.. .+|+.+|+|.+..... ...+.+|...+ ...+|||++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999995 4688999998865321 12234444333 33479999999999998899999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++++|||++...... ...
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence 99999888654 45899999999999999999999 889999999999999999999999999998754321 112
Q ss_pred cccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+. +..++.++|+||+|+++|+|++|..||......... ......... .. ..+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~--------~~----~~~ 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTV--------NV----ELP 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhcC--------Cc----CCc
Confidence 345899999999886 456889999999999999999999999643221111 111111000 01 122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
.....++.+++.+||+.||.+|| |+++++++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23346799999999999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=269.92 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=195.4
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-------ChhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-------NTDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 135 (347)
.+|...+.||+|+||.||+|.. .+|..+++|.+.... ....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4677889999999999999995 468999999875321 123677899999999999999999998763 468
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++++||+++++|.+++.... .+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999886543 4789999999999999999999 8899999999999999999999999999988653
Q ss_pred CCc--cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 216 MEE--SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 216 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... ........++..|+|||.+.+..++.++|+||||+++++|++|+.||...... ....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~------ 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKIATQPTK------ 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHHHHcCCCC------
Confidence 211 11122345788999999999888899999999999999999999998743211 111221111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+ .++....+.+.+++.+||+ +|..|||..+++.+
T Consensus 228 -~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 -P----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -C----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 1222334679999999998 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=276.14 Aligned_cols=253 Identities=27% Similarity=0.329 Sum_probs=198.0
Q ss_pred cccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccCC------ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN------NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 136 (347)
|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+|+.++.++ +|||++++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 55667899999999999984 357889999886431 234577899999999 5999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++++|.+++... ..+++..+..++.|++++|.||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999988653 45889999999999999999999 78999999999999999999999999999876543
Q ss_pred CccceeecccCCCCccccccccCCc--cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAK--LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ......+.......+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~----- 231 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKSKPPF----- 231 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHccCCCC-----
Confidence 3222223345788999999987654 7889999999999999999999986432111 1112222221111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 232 -------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 232 -------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 112235688999999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=275.28 Aligned_cols=242 Identities=27% Similarity=0.355 Sum_probs=192.4
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||+|+||.||+|.. .+|+.+++|.+..... ...+.+|++.++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44556799999999999995 4688999998864322 23577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+.+ ++.+++......+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.... .
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 975 888888666667899999999999999999999 7899999999999999999999999999876432 1
Q ss_pred eecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....++..|+|||.+. +..++.++|+||||+++|+|++|..|+......... .... ....+ ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~----~~~~~-------~~- 240 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIA----QNDSP-------TL- 240 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcCCC-------CC-
Confidence 22346788999999874 456888999999999999999999998644222111 1111 11110 00
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 --~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 --QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122468999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=272.94 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=193.7
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||.|+||.||++... +|+.+++|.+.... ....+.+|++.+++++|||++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 58999999986543 234688899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-------c
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-------K 220 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-------~ 220 (347)
.+++...+ .+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99886544 6899999999999999999999 88999999999999999999999999998876432211 1
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......++..|+|||...+...+.++|+||||++++++++|..||...... ... .....+...... .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~----~~~~~~~~~~~~--------~ 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIF----QNILNGKIEWPE--------D 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHH----HHHhcCCcCCCc--------c
Confidence 223345788999999998888899999999999999999999998744321 111 111111111110 0
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
. .....+.+++.+||+.+|++|||+..+.+.|+
T Consensus 224 ~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 224 V--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 02367899999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.08 Aligned_cols=242 Identities=21% Similarity=0.249 Sum_probs=187.5
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHH-hhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEG-LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|.. .+|+.||+|.+..... ...+..|... ....+|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4599999999999995 4689999999865321 1223444444 3455899999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999988654 45899999999999999999999 78999999999999999999999999998875432 223
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... ....+...... .....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~--------~~~~~ 219 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFD----NILSRRINWPE--------EVKEF 219 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHH----HHHhcccCCCC--------ccccc
Confidence 45788999999998888899999999999999999999999754322 1111 11111111000 11112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 3467999999999999999998776655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.05 Aligned_cols=251 Identities=19% Similarity=0.195 Sum_probs=182.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCCh---h----------HHHHHHHHhhcCCCCcceeeeeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNT---D----------SFSREVEGLSRVRHPNLVCLFGC 128 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~---~----------~~~~e~~~l~~l~h~niv~~~~~ 128 (347)
++|...+.||+|+||.||+|...+ +..+++|........ + ....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 567788999999999999999644 345666654322211 0 11223344566789999999987
Q ss_pred EEeCC----eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceE
Q 040826 129 CVEGG----EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK 204 (347)
Q Consensus 129 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~k 204 (347)
+.... ..++++++... ++.+.+... ...++..+..++.|++.||.||| +.+++||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 66543 34677887654 666665432 33678889999999999999999 88999999999999999999999
Q ss_pred EeecccceecCCCcc------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHH--
Q 040826 205 LSDFGLAKMLGMEES------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLT-- 276 (347)
Q Consensus 205 l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~-- 276 (347)
|+|||+++....... .......||+.|+|||...+..++.++||||||+++|+|++|+.||...........
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999987532211 112234689999999999999999999999999999999999999975422211111
Q ss_pred --HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 277 --RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 277 --~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.....+..+.... ..+..++.+++..||+.+|++||++.++.+.+
T Consensus 247 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-------------KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhhhhhcc-------------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111111111110 11236799999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.50 Aligned_cols=243 Identities=28% Similarity=0.383 Sum_probs=192.1
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.|...+.||+|+||.||+|... +++.+++|.+.... ....+.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555678999999999999954 67889999885421 12357789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+.+ +|.+.+......+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 96 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9974 888877655566899999999999999999999 889999999999999999999999999998765321
Q ss_pred eeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
....++..|+|||.+. ...++.++||||||+++|+|++|..|+...... ........ +.. +..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----~~~-------~~~ 234 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NES-------PAL 234 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhh----cCC-------CCc
Confidence 2345788999999874 346788999999999999999999998643211 11111111 110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 011233578999999999999999999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=281.60 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=195.4
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeC--CeE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEG--GEQ 135 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 135 (347)
..++|...+.||+|+||.||+|... +|+.+++|++... .....+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567777888999999999999965 6889999988542 2234577899999999 999999999987643 468
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++||||+++ +|.+++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 999999985 998888554 6889999999999999999999 8899999999999999999999999999988654
Q ss_pred CCcc----ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC----
Q 040826 216 MEES----KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK---- 286 (347)
Q Consensus 216 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 286 (347)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Confidence 3221 12233457889999998764 56788999999999999999999998643221 11111111100000
Q ss_pred ---------C---CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 287 ---------R---PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 287 ---------~---~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
. ........... ........++.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000000000 0111134679999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=281.97 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=197.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeC-----Ce
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 134 (347)
.++|...+.||+|+||.||++.. .+|..|++|.+... .....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35678888999999999999995 47899999988643 2234567899999999999999999987643 35
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++++||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999997 5898888654 46899999999999999999999 889999999999999999999999999998865
Q ss_pred CCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cc---
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PI--- 289 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~--- 289 (347)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ............... ..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhc
Confidence 4221 22233457889999998864 56889999999999999999999998654221 111111111000000 00
Q ss_pred ------------ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 040826 290 ------------KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE--IDKA 337 (347)
Q Consensus 290 ------------~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~--l~~~ 337 (347)
.....+... ........++.+++.+||+.+|.+|||++++++. ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 0111234678999999999999999999999976 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=302.92 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=189.1
Q ss_pred HHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeC-----
Q 040826 62 ENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEG----- 132 (347)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 132 (347)
.+-.++|...+.||+||||.||+++.+ +|+.||||++.-... ...+.+|+..+.+|+|||+|+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 445677888899999999999999965 899999999976532 23578899999999999999987643210
Q ss_pred --------------------------------------------------------------------------------
Q 040826 133 -------------------------------------------------------------------------------- 132 (347)
Q Consensus 133 -------------------------------------------------------------------------------- 132 (347)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040826 133 ----------------------------------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178 (347)
Q Consensus 133 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh 178 (347)
...|+-||||+.-+|.+++..+...-.....++++++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0126678888886666666443322246789999999999999999
Q ss_pred hccCCCceeCCCCCCCEEecCCCceEEeecccceecC-----------------CCccceeecccCCCCccccccccCC-
Q 040826 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG-----------------MEESKVFTDVRGTIGYMDPEYMTNA- 240 (347)
Q Consensus 179 ~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~- 240 (347)
+.|++||||||.||++++++.+||+|||++.... .......++..||.-|.|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 8899999999999999999999999999998721 0111234556799999999999865
Q ss_pred --ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 040826 241 --KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVA 318 (347)
Q Consensus 241 --~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~ 318 (347)
.|+.|+|+||||++++||+. ||.-.+.... .....+.+.-|.. ..+..+..+.=.+++.|+++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~LR~g~iP~~--------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----ILTNLRKGSIPEP--------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHH----HHHhcccCCCCCC--------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 3543333322 2233333322211 11222333567889999999
Q ss_pred CCCCCCCCHHHHHH
Q 040826 319 KSSKGRPTIDVVYE 332 (347)
Q Consensus 319 ~~p~~Rps~~ei~~ 332 (347)
+||++|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=272.28 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=193.0
Q ss_pred CeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
.+||+|+||.||++.. .+|+.+++|.+.... ....+.+|+..++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999986 478999999875433 2346888999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCC
Q 040826 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 228 (347)
+++.. ..+++.....++.|++.|++||| +.|++|+||+|+||++++++.++|+|||++...... ........++
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 179 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGT 179 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc-cccccccccC
Confidence 97743 35789999999999999999999 789999999999999999999999999988765322 1222334578
Q ss_pred CCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHH
Q 040826 229 IGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFES 308 (347)
Q Consensus 229 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 308 (347)
..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......... .. .+. ........
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~~----~~-------~~~--~~~~~~~~ 245 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNL----PP-------KLK--NLHKVSPS 245 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhC----Cc-------ccC--CcccCCHH
Confidence 8999999998888899999999999999999999998743221 1111111111 00 000 00112346
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 040826 309 ILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 309 l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.+++.+||+.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=281.96 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=195.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 135 (347)
.++|...+.||+|++|.||+|.. .+|..|++|++.... ....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788888999999999999995 468999999987542 23457789999999999999999987753 3468
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++|+||+.+ +|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLMES-DLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhhh-hHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999999964 898888544 44899999999999999999999 7899999999999999999999999999987653
Q ss_pred CCccc---eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC---
Q 040826 216 MEESK---VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP--- 288 (347)
Q Consensus 216 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 288 (347)
..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ..+.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhhh
Confidence 22211 1123467889999998865 46889999999999999999999999643221 1111111110000000
Q ss_pred ------cccccC-CCCC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 ------IKDFED-PRLN-----GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ------~~~~~~-~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+ .... ....+...+++.+++.+||+.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000 0000 0011223568999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=280.70 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=201.3
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCC-----eEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGG-----EQY 136 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 136 (347)
+|...+.||+|++|.||+|... +|..+++|.+.... ....+.+|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4667788999999999999964 58999999887643 3457889999999999999999999987764 789
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
++|||+++ +|.+++.... .+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999985 8988886544 7999999999999999999999 88999999999999999999999999999987653
Q ss_pred Ccc--ceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC------
Q 040826 217 EES--KVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR------ 287 (347)
Q Consensus 217 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 287 (347)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... +..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhhhc
Confidence 321 123334578899999999887 8899999999999999999999999754322 111111111100000
Q ss_pred ---CcccccC---CCC---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 040826 288 ---PIKDFED---PRL---NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE--IDKA 337 (347)
Q Consensus 288 ---~~~~~~~---~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~--l~~~ 337 (347)
....... ... ...........+.+++.+||+.+|.+|||+.+++.. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000 000 000111234678999999999999999999999974 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=270.44 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=193.9
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcC---CCCcceeeeeEEEeCCe-----
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRV---RHPNLVCLFGCCVEGGE----- 134 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 134 (347)
|...+.||+|+||.||+|... ++..+++|.+..... ...+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 445678999999999999975 589999999874322 23466777776666 59999999999987766
Q ss_pred EEEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+++|||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999986 8988886533 36899999999999999999999 78999999999999999999999999999887
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC---C--
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR---P-- 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~-- 288 (347)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|.+||..... .+....+......... +
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence 64221 12233478899999999988899999999999999999999988874332 2222222221111000 0
Q ss_pred -------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 -------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 -------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......... .....+....+.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1111234467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=276.05 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=190.0
Q ss_pred eeeec--CCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 73 FLGRG--SAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 73 ~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
.||+| +||+||++.. .+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++..++..++++||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 36666 9999999995 4799999999865432 246778999999999999999999999999999999999999
Q ss_pred ChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce---
Q 040826 146 NLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--- 221 (347)
Q Consensus 146 sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--- 221 (347)
+|.+++.+. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+............
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999988654 345889999999999999999999 8899999999999999999999999997544321111100
Q ss_pred ---eecccCCCCccccccccCC--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC-----------
Q 040826 222 ---FTDVRGTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----------- 285 (347)
Q Consensus 222 ---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 285 (347)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||....................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112245679999998763 478899999999999999999999875432211111100000000
Q ss_pred -----C--------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 -----K--------------RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 -----~--------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ..........+...........+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0000111112222233455678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.03 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=200.9
Q ss_pred HhcCcccC-CeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEe----CCeEE
Q 040826 64 AINNDWDR-RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVE----GGEQY 136 (347)
Q Consensus 64 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~ 136 (347)
++++|... ++||-|-.|.|-.|..+ +|+.+|+|++. +.....+|++..-.. .|||||.++++|.+ ...+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 46667643 67999999999999954 79999999884 334456788765444 59999999999875 34678
Q ss_pred EEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeecccce
Q 040826 137 LVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAK 212 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~ 212 (347)
+|||.++||.|...+.+. ...+++.++..|++||+.|+.||| +.+|.||||||+|+|.+. |..+||+|||.++
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 999999999999999764 457999999999999999999999 889999999999999974 5579999999999
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
... ........+-|+.|.|||++....|+...|+||+|+++|-|+.|.+||+..... .-.....+.+..+. .+|
T Consensus 213 ~t~--~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aispgMk~rI~~gq---y~F 286 (400)
T KOG0604|consen 213 ETQ--EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKRRIRTGQ---YEF 286 (400)
T ss_pred ccC--CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCChhHHhHhhccC---ccC
Confidence 753 234455667899999999999999999999999999999999999999864331 11122233344333 234
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+|++. ..++...+++...|..+|++|.|+.++.+
T Consensus 287 P~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 PEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 444442 34567888999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.13 Aligned_cols=263 Identities=26% Similarity=0.304 Sum_probs=194.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC-------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG------- 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 132 (347)
.++|...+.||+|+||.||+|... +++.+++|.+..... ...+.+|++.+++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999954 688999998864322 23567899999999999999999887543
Q ss_pred -CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 133 -GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 133 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
...++++||+.+ +|.+.+......+++..+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999976 787777665667999999999999999999999 889999999999999999999999999998
Q ss_pred eecCCCccc----------eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh
Q 040826 212 KMLGMEESK----------VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 212 ~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~ 280 (347)
......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 765322111 1122346788999998765 45888999999999999999999998754332 22222211
Q ss_pred hhcCCCC-------Cccccc----CCCCCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 281 DVSMGKR-------PIKDFE----DPRLNGN---INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 281 ~~~~~~~-------~~~~~~----~~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....... ...... ....... ........+.+++.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110000 000000 0000000 00112257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.15 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=199.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|++|.||++... +|+.+++|.+.... ....+.+|..++++++ ||||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35777889999999999999954 78999999886532 2346788999999998 99999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
||++++++|.+++...+ .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999986543 6999999999999999999999 8899999999999999999999999999988654322
Q ss_pred c-------------------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHH
Q 040826 219 S-------------------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 219 ~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~ 279 (347)
. .......++..|+|||...+..++.++|+||||++++++++|..|+...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~-- 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQK-- 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH--
Confidence 1 1222345788999999998888999999999999999999999998754321 11111
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTI----DVVYE 332 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~----~ei~~ 332 (347)
...... ..+....+.+.+++.+||+.+|.+|||+ .++++
T Consensus 234 --~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 --ILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 1111224579999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=271.64 Aligned_cols=257 Identities=25% Similarity=0.317 Sum_probs=193.7
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||+|++|.||+|... +++.+++|.+..... .....+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 345678999999999999965 578999998865432 234557899999999 999999999999999999999999
Q ss_pred CCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+|+|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+...... ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PP 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CC
Confidence 679999886543 56899999999999999999999 789999999999999999999999999998865422 12
Q ss_pred eecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC---------------
Q 040826 222 FTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG--------------- 285 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--------------- 285 (347)
.....++..|+|||.+. +..++.++|+||||+++++|++|+.||....... ............
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 23345788999999875 4567899999999999999999999886543221 111111100000
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...........+. .........+.+++.+||+.+|.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000 000111367999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=267.76 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=191.0
Q ss_pred CcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-------CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
+|...+.||+|+||.||++... .+..+++|.+... .....+..|+.++++++|||++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3666788999999999999854 3444555544321 1223566789999999999999999999988899999
Q ss_pred EeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
+||+++++|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||+|+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 3456899999999999999999999 889999999999999975 569999999987653
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........+..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~------- 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGPTP------- 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCCCC-------
Confidence 221 2223345788999999998888899999999999999999999998643211 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.....++.+++.+||+.+|++||++.++++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112234467999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=275.57 Aligned_cols=260 Identities=25% Similarity=0.296 Sum_probs=194.7
Q ss_pred cCccc-CCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----------------hHHHHHHHHhhcCCCCcceeeee
Q 040826 66 NNDWD-RRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----------------DSFSREVEGLSRVRHPNLVCLFG 127 (347)
Q Consensus 66 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------------~~~~~e~~~l~~l~h~niv~~~~ 127 (347)
++|.. .+.||.|+||.||+|... +|+.||+|.+...... ..+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 466999999999999954 6899999988653221 14678999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 128 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
++...+..+++|||+.+ +|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMAS-DLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEecccc-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 99999999999999975 899888543 45899999999999999999999 88999999999999999999999999
Q ss_pred cccceecCCCc-------------cceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh
Q 040826 208 FGLAKMLGMEE-------------SKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273 (347)
Q Consensus 208 fg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~ 273 (347)
||++....... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... +
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~ 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-D 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 99988654110 1111223467889999998764 4688999999999999999999998754332 2
Q ss_pred HHHHHHhhhcCCCCC-cc------------cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 274 QLTRKARDVSMGKRP-IK------------DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~-~~------------~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+............. .. ....+... ........++.+++.+||+.+|.+|||+.+++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 222222211111000 00 00000000 011123467899999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.74 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=187.8
Q ss_pred eeecCCeeEEEEEeCCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
+|.|+++.|+++.. +|+.||+|++... .....+.+|+..++.++|+||+++++++.+.+..+++|||+++++|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44444444455444 7899999998654 223478899999999999999999999999999999999999999999
Q ss_pred HhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc------ee
Q 040826 150 HLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK------VF 222 (347)
Q Consensus 150 ~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~------~~ 222 (347)
++... ...+++.....++.|+++||.||| +.+++|+||+|+||+++.++.++++|||.+......... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 98653 456889999999999999999999 889999999999999999999999999988755321111 11
Q ss_pred ecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----------CCCcc
Q 040826 223 TDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----------KRPIK 290 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 290 (347)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............. ...... .....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCccccccCchhhhcCCcC
Confidence 22346778999999875 358889999999999999999999997543222111111 100000 00000
Q ss_pred ----cccCCC----CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 ----DFEDPR----LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ----~~~~~~----l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...++. ...........++.+++.+||+.||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0111223445688999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=239.76 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=209.1
Q ss_pred cccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...++||+|.||+||+++ ..+++.||+|+++-+.+ .....+|+.+++.++|.||++++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 3445679999999999999 56789999999875433 357889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+. .|..+...-++.+.......++.|+++|+.++| ++++.|||+||.|.+|+.+|++|++|||+++..+. +....
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi-pvrcy 158 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCY 158 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC-ceEee
Confidence 88 999998777778999999999999999999999 88999999999999999999999999999997753 34455
Q ss_pred ecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC----CcccccCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----PIKDFEDPRL 297 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l 297 (347)
+..+.|..|.+|.++.+. -|+...|+||.||++.|+.....|..++.+..+++..+.+....... .+..+.|-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 666789999999999875 48889999999999999998777777777777888777765533211 0111111111
Q ss_pred CC---------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NG---------NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~---------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. .+-+.....=.+|++..+..+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 111222234567788888999999999998765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.88 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=184.8
Q ss_pred eeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHH---HHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 73 FLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREV---EGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.||+|+||.||++.. .+++.||+|.+..... ...+..|. ..++...|||++.+.+.+...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999985 4688999998865321 11233343 33445579999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence 99999888643 46899999999999999999999 789999999999999999999999999998754321 122
Q ss_pred cccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||......... .......... +.+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~--------~~~~~--- 220 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA--------VELPD--- 220 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhccC--------CCCCC---
Confidence 3468999999999875 46889999999999999999999999754221111 1111111111 11111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
....++.+++.+||..+|.+|| ++.++++
T Consensus 221 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 -SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1235799999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.01 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=193.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------G 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 133 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999995 478999999886532 224577899999999999999999988654 3
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++++||+.. +|..+. +..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 56999999975 777655 235889999999999999999999 78999999999999999999999999999875
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC----
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP---- 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 288 (347)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ..+.............
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence 422 1223456788999999876 46888999999999999999999999754321 1111111110000000
Q ss_pred ------------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 040826 289 ------------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE--IDKA 337 (347)
Q Consensus 289 ------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~--l~~~ 337 (347)
........+. .........+.+++.+||+.||.+|||+.+++.. ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000 0001123568899999999999999999999854 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=277.61 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=197.5
Q ss_pred cHHHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe
Q 040826 57 SKDEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE 131 (347)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 131 (347)
...++..+.++|...+.||+|+||.||++.. .+|+.||+|++.... ....+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666789999999999999999999984 578999999986532 23457789999999999999999998764
Q ss_pred C------CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 132 G------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 132 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 3 3467888876 6699887743 35899999999999999999999 889999999999999999999999
Q ss_pred eecccceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 206 SDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .......+....
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGT 236 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 99999876431 2233457889999998876 56888999999999999999999998643221 111111111100
Q ss_pred CCCCc----------------ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 285 GKRPI----------------KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 285 ~~~~~----------------~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..... ......... ........++.+++.+|++.||.+|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000000 0000123568999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=262.70 Aligned_cols=260 Identities=27% Similarity=0.364 Sum_probs=203.3
Q ss_pred CcccccHHHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHh-hcCCCCcceeee
Q 040826 52 GLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGL-SRVRHPNLVCLF 126 (347)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l-~~l~h~niv~~~ 126 (347)
....|+.++++.. ..||.|+||+|++-.. ++|+..|||+++.... ...+..|.+.. +.-+.||||+++
T Consensus 57 ~~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 4455666655544 5699999999999984 5899999999987544 44677787754 455799999999
Q ss_pred eEEEeCCeEEEEEeecCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc
Q 040826 127 GCCVEGGEQYLVYEFCAAGNLAQHLLR----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 127 ~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
|.+..++..++.||.|+- ||..+... ....+++..+-+|..-+..||.||.. ...++|||+||+|||++..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999999999999999976 77766532 34568999999999999999999986 568999999999999999999
Q ss_pred eEEeecccceecCCCccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh
Q 040826 203 PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~ 280 (347)
+||||||.+..+. ++...+.-.|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+......-+++..+.
T Consensus 207 vKLCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv- 283 (361)
T KOG1006|consen 207 VKLCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV- 283 (361)
T ss_pred EeeecccchHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-
Confidence 9999999998763 3333445568899999998863 4589999999999999999999999876554444444443
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.++....-. -..+....+.+++..|+.+|...||.+.++.++
T Consensus 284 ---~gdpp~l~~~~------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 ---IGDPPILLFDK------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---cCCCCeecCcc------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 33333221111 112344679999999999999999999988753
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.04 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=196.8
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
|...+.||+|++|.||+|... +++.+++|.+.... ....+..|+..+++++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 344577999999999999965 58999999987643 2346778999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++ +|.+++.+....+++..+..++.|++.||.+|| +.+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 85 999999766456999999999999999999999 78999999999999999999999999999886542221 22
Q ss_pred ecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC--------------C
Q 040826 223 TDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK--------------R 287 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------~ 287 (347)
....++..|+|||.+.+. .++.++|+||||++++++++|..||...... +.+........... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 233457789999998766 7889999999999999999999888654321 11111111110000 0
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
............. -+.....+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 0112457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=271.08 Aligned_cols=259 Identities=25% Similarity=0.289 Sum_probs=193.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYL 137 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 137 (347)
++++|...+.||.|+||.||++... +|+.+++|.+... .....+.+|+.+++.++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5678888999999999999999844 7899999987542 234567789999999999999999998865 557899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+. ++|.+++.. ..+++.....++.|+++||.||| +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 v~e~~~-~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 88 VTELLG-TDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred Eeehhc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 999985 589887743 35788888899999999999999 88999999999999999999999999999875422
Q ss_pred ccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC---------C
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK---------R 287 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~ 287 (347)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ......+...... .
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 ---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhccch
Confidence 1223456888999998765 578999999999999999999999986543211 1111111000000 0
Q ss_pred Cccccc-CCCCCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 PIKDFE-DPRLNGNIN-----RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ~~~~~~-~~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....+. .-......+ .....++.+++.+||+.+|++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000 1123679999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.16 Aligned_cols=234 Identities=28% Similarity=0.323 Sum_probs=190.9
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
||+|+||.||++... +++.+++|.+..... ...+..|+.++++++|||++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999998866432 34688899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccC
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRG 227 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 227 (347)
.+++.... .+++.....++.|+++|+.||| +.+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99986543 5899999999999999999999 7899999999999999999999999999988754321 12334567
Q ss_pred CCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 228 TIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 228 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
+..|++||...+...+.++|+||||+++|++++|..||..... .. ..........+ ++.....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~----~~~~~~~~~~~------------~~~~~~~ 218 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KE----IYEKILKDPLR------------FPEFLSP 218 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HH----HHHHHhcCCCC------------CCCCCCH
Confidence 8899999999888889999999999999999999999864332 11 11111111111 1111235
Q ss_pred HHHHHHHHhccCCCCCCCCHHH
Q 040826 308 SILKIAVLCVAKSSKGRPTIDV 329 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps~~e 329 (347)
.+.+++.+||..||++|||+.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=296.75 Aligned_cols=252 Identities=23% Similarity=0.247 Sum_probs=207.6
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEccc-----CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYK-----SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
...++|...+.||+|+||.|..++. .+++.||+|++.+ ..+...|+.|-.+|..-+.+=|+.++-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 3467888899999999999999995 4789999999976 456678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||++||+|..++.+.+ .+++..+.-+++.+..||.-|| +.|+|||||||+|||+|.+|.+||+|||.+-.+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999999997666 7999999999999999999999 88999999999999999999999999999988775
Q ss_pred CccceeecccCCCCcccccccc----C-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 217 EESKVFTDVRGTIGYMDPEYMT----N-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+........+|||.|.+||++. + +.|+..+|+||+|+++|||+.|.+||+ .+.+......+...... ..
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-----adslveTY~KIm~hk~~-l~ 301 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-----ADSLVETYGKIMNHKES-LS 301 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-----HHHHHHHHHHHhchhhh-cC
Confidence 5555667789999999999985 3 568999999999999999999999998 44444444444333211 11
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT---IDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~ei~~ 332 (347)
|.+. .+.+++..+|+++.+ .+|+.|.. +++|-.
T Consensus 302 FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 302 FPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 1100 123356777877666 78888887 666643
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=277.50 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=203.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
...|.....||+|.|+.|.+++. .++..||+|.+.+.... ..+.+|+++|+.++||||++++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 56678888999999999999994 47999999999875432 35789999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+.+|.+.+++.+++. ..+..+..++.|+..|++||| +++|+|||||++|+|++.+.++||+|||++..+. ..
T Consensus 135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YG 208 (596)
T ss_pred EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--cc
Confidence 99999999999987665 455889999999999999999 8899999999999999999999999999999875 34
Q ss_pred ceeecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......+|++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||.+..-. ........+...+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----~Lr~rvl~gk~rIp-------- 275 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----ELRPRVLRGKYRIP-------- 275 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----cccchheeeeeccc--------
Confidence 445667899999999999987764 7999999999999999999999843211 11111112221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.-...+..++++++|-.+|.+|+++++|.+
T Consensus 276 ----~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 ----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 112245778888899999999999999865
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=276.02 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=194.8
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC--
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG-- 133 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 133 (347)
+....++|...+.||+|+||.||++.. .+|..||+|.+..... ...+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 334567888899999999999999984 4789999998864322 235778999999999999999999887543
Q ss_pred ----eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 134 ----EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 134 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
..++|+||+ +++|.+++.. ..+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 6689887753 45899999999999999999999 8899999999999999999999999999
Q ss_pred cceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR- 287 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 287 (347)
++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...... ...............
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence 98764321 223456889999998876 45888999999999999999999999754321 111111111000000
Q ss_pred ---------------CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 ---------------PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ---------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.........+ ..........+.+++.+|++.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0011123346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=261.28 Aligned_cols=239 Identities=26% Similarity=0.282 Sum_probs=198.5
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|+..++||+|.||.|.+++ ..+|+.+|+|++++. .+......|-.+|+..+||.+..+--.++..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678888999999999999999 458999999999775 2345677899999999999999999889999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||..||.|.-++.+ ...+++...+-+-..|..||.||| +++|++||||.+|.|+|.+|.+||+|||++..-- ..
T Consensus 247 MeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KY 321 (516)
T ss_pred EEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc-cc
Confidence 999999999888855 445889989889999999999999 8999999999999999999999999999998632 34
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
...++..+||+.|+|||++....|..++|+|.+|+++|||++|+.||.... ...- ..-+..++...
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-h~kL----FeLIl~ed~kF--------- 387 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-HEKL----FELILMEDLKF--------- 387 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-hhHH----HHHHHhhhccC---------
Confidence 455778899999999999999999999999999999999999999998432 1122 22222222111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP 325 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp 325 (347)
+.....+...|+...|.+||.+|.
T Consensus 388 ---Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 ---PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---CccCCHHHHHHHHHHhhcChHhhc
Confidence 112234678888889999999995
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=279.59 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=194.0
Q ss_pred CCeeeecCCeeEEEEEeC-CCCEEEE---EE---cccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe--EEEEEee
Q 040826 71 RRFLGRGSAGLVYKGVLP-SGQVVAI---KH---IYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE--QYLVYEF 141 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vav---K~---~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~ 141 (347)
...||+|+|-+||+|... +|-.||= |. .......+.|..|+.+|+.|+||||++++..+.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 356999999999999954 5766662 21 1223344679999999999999999999999987554 7899999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+..|+|..|..+.+ ..+...+..|++||+.||.|||++ ..+|+|||||-+||||+. -|.|||+|+|+|...... .
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--H 200 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--c
Confidence 99999999997654 478899999999999999999987 679999999999999996 578999999999986422 2
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....||+.|||||.+. ..|+..+||||||+.++||.|+..|+.--.. ...+.+.+..|..|. .+...
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP~------sl~kV 268 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKPA------ALSKV 268 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCHH------Hhhcc
Confidence 22378999999999998 6899999999999999999999999874333 344455555554331 11111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
-+ .++.+++.+|+.. ..+|||+.|+++
T Consensus 269 ~d----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 KD----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CC----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12 4799999999998 999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.00 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=190.1
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeC----------
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEG---------- 132 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------- 132 (347)
.+|...+.||.|+||.||+|.. .+|..|++|.+.... ....+.+|+++++.++|||++++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788889999999999999995 468999999886543 335678899999999999999999876543
Q ss_pred ----CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEEee
Q 040826 133 ----GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLSD 207 (347)
Q Consensus 133 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl~d 207 (347)
...++++||+++ +|.+++.. ..+++..+..++.|+++||.||| +.|++|+||||+||+++ +++.++++|
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357899999975 89887743 35889999999999999999999 78999999999999997 456789999
Q ss_pred cccceecCCCccc--eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 208 FGLAKMLGMEESK--VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 208 fg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
||.+......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... .........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCC
Confidence 9998765321111 1122357889999997654 56888999999999999999999999754332211 111110000
Q ss_pred CCC--------Ccccc-----cCCCC-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 285 GKR--------PIKDF-----EDPRL-NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 285 ~~~--------~~~~~-----~~~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... ..... ..+.. ..........++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00000 00000 00001122357889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=305.30 Aligned_cols=251 Identities=29% Similarity=0.376 Sum_probs=199.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.+-++.....||.|.||.||-|. ..+|+..|+|.+.-.. .-..+.+|..++..++|||+|+++|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456667889999999999999 5679999999875432 223577899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
||||++|+|.+.+... ....+-....+..|++.|++||| +.||+||||||.||+++.+|.+|++|||.|.......
T Consensus 1313 MEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999988543 33555566667899999999999 8999999999999999999999999999999875432
Q ss_pred ---cceeecccCCCCccccccccCC---ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 219 ---SKVFTDVRGTIGYMDPEYMTNA---KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 219 ---~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
....+...||+.|||||++.+. ....+.||||+||+..||+||++|+..-.....-+..+. .|..|
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~----~gh~P---- 1460 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA----AGHKP---- 1460 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh----ccCCC----
Confidence 1224456799999999999763 456799999999999999999999973222222222221 22221
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.++.....+-.+++..||..||++|.++.|+++.
T Consensus 1461 -------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 -------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2333455678899999999999999888877764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=255.35 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=193.2
Q ss_pred CeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
+.||+|+++.|--++ ..+|..+|||++.+... .....+|++++.+++ |+||+.++++|++++.+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 459999999999998 67999999999976533 456889999999995 99999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeecccceecCC------Cc
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGLAKMLGM------EE 218 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~------~~ 218 (347)
..++++. ..+++.++.++.++|+.||.+|| .+||.|||+||+|||..+... +|||||.+..-... ..
T Consensus 164 LshI~~~-~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKR-KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHh-hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999653 45999999999999999999999 899999999999999976554 79999987764321 12
Q ss_pred cceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhh----------hhHHHHHHhhhc
Q 040826 219 SKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDA----------RDQLTRKARDVS 283 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----------~~~~~~~~~~~~ 283 (347)
.......+|+..|||||++. ...|+.++|.||||+++|-||+|.+||.+.=.. ..-.......+-
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22344567999999999763 346899999999999999999999999742110 111111222222
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.|... |.+..+ .....+..+|+...+-.++.+|.++..++.
T Consensus 320 EGkYe---FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYE---FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCc---CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22221 111111 123456777888888899999999988875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=275.63 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=194.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe----
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE---- 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 134 (347)
..++|...+.||+|++|.||+|... +++.|++|.+.... ....+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888899999999999999964 68899999886432 23456789999999999999999988765544
Q ss_pred --EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 135 --QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 135 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|+.||| +.|++|+||+|+||++++++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 5599998854 45899999999999999999999 7899999999999999999999999999988
Q ss_pred ecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC---
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP--- 288 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 288 (347)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+.............
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHh
Confidence 65321 233457888999998865 46788999999999999999999998644321 1122111111000000
Q ss_pred ------ccccc-------CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 ------IKDFE-------DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ------~~~~~-------~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+. .+.+. .........+.+++.+||+.+|.+|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00000 000112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=276.11 Aligned_cols=239 Identities=25% Similarity=0.291 Sum_probs=194.6
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
++.|.....+|.|+|+.|-.+. ..+++..++|++.+. ..+..+|+.++... +|||++++.+.+.+....++|||.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 5677778889999999999998 557899999999766 23334566555555 6999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe-cCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili-~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
.|+-+.+.+..... +. ..+..|+++++.|+.||| ++|++||||||+|||+ +..++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred cccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 99988888765443 33 788889999999999999 8999999999999999 58999999999999876433
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....+-|..|.|||+.....|++++|+||||++||+||+|+.||.....+ ..+...+..+. +
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~--------------~ 531 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPK--------------F 531 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCc--------------c
Confidence 22345688999999999999999999999999999999999999865444 22222222221 1
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+...++...+|+.+||+.||.+||++.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1233357999999999999999999999865
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=269.56 Aligned_cols=259 Identities=25% Similarity=0.298 Sum_probs=188.4
Q ss_pred CcccCCeeeecCCeeEEEEEeC-C--CCEEEEEEcccCC----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeC----Ce
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP-S--GQVVAIKHIYKSN----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEG----GE 134 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 134 (347)
+|...+.||+|+||.||++... + +..+|+|.+.... ....+.+|+.+++++ +||||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3566778999999999999954 4 7789999886432 234677899999999 599999999875432 45
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.+++++++.+ +|.+++.. ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~~-~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEecccC-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 7888998864 89888854 345899999999999999999999 889999999999999999999999999999865
Q ss_pred CCCcc---ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC---
Q 040826 215 GMEES---KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR--- 287 (347)
Q Consensus 215 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 287 (347)
..... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 42211 11223468899999998765 56889999999999999999999998643211 111111111000000
Q ss_pred ------C-------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 ------P-------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ------~-------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ........+. .........+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000000000 001112357999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=256.55 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=204.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe-CCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE-GGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 134 (347)
..++....++-+|.||.||.|.+. +.+.|.+|.+..... ...+..|.-.+..++|||+..+.+++.+ ...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 455777778899999999999643 345677887765433 3468889999999999999999998865 457
Q ss_pred EEEEEeecCCCChHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 135 QYLVYEFCAAGNLAQHLLR-------KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
.++++.++..|+|..++.. ..+.++..+...++.|++.|++||| +.+++|.||..+|.+|++...+||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEecc
Confidence 8899999999999999972 2355777888999999999999999 89999999999999999999999999
Q ss_pred cccceecCCCccceeec-ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCC
Q 040826 208 FGLAKMLGMEESKVFTD-VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
-.+++.+-+.+....+. ...+..||+||.+.+..|+.++|+||||+++|||+|. +.|+. +.++.+ ....+..|
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-eIDPfE----m~~ylkdG 514 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-EIDPFE----MEHYLKDG 514 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-ccCHHH----HHHHHhcc
Confidence 99999876666655433 3468899999999999999999999999999999984 55544 333322 22222223
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.+- -.+-+|+++++.+|.-||+..|++|||++++..-|.+..
T Consensus 515 yRl-----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 515 YRL-----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred cee-----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 221 122356789999999999999999999999999888763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=254.17 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=199.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CC----CCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe-CCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PS----GQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE-GGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 134 (347)
...|.....||+|.||.||++.- ++ ...+|+|++...++ .....+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 45677788899999999999963 22 23789999977633 4578899999999999999999999877 789
Q ss_pred EEEEEeecCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC----CceEEe
Q 040826 135 QYLVYEFCAAGNLAQHLLR----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK----LEPKLS 206 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~----~~~kl~ 206 (347)
.++++||.+. +|...++- ....++...+..++.||+.|+.||| ++-+.||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999998 89888842 2356889999999999999999999 8889999999999999887 899999
Q ss_pred ecccceecCCCccc--eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChh--------hhhHH
Q 040826 207 DFGLAKMLGMEESK--VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFD--------ARDQL 275 (347)
Q Consensus 207 dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~--------~~~~~ 275 (347)
|+|+++.+...-.. .....+.|.+|.|||.+.| ..|+++.|+||+|||+.||+|.++.|.+... ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987542222 2344678999999999987 4699999999999999999999988865322 12333
Q ss_pred HHHHhhhcCCC-------CCccc-------ccCCCCCCCCC-HH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 276 TRKARDVSMGK-------RPIKD-------FEDPRLNGNIN-RA-------DFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 276 ~~~~~~~~~~~-------~~~~~-------~~~~~l~~~~~-~~-------~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+........ .++++ +..... .+.+ .. -....++|+..+|..||.+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~-~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYY-DNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhc-CcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 43333321110 00110 000000 0100 00 01347888999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.77 Aligned_cols=220 Identities=23% Similarity=0.236 Sum_probs=174.8
Q ss_pred cCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCC
Q 040826 77 GSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD 155 (347)
Q Consensus 77 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 155 (347)
|.+|.||++.. .+|+.+|+|.+..... ...|...+....|||++++++++......+++|||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc
Confidence 89999999995 4789999999866432 3345555555679999999999999999999999999999999886543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccc
Q 040826 156 SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235 (347)
Q Consensus 156 ~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 235 (347)
.+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++++|||.+...... .....++..|+|||
T Consensus 81 -~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE 152 (237)
T cd05576 81 -NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPE 152 (237)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCc
Confidence 4899999999999999999999 889999999999999999999999999987654321 12234567899999
Q ss_pred cccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHH
Q 040826 236 YMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVL 315 (347)
Q Consensus 236 ~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~ 315 (347)
...+..++.++|+||+|+++|+|++|..|+...... . ...... .++......+.+++.+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~-------~~~~~~----~~~~~~~~~~~~li~~ 211 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------I-------NTHTTL----NIPEWVSEEARSLLQQ 211 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------c-------cccccc----CCcccCCHHHHHHHHH
Confidence 998888899999999999999999999876421100 0 000000 1111233578999999
Q ss_pred hccCCCCCCCCHH
Q 040826 316 CVAKSSKGRPTID 328 (347)
Q Consensus 316 cl~~~p~~Rps~~ 328 (347)
||+.||.+|||+.
T Consensus 212 ~l~~dp~~R~~~~ 224 (237)
T cd05576 212 LLQFNPTERLGAG 224 (237)
T ss_pred HccCCHHHhcCCC
Confidence 9999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=284.31 Aligned_cols=143 Identities=31% Similarity=0.443 Sum_probs=128.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...++||+|+||.||+|... +++.||+|++..... ...+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57788899999999999999965 689999999865432 246778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
||+.+++|.+++... ..+++..++.++.|++.||.||| ..+|+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999988653 35889999999999999999999 7899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=262.59 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=193.9
Q ss_pred cccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCCh---------hHHHHHHHHhhcCCCCcceeeeeEEE-eCCeEE
Q 040826 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---------DSFSREVEGLSRVRHPNLVCLFGCCV-EGGEQY 136 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 136 (347)
|-..++||+|||+.||++. +...+.||+|+-.-..+. ....+|..+.+.|.||.||++++++. +.+.+|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 4555789999999999999 556788999976433222 24678999999999999999999986 566889
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccccee
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKM 213 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~ 213 (347)
-|+|||+|.+|.-++.++ ..+++.+++.|+.||+.||.||... +.+|+|.||||.|||+.+ .|.+||+|||++..
T Consensus 545 TVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999998998888654 4589999999999999999999765 789999999999999964 57899999999998
Q ss_pred cCCCccc------eeecccCCCCcccccccc-C---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 214 LGMEESK------VFTDVRGTIGYMDPEYMT-N---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 214 ~~~~~~~------~~~~~~~~~~y~aPE~~~-~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+..+... .++...||++|++||++. + ..++.++||||+|+|+|..+.|++||.......+-+... .+.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN--TIl 700 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN--TIL 700 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh--chh
Confidence 8643332 244567999999999874 2 358899999999999999999999998665443322211 110
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. .+.+.- +..+-...+...++.+||+.--++|....++..
T Consensus 701 k-AtEVqF--------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 701 K-ATEVQF--------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred c-ceeccC--------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 011110 011122246888999999999888988877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.18 Aligned_cols=236 Identities=31% Similarity=0.435 Sum_probs=192.4
Q ss_pred CCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhc
Q 040826 78 SAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR 153 (347)
Q Consensus 78 ~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 153 (347)
+||.||+|... +|+.+++|.+..... ...+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 589999999976544 56889999999999999999999999999999999999999999998865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccc
Q 040826 154 KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233 (347)
Q Consensus 154 ~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~a 233 (347)
... +++..++.++.+++.++.+|| +.+++|+||+|+||++++++.++++|||.+....... ......++..|++
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 443 899999999999999999999 7899999999999999999999999999998764321 3344568889999
Q ss_pred cccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHH
Q 040826 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIA 313 (347)
Q Consensus 234 PE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 313 (347)
||...+..++.++|+||||++++++++|..|+......... ......+..... ........++.+++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~~i 221 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFP---------PPEWKISPEAKDLI 221 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHhccCCCCc---------cccccCCHHHHHHH
Confidence 99998888899999999999999999999998653222111 111111111100 00000335799999
Q ss_pred HHhccCCCCCCCCHHHHHH
Q 040826 314 VLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 314 ~~cl~~~p~~Rps~~ei~~ 332 (347)
.+||..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=252.88 Aligned_cols=239 Identities=23% Similarity=0.304 Sum_probs=193.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
.+|.....||+|+||.|.++.-+ +.+.+|||++.++ .+.+-...|-.+|... +-|.++.+..++.+-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46677888999999999999854 5678999999775 3334455677777665 478899999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+.||+|--.+++-+ .+.++.+.-++..||-||-+|| ++||++||||.+|||++.+|.+||+|||++...- -.
T Consensus 429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD 503 (683)
T ss_pred EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence 99999999988886654 4888899999999999999999 9999999999999999999999999999998643 23
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
...+...+||+.|+|||++...+|+.++|+||+|++||||+.|++||.+... +.+. +.+.....
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF---~aI~ehnv----------- 567 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELF---QAIMEHNV----------- 567 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHH---HHHHHccC-----------
Confidence 3445678899999999999999999999999999999999999999985432 2222 22221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPT 326 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps 326 (347)
.++...+.+...++...+.+.|.+|..
T Consensus 568 -syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 -SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -cCcccccHHHHHHHHHHhhcCCccccC
Confidence 233344467788888899999999954
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=264.94 Aligned_cols=241 Identities=27% Similarity=0.362 Sum_probs=195.8
Q ss_pred cCCeeeecCCeeEEEEE-eCCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
..+.||+|.||+||-|+ -++|+.||||++.+- .....+.+|+.+|..++||.||.+...+++.+..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 34679999999999999 568999999998653 4456899999999999999999999999999999999999977
Q ss_pred CChHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC---CceEEeecccceecCCCccc
Q 040826 145 GNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK---LEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 145 gsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~~~ 220 (347)
+..+.+ ....+.+++....-+..||+.||.||| -++|+|+||||+|||+... ..+||||||.++..+....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555555 445577999999999999999999999 8899999999999999753 4699999999999753322
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
....+||+.|+|||++.++.|+..-|+||+|+++|.-++|.-||.-+.+-.+++...+--. .|.-..+
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy-----------Pp~PW~e 790 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY-----------PPNPWSE 790 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc-----------CCCchhh
Confidence 3457899999999999999999999999999999999999999986655555444322111 1111223
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~ 331 (347)
+. ++..+|+...|+..-.+|-|...-+
T Consensus 791 is----~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 IS----PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cC----HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 33 4577777778888888888877654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=232.20 Aligned_cols=210 Identities=26% Similarity=0.359 Sum_probs=174.5
Q ss_pred CcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.......||+|++|.|-+-+ ..+|...|+|++...-+. ....+|+++..+. .+|.+|.++|.+......++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 33344669999999998888 458999999999765443 3566777765554 699999999999999999999999
Q ss_pred cCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 142 CAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 142 ~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|+. ||..+.. ..+..+++..+-+|+..+..||.|||+ ...++|||+||+||||+.+|.+|+||||.+..+. +
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~--d 201 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV--D 201 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh--h
Confidence 987 8887764 367789999999999999999999998 5689999999999999999999999999998764 3
Q ss_pred cceeecccCCCCcccccccc----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhh
Q 040826 219 SKVFTDVRGTIGYMDPEYMT----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 281 (347)
+-..+...|...|||||.+. ...|+.++||||||+++.||.+++.|+......-.++..++.+
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 33344456888999999875 3479999999999999999999999998777666666665544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=247.36 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=195.5
Q ss_pred cccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe--------CCe
Q 040826 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE--------GGE 134 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~ 134 (347)
|.-..++|+|.||.||++. -++|+.||+|++....+ .....+|+.+|..++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4445679999999999999 45688899987765332 3467899999999999999999988753 235
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
+++||.+|+. +|...+.+....++..++.+++.++..||.|+| ...|+|||+||.|+||+.+|.++|+|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 8999999998 999988776678999999999999999999999 788999999999999999999999999999765
Q ss_pred CCCccc---eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh-------hhc
Q 040826 215 GMEESK---VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR-------DVS 283 (347)
Q Consensus 215 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~-------~~~ 283 (347)
...... ..+..+.|.+|.+||.+.| ..|+++.|+|..||++.+|+|+.+.+++.... .++..+.. +.+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSITKEVW 253 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccCCcccC
Confidence 432221 1334567999999998876 57999999999999999999999988754332 22211111 111
Q ss_pred CCCCCc---ccccCCCCCCCCC---HHHH------HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 284 MGKRPI---KDFEDPRLNGNIN---RADF------ESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 284 ~~~~~~---~~~~~~~l~~~~~---~~~~------~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+...+ ..+..+.+..... ++-. .+..+|+..++..||++|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111 1111111111000 0111 367889999999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.64 Aligned_cols=261 Identities=18% Similarity=0.199 Sum_probs=199.4
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCC--CC----cceeeeeEEEeCCeE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVR--HP----NLVCLFGCCVEGGEQ 135 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~~~~ 135 (347)
.+++|.....+|+|.||.|-.+... ++..||+|+++.-.. .+...-|++++.++. .| -++.+.++++..++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 3788999999999999999999844 578999999876433 345667999999994 22 367788889999999
Q ss_pred EEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec----------------
Q 040826 136 YLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT---------------- 198 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~---------------- 198 (347)
|+|+|.+ |.|+.+++..+ -.+++...++.+..|+++++++|| +.+++|-||||+||++.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 44999999764 467999999999999999999999 88999999999999983
Q ss_pred ----CCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH
Q 040826 199 ----EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274 (347)
Q Consensus 199 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~ 274 (347)
.+..++++|||.++.-. ...+..+.|..|.|||++.+-+++.++||||+||||+|+.||...|+... ..+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-NLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-cHHH
Confidence 13458999999998743 22356678999999999999999999999999999999999999987433 2333
Q ss_pred HHHHHhhhcCCCCCc--------------------------ccccCCCC--C--CCCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 275 LTRKARDVSMGKRPI--------------------------KDFEDPRL--N--GNINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~--------------------------~~~~~~~l--~--~~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
+....+....-+..+ ....++.. . -........++.+|+.++|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 322222211110000 00000000 0 01122445789999999999999999
Q ss_pred CCHHHHHHH
Q 040826 325 PTIDVVYEE 333 (347)
Q Consensus 325 ps~~ei~~~ 333 (347)
+|+.|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=276.28 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=169.3
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-C----CCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeE------EEeC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-S----GQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGC------CVEG 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~~ 132 (347)
..++|...+.||+|+||.||+|... + +..||+|++......+....+ .+++..+.++..+... ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 3567888999999999999999964 4 689999988654433322222 1222222222222211 2345
Q ss_pred CeEEEEEeecCCCChHHHhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCC
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKDSV-------------------LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~ 193 (347)
...++|+||+.+++|.+++...... .....+..++.|++.||.||| +++|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHH
Confidence 6889999999999999988643311 122345679999999999999 889999999999
Q ss_pred CEEecC-CCceEEeecccceecCCCccceeecccCCCCccccccccCC----------------------ccCCcccHHH
Q 040826 194 NILLTE-KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA----------------------KLTCASDIYS 250 (347)
Q Consensus 194 Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~s 250 (347)
|||++. ++.+||+|||++...............+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 67999999999986543333333455788999999965322 2334679999
Q ss_pred HHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC----CCC--CCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 251 FGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR----LNG--NINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 251 lG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----l~~--~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
|||++|||+++..++.... ..+...................+. +.. ...........+|+.+||+.||.+|
T Consensus 365 lGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999765543211 111111100000000000000000 000 0000112345689999999999999
Q ss_pred CCHHHHHHH
Q 040826 325 PTIDVVYEE 333 (347)
Q Consensus 325 ps~~ei~~~ 333 (347)
||+.+++++
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=267.80 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=204.5
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC-hhHHHHHHHHhhcC-CCCcceeeeeEEEe-----CCeEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN-TDSFSREVEGLSRV-RHPNLVCLFGCCVE-----GGEQY 136 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~ 136 (347)
++.|...+.+|.|.+|.||+++ .++|+.+|+|+.....+ .++...|.++++.. +|||++.++|++.. ++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4455666789999999999999 56899999999988655 45677888998888 59999999999864 56899
Q ss_pred EEEeecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 137 LVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
||||||.+||..|++++ .+..+.|..+.-|++.++.|+.+|| .+.++|||+|-.|||++.++.+|++|||++..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999999965 3677999999999999999999999 8889999999999999999999999999998875
Q ss_pred CCccceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.. ........||+.|||||++.- ..|+..+|+||||++..||.-|.+|+....+... .-.+...
T Consensus 175 sT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----LF~IpRN----- 243 (953)
T KOG0587|consen 175 ST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPRN----- 243 (953)
T ss_pred cc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----hccCCCC-----
Confidence 32 333455689999999999853 3577899999999999999999999875443311 1111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
|....--+.....++.+++..||.+|-.+||++.+++++
T Consensus 244 ----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 ----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111112244677899999999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=257.92 Aligned_cols=256 Identities=21% Similarity=0.205 Sum_probs=175.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-----------------CCCCEEEEEEcccCCC----------------hhHHHHHH
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-----------------PSGQVVAIKHIYKSNN----------------TDSFSREV 111 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~----------------~~~~~~e~ 111 (347)
.++|...++||+|+||.||+|.. .+++.||||++..... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56788899999999999999963 2356799999864321 11233466
Q ss_pred HHhhcCCCCc-----ceeeeeEEEe--------CCeEEEEEeecCCCChHHHhhcCC-----------------------
Q 040826 112 EGLSRVRHPN-----LVCLFGCCVE--------GGEQYLVYEFCAAGNLAQHLLRKD----------------------- 155 (347)
Q Consensus 112 ~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 155 (347)
..+.+++|.+ ++++++++.. .+..++||||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6667776554 3667776643 356899999999999999885321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccc
Q 040826 156 SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235 (347)
Q Consensus 156 ~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 235 (347)
..+++..+..++.|++.+|.||| +.+++||||||+||+++.++.++|+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12456778899999999999999 789999999999999999999999999998764322111111223478999999
Q ss_pred cccCCc--------------------cC--CcccHHHHHHHHHHHHhCCC-CcCCChhhhhHHHH------HHhhhcCCC
Q 040826 236 YMTNAK--------------------LT--CASDIYSFGIVALQLLSGQK-VIELDFDARDQLTR------KARDVSMGK 286 (347)
Q Consensus 236 ~~~~~~--------------------~~--~~~Dv~slG~il~~lltg~~-p~~~~~~~~~~~~~------~~~~~~~~~ 286 (347)
.+.... +. .+.|+||+||++++|+++.. |+............ .++......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875322 11 24799999999999999875 55321111111111 111111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSS---KGRPTIDVVYEE 333 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p---~~Rps~~ei~~~ 333 (347)
..+ .......+...+|+.++|..+| .+|+|+.|++++
T Consensus 461 ~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 100 0111223578888888998765 689999999863
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=258.69 Aligned_cols=239 Identities=22% Similarity=0.231 Sum_probs=197.6
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCC-EEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQ-VVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+......||-||||.|-++..++.. .+|+|.+++. ...+....|-.+|..++.|.|+++|-.|.++...|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3344456999999999999976544 3788888664 234567789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
-|-||.|+..+...+ .+......-++..+.+|+.||| ++||++|||||+|.+++.+|-+||.|||.++... ...
T Consensus 501 aClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGR 574 (732)
T ss_pred hhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc--cCC
Confidence 999999999886544 5888889999999999999999 8999999999999999999999999999999875 344
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.+..++||+.|.|||++.+...+.++|.||||+++|||++|++||....+. ..+..+.+.+..- .
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkGid~i--------------~ 639 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKGIDKI--------------E 639 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhhhhhh--------------h
Confidence 456789999999999999999999999999999999999999999854332 2333333333211 2
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPT 326 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps 326 (347)
+++.......+|+.+.+..+|.+|..
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 23344467888899999999999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.56 Aligned_cols=242 Identities=28% Similarity=0.410 Sum_probs=188.0
Q ss_pred ccCCeeeecCCee-EEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 69 WDRRFLGRGSAGL-VYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 69 ~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
...+.+|.|+.|+ ||+|.+ +|+.||||++.... .+...+|+..|+.- .||||+++++.-.+.+..|++.|.|.. +
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 3445689999887 699999 68899999886543 23456899999888 599999999999999999999999988 9
Q ss_pred hHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---C--CceEEeecccceecCCCc
Q 040826 147 LAQHLLRKD---SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---K--LEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 147 L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~--~~~kl~dfg~~~~~~~~~ 218 (347)
|.+++.... ........+..+.|++.||++|| +.+|+||||||.||||+. + ..++|+|||+++.+....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999997631 11222445778899999999999 789999999999999986 3 468999999999876433
Q ss_pred c--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 S--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ....+..||.+|+|||.+....-+.++|+||+||++|+.++| .+||......+ ..+..+......+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~NIl~~~~~L~~L~~- 737 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------ANILTGNYTLVHLEP- 737 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------hhhhcCccceeeecc-
Confidence 2 224567899999999999988888899999999999999997 78887443221 112222222111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..++ +..+|+.+|++++|..||++.+|+.
T Consensus 738 ------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 ------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 7899999999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=251.80 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=188.3
Q ss_pred cccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||-|+||.|.++. .++...+|+|.+.+.. .......|-++|..-..+=||+++-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 4455779999999999998 5567789999997643 234567888999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC----
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME---- 217 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---- 217 (347)
++||++-.+|.+.+ .|.+..++-+++.+..|+++.| ..|+|||||||+|||||.+|.+||+|||+++-+...
T Consensus 711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999999887654 4888889999999999999999 889999999999999999999999999998643110
Q ss_pred ----------cc-----------ce----------------eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh
Q 040826 218 ----------ES-----------KV----------------FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS 260 (347)
Q Consensus 218 ----------~~-----------~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt 260 (347)
++ .. ....+||..|+|||++....|+..+|+||.|++||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 00 00 012368999999999999999999999999999999999
Q ss_pred CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHH
Q 040826 261 GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIA 313 (347)
Q Consensus 261 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 313 (347)
|+.||..+.+...++... ....+++--..+..++++..-+.+|+
T Consensus 867 g~~pf~~~tp~~tq~kv~---------nw~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVI---------NWRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred CCCCccCCCCCcceeeee---------ehhhccccccccccCHHHHHHHHHHh
Confidence 999998765554432211 13344555556677777777777765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=235.16 Aligned_cols=242 Identities=24% Similarity=0.350 Sum_probs=192.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
.++|+..+.||+|+|+.|-.+.+ ++.+.+|+|++++.- +.+-...|-.+.... +||.+|.+..++.++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 45688889999999999999994 578899999887641 222244566666555 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|.||.+||+|--++++ ...++++.++-+...|+.||.||| ++||++||||.+|+|++..|.+|++|+|+++... .
T Consensus 329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 9999999999776654 445999999999999999999999 8999999999999999999999999999998743 3
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCC------hhhhhHHHHHHhhhcCCCCCccc
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELD------FDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+...++..+||+.|.|||.+.+..|...+|+|+||++++||+.|+.||..- ...++.+..+.-+ ..
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---kq----- 475 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---KQ----- 475 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh---hc-----
Confidence 445567789999999999999999999999999999999999999999742 1122222222211 11
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT 326 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps 326 (347)
+ .+++........+++.-|.+||.+|..
T Consensus 476 i-------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 I-------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c-------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 0 122223344566777789999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=223.70 Aligned_cols=208 Identities=35% Similarity=0.578 Sum_probs=183.6
Q ss_pred eeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
||+|++|.||++... +|+.+++|.+..... ...+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 489999999987665 3789999999999999999999999999899999999999899999
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCccceeecccCC
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEESKVFTDVRGT 228 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 228 (347)
++......+++..+..++.++++++.+|| +.+++|+||+|.||+++. ++.++++|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98765456899999999999999999999 789999999999999999 89999999999987543221 22334578
Q ss_pred CCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHH
Q 040826 229 IGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307 (347)
Q Consensus 229 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 307 (347)
..|++||..... .++.++|+|++|++++++ .
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~ 188 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------P 188 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------H
Confidence 899999999877 788999999999999999 3
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 308 SILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 308 ~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.+++.+|++.+|.+||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 58899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=236.08 Aligned_cols=258 Identities=24% Similarity=0.295 Sum_probs=192.6
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC-----CeEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GEQYL 137 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 137 (347)
....+.||.|+||.||.++.+ +|+.|++|++..-- ....+.+|+.+|...+|.|++..++..... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345678999999999999965 79999999886432 234677899999999999999988876543 25678
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++|.+.. +|.+.+. ..+.++...+.-++.||++||.||| +.+|.||||||.|.|++.|..+||||||+++....+
T Consensus 135 ~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8888876 7777553 4566888899999999999999999 899999999999999999999999999999987766
Q ss_pred ccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhh---------------
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD--------------- 281 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~--------------- 281 (347)
....++..+.|-.|.|||.+.| ..|+.+.||||+||++.||+..+-.|....+ .+++..+..-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 6666777788999999999987 5799999999999999999988877753221 1111111111
Q ss_pred ----hcCCCCCcccccCCCCCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 282 ----VSMGKRPIKDFEDPRLNGNIN-RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 282 ----~~~~~~~~~~~~~~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+..+....++ -+.+....+ .....+-..+.+.++.+||++|.+.++.+..
T Consensus 289 Ak~H~LR~~~k~Ps--~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPD--TQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hHHHhhccCCCCCC--ccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1111111111 011111111 1122456677778999999999998887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=221.87 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=203.7
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEe--CCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVE--GGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e 140 (347)
.++|...+++|+|-++.||.|. ..+++.+++|.+.+ .....+.+|+.+|..+. ||||+++++...+ .....|++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4667788899999999999999 55788999998854 34556889999999997 9999999999876 346789999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~ 219 (347)
|.++.+...+. +.++...++..+.+++.||.|+| +.||.|||+||.|++||. ...++|+|+|++..+.+ .
T Consensus 116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp--~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--G 186 (338)
T ss_pred hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC--C
Confidence 99986665544 34788889999999999999999 899999999999999995 55799999999999864 3
Q ss_pred ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-----CCccccc
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK-----RPIKDFE 293 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 293 (347)
...+..+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||..+.+..+++..+++.....+ ..+.-.+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 44455567778899998875 46788999999999999999999999988888888877776543221 1111223
Q ss_pred CCCCCCCC---------------CH-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNI---------------NR-ADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~---------------~~-~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+|.+.+.. .. -..++..+|+...|..|-.+|||+.|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 33322210 00 11267889999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=232.54 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=191.7
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCC-----C---CcceeeeeEEEe----
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVR-----H---PNLVCLFGCCVE---- 131 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~---- 131 (347)
.+|...++||.|.|++||+|. ..+.+.||+|+.+.... .+....|+.+|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 568888999999999999999 45678999999987655 456788999999884 2 369999998864
Q ss_pred CCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC----------
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK---------- 200 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~---------- 200 (347)
+.++|+|+|+. |.+|..++... -.-++...+.+|++|++.||.|||..| ||+|.||||+|||+..+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhh
Confidence 56899999998 44899988654 345899999999999999999999855 99999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 040826 201 -------------------------------------------------------------------------------- 200 (347)
Q Consensus 201 -------------------------------------------------------------------------------- 200 (347)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------------------------------------------------------------CceE
Q 040826 201 ----------------------------------------------------------------------------LEPK 204 (347)
Q Consensus 201 ----------------------------------------------------------------------------~~~k 204 (347)
-++|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0133
Q ss_pred EeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCCh-----hhhhHHHHHH
Q 040826 205 LSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF-----DARDQLTRKA 279 (347)
Q Consensus 205 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~-----~~~~~~~~~~ 279 (347)
|+|||-|..+. ..++.-..|..|.|||++.+..|+..+||||++|++|||+||-..|.+.. .+++.+..+.
T Consensus 395 IaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ 470 (590)
T KOG1290|consen 395 IADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM 470 (590)
T ss_pred Eeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence 34444333321 11222235778999999999999999999999999999999999887532 1233333333
Q ss_pred hhhc-------CCCCCcccccCCC-------------C------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 280 RDVS-------MGKRPIKDFEDPR-------------L------NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 280 ~~~~-------~~~~~~~~~~~~~-------------l------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.-.. .+...-.+|++.. | .-.++.+...++.+++.-||+.+|++|||+.+.++
T Consensus 471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 2211 1111112222211 0 11446678889999999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=243.50 Aligned_cols=195 Identities=26% Similarity=0.327 Sum_probs=169.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----------hhHHHHHHHHhhcCC---CCcceeeeeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----------TDSFSREVEGLSRVR---HPNLVCLFGCCV 130 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~---h~niv~~~~~~~ 130 (347)
...|...+++|.|+||.|++|.++ +...|++|.+.+.+- -.....|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 345778899999999999999976 456899999977531 124667999999997 999999999999
Q ss_pred eCCeEEEEEeec-CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 131 EGGEQYLVYEFC-AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 131 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
+++.+|++||-. ++.+|.+++..+. .+++.++..|++|++.|+++|| +.||+|||||-+|+.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999986 4558999886544 4899999999999999999999 8999999999999999999999999999
Q ss_pred cceecCCCccceeecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcC
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~ 266 (347)
.+.... +..+...+||..|.|||++.|.+|- ..-|||++|++||-++....|++
T Consensus 716 saa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998754 3445567899999999999998764 67899999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=222.93 Aligned_cols=258 Identities=24% Similarity=0.296 Sum_probs=194.9
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCC------e
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGG------E 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 134 (347)
.+|...+.+|.|.- .|..+. .-.++.|++|+...+. ......+|+..+..++|+|+++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667788898887 555555 3368999999886542 2345778999999999999999999987543 5
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.|+|||+|.. +|...+.. .+.-..+..++.|++.|+.||| +.||+||||||+||++..++.+||.|||+++.-
T Consensus 96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 7999999987 99888752 3566788899999999999999 899999999999999999999999999999875
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCCh-----------------hhhhHHHH
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDF-----------------DARDQLTR 277 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~-----------------~~~~~~~~ 277 (347)
... ..++..+.+..|.|||++.+..+...+||||+||++.||++|...|.+.. ...+++..
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 322 45677889999999999999889999999999999999999998776321 01122222
Q ss_pred HHhhhcCCCCCccc------ccCCCCCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 278 KARDVSMGKRPIKD------FEDPRLNG--NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 278 ~~~~~~~~~~~~~~------~~~~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+......+.... +-|..... +.++.......+|+.+||-.||++|-|+++++++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 22222222111111 11111111 1123344678889999999999999999998863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=216.63 Aligned_cols=197 Identities=36% Similarity=0.516 Sum_probs=170.1
Q ss_pred cccCCeeeecCCeeEEEEEeCC-CCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 68 DWDRRFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
|...+.||.|++|.||++...+ ++.+++|.+.... ....+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3456789999999999999764 8899999997654 35678899999999999999999999998899999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++......+++.....++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998654433789999999999999999999 779999999999999999999999999998876533211223
Q ss_pred cccCCCCccccccc-cCCccCCcccHHHHHHHHHHHHhCCCCcCC
Q 040826 224 DVRGTIGYMDPEYM-TNAKLTCASDIYSFGIVALQLLSGQKVIEL 267 (347)
Q Consensus 224 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~lltg~~p~~~ 267 (347)
...++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=244.72 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=199.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEccc--CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYK--SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.+|.|.+|.||+++. .+++..|+|.+.- ..+.....+|+-+++..+||||+.++|.+......+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 34666778899999999999994 4789999998864 34556678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
|.+|+|.+..+.. +++++.++...++...+|+.||| +.|-+|||||-.||++++.|.+|++|||.+..+.. ....
T Consensus 94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~K 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAK 168 (829)
T ss_pred cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh-hhhh
Confidence 9999999966544 56999999999999999999999 88999999999999999999999999999887642 2334
Q ss_pred eecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....||+.|||||+.. ...|...+|+|++|++..|+-..++|...-.+... +...-+ .... .|.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTk----S~~q-----pp~lk 238 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-LFLMTK----SGFQ-----PPTLK 238 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-HHHhhc----cCCC-----CCccc
Confidence 56678999999999774 56789999999999999999887776543222211 111111 1111 11111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+ .....+.+.++++.|+.++|.+|||++..+.
T Consensus 239 D--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 1133467999999999999999999987764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=209.99 Aligned_cols=260 Identities=19% Similarity=0.250 Sum_probs=196.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcC-CCCcceeeeeE-EEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRV-RHPNLVCLFGC-CVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e 140 (347)
.+.|...+.+|+|.||.+-++... +.+.+++|-+..+- ...+|.+|...--.| .|.||+..+++ +++.+.+.+++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 456777788999999999999954 67889999887654 456899998766566 48899988865 566778889999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--CCCceEEeecccceecCCCc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~~~kl~dfg~~~~~~~~~ 218 (347)
|++.|+|...+.. ..+.+....+++.|++.|+.|+| +++++|||||.+||||- +.-.+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--- 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--- 174 (378)
T ss_pred cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC---
Confidence 9999999988744 34778888899999999999999 89999999999999985 34479999999988643
Q ss_pred cceeecccCCCCccccccccC---C--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 219 SKVFTDVRGTIGYMDPEYMTN---A--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
........+..|.+||.... + ...+.+|+|+||+++|..+||..|++........+..+.+-........+..+
T Consensus 175 -~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 175 -TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred -ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 22233345678999997642 2 35678999999999999999999998554444444444433222122222222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
. .++ +.+.++..+-+.++|++|--..++.+.-.+...+..
T Consensus 254 ~-----~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 254 N-----PFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred c-----ccC----HHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 2 222 467888888999999999888888887777766654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=232.80 Aligned_cols=197 Identities=25% Similarity=0.243 Sum_probs=166.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCCC------CcceeeeeEEEeCCeE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVRH------PNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~ 135 (347)
+-.+|......|+|.|++|..|... -|+.||||++..... ...-..|+++|++|+. -|+++++-.|...+++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 4567888888999999999999954 578999999977643 4566789999999952 3799999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccce
Q 040826 136 YLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAK 212 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~ 212 (347)
|||||...- +|.+.+..-+ --+....+..++.|++-||..|. ..|++|.||||.|||++++. .+||||||.|.
T Consensus 510 ClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccc
Confidence 999999866 9999886533 34777889999999999999999 78999999999999999754 68999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCC
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIEL 267 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~ 267 (347)
.... +..++.-.+..|.|||++.|.+|+...|+||+||+||||.||+-.|.+
T Consensus 586 ~~~e---neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 586 FASE---NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccc---ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 7542 233444566789999999999999999999999999999999988864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=203.23 Aligned_cols=172 Identities=22% Similarity=0.180 Sum_probs=133.0
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|||.+++...+..+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------Q 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------c
Confidence 6899999766667999999999999999999999 555 999999999999999 9998865322 1
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..|+..|+|||++.+..++.++||||||+++|+|++|+.||.........+............. - ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~ 134 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR--------D-RSNLES 134 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc--------c-cccHHH
Confidence 2578999999999999999999999999999999999999875443333333333222111100 0 011112
Q ss_pred HHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 305 DFE--SILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 305 ~~~--~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+ ++.+++.+||+.+|.+|||+.++++.+..+..+..
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~ 174 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL 174 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence 222 69999999999999999999999999988865543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=217.20 Aligned_cols=266 Identities=26% Similarity=0.282 Sum_probs=201.8
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 135 (347)
+....+.|...++||.|.|++||+++.. .++.||+|.+..........+|++.|..+. +.||+++.+++..++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3445567888999999999999999843 467899999998888888999999999995 99999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceec
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKML 214 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~ 214 (347)
.+|+||++..+..++... ++...+..+++.++.||.++| .+||+|||+||+|++.+. -+.-.|.|||++...
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999888887744 668889999999999999999 999999999999999985 457899999999721
Q ss_pred CCC---------------c------------------c----------ceeecccCCCCccccccccC-CccCCcccHHH
Q 040826 215 GME---------------E------------------S----------KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYS 250 (347)
Q Consensus 215 ~~~---------------~------------------~----------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s 250 (347)
... . . ...-...||++|.|||++.. ...+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 000 0 0 00111358999999999875 45678999999
Q ss_pred HHHHHHHHHhCCCCcCCChhhhhHHHHHHhhh----------cCCC------CC----------cccccCCCCC------
Q 040826 251 FGIVALQLLSGQKVIELDFDARDQLTRKARDV----------SMGK------RP----------IKDFEDPRLN------ 298 (347)
Q Consensus 251 lG~il~~lltg~~p~~~~~~~~~~~~~~~~~~----------~~~~------~~----------~~~~~~~~l~------ 298 (347)
.|++++-+++++.||....++.+.+.+.+... ..+. .. ...+.-..+.
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999976555444433332211 0111 00 0000000000
Q ss_pred ---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 ---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....-....+++|+.+|+..||.+|.|+++.+++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111222488999999999999999999998863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=250.54 Aligned_cols=195 Identities=15% Similarity=0.207 Sum_probs=138.0
Q ss_pred cCCC-CcceeeeeEE-------EeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCcee
Q 040826 116 RVRH-PNLVCLFGCC-------VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187 (347)
Q Consensus 116 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 187 (347)
.++| .||..+++.+ .....+.+++|++.+ +|.+++......+++..++.++.|+++||.||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4445 5777777766 223457788998755 999999765667999999999999999999999 899999
Q ss_pred CCCCCCCEEecCC-------------------CceEEeecccceecCCCcc---------------ceeecccCCCCccc
Q 040826 188 RDIKLTNILLTEK-------------------LEPKLSDFGLAKMLGMEES---------------KVFTDVRGTIGYMD 233 (347)
Q Consensus 188 ~dl~p~Nili~~~-------------------~~~kl~dfg~~~~~~~~~~---------------~~~~~~~~~~~y~a 233 (347)
|||||+|||++.. +.+|++|||+++....... .......||..|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4456666666543210000 00011347888999
Q ss_pred cccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHH
Q 040826 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIA 313 (347)
Q Consensus 234 PE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~ 313 (347)
||++.+..++.++|||||||++|||++|.+|+.... ........... .+.. .........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~----------~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL----------PPQI-----LLNWPKEASFC 245 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc----------Chhh-----hhcCHHHHHHH
Confidence 999999999999999999999999999887754211 11111111110 0000 01123466888
Q ss_pred HHhccCCCCCCCCHHHHHH
Q 040826 314 VLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 314 ~~cl~~~p~~Rps~~ei~~ 332 (347)
.+||+++|.+|||+.|+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=186.32 Aligned_cols=262 Identities=17% Similarity=0.172 Sum_probs=208.1
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
-.|...++||+|+||.++.|+ +-+++.||||.-...++..++..|....+.|. .++|..++-+-..+..-.||+|..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 467888999999999999999 56899999998888888889999999999885 788988888877777888999988
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-----CceEEeecccceecCCCc
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-----LEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-----~~~kl~dfg~~~~~~~~~ 218 (347)
|.||.|++.-.+..|+...++.++.|++.-++++| ++.+|.|||||+|+||..- ..+.++|||++..+.+..
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 66999998888889999999999999999999999 8899999999999999643 358999999999886433
Q ss_pred ------cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 219 ------SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 219 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..+.....||.+||+-....+...+..-|.=|||.+++++|.|..|+.+-..+. ....-..+ ++.+-..-
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~kYeKI--Ge~Kr~T~ 259 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKEKYEKI--GETKRSTP 259 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHHHHHHh--ccccccCC
Confidence 334566789999999999999999999999999999999999999998532211 11111111 11111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+. +.....++++...+...-..+-.+-|..+-+...+.+++..
T Consensus 260 i~-----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 IE-----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HH-----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 11 12223445677776656566667779999999999888764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=199.93 Aligned_cols=162 Identities=22% Similarity=0.209 Sum_probs=125.6
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC--CCCEEEEEEcccCC-------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP--SGQVVAIKHIYKSN-------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|... +++.+|+|++.... ....+.+|++++++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4567888999999999999999854 57788999865321 13458899999999999999853322 246
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCC-CCCCEEecCCCceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI-KLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl-~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.++||||++|++|.. .. ... ...++.|++++|.||| +.|++|||| ||+|||++.++.++|+|||+++.
T Consensus 93 ~~LVmE~~~G~~L~~-~~-~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR-PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHH-hC-ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 799999999999963 21 111 1467899999999999 889999999 99999999999999999999997
Q ss_pred cCCCccc-------eeecccCCCCccccccccC
Q 040826 214 LGMEESK-------VFTDVRGTIGYMDPEYMTN 239 (347)
Q Consensus 214 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~ 239 (347)
....... ......++..|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 6432211 1123457888999998853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-24 Score=189.54 Aligned_cols=257 Identities=19% Similarity=0.201 Sum_probs=194.2
Q ss_pred CcccCCeeeecCCeeEEEEEeCCC--CEEEEEEcccCCCh--hHHHHHHHHhhcCCC----CcceeeeeEE-EeCCeEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSG--QVVAIKHIYKSNNT--DSFSREVEGLSRVRH----PNLVCLFGCC-VEGGEQYL 137 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~--~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 137 (347)
+|...++||+|+||.||.+...+. ..+|+|........ ..+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788889999999999999996543 47888877654322 268889998888862 5888888887 46778899
Q ss_pred EEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-----CceEEeecccc
Q 040826 138 VYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-----LEPKLSDFGLA 211 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-----~~~kl~dfg~~ 211 (347)
||+.. |.+|.++..... ..++.....+++.|++.+|.+|| +.|++||||||.|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 669999875544 78999999999999999999999 8999999999999999854 46999999999
Q ss_pred e--ecCCCcc----c--e-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHh
Q 040826 212 K--MLGMEES----K--V-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKAR 280 (347)
Q Consensus 212 ~--~~~~~~~----~--~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~ 280 (347)
+ .+..... . . .....||..|.++....+...+.+.|+||++.++.+++.|..|+...... .........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 4321111 1 1 12355999999999999999999999999999999999999998643321 111111111
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
...... ..... ..++.++...+-..+...+|....+...+++.....
T Consensus 255 ~~~~~~-----------~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLLTDR-----------FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhcccc-----------ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111110 01112 245666666566689999999999999998887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=186.40 Aligned_cols=243 Identities=18% Similarity=0.281 Sum_probs=185.6
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
..+|.+...|..|+|++..+. ++.|++.-. ...++|..|.-.|+-..||||++++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 356889999999999996544 556665432 234578889999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe--ecccceecCCCccceee
Q 040826 147 LAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS--DFGLAKMLGMEESKVFT 223 (347)
Q Consensus 147 L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~--dfg~~~~~~~~~~~~~~ 223 (347)
|+..++.. +-.....++.+++.++++|++|||+. ..-+--..|++..++||++.+.+|+ |--.+. ...
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------qe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEV 344 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------ecc
Confidence 99999754 34567788999999999999999975 3334455799999999999887764 221111 112
Q ss_pred cccCCCCccccccccCCccC---CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLT---CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
+..-.+.|++||.++..+-+ .++|+|||++++|||.|...||..-.+.+-.+. ....+ ++-.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----ialeg-----------lrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----IALEG-----------LRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----hhhcc-----------cccc
Confidence 23356789999999876533 579999999999999999999974332222211 11112 2224
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
+++.....+.+|+.-|+..||.+||.+..|+-.||++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 44555678999999999999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=172.80 Aligned_cols=261 Identities=19% Similarity=0.163 Sum_probs=204.2
Q ss_pred hcCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC-CcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-PNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
...|...++||+|+||.+|.|. ..+|+.||+|.-.+......+..|..+.+.+++ ..|..+..+..+...-.+||+..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 5678899999999999999999 668999999988887777888999999999974 56777777777788889999988
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeecccceecCCCcc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~~ 219 (347)
|.||.+++.-....++....+-++-|++.-++|+| .++++||||||+|+|..- ...+.++|||++..+.+...
T Consensus 94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 66999988666677999999999999999999999 889999999999999863 45799999999998753222
Q ss_pred ------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh-H-HHHHHhhhcCCCCCccc
Q 040826 220 ------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD-Q-LTRKARDVSMGKRPIKD 291 (347)
Q Consensus 220 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~ 291 (347)
.......||.+|.+-....+...+...|+=|+|.+|.++..|..|+++-..... + ++.+...-... ++.
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~--~ie- 246 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST--PIE- 246 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC--CHH-
Confidence 222335689999988888888888899999999999999999999986433221 1 22221111110 000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
......+.+..-.+..|-..--++-|....+.+.+.-++++
T Consensus 247 --------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 247 --------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred --------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 11223346788888888888888889999888888877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-22 Score=181.69 Aligned_cols=255 Identities=32% Similarity=0.399 Sum_probs=195.5
Q ss_pred cccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCC-cceeeeeEEEeCCeEEEEEee
Q 040826 68 DWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHP-NLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 141 (347)
|...+.||.|+|+.||++... ..+++|.+..... ...+.+|...+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 445677999999999999986 7889998876533 44688999999999988 799999999777778999999
Q ss_pred cCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCCCc
Q 040826 142 CAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 142 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 218 (347)
+.++++.+++.... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997665443 26899999999999999999999 88899999999999999988 79999999998654322
Q ss_pred cc-----eeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCC
Q 040826 219 SK-----VFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRP 288 (347)
Q Consensus 219 ~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 288 (347)
.. ......++..|++||.+.+ ..++...|+||+|++++++++|..|+...... .............. .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--S 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--c
Confidence 21 2355679999999999987 57888999999999999999999997654421 11222221111111 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
... .............+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 00001012223578889999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=206.30 Aligned_cols=250 Identities=21% Similarity=0.258 Sum_probs=183.2
Q ss_pred cCCeeeecCCeeEEEEEe-CCCCEEEEEEcc----cCCChh----HHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 70 DRRFLGRGSAGLVYKGVL-PSGQVVAIKHIY----KSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
....+|.|++|.|+.... ........|... +..... .+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467799999998887773 233333333322 222111 24456777788899999888877766555555599
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
|+++ +|..++... ..+....+..+++|+..|+.|+| ..|+.|||+|++|++++.+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988554 35888999999999999999999 88999999999999999999999999999987654333
Q ss_pred --ceeecccCCCCccccccccCCccCC-cccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 --KVFTDVRGTIGYMDPEYMTNAKLTC-ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 --~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.......|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+++....... .. ......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~---~~--~~~~~~-- 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS---DQ--RNIFEG-- 549 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc---cc--cccccC--
Confidence 3355678999999999999988875 6899999999999999999998654443332100000 00 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+......+...++.++|+.||.+|.|+++|++
T Consensus 550 -~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 -PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00122344467888889999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=173.29 Aligned_cols=169 Identities=12% Similarity=0.052 Sum_probs=131.9
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--hh---------HHHHHHHHhhcCCCCcceeeeeEEEeC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TD---------SFSREVEGLSRVRHPNLVCLFGCCVEG 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~---------~~~~e~~~l~~l~h~niv~~~~~~~~~ 132 (347)
..++|...+++|.|+||.||+... ++..+++|.+.+... .. .+.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 577899999975422 11 157899999999999999998886543
Q ss_pred --------CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceE
Q 040826 133 --------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK 204 (347)
Q Consensus 133 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~k 204 (347)
+..+++|||++|.+|.++.. ++. ....+++.++..+| ..|++|+|++|+|++++++| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35899999999999988631 222 24568999999999 89999999999999999988 99
Q ss_pred EeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHH
Q 040826 205 LSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259 (347)
Q Consensus 205 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ll 259 (347)
++|||........... ..++....+..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999987654211111 01334445667999999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=167.70 Aligned_cols=136 Identities=21% Similarity=0.239 Sum_probs=107.2
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-----------hhH-----------------HHHHHHHhhcCCCCcce
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-----------TDS-----------------FSREVEGLSRVRHPNLV 123 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~-----------------~~~e~~~l~~l~h~niv 123 (347)
..||+|++|.||+|...+|+.||+|++..... ... ...|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 56999999999999987899999999865421 011 23488999999877764
Q ss_pred eeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCceeCCCCCCCEEecCCCc
Q 040826 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL-HHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-h~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
........ ..++||||++++++...... ...++.....+++.|++.+|.++ | +.|++||||||+||+++ ++.
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCc
Confidence 43332222 23899999999777654332 34688999999999999999999 6 77999999999999998 478
Q ss_pred eEEeecccceec
Q 040826 203 PKLSDFGLAKML 214 (347)
Q Consensus 203 ~kl~dfg~~~~~ 214 (347)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=162.75 Aligned_cols=138 Identities=22% Similarity=0.240 Sum_probs=109.6
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh----------------------------hHHHHHHHHhhcCCCCcc
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT----------------------------DSFSREVEGLSRVRHPNL 122 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~e~~~l~~l~h~ni 122 (347)
...||+|++|+||+|...+|+.||+|.+...... ..+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999778999999998764210 113478889999998887
Q ss_pred eeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCC
Q 040826 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 123 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~ 201 (347)
.....+... ..++||||++++++...... ...++.....+++.|++.++.++| . .|++|+||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 544443333 24899999998865443222 235778899999999999999999 6 8999999999999999 78
Q ss_pred ceEEeecccceecC
Q 040826 202 EPKLSDFGLAKMLG 215 (347)
Q Consensus 202 ~~kl~dfg~~~~~~ 215 (347)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=181.06 Aligned_cols=219 Identities=27% Similarity=0.425 Sum_probs=166.9
Q ss_pred hhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCC
Q 040826 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193 (347)
Q Consensus 114 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~ 193 (347)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.-...+.++++.||.|||+ +.-..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 467889999999999999999999999999999999998877778888999999999999999995 333499999999
Q ss_pred CEEecCCCceEEeecccceecCC-CccceeecccCCCCccccccccCCc-------cCCcccHHHHHHHHHHHHhCCCCc
Q 040826 194 NILLTEKLEPKLSDFGLAKMLGM-EESKVFTDVRGTIGYMDPEYMTNAK-------LTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 194 Nili~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
|.+++....+|++|||+...... ..........-..-|.|||.+.+.. .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999887532 1111122223455799999987641 466799999999999999999999
Q ss_pred CCChhhhhHHHHHHhhhcC-CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 266 ELDFDARDQLTRKARDVSM-GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.......+. .+....+.. +..+. .|.+... .+..+++..++.+||..+|.+||++.+|...++.+....
T Consensus 159 ~~~~~~~~~-~eii~~~~~~~~~~~----rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKKGGSNPF----RPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCCh-HHHHHHHHhcCCCCc----Ccchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 864333332 112211221 11111 1111100 033457999999999999999999999999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=188.94 Aligned_cols=252 Identities=19% Similarity=0.188 Sum_probs=188.4
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEEEe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 140 (347)
-.+.|...+.+|+|+||+||.|...+|+.||+|.-.+....+. .--.+++.||+ -+.|+++..++...+..+||+|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-eehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3456777889999999999999987899999998876654432 22234555565 3456667777777788899999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-------CCCceEEeeccccee
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-------EKLEPKLSDFGLAKM 213 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-------~~~~~kl~dfg~~~~ 213 (347)
|.+.|||.+++. .....++...+.++.|++..+.+|| ..+|||+||||+|.||. ++..++|+|||.+..
T Consensus 775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 999999999986 4556899999999999999999999 88999999999999995 344699999998876
Q ss_pred cCC-CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 214 LGM-EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 214 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+.. .+...+...++|-.+--+|...|.+++..+|.|.|+.+++-||.|+..- ...+.. ..
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~g~~---~~ 911 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKNGSS---WM 911 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcCCcc---ee
Confidence 643 3334677888999999999999999999999999999999999997421 111110 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.++.+.--+.++. ..++....|..|-..=|...++...++..+.+..
T Consensus 912 ~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 912 VKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred ccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 1111111222333 3344444555444445889999999998877643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=194.70 Aligned_cols=245 Identities=24% Similarity=0.255 Sum_probs=176.0
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh---hHHHHHHHH--hhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT---DSFSREVEG--LSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++...+.||.+.|=.|.+|+..+|. |+||++.+.... +.+.+++.- ...++|||.+++.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556678999999999999998888 899988765432 344444433 4455899999998887777788899999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec-CCCcc-
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEES- 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~-~~~~~- 219 (347)
... +|+|.+.. .+.+..-+..=|+.|++.|+.-+| ..||+|||||.+||||+.=+-+.|+||..-+.. .+.+.
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 877 99998843 344566666668899999999999 899999999999999999889999999765432 11111
Q ss_pred ce----eecccCCCCccccccccC----------Cc-cCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhh-
Q 040826 220 KV----FTDVRGTIGYMDPEYMTN----------AK-LTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV- 282 (347)
Q Consensus 220 ~~----~~~~~~~~~y~aPE~~~~----------~~-~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~- 282 (347)
.. +.......+|.|||.+.. .+ .+++.||||+||++.||++ |+++|.. .++..+....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~~~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSGNA 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhccCc
Confidence 11 222234557999997743 12 5678999999999999987 5777752 2222221110
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
..++.-+..+.| ..+.+|+..|++.||.+|.|+++.++.-
T Consensus 253 ~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 253 DDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred cCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 000000111111 2589999999999999999999999873
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=155.08 Aligned_cols=182 Identities=15% Similarity=0.070 Sum_probs=136.6
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh------hHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeec
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT------DSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
....|++|+||+|+.+.. .+..++.+.+...... ..+.+|+++|++++ |+++..++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999997766 6777887777655442 14778999999995 5788888875 3468999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCC-CCCCEEecCCCceEEeecccceecCCCccc-
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI-KLTNILLTEKLEPKLSDFGLAKMLGMEESK- 220 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl-~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 220 (347)
+|.+|...... ....++.|+++++.++| +.|++|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99888654311 11357889999999999 899999999 799999999999999999999865432210
Q ss_pred ---ee--------ecccCCCCccccccccC-CccC-CcccHHHHHHHHHHHHhCCCCcCC
Q 040826 221 ---VF--------TDVRGTIGYMDPEYMTN-AKLT-CASDIYSFGIVALQLLSGQKVIEL 267 (347)
Q Consensus 221 ---~~--------~~~~~~~~y~aPE~~~~-~~~~-~~~Dv~slG~il~~lltg~~p~~~ 267 (347)
.. .-...++.|++|+...- ...+ ...+.++.|.-+|.++|++.+.-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 00125677777774432 1223 578999999999999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=164.69 Aligned_cols=227 Identities=19% Similarity=0.235 Sum_probs=143.1
Q ss_pred ccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCC----------CCcceeeeeEEE--
Q 040826 69 WDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVR----------HPNLVCLFGCCV-- 130 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~----------h~niv~~~~~~~-- 130 (347)
...+.||.|+++.||.++.. +|+.+++|....... .+.+.+|.-....+. |-.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34567999999999999965 689999998865432 234555544333321 112222222211
Q ss_pred -------eC---C-----eEEEEEeecCCCChHHHhh---cCCC---CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCC
Q 040826 131 -------EG---G-----EQYLVYEFCAAGNLAQHLL---RKDS---VLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189 (347)
Q Consensus 131 -------~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~---~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 189 (347)
.. + +.+++|+-+.+ +|.+++. .... .+....++.+..|+.+.+++|| ..|++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 11 1 23678888866 8888763 2221 2334455667789999999999 88999999
Q ss_pred CCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccC--------CccCCcccHHHHHHHHHHHHhC
Q 040826 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--------AKLTCASDIYSFGIVALQLLSG 261 (347)
Q Consensus 190 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~lltg 261 (347)
|+|+|++++.+|.+.|+||+.....+. .......+..|.|||.... -.++.+.|.|+||+++|.|+++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999988776432 1111345678999997643 2578899999999999999999
Q ss_pred CCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 262 QKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 262 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
..||........... .-..+. +.++.+..|+..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999985432211100 001233 566789999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-22 Score=182.46 Aligned_cols=229 Identities=29% Similarity=0.336 Sum_probs=180.9
Q ss_pred eeecCCeeEEEEEe----CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 74 LGRGSAGLVYKGVL----PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 74 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+|+|.||.|+++.. +.|..+++|.+.+.. .......|-.++..++ ||.++++...+..++..++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998862 356788888876542 2224556777888886 99999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|.|...+.+. ..+.+.........++-++.++| +.+++|+|+|++||+++.+|.+++.|||+++..-....
T Consensus 82 g~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 82 GDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred chhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 9998877543 44677777778888999999999 89999999999999999999999999999986432211
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
.+||..|||||++. ....++|.||||+++++|+||..||.. + ..+.+...+. .+++.
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~----~~~~Il~~~~------------~~p~~ 209 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----D----TMKRILKAEL------------EMPRE 209 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----H----HHHHHhhhcc------------CCchh
Confidence 17999999999998 567799999999999999999999984 2 2222221111 34556
Q ss_pred HHHHHHHHHHHhccCCCCCCCCH--HHHHHHH
Q 040826 305 DFESILKIAVLCVAKSSKGRPTI--DVVYEEI 334 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~--~ei~~~l 334 (347)
.......++..++..+|.+|.-. ..+.+..
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 66788888999999999999665 3444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=149.58 Aligned_cols=134 Identities=22% Similarity=0.257 Sum_probs=103.3
Q ss_pred ccCCeeeecCCeeEEEEEeCCCCEEEEEEcccC--CChhHHHHHHHHhhcC-----CCCcceeeeeEEEeCC---e-EEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS--NNTDSFSREVEGLSRV-----RHPNLVCLFGCCVEGG---E-QYL 137 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l 137 (347)
...++||+|+||.||. .+.....+||++... .....+.+|+..++.+ .||||++++|++.++. . +.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333468887653 2345789999999999 5799999999998863 3 347
Q ss_pred EEee--cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhhccCCCceeCCCCCCCEEecC----CCceEEeeccc
Q 040826 138 VYEF--CAAGNLAQHLLRKDSVLTWERRVKILRDCALAL-RYLHHYIDGCIVHRDIKLTNILLTE----KLEPKLSDFGL 210 (347)
Q Consensus 138 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~Lh~~~~~~i~H~dl~p~Nili~~----~~~~kl~dfg~ 210 (347)
|+|| +.++||.+++.+. .+++. ..++.|++.++ .||| +++|+||||||+||+++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 5678999999653 35555 35677888777 9999 889999999999999974 33799999543
Q ss_pred c
Q 040826 211 A 211 (347)
Q Consensus 211 ~ 211 (347)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=156.81 Aligned_cols=197 Identities=19% Similarity=0.223 Sum_probs=139.6
Q ss_pred CCCcceeeeeEEEe---------------------------CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHH
Q 040826 118 RHPNLVCLFGCCVE---------------------------GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC 170 (347)
Q Consensus 118 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi 170 (347)
.||||+++.++|.+ ....|+||..++. ||.+++-. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 49999999987643 1246899999887 99999844 346777788899999
Q ss_pred HHHHHHhhhccCCCceeCCCCCCCEEec--CCC--ceEEeecccceecCCC-----ccceeecccCCCCccccccccCCc
Q 040826 171 ALALRYLHHYIDGCIVHRDIKLTNILLT--EKL--EPKLSDFGLAKMLGME-----ESKVFTDVRGTIGYMDPEYMTNAK 241 (347)
Q Consensus 171 ~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~--~~kl~dfg~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~ 241 (347)
++|+.||| .+|+.|||+|++|||+. +|+ .++++|||.+---... .....-..-|...-||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 89999999999999984 333 4799999976532110 001111234778899999886432
Q ss_pred ------cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHH
Q 040826 242 ------LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVL 315 (347)
Q Consensus 242 ------~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~ 315 (347)
--.++|.|+.|.+.||+++...||+......-+. +.+.+-.-|.+.+ .+...+.+|+..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-----------r~Yqe~qLPalp~----~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-----------RTYQESQLPALPS----RVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-----------hhhhhhhCCCCcc----cCChHHHHHHHH
Confidence 1248999999999999999999998521111111 1122222222222 333578999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q 040826 316 CVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 316 cl~~~p~~Rps~~ei~~~l~ 335 (347)
.|+.||.+|+|..-....|+
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999876665554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=151.87 Aligned_cols=139 Identities=20% Similarity=0.170 Sum_probs=109.0
Q ss_pred CcccCCeeeecCCeeEEEEE--eCCCCEEEEEEcccCCC--------------------------hhHHHHHHHHhhcCC
Q 040826 67 NDWDRRFLGRGSAGLVYKGV--LPSGQVVAIKHIYKSNN--------------------------TDSFSREVEGLSRVR 118 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~--------------------------~~~~~~e~~~l~~l~ 118 (347)
.|...+.||+|++|.||+|. ..+|+.||+|.+..... ...+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 56899999998865321 012457999999997
Q ss_pred CCc--ceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-ceeCCCCCCCE
Q 040826 119 HPN--LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC-IVHRDIKLTNI 195 (347)
Q Consensus 119 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~-i~H~dl~p~Ni 195 (347)
+.+ +.++++. ...++||||+++++|....... ..+.......++.|++.++.+|| ..| ++|+||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 532 3334432 2358999999998887654332 34566677899999999999999 788 99999999999
Q ss_pred EecCCCceEEeecccceec
Q 040826 196 LLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 196 li~~~~~~kl~dfg~~~~~ 214 (347)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999988754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.9e-19 Score=147.91 Aligned_cols=132 Identities=23% Similarity=0.332 Sum_probs=111.5
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+.||+|++|.||+|.. +|..+++|....... ...+.+|+.++..+.|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999998 677899997654321 12467899999999999888777777777788999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
++|++|.+++.... . ....++.+++.++.++| +.+++|+|++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885422 2 78889999999999999 88999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=144.08 Aligned_cols=135 Identities=17% Similarity=0.149 Sum_probs=106.6
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC------------------------hhHHHHHHHHhhcCCCCc-
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN------------------------TDSFSREVEGLSRVRHPN- 121 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~e~~~l~~l~h~n- 121 (347)
.|...+.||+|+||.||++...+|+.||||++..+.. ......|...+..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3667788999999999999988899999998654320 112567888888887764
Q ss_pred -ceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC
Q 040826 122 -LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK 200 (347)
Q Consensus 122 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~ 200 (347)
+...++ ....+++|||+++++|.+.... .....++.+++.++.++| ..|++|+||+|+||+++++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 333333 2456899999999998765421 345678899999999999 7899999999999999999
Q ss_pred CceEEeecccceecC
Q 040826 201 LEPKLSDFGLAKMLG 215 (347)
Q Consensus 201 ~~~kl~dfg~~~~~~ 215 (347)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-20 Score=163.54 Aligned_cols=172 Identities=25% Similarity=0.402 Sum_probs=129.8
Q ss_pred eEEEEEeecCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 134 EQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
..++.|++|...+|.+++.. .....++.....++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 46899999999999999964 34567888999999999999998 57899999999999999999999999998
Q ss_pred eecCCCc-----cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 212 KMLGMEE-----SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 212 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
....... ....+...||..||+||.+.+..|+.++||||||++|+|+++ -..++. - .....++..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r----~~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----R----IATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----H----HHhhhhhhcC
Confidence 8765333 233555679999999999999999999999999999999997 333322 1 1111222222
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
.-+ |....+. +.=+.|+++++.+.|.+||++.+.
T Consensus 476 ~ip------~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 476 IIP------PEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CCC------hHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 211 0000011 235678889999999999954443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=143.50 Aligned_cols=128 Identities=24% Similarity=0.371 Sum_probs=104.3
Q ss_pred eeeecCCeeEEEEEeCCCCEEEEEEcccCC--C--------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--N--------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.||+|++|.||+|.+ +|..+++|...... . ...+.+|+++++.+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 57789999865421 1 134668999999998887655555555666778999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
+|++|.+.+..... .++.|++.+|.+|| +.+++|+|++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999987743211 78999999999999 88999999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=161.23 Aligned_cols=134 Identities=24% Similarity=0.325 Sum_probs=108.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEE-cccC-C--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKH-IYKS-N--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~-~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
..|...+.||+|+||.||+|.+.++. +++|+ .... . ....+.+|+++++.++|+++.....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456788999999999999975544 33333 2221 1 123577899999999999998887777777778
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
++||||+++++|.+++. ....++.|+++++.+|| +.+++||||||+||++ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999874 35678999999999999 8899999999999999 677999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.6e-18 Score=162.31 Aligned_cols=210 Identities=25% Similarity=0.259 Sum_probs=140.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.+..|++|-||...++ +.+..|+|.-+... +++ ||..+ .+..+.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----------ilR-----nilt~------a~npfvv------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----------ILR-----NILTF------AGNPFVV------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch----------hhh-----ccccc------cCCccee------
Confidence 45667788999999999999865 56777874321111 111 11111 1122223
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc------
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE------ 218 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~------ 218 (347)
|+-.+.+...+ .++... +.+++||| +.||+|||+||+|.+|+.-|.+|++|||++.......
T Consensus 136 gDc~tllk~~g-~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 GDCATLLKNIG-PLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred chhhhhcccCC-CCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 34344343322 233222 77999999 8999999999999999999999999999987542111
Q ss_pred ------cc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 219 ------SK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 219 ------~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.. .-...+||+.|.|||++....|...+|+|++|+++|+.+.|..||..+.+.+ -+..++.+... ..
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i~----wp 278 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE----WP 278 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhcc----cc
Confidence 01 1234579999999999999999999999999999999999999998663321 11112211110 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
+-+.....+..+++.+.|+.+|..|---.
T Consensus 279 ---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 ---------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ---------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 01122335789999999999999995433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-16 Score=126.16 Aligned_cols=134 Identities=20% Similarity=0.167 Sum_probs=113.1
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC--CcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH--PNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
.+.||+|.++.||++...+ ..+++|..........+.+|...++.++| .++.+++++....+..++++||++++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 4679999999999999854 78999988665445678899999999976 58888888887778899999999987775
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+ +......++.++++++.++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 82 ~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 5566778899999999999954446899999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=130.69 Aligned_cols=135 Identities=21% Similarity=0.236 Sum_probs=96.6
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh----hH----------------------HHHHHHHhhcCCCCc--c
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT----DS----------------------FSREVEGLSRVRHPN--L 122 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~----------------------~~~e~~~l~~l~h~n--i 122 (347)
.+.||+|+||.||+|...+|+.||+|.+...... .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999878999999988653211 11 124555555554332 3
Q ss_pred eeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCC
Q 040826 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 123 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~ 201 (347)
.+.+++ ...+++|||++++++......... . ......++.+++.++.++| . .+++|+||+|+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CC
Confidence 334332 245899999999543221111100 1 1667889999999999999 6 8999999999999999 88
Q ss_pred ceEEeecccceecC
Q 040826 202 EPKLSDFGLAKMLG 215 (347)
Q Consensus 202 ~~kl~dfg~~~~~~ 215 (347)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.7e-15 Score=135.56 Aligned_cols=139 Identities=20% Similarity=0.196 Sum_probs=98.6
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChh------------------------------------------HHH
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD------------------------------------------SFS 108 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------------------~~~ 108 (347)
.++||.|++|+||+|++.+|+.||||+..+..... ++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 47899999999999999999999999986542110 234
Q ss_pred HHHHHhhcCC----CCcceeeeeEEE-eCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHhhhccC
Q 040826 109 REVEGLSRVR----HPNLVCLFGCCV-EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-ALRYLHHYID 182 (347)
Q Consensus 109 ~e~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~Lh~~~~ 182 (347)
+|...+.++. |.+-+.+-..+. ..+..++||||++|++|.+.......... ..+++.+++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 4555555442 322233333332 24467999999999999887643221122 3345555555 467778 7
Q ss_pred CCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 183 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
.|++|+|++|+||++++++.++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999988653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.3e-16 Score=131.24 Aligned_cols=133 Identities=20% Similarity=0.228 Sum_probs=103.3
Q ss_pred CCeee-ecCCeeEEEEEeCCCCEEEEEEcccCC---------------ChhHHHHHHHHhhcCCCCcc--eeeeeEEEeC
Q 040826 71 RRFLG-RGSAGLVYKGVLPSGQVVAIKHIYKSN---------------NTDSFSREVEGLSRVRHPNL--VCLFGCCVEG 132 (347)
Q Consensus 71 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 132 (347)
...|| .||.|+||.+... +..+++|.+.... ....+.+|+.++.++.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999984 6778888774321 12356789999999988774 5666654332
Q ss_pred -C---eEEEEEeecCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 133 -G---EQYLVYEFCAA-GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 133 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
. ..++|+|++++ .+|.+++... .++.. .+.|+++++.+|| ..|++|+||||+|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6898887442 34443 3578999999999 89999999999999999999999999
Q ss_pred ccccee
Q 040826 208 FGLAKM 213 (347)
Q Consensus 208 fg~~~~ 213 (347)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.6e-18 Score=159.53 Aligned_cols=250 Identities=20% Similarity=0.230 Sum_probs=185.2
Q ss_pred cccCCeeeecCCeeEEEEEeC--CCCEEEEEEcccCC-C---hhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEe
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP--SGQVVAIKHIYKSN-N---TDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 140 (347)
|...+.||+|+|+.|-..... ....+++|.+.... . ......|..+-+.++ |+|++.+++...+.+..++.++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 444566999999999888753 34456666665432 1 123444666777776 9999999999999999999999
Q ss_pred ecCCCChHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCC--
Q 040826 141 FCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGM-- 216 (347)
Q Consensus 141 ~~~~gsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~-- 216 (347)
|.+++++.+-+ .......+.......+.|+..++.|+|. ..++.|+|++|+|.+++..+ .+++.|||++..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99999998877 3333256777788899999999999996 56899999999999999999 999999999998765
Q ss_pred CccceeecccC-CCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 217 EESKVFTDVRG-TIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 217 ~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..........| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+............+...-.. ..
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 251 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR--------FT 251 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc--------cc
Confidence 22333455667 9999999999884 55678999999999999999999987654443332222221100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~ 331 (347)
....+.+. ....++...++..+|..|.+.+++-
T Consensus 252 ~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QLPWNSIS----DQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cCccccCC----hhhhhcccccccCCchhcccccccc
Confidence 11111222 3466777778889999999988764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.8e-14 Score=129.83 Aligned_cols=140 Identities=16% Similarity=0.142 Sum_probs=93.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC-CCEEEEEEcccCCCh------------------------------------h--
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSNNT------------------------------------D-- 105 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~------------------------------------~-- 105 (347)
...|+. ++||+|++|+||+|++++ |+.||||+..+.... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 344655 789999999999999876 999999999754210 0
Q ss_pred ----HHHHHHHHhhcCC----CCcceeeeeEEEe-CCeEEEEEeecCCCChHHHh--hcCCC---CCCHHHHHHHHHHHH
Q 040826 106 ----SFSREVEGLSRVR----HPNLVCLFGCCVE-GGEQYLVYEFCAAGNLAQHL--LRKDS---VLTWERRVKILRDCA 171 (347)
Q Consensus 106 ----~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~---~~~~~~~~~i~~qi~ 171 (347)
++.+|...+.++. +.+.+.+-.++.+ .+..++||||++|+++.+.- ...+. .+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1334444444442 3333443344332 45678999999999998743 22221 12222222333333
Q ss_pred HHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccceecC
Q 040826 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLAKMLG 215 (347)
Q Consensus 172 ~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~~~~~ 215 (347)
. ..|++|+|++|+||+++.++ .+++.|||++..+.
T Consensus 277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 2 56999999999999999888 99999999988753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=122.61 Aligned_cols=201 Identities=22% Similarity=0.263 Sum_probs=140.4
Q ss_pred HHhhcCCCCcceeeeeEEEeC-----CeEEEEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 040826 112 EGLSRVRHPNLVCLFGCCVEG-----GEQYLVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDG 183 (347)
Q Consensus 112 ~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 183 (347)
..+-.+-|.|+++++.++.+. .+..++.||+..|++..+|++ .+..+......+|+.||..||.|||+. ..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345555799999999988753 357899999999999999965 345688888999999999999999975 78
Q ss_pred CceeCCCCCCCEEecCCCceEEeecccceecCC----CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHH
Q 040826 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM----EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259 (347)
Q Consensus 184 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ll 259 (347)
.++|+++.-+.|++..+|-+|++-- ....... ..........+.++|.+||.=....-+-++|||+||+-..+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999988887532 2111111 1111223345678999999877777778999999999999998
Q ss_pred hCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 260 SGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 260 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
-+.............-... ...+....++.-++. +..|++..|..||+|++++.+
T Consensus 277 ilEiq~tnseS~~~~ee~i-------a~~i~~len~lqr~~------------i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI-------ANVIIGLENGLQRGS------------ITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhh-------hhheeeccCccccCc------------CcccccCCCCCCcchhhhhcC
Confidence 8764322111100000111 111222233332223 334999999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.8e-14 Score=127.54 Aligned_cols=243 Identities=24% Similarity=0.245 Sum_probs=180.1
Q ss_pred cccCCeeee--cCCeeEEEEEe---CCCCEEEEEEcccC----CChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEE
Q 040826 68 DWDRRFLGR--GSAGLVYKGVL---PSGQVVAIKHIYKS----NNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 68 ~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 137 (347)
+.....+|. |.+|.+|.+.. .++..+|+|+-... .....-.+|......++ |+|.++.+..+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 444567999 99999999985 35778899874332 22233345666666664 9999998888899999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeecccce
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL----ALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAK 212 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~ 212 (347)
-+|.+.. +|.++.......++...++..+.+..+ |+.++| ..+++|.|++|.||+...+ ...+++|||+..
T Consensus 196 qtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeE
Confidence 9999964 898888776666888888888888888 999999 8999999999999999999 889999999998
Q ss_pred ecCCCccc----eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh-hhHHHHHHhhhcCCCC
Q 040826 213 MLGMEESK----VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA-RDQLTRKARDVSMGKR 287 (347)
Q Consensus 213 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 287 (347)
.++..... ......+...|++||...+ -++...|+|++|.++.+..++..++..+... ..+ ...+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-------~r~~-- 341 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-------LRQG-- 341 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-------cccc--
Confidence 87654321 1223367889999998876 4677999999999999999988766533111 010 0000
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+..++......++..++..+++.+|..|++.+.+..
T Consensus 342 --------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111111122235666888899999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=110.07 Aligned_cols=126 Identities=19% Similarity=0.135 Sum_probs=94.8
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCccee-eeeEEEeCCeEEEEEeecCCCChHH
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVC-LFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
+.++.|.++.||++... |..+++|...... ....+..|...++.+.+.++++ ++.+ ..+..++||||++|.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 56889999999999974 7789999876553 2345678999999886555443 4433 2334579999999988764
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----ceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC-----IVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~-----i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
. . ......+.+++++++.|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~-----~----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E-----D----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-----c----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 2 0 111345678999999999 555 59999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-12 Score=120.28 Aligned_cols=164 Identities=24% Similarity=0.284 Sum_probs=124.4
Q ss_pred eCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHH
Q 040826 87 LPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV 164 (347)
Q Consensus 87 ~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 164 (347)
..++.+|.|........ .+...+.+..|+.++||||++++..++.++..|+|+|-+. .|..++.+.+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 44678888877765544 4457788899999999999999999999999999999874 6666665432 44555
Q ss_pred HHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCC
Q 040826 165 KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244 (347)
Q Consensus 165 ~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 244 (347)
-.+.||+.||.|||+ ..+++|+++.-..|+++..|..||++|.++....... ........--.|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~-~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN-APAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC-cccccchhhhcccChhhcCccc--c
Confidence 578999999999987 5689999999999999999999999998776532111 1111222233456666554333 3
Q ss_pred cccHHHHHHHHHHHHhC
Q 040826 245 ASDIYSFGIVALQLLSG 261 (347)
Q Consensus 245 ~~Dv~slG~il~~lltg 261 (347)
..|.|.||+++++++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 57999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.3e-12 Score=99.17 Aligned_cols=140 Identities=22% Similarity=0.301 Sum_probs=105.7
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
...++.+|+-+.|+++.+ .|+...||.-.+.. ......+|...+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 346789999999999999 57877777554432 1235678999998886545554444556666778999
Q ss_pred eecCC-CChHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeeccccee
Q 040826 140 EFCAA-GNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGLAKM 213 (347)
Q Consensus 140 e~~~~-gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~ 213 (347)
||++| .++.+++...... ........+++++=+.+.-|| .++++|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4788888654332 333334788999999999999 899999999999999986653 58999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-10 Score=102.04 Aligned_cols=259 Identities=15% Similarity=0.126 Sum_probs=159.4
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCccee--------eeeEEEeCCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC--------LFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~--------~~~~~~~~~~~~lv~e~~ 142 (347)
.+.||+|+-+.+|-.---.+ .+-|++....-......-..+...-.||-+.. ++|- ..+....++|+..
T Consensus 16 gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP~v 92 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMPKV 92 (637)
T ss_pred CccccCCccceeeecchhhc--hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecccC
Confidence 46799999999986542122 24566655433322111111222223543222 1111 1122367788888
Q ss_pred CCC-ChHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 143 AAG-NLAQHLL-----RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 143 ~~g-sL~~~l~-----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
.+. ...+++. ++-....|.-.++.++.++.+.+.|| ..|.+-+|.+++|+|+.+++.++|.|-..-...
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-- 167 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-- 167 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec--
Confidence 765 2333331 23356899999999999999999999 889999999999999999999999986544432
Q ss_pred CccceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhC-CCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 217 EESKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSG-QKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
......-..+|...|.+||... +..-+..+|.|.||+++++++.| ++||.+-....+...-...++..+.-.+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 2344455667999999999765 34566789999999999999887 88887421110000000001111110000
Q ss_pred cccC----CCCCCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHH
Q 040826 291 DFED----PRLNGNINRADFESILKIAVLCVAK--SSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 291 ~~~~----~~l~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~ei~~~l~~~ 337 (347)
.... |.-...--...+.++..|..+|+.. ++.-|||.+-.+..|..+
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0000 0000011122346788899999876 467899999999988877
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-11 Score=103.62 Aligned_cols=140 Identities=24% Similarity=0.307 Sum_probs=107.7
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCC--cceeeeeEEEeC---CeEEEEEeecC
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHP--NLVCLFGCCVEG---GEQYLVYEFCA 143 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 143 (347)
+.|+.|.++.+|++...+|..+++|...... ....+.+|.++++.+.+. ++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777899999886643 345788999999999753 356666665543 25689999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------------
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI------------------------------------------ 181 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------------ 181 (347)
|.++.+.+.. ..++......++.++++++..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888765422 34677777778888888888888421
Q ss_pred -----------CCCceeCCCCCCCEEecC--CCceEEeeccccee
Q 040826 182 -----------DGCIVHRDIKLTNILLTE--KLEPKLSDFGLAKM 213 (347)
Q Consensus 182 -----------~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~ 213 (347)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=5e-11 Score=97.34 Aligned_cols=135 Identities=19% Similarity=0.149 Sum_probs=96.3
Q ss_pred CeeeecCCeeEEEEEeCC-------CCEEEEEEcccCC-----------------------C-hhH----HHHHHHHhhc
Q 040826 72 RFLGRGSAGLVYKGVLPS-------GQVVAIKHIYKSN-----------------------N-TDS----FSREVEGLSR 116 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-----------------------~-~~~----~~~e~~~l~~ 116 (347)
..||.|--+.||.|...+ +..+|+|...... + ... ..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999774320 0 011 2278888888
Q ss_pred CCC--CcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCceeCCCCCC
Q 040826 117 VRH--PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL-HHYIDGCIVHRDIKLT 193 (347)
Q Consensus 117 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-h~~~~~~i~H~dl~p~ 193 (347)
+.. -++..++++ ..-++||||+.+..+..-.. ....++......+..+++.++..+ | ..|++|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 853 345555543 45689999997643322111 122345566677889999999998 7 789999999999
Q ss_pred CEEecCCCceEEeecccceecC
Q 040826 194 NILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 194 Nili~~~~~~kl~dfg~~~~~~ 215 (347)
||+++ ++.+.++|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.9e-11 Score=94.79 Aligned_cols=128 Identities=23% Similarity=0.350 Sum_probs=96.1
Q ss_pred eeeecCCeeEEEEEeCCCCEEEEEEcccCC--C--------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--N--------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.+++|+-+.++.+.+. |..+++|.-.+.. . .....+|..++.++.--.+....=+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999874 3446666443321 1 124667888888886444444444445666778999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
+|..|.+.+... ...++..+=.-+.-|| ..||+|+||+++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998888888544 2456777778889999 89999999999999999775 99999999875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-10 Score=104.12 Aligned_cols=139 Identities=22% Similarity=0.224 Sum_probs=94.7
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChh------------------------------------------HHH
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD------------------------------------------SFS 108 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------------------~~~ 108 (347)
.++++.++-|+||+|++++|+.||||+.+++-... ++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 47899999999999999999999999987651100 244
Q ss_pred HHHHHhhcCC-----CCcceeeeeEE-EeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 040826 109 REVEGLSRVR-----HPNLVCLFGCC-VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182 (347)
Q Consensus 109 ~e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 182 (347)
+|...+.++. .++ +.+=.++ +-.+...|+|||++|..+.+.........+...+.....++.--.-+ .
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-----~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-----R 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-----h
Confidence 5555555442 233 2332333 33567789999999998888753333334543333333222211112 4
Q ss_pred CCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 183 ~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
.|++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 589999999999999999999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.2e-12 Score=116.37 Aligned_cols=245 Identities=18% Similarity=0.191 Sum_probs=170.9
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe--CCCCEEEEEEcccCCCh----hHHHHHHHHhhcC-CCCcceeeeeEEEeCCeE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL--PSGQVVAIKHIYKSNNT----DSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 135 (347)
....+|.....||.|.|+.|+.... .++..+++|.+.+.... ..-..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788888999999999999874 36778999877654321 1223455555555 477888877777766777
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeecccceec
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKML 214 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 214 (347)
++=.||++++++.... .....+.+...+++..|++.++.++| +..++|+|++|+||++..+ +..+++|||.+..+
T Consensus 342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 7999999999887665 23345777788899999999999999 8899999999999999986 78899999988642
Q ss_pred CCCccceeecccCCCCcc--ccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 215 GMEESKVFTDVRGTIGYM--DPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
... .....+.-+++ +|+......+..+.|++|||..+.+.+++........ .+..+..+..
T Consensus 418 ~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i~~~~~----- 480 (524)
T KOG0601|consen 418 AFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTIRSGDT----- 480 (524)
T ss_pred cee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceeeecccc-----
Confidence 111 11112333444 5555567788899999999999999999876433110 0111111211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~ 335 (347)
+.+. .....+..+...+...++..||++.+.....+
T Consensus 481 --p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 --PNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --cCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111 11145667777788899999999988766544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-09 Score=98.00 Aligned_cols=212 Identities=17% Similarity=0.225 Sum_probs=149.9
Q ss_pred CCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeEEEEEeecCC-CChHH
Q 040826 78 SAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQYLVYEFCAA-GNLAQ 149 (347)
Q Consensus 78 ~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~ 149 (347)
...+.|++.. -+|..|++|+++.... ......-++.++++.|+|+|++.+++.. +...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4567899984 4899999999954432 2234456789999999999999998763 4578999999986 47888
Q ss_pred HhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 150 HLLRK--------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 150 ~l~~~--------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
+.... +...++..+|.++.|+..||.++| +.|+.-+-|.|.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 66431 234778899999999999999999 8899999999999999999999999998877654
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCC-ChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIEL-DFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.++. +.+.+ -.+-|.=.||.+++.|.||..--.. +..... ..+
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----~~~-------------- 488 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----HLT-------------- 488 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH----HHH--------------
Confidence 3321 11111 1367888999999999999532110 000000 011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.+......++++++......++++ -++.+++..+
T Consensus 489 -----~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 -----RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -----HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 112233356777777777777776 6666665543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-09 Score=92.86 Aligned_cols=138 Identities=15% Similarity=0.114 Sum_probs=98.6
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh-------------hHHHHHHHHhhcCCCCc--ceeeeeEEEe-----
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT-------------DSFSREVEGLSRVRHPN--LVCLFGCCVE----- 131 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------~~~~~e~~~l~~l~h~n--iv~~~~~~~~----- 131 (347)
+.+-......|.+..+ +|+.+.+|........ ..+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444445667666 6788999977443311 13778888888874322 2334444432
Q ss_pred CCeEEEEEeecCCC-ChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-------CCc
Q 040826 132 GGEQYLVYEFCAAG-NLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-------KLE 202 (347)
Q Consensus 132 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-------~~~ 202 (347)
....++|+|++++. +|.+++... ....+......++.+++..+.-|| ..|++|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999985 788887532 234566777889999999999999 899999999999999975 468
Q ss_pred eEEeeccccee
Q 040826 203 PKLSDFGLAKM 213 (347)
Q Consensus 203 ~kl~dfg~~~~ 213 (347)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-11 Score=115.79 Aligned_cols=244 Identities=19% Similarity=0.193 Sum_probs=158.9
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++...+.+-+|.++.++.+.- .+|...+.|..... ...+....+-.++-.-++|-++...--+......+|+++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 444445677899999988772 23422222222111 111122222222222334555544444445667899999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC---
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME--- 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 217 (347)
|..+++|...++..+ ..+....+-....+.+++++|| ...+.|+|++|.|.++..++..+++|||.......-
T Consensus 885 ~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999998886544 3455555566677889999999 677899999999999999999999999733321100
Q ss_pred ---------------------------ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh
Q 040826 218 ---------------------------ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD 270 (347)
Q Consensus 218 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~ 270 (347)
+........+|..|.+||...+......+|+|++|+.+++.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00112224589999999999999989999999999999999999999985543
Q ss_pred hhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 040826 271 ARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 328 (347)
. ...+.+..+..+.. ....+...+..+++...+..+|.+|-.+.
T Consensus 1041 q-----~~f~ni~~~~~~~p---------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 Q-----QIFENILNRDIPWP---------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h-----hhhhccccCCCCCC---------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 3 22233322221111 12223345677888888889999997665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=88.38 Aligned_cols=123 Identities=24% Similarity=0.283 Sum_probs=80.4
Q ss_pred eEEEEEeCCCCEEEEEEcccCC--------------C--------------hhHHHHHHHHhhcCCCC--cceeeeeEEE
Q 040826 81 LVYKGVLPSGQVVAIKHIYKSN--------------N--------------TDSFSREVEGLSRVRHP--NLVCLFGCCV 130 (347)
Q Consensus 81 ~V~~~~~~~~~~vavK~~~~~~--------------~--------------~~~~~~e~~~l~~l~h~--niv~~~~~~~ 130 (347)
.||.|...+|..+|+|...... . .....+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999874320 0 01356799999999755 455555442
Q ss_pred eCCeEEEEEeecC--CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhhccCCCceeCCCCCCCEEecCCCceEEee
Q 040826 131 EGGEQYLVYEFCA--AGNLAQHLLRKDSVLTWERRVKILRDCALALRY-LHHYIDGCIVHRDIKLTNILLTEKLEPKLSD 207 (347)
Q Consensus 131 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~d 207 (347)
.-.+||||++ |..+..+.... ++......++.+++..+.. +| ..|++|+||++.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3469999998 64454432211 1133455677777775555 56 8899999999999999988 999999
Q ss_pred cccceec
Q 040826 208 FGLAKML 214 (347)
Q Consensus 208 fg~~~~~ 214 (347)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.7e-09 Score=98.31 Aligned_cols=141 Identities=18% Similarity=0.169 Sum_probs=93.2
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChh---------------------------------------HHHHH
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD---------------------------------------SFSRE 110 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~e 110 (347)
..+.||..+.|+||+|++++|+.||||+.++.-... +|.+|
T Consensus 165 ~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 165 DEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred CcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 346899999999999999999999999987651110 24455
Q ss_pred HHHhhcC----CCCc---ceeeeeEEE-eCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 040826 111 VEGLSRV----RHPN---LVCLFGCCV-EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182 (347)
Q Consensus 111 ~~~l~~l----~h~n---iv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 182 (347)
.+...+. .|-+ -+.+=.++. -.+...|+|||++|..+.|.-.-....++...+..-+.+.. +++...
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~-----~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY-----LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH-----HHHHHh
Confidence 5444333 2434 111222222 24578899999999977765432223355554444333332 222224
Q ss_pred CCceeCCCCCCCEEecC----CCceEEeecccceecC
Q 040826 183 GCIVHRDIKLTNILLTE----KLEPKLSDFGLAKMLG 215 (347)
Q Consensus 183 ~~i~H~dl~p~Nili~~----~~~~kl~dfg~~~~~~ 215 (347)
.|++|+|-+|.||+++. ++.+.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 58999999999999994 6789999999988654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.4e-09 Score=87.73 Aligned_cols=131 Identities=25% Similarity=0.233 Sum_probs=94.4
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccC----------CC--------------hhHHHHHHHHhhcCCCC--cce
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS----------NN--------------TDSFSREVEGLSRVRHP--NLV 123 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------~~--------------~~~~~~e~~~l~~l~h~--niv 123 (347)
...+||-|--+.||.|..++|..+++|.=.-. .+ .....+|.+.|.++... .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45789999999999999999999999953211 00 11356888999998644 555
Q ss_pred eeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
+.+++ +..++|||+++|-.|...- +.......++..+++-+..+- ..|++|+|+++-||+++++|.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCE
Confidence 55543 4668999999996665422 123333444555555555555 5789999999999999999999
Q ss_pred EEeeccccee
Q 040826 204 KLSDFGLAKM 213 (347)
Q Consensus 204 kl~dfg~~~~ 213 (347)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999965554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-08 Score=81.60 Aligned_cols=135 Identities=17% Similarity=0.116 Sum_probs=101.5
Q ss_pred eeecCCeeEEEEEeCCCCEEEEEEccc--------CCChhHHHHHHHHhhcCCCC--cceeeeeEEE-e----CCeEEEE
Q 040826 74 LGRGSAGLVYKGVLPSGQVVAIKHIYK--------SNNTDSFSREVEGLSRVRHP--NLVCLFGCCV-E----GGEQYLV 138 (347)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~--------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~-~----~~~~~lv 138 (347)
-|+||.+.|+.... +|..+-+|.-.. +.....|.+|...+.++..- .+.++. ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 57799999999877 455788887642 23456899999999988522 234443 222 1 2246899
Q ss_pred EeecCC-CChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc--eEEeeccccee
Q 040826 139 YEFCAA-GNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE--PKLSDFGLAKM 213 (347)
Q Consensus 139 ~e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~ 213 (347)
+|-+++ .+|.+++.+.. .+.+......++.+++..+.-|| ..|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 48888875432 35677788899999999999999 899999999999999986667 99999976554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.6e-10 Score=103.31 Aligned_cols=151 Identities=21% Similarity=0.276 Sum_probs=99.5
Q ss_pred HHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee--------ecccCCCCcccccccc
Q 040826 167 LRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF--------TDVRGTIGYMDPEYMT 238 (347)
Q Consensus 167 ~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~ 238 (347)
+.+++.|+.|+|+ +.+++|+.|.|++|.++.++..|+++|+.+........... .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999997 78999999999999999999999999987765432111111 1123567899999999
Q ss_pred CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhcc
Q 040826 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVA 318 (347)
Q Consensus 239 ~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~ 318 (347)
+...+.++|+||+|+++|.+..|..+.......... ......... ...+ .++.+.+.++.+=+.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~~~~~~~--~~~~-------~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSFSRNLLN--AGAF-------GYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch---hhhhhcccc--cccc-------cccccCcHHHHHHHHHHhc
Confidence 988889999999999999999554433221111111 111111111 0000 1112233456666666999
Q ss_pred CCCCCCCCHHHHH
Q 040826 319 KSSKGRPTIDVVY 331 (347)
Q Consensus 319 ~~p~~Rps~~ei~ 331 (347)
.++..||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999777664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.1e-08 Score=81.30 Aligned_cols=107 Identities=24% Similarity=0.241 Sum_probs=82.5
Q ss_pred hhHHHHHHHHhhcCCC--CcceeeeeEEEeC----CeEEEEEeecCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 040826 104 TDSFSREVEGLSRVRH--PNLVCLFGCCVEG----GEQYLVYEFCAAG-NLAQHLLRKDSVLTWERRVKILRDCALALRY 176 (347)
Q Consensus 104 ~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~ 176 (347)
.....+|...+.++.. -...+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457788887777742 2344555555442 2458999999884 78888865333 6667788899999999999
Q ss_pred hhhccCCCceeCCCCCCCEEecCCC---ceEEeecccceec
Q 040826 177 LHHYIDGCIVHRDIKLTNILLTEKL---EPKLSDFGLAKML 214 (347)
Q Consensus 177 Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~dfg~~~~~ 214 (347)
|| ..|++|+|+++.|||++.++ .+.++||+.+...
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 89999999999999999887 8999999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-07 Score=80.37 Aligned_cols=138 Identities=17% Similarity=0.214 Sum_probs=86.9
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCc--ceeeeeEEEeCCeEEEEEeecCCCC-hH
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPN--LVCLFGCCVEGGEQYLVYEFCAAGN-LA 148 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L~ 148 (347)
.+||+|..+.||+. .|..+++|............+|.+.++.+..-. +.+.+.+....+...++||+++|.+ +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 56999999999984 255678898877666667889999998886333 4566777777777889999999963 11
Q ss_pred HHh---------------------hcCC-CCCCHHHHH-HHHHH----------HHH-HHHHhhhc-cCCCceeCCCCCC
Q 040826 149 QHL---------------------LRKD-SVLTWERRV-KILRD----------CAL-ALRYLHHY-IDGCIVHRDIKLT 193 (347)
Q Consensus 149 ~~l---------------------~~~~-~~~~~~~~~-~i~~q----------i~~-~l~~Lh~~-~~~~i~H~dl~p~ 193 (347)
..+ +.-. ......... .+..+ +.+ ...+|... ....++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111 1100 011111100 01000 000 11111111 1345789999999
Q ss_pred CEEecCCCceEEeeccccee
Q 040826 194 NILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 194 Nili~~~~~~kl~dfg~~~~ 213 (347)
|+++++++ +.++||+.+..
T Consensus 164 Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cEEEcCCC-cEEEechhcCc
Confidence 99999888 99999987764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=3e-07 Score=75.72 Aligned_cols=135 Identities=16% Similarity=0.140 Sum_probs=88.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh--h---------HHHHHHHHhhcCC---CCcceeeeeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--D---------SFSREVEGLSRVR---HPNLVCLFGCCV 130 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~---------~~~~e~~~l~~l~---h~niv~~~~~~~ 130 (347)
..+|...+.+.......|.+... +|..+++|...+.... + ...+.+..+.++. -.....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45566667777777777877777 5788999977653211 1 1334444444442 223333333322
Q ss_pred e-----CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 131 E-----GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 131 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
. ....+++|||++|..|.+... +++ .+...+.+++.-|| ..|+.|+|++|+|++++++ .+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEE
Confidence 2 235678999999988866431 222 24456778899999 8999999999999999965 5999
Q ss_pred eeccccee
Q 040826 206 SDFGLAKM 213 (347)
Q Consensus 206 ~dfg~~~~ 213 (347)
.||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99976553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=73.37 Aligned_cols=153 Identities=22% Similarity=0.263 Sum_probs=102.2
Q ss_pred cccccHHHHHHHhcCcccCCe---eeecCCeeEEEEEeCCCCEEEEEEcccCCC---------------------hhH--
Q 040826 53 LYRFSKDEIENAINNDWDRRF---LGRGSAGLVYKGVLPSGQVVAIKHIYKSNN---------------------TDS-- 106 (347)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------------~~~-- 106 (347)
+...+.+.+..+.++...... |++|--+.||+|...++..+|+|++..... ...
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 344566666666666555544 456777789999988899999998854310 000
Q ss_pred ---HHHHHHHhhcCC--CCcceeeeeEEEeCCeEEEEEeecCCCChH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 040826 107 ---FSREVEGLSRVR--HPNLVCLFGCCVEGGEQYLVYEFCAAGNLA-QHLLRKDSVLTWERRVKILRDCALALRYLHHY 180 (347)
Q Consensus 107 ---~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~ 180 (347)
...|...|+++. +-.+.+.+++.. -.|||||+.....- =.| +.-.+.......+..++++.+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH-
Confidence 335777777774 334444554433 35899998653110 001 12223333677788888888888873
Q ss_pred cCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 181 ~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
..+++|+||+.-|||+. ++.+.++|||-+...
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 47999999999999999 889999999987754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-06 Score=74.64 Aligned_cols=138 Identities=17% Similarity=0.130 Sum_probs=84.3
Q ss_pred eeecCC-eeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCCCChHHHh
Q 040826 74 LGRGSA-GLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL 151 (347)
Q Consensus 74 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 151 (347)
|..|.+ +.||+.... +..+.+|...... .....+|+.+++.+. +--+.+++++....+..++|||+++|.++....
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~ 83 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALW 83 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhh
Confidence 445555 788999864 4778888775543 445778998888884 344556777766666789999999997776431
Q ss_pred -------------------hcCC---CCCCHH--HHHHHHH--------------------HHHHHHHHhhhc----cCC
Q 040826 152 -------------------LRKD---SVLTWE--RRVKILR--------------------DCALALRYLHHY----IDG 183 (347)
Q Consensus 152 -------------------~~~~---~~~~~~--~~~~i~~--------------------qi~~~l~~Lh~~----~~~ 183 (347)
+... ..+... ....... ........|-.. ...
T Consensus 84 ~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 163 (244)
T cd05150 84 EELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL 163 (244)
T ss_pred cccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence 0100 011100 0000000 011112222110 134
Q ss_pred CceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 184 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 589999999999999987788999987654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=2e-06 Score=73.14 Aligned_cols=141 Identities=19% Similarity=0.183 Sum_probs=83.3
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCC--cceeeeeEEE---eCCeEEEEEeecCCCC
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP--NLVCLFGCCV---EGGEQYLVYEFCAAGN 146 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~gs 146 (347)
+.++.|..+.||+....+ ..+++|..........+.+|..+++.+... .+..++.... .....+++|++++|.+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 468999999999999877 689999876663445677888888887532 3455555433 2345789999999987
Q ss_pred hHH----------------Hh---hcC---CCCCCHHH---------HHHH------------HHHHHH-HHHHhhhc--
Q 040826 147 LAQ----------------HL---LRK---DSVLTWER---------RVKI------------LRDCAL-ALRYLHHY-- 180 (347)
Q Consensus 147 L~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~qi~~-~l~~Lh~~-- 180 (347)
+.. .+ ++. ...+.... .... ...+.+ .+..++..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 776 11 111 01111100 0000 111222 23333321
Q ss_pred --cCCCceeCCCCCCCEEec-CCCceEEeeccccee
Q 040826 181 --IDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKM 213 (347)
Q Consensus 181 --~~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~ 213 (347)
....++|+|+.|+||+++ +++.+-|+||+.+..
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 246799999999999999 566667999987664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=68.58 Aligned_cols=128 Identities=17% Similarity=0.179 Sum_probs=91.0
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHH
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQH 150 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 150 (347)
.+.|++|.+|.||+|.+. |..+|+|+-..++....+..|.++|..+.-.++.+=+-.+. .-++.|||++|.+|.+.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L~~~ 102 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcchhhh
Confidence 456999999999999994 56899999988888899999999999987666554332222 22355999999888876
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCC-CCCEEecCCCceEEeeccccee
Q 040826 151 LLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK-LTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 151 l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~-p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.... ...+ ...+++.---|. ..||-|+.|. |...++..++.+.|+||..++.
T Consensus 103 ~~~~----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 103 EIGG----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcc----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 5321 2222 233445433344 6789999987 5544555555999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.4e-05 Score=65.61 Aligned_cols=127 Identities=22% Similarity=0.252 Sum_probs=89.9
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC------------------ChhHHHHHHHHhhcCC------CCcceee
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN------------------NTDSFSREVEGLSRVR------HPNLVCL 125 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~e~~~l~~l~------h~niv~~ 125 (347)
...+||+|+.=.||. ++++...+||+..+.. ...+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999988885 4455667888776554 2345667776665555 7899999
Q ss_pred eeEEEeCCeEEEEEeecCC------CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 126 FGCCVEGGEQYLVYEFCAA------GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
+|+.+++....+|+|.+.+ .||.+++.+. .++. ...+.+.++ ..+|- ..+|+.+|++|+||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEe
Confidence 9999999999999999743 3788888443 3454 444444444 44554 567999999999999964
Q ss_pred CC----ceEEee
Q 040826 200 KL----EPKLSD 207 (347)
Q Consensus 200 ~~----~~kl~d 207 (347)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.3e-06 Score=72.01 Aligned_cols=73 Identities=12% Similarity=0.157 Sum_probs=46.0
Q ss_pred CeeeecCCee-EEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCC---cceeeeeEEEeC---CeEEEEEeecCC
Q 040826 72 RFLGRGSAGL-VYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP---NLVCLFGCCVEG---GEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~ 144 (347)
+.++.|+... ||+. +..+++|............+|.+.++.+... .+..+++..... ...+++|++++|
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 4578777765 8875 2357778765544455788999998877531 233333332221 234789999998
Q ss_pred CChH
Q 040826 145 GNLA 148 (347)
Q Consensus 145 gsL~ 148 (347)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.9e-05 Score=69.68 Aligned_cols=77 Identities=10% Similarity=0.056 Sum_probs=57.5
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC---CcceeeeeEEEe---CCeEEEEEeecC
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH---PNLVCLFGCCVE---GGEQYLVYEFCA 143 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~ 143 (347)
..+.||.|..+.||.....+++ +.+|..........+..|...++.+.- -.+.++++++.. .+..++|||+++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 4467999999999999875664 666764332345688899999988853 357778877654 366899999999
Q ss_pred CCCh
Q 040826 144 AGNL 147 (347)
Q Consensus 144 ~gsL 147 (347)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=79.78 Aligned_cols=76 Identities=13% Similarity=0.306 Sum_probs=56.1
Q ss_pred CCeeeecCCeeEEEEEeCCC---CEEEEEEcccCC---ChhHHHHHHHHhhcCC-CCcc--eeeeeEEEeC---CeEEEE
Q 040826 71 RRFLGRGSAGLVYKGVLPSG---QVVAIKHIYKSN---NTDSFSREVEGLSRVR-HPNL--VCLFGCCVEG---GEQYLV 138 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~---~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 138 (347)
.+.++.|.++.+|+....++ ..+++|+..... ....+.+|..+++.+. |+++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56688999999999886554 367788765432 2346889999999995 6654 6777777654 467899
Q ss_pred EeecCCCC
Q 040826 139 YEFCAAGN 146 (347)
Q Consensus 139 ~e~~~~gs 146 (347)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7e-08 Score=89.69 Aligned_cols=182 Identities=23% Similarity=0.221 Sum_probs=128.3
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCc-ceeeeeEEEeCCeEEEEEeecCCC-ChHH
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPN-LVCLFGCCVEGGEQYLVYEFCAAG-NLAQ 149 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~~ 149 (347)
+.+++++++.++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-++.+...++.++++.++ +...
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 447889999999988422233335655433 34446788999999999 666666666677888999999887 3222
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCC
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTI 229 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 229 (347)
......-.+...+...+.+.-.++++++| +..-+|+| ||+..+ +..+.+||+....+.... ......++.
T Consensus 325 ~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~ 394 (829)
T KOG0576|consen 325 EMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTP 394 (829)
T ss_pred cCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCC
Confidence 22112222444455556677778899999 44457888 766665 688999999887664322 334567899
Q ss_pred CccccccccCCccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 230 ~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
.|+|||+.....+....|+|++|.-..++--|.+|-.
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999987777777776654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=69.62 Aligned_cols=141 Identities=16% Similarity=0.104 Sum_probs=83.8
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCc--ceeeeeE------EEeCCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPN--LVCLFGC------CVEGGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~ 142 (347)
.+.+..|....+|+....+ ..+++|.... ........|+.++..+.+.+ +.+++.. ....+..+++++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 3557778888999988754 4688888765 44455667888777774322 3333321 12345678999999
Q ss_pred CCCChHH-----------Hh---hc--CC--------CCCCHHHHH----------HHHHHHHHHHHHhhh----ccCCC
Q 040826 143 AAGNLAQ-----------HL---LR--KD--------SVLTWERRV----------KILRDCALALRYLHH----YIDGC 184 (347)
Q Consensus 143 ~~gsL~~-----------~l---~~--~~--------~~~~~~~~~----------~i~~qi~~~l~~Lh~----~~~~~ 184 (347)
+|.++.. .+ +. .+ ....|.... .....+..++.++.. ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9866421 01 10 00 001111110 011112333444432 11357
Q ss_pred ceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 185 i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987778999987664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.8e-05 Score=65.46 Aligned_cols=72 Identities=17% Similarity=0.152 Sum_probs=47.2
Q ss_pred CeeeecCCeeEEEEEeCC--CCEEEEEEcccCCCh-hHHHHHHHHhhcCCCCcce-eeeeEEEeCCeEEEEEeecCCCCh
Q 040826 72 RFLGRGSAGLVYKGVLPS--GQVVAIKHIYKSNNT-DSFSREVEGLSRVRHPNLV-CLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~-~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
+.|..|-...+|+....+ +..+++|........ -...+|..+++.+...+++ ++++... -.++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998764 678889976543221 2334788888888543333 3333322 2479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=66.99 Aligned_cols=135 Identities=15% Similarity=0.097 Sum_probs=77.7
Q ss_pred eeeecCCeeEEEEEeCCCCEEEEEEcccCCCh--hHHHHHHHHhhcCCCCcce-eeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLV-CLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
.+..|-.+.+|+... +|..+++|........ -...+|..+++.+....+. +++... . -++|+||++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 356688889998874 5677888876543222 2457888888888643333 333322 2 368999999866532
Q ss_pred H--------------h---hcC---CCCCCHH-HHHHHHHHH---------HHHHHHhhhc-----cCCCceeCCCCCCC
Q 040826 150 H--------------L---LRK---DSVLTWE-RRVKILRDC---------ALALRYLHHY-----IDGCIVHRDIKLTN 194 (347)
Q Consensus 150 ~--------------l---~~~---~~~~~~~-~~~~i~~qi---------~~~l~~Lh~~-----~~~~i~H~dl~p~N 194 (347)
. + ++. +.+++.. ....+..++ ...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 111 1112211 111211111 1111112111 12358999999999
Q ss_pred EEecCCCceEEeeccccee
Q 040826 195 ILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 195 ili~~~~~~kl~dfg~~~~ 213 (347)
|++++++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999987764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00013 Score=65.24 Aligned_cols=156 Identities=15% Similarity=0.130 Sum_probs=85.5
Q ss_pred ccHHHHHHHhcCccc-----CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-----CCcceee
Q 040826 56 FSKDEIENAINNDWD-----RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-----HPNLVCL 125 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~ 125 (347)
++.+++......|.. .+.++.|....+|+....+| .+++|+.. .........+...+..+. .|.+++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 344555555555543 24566777789999987655 68888775 333444445566665553 2332221
Q ss_pred e-e--EEEeCCeEEEEEeecCCCChH-----------HHh---hcCCC--------C--C-CHHHHHH------------
Q 040826 126 F-G--CCVEGGEQYLVYEFCAAGNLA-----------QHL---LRKDS--------V--L-TWERRVK------------ 165 (347)
Q Consensus 126 ~-~--~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~--------~--~-~~~~~~~------------ 165 (347)
. | +....+..+++++|++|..+. +.+ +.... . + .+.....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 1 1 112355678999999986431 111 11000 0 1 1111111
Q ss_pred HHHH-HHHHHHHhhhc----cCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 166 ILRD-CALALRYLHHY----IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 166 i~~q-i~~~l~~Lh~~----~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+.+ +...+..+... ...+++|+|+.|.||+++++...-++||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122232210 246899999999999999765568999987764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2e-05 Score=64.47 Aligned_cols=102 Identities=24% Similarity=0.212 Sum_probs=80.7
Q ss_pred HHHHHhhcCCC-CcceeeeeEEEeCCeEEEEEeecCCCChHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCc
Q 040826 109 REVEGLSRVRH-PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLL--RKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185 (347)
Q Consensus 109 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 185 (347)
.|.-+++.+.+ +++.+++|.|-. +++.||...+++..... ..-...+|..+.+++.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57778888865 699999999843 57899998766642110 011247899999999999999999996555678
Q ss_pred eeCCCCCCCEEecCCCceEEeecccceec
Q 040826 186 VHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 186 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
...|++++|+-+++++++|++|.......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00032 Score=62.41 Aligned_cols=156 Identities=13% Similarity=0.114 Sum_probs=90.2
Q ss_pred cHHHHHHHhcCccc-----CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCc--ceeeeeE-
Q 040826 57 SKDEIENAINNDWD-----RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPN--LVCLFGC- 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~- 128 (347)
+.+++....+.|.. .+.++.|....+|+....+| .+++|.............|.+++..+.... +.+++..
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 44566665555544 34566777789999887555 577887766444555666777777764222 3333321
Q ss_pred -----EEeCCeEEEEEeecCCCChH----H-------Hh---hc--CC---C------CCCHHHHH------------HH
Q 040826 129 -----CVEGGEQYLVYEFCAAGNLA----Q-------HL---LR--KD---S------VLTWERRV------------KI 166 (347)
Q Consensus 129 -----~~~~~~~~lv~e~~~~gsL~----~-------~l---~~--~~---~------~~~~~~~~------------~i 166 (347)
....+..+++++|++|.++. + .+ +. .+ . ...|.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 12245678999999885431 1 11 11 00 0 00111000 00
Q ss_pred HHHHHHHHHHhhh----ccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 167 LRDCALALRYLHH----YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 167 ~~qi~~~l~~Lh~----~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...+.+.+.++.. ....+++|+|+++.|+++++++...|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1122334444432 1247899999999999999887778999987753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.8e-05 Score=75.97 Aligned_cols=195 Identities=19% Similarity=0.168 Sum_probs=129.2
Q ss_pred HHHHHHhhcCCCCcceeeeeEEEeCCeE----EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC
Q 040826 108 SREVEGLSRVRHPNLVCLFGCCVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183 (347)
Q Consensus 108 ~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 183 (347)
..|+..+..+.|+|+..++.+-...... .+..+++..-++...+... ...+....+.+..+..+|+.++| ..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h---~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH---SL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH---Hh
Confidence 3466778888999999999887654332 2445677777777766443 45788899999999999999999 44
Q ss_pred CceeCCCCCC---CEEecCCCceEEe--ecccceecCCCccceeecccCCCCccccccccCCccCC--cccHHHHHHHHH
Q 040826 184 CIVHRDIKLT---NILLTEKLEPKLS--DFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC--ASDIYSFGIVAL 256 (347)
Q Consensus 184 ~i~H~dl~p~---Nili~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Dv~slG~il~ 256 (347)
...|.-+..+ +--.+..+.+..+ ||+.+..+..... ......+..+.+||......+.. ..|+|++|....
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 4455544444 4445566667766 8887776542221 12223456677888777655544 479999999999
Q ss_pred HHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 257 QLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 257 ~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
.+..|..+...... ...+++.. .. ..+......|+..++++|++..+++...
T Consensus 384 ~~~~~~~i~~~~~~------------------~~~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV------------------PVSLLDVL----ST----SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccc------------------hhhhhccc----cc----hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99988765431100 01111110 00 1466667779999999999999988653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=64.78 Aligned_cols=73 Identities=25% Similarity=0.259 Sum_probs=47.8
Q ss_pred CeeeecCCeeEEEEEeCC-------CCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcce-eeeeEEEeCCeEEEEEeec
Q 040826 72 RFLGRGSAGLVYKGVLPS-------GQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLV-CLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 142 (347)
+.+..|-...+|+....+ ++.+++|....... .....+|..++..+...++. ++++++. + ..|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 346667778999998655 57899998765432 23566788888888533333 4444433 2 3589999
Q ss_pred CCCChH
Q 040826 143 AAGNLA 148 (347)
Q Consensus 143 ~~gsL~ 148 (347)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00051 Score=56.20 Aligned_cols=123 Identities=28% Similarity=0.352 Sum_probs=85.3
Q ss_pred cCcccCCeeeecCC-eeEEEEEeCCCCEEEEEEccc---C---------C--C---------hhHHHHHHHHhhcCC---
Q 040826 66 NNDWDRRFLGRGSA-GLVYKGVLPSGQVVAIKHIYK---S---------N--N---------TDSFSREVEGLSRVR--- 118 (347)
Q Consensus 66 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~---------~--~---------~~~~~~e~~~l~~l~--- 118 (347)
..+...+.||.|.- |.||++.. +|+.+|+|.+.. . . . ..-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56777888999999 99999999 678999998311 0 0 0 123677888777774
Q ss_pred CCcc--eeeeeEEEeC------------------CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040826 119 HPNL--VCLFGCCVEG------------------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178 (347)
Q Consensus 119 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh 178 (347)
+.++ ++.+|+..-. ..+.+|.||.+... .+... -+.++.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4455 8888886322 12467777766532 12222 3445566677788
Q ss_pred hccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 179 ~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899999999999976 3478999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0016 Score=59.52 Aligned_cols=73 Identities=19% Similarity=0.162 Sum_probs=51.5
Q ss_pred CeeeecCCeeEEEEEeCCC-CEEEEEEcccC---------CChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEE
Q 040826 72 RFLGRGSAGLVYKGVLPSG-QVVAIKHIYKS---------NNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~---------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 138 (347)
+.||-|.++.||++...+| +.++||.-.+. -..+....|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998776 48999975421 12345667888887763 2345666655 34557899
Q ss_pred EeecCCCC
Q 040826 139 YEFCAAGN 146 (347)
Q Consensus 139 ~e~~~~gs 146 (347)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00087 Score=58.51 Aligned_cols=31 Identities=32% Similarity=0.462 Sum_probs=25.8
Q ss_pred CCceeCCCCCCCEEecCCCc-eEEeeccccee
Q 040826 183 GCIVHRDIKLTNILLTEKLE-PKLSDFGLAKM 213 (347)
Q Consensus 183 ~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~ 213 (347)
..++|+|++|.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00019 Score=62.49 Aligned_cols=131 Identities=14% Similarity=0.079 Sum_probs=89.5
Q ss_pred cccCCeeeecCCeeEEEEEeCCCCEEEEEEcccC----------C------Ch--------hHHHHHHHHhhcCC-CC-c
Q 040826 68 DWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS----------N------NT--------DSFSREVEGLSRVR-HP-N 121 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------~------~~--------~~~~~e~~~l~~l~-h~-n 121 (347)
+...+.||-|--+.||.+...+|+..++|.=.-. . .. -...+|...|+.+. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5567889999999999999999999998842100 0 00 02446777777774 21 2
Q ss_pred ceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 122 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
+.+.++ .+..++|||++.+-+|...-.- .+.+ .+...+..-+.-|- ..|+||+|.+--||++++++
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHH---HcCceecccchheeEEecCC
Confidence 333333 3467899999998777553211 1222 23444444555565 78999999999999999999
Q ss_pred ceEEeecccce
Q 040826 202 EPKLSDFGLAK 212 (347)
Q Consensus 202 ~~kl~dfg~~~ 212 (347)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999996443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.002 Score=57.27 Aligned_cols=137 Identities=21% Similarity=0.263 Sum_probs=94.7
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccC-----------------------CChhH-----HHHHHHHhhcCCCCcce
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKS-----------------------NNTDS-----FSREVEGLSRVRHPNLV 123 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----------------------~~~~~-----~~~e~~~l~~l~h~niv 123 (347)
..|..|--+.||.+...+|..+|||++..+ .+... ...|+..|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457889999999999889999999987433 01111 23577788888765543
Q ss_pred eeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
..--.... ...|||+|+-. .=...=.-+...++...+..+-.|++.-+.-|.+. .+++|.||+--|+|+-+ |.+
T Consensus 230 ~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-CEE
Confidence 32222221 34689999853 21111111344577778888889999999988874 48999999999998875 589
Q ss_pred EEeecccceec
Q 040826 204 KLSDFGLAKML 214 (347)
Q Consensus 204 kl~dfg~~~~~ 214 (347)
.++|.+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998776643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.002 Score=56.86 Aligned_cols=130 Identities=18% Similarity=0.185 Sum_probs=78.0
Q ss_pred cCCeeEEEEEeCCCCEEEEEEccc-C---CChhHHHHHHHHhhcCCC--CcceeeeeEEEeCC--eEEEEEeecCCCChH
Q 040826 77 GSAGLVYKGVLPSGQVVAIKHIYK-S---NNTDSFSREVEGLSRVRH--PNLVCLFGCCVEGG--EQYLVYEFCAAGNLA 148 (347)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~-~---~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~ 148 (347)
|....+|.... +++.++++ ..+ . .......+|+.+++.+.- .-....+++|.++. ..+.||+|.+|..+.
T Consensus 36 G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 36 GWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 33334455444 37888888 332 1 223356677888777742 23455667776655 779999999985332
Q ss_pred HHhhcCCCCCCHHHHHHHH-HHHHHHHHHhhhcc----------------------------------------------
Q 040826 149 QHLLRKDSVLTWERRVKIL-RDCALALRYLHHYI---------------------------------------------- 181 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~-~qi~~~l~~Lh~~~---------------------------------------------- 181 (347)
+.+.. .+.. .+.+ ..+++.|.-||+-.
T Consensus 114 ~~~~~----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 114 SALPP----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred CcCCc----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 21110 0000 1111 23444444444211
Q ss_pred ---------CCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 182 ---------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 182 ---------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
...++|+|+++.|++++.++-+-|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 135899999999999999988999999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0017 Score=56.86 Aligned_cols=74 Identities=19% Similarity=0.236 Sum_probs=49.2
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
..+.++-|..+.+|+.. .+++.+.+|.-. ......|..|.+-|+.|. .-.+.+++++....+..+|++||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34568889999999988 477889999776 444567888998888883 345678888877777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.082 Score=48.47 Aligned_cols=71 Identities=13% Similarity=0.108 Sum_probs=47.8
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccC-----C----ChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEE
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS-----N----NTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~----~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 138 (347)
.+.+|-|....||+.... +..++||.-.+. . ....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999998874 456889976521 1 2233345566666553 246777777766 346788
Q ss_pred EeecCC
Q 040826 139 YEFCAA 144 (347)
Q Consensus 139 ~e~~~~ 144 (347)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0063 Score=54.28 Aligned_cols=156 Identities=20% Similarity=0.253 Sum_probs=91.1
Q ss_pred ccHHHHHHHhcCcccC-----CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC---Cc---cee
Q 040826 56 FSKDEIENAINNDWDR-----RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH---PN---LVC 124 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h---~n---iv~ 124 (347)
+..++...+...|... ..|.+ .-..+|+....+|+. ++|...+.....+...|...+..+.- += +..
T Consensus 11 ~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~ 88 (331)
T COG2334 11 LTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPS 88 (331)
T ss_pred cChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 4445555554444332 33444 567899999877776 89988877556677788888888731 11 111
Q ss_pred eeeEE--EeCC--eEEEEEeecCCCChHH------------Hh---hc--------CC---CCCCHH-------------
Q 040826 125 LFGCC--VEGG--EQYLVYEFCAAGNLAQ------------HL---LR--------KD---SVLTWE------------- 161 (347)
Q Consensus 125 ~~~~~--~~~~--~~~lv~e~~~~gsL~~------------~l---~~--------~~---~~~~~~------------- 161 (347)
.=|-. .-.. ..+-+++|++|..+.. ++ +. .. ....|.
T Consensus 89 ~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~ 168 (331)
T COG2334 89 LDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLV 168 (331)
T ss_pred CCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhccc
Confidence 11111 1123 7788999999977662 11 10 00 012222
Q ss_pred ----HHHHHHHHHHHHHHHhhhccCCC---ceeCCCCCCCEEecCCCc-eEEeeccccee
Q 040826 162 ----RRVKILRDCALALRYLHHYIDGC---IVHRDIKLTNILLTEKLE-PKLSDFGLAKM 213 (347)
Q Consensus 162 ----~~~~i~~qi~~~l~~Lh~~~~~~---i~H~dl~p~Nili~~~~~-~kl~dfg~~~~ 213 (347)
.+..+...+......+-.....+ ++|+|+.|.||+++++.. .-+.||+-+..
T Consensus 169 ~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 169 EPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred CchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 22222232333333332222334 999999999999999885 88999987653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0034 Score=56.67 Aligned_cols=138 Identities=20% Similarity=0.253 Sum_probs=79.1
Q ss_pred CeeeecCCeeEEEEEeCC-----CCEEEEEEcccCCCh-hHHHHHHHHhhcCCCCcce-eeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLPS-----GQVVAIKHIYKSNNT-DSFSREVEGLSRVRHPNLV-CLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.+..|-...+|+....+ ++.+++|........ -+-.+|..+++.+...++. ++++.+.. + .|.+|+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 345557888999987543 367889977654321 1235688888888643433 44454432 2 58999987
Q ss_pred CChHHH-----------------hhcCC---C--CCCHHHHHHHHHHH-----------------HHHHHHhhh-----c
Q 040826 145 GNLAQH-----------------LLRKD---S--VLTWERRVKILRDC-----------------ALALRYLHH-----Y 180 (347)
Q Consensus 145 gsL~~~-----------------l~~~~---~--~~~~~~~~~i~~qi-----------------~~~l~~Lh~-----~ 180 (347)
.++... +++.. . ...+....++..++ ...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 11111 0 11122333332221 111112211 1
Q ss_pred cCCCceeCCCCCCCEEecC-CCceEEeeccccee
Q 040826 181 IDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKM 213 (347)
Q Consensus 181 ~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~ 213 (347)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1346899999999999986 46899999987764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0014 Score=60.63 Aligned_cols=70 Identities=16% Similarity=0.130 Sum_probs=46.5
Q ss_pred EEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEEEEeecCCCChHHHhhcC
Q 040826 83 YKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYLVYEFCAAGNLAQHLLRK 154 (347)
Q Consensus 83 ~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~ 154 (347)
+.|....|..+ ..-+.-..+...+.-..+.++.+.|+|....+.+... .....+|+|++.. ||.+.+...
T Consensus 6 ~~a~~~~~~~c-~nglplt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~ 76 (725)
T KOG1093|consen 6 FFAQEKPGDVC-SNGLPLTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG 76 (725)
T ss_pred EehhcCCCccc-cCCCcCCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc
Confidence 44444444433 3223333445566777888999999999998887654 3357889999865 999987543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0044 Score=51.22 Aligned_cols=113 Identities=17% Similarity=0.094 Sum_probs=73.2
Q ss_pred cCCeeEEEEEeCCCCEEEEEEcccC-C--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhc
Q 040826 77 GSAGLVYKGVLPSGQVVAIKHIYKS-N--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR 153 (347)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~-~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 153 (347)
++.++.-.+..+-|. ..+|++.+. . ....|..+.+++.+++ .|+++.. .+...+.++.|+|......
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i~----- 142 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKIN----- 142 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcccc-----
Confidence 444555555543344 345555443 2 2345778888988887 5777763 2444677899998653211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 154 KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 154 ~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
.. -.+.++ ..+|.-.|+. +.+.+|+|-.|+|||-|..|.+||.|-+
T Consensus 143 -----~~---N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 143 -----FS---NFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred -----hh---HHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence 00 111221 3567777865 5789999999999999999999999965
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.011 Score=52.68 Aligned_cols=30 Identities=30% Similarity=0.365 Sum_probs=25.9
Q ss_pred CCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 182 ~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
..+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367899999999999998 678999998655
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.059 Score=49.13 Aligned_cols=71 Identities=15% Similarity=0.137 Sum_probs=46.3
Q ss_pred CeeeecCCeeEEEEEeCC-CCEEEEEEcccC--------CChhHHHHHHHHhhcCC--CCc-ceeeeeEEEeCCeEEEEE
Q 040826 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYKS--------NNTDSFSREVEGLSRVR--HPN-LVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--------~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 139 (347)
+.||-|.-.-||++...+ +..|+||.-.+. -..+...-|.+.|+... .|. +.+++. .+.....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence 468999999999999753 567999865321 12234566777877764 443 444443 3344566788
Q ss_pred eecCC
Q 040826 140 EFCAA 144 (347)
Q Consensus 140 e~~~~ 144 (347)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.093 Score=47.05 Aligned_cols=94 Identities=15% Similarity=0.097 Sum_probs=57.3
Q ss_pred cccccHHHHHHHhcCcccC---C-eeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCc--cee-
Q 040826 53 LYRFSKDEIENAINNDWDR---R-FLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPN--LVC- 124 (347)
Q Consensus 53 ~~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~n--iv~- 124 (347)
...++.+.+..+...+... + ..=.+.-..||+....+|..+++|...+.. .......|.+.+..+.... ++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4456777777766555332 1 112345667999998788889999886543 4456677887777663211 121
Q ss_pred --eee--EEEeCCeEEEEEeecCCCC
Q 040826 125 --LFG--CCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 125 --~~~--~~~~~~~~~lv~e~~~~gs 146 (347)
.-| +...++..+.++++.+|..
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 112 1223456788999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0074 Score=54.20 Aligned_cols=138 Identities=16% Similarity=0.211 Sum_probs=77.2
Q ss_pred CeeeecCCeeEEEEEeCC----CCEEEEEEcccCCCh-hHHHHHHHHhhcCCCCcce-eeeeEEEeCCeEEEEEeecCCC
Q 040826 72 RFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNT-DSFSREVEGLSRVRHPNLV-CLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g 145 (347)
+.|..|-...+|+....+ +..|++|........ -+-.+|..+++.+...++. ++++++. ++ ++.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 345557778889887543 237889977554321 1234788888888654443 3444432 22 589999876
Q ss_pred ChHH-------Hh----------hcCC----C-CCCHHHHHHHHHHH----------------------HHHHHHhhhc-
Q 040826 146 NLAQ-------HL----------LRKD----S-VLTWERRVKILRDC----------------------ALALRYLHHY- 180 (347)
Q Consensus 146 sL~~-------~l----------~~~~----~-~~~~~~~~~i~~qi----------------------~~~l~~Lh~~- 180 (347)
+|.. .+ +... . .-.+..+.++..++ .+-+..+...
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5522 01 1111 0 11223332322221 1111111110
Q ss_pred ----cCCCceeCCCCCCCEEecC-CCceEEeeccccee
Q 040826 181 ----IDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKM 213 (347)
Q Consensus 181 ----~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~ 213 (347)
...-++|+|+.+.||++++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 0124799999999999975 56899999987764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.013 Score=60.59 Aligned_cols=157 Identities=19% Similarity=0.240 Sum_probs=87.8
Q ss_pred cccHHHHHHHh-cCcccC---CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-------CCcce
Q 040826 55 RFSKDEIENAI-NNDWDR---RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-------HPNLV 123 (347)
Q Consensus 55 ~~~~~~~~~~~-~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-------h~niv 123 (347)
.++.+++.... +.|... +.|+ |..-.+|+....+|..+++|+............|...+..+. -|.++
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i 88 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLI 88 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeee
Confidence 35555554432 333322 4454 456788999887888999999987655545555556665442 23333
Q ss_pred eee-e----EEEe-CC--eEEEEEeecCCCChHHH--------------h---hc------C---CCCCCHH--------
Q 040826 124 CLF-G----CCVE-GG--EQYLVYEFCAAGNLAQH--------------L---LR------K---DSVLTWE-------- 161 (347)
Q Consensus 124 ~~~-~----~~~~-~~--~~~lv~e~~~~gsL~~~--------------l---~~------~---~~~~~~~-------- 161 (347)
+.. | .... ++ ..+-+++|.+|..+.+. + .. . ...+.|.
T Consensus 89 ~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~ 168 (1013)
T PRK06148 89 PSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRAR 168 (1013)
T ss_pred ecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhh
Confidence 322 1 1111 22 45678999999776541 0 00 0 0111121
Q ss_pred ---------HHHHHHHHHHHHHH-----HhhhccCCCceeCCCCCCCEEecCCC--ceE-Eeeccccee
Q 040826 162 ---------RRVKILRDCALALR-----YLHHYIDGCIVHRDIKLTNILLTEKL--EPK-LSDFGLAKM 213 (347)
Q Consensus 162 ---------~~~~i~~qi~~~l~-----~Lh~~~~~~i~H~dl~p~Nili~~~~--~~k-l~dfg~~~~ 213 (347)
....++.++.+... .+.+ ...+++|+|+++.||+++.++ .+. |+|||.+..
T Consensus 169 ~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 169 DRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 11222223333222 1221 246799999999999999875 555 999997764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.025 Score=50.34 Aligned_cols=32 Identities=22% Similarity=0.340 Sum_probs=28.5
Q ss_pred CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 182 ~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..+++|+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0098 Score=53.70 Aligned_cols=63 Identities=17% Similarity=0.092 Sum_probs=42.1
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK 200 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~ 200 (347)
...++=+|.+|.++..++....+ ++....+++.-.++|+-.+-- -.+++|.|++|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~--pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQ--PEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccC--hHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence 34567778888899888865543 334455555555555443321 4589999999999999643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.73 Score=41.63 Aligned_cols=71 Identities=20% Similarity=0.189 Sum_probs=45.8
Q ss_pred eeeecCCeeEEEEEeCCC-CEEEEEEcccC---------CChhHHHHHHHHhhcCC--CCc-ceeeeeEEEeCCeEEEEE
Q 040826 73 FLGRGSAGLVYKGVLPSG-QVVAIKHIYKS---------NNTDSFSREVEGLSRVR--HPN-LVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~---------~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 139 (347)
.+|-|...-||++..++| +.++||.-.+. -......-|...|+... .|. +.+++. .+.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478899999999997654 58999965321 11234556777777664 343 334443 3444566899
Q ss_pred eecCCC
Q 040826 140 EFCAAG 145 (347)
Q Consensus 140 e~~~~g 145 (347)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.00067 Score=70.05 Aligned_cols=158 Identities=16% Similarity=0.071 Sum_probs=108.8
Q ss_pred HHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEEeecCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcc
Q 040826 107 FSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVYEFCAAGNLAQHLLRKD---SVLTWERRVKILRDCALALRYLHHYI 181 (347)
Q Consensus 107 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~Lh~~~ 181 (347)
...|.+.++...|+++.....-... ....+..++|+.+|.+.+.+.++. +.+...-......+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3344445566678877766554433 335678899999999999886532 22333333333333344444444322
Q ss_pred --CCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHH
Q 040826 182 --DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259 (347)
Q Consensus 182 --~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ll 259 (347)
+.-.+|+++++-|.+|..+-+++++++|+.+... ......+...+++.|+.|+....-.++.++|+|..|+-+|...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 3347899999999999999999999999998322 2222234456778889999888888888899999999999998
Q ss_pred hCCCCc
Q 040826 260 SGQKVI 265 (347)
Q Consensus 260 tg~~p~ 265 (347)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.076 Score=48.61 Aligned_cols=73 Identities=16% Similarity=0.224 Sum_probs=43.2
Q ss_pred CeeeecCCeeEEEEEeCCC--CE-----EEEEEcccCCC-hhHHHHHHHHhhcCCCCccee-eeeEEEeCCeEEEEEeec
Q 040826 72 RFLGRGSAGLVYKGVLPSG--QV-----VAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVC-LFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~ 142 (347)
+.+..|-...+|++...++ .. |+++....... .-+-.+|..+++.+...++.+ +++.+.. +++.||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 4555688889999985433 22 44443322111 112346888888887555444 4444432 5899999
Q ss_pred CCCChH
Q 040826 143 AAGNLA 148 (347)
Q Consensus 143 ~~gsL~ 148 (347)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987653
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.063 Score=46.03 Aligned_cols=78 Identities=18% Similarity=0.065 Sum_probs=54.2
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC-CChHHH
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA-GNLAQH 150 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~ 150 (347)
..+..|..+.|+.+...+|...++|...+......-......|+..+-...+++++.- ...-.+++|...+ .+|.+.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~~ 85 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLASL 85 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhhc
Confidence 3466799999999999999999999987665533222223457777766778888754 3355788899844 466544
Q ss_pred h
Q 040826 151 L 151 (347)
Q Consensus 151 l 151 (347)
.
T Consensus 86 ~ 86 (253)
T PF04655_consen 86 P 86 (253)
T ss_pred c
Confidence 3
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.0041 Score=46.74 Aligned_cols=46 Identities=22% Similarity=0.226 Sum_probs=35.1
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcC
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV 117 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l 117 (347)
.++||.|+.|+||+|++++|+.||||+..+.- ...+...+.+++.+
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i-~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGI-EEQIEADLRILRRL 61 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHH-HHHHHHHHHHHHHH
Confidence 46899999999999999999999999876543 33445555555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.13 Score=43.04 Aligned_cols=73 Identities=16% Similarity=0.232 Sum_probs=47.7
Q ss_pred eeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
+.-|.....|...+ +...+-+|+-. ......|..|+.-|+.+. --++.+++.+-.+.+..++|+||.+-+.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~-~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQ-REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecc-hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44344444444443 45678888542 233456778887776664 345677777777888999999999987665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 347 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 4e-99
Identities = 101/286 (35%), Positives = 160/286 (55%), Gaps = 11/286 (3%)
Query: 55 RFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHI---YKSNNTDSFSREV 111
RFS E++ A +N ++ LGRG G VYKG L G +VA+K + F EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 112 EGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD---SVLTWERRVKILR 168
E +S H NL+ L G C+ E+ LVY + A G++A L + L W +R +I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 169 DCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228
A L YLH + D I+HRD+K NILL E+ E + DFGLAK++ +++ V T VRGT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 229 IGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ---LTRKARDVSMG 285
IG++ PEY++ K + +D++ +G++ L+L++GQ+ +L A D L + + +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-LK 257
Query: 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTI-DVV 330
++ ++ D L GN + E ++++A+LC S RP + +VV
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 9e-99
Identities = 107/307 (34%), Positives = 153/307 (49%), Gaps = 20/307 (6%)
Query: 38 SPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKH 97
S YR ++E A NN + +G G G VYKGVL G VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 98 IYKSNNTDS------FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL 151
+S F E+E LS RHP+LV L G C E E L+Y++ GNL +HL
Sbjct: 71 R----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 152 LRKDS---VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208
D ++WE+R++I A L YLH I+HRD+K NILL E PK++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 209 GLAKM-LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIEL 267
G++K ++++ + T V+GT+GY+DPEY +LT SD+YSFG+V ++L + I
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 268 DFDARDQ-LTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT 326
L A S ++ DP L I AV C+A SS+ RP+
Sbjct: 244 SLPREMVNLAEWAV-ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 327 I-DVVYE 332
+ DV+++
Sbjct: 303 MGDVLWK 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 6e-92
Identities = 87/304 (28%), Positives = 147/304 (48%), Gaps = 25/304 (8%)
Query: 44 EIYSTTWSGLYRFSKDEIENAINN------DWDRRFLGRGSAGLVYKGVLPSGQVVAIKH 97
+ + + + FS E++N NN +G G G+VYKG + VA+K
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 98 IYKSNNTDS------FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL 151
+ + + F +E++ +++ +H NLV L G +G + LVY + G+L L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 152 LRKDS--VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209
D L+W R KI + A + +LH + +HRDIK NILL E K+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 210 LAKMLGMEE-SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELD 268
LA+ + + + + GT YM PE + ++T SDIYSFG+V L++++G + D
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV--D 235
Query: 269 FDARDQ-LTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTI 327
Q L ++ ++ I+D+ D ++ + + E++ +A C+ + RP I
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 328 -DVV 330
V
Sbjct: 295 KKVQ 298
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-62
Identities = 73/306 (23%), Positives = 117/306 (38%), Gaps = 29/306 (9%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVE--G 113
+ + RG G V+K L + VA+K I+ + S+ E E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVK-IFPIQDKQSWQNEYEVYS 71
Query: 114 LSRVRHPNLVCLFGCCVEG----GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD 169
L ++H N++ G G + +L+ F G+L+ L K +V++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 170 CALALRYLHHYIDG-------CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222
A L YLH I G I HRDIK N+LL L ++DFGLA +S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 223 TDVR-GTIGYMDPEYM-----TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA----- 271
T + GT YM PE + D+Y+ G+V +L S + D
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNI-NRADFESILKIAVLCVAKSSKGRPTIDVV 330
+++ + M + + + P L A + + C ++ R + V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 331 YEEIDK 336
E I +
Sbjct: 310 GERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-53
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG 133
+GRG+ G+V K + VAIK I + +F E+ LSRV HPN+V L+G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN-- 72
Query: 134 EQYLVYEFCAAGNLAQHLLRKDSV--LTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191
LV E+ G+L L + + T + C+ + YLH ++HRD+K
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 192 LTNILLTEKLE-PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
N+LL K+ DFG A + T+ +G+ +M PE + + D++S
Sbjct: 133 PPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFS 188
Query: 251 FGIVALQLLSGQK 263
+GI+ ++++ +K
Sbjct: 189 WGIILWEVITRRK 201
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-52
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCC 129
+G GS G V++ G VA+K + + + F REV + R+RHPN+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDS--VLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ +V E+ + G+L + L + + L RR+ + D A + YLH+ + IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
R++K N+L+ +K K+ DFGL+++ GT +M PE + + SD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 248 IYSFGIVALQLLSGQ 262
+YSFG++ +L + Q
Sbjct: 222 VYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-51
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 74 LGRGSAGLVYKGVLPS-GQVVAIKHIYKSNNTD---------SFSREVEGLSRVRHPNLV 123
+G+G GLV+KG L VVAIK + ++ F REV +S + HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L+G +V EF G+L LL K + W +++++ D AL + Y+ + +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 184 CIVHRDIKLTNILLTEKLE-----PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
IVHRD++ NI L E K++DFGL++ + + + G +M PE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 239 --NAKLTCASDIYSFGIVALQLLSGQK 263
T +D YSF ++ +L+G+
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-50
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS------FSREVEGLSRVRHPNLVCLFG 127
+G G G VY+ G VA+K + D +E + + ++HPN++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
C++ LV EF G L + L K + + V A + YLH I+H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 188 RDIKLTNILLTEKLEP--------KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
RD+K +NIL+ +K+E K++DFGLA+ G +M PE +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEVIRA 188
Query: 240 AKLTCASDIYSFGIVALQLLSGQ 262
+ + SD++S+G++ +LL+G+
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGE 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-49
Identities = 64/317 (20%), Positives = 109/317 (34%), Gaps = 40/317 (12%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVE--G 113
+ E ++N +GRG G VYKG L + VA+K ++ N +F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK-VFSFANRQNFINEKNIYR 60
Query: 114 LSRVRHPNLVCLFGCCVEGG-----EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILR 168
+ + H N+ E LV E+ G+L ++L W ++
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAH 118
Query: 169 DCALALRYLHHYIDG------CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG------- 215
L YLH + I HRD+ N+L+ +SDFGL+ L
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 216 MEESKVFTDVRGTIGYMDPEYMTNA-------KLTCASDIYSFGIVALQLLSGQKVIELD 268
EE GTI YM PE + A D+Y+ G++ ++ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 269 FDAR-------DQLTRKARDVSMGKRPIKDFEDPRL--NGNINRADFESILKIAVLCVAK 319
++ M ++ + P+ N S+ + C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 320 SSKGRPTIDVVYEEIDK 336
++ R T E + +
Sbjct: 299 DAEARLTAQXAEERMAE 315
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-47
Identities = 33/199 (16%), Positives = 78/199 (39%), Gaps = 18/199 (9%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCC 129
L +G ++KG G + +K + + + F+ E L HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 130 VEGGEQYL--VYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
+ + + G+L L + V+ + VK D A + +LH ++ I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIP 135
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL---T 243
+ ++++ E + ++S + ++ PE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNR 189
Query: 244 CASDIYSFGIVALQLLSGQ 262
++D++SF ++ +L++ +
Sbjct: 190 RSADMWSFAVLLWELVTRE 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 74 LGRGSAGLVYKGVL-PSGQVVAIKHIYK--SNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
LG+G G K +G+V+ +K + + +F +EV+ + + HPN++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
+ + E+ G L + DS W +RV +D A + YLH I+HRD+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDL 134
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEES-------------KVFTDVRGTIGYMDPEYM 237
N L+ E ++DFGLA+++ E++ K V G +M PE +
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQK 263
D++SFGIV +++
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-46
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 52/294 (17%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVE--GLSRVRHPNLVCLFGCCVE 131
+G+G G V+ G G+ VA+K ++ + S+ RE E +RH N++ ++
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 132 GGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG---- 183
G YL+ ++ G+L +L K + L + +K+ L +LH I
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 184 -CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF---TDVRGTIGYMDPE---- 235
I HRD+K NIL+ + ++D GLA + ++V GT YM PE
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293
+ + +D+YSFG++ ++ +++++
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGG---------------------IVEEYQ 259
Query: 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI--DVVYEEIDKAWKNTMVEM 345
P + + +E + +I K RP+ +E + M E
Sbjct: 260 LPYHDLVPSDPSYEDMREIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTEC 308
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCC 129
+G+G G VY G G+V AI+ I + + F REV + RH N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ ++ C L + VL + +I ++ + YLH I+H+D
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD 155
Query: 190 IKLTNILLTEKLEPKLSDFGLAKM----LGMEESKVFTDVRGTIGYMDPEYMTNAKL--- 242
+K N+ + ++DFGL + G + ++ PE +
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 243 ------TCASDIYSFGIVALQLLSGQ 262
+ SD+++ G + +L + +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCC 129
+G GS G VYKG G V A+K + + T +F EV L + RH N++ G
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ +V ++C +L HL ++ ++ + I R A + YLH I+HRD
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRD 145
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLG-MEESKVFTDVRGTIGYMDPEYMTNA---KLTCA 245
+K NI L E K+ DFGLA S F + G+I +M PE + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 246 SDIYSFGIVALQLLSGQ 262
SD+Y+FGIV +L++GQ
Sbjct: 206 SDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-44
Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 52/294 (17%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVE--GLSRVRHPNLVCLFGCCVE 131
+G+G G V++G G+ VA+K I+ S + S+ RE E +RH N++ +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 132 GGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--- 184
+L+ + G+L +L + + L ++I+ A L +LH I G
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 185 --IVHRDIKLTNILLTEKLEPKLSDFGLAKML---GMEESKVFTDVRGTIGYMDPE---- 235
I HRD+K NIL+ + + ++D GLA M + GT YM PE
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293
+ DI++FG+V ++ ++D++
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG---------------------IVEDYK 230
Query: 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI--DVVYEEIDKAWKNTMVEM 345
P + N FE + K+ + RP I + + M E
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKEC 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-43
Identities = 66/294 (22%), Positives = 110/294 (37%), Gaps = 52/294 (17%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVE--GLSRVRHPNLVCLFGCCVE 131
+G+G G V++G G+ VA+K I+ S S+ RE E +RH N++ +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 132 GGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--- 184
+LV ++ G+L +L +T E +K+ A L +LH I G
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 185 --IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF---TDVRGTIGYMDPEYMTN 239
I HRD+K NIL+ + ++D GLA + GT YM PE + +
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 240 AKL------TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293
+ +DIY+ G+V ++ + +D++
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGG---------------------IHEDYQ 264
Query: 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI--DVVYEEIDKAWKNTMVEM 345
P + + E + K+ K RP I E + M E
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMREC 313
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 26/266 (9%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSR-----EVEGLSRVRHPNLVCL 125
+ +GRG VY+ L G VA+K + + D+ +R E++ L ++ HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRV-KILRDCALALRYLHHYID 182
+ +E E +V E AG+L++ + +K L ER V K AL ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
++HRDIK N+ +T KL D GL + + + + V GT YM PE +
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
SDI+S G + ++ + Q D L +K I+ + P L +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----------IEQCDYPPLPSDHY 263
Query: 303 RADFESILKIAVLCVAKSSKGRPTID 328
+ ++ +C+ + RP +
Sbjct: 264 SEELRQLVN---MCINPDPEKRPDVT 286
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 30/265 (11%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLF 126
+ +G GS G G+ IK I S + REV L+ ++HPN+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCI 185
E G Y+V ++C G+L + + + VL E ++ LAL+++H D I
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRDIK NI LT+ +L DFG+A++L + GT Y+ PE N
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNK 205
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARD--QLTRKARDVSMGKRPIKDFEDPRLNGNINR 303
SDI++ G V +L + + F+A L K I P ++ + +
Sbjct: 206 SDIWALGCVLYELCTLKHA----FEAGSMKNLVLK----------IISGSFPPVSLHYSY 251
Query: 304 ADFESILKIAVLCVAKSSKGRPTID 328
D S++ ++ + RP+++
Sbjct: 252 -DLRSLVS---QLFKRNPRDRPSVN 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 64/204 (31%), Positives = 86/204 (42%), Gaps = 16/204 (7%)
Query: 68 DWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRV-RHP 120
+ R LG GS G V+K G++ A+K EV +V +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH 179
V L EGG YL E C +L QH + L E +V LRD LAL +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLP-EAQVWGYLRDTLLALAHLH- 174
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+VH D+K NI L + KL DFGL LG G YM PE +
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPE-LLQ 229
Query: 240 AKLTCASDIYSFGIVALQLLSGQK 263
A+D++S G+ L++ +
Sbjct: 230 GSYGTAADVFSLGLTILEVACNME 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 35 KRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVA 94
E S G F ++ LG G+ G + + + VA
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDV------------LGHGAEGTIVYRGMFDNRDVA 52
Query: 95 IKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR 153
+K I + + REV+ L HPN++ F + QY+ E CA L +++ +
Sbjct: 53 VKRILPECFSFA-DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ 110
Query: 154 KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-----LEPKLSDF 208
KD + +L+ L +LH IVHRD+K NIL++ ++ +SDF
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 209 GLAKML--GMEESKVFTDVRGTIGYMDPEYM---TNAKLTCASDIYSFGIVALQLLSG 261
GL K L G + V GT G++ PE + T DI+S G V ++S
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 56/244 (22%), Positives = 89/244 (36%), Gaps = 17/244 (6%)
Query: 28 KNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRR--FLGRGSAGLVYKG 85
K + + + + + E W +GRGS G V++
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77
Query: 86 V-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144
+G A+K + E+ + + P +V L+G EG + E
Sbjct: 78 KDKQTGFQCAVKKV---RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 145 GNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LE 202
G+L Q L+++ L E R L L YLH I+H D+K N+LL+
Sbjct: 135 GSLGQ-LIKQMGCLP-EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSR 189
Query: 203 PKLSDFGLAKMLGMEESKVFT----DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQL 258
L DFG A L + + GT +M PE + DI+S + L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
Query: 259 LSGQ 262
L+G
Sbjct: 250 LNGC 253
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 18/216 (8%)
Query: 59 DEIENAINNDWDRR--FLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT----DSFSREV 111
+ + + + + +GRGS VYKG+ + VA + T F E
Sbjct: 17 KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 112 EGLSRVRHPNLVCLFGCCVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKIL 167
E L ++HPN+V + + LV E +G L L++ V+ +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWC 135
Query: 168 RDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESKVFTDVR 226
R L++LH I+HRD+K NI +T K+ D GLA + +K V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVI 191
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
GT +M PE K + D+Y+FG+ L++ + +
Sbjct: 192 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-38
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 19/221 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLF 126
+G GS G K G+++ K + + T+ EV L ++HPN+V +
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 127 GCCVE--GGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRV-KILRDCALALRYLH--H 179
++ Y+V E+C G+LA + K+ E V +++ LAL+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
++HRD+K N+ L K KL DFGLA++L + S T V GT YM PE M
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD--QLTRK 278
SDI+S G + +L + F A +L K
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGK 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 67 NDWDRR-FLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNL 122
++ R LG+G+ G+VY G L + +AIK I + ++ E+ ++H N+
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCALALRYLHHY 180
V G E G + E G+L+ L K L + + L+YLH
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-- 139
Query: 181 IDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE--YM 237
D IVHRDIK N+L+ K+SDFG +K L T GT+ YM PE
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDK 197
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQ 262
A+DI+S G +++ +G+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G G G V+K G+ IK + +N + REV+ L+++ H N+V GC
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 131 EGGEQ----------------YLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALA 173
++ EFC G L Q + ++ + ++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
+ Y+H +++RD+K +NI L + + K+ DFGL L + T +GT+ YM
Sbjct: 135 VDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTLRYMS 189
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQK 263
PE +++ D+Y+ G++ +LL
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 62 ENAINNDWD-RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN---NTDSFSREVEGLSR 116
++ N+ W LG+G+ V++G +G + AIK + D RE E L +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 117 VRHPNLVCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCAL 172
+ H N+V LF E + L+ EFC G+L L + +LRD
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGT 228
+ +L IVHR+IK NI+ + KL+DFG A+ +E+ + F + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGT 178
Query: 229 IGYMDPEYMTNAKL--------TCASDIYSFGIVALQLLSGQ 262
Y+ P+ A L D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGCC 129
+G+GS G V+KG+ + +VVAIK I D +E+ LS+ P + +G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
++ + +++ E+ G+ LL + L + ILR+ L YLH + I HRD
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLL-EPGPLDETQIATILREILKGLDYLHS--EKKI-HRD 144
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
IK N+LL+E E KL+DFG+A L + K T V GT +M PE + + +DI+
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIW 203
Query: 250 SFGIVALQLLSGQ 262
S GI A++L G+
Sbjct: 204 SLGITAIELARGE 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 74 LGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFGCC 129
LG G+ G+V+K PSG V+A K I+ + RE++ L P +V +G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
GE + E G+L Q +L+K + + K+ L YL I+HRD
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRD 157
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
+K +NIL+ + E KL DFG++ L +S + V GT YM PE + + SDI+
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIW 214
Query: 250 SFGIVALQLLSGQ 262
S G+ +++ G+
Sbjct: 215 SMGLSLVEMAVGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 62 ENAINNDWD-RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN---NTDSFSREVEGLSR 116
++ N+ W LG+G+ V++G +G + AIK + D RE E L +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 117 VRHPNLVCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTW-ERRV-KILRDCAL 172
+ H N+V LF E + L+ EFC G+L L + E +LRD
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGT 228
+ +L + IVHR+IK NI+ + KL+DFG A+ +E+ + F + GT
Sbjct: 124 GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGT 178
Query: 229 IGYMDPEYMTNAKL--------TCASDIYSFGIVALQLLSGQ 262
Y+ P+ A L D++S G+ +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-36
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 32/217 (14%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFG 127
+ LGRG G+V++ AIK I N + REV+ L+++ HP +V F
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 128 CCVEGGEQ------------YLVYEFCAAGNLAQHLLRKDSVLTWERRV--KILRDCALA 173
+E Y+ + C NL + + ++ ER V I A A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-----------GMEESKVF 222
+ +LH ++HRD+K +NI T K+ DFGL + M
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259
T GT YM PE + + DI+S G++ +LL
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
+G G+ +V P + VAIK I + D +E++ +S+ HPN+V +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK--------ILRDCALALRYLHHYI 181
V E +LV + + G++ +++ + ILR+ L YLH
Sbjct: 83 VVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-- 139
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT-IG---YMDPEYM 237
+G I HRD+K NILL E +++DFG++ L VR T +G +M PE M
Sbjct: 140 NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 238 TNAKL-TCASDIYSFGIVALQLLSGQ 262
+ +DI+SFGI A++L +G
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 55/254 (21%), Positives = 108/254 (42%), Gaps = 26/254 (10%)
Query: 28 KNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDR-RFLGRGSAGLVYKGV 86
K + + ++ T S +E + + + +G G + V++ +
Sbjct: 18 KETAAAKFERQHMDSPDL-GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVL 76
Query: 87 LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNL--VCLFGCCVEGGEQYLVYE 140
Q+ AIK++ DS+ E+ L++++ + + L+ + Y+V E
Sbjct: 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK 200
C +L L +K S+ WER+ ++ A+ +H + IVH D+K N L+ +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 191
Query: 201 LEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPE-----------YMTNAKLTCASDI 248
KL DFG+A + + + V D G + YM PE + +K++ SD+
Sbjct: 192 -MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 249 YSFGIVALQLLSGQ 262
+S G + + G+
Sbjct: 251 WSLGCILYYMTYGK 264
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 46/228 (20%), Positives = 83/228 (36%), Gaps = 38/228 (16%)
Query: 65 INNDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRV- 117
++ +G G G V+K V G + AIK K REV + +
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW--ERRVK-ILRDCALAL 174
+H ++V F E + E+C G+LA + ++++ E +K +L L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEP-------------------KLSDFGLAKMLG 215
RY+H +VH DIK +NI ++ P K+ D G +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 216 MEESKVFTDVRGTIGYMDPE-YMTNAKLTCASDIYSFGIVALQLLSGQ 262
+ + G ++ E N +DI++ + + +
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 32/219 (14%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCC 129
LG+G+ G V K + AIK I + + EV L+ + H +V +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 130 VEGGEQ-------------YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRY 176
+E ++ E+C G L + ++ + ++ R AL Y
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-------------GMEESKVFT 223
+H I+HRD+K NI + E K+ DFGLAK + S T
Sbjct: 132 IH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 224 DVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSG 261
GT Y+ E + D+YS GI+ +++
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 63/190 (33%), Positives = 102/190 (53%), Gaps = 5/190 (2%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
LG GS G VYK + +GQ+VAIK + ++ +E+ + + P++V +G +
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
+ ++V E+C AG+++ + ++ LT + IL+ L YLH I HRDIK
Sbjct: 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF--MRKI-HRDIKA 153
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
NILL + KL+DFG+A L +K T + GT +M PE + C +DI+S G
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 253 IVALQLLSGQ 262
I A+++ G+
Sbjct: 213 ITAIEMAEGK 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 19/203 (9%)
Query: 75 GRGSAGLVYKGV-LPSGQVVAIKHI----YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
G V P+G+ V ++ I + E+ HPN+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ E ++V F A G+ + L+ + IL+ AL Y+HH G + H
Sbjct: 96 IADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYV-H 151
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR------GTIGYMDPEYMTNAK 241
R +K ++IL++ + LS + + + ++ PE +
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 242 L--TCASDIYSFGIVALQLLSGQ 262
SDIYS GI A +L +G
Sbjct: 212 QGYDAKSDIYSVGITACELANGH 234
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNL--VCL 125
+ +G G + V++ + Q+ AIK++ DS+ E+ L++++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + Y+V E C +L L +K S+ WER+ ++ A+ +H + I
Sbjct: 94 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GI 148
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPE--------- 235
VH D+K N L+ + KL DFG+A + + + V D GT+ YM PE
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSGQ 262
+ +K++ SD++S G + + G+
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 66 NNDWDR-RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHP 120
+ + +G G + V++ + Q+ AIK++ DS+ E+ L++++
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 121 NL--VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
+ + L+ + Y+V E C +L L +K S+ WER+ ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 125
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPE-- 235
+ IVH D+K N L+ + KL DFG+A + + + V D GT+ YM PE
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 236 ---------YMTNAKLTCASDIYSFGIVALQLLSGQ 262
+ +K++ SD++S G + + G+
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-34
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCL 125
LG+GS VY+ + +G VAIK I K EV+ +++HP+++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + YLV E C G + ++L + + + + YLH + I
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GI 133
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+ L+N+LLT + K++DFGLA L M K +T + GT Y+ PE T +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARD 273
SD++S G + LL G FD
Sbjct: 193 SDVWSLGCMFYTLLIG----RPPFDTDT 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 62/288 (21%), Positives = 102/288 (35%), Gaps = 40/288 (13%)
Query: 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFG 127
+ LG G V L G A+K I D RE + HPN++ L
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 128 CCVE----GGEQYLVYEFCAAGNLAQHL---LRKDSVLTWERRV-KILRDCALALRYLHH 179
C+ E +L+ F G L + K + LT E ++ +L L +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLLLGICRGLEAIH- 151
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--------FTDVRGTIGY 231
HRD+K TNILL ++ +P L D G + + R TI Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 232 MDPEYM---TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP 288
PE ++ + +D++S G V ++ G+ +D Q +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE----GPYDMVFQKGDSVALAVQNQLS 265
Query: 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
I PR + + +L + RP I ++ +++
Sbjct: 266 IPQS--PRHS-----SALWQLLNS---MMTVDPHQRPHIPLLLSQLEA 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLF--- 126
LG G G V + + +G+ VAIK + + + + E++ + ++ HPN+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 127 ---GCCVEGGEQYLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYI 181
L E+C G+L ++L + + L +L D + ALRYLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 182 DGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ I+HRD+K NI+L + K+ D G AK +++ ++ T+ GT+ Y+ PE +
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFVGTLQYLAPELLE 196
Query: 239 NAKLTCASDIYSFGIVALQLLSGQ 262
K T D +SFG +A + ++G
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGF 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
RFLG+G ++ + +V A K + K + + S E+ + H ++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
G + ++V E C +L + R+ ++ E R LR L +YLH +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 162
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+KL N+ L E LE K+ DFGLA + + + + GT Y+ PE ++ +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 221
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARD 273
D++S G + LL G+ F+
Sbjct: 222 VDVWSIGCIMYTLLVGK----PPFETSC 245
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
RFLG+G ++ + +V A K + K + + S E+ + H ++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
G + ++V E C +L + R+ ++ E R LR L +YLH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 136
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRD+KL N+ L E LE K+ DFGLA + + + + GT Y+ PE ++ +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 195
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARD 273
D++S G + LL G+ F+
Sbjct: 196 VDVWSIGCIMYTLLVGK----PPFETSC 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 46 YSTTWSGLYRFSKDEIENAINND-W--DR------RFLGRGSAGLVYKGVLPSGQV-VAI 95
+T L + S + A+ D W + +GRG+ G V+ G L + VA+
Sbjct: 85 LLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 96 KHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL 151
K + F +E L + HPN+V L G C + Y+V E G+ L
Sbjct: 145 KSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 152 LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211
+ + L + ++++ D A + YL C +HRD+ N L+TEK K+SDFG++
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 212 KMLGMEESKVFTDVRGT----IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ V+ G + + PE + + + SD++SFGI+
Sbjct: 261 REE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEG 132
LG GS+G V G+ VA+K + D E++ L+ HPN++ +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 133 GEQYLVYEFCAAGNLAQHLLRKD------SVLTWERRVKILRDCALALRYLHHYIDGCIV 186
Y+ E C NL + K+ + + +LR A + +LH I+
Sbjct: 82 RFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKII 137
Query: 187 HRDIKLTNILLTEKLEP-------------KLSDFGLAKMLGMEESKVFTDVR---GTIG 230
HRD+K NIL++ +SDFGL K L +S T++ GT G
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 231 YMDPE-------YMTNAKLTCASDIYSFGIVALQLLSG 261
+ PE T +LT + DI+S G V +LS
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-34
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 19/221 (8%)
Query: 57 SKDEIENAINNDWD--RRF-----LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--S 106
K + D D + LG G+ G VYK +G + A K I + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62
Query: 107 FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI 166
+ E+E L+ HP +V L G G+ +++ EFC G + +L D LT + +
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 167 LRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
R AL +LH I HRD+K N+L+T + + +L+DFG++ K + +
Sbjct: 123 CRQMLEALNFLHS--KRII-HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI- 178
Query: 227 GTIGYMDPEYMTNAKLT-----CASDIYSFGIVALQLLSGQ 262
GT +M PE + + +DI+S GI +++ +
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 59/192 (30%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI--YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G+G++G VY + + +GQ VAI+ + + + E+ + ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E ++V E+ A G+L + ++ + + + R+C AL +LH ++HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K NILL KL+DFG + E+SK T V GT +M PE +T DI+S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 251 FGIVALQLLSGQ 262
GI+A++++ G+
Sbjct: 202 LGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 9/192 (4%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI--YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+G GS G+V SG+ VA+K + K + EV + +H N+V ++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G E +++ EF G L + L E+ + AL YLH ++HRDI
Sbjct: 113 VGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
K +ILLT KLSDFG + + K + V GT +M PE ++ + DI+S
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWS 226
Query: 251 FGIVALQLLSGQ 262
GI+ ++++ G+
Sbjct: 227 LGIMVIEMVDGE 238
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCLFGCC 129
+ LG G G+V G VAIK I K + D F E + + + H LV L+G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
+ +++ E+ A G L +L ++ +++ +D A+ YL ++ H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL-----H 143
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMTNAKLTC 244
RD+ N L+ ++ K+SDFGL++ + +T G+ + + PE + +K +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 245 ASDIYSFGIV 254
SDI++FG++
Sbjct: 201 KSDIWAFGVL 210
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGCC 129
+ +G G GLV+ G + VAIK I + F E E + ++ HP LV L+G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
+E LV EF G L+ +L + + E + + D + YL I H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI-----H 127
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMTNAKLTC 244
RD+ N L+ E K+SDFG+ + + +T GT + + PE + ++ +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 245 ASDIYSFGIV 254
SD++SFG++
Sbjct: 185 KSDVWSFGVL 194
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 10/198 (5%)
Query: 71 RRFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLVC 124
RR +GRG G VY+ ++VA+K + ++ ++D RE R++ P++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
+ G+ Y+ +LA +LR+ L R V I+R AL H G
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAA-MLRRQGPLAPPRAVAIVRQIGSALDAAHA--AG- 154
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
HRD+K NIL++ L DFG+A E+ + GT+ YM PE + + T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 245 ASDIYSFGIVALQLLSGQ 262
+DIY+ V + L+G
Sbjct: 215 RADIYALTCVLYECLTGS 232
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCV 130
LG G+ V+ +G++ A+K I KS S E+ L +++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCIVHRD 189
YLV + + G L +L + T E+ +++ A++YLH + IVHRD
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGV-YT-EKDASLVIQQVLSAVKYLH---ENGIVHRD 131
Query: 190 IKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
+K N+L E ++DFGL+K ME++ + + GT GY+ PE + + A
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 247 DIYSFGIVALQLLSG 261
D +S G++ LL G
Sbjct: 189 DCWSIGVITYILLCG 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
LGRG+ +VY+ + + A+K + K+ + E+ L R+ HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCIVHRD 189
E LV E G L ++ K + ER ++ A+ YLH + IVHRD
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGY-YS-ERDAADAVKQILEAVAYLH---ENGIVHRD 173
Query: 190 IKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
+K N+L K++DFGL+K+ +E + V GT GY PE +
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231
Query: 247 DIYSFGIVALQLLSG 261
D++S GI+ LL G
Sbjct: 232 DMWSVGIITYILLCG 246
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 16/190 (8%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGCC 129
+ LG G G+V G VA+K I K + F +E + + ++ HP LV +G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
+ Y+V E+ + G L +L L + +++ D + +L H +I H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI-----H 127
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMTNAKLTC 244
RD+ N L+ L K+SDFG+ + + + GT + + PE K +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 245 ASDIYSFGIV 254
SD+++FGI+
Sbjct: 185 KSDVWAFGIL 194
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 59/250 (23%), Positives = 108/250 (43%), Gaps = 11/250 (4%)
Query: 18 KHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWD-RRFLGR 76
K + + K K W Y + + + + +D LG
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 77 GSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGCCVEGG 133
G+ G+V++ +G A K + + +D + +E++ +S +RHP LV L +
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193
E ++YEF + G L + + + + ++ + V+ +R L ++H + VH D+K
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPE 284
Query: 194 NILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSF 251
NI+ T K KL DFGL L + + GT + PE + +D++S
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 252 GIVALQLLSG 261
G+++ LLSG
Sbjct: 343 GVLSYILLSG 352
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 62/195 (31%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSG----QVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
+ +G G G V G L VAIK + K T+ F E + + HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G + +V E+ G+L L + D+ T + V +LR A ++YL Y
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 168
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTN 239
VHRD+ NIL+ L K+SDFGL ++L + +T G I + PE +
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 240 AKLTCASDIYSFGIV 254
K T ASD++S+GIV
Sbjct: 225 RKFTSASDVWSYGIV 239
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSG----QVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
+ +G G +G V G L VAIK + K+ T+ F E + + HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G G +V E+ G+L L D T + V +LR +RYL Y+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTN 239
HRD+ N+L+ L K+SDFGL+++L + +T G I + PE +
Sbjct: 174 -----HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 240 AKLTCASDIYSFGIV 254
+ ASD++SFG+V
Sbjct: 229 RTFSSASDVWSFGVV 243
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 29/264 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVE-GLSRVRHPNLVCLFGC 128
LGRG+ G+V K +PSGQ++A+K I + N+ +++ + V P V +G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 129 CVEGGEQYLVYEFCAAG--NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
G+ ++ E + ++ K + + KI AL +LH ++
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 132
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE----YMTNAKL 242
HRD+K +N+L+ + K+ DFG++ L + G YM PE +
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
+ SDI+S GI ++L + + QL + + + P+L +
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-----------VVEEPSPQLPADKF 239
Query: 303 RADFESILKIAVLCVAKSSKGRPT 326
A+F C+ K+SK RPT
Sbjct: 240 SAEFVDFTS---QCLKKNSKERPT 260
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 71 RRFLGRGSAGLVYKGVL--PSGQV-VAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVC 124
LG G+ G V +GV Q+ VAIK + + +T+ RE + + ++ +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYID 182
L G C + LV E G L + L+ K + ++L ++ ++YL +++
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV- 132
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTNA 240
HRD+ N+LL + K+SDFGL+K LG ++S G + + PE +
Sbjct: 133 ----HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 241 KLTCASDIYSFGIV 254
K + SD++S+G+
Sbjct: 189 KFSSRSDVWSYGVT 202
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
R LG+G G VY S ++A+K + K+ REVE S +RHPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+G + YL+ E+ G + + L +K S +R + + A AL Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RV 130
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRDIK N+LL E K++DFG + S+ + GT+ Y+ PE +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTD-LCGTLDYLPPEMIEGRMHDEK 187
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQ 274
D++S G++ + L G + F+A
Sbjct: 188 VDLWSLGVLCYEFLVG----KPPFEANTY 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 69/237 (29%), Positives = 109/237 (45%), Gaps = 35/237 (14%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCL 125
R LG+GS G V +GQ A+K I K + +S REV+ L ++ HPN++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+ + G YLV E G L ++ + + E +I+R + Y+H
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FS-EVDAARIIRQVLSGITYMHKN---K 146
Query: 185 IVHRDIKLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
IVHRD+K N+LL K + ++ DFGL+ E SK D GT Y+ PE + +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYIAPE-VLHGT 203
Query: 242 LTCASDIYSFGIVALQLLSG-------------QKVI--ELDFDAR--DQLTRKARD 281
D++S G++ LLSG +KV + F+ +++ A+D
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 19/196 (9%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV---VAIKHIYKSNNTDS----FSREVEGLSRVRHPNL 122
+ +G G G VYKG+L SG+ VAIK + K+ T+ F E + + H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
+ L G + ++ E+ G L + L KD + + V +LR A ++YL +Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMT 238
+ HRD+ NIL+ L K+SDFGL+++L + +T G I + PE ++
Sbjct: 169 V-----HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 239 NAKLTCASDIYSFGIV 254
K T ASD++SFGIV
Sbjct: 224 YRKFTSASDVWSFGIV 239
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 29/247 (11%)
Query: 16 LIKHVAKSKIQGKNKGCMPKR-KSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDR--R 72
L+ + K+ + R + PT + + + KD E I + R
Sbjct: 228 LVAY------YSKHADGLCHRLTTVCPTSKPQTQGLA------KDAWE--IPRESLRLEV 273
Query: 73 FLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCLFGCCV 130
LG+G G V+ G VAIK + K ++F +E + + ++RH LV L+
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 131 EGGEQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
E Y+V E+ + G+L L L + V + A + Y+ +Y+ H
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-----H 386
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD++ NIL+ E L K++DFGLA+++ E + I + PE + T SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 248 IYSFGIV 254
++SFGI+
Sbjct: 447 VWSFGIL 453
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 72 RFLGRGSAGLVYKGVLPSGQV-VAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGC 128
LG G G VY+GV + VA+K + K + + F +E + ++HPNLV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYL--HHYIDGCI 185
C Y++ EF GNL +L ++ + + + A+ YL ++I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI---- 340
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
HR++ N L+ E K++DFGL++++ + + I + PE + K +
Sbjct: 341 -HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 246 SDIYSFGIV 254
SD+++FG++
Sbjct: 400 SDVWAFGVL 408
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 32 CMPKRKSPKPTK-EIYSTTWSGLYRFSKDEIE-NAINNDWDRRFLGRGSAGLVYKGVL-- 87
P + P P ++ + +S ++ N LG G+ G V +GV
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359
Query: 88 PSGQV-VAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142
Q+ VAIK + K + RE + + ++ +P +V L G C + LV E
Sbjct: 360 RKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMA 417
Query: 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEK 200
G L + L+ K + ++L ++ ++YL ++ VHR++ N+LL +
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF-----VHRNLAARNVLLVNR 472
Query: 201 LEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTNAKLTCASDIYSFGIVALQL 258
K+SDFGL+K LG ++S G + + PE + K + SD++S+G+ +
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 259 LS-GQK 263
LS GQK
Sbjct: 533 LSYGQK 538
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 41/280 (14%)
Query: 33 MPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRF-----LGRGSAGLVYKGV- 86
M +E + + + + LG G+ G V
Sbjct: 1 MHHHHHHSSGRENLYFQGD--LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRD 58
Query: 87 LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142
+ AIK I K++ + EV L + HPN++ L+ + YLV E
Sbjct: 59 KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 143 AAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201
G L ++ + E I++ + YLH + IVHRD+K N+LL K
Sbjct: 119 KGGELFDEIIHRMK-FN-EVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKE 173
Query: 202 E---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQL 258
+ K+ DFGL+ + E K + GT Y+ PE + K D++S G++ L
Sbjct: 174 KDALIKIVDFGLSAV--FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFIL 230
Query: 259 LSG-------------QKVI--ELDFDAR--DQLTRKARD 281
L+G +KV + FD+ ++ A+D
Sbjct: 231 LAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 61/196 (31%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLVCLFG 127
LG G VY VAIK I+ F REV S++ H N+V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
E YLV E+ L++ + L+ + + +++ H IVH
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKHAHDM--R-IVH 134
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPEYMTNAKLTCAS 246
RDIK NIL+ K+ DFG+AK L E S T+ V GT+ Y PE +
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 247 DIYSFGIVALQLLSGQ 262
DIYS GIV ++L G+
Sbjct: 194 DIYSIGIVLYEMLVGE 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLF 126
LG+GS G V K + Q A+K I K++ +T + REVE L ++ HPN++ LF
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCI 185
+ Y+V E G L ++++ + E +I++ + Y+H + I
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKR-FS-EHDAARIIKQVFSGITYMHKH---NI 142
Query: 186 VHRDIKLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
VHRD+K NILL K + K+ DFGL+ +++ D GT Y+ PE +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 243 TCASDIYSFGIVALQLLSG 261
D++S G++ LLSG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 74 LGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCL 125
LG+G+ G V +G +VA+K + + + D F RE++ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 126 FGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
G G Q LV E+ +G L L R + L R + + YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCV 149
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTN 239
HRD+ NIL+ + K++DFGLAK+L +++ V + I + PE +++
Sbjct: 150 -----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 240 AKLTCASDIYSFGIV 254
+ SD++SFG+V
Sbjct: 205 NIFSRQSDVWSFGVV 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV---VAIKHIYKSNNTDS----FSREVEGLSRVRHPNL 122
+ LG G+ G VYKG+ +V VAIK + + E ++ V +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
L G C+ L+ + G L ++ + + + A + YL
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYM 237
+ HRD+ N+L+ K++DFGLAK+LG EE + G I +M E +
Sbjct: 139 V-----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191
Query: 238 TNAKLTCASDIYSFGIV 254
+ T SD++S+G+
Sbjct: 192 LHRIYTHQSDVWSYGVT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 54/251 (21%), Positives = 103/251 (41%), Gaps = 11/251 (4%)
Query: 17 IKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWD-RRFLG 75
++ G + Y W + + ++ + +D LG
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 76 RGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGCCVEG 132
G+ G+V++ V +G+V K I D + E+ ++++ HP L+ L +
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
E L+ EF + G L + +D ++ + +R L+++H + IVH DIK
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKP 177
Query: 193 TNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
NI+ K K+ DFGLA + ++ T + PE + + +D+++
Sbjct: 178 ENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 235
Query: 251 FGIVALQLLSG 261
G++ LLSG
Sbjct: 236 IGVLGYVLLSG 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 26/252 (10%)
Query: 18 KHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTT--WSGLYRFSKDEIENAINNDWDRRFLG 75
+ KSK +P +P + + + + Y SK EI LG
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEI------------LG 98
Query: 76 RGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGCCVEG 132
G G V+K +G +A K I D E+ ++++ H NL+ L+
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCIVHRDIK 191
+ LV E+ G L ++ + LT E ++ +R++H I+H D+K
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESYNLT-ELDTILFMKQICEGIRHMHQMY---ILHLDLK 214
Query: 192 LTNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
NIL + K+ DFGLA+ + + GT ++ PE + ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 250 SFGIVALQLLSG 261
S G++A LLSG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 34 PKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVV 93
+ E Y + W + E++ + +G+G G V G G V
Sbjct: 172 VMEGTVAAQDEFYRSGW----ALNMKELKL-------LQTIGKGEFGDVMLGDY-RGNKV 219
Query: 94 AIKHIYKSNNT-DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ-YLVYEFCAAGNLAQHL 151
A+K I K++ T +F E ++++RH NLV L G VE Y+V E+ A G+L +L
Sbjct: 220 AVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 152 L-RKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208
R SVL + +K D A+ YL ++++ HRD+ N+L++E K+SDF
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-----HRDLAARNVLVSEDNVAKVSDF 333
Query: 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
GL K E S + + + PE + K + SD++SFGI+
Sbjct: 334 GLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 12/188 (6%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGCC 129
LG+G G V+ G VAIK + K F +E + + ++RH LV L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 130 VEGGEQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIV 186
E Y+V E+ + G+L L L + V + A + Y+ +Y+
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----- 302
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRD++ NIL+ E L K++DFGLA+++ E + I + PE + T S
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 247 DIYSFGIV 254
D++SFGI+
Sbjct: 363 DVWSFGIL 370
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 23/264 (8%), Positives = 53/264 (20%), Gaps = 47/264 (17%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCL 125
L G +V+ + + A+K + + +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 126 FGCC--------------------------VEGGEQYLVYEFCAA-----GNLAQHLLRK 154
L+ + + +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 155 DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214
+ L +VH N+ + L D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 215 GMEESKVFTDVRGTIGYMDPEYMT--NAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR 272
G + Y E++ A T A + + G+ ++ L
Sbjct: 245 G----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 273 DQLTRKARDVSMGKRPIKDFEDPR 296
++ G + F
Sbjct: 301 KGSWKRPSLRVPGTDSL-AFGSCT 323
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 20/195 (10%)
Query: 72 RFLGRGSAGLVYKGVLPSGQV---VAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLV 123
+ LG G+ G V KG +V VA+K + K+ D E + ++ +P +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
+ G C E LV E G L L+++ + + ++++ ++ ++YL +++
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTN 239
HRD+ N+LL + K+SDFGL+K L +E+ G + + PE +
Sbjct: 140 -----HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 240 AKLTCASDIYSFGIV 254
K + SD++SFG++
Sbjct: 195 YKFSSKSDVWSFGVL 209
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 72 RFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNL 122
R LG G G V +G+ VA+K + K + + +E+E L + H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI 85
Query: 123 VCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--H 178
V G C E G L+ EF +G+L ++L + + + ++++K + YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEY 236
Y+ HRD+ N+L+ + + K+ DFGL K + ++ V D + + PE
Sbjct: 146 QYV-----HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 237 MTNAKLTCASDIYSFGIV 254
+ +K ASD++SFG+
Sbjct: 201 LMQSKFYIASDVWSFGVT 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-32
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 14/196 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
LG+G+ +V + V +G A K I + RE +++HPN+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
E YLV++ G L + ++ ++ + ++ ++ Y H IVHR
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCH---SNGIVHR 129
Query: 189 DIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
++K N+LL K + KL+DFGLA + +S+ + GT GY+ PE + +
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 246 SDIYSFGIVALQLLSG 261
DI++ G++ LL G
Sbjct: 188 VDIWACGVILYILLVG 203
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 22/204 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVE-GLSRVRHPNLVCLFGC 128
+GRG+ G V K V PSGQ++A+K I + + +++ + P +V +G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV------KILRDCALALRYLHHYID 182
G+ ++ E + K + + KI AL +L +
Sbjct: 90 LFREGDCWICMELMSTSFDK---FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--N 144
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE----YMT 238
I+HRDIK +NILL KL DFG++ L +S T G YM PE +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 239 NAKLTCASDIYSFGIVALQLLSGQ 262
SD++S GI +L +G+
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGR 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 13/194 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT-DSFSREVEGLSRVRHPNLVCLFGCCVE 131
LGRG G+V++ V S + K + +E+ L+ RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLH-HYIDGCIVHRD 189
E +++EF + ++ + + L ER + + AL++LH H I H D
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELN-EREIVSYVHQVCEALQFLHSHN----IGHFD 127
Query: 190 IKLTNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
I+ NI+ + K+ +FG A+ L + F + Y PE + ++ A+D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 248 IYSFGIVALQLLSG 261
++S G + LLSG
Sbjct: 186 MWSLGTLVYVLLSG 199
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 23/198 (11%)
Query: 72 RFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNL 122
R LG G G V +G++VA+K K++ + +E++ L + H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVK-ALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 123 VCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH-- 178
+ GCC + G LV E+ G+L + L + S + + + + + YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSL-RDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEY 236
HYI HRD+ N+LL K+ DFGLAK + +V D + + PE
Sbjct: 154 HYI-----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 237 MTNAKLTCASDIYSFGIV 254
+ K ASD++SFG+
Sbjct: 209 LKEYKFYYASDVWSFGVT 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 34/291 (11%)
Query: 72 RFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVC 124
+ LG+G+ G V +G+VVA+K + S + F RE+E L ++H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 125 LFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
G C G + L+ E+ G+L +L + + + ++ + YL Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMT 238
I HRD+ NIL+ + K+ DFGL K+L ++ KV I + PE +T
Sbjct: 136 I-----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
+K + ASD++SFG+V +L + + + + +G L
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 299 GNINRAD--------FESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341
+ + I I C + RP+ + +D+ N
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT--------DSFSREVEGLSRVRHPNLVC 124
LG G +V K +G+ A K I K + + REV L +RHPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDG 183
L + L+ E + G L L K+S LT E + L+ + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES-LT-EDEATQFLKQILDGVHYLH---SK 127
Query: 184 CIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I H D+K NI+L +K P KL DFG+A +E F ++ GT ++ PE +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 240 AKLTCASDIYSFGIVALQLLSG 261
L +D++S G++ LLSG
Sbjct: 186 EPLGLEADMWSIGVITYILLSG 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 34/291 (11%)
Query: 72 RFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVC 124
+ LG+G+ G V +G+VVA+K + S + F RE+E L ++H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 125 LFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
G C G + L+ E+ G+L +L + + + ++ + YL Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMT 238
I HRD+ NIL+ + K+ DFGL K+L ++ KV I + PE +T
Sbjct: 167 I-----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
+K + ASD++SFG+V +L + + + + +G L
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT--------YIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 299 GNINRAD--------FESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341
+ + I I C + RP+ + +D+
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 61/210 (29%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN---------------NTDSFSREVEGLS 115
R LG G+ G V AIK I KS + E+ L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 116 RVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALAL 174
+ HPN++ LF + YLV EF G L + ++ + E I++ +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FD-ECDAANIMKQILSGI 159
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGY 231
YLH + IVHRDIK NILL K K+ DFGL+ + D GT Y
Sbjct: 160 CYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYY 214
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
+ PE + K D++S G++ LL G
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
R LG+G G VY + ++A+K + K RE+E S +RHPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + YL+ EF G L + L +K +R + + A AL Y H +
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHER---KV 135
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRDIK N+L+ K E K++DFG + + T + GT+ Y+ PE +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIEGKTHDEK 192
Query: 246 SDIYSFGIVALQLLSG-------------QKVIELDF--------DARDQLTR 277
D++ G++ + L G ++++ +D ++D +++
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 72 RFLGRGSAGLVYKGVLPSGQV-VAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGC 128
LG G G VY+GV + VA+K + K + + F +E + ++HPNLV L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYL--HHYIDGCI 185
C Y++ EF GNL +L ++ + + + A+ YL ++I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI---- 133
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
HRD+ N L+ E K++DFGL++++ + + I + PE + K +
Sbjct: 134 -HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 246 SDIYSFGIV 254
SD+++FG++
Sbjct: 193 SDVWAFGVL 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 38/216 (17%), Positives = 68/216 (31%), Gaps = 27/216 (12%)
Query: 71 RRFLGRGSAGLVYKGV------LPSGQVVAIKHIYKSNNTDSF--SREVEGLSRVRHPNL 122
LG G+ VY+ + Q +K +N + + ++ +E L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDS----VLTWERRVKILRDCALALRYLH 178
+ + + LV E + G L + + V+ + + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEP-----------KLSDFGLAK-MLGMEESKVFTDVR 226
D I+H DIK N +L L D G + M + +FT
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
T G+ E ++N D + +L G
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 34/240 (14%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-------NTDSFSREVEGLSRVRHPNLV 123
+G+G +V + + +GQ A+K + + +T+ RE ++HP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW--ERRVK-ILRDCALALRYLHHY 180
L G Y+V+EF +L ++++ E +R ALRY H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147
Query: 181 IDGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
D I+HRD+K +LL K KL FG+A LG E V GT +M PE +
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205
Query: 238 TNAKLTCASDIYSFGIVALQLLSG------------QKVI--ELDFDAR--DQLTRKARD 281
D++ G++ LLSG + +I + + R ++ A+D
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKD 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 32/265 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSR-VRHPNLVCLFGC 128
+G G+ G V+K +G V+A+K + +S N + +++ + + P +V FG
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCIVH 187
+ + ++ E + + ER + K+ AL YL ++H
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP--ERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE-----YMTNAKL 242
RD+K +NILL E+ + KL DFG++ L + K G YM PE T
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
+D++S GI ++L +GQ + + LT+ + E P L G++
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-----------VLQEEPPLLPGHMG 255
Query: 303 -RADFESILKIAVLCVAKSSKGRPT 326
DF+S +K C+ K + RP
Sbjct: 256 FSGDFQSFVK---DCLTKDHRKRPK 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 28/236 (11%)
Query: 31 GCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVL--P 88
++ Y+ + Y ++ IE R +G G G V++G+ P
Sbjct: 362 SETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSP 414
Query: 89 SGQV--VAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142
VAIK K+ +DS F +E + + HP++V L G E +++ E C
Sbjct: 415 ENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELC 472
Query: 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEK 200
G L L + L + + AL YL + VHRDI N+L++
Sbjct: 473 TLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF-----VHRDIAARNVLVSSN 527
Query: 201 LEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTNAKLTCASDIYSFGIV 254
KL DFGL++ ME+S + +G I +M PE + + T ASD++ FG+
Sbjct: 528 DCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVC 124
LG G +V K +G A K I K + + REV L +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDG 183
L + L+ E + G L L +K+S L+ E ++ + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES-LS-EEEATSFIKQILDGVNYLH---TK 134
Query: 184 CIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I H D+K NI+L +K P KL DFGLA + E+ F ++ GT ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 240 AKLTCASDIYSFGIVALQLLSG 261
L +D++S G++ LLSG
Sbjct: 193 EPLGLEADMWSIGVITYILLSG 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
LG+GS G V K + Q A+K I K++ +T + REVE L ++ HPN++ LF
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+ Y+V E G L ++++ + +I++ + Y+H IVHR
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH---KHNIVHR 145
Query: 189 DIKLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
D+K NILL K + K+ DFGL+ +++ D GT Y+ PE +
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVL-RGTYDEK 202
Query: 246 SDIYSFGIVALQLLSG 261
D++S G++ LLSG
Sbjct: 203 CDVWSAGVILYILLSG 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS----------NNTDSFSREVEGLSRVRHP 120
+ LG G+ G V + + VAI+ I K + + E+E L ++ HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH 179
++ + + + Y+V E G L ++ L E K LA++YLH
Sbjct: 201 CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LK-EATCKLYFYQMLLAVQYLH- 256
Query: 180 YIDGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE- 235
+ I+HRD+K N+LL+ + E K++DFG +K+ + E+ + + GT Y+ PE
Sbjct: 257 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEV 312
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSG 261
+ A A D +S G++ LSG
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 72 RFLGRGSAGLVYKGVL--------PSGQVVAIKHIYK--SNNTDSFSREVEGLSRVRHPN 121
LG+G+ ++KGV V +K + K N ++SF +S++ H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HH 179
LV +G CV G E LV EF G+L +L + + + ++++ + A A+ +L +
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 180 YIDGCIVHRDIKLTNILLTEKLEP--------KLSDFGLAKMLGMEESKVFTDVRGTIGY 231
I H ++ NILL + + KLSD G++ + ++ I +
Sbjct: 134 LI-----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-----RIPW 183
Query: 232 MDPEYMTNAKL-TCASDIYSFGIV 254
+ PE + N K A+D +SFG
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTT 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 19/234 (8%)
Query: 26 QGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKG 85
+ N G K P + + + ++ ++ + LG G G V+
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKL-------EKKLGAGQFGEVWMA 207
Query: 86 VLPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143
VA+K + K + +F E + ++H LV L + Y++ EF A
Sbjct: 208 TYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMA 265
Query: 144 AGNLAQHL-LRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEK 200
G+L L + S + + A + ++ +YI HRD++ NIL++
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI-----HRDLRAANILVSAS 320
Query: 201 LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
L K++DFGLA+++ E + I + PE + T SD++SFGI+
Sbjct: 321 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVC 124
LG G +V K +G A K I K + REV L +V HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDG 183
L + L+ E + G L L +K+S L+ E ++ + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES-LS-EEEATSFIKQILDGVNYLH---TK 134
Query: 184 CIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I H D+K NI+L +K P KL DFGLA + E+ F ++ GT ++ PE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 240 AKLTCASDIYSFGIVALQLLSG 261
L +D++S G++ LLSG
Sbjct: 193 EPLGLEADMWSIGVITYILLSG 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
LG+G+ +V + V +G A K I + RE +++HPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCIVH 187
E YLV++ G L + ++ ++ + E ++ ++ Y H IVH
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF-YS-EADASHCIQQILESIAYCH---SNGIVH 151
Query: 188 RDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
R++K N+LL K + KL+DFGLA + +S+ + GT GY+ PE + +
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 245 ASDIYSFGIVALQLLSG 261
DI++ G++ LL G
Sbjct: 210 PVDIWACGVILYILLVG 226
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 21/197 (10%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV--VAIKHIYKSNNTDS------FSREVEGLSRVRHPN 121
LG GS G+V +G PSG+ VA+K K + F REV + + H N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HH 179
L+ L+G + +V E G+L L + + A + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYM 237
+I HRD+ N+LL + K+ DFGL + L + + PE +
Sbjct: 142 FI-----HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 238 TNAKLTCASDIYSFGIV 254
+ ASD + FG+
Sbjct: 197 KTRTFSHASDTWMFGVT 213
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV---VAIKHIYKSNNTDS----FSREVEGLSRVRHPNL 122
+ LG G+ G VYKG+ +V VAIK + + E ++ V +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
L G C+ L+ + G L ++ + + + A + YL
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYM 237
+ HRD+ N+L+ K++DFGLAK+LG EE + G I +M E +
Sbjct: 139 V-----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191
Query: 238 TNAKLTCASDIYSFGIV 254
+ T SD++S+G+
Sbjct: 192 LHRIYTHQSDVWSYGVT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT-----------DSFSREVEGLSRV-RHP 120
LGRG + +V + + P+ + A+K I + ++ +EV+ L +V HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHH 179
N++ L +LV++ G L +L K + L+ E+ KI+R + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LS-EKETRKIMRALLEVICALH- 141
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE---- 235
IVHRD+K NILL + + KL+DFG + ++ + +V GT Y+ PE
Sbjct: 142 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEIIEC 197
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSG 261
+ D++S G++ LL+G
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 74 LGRGSAGLVYKG---VLPSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCLF- 126
+ G G +Y + +G+ V +K + S + ++ E + L+ V HP++V +F
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 127 ----GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
Y+V E+ +L + +K L + L + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS--I 201
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
G +V+ D+K NI+LTE+ + KL D G + + GT G+ PE +
Sbjct: 202 G-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR-TGP 253
Query: 243 TCASDIYSFGIVALQLLSGQ 262
T A+DIY+ G L
Sbjct: 254 TVATDIYTVGRTLAALTLDL 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 24/199 (12%)
Query: 72 RFLGRGSAGLVYKGVLPSG----QVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
+GRG G VY G L A+K + F E + HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 124 CLFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHY 180
L G C+ +V + G+L + + T + + A ++YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG-----YMDPE 235
VHRD+ N +L EK K++DFGLA+ M + + ++ T +M E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 236 YMTNAKLTCASDIYSFGIV 254
+ K T SD++SFG++
Sbjct: 203 SLQTQKFTTKSDVWSFGVL 221
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 38/272 (13%), Positives = 73/272 (26%), Gaps = 65/272 (23%)
Query: 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEGLSR-------- 116
LG+ + +G+ + Y + S EV L
Sbjct: 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 117 --------------VRHPNLVCLFGCCVEGGEQYLVYEF----CAAGNLAQ------HLL 152
V+ P + ++ + +++ F NL
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 153 RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212
L R+++ L LHHY +VH ++ +I+L ++ L+ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 213 MLGMEESKVFTDVRGTIGYMDPEYMT----------NAKLTCASDIYSFGIVALQLLSGQ 262
G G+ PE +T A D ++ G+ +
Sbjct: 260 RDGAS-----AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 263 ---------KVIELDFDARDQLTRKARDVSMG 285
E F + + + R + G
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 18/196 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSG----QVVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
+GRG G VY G L A+K I F E + HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 125 LFGCCVEGGEQ-YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G C+ +V + G+L + + T + + A +++L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMT 238
VHRD+ N +L EK K++DFGLA+ + +E + G + +M E +
Sbjct: 214 ----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 239 NAKLTCASDIYSFGIV 254
K T SD++SFG++
Sbjct: 270 TQKFTTKSDVWSFGVL 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 61/187 (32%), Positives = 94/187 (50%), Gaps = 14/187 (7%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE 131
+ +G+G G V G G VA+K I +F E ++++RH NLV L G VE
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 132 GGEQ-YLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIVH 187
Y+V E+ A G+L +L R SVL + +K D A+ YL ++++ H
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-----H 140
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
RD+ N+L++E K+SDFGL K E S + + + PE + K + SD
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 248 IYSFGIV 254
++SFGI+
Sbjct: 197 VWSFGIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT--------DSFSREVEGLSRVRHPNLVC 124
LG G +V K +G A K I K + REV L ++HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDG 183
L + L+ E A G L L K+S LT E + L+ + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKES-LT-EEEATEFLKQILNGVYYLH---SL 133
Query: 184 CIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I H D+K NI+L ++ P K+ DFGLA + + F ++ GT ++ PE +
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 240 AKLTCASDIYSFGIVALQLLSG 261
L +D++S G++ LLSG
Sbjct: 192 EPLGLEADMWSIGVITYILLSG 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-----YKSNNTDSFSREVEGLSRVRHPNLVCLFG 127
+G GS G VY + + +VVAIK + + +EV L ++RHPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
C + +LV E+C G+ + L L + L YLH I H
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS--HNMI-H 177
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE---YMTNAKLTC 244
RD+K NILL+E KL DFG A ++ S V GT +M PE M +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 232
Query: 245 ASDIYSFGIVALQLLSGQ 262
D++S GI ++L +
Sbjct: 233 KVDVWSLGITCIELAERK 250
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 17 IKHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDR----R 72
I+ + Q N K+ + K + + + + A + +
Sbjct: 41 IRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKD 100
Query: 73 FLGRGSAGLVYKGV-LPSGQVVAIKHIYKS----------NNTDSFSREVEGLSRVR-HP 120
+GRG + +V + V +G A+K + + ++ RE L +V HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHH 179
+++ L +LV++ G L +L K + L+ E+ I+R A+ +LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LS-EKETRSIMRSLLEAVSFLH- 217
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE---- 235
IVHRD+K NILL + ++ +LSDFG + +E + ++ GT GY+ PE
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCGTPGYLAPEILKC 273
Query: 236 --YMTNAKLTCASDIYSFGIVALQLLSG 261
T+ D+++ G++ LL+G
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGC 128
LG+G+ +V + V + +GQ A I + RE ++HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCIVH 187
E G YL+++ G L + ++ ++ + E ++ A+ + H +VH
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY-YS-EADASHCIQQILEAVLHCH---QMGVVH 133
Query: 188 RDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
R++K N+LL KL+ KL+DFGLA + E + + GT GY+ PE +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192
Query: 245 ASDIYSFGIVALQLLSG 261
D+++ G++ LL G
Sbjct: 193 PVDLWACGVILYILLVG 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LG G+ G V+ SG IK I K + E+E L + HPN++ +F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW--ERRV-KILRDCALALRYLHHYIDGCIV 186
+ Y+V E C G L + ++ + E V ++++ AL Y H +V
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 187 HRDIKLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
H+D+K NIL + K+ DFGLA++ + + T+ GT YM PE + +T
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYMAPE-VFKRDVT 203
Query: 244 CASDIYSFGIVALQLLSG 261
DI+S G+V LL+G
Sbjct: 204 FKCDIWSAGVVMYFLLTG 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 18/191 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGCC 129
LG G G V+ G VA+K + K + F E + +++H LV L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 130 VEGGEQYLVYEFCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYL--HHYIDGCIV 186
+ Y++ E+ G+L L LT + + + A + ++ +YI
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----- 131
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMTNAKLT 243
HRD++ NIL+++ L K++DFGLA+++ E +T G I + PE + T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 244 CASDIYSFGIV 254
SD++SFGI+
Sbjct: 189 IKSDVWSFGIL 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 68 DWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCL 125
D + LG GS + K V S Q A+K I K ++ +E+ L HPN+V L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-KEITALKLCEGHPNIVKL 71
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGC 184
+ +LV E G L + + +K + E I+R A+ ++H D
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKH-FS-ETEASYIMRKLVSAVSHMH---DVG 126
Query: 185 IVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
+VHRD+K N+L T++ + K+ DFG A++ +++ T+ Y PE +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 242 LTCASDIYSFGIVALQLLSG 261
+ D++S G++ +LSG
Sbjct: 186 YDESCDLWSLGVILYTMLSG 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV--VAIKHI---YKSNNTDSFSREVEGLSRVRHPNLVC 124
R +G G G V++G+ P VAIK + + F +E + + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYID 182
L G E +++ E C G L L + L + + AL YL ++
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV- 138
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT--IGYMDPEYMTNA 240
HRDI N+L++ KL DFGL++ + E+S + +G I +M PE +
Sbjct: 139 ----HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFR 192
Query: 241 KLTCASDIYSFGIV 254
+ T ASD++ FG+
Sbjct: 193 RFTSASDVWMFGVC 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCV 130
+G G+ G VYKG + +GQ+ AIK + + + +E+ L + H N+ +G +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 131 EGGEQY------LVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYID 182
+ LV EFC AG++ L++ K + L E I R+ L +LH
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 147
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
++HRDIK N+LLTE E KL DFG++ L + T + GT +M PE + +
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDEN 206
Query: 243 TCAS-----DIYSFGIVALQLLSGQ 262
A+ D++S GI A+++ G
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+GRGS G V V + A K I K + D F +E+E + + HPN++ L+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
+ + YLV E C G L + ++ K +I++D A+ Y H + HRD+
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH---KLNVAHRDL 132
Query: 191 KLTNILLTEKLE---PKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
K N L KL DFGLA + K+ GT Y+ P+ + D
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVSPQVL-EGLYGPECD 189
Query: 248 IYSFGIVALQLLSG 261
+S G++ LL G
Sbjct: 190 EWSAGVMMYVLLCG 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKS----------NNTDSFSREVEGLSRVRHPNL 122
LG G+ G V + + VAIK I K + + E+E L ++ HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYI 181
+ + + + Y+V E G L ++ L E LA++YLH
Sbjct: 78 IKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKR-LK-EATCKLYFYQMLLAVQYLH--- 131
Query: 182 DGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE--- 235
+ I+HRD+K N+LL+ + E K++DFG +K+ + E+ + + GT Y+ PE
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLV 189
Query: 236 YMTNAKLTCASDIYSFGIVALQLLSG 261
+ A A D +S G++ LSG
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 21/196 (10%)
Query: 72 RFLGRGSAGLVYKGVL-PSGQ----VVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLV 123
+ LG G G V+KGV P G+ V IK + + + + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G C G LV ++ G+L H+ + L + + A + YL H +
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMT 238
HR++ N+LL + +++DFG+A +L ++ ++ I +M E +
Sbjct: 138 -----HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIH 190
Query: 239 NAKLTCASDIYSFGIV 254
K T SD++S+G+
Sbjct: 191 FGKYTHQSDVWSYGVT 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 51/252 (20%), Positives = 98/252 (38%), Gaps = 37/252 (14%)
Query: 40 KPTKEIYSTTWSGLYRFSKDEIENAINNDWD-RRFLGRGSAGLVYKGVLPSGQVVAIKHI 98
K+I S + +Y + ++ ND+ R L +G + + A+K
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKY 62
Query: 99 YKS-------------------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139
KS + D F E++ ++ +++ + G E Y++Y
Sbjct: 63 EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
Query: 140 EFCAAGNLAQHLLRKDSVLTWERR-------VKILRDCALALRYLHHYIDGCIVHRDIKL 192
E+ ++ + + I++ + Y+H+ + I HRD+K
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKP 180
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC---ASDIY 249
+NIL+ + KLSDFG ++ M + K+ RGT +M PE + + + DI+
Sbjct: 181 SNILMDKNGRVKLSDFGESEY--MVDKKIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIW 236
Query: 250 SFGIVALQLLSG 261
S GI +
Sbjct: 237 SLGICLYVMFYN 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSR-VRHPNLVCLFGCCVE 131
+G GS + + + + A+K I KS + E+E L R +HPN++ L +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCIVHRDI 190
G Y+V E G L +LR+ + ER +L + YLH +VHRD+
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKF-FS-EREASAVLFTITKTVEYLH---AQGVVHRDL 142
Query: 191 KLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
K +NIL ++ ++ DFG AK L E+ + T ++ PE + A
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAPEVLERQGYDAAC 201
Query: 247 DIYSFGIVALQLLSG 261
DI+S G++ +L+G
Sbjct: 202 DIWSLGVLLYTMLTG 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-29
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 22/198 (11%)
Query: 72 RFLGRGSAGLVYKGVLPSG----QVVAIK---HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
R +G+G G+VY G AIK I + ++F RE + + HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 125 LFGCCVEG-GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G + G +++ + G+L Q + T + + A + YL ++
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG-----YMDPEY 236
HRD+ N +L E K++DFGLA+ + + + ++ + + E
Sbjct: 147 -----HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALES 199
Query: 237 MTNAKLTCASDIYSFGIV 254
+ + T SD++SFG++
Sbjct: 200 LQTYRFTTKSDVWSFGVL 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 23/196 (11%)
Query: 72 RFLGRGSAGLVYKGVL--PSGQV--VAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
R LG G G VY+GV G+ VA+K K + T F E + + HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL--HHYI 181
L G E +++ E G L +L R + L V A+ YL + +
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMT 238
HRDI + NIL+ KL DFGL++ + E + + T I +M PE +
Sbjct: 136 -----HRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESIN 187
Query: 239 NAKLTCASDIYSFGIV 254
+ T ASD++ F +
Sbjct: 188 FRRFTTASDVWMFAVC 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRH-PNLVCLFG 127
LGRG +V + + +GQ A K + K E+ L + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCIV 186
E L+ E+ A G + L + + + E V ++++ + YLH IV
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIV 153
Query: 187 HRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
H D+K NILL+ K+ DFG+++ + + ++ GT Y+ PE + +T
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYDPIT 211
Query: 244 CASDIYSFGIVALQLLSG 261
A+D+++ GI+A LL+
Sbjct: 212 TATDMWNIGIIAYMLLTH 229
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPN 121
R LG G+ G VY+G + PS VA+K + ++ F E +S+ H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 135
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR------KDSVLTWERRVKILRDCALALR 175
+V G ++ ++++ E A G+L L + S L + + RD A +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 176 YL--HHYIDGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIG 230
YL +H+I HRDI N LLT K+ DFG+A+ + + + +G
Sbjct: 196 YLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYR--KGGCA 246
Query: 231 Y-----MDPEYMTNAKLTCASDIYSFGIV 254
M PE T +D +SFG++
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFG 127
++ LG G G V + +GQ A+K +Y S +EV+ + P++VC+
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILD 89
Query: 128 CCVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYID 182
++ E G L + + ER +I+RD A+++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---S 146
Query: 183 GCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I HRD+K N+L T K + KL+DFG AK T Y+ PE +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYVAPEVLGP 203
Query: 240 AKLTCASDIYSFGIVALQLLSG 261
K + D++S G++ LL G
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCG 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPN 121
R LG G+ G VY+G + PS VA+K + ++ F E +S+ H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 94
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR------KDSVLTWERRVKILRDCALALR 175
+V G ++ ++++ E A G+L L + S L + + RD A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 176 YL--HHYIDGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIG 230
YL +H+I HRDI N LLT K+ DFG+A+ + + + +G
Sbjct: 155 YLEENHFI-----HRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR--KGGCA 205
Query: 231 Y-----MDPEYMTNAKLTCASDIYSFGIV 254
M PE T +D +SFG++
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 57/245 (23%), Positives = 104/245 (42%), Gaps = 39/245 (15%)
Query: 41 PTKEIYSTTWSGLYRFSKDEIENAINNDW--DR------RFLGRGSAGLVYKGVL----P 88
+ + SGL +E++N + D DR + LG G G V +G L
Sbjct: 2 GSSHHHHHHSSGLVPRGSEELQNKLE-DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 89 SGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCCVEGGEQ-----YLVY 139
+ VA+K + N++ F E + HPN++ L G C+E Q ++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 140 EFCAAGNLAQHLLR-----KDSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKL 192
F G+L +LL + + +K + D AL + YL +++ HRD+
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL-----HRDLAA 175
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT---IGYMDPEYMTNAKLTCASDIY 249
N +L + + ++DFGL+K + + R + ++ E + + T SD++
Sbjct: 176 RNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 250 SFGIV 254
+FG+
Sbjct: 234 AFGVT 238
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 35/268 (13%), Positives = 72/268 (26%), Gaps = 66/268 (24%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVR------- 118
LG+ + +G+ + Y + S EV L +R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 119 ------------------HPNLVCLFGCC--VEGGEQYLVYEFCAA-----GNLAQHLLR 153
++ + + ++ +Y + G +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 154 KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213
L R+++ L LHHY +VH ++ +I+L ++ L+ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKL-----------TCASDIYSFGIVALQLLSG- 261
G + G+ PE T + D ++ G+V +
Sbjct: 256 DGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 262 --------QKVIELDFDARDQLTRKARD 281
E F + + + R
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRA 338
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPN 121
LG G VYKG L Q VAIK + K F E +R++HPN
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTWERRVKI 166
+VCL G + +++ +C+ G+L + L S L V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 167 LRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224
+ A + YL HH VH+D+ N+L+ +KL K+SD GL + + + +
Sbjct: 134 VAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL 186
Query: 225 VRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ + I +M PE + K + SDI+S+G+V
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPN 121
R LG+GS G+VY+GV VAIK + + F E + +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHH 89
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCAL 172
+V L G +G ++ E G+L +L + + + +++ + A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 173 ALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG 230
+ YL + + VHRD+ N ++ E K+ DFG+ + + E+ + +G G
Sbjct: 150 GMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYR--KGGKG 200
Query: 231 Y-----MDPEYMTNAKLTCASDIYSFGIV 254
M PE + + T SD++SFG+V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 31/207 (14%)
Query: 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLV 123
R LG+G G V + L S VA+K + S F RE + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 124 CLFGCCVEGGEQ------YLVYEFCAAGNLAQHLL-----RKDSVLTWERRVKILRDCAL 172
L G + + ++ F G+L LL L + V+ + D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 173 ALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT-- 228
+ YL ++I HRD+ N +L E + ++DFGL++ + + +
Sbjct: 149 GMEYLSSRNFI-----HRDLAARNCMLAEDMTVCVADFGLSRK--IYSGDYYRQGCASKL 201
Query: 229 -IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ ++ E + + T SD+++FG+
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVT 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 72 RFLGRGSAGLVYKG---VLPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLV 123
LG G V+ + VA+K + D F RE + + + HP +V
Sbjct: 18 EILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 124 CLFGCCVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
++ Y+V E+ L ++ + +T +R ++++ D AL + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD---VRGTIGYMDPEY 236
G I+HRD+K NI+++ K+ DFG+A+ + + T V GT Y+ PE
Sbjct: 135 N--G-IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 237 MTNAKLTCASDIYSFGIVALQLLSGQ 262
+ SD+YS G V ++L+G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 72 RFLGRGSAGLVYKGVLPSG------QVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNL 122
LG G+ G V+ + +VA+K + K + + F RE E L+ ++H ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHI 105
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHL--------------LRKDSVLTWERRVKILR 168
V FG C EG +V+E+ G+L + L L + + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 169 DCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
A + YL H+ VHRD+ N L+ + L K+ DFG+++ + S + V
Sbjct: 166 QVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVG 217
Query: 227 GT----IGYMDPEYMTNAKLTCASDIYSFGIV 254
G I +M PE + K T SD++SFG+V
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 60/242 (24%), Positives = 89/242 (36%), Gaps = 57/242 (23%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKS-------NNTDSFSREVEGLSRVRHPNLVCL 125
+G+GS G+V + + + AIK + K+ + + EV + ++ HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRV--------------------- 164
+ + LV E C G+L L T + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 165 ------------------KILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLEPK 204
I+R AL YLH + I HRDIK N L + + E K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 205 LSDFGLAKMLG---MEESKVFTDVRGTIGYMDPE--YMTNAKLTCASDIYSFGIVALQLL 259
L DFGL+K E T GT ++ PE TN D +S G++ LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 260 SG 261
G
Sbjct: 271 MG 272
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVR-HPNLVCLF 126
RR L G VY+ + SG+ A+K + + + +EV + ++ HPN+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 127 GCCV-------EGGEQYLVYEFCAAGNLAQHLLRKDSV--LTWERRV-KILRDCALALRY 176
G ++L+ G L + L + +S L+ V KI A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQH 151
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-----------V 225
+H I+HRD+K+ N+LL+ + KL DFG A + ++
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 226 RGTIGYMDPE---YMTNAKLTCASDIYSFGIVALQLLSGQ 262
T Y PE +N + DI++ G + L Q
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 37/212 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLV 123
R LG G+ G V+ +VA+K + F RE E L+ ++H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTWERRVKILR 168
+G C +G +V+E+ G+L + L + L + + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 169 DCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
A + YL H++ HRD+ N L+ L K+ DFG+++ + S + V
Sbjct: 141 QIASGMVYLASQHFV-----HRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVG 192
Query: 227 GT----IGYMDPEYMTNAKLTCASDIYSFGIV 254
G I +M PE + K T SD++SFG++
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 20/238 (8%)
Query: 34 PKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQV 92
P + P P ++ + K+ I + + LG G G V + + +
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY--KVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 93 VAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ----YLVYEFCAAGNL 147
A+K + REVE R + P++V + +V E G L
Sbjct: 90 FALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146
Query: 148 AQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP--- 203
+ + ER +I++ A++YLH I HRD+K N+L T K
Sbjct: 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 203
Query: 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSG 261
KL+DFG AK T T Y+ PE + K + D++S G++ LL G
Sbjct: 204 KLTDFGFAKET--TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 72 RFLGRGSAGLVYKGVL---PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHPNLV 123
+G G+ G V K + AIK + K + F+ E+E L ++ HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILR 168
L G C G YL E+ GNL L + S L+ ++ +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 169 DCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
D A + YL +I HRD+ NIL+ E K++DFGL++ G E T R
Sbjct: 150 DVARGMDYLSQKQFI-----HRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 227 GTIGYMDPEYMTNAKLTCASDIYSFGIV 254
+ +M E + + T SD++S+G++
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVL 230
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-27
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 71 RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS--NNTDSFSREVEGLSRVR-HPNLVCLF 126
LG G+ V + L + Q A+K I K + REVE L + + H N++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERR-VKILRDCALALRYLHHYIDGCI 185
E YLV+E G++ H+ ++ E +++D A AL +LH + I
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FN-ELEASVVVQDVASALDFLH---NKGI 132
Query: 186 VHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVR--------GTIGYMDP 234
HRD+K NIL + K+ DF L G++ + + + G+ YM P
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGS--GIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 235 E-----YMTNAKLTCASDIYSFGIVALQLLSG 261
E + D++S G++ LLSG
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 56/226 (24%)
Query: 72 RFLGRGSAGLVYKGVLPSG------QVVAIKHIYKSNNTDS----FSREVEGLSRVRHPN 121
R +G G+ G V++ P +VA+K + K + F RE ++ +PN
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMAEFDNPN 111
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR-----------------------KDSVL 158
+V L G C G L++E+ A G+L + L L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 159 TWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216
+ ++ I R A + YL + VHRD+ N L+ E + K++DFGL++
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIADFGLSR---- 222
Query: 217 EESKVFTD---VRGTIGY-----MDPEYMTNAKLTCASDIYSFGIV 254
+++ M PE + + T SD++++G+V
Sbjct: 223 ---NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 70/238 (29%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
+ LG GS V + + AIK HI K N +RE + +SR+ HP
Sbjct: 36 KILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYL 177
V L+ + + Y + G L +++ RK E + I+ AL YL
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD-ETCTRFYTAEIV----SALEYL 146
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD-VRGTIGYMDPEY 236
H I+HRD+K NILL E + +++DFG AK+L E + + GT Y+ PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 237 MTNAKLTCASDIYSFGIVALQLLSG-------------QKVIELDFDARDQLTRKARD 281
+T +SD+++ G + QL++G QK+I+L++D ++ KARD
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 64/249 (25%)
Query: 57 SKDEIENAINNDW--DR------RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSN 102
S D + + W R + LG G G V K VA+K + K N
Sbjct: 6 SVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KEN 64
Query: 103 NTDS----FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---- 154
+ S E L +V HP+++ L+G C + G L+ E+ G+L L
Sbjct: 65 ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 155 -------------------DSVLTWERRVKILRDCALALRYL--HHYIDGCIVHRDIKLT 193
+ LT + + ++YL + HRD+
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV-----HRDLAAR 179
Query: 194 NILLTEKLEPKLSDFGLAKMLGMEESKVFTD---VRGTIG-----YMDPEYMTNAKLTCA 245
NIL+ E + K+SDFGL++ V+ + V+ + G +M E + + T
Sbjct: 180 NILVAEGRKMKISDFGLSR-------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 246 SDIYSFGIV 254
SD++SFG++
Sbjct: 233 SDVWSFGVL 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHP 120
+ LG G+ G V + + VA+K + KS E++ +S + +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHE 110
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK-------------DSVLTWERRVKIL 167
N+V L G C GG ++ E+C G+L L RK +S + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 168 RDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFT 223
A + +L + I HRD+ N+LLT K+ DFGLA+ + M +S V
Sbjct: 171 SQVAQGMAFLASKNCI-----HRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNYIVKG 224
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
+ R + +M PE + + T SD++S+GI+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 72 RFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNNTDS----FSREVEGLSRV-R 118
+ LG G+ G V VA+K + K + T+ E+E + + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 99
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERR 163
H N++ L G C + G Y++ E+ + GNL ++L + + +T++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 164 VKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
V A + YL I HRD+ N+L+TE K++DFGLA+ +
Sbjct: 160 VSCTYQLARGMEYLASQKCI-----HRDLAARNVLVTENNVMKIADFGLARD--INNIDY 212
Query: 222 FTDVRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ + +M PE + + T SD++SFG++
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 72 RFLGRGSAGLVYKGVL--------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-R 118
+ LG G G V VA+K + K + T+ E+E + + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERR 163
H N++ L G C + G Y++ E+ + GNL ++L + + +T++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 164 VKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
V A + YL I HRD+ N+L+TE K++DFGLA+ +
Sbjct: 206 VSCTYQLARGMEYLASQKCI-----HRDLAARNVLVTENNVMKIADFGLARD--INNIDY 258
Query: 222 FTDVRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ + +M PE + + T SD++SFG++
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 16/173 (9%)
Query: 100 KSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLT 159
+ D+ S ++ + N V Y+ + C NL + R+ S+
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 160 WERRV--KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML--- 214
E V I A A+ +LH ++HRD+K +NI T K+ DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 215 --------GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLL 259
M T GT YM PE + + DI+S G++ +LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 72 RFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNNTDS----FSREVEGLSRV-R 118
+ LG G+ G V VA+K + KS+ T+ E+E + + +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGK 133
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTWERR 163
H N++ L G C + G Y++ E+ + GNL ++L + L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 164 VKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
V A + YL I HRD+ N+L+TE K++DFGLA+ +
Sbjct: 194 VSCAYQVARGMEYLASKKCI-----HRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDY 246
Query: 222 FTDVRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ + +M PE + + T SD++SFG++
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 60/268 (22%), Positives = 102/268 (38%), Gaps = 58/268 (21%)
Query: 34 PKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDW--DR------RFLGRGSAGLVYKG 85
+ +S ++ + S F D E + W R + LG G+ G V
Sbjct: 7 FRYESQLQMVQVTGS--SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA 64
Query: 86 VL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHPNLVCLFGCCVEGGE 134
VA+K + K S E++ ++++ H N+V L G C G
Sbjct: 65 TAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 135 QYLVYEFCAAGNLAQHLLRK-----------------------DSVLTWERRVKILRDCA 171
YL++E+C G+L + LR +VLT+E + A
Sbjct: 124 IYLIFEYCCYGDL-LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 172 LALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT- 228
+ +L + HRD+ N+L+T K+ DFGLA+ + +
Sbjct: 183 KGMEFLEFKSCV-----HRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNYVVRGNAR 235
Query: 229 --IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ +M PE + T SD++S+GI+
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGIL 263
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHP 120
+ LGRG+ G V + + + VA+K + K T S E++ L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 91
Query: 121 NLVCLFGCC-VEGGEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRV 164
N+V L G C GG ++ EFC GNL+ +L K LT E +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 165 KILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222
A + +L I HRD+ NILL+EK K+ DFGLA+ + + +
Sbjct: 152 CYSFQVAKGMEFLASRKCI-----HRDLAARNILLSEKNVVKICDFGLARD--IYKDPDY 204
Query: 223 TDVRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ +M PE + + T SD++SFG++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 43/217 (19%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHP 120
+ LG G+ G V + + VA+K + K + + E++ LS + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK------------------DSVLTWER 162
N+V L G C GG ++ E+C G+L + LR+ + L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDL-LNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 163 RVKILRDCALALRYL--HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220
+ A + +L + I HRD+ NILLT K+ DFGLA+ ++
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI-----HRDLAARNILLTHGRITKICDFGLARD--IKNDS 199
Query: 221 VFTDVRGT---IGYMDPEYMTNAKLTCASDIYSFGIV 254
+ + +M PE + N T SD++S+GI
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
R LG+G G V + +G++ A K I K E + L +V +
Sbjct: 190 RVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V L LV G+L H+ E R + L LH
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--- 303
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
IV+RD+K NILL + ++SD GLA + E + V GT+GYM PE + N +
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMAPEVVKNER 361
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
T + D ++ G + ++++GQ
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 11/195 (5%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G GS G+V+K +GQ+VAIK +S + RE+ L +++HPNLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+LV+E+C + L R + I A+ + H + +HR
Sbjct: 71 FRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHR 126
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASD 247
D+K NIL+T+ KL DFG A++L S + D T Y PE + D
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVATRWYRSPELLVGDTQYGPPVD 185
Query: 248 IYSFGIVALQLLSGQ 262
+++ G V +LLSG
Sbjct: 186 VWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G GS G+V K +G++VAIK +S++ RE++ L ++RH NLV L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
C + YLV+EF + L + L ++ K L + + H + I+HR
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHR 148
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASD 247
DIK NIL+++ KL DFG A+ L +V+ D T Y PE + A D
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 248 IYSFG-IVALQLLSGQ 262
+++ G +V ++ G+
Sbjct: 208 VWAIGCLVT-EMFMGE 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
R +G+GS G V + ++ A+K + N + +E++ + + HP L
Sbjct: 21 RAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V L+ + + ++V + G+L HL +++ E VK+ + + +AL YL +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK-EETVKLFICELVMALDYLQNQ- 134
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I+HRD+K NILL E ++DF +A M + T + GT YM PE ++ K
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAM--LPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 242 L---TCASDIYSFGIVALQLLSGQ 262
+ A D +S G+ A +LL G+
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 24/206 (11%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
+GRG+ V K +GQV A+K + K F E + L +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYIDG 183
L + YLV E+ G+L L + + + L + +A+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRL--- 181
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
VHRDIK NILL +L+DFG L + + GT Y+ PE +
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 244 CASDIY-------SFGIVALQLLSGQ 262
+ Y + G+ A ++ GQ
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 19/203 (9%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
R LGRG G V+ K +G++ A K + K E + L++V +
Sbjct: 191 RVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTW--ERRVKI-LRDCALALRYLHH 179
V L + LV G++ H+ D E R L +LH
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
I++RD+K N+LL + ++SD GLA L ++K GT G+M PE +
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 240 AKLTCASDIYSFGIVALQLLSGQ 262
+ + D ++ G+ ++++ +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
LG+G+ G V K +G+ A+K I + E L RHP L
Sbjct: 156 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYIDG 183
L V E+ G L HL ++ V + E R + + AL YLH +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFS-EDRARFYGAEIVSALDYLHSEKN- 269
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
+V+RD+KL N++L + K++DFGL K G+++ GT Y+ PE + +
Sbjct: 270 -VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
A D + G+V +++ G+ L F +D
Sbjct: 328 RAVDWWGLGVVMYEMMCGR----LPFYNQDH 354
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 14/224 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFG 127
+ LG G+ G V V + + VA+K + D +E+ + H N+V +G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
EG QYL E+C+ G L + + + + + + YLH I H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGI---GITH 128
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMTNAKLTCA- 245
RDIK N+LL E+ K+SDFGLA + + + GT+ Y+ PE + +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289
D++S GIV +L+G EL +D ++ D K +
Sbjct: 189 VDVWSCGIVLTAMLAG----ELPWDQPSDSCQEYSDWKEKKTYL 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-23
Identities = 61/257 (23%), Positives = 89/257 (34%), Gaps = 37/257 (14%)
Query: 34 PKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQV 92
P + +S Y LG G+ G V+ V +
Sbjct: 6 PPKAVELEGLAACEGEYSQKYSTMSP--------------LGSGAFGFVWTAVDKEKNKE 51
Query: 93 VAIKHIYKS----------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142
V +K I K + E+ LSRV H N++ + G LV E
Sbjct: 52 VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH 111
Query: 143 AAGN-LAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201
+G L + R + I R A+ YL I+HRDIK NI++ E
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLAS-YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167
Query: 202 EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA-SDIYSFGIVALQLLS 260
KL DFG A +E K+F GTI Y PE + +++S G+ L+
Sbjct: 168 TIKLIDFGSAAY--LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
Query: 261 GQKVIELDFDARDQLTR 277
E F ++
Sbjct: 226 E----ENPFCELEETVE 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.0 bits (240), Expect = 4e-23
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGCC 129
+G G+ G+VYK G+ A+K I + RE+ L ++H N+V L+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVHR 188
LV+E +L + L + L K L + Y H ++HR
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-SVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASD 247
D+K N+L+ + E K++DFGLA+ G+ + +T T+ Y P+ + +K + D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 248 IYSFGIVALQLLSGQ 262
I+S G + ++++G
Sbjct: 184 IWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-23
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGCC 129
+G G+ G+VYK G++VA+K I + RE+ L + HPN+V L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVHR 188
LV+EF +L + L + L + ++K L + + H + I+HR
Sbjct: 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASD 247
D+K N+L+ KL+DFGLA+ G+ + +T T+ Y P+ + +K + + D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 248 IYSFGIVALQLLSGQ 262
I+S G + ++++G+
Sbjct: 203 IWSIGCIFAEMITGK 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---REVEGLSRVRHPNLVCLFG 127
+ LG G+ G V V + + VA+K + D +E+ + H N+V +G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
EG QYL E+C+ G L + + + + + + YLH I H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHGI---GITH 128
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMTNAKLTCA- 245
RDIK N+LL E+ K+SDFGLA + + + GT+ Y+ PE + +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287
D++S GIV +L+G EL +D ++ D K
Sbjct: 189 VDVWSCGIVLTAMLAG----ELPWDQPSDSCQEYSDWKEKKT 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 64/300 (21%)
Query: 33 MPKRKSPKP---TKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LP 88
M R + EI +T++ L R+ + + +G G+ G+V
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQ------------NLKPIGSGAQGIVCAAYDAI 48
Query: 89 SGQVVAIKHIYK--SNNTDS--FSREVEGLSRVRHPNLVCLF------GCCVEGGEQYLV 138
+ VAIK + + N T + RE+ + V H N++ L E + Y+V
Sbjct: 49 LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 139 YEFCAAGNLAQHLLRKDSVLTWERRV----KILRDCALALRYLHHYIDGCIVHRDIKLTN 194
E A NL Q +++ + L ER ++L +++LH I+HRD+K +N
Sbjct: 109 MELMDA-NLCQ-VIQME--LDHERMSYLLYQMLC----GIKHLH---SAGIIHRDLKPSN 157
Query: 195 ILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIV 254
I++ K+ DFGLA+ S + T T Y PE + DI+S G +
Sbjct: 158 IVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 255 ALQLLSGQKVIELDFDARDQLTR------------------KARDV--SMGKRPIKDFED 294
+++ G V+ D DQ + R + K FE
Sbjct: 216 MGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGC 128
+G+G+ V + +G+ VAIK I K+ + REV + + HPN+V LF
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
YL+ E+ + G + +L+ + E R R A++Y H IVHR
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQK---RIVHR 138
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC--AS 246
D+K N+LL + K++DFG + G Y PE + K
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAPE-LFQGKKYDGPEV 195
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARD 273
D++S G++ L+SG L FD ++
Sbjct: 196 DVWSLGVILYTLVSGS----LPFDGQN 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-22
Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
+G G+ G V+K + ++VA+K + ++ + RE+ L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYLHHYIDG 183
+ LV+EFC +L ++ + L VK +L+ L + H
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLD-PEIVKSFLFQLLK----GLGFCHSR--- 120
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL- 242
++HRD+K N+L+ E KL++FGLA+ G+ + ++ T+ Y P+ + AKL
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 243 TCASDIYSFG 252
+ + D++S G
Sbjct: 180 STSIDMWSAG 189
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
+ +GRG+ G V K + +V A+K + K T F E + L +
Sbjct: 80 KVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
L + YLV ++ G+L L + + L E + L + +A+ +H
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQL- 194
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPE----- 235
VHRDIK NIL+ +L+DFG ME+ V + V GT Y+ PE
Sbjct: 195 --HYVHRDIKPDNILMDMNGHIRLADFGSCL-KLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 236 YMTNAKLTCASDIYSFGIVALQLLSGQ 262
+ D +S G+ ++L G+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 41/256 (16%)
Query: 70 DRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYK--SNNTDS--FSREVEGLSRVRHPNLVC 124
+ + +G G+ G+V + VAIK + + N T + RE+ + V H N++
Sbjct: 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 125 LF------GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
L E + YLV E A NL Q +++ + L ER +L +++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQ-VIQME--LDHERMSYLLYQMLCGIKHLH 181
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
I+HRD+K +NI++ K+ DFGLA+ S + T T Y PE +
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR------------------KAR 280
DI+S G + +++ K++ D DQ + R
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295
Query: 281 DV--SMGKRPIKDFED 294
+ + K F
Sbjct: 296 NYVENRPKYAGLTFPK 311
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-22
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 74 LGRGSAG---LVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEG-------LSRVRHPNL 122
LG+G G V K +G++ A+K + K+ + +++ L V+HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFI 83
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V L GG+ YL+ E+ + G L L ++ + E L + ++AL +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFM-EDTACFYLAEISMALGHLHQK- 140
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I++RD+K NI+L + KL+DFGL K + + V GTI YM PE + +
Sbjct: 141 --GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 242 LTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
A D +S G + +L+G F ++
Sbjct: 198 HNRAVDWWSLGALMYDMLTGA----PPFTGENR 226
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVC 124
LG+G+ G V K +G+ A+K I + E L RHP L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC-ALALRYLHHYIDG 183
L V E+ G L HL ++ V T E R + AL YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFT-EERARFYGAEIVSALEYLH---SR 124
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
+V+RDIKL N++L + K++DFGL K G+ + GT Y+ PE + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
A D + G+V +++ G+ L F +D
Sbjct: 184 RAVDWWGLGVVMYEMMCGR----LPFYNQDH 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS--------REVEGLSRVRH--PNL 122
LG G G VY G+ + VAIKH+ K +D EV L +V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 123 VCLFGCCVEGGEQYLVYEFCA-AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI 181
+ L L+ E +L + + ++ R A+R+ H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC- 168
Query: 182 DGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
++HRDIK NIL+ + E KL DFG +L + V+TD GT Y PE++
Sbjct: 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 223
Query: 241 KLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
+ ++ ++S GI+ ++ G ++ F+ +++ R
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIR 257
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFS-REVEGLSRVRHPNLV 123
LG+GS G V+ + Q+ A+K + + + R++ L V HP +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFIV 89
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYID 182
L G+ YL+ +F G+L L K+ + T E VK L + ALAL +LH
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFT-EEDVKFYLAELALALDHLHSL-- 145
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+K NILL E+ KL+DFGL+K ++ K GT+ YM PE +
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
T ++D +SFG++ ++L+G L F +D+
Sbjct: 204 TQSADWWSFGVLMFEMLTGT----LPFQGKDR 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
LG+GS G V KG + ++ A+K + + ++ + E L+ + P L
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L C Y V E+ G+L H+ + V + A+ L +L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SK 461
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
I++RD+KL N++L + K++DFG+ K + + GT Y+ PE +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARD 273
+ D ++FG++ ++L+GQ F+ D
Sbjct: 521 KSVDWWAFGVLLYEMLAGQ----APFEGED 546
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 74 LGRGSAGLVYKG-VLPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
LG G+ VYKG + +VA+K I + + + REV L ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVH 187
LV+E+ +L Q+L +++ VK L L Y H ++H
Sbjct: 69 IHTEKSLTLVFEYLDK-DLKQYLDDCGNIIN-MHNVKLFLFQLLRGLAYCHRQ---KVLH 123
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCAS 246
RD+K N+L+ E+ E KL+DFGLA+ + +K + + T+ Y P+ + + +
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 247 DIYSFGIVALQLLSGQ 262
D++ G + ++ +G+
Sbjct: 183 DMWGVGCIFYEMATGR 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G V G +G VA+K I + RE++ L RHP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + ++V E+ + G L ++ + V E R ++ + A+ Y H + +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRH---MV 132
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
VHRD+K N+LL + K++DFGL+ M M + + G+ Y PE ++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 246 -SDIYSFGIVALQLLSGQKVIELDFDARD--QLTRK 278
DI+S G++ LL G L FD L +K
Sbjct: 191 EVDIWSCGVILYALLCGT----LPFDDEHVPTLFKK 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-21
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVR----HP 120
LG+G G V+ G L VAIK I ++ ++ + EV L +V HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGN-LAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
++ L LV E L ++ K + R A+++ H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCHS 157
Query: 180 YIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+VHRDIK NIL+ + KL DFG +L + +TD GT Y PE+++
Sbjct: 158 R---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEWIS 211
Query: 239 NAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
+ + ++S GI+ ++ G ++ F+ ++
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCG----DIPFERDQEILE 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
LG+GS G V KG + ++ A+K + + ++ + E L+ + P L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYID 182
L C Y V E+ G+L H+ + E + A+ L +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLFFLQ---S 139
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+KL N++L + K++DFG+ K + + GT Y+ PE +
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
+ D ++FG++ ++L+GQ F+ D+
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ----APFEGEDE 226
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 20/200 (10%)
Query: 74 LGRGSAGLV----YKGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
LG+GS G V +K + Q AIK + ++ + E LS HP L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC-ALALRYLHHYID 182
+F + V E+ G+L H+ R L L++LH
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILGLQFLH---S 136
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
IV+RD+KL NILL + K++DFG+ K M GT Y+ PE + K
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 243 TCASDIYSFGIVALQLLSGQ 262
+ D +SFG++ ++L GQ
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 25/200 (12%), Positives = 51/200 (25%), Gaps = 44/200 (22%)
Query: 71 RRFLGRGSAGLVYKG---VLPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNL 122
F G ++ L + VA+ + LSR+ P +
Sbjct: 36 LIFHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
+ +V E+ G+L + D+ + ++ ++ A A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHR--A 148
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
G + + + ++ + L+ M
Sbjct: 149 G-VALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA------- 179
Query: 243 TCASDIYSFGIVALQLLSGQ 262
DI G LL +
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 19/202 (9%)
Query: 72 RFLGRGSAGLVYKG-VLPSGQVVAIK-----HIYKSNNTDSFSRE---VEGLSRVRHPNL 122
R +GRG G VY +G++ A+K I E + +S P +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
VC+ + + + G+L HL + V + E ++ + L L ++H+
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFS-EADMRFYAAEIILGLEHMHNR- 311
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE-YMTNA 240
+V+RD+K NILL E ++SD GLA ++ GT GYM PE
Sbjct: 312 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 366
Query: 241 KLTCASDIYSFGIVALQLLSGQ 262
++D +S G + +LL G
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGH 388
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
LG+GS G V K +G + A+K I + ++ + E LS HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC-ALALRYLHHYID 182
LF C + V EF G+L H+ + E R + AL +LH D
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISALMFLH---D 142
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+KL N+LL + KL+DFG+ K G+ GT Y+ PE +
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
A D ++ G++ ++L G F+A ++
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH----APFEAENE 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
+GRGS V K + ++ A++ + + D E + HP LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYID 182
L C + V E+ G+L H+ ++ L E + + +LAL YLH +
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP-EEHARFYSAEISLALNYLH---E 171
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+KL N+LL + KL+D+G+ K G+ + GT Y+ PE +
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 243 TCASDIYSFGIVALQLLSGQ 262
+ D ++ G++ ++++G+
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 73 FLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS--------REVEGLSRVRHPNLV 123
FLG G VYK + Q+VAIK I K + RE++ L + HPN++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYLH 178
L LV++F +L + VLT +K L+ L YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT-PSHIKAYMLMTLQ----GLEYLH 129
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ I+HRD+K N+LL E KL+DFGLAK G ++ +T T Y PE +
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLF 185
Query: 239 NAKL-TCASDIYSFGIVALQLLSGQ 262
A++ D+++ G + +LL
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
LG G+ VYKG+ +G VA+K + K ++ + RE+ + ++H N+V L+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 129 CVEGGEQYLVYEFCA---AGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYLHHY 180
+ LV+EF + + VK +L+ L + H
Sbjct: 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ----GLAFCHE- 126
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+HRD+K N+L+ ++ + KL DFGLA+ G+ F+ T+ Y P+ + +
Sbjct: 127 --NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGS 183
Query: 241 KL-TCASDIYSFGIVALQLLSGQ 262
+ + + DI+S G + ++++G+
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 49/237 (20%), Positives = 94/237 (39%), Gaps = 46/237 (19%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS----------------------------N 102
+G+GS G+V A+K + K
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 103 NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ---YLVYEFCAAGNLAQHLLRKDSVLT 159
+ +E+ L ++ HPN+V L ++ + Y+V+E G + + + L+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLS 135
Query: 160 WERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219
++ +D + YLH+ I+HRDIK +N+L+ E K++DFG++ ++
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 220 KVFTDVRGTIGYMDPEYMTNAKLT---CASDIYSFGIVALQLLSGQKVIELDFDARD 273
+ V GT +M PE ++ + A D+++ G+ + GQ F
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ----CPFMDER 244
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 39/200 (19%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCC 129
+ LG G G V + + + A+K + REVE R + P++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVY 80
Query: 130 VEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRV-KILRDCALALRYLHHYIDGC 184
+V E G L + + ER +I++ A++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 185 IVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I HRD+K N+L T K KL+DFG AK + G Y D
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTGE-KY-DKS------ 178
Query: 242 LTCASDIYSFGIVALQLLSG 261
D++S G++ LL G
Sbjct: 179 ----CDMWSLGVIMYILLCG 194
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 51/235 (21%)
Query: 70 DRRFLGRGSAGLVYKGVL-PSGQVVAIKHI-----YKSNNTDSFSREVEGLSRVRHPNLV 123
D + +G GS G+VY+ L SG++VAIK + +K+ RE++ + ++ H N+V
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIV 110
Query: 124 CLFGCCVEGGEQ------YLVYEFCAAGNLAQ---HLLRKDSVLTWERRVK-----ILRD 169
L GE+ LV ++ + + H R L VK + R
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFR- 167
Query: 170 CALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGMEESKVFTDVR 226
+L Y+H I HRDIK N+LL T L KL DFG AK L +
Sbjct: 168 ---SLAYIHS---FGICHRDIKPQNLLLDPDTAVL--KLCDFGSAKQL--VRGEPNVSYI 217
Query: 227 GTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDF---DARDQLTR 277
+ Y PE + A T + D++S G V +LL GQ + F DQL
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVE 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRV-RHPNLV 123
+GRGS V K + ++ A+K + + D E + HP LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYID 182
L C + V E+ G+L H+ ++ L E + + +LAL YLH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP-EEHARFYSAEISLALNYLHER-- 129
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I++RD+KL N+LL + KL+D+G+ K G+ + GT Y+ PE +
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 187
Query: 243 TCASDIYSFGIVALQLLSGQ 262
+ D ++ G++ ++++G+
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 23/213 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS------NNTDSFSREVEGLSRVRHPNLVC 124
LG GS G V + + + A+K + K N + +E++ L R+RH N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 125 LFGCCVEGGEQ--YLVYEFCAAGN--LAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
L +Q Y+V E+C G + + K + L YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAH-GYFCQLIDGLEYLHSQ 128
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMTN 239
IVH+DIK N+LLT K+S G+A+ L + G+ + PE
Sbjct: 129 ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 240 AKL--TCASDIYSFGIVALQLLSGQKVIELDFD 270
DI+S G+ + +G F+
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGL----YPFE 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 42/233 (18%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFS-------------REVEGLSRVR 118
RF+ GS G V GV G VAIK ++ + + RE+ L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 119 HPNLVCLFGCCV-----EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILR 168
HPN++ L V + YLV E +LAQ + + V++ + ++ IL
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS-PQHIQYFMYHILL 145
Query: 169 DCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGT 228
L LH + +VHRD+ NILL + + + DF LA+ T
Sbjct: 146 ----GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH 196
Query: 229 IGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDF---DARDQLTR 277
Y PE + K T D++S G V ++ + K + F +QL +
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL---FRGSTFYNQLNK 245
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 60/212 (28%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 74 LGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSR-VRHPNLV 123
+G+GS G V K A+K I K E L + V+HP LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYID 182
L + Y V ++ G L HL +++ E R + + A AL YLH
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFL-EPRARFYAAEIASALGYLHSL-- 158
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
IV+RD+K NILL + L+DFGL K +E + + GT Y+ PE +
Sbjct: 159 -NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274
D + G V ++L G F +R+
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL----PPFYSRNT 244
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
+ +GRG+ G V K + +V A+K + K +++ F E + ++ P +
Sbjct: 75 KVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V LF + Y+V E+ G+L + D + E+ + + LAL +H
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VP-EKWARFYTAEVVLALDAIHSM- 187
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-- 239
+HRD+K N+LL + KL+DFG + E GT Y+ PE + +
Sbjct: 188 --GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 240 --AKLTCASDIYSFGIVALQLLSGQ 262
D +S G+ ++L G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLFGC 128
LG G+ G VYK + + + VAIK I + + REV L ++H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHHYIDGCIVH 187
+L++E+ +L + + K+ ++ R +K L + + H +H
Sbjct: 102 IHHNHRLHLIFEYAEN-DLKK-YMDKNPDVS-MRVIKSFLYQLINGVNFCHSR---RCLH 155
Query: 188 RDIKLTNILLTEKLEP-----KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
RD+K N+LL+ K+ DFGLA+ G+ + FT T+ Y PE + ++
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRH 214
Query: 243 -TCASDIYSFG 252
+ + DI+S
Sbjct: 215 YSTSVDIWSIA 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 34/233 (14%)
Query: 74 LGRGSAGLVYKGV---LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+GRG+ G VYK + A+K I + + S RE+ L ++HPN++ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 131 EGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRD---CAL-----ALRYLHHY 180
++ +L++++ +L + + ++ V++ R L + YLH
Sbjct: 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 181 IDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEESKVFTDVRG---TIGYMD 233
++HRD+K NIL+ + K++D G A++ K D+ T Y
Sbjct: 148 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRA 203
Query: 234 PEYMTNAKL-TCASDIYSFGIVALQLLSGQ--------KVIELDFDARDQLTR 277
PE + A+ T A DI++ G + +LL+ + + + DQL R
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG G+ G V G +G VA+K I + RE++ L RHP+++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + ++V E+ + G L ++ + + E R ++ + + Y H + +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR-RLFQQILSGVDYCHRH---MV 137
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC- 244
VHRD+K N+LL + K++DFGL+ M M + + G+ Y PE + + +L
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPE-VISGRLYAG 194
Query: 245 -ASDIYSFGIVALQLLSGQKVIELDFDARD--QLTRK 278
DI+S G++ LL G L FD L +K
Sbjct: 195 PEVDIWSSGVILYALLCGT----LPFDDDHVPTLFKK 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 24/246 (9%)
Query: 29 NKGCMPKRKSPKPTKEIYSTTW-SGLYRFSKDEIENAINNDWDR-RFLGRGSAGLVY--- 83
N K + KE + L ++ A + +DR + LG GS G V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 84 -KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137
K SG A+K + K + E L V P LV L + Y+
Sbjct: 62 HKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDC-ALALRYLHHYIDGCIVHRDIKLTNIL 196
V E+ A G + HL R+ + E + L YLH +++RD+K N+L
Sbjct: 119 VMEYVAGGEMFSHL-RRIGRFS-EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLL 173
Query: 197 LTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVAL 256
+ ++ +++DFG AK + + + +T + GT + PE + + A D ++ G++
Sbjct: 174 IDQQGYIQVTDFGFAKRV---KGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 257 QLLSGQ 262
++ +G
Sbjct: 230 EMAAGY 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 74 LGRGSAGLVYKG--VLPSGQVVAIKHIYKSNNTDSFS----REV---EGLSRVRHPNLVC 124
+G G+ G V+K + G+ VA+K + + REV L HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 125 LFGCCVEGGEQ-----YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLH 178
LF C LV+E +L +L + +K ++ L +LH
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
+ +VHRD+K NIL+T + KL+DFGLA++ + + T V T+ Y PE +
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLL 192
Query: 239 NAKLTCASDIYSFG 252
+ D++S G
Sbjct: 193 QSSYATPVDLWSVG 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSF----SREVEGLSRVRHPNLVCLFGC 128
+G+G+ G V+K +GQ VA+K + N + F RE++ L ++H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 129 CVEGGEQ--------YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRYLHH 179
C YLV++FC +LA L T +K +++ L Y+H
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT-LSEIKRVMQMLLNGLYYIHR 142
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215
I+HRD+K N+L+T KL+DFGLA+
Sbjct: 143 N---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 23/196 (11%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS-------REV---EGLSRVRHPNL 122
+G G+ G VYK SG VA+K + N REV L HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 123 VCLFGCCVEGGEQ-----YLVYEFCAAGNLAQHLLRKDSVLTWERRVK-ILRDCALALRY 176
V L C LV+E +L +L + +K ++R L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY 236
LH CIVHRD+K NIL+T KL+DFGLA++ + + T V T+ Y PE
Sbjct: 136 LHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEV 190
Query: 237 MTNAKLTCASDIYSFG 252
+ + D++S G
Sbjct: 191 LLQSTYATPVDMWSVG 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 72 RFLGRGSAGLVY----KGVLPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNL 122
R LG GS G V+ + +G+ A+K + + + + E LS V HP +
Sbjct: 12 RTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYL 177
+ ++G + + +++ ++ G L L RK K + LAL YL
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFP-NPVAKFYAAEVC----LALEYL 122
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H I++RD+K NILL + K++DFG AK +T + GT Y+ PE +
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDYIAPEVV 175
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQ 262
+ + D +SFGI+ ++L+G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 39/210 (18%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHI-----YKSNNTDSFSREVEGLSRVRHPNLVCLFGC 128
+G GS G+V++ L VAIK + +K +RE++ + V+HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAF 100
Query: 129 CVEGGEQ------YLVYEFCAAGNLAQ---HLLRKDSVLTWERRVK-----ILRDCALAL 174
G++ LV E+ + + H + + +K +LR +L
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLR----SL 154
Query: 175 RYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
Y+H I HRDIK N+LL KL DFG AK+L + + Y
Sbjct: 155 AYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRA 209
Query: 234 PEYMTNAKL-TCASDIYSFGIVALQLLSGQ 262
PE + A T DI+S G V +L+ GQ
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 11/195 (5%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCC 129
+ +G G+ G+ + ++VA+K+I + ++ RE+ +RHPN+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ ++ E+ + G L + + E R + + Y H I HRD
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEAR-FFFQQLLSGVSYCHSM---QICHRD 141
Query: 190 IKLTNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA-S 246
+KL N LL P K+ DFG +K + S+ + V GT Y+ PE + + +
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIA 199
Query: 247 DIYSFGIVALQLLSG 261
D++S G+ +L G
Sbjct: 200 DVWSCGVTLYVMLVG 214
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIK-----HIYKSNNTDSFSREVEGLSRVRHPNLVCL 125
LG GS G V + Q VA+K + KS+ RE+ L +RHP+++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + +V E+ A G L +++ K + E R + + A+ Y H + I
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRH---KI 129
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
VHRD+K N+LL + L K++DFGL+ + M + G+ Y PE +
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 246 -SDIYSFGIVALQLLSGQKVIELDFD 270
D++S GIV +L G+ L FD
Sbjct: 188 EVDVWSCGIVLYVMLVGR----LPFD 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFS--REVEGLSRVRHPNLVCLFGC 128
R G+G+ G V G +G VAIK + + + ++ L+ + HPN+V L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 129 CVEGGEQ-------YLVYEFCAA--GNLAQHLLRKDSVLTWERRVK-----ILRDCALAL 174
GE+ +V E+ ++ R+ +K ++R ++
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL-IKVFLFQLIR----SI 142
Query: 175 RYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
LH + HRDIK N+L+ KL DFG AK L E + Y
Sbjct: 143 GCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRA 199
Query: 234 PEYMTNAKL-TCASDIYSFGIVALQLLSGQ 262
PE + + T A DI+S G + +++ G+
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 37/217 (17%)
Query: 18 KHVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRG 77
+H Q + P + + W R+ + +G G
Sbjct: 17 QHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL------------IGTG 64
Query: 78 SAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF-----G 127
S G V + +VVAIK I + RE+ L+R+ H ++V +
Sbjct: 65 SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYLHHYID 182
+ E Y+V E + + + L R LT E +K +L ++Y+H
Sbjct: 125 DVEKFDELYVVLEIADS-DFKK-LFRTPVYLT-ELHIKTLLYNLLV----GVKYVH---S 174
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219
I+HRD+K N L+ + K+ DFGLA+ + E+
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 74/298 (24%), Positives = 117/298 (39%), Gaps = 64/298 (21%)
Query: 34 PKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGV-LPSGQV 92
P +S +E+ T W + D + +G G+ G V V +G
Sbjct: 5 PPARSGFYRQEVTKTAWEVRAVYR------------DLQPVGSGAYGAVCSAVDGRTGAK 52
Query: 93 VAIKHIYK--SNNTDS--FSREVEGLSRVRHPNLVCLF------GCCVEGGEQYLVYEFC 142
VAIK +Y+ + + RE+ L +RH N++ L + + YLV F
Sbjct: 53 VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM 112
Query: 143 AAGNLAQHLLRKDSVLTWERR----VKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198
+L L K L +R ++L+ LRY+H I+HRD+K N+ +
Sbjct: 113 GT-DL--GKLMKHEKLGEDRIQFLVYQMLK----GLRYIH---AAGIIHRDLKPGNLAVN 162
Query: 199 EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQ 257
E E K+ DFGLA+ E T T Y PE + N T DI+S G + +
Sbjct: 163 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 258 LLSGQKVIELDFDARDQLTR-------------------KARDV--SMGKRPIKDFED 294
+++G K + D DQL +A++ + + KDF
Sbjct: 219 MITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 275
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 51/243 (20%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYK--SNNTDS---FSREVEGLSRVRHPNLVCL 125
+GRGS G VY + + VAIK + + + D RE+ L+R++ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYIIRL 90
Query: 126 FGCCV-----EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALR 175
+ + + E Y+V E + +L + L + LT E +K +L
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKK-LFKTPIFLT-EEHIKTILYNLLL----GEN 143
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD-- 233
++H + I+HRD+K N LL + K+ DFGLA+ + E+ +
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 234 -------------------PEYMTNAKL-TCASDIYSFG-IVALQLLSGQKVIELDFDAR 272
PE + + T + DI+S G I A +LL+ + D R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDPTNR 259
Query: 273 DQL 275
L
Sbjct: 260 FPL 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 55/261 (21%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G G+ G V + SG+ VAIK + + ++ F+ RE+ L ++H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 127 ------GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALR 175
+ YLV F +L + ++ + E +++ +L+ L+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQK-IMGLK--FS-EEKIQYLVYQMLK----GLK 140
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235
Y+H +VHRD+K N+ + E E K+ DFGLA+ E T T Y PE
Sbjct: 141 YIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPE 193
Query: 236 YMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR----------------- 277
+ + DI+S G + ++L+G K + D DQLT+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 278 --KARDV--SMGKRPIKDFED 294
A+ S+ + P KDF
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQ 273
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 62/269 (23%), Positives = 107/269 (39%), Gaps = 58/269 (21%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCLF- 126
+ LG G GLV+ V + VAIK I ++ RE++ + R+ H N+V +F
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFE 75
Query: 127 -------------GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILR 168
G E Y+V E+ +L + + L E + +LR
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DL--ANVLEQGPLL-EEHARLFMYQLLR 131
Query: 169 DCALALRYLHHYIDGCIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESK--VFTDV 225
L+Y+H ++HRD+K N+ + TE L K+ DFGLA+++ S ++
Sbjct: 132 ----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 226 RGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSG-------------QKVIEL---- 267
T Y P + + T A D+++ G + ++L+G Q ++E
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 268 DFDARDQLTRKARD--VSMGKRPIKDFED 294
+ R +L + P K
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 67/261 (25%), Positives = 107/261 (40%), Gaps = 54/261 (20%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G G+ G V +G VA+K + + + + RE+ L ++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 127 ------GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALR 175
E + YLV A +L + + K LT + V+ ILR L+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGA-DL--NNIVKCQKLT-DDHVQFLIYQILR----GLK 146
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235
Y+H I+HRD+K +N+ + E E K+ DFGLA+ + T T Y PE
Sbjct: 147 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRAPE 199
Query: 236 YMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR----------------- 277
M N DI+S G + +LL+G + + D DQL
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 278 --KARDV--SMGKRPIKDFED 294
AR+ S+ + P +F +
Sbjct: 259 SESARNYIQSLTQMPKMNFAN 279
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 74 LGRGSAG---LVYKGVLP-SGQVVAIKHIYKS------NNTDSFSREVEGLSRVRH-PNL 122
LG G+ G LV K +G++ A+K + K+ T+ E + L +R P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKI-LRDCALALRYLHHYI 181
V L + +L+ ++ G L HL + T E V+I + + LAL +LH
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFT-EHEVQIYVGEIVLALEHLHKL- 178
Query: 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR-GTIGYMDPEYMTNA 240
I++RDIKL NILL L+DFGL+K + + GTI YM P+ +
Sbjct: 179 --GIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 241 KL--TCASDIYSFGIVALQLLSGQ 262
A D +S G++ +LL+G
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 66/270 (24%), Positives = 108/270 (40%), Gaps = 68/270 (25%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---------REVEGLSRVRHPN 121
++G G+ G+V + VAIK I F RE++ L R RH N
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 122 LVCLF-----GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCA 171
++ + + + Y+V + +L + L K L+ + ILR
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DL--YKLLKTQHLS-NDHICYFLYQILR--- 139
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF--TDVRGTI 229
L+Y+H ++HRD+K +N+LL + K+ DFGLA++ + T+ T
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 230 GYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDF---DARDQLTR-------- 277
Y PE M N+K T + DI+S G + ++LS + I F DQL
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI---FPGKHYLDQLNHILGILGSP 251
Query: 278 -----------KARDV--SMGKRPIKDFED 294
KAR+ S+ + +
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNR 281
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 54/239 (22%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS---------REVEGLSRVRHPN 121
LG G+ G+V P+G++VAIK I + F RE++ L +H N
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 122 LVCLF-----GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCA 171
++ +F E Y++ E +L H + +L+ + ++ LR
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DL--HRVISTQMLS-DDHIQYFIYQTLR--- 123
Query: 172 LALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIG- 230
A++ LH ++HRD+K +N+L+ + K+ DFGLA+++ + G
Sbjct: 124 -AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 231 --------YMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDF---DARDQLTR 277
Y PE M + + A D++S G + +L + + F D R QL
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI----FPGRDYRHQLLL 234
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYK--SNNTDS---FSREVEGLSRVR-HPNLVC 124
+ LG+G+ G+V+K + +G+VVA+K I+ N+TD+ F RE+ L+ + H N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVN 73
Query: 125 LFGCCV--EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVK-----ILRDCALALRYL 177
L + YLV+++ +L H + + ++L + +++ ++YL
Sbjct: 74 LLNVLRADNDRDVYLVFDYMET-DL--HAVIRANILE-PVHKQYVVYQLIK----VIKYL 125
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H G ++HRD+K +NILL + K++DFGL++ +
Sbjct: 126 H---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 238 TNAKLT 243
LT
Sbjct: 183 DQPILT 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 55/257 (21%), Positives = 98/257 (38%), Gaps = 67/257 (26%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+ LG GS G+V + + SG+ A+K + + + RE++ + + H N++ L
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--RELDIMKVLDHVNIIKLVDYFY 70
Query: 131 EGGEQ--------------------------------------YLVYEFCAA--GNLAQH 150
G++ ++ E+ + +
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 151 LLRKDSVLTWERRVK-----ILRDCALALRYLHHYIDGCIVHRDIKLTNILL-TEKLEPK 204
+R + + + R A+ ++H I HRDIK N+L+ ++ K
Sbjct: 131 FIRSGRSIP-MNLISIYIYQLFR----AVGFIHS---LGICHRDIKPQNLLVNSKDNTLK 182
Query: 205 LSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQK 263
L DFG AK L S+ + Y PE M A T + D++S G V +L+ G+
Sbjct: 183 LCDFGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 264 VIELDF---DARDQLTR 277
+ F + DQL R
Sbjct: 241 L----FSGETSIDQLVR 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 55/270 (20%), Positives = 107/270 (39%), Gaps = 46/270 (17%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCC 129
R LGRG V++ + + + + V +K + K RE++ L +R PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 130 VEGGEQ--YLVYEFCAAGNLAQHL--LRKDSV--LTWERRVKILRDCALALRYLHHYIDG 183
+ + LV+E + Q L + +E IL+ AL Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE----ILK----ALDYCHS---M 149
Query: 184 CIVHRDIKLTNILL-TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL 242
I+HRD+K N+++ E + +L D+GLA+ + + + + PE + + ++
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 243 -TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR--------------------KARD 281
+ D++S G + ++ ++ D DQL R
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 282 V--SMGKRPIKDFEDPRLNGNINRADFESI 309
+G+ K +E + N + E++
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEAL 297
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 5e-11
Identities = 31/202 (15%), Positives = 53/202 (26%), Gaps = 54/202 (26%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHI----YKSNNTDSFSREVEGLSRV------------ 117
+G G G V++ + VAIK I N E L +
Sbjct: 28 IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 118 ---RHPNLVCLFGCCV------------------------------EGGEQYLVYEFCAA 144
R + L + + ++V EF
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK 204
G + + K + + IL +L + HRD+ N+LL + K
Sbjct: 147 GIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKK 202
Query: 205 LSDFGLAKMLGMEESKVFTDVR 226
L K + + +
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSII 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 52/236 (22%), Positives = 83/236 (35%), Gaps = 41/236 (17%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTDS----FSREVEGLSRV-RHP 120
+ LGRG+ G V + + + VA+K + K T S E++ L + H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 86
Query: 121 NLVCLFGCC-VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
N+V L G C GG ++ EFC GNL+ +L +R + + R+
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGARFRQG 138
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+ D+K +T S F K L E +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE------------EEEAPEDLY 186
Query: 240 AKLTCASDIYSFGI-VA--LQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
+ + VA ++ L+ +K I D AR+ L + V I DF
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK-----ICDF 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 26/71 (36%), Positives = 41/71 (57%), Gaps = 1/71 (1%)
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLT 243
+HRD+ NILL+EK K+ DFGLA+ + + D R + +M PE + + T
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273
Query: 244 CASDIYSFGIV 254
SD++SFG++
Sbjct: 274 IQSDVWSFGVL 284
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 59/266 (22%), Positives = 93/266 (34%), Gaps = 79/266 (29%)
Query: 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVR-----HPN---L 122
LG G V+ + + VA+K + KS T++ E+ L VR PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 123 VCLFGC-CVEGGE---QYLVYEFCAAG-NLAQHLLR-KDSVLTWERRVKILRDCALALRY 176
V L + G +V+E G +L + +++ L KI++ L Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 177 LHHYIDGCIVHRDIKLTNILLT-------------------------------------- 198
LH I+H DIK NILL+
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 199 -----------EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
EKL+ K++D G A K FT+ T Y E + + +D
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 248 IYSFGIVALQLLSGQKVIELDFDARD 273
I+S +A +L +G + F+
Sbjct: 276 IWSTACMAFELATGDYL----FEPHS 297
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVR---------- 118
R LG G V+ + + VA+K I + + T++ E++ L RV
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 119 -HPNLVCL---FGCCVEGGEQY-LVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCAL 172
+++ L F G +V+E NL + + + + +I + L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 173 ALRYLHHYIDGC-IVHRDIKLTNILLTEKLEP------KLSDFGLAKMLGMEESKVFTDV 225
L Y+H C I+H DIK N+L+ P K++D G A + +T+
Sbjct: 143 GLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNS 195
Query: 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
T Y PE + A C +DI+S + +L++G
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 45/256 (17%)
Query: 31 GCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIEN----AINNDWDRRF-----LGRGSAGL 81
G K++ G D+ + ++ R+ +G+GS G
Sbjct: 62 GLNAKKRQGMT---------GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQ 112
Query: 82 VYKGV-LPSGQVVAIKHIYKSNNTDSFSR----EVEGLSRVRH------PNLVCLFGCCV 130
V K Q VA+K + N F R E+ L +R N++ +
Sbjct: 113 VVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSV--LTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+ +E + NL + L++K+ + K L LH I+H
Sbjct: 170 FRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHC 224
Query: 189 DIKLTNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
D+K NILL ++ K+ DFG + E +V+T ++ + Y PE + A+
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFYRAPEVILGARYGMPI 280
Query: 247 DIYSFGIVALQLLSGQ 262
D++S G + +LL+G
Sbjct: 281 DMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 57/252 (22%), Positives = 98/252 (38%), Gaps = 40/252 (15%)
Query: 34 PKRKSPKPTKEIYSTTW---SGLYRFSKDEIENAINNDWDRRF-----LGRGSAGLVYKG 85
S K +++Y+ + + Y E W R+ +G+GS G V K
Sbjct: 21 QSMSSHKKERKVYNDGYDDDNYDYIVKNGEK-------WMDRYEIDSLIGKGSFGQVVKA 73
Query: 86 V-LPSGQVVAIKHIYKSNNTDSFSR----EVEGLSRVRHP------NLVCLFGCCVEGGE 134
+ VAIK I N +F EV L + +V L +
Sbjct: 74 YDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130
Query: 135 QYLVYEFCAAGNLAQHLLRKDSV--LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
LV+E + NL LLR + ++ K + AL +L + I+H D+K
Sbjct: 131 LCLVFEMLSY-NLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKP 187
Query: 193 TNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
NILL K+ DFG + +++ ++ + Y PE + A D++S
Sbjct: 188 ENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWS 243
Query: 251 FGIVALQLLSGQ 262
G + +++ +G+
Sbjct: 244 LGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 28/148 (18%), Positives = 54/148 (36%), Gaps = 11/148 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFGCC 129
+ +G G+ G + G L + + VAIK + E ++ + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
G +V E +L D + + + I + Y+H +++RD
Sbjct: 75 PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRD 130
Query: 190 IKLTNILLTEKLEPK-----LSDFGLAK 212
+K N L+ + DF LAK
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 33/146 (22%), Positives = 55/146 (37%), Gaps = 9/146 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFGCC 129
R +G GS G +Y G + + + VAIK E + ++ + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
VEG LV + +L L+ + + + + ++H +HRD
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRD 128
Query: 190 IKLTNILLTEKLEPK---LSDFGLAK 212
IK N L+ + DFGLAK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 17/152 (11%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFGCC 129
R +G GS G++++G L + Q VAIK + ++ E + + ++
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 130 VEGGEQYLVYEFCAA--GNLAQHLLRKDSVLTWERRVKILRDCALA-LRYLHHYIDGCIV 186
EG LV + +L RK SV T V + LA ++ +H +V
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT----VAMAAKQMLARVQSIHEK---SLV 128
Query: 187 HRDIKLTNILLTEKLEPK-----LSDFGLAKM 213
+RDIK N L+ + DFG+ K
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 9/147 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFGCC 129
R +G GS G +Y G + +G+ VAIK E + ++ + + C
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
EG +V E +L + + + + + Y+H +HRD
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRD 130
Query: 190 IKLTNILLTEKLEPK---LSDFGLAKM 213
+K N L+ + + DFGLAK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 3e-06
Identities = 40/282 (14%), Positives = 85/282 (30%), Gaps = 85/282 (30%)
Query: 99 YKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDS-- 156
+K N D + +E L +E E +++ + + +
Sbjct: 347 WKHVNCDKLTTIIE----------SSL--NVLEPAEYRKMFDRLS-------VFPPSAHI 387
Query: 157 ---VLT--W--------ERRVKILRDCALALR-------YLHH-YIDGCI-------VHR 188
+L+ W V L +L + + Y++ + +HR
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 189 DI----KLTNILLTEKLEPKLSD------FG--LAKMLGMEESKVFTDVRGTIGYMDPEY 236
I + ++ L P D G L + E +F V ++D +
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-----FLDFRF 502
Query: 237 MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA-RDQLTRKARDVSMGKRPIKDFEDP 295
+ K+ S ++ L L + + I DF P
Sbjct: 503 L-EQKIRHDSTAWNASGSILNTL-------QQLKFYKPYICDNDPKYERLVNAILDFL-P 553
Query: 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
++ N+ + + +L+IA++ + ++EE K
Sbjct: 554 KIEENLICSKYTDLLRIALM---------AEDEAIFEEAHKQ 586
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 42/186 (22%)
Query: 59 DEIENAINNDWD-RRFLGRGSAGLVYKGVLPSGQVVAIK-------------------HI 98
+ I + W +G+G G +Y + S + V
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 99 YKSNNTDSFSREVEGLSRVRH---PNLVCLFGCCVEGGEQY--LVYEFCAAGNLAQHLL- 152
Y+ ++ ++++ P G + G+ Y ++ + G+ Q +
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYE 143
Query: 153 ---RKDSVLTWERRVKILRDCAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK--LS 206
++ S T V L L L Y+H + VH DIK +N+LL K + L
Sbjct: 144 ANAKRFSRKT----VLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLV 196
Query: 207 DFGLAK 212
D+GLA
Sbjct: 197 DYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 41/220 (18%), Positives = 66/220 (30%), Gaps = 46/220 (20%)
Query: 19 HVAKSKIQGKNKGCMPKRKSPKPTKEIYSTTWSGLYRFSKDEIENAINNDWD-RRFLGRG 77
H G + G P E +++ N W + +G G
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPE-------------GKVLDDMEGNQWVLGKKIGSG 48
Query: 78 SAGLVYKGV-LPSGQVVAIK----------------HIYKSNNTDSFSREVEGLSRVRH- 119
GL+Y + A Y+ ++ ++ +
Sbjct: 49 GFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYL 108
Query: 120 --PNLVCLFGCCVEGGEQY--LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCAL-AL 174
P G G Y +V E G Q + ++ + V L L L
Sbjct: 109 GIPLFYG-SGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK-KSTVLQLGIRMLDVL 164
Query: 175 RYLHHYIDGCIVHRDIKLTNILLTEKLEPK--LSDFGLAK 212
Y+H VH DIK N+LL K + L+D+GL+
Sbjct: 165 EYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 29/171 (16%), Positives = 55/171 (32%), Gaps = 39/171 (22%)
Query: 72 RFLGRGSAGLVYKGV---------LPSGQVVAIK------------HIYKSNNTDSFSRE 110
F R + G++Y+ P Q ++K + ++ +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 111 VEGLSRVRHPNLVCLFGCCVEGGE-QYLVYEFCAAGNLAQHLLRKD-----SVLTWERRV 164
+ L + G V + ++LV G Q L S + V
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS----V 161
Query: 165 KILRDCAL-ALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK--LSDFGLAK 212
+ L AL +LH VH ++ NI + + + + L+ +G A
Sbjct: 162 LQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.82 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.84 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.27 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.0 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.13 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.19 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.27 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=413.84 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=209.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.+. ++..||||++..... .+.|.+|+++|++++||||++++|++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667788999999999999853 477899999976433 3579999999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 138 VYEFCAAGNLAQHLLRK------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
||||+++|+|.+++... ...+++..++.++.|+++||.||| +++|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 246999999999999999999999 789999999999999999999999
Q ss_pred eecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhc
Q 040826 206 SDFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+|||+++......... .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... .+ ....+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~----~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NE----VIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HH----HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHH
Confidence 9999998764333222 233468999999999999999999999999999999999 8999875322 12 222222
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.+... ..+..+++++.+|+.+||+.||++|||+.+|.+.|+++.+.
T Consensus 245 ~~~~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 QGRVL-----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22211 11223446899999999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-59 Score=407.59 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=202.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+++...++||+|+||.||+|.+.+ .||||.+..... .+.|.+|+.++++++||||++++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456677889999999999999753 589999865332 2468899999999999999999998754 568999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc-cc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-SK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 220 (347)
+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999877778999999999999999999999 7899999999999999999999999999998754322 22
Q ss_pred eeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
......||+.|||||++.+ .+|+.++|||||||++|||+||+.||................... |.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----------p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----------PDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----------CCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----------CCc
Confidence 3455679999999999864 468999999999999999999999997533222222222221111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
. ....++++++.+|+.+||+.||++|||+.||++.|+.+
T Consensus 260 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 S-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp T-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred c-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 12223456899999999999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=414.57 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=204.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
+++...++||+|+||.||+|.+. +++.||||++..... .+.|.+|+++|++++|||||+++|++.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666788999999999999853 478899999976433 3579999999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 138 VYEFCAAGNLAQHLLRK--------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
||||+++|+|.+++... ..++++.+++.++.|++.||.||| +++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999998653 245899999999999999999999 7899999999999999999999
Q ss_pred EEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhh
Q 040826 204 KLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARD 281 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 281 (347)
||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~---- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDC---- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HHHHHH----
Confidence 9999999987643322 22344679999999999999999999999999999999999 8999875332 122222
Q ss_pred hcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+..+.+. ..+..+++++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 273 i~~g~~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGREL-----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCC-----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCC-----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2222211 11223446799999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=410.89 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=207.3
Q ss_pred CcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++...++||+|+||.||+|.+. +++.||||++.... ..+.|.+|+.++++++||||++++|++.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3445678999999999999862 46789999997543 24579999999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc
Q 040826 138 VYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~ 202 (347)
||||+++|+|.+++... ...+++..+++++.|+++||.||| +++++||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 99999999999999542 235899999999999999999999 789999999999999999999
Q ss_pred eEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHh
Q 040826 203 PKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~ 280 (347)
+||+|||+++....... ...+...||+.|+|||++.+..|+.++|||||||++|||+| |..||..... .+. ..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~----~~ 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDV----VE 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHH----HH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHH----HH
Confidence 99999999987643322 22345679999999999999999999999999999999998 8889874322 222 22
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.+..+... +.+.+++.++.+|+.+||+.||++||||.||++.|+..
T Consensus 259 ~i~~~~~~-----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVL-----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222211 12224456899999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=408.16 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=201.2
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788899999999999999995 4799999999975432 3468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|++||+|.+++... ...+++..++.++.|++.||.||| ++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999653 456899999999999999999999 789999999999999999999999999999876421 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... +.+. .+..+..+ ..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~----~i~~~~~~-------~~-- 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVL----KIISGSFP-------PV-- 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH----HHHHTCCC-------CC--
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHH----HHHcCCCC-------CC--
Confidence 2234567999999999999999999999999999999999999999754322 2222 22222211 11
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.++.+|+.+||++||++|||+.|+++
T Consensus 246 --~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 --SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123357999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=403.12 Aligned_cols=254 Identities=24% Similarity=0.249 Sum_probs=207.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.|...++||+|+||.||+|.. .+|+.||||++..... ..+|+.++++++|||||++++++.+++..|+||||++|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 4566778899999999999995 4799999999975433 24799999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCCCccc---
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESK--- 220 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~--- 220 (347)
|+|.+++.+.+ .+++..+..++.|++.||.||| +++|+||||||+|||++.+| .+||+|||+++........
T Consensus 135 g~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 135 GSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999997544 5999999999999999999999 89999999999999999987 5999999999876432211
Q ss_pred -eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 -VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......||+.|||||++.+..|+.++|||||||++|||+||+.||....... ....+.. +..+..
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~----~~~~~~--------- 276 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIAS----EPPPIR--------- 276 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHH----SCCGGG---------
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHc----CCCCch---------
Confidence 1233579999999999999999999999999999999999999997543221 1111111 111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.++....+++.+++.+||++||.+|||+.|+++.|...+++
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 11223346799999999999999999999999999988765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-57 Score=400.42 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=206.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..|...++||+|+||.||+|... +|+.||||++... ...+.+.+|+.+|++++||||+++++++.+++..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999964 7999999998643 34567889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++|+|.+++.+ ..+++..+..++.|++.||.||| ++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcc
Confidence 99999998865 35899999999999999999999 789999999999999999999999999999876432 2334
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+.+..+... ..+ .+ ...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~----~~~-------~~--~~~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDN----LPP-------RL--KNL 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHS----SCC-------CC--SCG
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcC----CCC-------CC--Ccc
Confidence 567899999999999999999999999999999999999999975432 2222222211 111 00 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+++.+|+.+||++||++|||+.|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 123357999999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=405.66 Aligned_cols=270 Identities=25% Similarity=0.354 Sum_probs=218.0
Q ss_pred ccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCC------CCEEEEEEcccCCCh---hHHHHHHHHhhcCCC-Ccceee
Q 040826 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPS------GQVVAIKHIYKSNNT---DSFSREVEGLSRVRH-PNLVCL 125 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h-~niv~~ 125 (347)
++.++++...++|...+.||+|+||.||+|.+.. ++.||||.+...... ..+.+|+.+|+++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445666667889999999999999999998532 357999999765443 468899999999965 899999
Q ss_pred eeEEEeC-CeEEEEEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCC
Q 040826 126 FGCCVEG-GEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189 (347)
Q Consensus 126 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 189 (347)
+|+|.+. +..++|||||++|+|.+++... ...+++..+..++.|++.||.||| +++++|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9998764 5689999999999999999642 245899999999999999999999 78999999
Q ss_pred CCCCCEEecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCC
Q 040826 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIEL 267 (347)
Q Consensus 190 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~ 267 (347)
|||+|||+++++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987643332 23445678999999999999999999999999999999998 8999875
Q ss_pred ChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 268 DFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
...... +..... .+.+. ..+..+++++.+++.+||+.||++|||+.||+++|+++++.+.-
T Consensus 291 ~~~~~~-~~~~i~---~g~~~-----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 291 VKIDEE-FCRRLK---EGTRM-----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp CCCSHH-HHHHHH---HTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred CCHHHH-HHHHHH---cCCCC-----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 332222 222221 12111 11122346799999999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=400.22 Aligned_cols=271 Identities=22% Similarity=0.270 Sum_probs=202.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChh-HHHHHHHHhhcCCCCcceeeeeEEEeCC----eEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD-SFSREVEGLSRVRHPNLVCLFGCCVEGG----EQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 140 (347)
++|...+.||+|+||.||+|.+ +|+.||||++....... ....|+..+.+++||||+++++++.+++ ..++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4566778899999999999998 68999999996543322 2334666677889999999999998653 5799999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI-----DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|+++|+|.+++... .+++..+.+++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999653 5899999999999999999999431 2389999999999999999999999999998764
Q ss_pred CCccc---eeecccCCCCccccccccCC------ccCCcccHHHHHHHHHHHHhCCCCcCCChhh----------hhHHH
Q 040826 216 MEESK---VFTDVRGTIGYMDPEYMTNA------KLTCASDIYSFGIVALQLLSGQKVIELDFDA----------RDQLT 276 (347)
Q Consensus 216 ~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----------~~~~~ 276 (347)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||.+|+...... .....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 33222 12345799999999998754 4788999999999999999998876432111 11112
Q ss_pred HHHhhhcCCCCCcccccCCCCCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNG-NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~~ 345 (347)
.......... .+|.+.. ....+....+.+|+.+||+.||++||||.||++.|+++.++..++|
T Consensus 240 ~~~~~~~~~~------~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ik~ 303 (303)
T 3hmm_A 240 EMRKVVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303 (303)
T ss_dssp HHHHHHTTSC------CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHHHHhccc------CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 2222221111 1111111 1123566789999999999999999999999999999987665543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=393.19 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=207.1
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|.. .+|+.||+|.+.+. .....+.+|+++|++++||||+++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999995 57999999998642 34567899999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc-
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE- 218 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 218 (347)
||++||+|.+++.+. +.+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999754 45999999999999999999999 7899999999999999999999999999999875332
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||...... . ....+..+.....
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~----~~~~i~~~~~~~p-------- 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-L----IFAKIIKLEYDFP-------- 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHHTCCCCC--------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHcCCCCCC--------
Confidence 22345678999999999999999999999999999999999999999754321 1 2222222222111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~ 331 (347)
..+ .+++.+|+.+||++||++|||++|++
T Consensus 255 ~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122 35689999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=383.10 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=191.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|++++++++||||+++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36788999999999999999995 479999999986532 234688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+ +|+|.+++.+. ..+++..+..++.|++.||+||| ++||+||||||+|||+++++.+||+|||+++....
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 9999 56999998664 45999999999999999999999 78999999999999999999999999999987532
Q ss_pred cceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...... ...+.+..+..+..
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~~i~~~~~~~p------- 232 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFKNISNGVYTLP------- 232 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCCCCC-------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCCCC-------
Confidence 223445689999999999998876 57999999999999999999999754221 22222222222211
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+ ++++.+|+.+||++||++|||++|+++
T Consensus 233 -~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 -KFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122 357899999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=387.66 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=195.2
Q ss_pred ccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeEEEEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQYLVY 139 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 139 (347)
...++||+|+||.||+|... ++..||+|.+..... .+.+.+|+.++++++||||+++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999954 689999999865432 3468899999999999999999999875 34689999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEecC-CCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~ 216 (347)
||+++|+|.+++.+. ..+++..+..++.|++.||+||| +++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 999999999999654 45899999999999999999999 666 999999999999984 7899999999998643
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
........||+.|||||++.+ +|+.++|||||||++|+|+||+.||........ ..+.+..+..+. .
T Consensus 184 --~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~~i~~~~~~~------~ 250 (290)
T 3fpq_A 184 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPA------S 250 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCCCG------G
T ss_pred --CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HHHHHHcCCCCC------C
Confidence 223445689999999998875 699999999999999999999999964332222 222222222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+ +++.+|+.+||++||++|||+.|+++
T Consensus 251 ~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222 46899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=401.23 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=206.4
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+.|...+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.+|+.++||||+++++++.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4588889999999999999995 47999999998654 33457899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+||+|.+++... .+++..+..++.|++.||.||| ++||+||||||+|||++.+|.+||+|||++..+... ....
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 304 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 304 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCB
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cccc
Confidence 999999988543 4899999999999999999999 789999999999999999999999999999876432 2334
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.+..+... ..+ .+ ...
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~----~~~-------~~--~~~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN----LPP-------RL--KNL 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS----CCC-------CC--SCT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcC----CCC-------CC--ccc
Confidence 5668999999999999999999999999999999999999999754322 222222211 111 00 001
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....++.+|+.+||++||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122357999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-56 Score=388.31 Aligned_cols=245 Identities=27% Similarity=0.306 Sum_probs=196.2
Q ss_pred cCcccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+|++++++++||||+++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5688889999999999999984 257899999986532 23467889999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||++||+|.+++.+.+ .+++..+..++.|++.||.||| ++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999997644 5999999999999999999999 789999999999999999999999999999865322
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... +.+. .+..+..+..
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~----~i~~~~~~~p------- 246 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMT----MILKAKLGMP------- 246 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHHCCCCCC-------
T ss_pred -CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHH----HHHcCCCCCC-------
Confidence 22344568999999999999999999999999999999999999999754322 2222 2222222111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTI-----DVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~ei~~ 332 (347)
...++++.+|+.+||++||++|||+ +|+++
T Consensus 247 -----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 247 -----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1123578999999999999999995 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=376.33 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=187.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCC-------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGG------- 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 133 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... .+.+.+|+.+|++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35688889999999999999995 4799999999865443 246889999999999999999999987544
Q ss_pred -----eEEEEEeecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 134 -----EQYLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 134 -----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
..|+||||+++|+|.+++.... ....+..++.++.|+++||+||| ++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997543 23566778899999999999999 7899999999999999999999999
Q ss_pred ecccceecCCCccc-----------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHH
Q 040826 207 DFGLAKMLGMEESK-----------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQL 275 (347)
Q Consensus 207 dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~ 275 (347)
|||+++........ ......||+.|||||++.+..|+.++|||||||++|||++ ||........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~-- 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR-- 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH--
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH--
Confidence 99999876432211 1234579999999999999999999999999999999996 6653222111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..........+ .......+...+|+.+||++||.+|||+.|+++
T Consensus 236 --~~~~~~~~~~p-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 --TLTDVRNLKFP-----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --HHHHHHTTCCC-----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHhcCCCC-----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122111111 011123356788999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=373.95 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=205.9
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 135 (347)
+....++|...+.||+|+||.||+|+.+ +++.||+|.+........+.+|+++++.+ +||||+++++++.+.+..
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3345678999999999999999999842 56789999998877777889999999998 699999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeecccceec
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKML 214 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 214 (347)
++||||+++|+|.+++. .+++..+..++.|++.||.||| ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999883 4899999999999999999999 8899999999999999876 79999999999865
Q ss_pred CCCcc---------------------------ceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 215 GMEES---------------------------KVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 215 ~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
..... .......||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 32211 112345799999999999875 58999999999999999999999997
Q ss_pred CChhhhhHHHHHHhhhcC-----------------CCCCcc------------cccCCCCCC---------CCCHHHHHH
Q 040826 267 LDFDARDQLTRKARDVSM-----------------GKRPIK------------DFEDPRLNG---------NINRADFES 308 (347)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~------------~~~~~~l~~---------~~~~~~~~~ 308 (347)
...+..+++..+...... ...+.. ....|.+.. .......++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 665554444433321100 000000 000000000 000112357
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 040826 309 ILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 309 l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+|+.+||+.||.+|||++|+++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc
Confidence 889999999999999999999886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=370.44 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=201.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe------CCe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE------GGE 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 134 (347)
++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.+|++++||||+++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788899999999999999995 4799999999976433 2357789999999999999999998764 357
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.|+||||++ |+|.+++... ..+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||+++.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999997 5899988654 46999999999999999999999 889999999999999999999999999999875
Q ss_pred CCCc---cceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 215 GMEE---SKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 215 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.... ........||+.|+|||++.+. .++.++||||+||++|||++|++||.... ..+.+..+............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChHHh
Confidence 4321 2234456899999999998875 57899999999999999999999997543 23333333333221111000
Q ss_pred ccc------------CCCCCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFE------------DPRLNGN---INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~------------~~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... .+..... .......++.+|+.+||..||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000 00112357889999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=357.34 Aligned_cols=286 Identities=35% Similarity=0.589 Sum_probs=240.4
Q ss_pred CCCcccccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeee
Q 040826 50 WSGLYRFSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLF 126 (347)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~ 126 (347)
......|+..++....++|...+.||+|+||.||+|...+|+.||+|++.... ....+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 34567789999999999999999999999999999998889999999997643 234688999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 127 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
+++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+..|++|+||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999999753 3459999999999999999999995333399999999999999999999
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh---hhhHHHHHHh
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD---ARDQLTRKAR 280 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~---~~~~~~~~~~ 280 (347)
+|+|||++...............||..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......+..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999998754444445556799999999999988999999999999999999999999963211 1111222333
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
... .........+..+......+....+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 222 2234556667777778889999999999999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=382.09 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=209.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+..... .+.+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46788999999999999999995 4799999999876432 45688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC--CceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK--LEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~--~~~kl~dfg~~~~~~~~~~ 219 (347)
++||+|.+++......+++..+..++.|++.||.||| +++|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999999776677999999999999999999999 7899999999999999854 89999999999987532
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..|+.++|||||||++|+|++|..||...... +.+.. +......... ....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~----i~~~~~~~~~----~~~~ 381 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRN----VKSCDWNMDD----SAFS 381 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH----HHTTCCCCCS----GGGT
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHH----HHhCCCCCCc----cccc
Confidence 3344567999999999999999999999999999999999999999754322 22222 2222211111 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+ .+++.+|+.+||+.||.+|||+.|+++
T Consensus 382 ~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 356889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=356.53 Aligned_cols=280 Identities=36% Similarity=0.604 Sum_probs=231.1
Q ss_pred ccHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCC
Q 040826 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGG 133 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 133 (347)
++..+++..+++|...+.||+|+||.||+|...+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 333445556789999999999999999999988899999999876543 357889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccc
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKD---SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999986543 35899999999999999999999 78999999999999999999999999999
Q ss_pred ceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh-hHHHHHHhhhcCCCCC
Q 040826 211 AKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR-DQLTRKARDVSMGKRP 288 (347)
Q Consensus 211 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 288 (347)
+........ .......||..|+|||.+.+..++.++||||||+++|+|++|+.||....... .....+.... .....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-ccccc
Confidence 987542222 22233458999999999988899999999999999999999999997543221 1111111111 11223
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 289 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.....++.+......+....+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 455666777777888999999999999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=375.03 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=199.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHH---HHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSRE---VEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++.+. .......+| +.+++.++||||+++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46788999999999999999995 47999999998643 223333444 5677788999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|+||||++||+|.+++.+. +.+++..+..++.|++.||.||| ++||+||||||+|||++.+|.+||+|||+|....
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999764 45999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCccceeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. .....+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||....... .....+.+........
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCCCCCC----
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCCCCCC----
Confidence 32 234568999999999996 4679999999999999999999999997532211 1122222222221111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
.. ...++.+|+.+||++||.+|++ +.||.+
T Consensus 415 ----~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 ----DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----TT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----cc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 12 2357899999999999999998 567654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=341.67 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=215.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|...+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 5677888999999999999998888999999997654 456789999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.............
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9999999877777999999999999999999999 7899999999999999999999999999998654333333344
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ...+..+... ..+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~----~~~~~~~~~~-----------~~~~ 230 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EV----VEDISTGFRL-----------YKPR 230 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HH----HHHHHTTCCC-----------CCCT
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HH----HHHHhcCccC-----------CCCC
Confidence 557788999999998899999999999999999999 88888743322 11 1222211111 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.....+.+++.+||+.||.+|||+.++++.|+++.+.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 12357999999999999999999999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=335.65 Aligned_cols=280 Identities=30% Similarity=0.528 Sum_probs=229.6
Q ss_pred CcccccHHHHHHHhcCcccC------CeeeecCCeeEEEEEeCCCCEEEEEEcccCC------ChhHHHHHHHHhhcCCC
Q 040826 52 GLYRFSKDEIENAINNDWDR------RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN------NTDSFSREVEGLSRVRH 119 (347)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~h 119 (347)
....|+..++..++++|... +.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45778999999999999887 8999999999999997 68899999986532 13468899999999999
Q ss_pred CcceeeeeEEEeCCeEEEEEeecCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 120 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
|||+++++++.+.+..+++|||+++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999864 3456999999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLT 276 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~ 276 (347)
+.++.++|+|||++......... ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...... ....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHH
Confidence 99999999999999876432222 2334568999999998876 5889999999999999999999999754322 1112
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.+...............++.+ ........+.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222222223333334444433 2456678889999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=336.50 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=213.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|...++..||+|.+.... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 45778889999999999999998888899999997654 45678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++...+..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++............
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999776667999999999999999999999 789999999999999999999999999999876544433344
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ..+.... .+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~----~~~~~~~----~~------- 227 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKV----SQGHRLY----RP------- 227 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHH----HTTCCCC----CC-------
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-HHHHHH----HcCCCCC----CC-------
Confidence 4556778999999999899999999999999999999 99888643322 111111 1111110 01
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
....+.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112257999999999999999999999999998873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=343.74 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=209.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56777889999999999999964 68999999886543 2356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce-
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV- 221 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~- 221 (347)
++++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999876777999999999999999999999 7899999999999999999999999999998764322211
Q ss_pred ------------eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH----HHHHHhhhcCC
Q 040826 222 ------------FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ----LTRKARDVSMG 285 (347)
Q Consensus 222 ------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~----~~~~~~~~~~~ 285 (347)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..|+......... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~---- 242 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR---- 242 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----
Confidence 11456899999999999999999999999999999999999988643221110 0111100
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
. .+..+++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 243 ----------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 ----------Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0112224689999999999999999999999999998543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=344.28 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=209.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... .+..||+|.+..... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999964 344699999976533 3468899999999999999999999999889999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++++|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999777677999999999999999999999 789999999999999999999999999999876533
Q ss_pred ccc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 218 ESK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 218 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
... ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....... +...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~----~~~~------ 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVEE----GYRL------ 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHT----TCCC------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHc----CCCC------
Confidence 222 1223346778999999998899999999999999999999 99998643222 11121111 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+..+...+.+++.+||+.||.+|||+.+|++.|+.++++.
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111123367999999999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=338.67 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=212.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||++...++..||+|.+.... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 45778889999999999999999888899999997654 45678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++............
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999999775667999999999999999999999 789999999999999999999999999999865433333333
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ........ +... ..+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~----~~~~-----------~~~ 243 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQ----GLRL-----------YRP 243 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHT----TCCC-----------CCC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhc----ccCC-----------CCC
Confidence 4456788999999998889999999999999999998 99998743322 22222211 1111 001
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
....+.+.+++.+||+.||.+|||+.++++.|++++++.
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 112257999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=339.50 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=203.9
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
+....++|...+.||+|+||.||+|.. +|+.||+|.+...... ..+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 333467888899999999999999987 6889999998765422 35789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEecCCCceEEeecccce
Q 040826 137 LVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999997543 24899999999999999999999 778 9999999999999999999999999997
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
.... .........||..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........ ....
T Consensus 188 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~--~~~~----- 258 (309)
T 3p86_A 188 LKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFK--CKRL----- 258 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHHS--CCCC-----
T ss_pred cccc-cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc--CCCC-----
Confidence 6432 2222344578999999999999999999999999999999999999997543221 11111111 1110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+.....++.+++.+||+.||.+|||+.++++.|+.++++.
T Consensus 259 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 -------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111223357999999999999999999999999999997653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=334.31 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=206.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46788899999999999999994 57899999998643 3456788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++|+|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 9999999998654 5899999999999999999999 7899999999999999999999999999998764322 23
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....||..|+|||.+.+..++.++||||||+++|+|++|..||........ ........ .... ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---~~~~----------~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNG---TPEL----------QN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHC---SCCC----------SC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC---CCCC----------CC
Confidence 3456799999999999999999999999999999999999999975433222 11111111 1000 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+......+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123357999999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=348.42 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=210.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC--------CCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEG 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||+|... ++..||+|.+...... ..+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999852 3457999999765432 4688999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| ++|++||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999996543 35899999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 99999999999999876432221 2233456789999999999999999999999999999999 8888864322 1211
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
... ..+... ..+..+..++.+++.+||+.||.+|||+.|+++.|++++.-..
T Consensus 316 ~~~----~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 316 KLL----KEGHRM-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHH----HTTCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH----hcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111 111110 1112334679999999999999999999999999999986543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=351.66 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=209.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+...... ..+.+|+.++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456778889999999999999975 7899999998765332 367899999999999999999999998889999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++|+|.+++...+..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999876667999999999999999999999 789999999999999999999999999999865322211
Q ss_pred ee-ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 221 VF-TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 221 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... . .... +..+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-~-~~~~---~~~~~~~---------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-Q-TREF---VEKGGRL---------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-H-HHHH---HHTTCCC----------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-H-HHHH---HHcCCCC----------
Confidence 11 11235678999999998899999999999999999998 88888643221 1 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
..+..+++++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 335 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1111234679999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=333.27 Aligned_cols=262 Identities=18% Similarity=0.182 Sum_probs=215.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+........+.+|+..++.+ +|+|++++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 35688889999999999999995 578999999998777777899999999999 7999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc-----eEEeecccceecCCC
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE-----PKLSDFGLAKMLGME 217 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~-----~kl~dfg~~~~~~~~ 217 (347)
+++|.+++...+..+++..++.++.|++.||.||| +.|++||||||+||+++.++. ++|+|||++......
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 88999999876677999999999999999999999 889999999999999987776 999999999876533
Q ss_pred cc------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh--hhhHHHHHHhhhcCCCCCc
Q 040826 218 ES------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD--ARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 218 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 289 (347)
.. .......||..|+|||.+.+..++.++||||||+++|+|++|+.||..... ................ .
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~ 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP--L 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--H
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc--H
Confidence 22 123445699999999999999999999999999999999999999976322 1111222111111100 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.. +.. ..++++.+++.+||+.||.+|||+.+|++.|++++++.
T Consensus 243 ~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 243 RE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00 001 22357999999999999999999999999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=332.36 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=213.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|...+++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 5677888999999999999998888999999997654 456789999999999999999999999998999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999999877677999999999999999999999 7899999999999999999999999999998654322222334
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ....+..+... ..+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~----~~~~i~~~~~~-----------~~~~ 228 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-E----VVEDISTGFRL-----------YKPR 228 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H----HHHHHHTTCCC-----------CCCT
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-H----HHHHHhcCCcC-----------CCCc
Confidence 457788999999998889999999999999999999 88888743221 1 11222222111 0011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.....+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 12357999999999999999999999999999997653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=337.35 Aligned_cols=263 Identities=26% Similarity=0.345 Sum_probs=206.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCC----eEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGG----EQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 140 (347)
++|...+.||+|+||.||+|... |+.||+|++..... ......|+..+++++||||+++++++.... ..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 56778889999999999999974 79999999865432 234566888899999999999999998744 4799999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC----------CceeCCCCCCCEEecCCCceEEeeccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG----------CIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~----------~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
|+++|+|.+++... .+++..++.++.|++.||.||| +. +++||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999653 4899999999999999999999 67 999999999999999999999999999
Q ss_pred ceecCCCccc-eeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhh-----------h
Q 040826 211 AKMLGMEESK-VFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDAR-----------D 273 (347)
Q Consensus 211 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~-----------~ 273 (347)
+......... ......||..|+|||.+.+ ..++.++||||||+++|+|+||+.||....... .
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9876433222 2333578999999999986 456778999999999999999999997532210 0
Q ss_pred HHHHHHhhhcCCCCCcccccCCCCCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 274 QLTRKARDVSMGKRPIKDFEDPRLNGN-INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
............. ..+.+... ......+++.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 258 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKK------KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSC------CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhccc------CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111111 01111111 1224567899999999999999999999999999999654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=346.67 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=200.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... ++..||+|.+..... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888899999999999999854 577899999976533 3468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++...+..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999877777999999999999999999999 789999999999999999999999999999876432
Q ss_pred ccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 218 ESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 218 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +...........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i~~~~~~---------- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAVDEGYRL---------- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHHHTTEEC----------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCC----------
Confidence 2211 122335778999999998899999999999999999998 99998643221 111111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.....+...+.+++.+||+.||.+|||+.+|++.|+.++++.
T Consensus 270 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 270 -----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111123467999999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=337.68 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788889999999999999996 5899999999865432 245779999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 999999999998654 35899999999999999999999 789999999999999999999999999999865422
Q ss_pred ceeecccCCCCccccccccCCccC-CcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLT-CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||+.|+|||.+.+..++ .++||||||+++|+|++|+.||...... .....+..+....+.
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~p~------- 235 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-----ELRERVLRGKYRIPF------- 235 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCCT-------
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCCCC-------
Confidence 223456799999999999887765 7899999999999999999999754322 112222222211111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....++.+|+.+||+.||.+|||+.|+++.
T Consensus 236 -----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 -----YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 123568899999999999999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.49 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=211.6
Q ss_pred cccccHHHHHHHhcC----------cccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCC
Q 040826 53 LYRFSKDEIENAINN----------DWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRH 119 (347)
Q Consensus 53 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h 119 (347)
...++.++++.+++. |...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345788888887764 556678999999999999965 79999999986543 34568899999999999
Q ss_pred CcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 120 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
|||+++++++...+..++||||+++++|.+++.+ ..+++..+..++.|++.||.||| +.|++||||||+||+++.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998854 45899999999999999999999 789999999999999999
Q ss_pred CCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHH
Q 040826 200 KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 200 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~ 279 (347)
++.+||+|||++...... ........||..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 177 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~~~~~ 254 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLR 254 (321)
T ss_dssp TCCEEECCCTTCEECCSS-SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHH
T ss_pred CCcEEEeeeeeeeecccC-ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh
Confidence 999999999999876432 22234557999999999999999999999999999999999999999754322 1111111
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
. ...+ .+ .........+.+++.+||+.||.+|||+.++++.
T Consensus 255 ~----~~~~-------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 D----SPPP-------KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H----SSCC-------CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c----CCCC-------Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111 00 0011223579999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=341.88 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=205.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCCh--hHHHHHHHHhhcCCCCcceeeeeEEEe--CCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 135 (347)
.++|...+.||+|+||.||+|.+ .+|+.||+|++...... ..+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35677889999999999999984 36889999998765432 468899999999999999999999864 3568
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++||||+++|+|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999776667999999999999999999999 7899999999999999999999999999998764
Q ss_pred CCcc--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh-----------HHHHHHhhh
Q 040826 216 MEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD-----------QLTRKARDV 282 (347)
Q Consensus 216 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~-----------~~~~~~~~~ 282 (347)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+..+..... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 3221 122334567789999999988999999999999999999999998864322110 000111111
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
..+.. ...+..+++++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 246 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 246 KNNGR-----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HTTCC-----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hccCc-----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11110 112223446899999999999999999999999999999654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=352.35 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=209.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCC-eEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG-EQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|.+. |+.||||.+......+.+.+|+.++++++||||+++++++.... ..++||||++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 567888899999999999999984 78999999988777788999999999999999999999987765 7899999999
Q ss_pred CCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRKDS-VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|+|.+++...+. .+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++..... .
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 343 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 343 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----c
Confidence 9999999976543 4799999999999999999999 789999999999999999999999999999864321 1
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+....... +... ..
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~----~~~~-----------~~ 407 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEK----GYKM-----------DA 407 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-TTHHHHHHT----TCCC-----------CC
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc----CCCC-----------CC
Confidence 22357889999999999999999999999999999998 9998864322 122222211 1110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 223346899999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=336.25 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=205.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+|+..+++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35688889999999999999995 4789999998854322 24678999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999986543 5899999999999999999999 7899999999999999999999999999998764333
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||........... ...........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~------- 234 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK----HIQDSVPNVTT------- 234 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH----HHSSCCCCHHH-------
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HhhccCCCcch-------
Confidence 3334445789999999999999999999999999999999999999976543322211 11111111100
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHh
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP-TIDVVYEEIDKAWKN 340 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~ei~~~l~~~~~~ 340 (347)
......+..+.+++.+||+.||.+|| +++++.+.|+.++.+
T Consensus 235 -~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 -DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11112335799999999999999998 999999999887644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=346.03 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=214.3
Q ss_pred ccHHHHHHHhcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceee
Q 040826 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCL 125 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~ 125 (347)
+....++...++|...+.||+|+||.||+|.+ .+++.||+|.+...... ..+.+|+.+++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555678899999999999999999973 24678999999765443 3588999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEeecCCCChHHHhhcCCC------------------------------------------------
Q 040826 126 FGCCVEGG-EQYLVYEFCAAGNLAQHLLRKDS------------------------------------------------ 156 (347)
Q Consensus 126 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 156 (347)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988754 48999999999999999965422
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 157 -----------------VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 157 -----------------~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
.+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 2889999999999999999999 78999999999999999999999999999986543222
Q ss_pred -ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 220 -KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 220 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.................. .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~------------ 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-M------------ 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-C------------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-C------------
Confidence 22344567889999999999899999999999999999998 99998754333222222111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+.....++.+++.+||+.||.+|||+.+++++|++++++.
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 011122357999999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=332.25 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=199.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|.... +..||+|....... .+.+.+|+..+++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4577888999999999999998642 45799999876433 346889999999999999999999974 567899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876433
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....... +...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~~----~~~~-------- 236 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIEN----GERL-------- 236 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT----TCCC--------
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHHc----CCCC--------
Confidence 3323333456788999999998889999999999999999997 88888754322 22222211 1110
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+......+.+++.+||+.||.+|||+.++++.|++++++..
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111233679999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=334.77 Aligned_cols=250 Identities=20% Similarity=0.231 Sum_probs=207.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|... +|+.+|+|.+..... ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 467888899999999999999964 688999999875432 346789999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC--CCceEEeecccceecCCCccc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE--KLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~~~~~~~~ 220 (347)
++|+|.+++......+++..++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||++...... .
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~ 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--D 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--C
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--C
Confidence 999999999776667999999999999999999999 789999999999999997 789999999999876432 2
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.. +........ ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~----~~~~~~~~~----~~- 228 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMN----AEYTFDEEA----FK- 228 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHH----TCCCCCHHH----HT-
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHc----CCCCCChhh----hc-
Confidence 334567899999999999988999999999999999999999999754322 11222221 111111000 00
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....++.+++.+||+.||.+|||+.|+++
T Consensus 229 ---~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 ---EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12357999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.44 Aligned_cols=261 Identities=16% Similarity=0.119 Sum_probs=213.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+........+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 35788889999999999999995 578999999998776677899999999999 8999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc-----eEEeecccceecCCC
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE-----PKLSDFGLAKMLGME 217 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~-----~kl~dfg~~~~~~~~ 217 (347)
+++|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++. ++|+|||++......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 88999999776677999999999999999999999 789999999999999999887 999999999876432
Q ss_pred ccc------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCc
Q 040826 218 ESK------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 218 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 289 (347)
... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......+........ .
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~--~ 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--I 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC--H
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC--H
Confidence 221 124567999999999999999999999999999999999999999753211 111111111110000 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
. .. ....+ ++.+++.+||+.||.+||++.+|.+.|+++++..
T Consensus 242 ~-~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 E-VL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H-HH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-HH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 00 00122 7999999999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=336.36 Aligned_cols=249 Identities=26% Similarity=0.335 Sum_probs=204.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888899999999999999965 689999999875432 35688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~ 211 (347)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999654 46999999999999999999999 78999999999999998877 7999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .... .+..+......
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~----~i~~~~~~~~~ 239 (361)
T 2yab_A 167 HEIED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----NITAVSYDFDE 239 (361)
T ss_dssp EECCT--TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH----HHHTTCCCCCH
T ss_pred eEcCC--CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHhcCCCCCc
Confidence 87643 22334567999999999999999999999999999999999999999754322 1122 22222111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ...+++.+|+.+||..||.+|||+.|+++
T Consensus 240 ----~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 240 ----EFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----hhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001 12357899999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.54 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=211.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCC--eEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG--EQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46778889999999999999965 5899999998753 33467889999999999999999999988755 789999
Q ss_pred eecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe----cCCCceEEeeccccee
Q 040826 140 EFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----TEKLEPKLSDFGLAKM 213 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----~~~~~~kl~dfg~~~~ 213 (347)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997533 34899999999999999999999 7899999999999999 7788899999999987
Q ss_pred cCCCccceeecccCCCCcccccccc--------CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh---hHHHHHHhhh
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMT--------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR---DQLTRKARDV 282 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~---~~~~~~~~~~ 282 (347)
.... .......||..|+|||.+. +..++.++||||||+++|+|++|+.||....... ..........
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 6432 2233456899999999886 5688999999999999999999999997433222 2222222221
Q ss_pred cCCCC---------CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 283 SMGKR---------PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 283 ~~~~~---------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
..... .....................+.+++.+||+.||++|||+.|+++...+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11100 00000011112245678888999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=331.23 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=211.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|...++..||+|.+.... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 46788889999999999999998888899999987643 4567899999999999999999999876 456899999999
Q ss_pred CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||++++++.++|+|||.+...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999986532 36899999999999999999999 78999999999999999999999999999988654433333
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +..... ..+... ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~----~~~~~~-----------~~ 231 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL----ERGYRM-----------VR 231 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH----HTTCCC-----------CC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHH----hcccCC-----------CC
Confidence 44557889999999998889999999999999999999 88888643221 111111 111110 01
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.....+++.+++.+||+.||.+|||+.++++.|++++...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1122357999999999999999999999999999997653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=327.02 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=208.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 56888899999999999999964 689999999875432 2467899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++ +|.+.+......+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9987 777777666677999999999999999999999 789999999999999999999999999999876422 22
Q ss_pred eeecccCCCCccccccccCCc-cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc-cc-------
Q 040826 221 VFTDVRGTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI-KD------- 291 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~------- 291 (347)
......+|..|+|||.+.+.. ++.++||||||+++|+|++|..|+.......+.+....+......... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 334457899999999998765 899999999999999999999887655555555554444322211100 00
Q ss_pred -----ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 -----FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 -----~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
................++.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000001112234467899999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=355.35 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=210.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..++|...+.||+|+||.||+|.+.++..||||.+.... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 356778889999999999999999888999999997643 4568999999999999999999999976 66789999999
Q ss_pred CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++|+|.+++... ...+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999753 236889999999999999999999 7899999999999999999999999999998764332222
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+........... .
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~~~~~---------------~ 405 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALERGYRM---------------P 405 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHHTCCC---------------C
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC---------------C
Confidence 334456788999999998889999999999999999999 9999874322 2222222221111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.+..+++++.+++.+||+.||++|||+.+|++.|++++.
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 112334679999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.10 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=210.9
Q ss_pred HHHHHHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEe
Q 040826 58 KDEIENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVE 131 (347)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 131 (347)
..++....++|...+.||+|+||.||+|... +|+.||+|++... .....+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455788999999999999999999965 5789999998642 334458899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.+..++||||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876677999999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
...............||+.|+|||++. +..++.++||||||+++|||++|+.||...... +....+........
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKERFQ 301 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhcccccc
Confidence 876544444444567999999999987 567999999999999999999999999754322 22222222111000
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYE 332 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~ 332 (347)
. |.....+ .+++.+|+.+||..+|++ ||+++|+++
T Consensus 302 --~-----p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 --F-----PTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --C-----CSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --C-----CcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 1111122 257899999999888887 999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=332.08 Aligned_cols=247 Identities=26% Similarity=0.291 Sum_probs=204.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|..+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888899999999999999964 7899999998653 3456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... ..+++..++.++.|++.||.||| ++|++||||||+||+++.+|.+||+|||++..... .
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-D 158 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-T
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-C
Confidence 9999999999988654 45899999999999999999999 78999999999999999999999999999986432 2
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........||+.|+|||++.+..++.++|+||||+++|+|++|+.||...... .. ...+.......
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~----~~~i~~~~~~~--------- 224 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RL----FELILMEEIRF--------- 224 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHCCCCC---------
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HH----HHHHHcCCCCC---------
Confidence 22334567999999999999999999999999999999999999999754321 11 11121111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
+.....++.+|+.+||+.||.+|| ++.+|+++
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112235799999999999999999 89988763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=331.62 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|...+|+.||+|++..... ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467888899999999999999988899999999875432 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++ +|.+++......+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ..
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VR 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cc
Confidence 9986 898888777777999999999999999999999 789999999999999999999999999999876422 22
Q ss_pred eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-ccccc-----
Q 040826 221 VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IKDFE----- 293 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 293 (347)
......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+............. .....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2344568999999999876 56899999999999999999999999754332 2222222222111110 00000
Q ss_pred -C---CCCC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 -D---PRLN----GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 -~---~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. .... .........++.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000 0001122357899999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=330.68 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=208.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 135 (347)
++|...+.||+|+||.||+|.+ .+|+.||+|.+.... ....+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3466778899999999999983 368899999987543 346788999999999999999999999876 668
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999776677999999999999999999999 7899999999999999999999999999998765
Q ss_pred CCcc--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh----------hhHHHHHHhhhc
Q 040826 216 MEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA----------RDQLTRKARDVS 283 (347)
Q Consensus 216 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----------~~~~~~~~~~~~ 283 (347)
.... .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+..+... ............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 4332 2233456788899999999989999999999999999999999886533211 111122222222
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.+.. ...+....+++.+++.+||+.||.+|||+.++++.|++++
T Consensus 258 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKR-----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCC-----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 0112233467999999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.66 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=210.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC--------CCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEG 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||+|... ++..||+|++...... ..+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888899999999999999842 2357999999765443 4688999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999996543 45999999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
+.++.+||+|||++........ .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987643222 22333457889999999999999999999999999999999 8888864322 111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
...+..+... ..+.....++.+++.+||+.||.+|||+.+|++.|+.++...
T Consensus 303 ---~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 303 ---FKLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ---HHHHHTTCCC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ---HHHHHcCCCC-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1222222111 011122357999999999999999999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=329.06 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=203.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhc--CCCCcceeeeeEEEe----CCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSR--VRHPNLVCLFGCCVE----GGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. +|+.||+|++... ....+..|.+++.. ++||||+++++++.. ....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 46788889999999999999998 6899999998654 33455566666665 789999999998654 2468999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI-----DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||... +.+++||||||+||+++.++.+||+|||++..
T Consensus 85 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp ECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999999999943 46899999999999999999999422 46899999999999999999999999999986
Q ss_pred cCCCccce---eecccCCCCccccccccCC------ccCCcccHHHHHHHHHHHHhC----------CCCcCCChhhhhH
Q 040826 214 LGMEESKV---FTDVRGTIGYMDPEYMTNA------KLTCASDIYSFGIVALQLLSG----------QKVIELDFDARDQ 274 (347)
Q Consensus 214 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~lltg----------~~p~~~~~~~~~~ 274 (347)
........ .....||..|+|||.+.+. .++.++||||||+++|+|++| ..||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 54322221 2334789999999999876 566799999999999999999 7777643322222
Q ss_pred HHHHHhhhcCCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 275 LTRKARDVSMGKRPIKDFEDPRL-NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
............. .+.+ ..........++.+++.+||+.||.+|||+.+|++.|+++
T Consensus 243 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 FEDMRKVVCVDQQ------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHTTSCC------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhHHHhccCC------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222222111110 0011 0112335678899999999999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=326.43 Aligned_cols=249 Identities=30% Similarity=0.501 Sum_probs=202.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh---------hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT---------DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
++|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5677788999999999999996 47899999998653321 56889999999999999999999986554
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEecCCCc-----eEEeec
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLTEKLE-----PKLSDF 208 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~~~~~-----~kl~df 208 (347)
++||||+++|+|.+++......+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++. ++|+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999999999877778999999999999999999999 778 999999999999988776 999999
Q ss_pred ccceecCCCccceeecccCCCCccccccc--cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYM--TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
|++.... .......++..|+|||.+ ....++.++||||||+++|+|++|+.||................. +.
T Consensus 174 g~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~ 247 (287)
T 4f0f_A 174 GLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--GL 247 (287)
T ss_dssp TTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--CC
T ss_pred Ccccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--CC
Confidence 9987543 223446789999999998 455688999999999999999999999975433222212111111 11
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
. + .......+++.+++.+||+.||.+|||+.++++.|++
T Consensus 248 ~-------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 R-------P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp C-------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred C-------C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0 1 1112334679999999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=332.92 Aligned_cols=261 Identities=26% Similarity=0.351 Sum_probs=213.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|.. .+++.||+|.+..... .+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788889999999999999984 3567899999976544 35688999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDS-----------------VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
.++||||+++|+|.+++..... .+++..++.++.|++.||.||| +.|++|+||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999965432 4899999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 99999999999999876533222 2233456788999999998899999999999999999999 999887543322222
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
. ........ .........+.+++.+||+.||.+|||+.++++.|++++.+...
T Consensus 259 ~-~~~~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 259 K-MIKEGFRM--------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp H-HHHHTCCC--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred H-HhccCCCC--------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 2 22111110 00112235799999999999999999999999999999877544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=329.51 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=196.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.... .+|+|.+..... ...+.+|+.++++++||||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3567788999999999999998743 599999875433 24688999999999999999999964 5567899999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC-cc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME-ES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~ 219 (347)
|+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999777778999999999999999999999 789999999999999999999999999999765421 12
Q ss_pred ceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.......|+..|+|||.+. +..++.++||||||+++|+|++|+.||..................... . +
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~-----~- 248 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD--L-----S- 248 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC--T-----T-
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc--h-----h-
Confidence 2234456899999999986 567888999999999999999999999754433322222222111110 0 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.....+++++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 249 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 ---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1112334679999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=325.70 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=202.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|...+|+.||+|++.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4678889999999999999999889999999986543 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++......+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccc
Confidence 987 999998776677999999999999999999999 789999999999999999999999999999865422 222
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cccc-----ccC
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIKD-----FED 294 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~ 294 (347)
.....+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.+....+....... .... ..+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 334568999999999876 4589999999999999999999999975432 2223333222111100 0000 000
Q ss_pred CCCC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 PRLN-------GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+... ........+++.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0111123457899999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=339.06 Aligned_cols=267 Identities=15% Similarity=0.145 Sum_probs=206.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC------CCEEEEEEcccCCCh-------------hHHHHHHHHhhcCCCCcceee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS------GQVVAIKHIYKSNNT-------------DSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-------------~~~~~e~~~l~~l~h~niv~~ 125 (347)
.++|...+.||+|+||.||+|.+.+ ++.||+|.+...... .....|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578888999999999999999654 478999998654321 123445566777889999999
Q ss_pred eeEEEeC----CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--C
Q 040826 126 FGCCVEG----GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--E 199 (347)
Q Consensus 126 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~ 199 (347)
++++... ...++||||+ +++|.+++......+++..++.++.|++.||.||| +.+++||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence 9998764 4589999999 88999999877678999999999999999999999 78999999999999999 8
Q ss_pred CCceEEeecccceecCCCccc------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh
Q 040826 200 KLEPKLSDFGLAKMLGMEESK------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273 (347)
Q Consensus 200 ~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~ 273 (347)
++.+||+|||++......... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876432211 11334599999999999999999999999999999999999999985332222
Q ss_pred HHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 274 QLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
........... ....+.++.+.. ...+.++.+++.+||+.||.+|||+.+|++.|++++++.
T Consensus 270 ~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 270 YVRDSKIRYRE---NIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHH---CHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhh---hHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 21111111111 112222222110 122357999999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.00 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCE----EEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQV----VAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.+. +|+. ||+|.+... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 46778889999999999999953 4543 588887543 3345789999999999999999999999875 4789
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++||+++|+|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999887778999999999999999999999 789999999999999999999999999999876433
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ........ +...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~---~~~~------- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK---GERL------- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT---TCCC-------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHc---CCCC-------
Confidence 222 2233456889999999999999999999999999999999 99998754322 11211111 1100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.....+..++.+++.+||+.||.+|||+.++++.|+.+.++.
T Consensus 239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 239 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 111123357999999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.90 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=210.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4678999999999999999999964 347899999976543 2468899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCC
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD-----------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~ 191 (347)
.++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+++|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 999999999999999996532 56899999999999999999999 7899999999
Q ss_pred CCCEEecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCCh
Q 040826 192 LTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDF 269 (347)
Q Consensus 192 p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~ 269 (347)
|+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 22334567889999999998889999999999999999999 998987433
Q ss_pred hhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 270 DARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.. . ....+..+... ..+.....++.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus 282 ~~-~----~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 HE-E----VIYYVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HH-H----HHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred hH-H----HHHHHhCCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 21 1 11112222111 111123357999999999999999999999999999986543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=357.60 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=212.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.+. ++..||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 456778889999999999999976 48899999997653 4568999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++|+|.+++... ...+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999753 456899999999999999999999 7899999999999999999999999999998764333333
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............. .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~---------------~ 439 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRM---------------E 439 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHHTTCCC---------------C
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC---------------C
Confidence 334456789999999998899999999999999999999 8888864322 1211111111110 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.+..+.+++.+|+.+||+.||.+|||+.+|++.|+.++++
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1223346799999999999999999999999999987644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=352.89 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=204.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|.+.++..||+|.+.... ..+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45677888999999999999999888889999997643 45679999999999999999999999865 67899999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|+|.+++... +..+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++...........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99999999653 356899999999999999999999 78999999999999999999999999999987643333333
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+....... +... ..
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~----~~~~-----------~~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER----GYRM-----------PC 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHT----TCCC-----------CC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc----CCCC-----------CC
Confidence 34557889999999998899999999999999999999 8888864322 122222211 1110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
+..+++.+.+++.+||+.||++|||+.++++.|++++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 22344679999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=342.85 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=207.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888899999999999999942 4678999999754332 3688899999999999999999999998899
Q ss_pred EEEEeecCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceEEe
Q 040826 136 YLVYEFCAAGNLAQHLLRKD------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPKLS 206 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~ 206 (347)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| ++|++||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 45899999999999999999999 78999999999999999555 59999
Q ss_pred ecccceecCCCc-cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcC
Q 040826 207 DFGLAKMLGMEE-SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 207 dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
|||++....... ........+|..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ..+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~----~~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVL----EFVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH----HHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH----HHHHc
Confidence 999997542211 122334567889999999998899999999999999999998 88888743321 111 11211
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+... .....+...+.+|+.+||+.||.+|||+.+|++.|+.+.++.
T Consensus 302 ~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 302 GGRM-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCC-----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111 111123357999999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=329.76 Aligned_cols=249 Identities=27% Similarity=0.325 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888899999999999999964 68999999986542 235688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~ 211 (347)
++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999998654 45899999999999999999999 78999999999999999887 7999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ........ .......
T Consensus 166 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~----~~~~~~~ 238 (326)
T 2y0a_A 166 HKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSA----VNYEFED 238 (326)
T ss_dssp EECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHH----TCCCCCH
T ss_pred eECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHh----cCCCcCc
Confidence 876422 2234457999999999999999999999999999999999999999754322 11221111 1111100
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. .......+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 239 EY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HH--------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc--------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0012357899999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=331.84 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=209.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.. .++..||+|.+...... ..+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999985 24578999999765433 4678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCC
Q 040826 136 YLVYEFCAAGNLAQHLLRKD-----------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p 192 (347)
++||||+++++|.+++.... ..+++..++.++.|+++||.||| +.+++|+||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999996532 23889999999999999999999 78999999999
Q ss_pred CCEEecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChh
Q 040826 193 TNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFD 270 (347)
Q Consensus 193 ~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~ 270 (347)
+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876433222 2233456788999999999899999999999999999999 9999875432
Q ss_pred hhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 271 ARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
. . ...... .+... .......+++.+++.+||+.||.+|||+.++++.|+++++.
T Consensus 259 ~-~-~~~~~~---~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E-R-LFNLLK---TGHRM-----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G-G-HHHHHH---TTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H-H-HHHHhh---cCCcC-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2 1 111111 11110 11112336799999999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.26 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=204.4
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
...++|...+.||+|+||.||+|.. .+|+.+|+|.+..... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467888899999999999999985 4789999999876542 3468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec---CCCceEEeecccceec
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT---EKLEPKLSDFGLAKML 214 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~ 214 (347)
||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.|++||||||+||+++ +++.+||+|||++...
T Consensus 88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999988664 45999999999999999999999 78999999999999998 5678999999999876
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+.. +..... .
T Consensus 164 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~----~~~~~~---~ 234 (444)
T 3soa_A 164 EGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKA----GAYDFP---S 234 (444)
T ss_dssp CTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH----TCCCCC---T
T ss_pred cCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh----CCCCCC---c
Confidence 432 22234567999999999999999999999999999999999999999754321 22222221 211111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.. . ...+++.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~~~-~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEW-D----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc-c----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 1 22357999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=333.35 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=191.4
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..++|...+.||+|+||.||+|... +++.||+|.+......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 4567888999999999999999965 688999999987766777889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeecccceecCCCcc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~~ 219 (347)
++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++. ++.+||+|||++..... .
T Consensus 131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~ 204 (349)
T 2w4o_A 131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--Q 204 (349)
T ss_dssp CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--c
Confidence 999999998654 45899999999999999999999 789999999999999975 88999999999986532 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||..|+|||.+.+..++.++||||||+++|+|++|..||............... ..... ..+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~----~~~~~---~~~---- 273 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN----CEYYF---ISP---- 273 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT----TCCCC---CTT----
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh----CCCcc---CCc----
Confidence 2233456899999999999999999999999999999999999999754433222222221 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......++.+|+.+||+.||++|||+.++++
T Consensus 274 -~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123357999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=336.45 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=208.7
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCC---ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSN---NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
..++|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357888899999999999999995 245689999997542 345788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCC
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDS----------------------VLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~ 191 (347)
..++||||+++|+|.+++..... .+++..++.++.|++.||.||| +.|++|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999975432 3789999999999999999999 7899999999
Q ss_pred CCCEEecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCCh
Q 040826 192 LTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDF 269 (347)
Q Consensus 192 p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~ 269 (347)
|+||+++.++.++|+|||++......... ......+|..|+|||.+.+..++.++||||||+++|+|+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866433222 2333457889999999998899999999999999999998 999987543
Q ss_pred hhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 270 DARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
..... ...... +... ..+....+++.+++.+||+.||.+|||+.++++.|+.++.+.-.
T Consensus 280 ~~~~~-~~~~~~---~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 280 VDANF-YKLIQN---GFKM-----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CSHHH-HHHHHT---TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cHHHH-HHHHhc---CCCC-----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 32222 111111 1100 11112236799999999999999999999999999999765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=329.17 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=215.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|... ++..||+|.+..... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 467778889999999999999965 588999999976543 467889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999999753 456999999999999999999999 7899999999999999999999999999998765444444
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 300 (347)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ............ .
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~~~~~---------------~ 232 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRM---------------E 232 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCC---------------C
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhccCCC---------------C
Confidence 444567889999999998899999999999999999999 88888643221 111111111110 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 301 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
......+.+.+++.+||+.||.+|||+.++++.|+.++++..
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111233579999999999999999999999999999988754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.32 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=208.8
Q ss_pred cCcccCC-eeeecCCeeEEEEEeC---CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRR-FLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+ .||+|+||.||+|... ++..||+|.+..... ...+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444444 8999999999999853 577899999977543 34688999999999999999999998 55678999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999777777999999999999999999999 7899999999999999999999999999998764332
Q ss_pred cce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +... .+..+...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~----~i~~~~~~------- 232 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA----FIEQGKRM------- 232 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHH----HHHTTCCC-------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHH----HHhcCCcC-------
Confidence 221 223346889999999998889999999999999999998 99998754322 1111 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+.....++.+++.+||+.||.+|||+.++++.|+.++.+.-
T Consensus 233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1112234679999999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=331.36 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=203.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467888899999999999999965 78999999986543 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc-c
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-S 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 219 (347)
|+++|+|.+++... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999988543 45899999999999999999999 7899999999999999999999999999998654222 2
Q ss_pred ceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||..|+|||.+.+..+ +.++||||||+++|+|++|+.||............+...... .. +
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~----~--- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----LN----P--- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----ST----T---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----CC----c---
Confidence 22345679999999999987765 778999999999999999999997654433332222221110 00 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+.+|+.+||+.||.+|||+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0122357889999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=326.22 Aligned_cols=264 Identities=19% Similarity=0.191 Sum_probs=208.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEE-EeCCeEEEEEee
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCC-VEGGEQYLVYEF 141 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 141 (347)
..++|...+.||+|+||.||+|.. .+++.||+|.+........+.+|+.+++.++|++++..+..+ ...+..+++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 457899999999999999999995 578999999887776667789999999999988777766655 567788999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecCCCc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 218 (347)
+ +++|.+++......+++..++.++.|++.||.||| +.+++||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 88999999766677999999999999999999999 7899999999999999 788999999999998764332
Q ss_pred c------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCcc
Q 040826 219 S------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 219 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (347)
. .......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............... ..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 240 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--IE 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--HH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--hh
Confidence 2 1223457899999999999999999999999999999999999999753211 111111111111100 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.+.. ..++++.+++.+||+.||.+|||+.++++.|++++++..
T Consensus 241 -----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 -----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0000 123579999999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=328.25 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=200.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
++|...+.||+|+||.||++.. .++.||+|.+........+.+|+..+++++||||+++++++. +..++||||+++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCC
Confidence 4677788999999999999998 478899999987766778999999999999999999999876 3478999999999
Q ss_pred ChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc-eEEeecccceecCCCcccee
Q 040826 146 NLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE-PKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 146 sL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|.+++.... ..+++..++.++.|+++||.|||+.+.+|++||||||+||+++.++. +||+|||++...... .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~ 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----M 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----c
Confidence 9999997544 35789999999999999999999432289999999999999998886 799999998764321 2
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............. ...+..+ .....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~-------~~~~~-- 228 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRP-------PLIKN-- 228 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---HHTTCCC-------CCBTT--
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---HhcCCCC-------Ccccc--
Confidence 23468999999999999999999999999999999999999997432222211111 1111111 11112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
....+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 229 --~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 229 --LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 23579999999999999999999999999998854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.63 Aligned_cols=263 Identities=19% Similarity=0.188 Sum_probs=211.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEE-EeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCC-VEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+........+.+|+.+++.++|++++..+..+ ...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46788889999999999999995 578999999988777777899999999999988877666555 5677889999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecCCCcc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
+++|.+++......+++..++.++.|++.||.||| +++++|+||||+||++ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 88999999766677999999999999999999999 7899999999999999 4888999999999987653322
Q ss_pred c------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCccc
Q 040826 220 K------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 220 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (347)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............... ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~- 240 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--IE- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--HH-
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--hH-
Confidence 1 124457899999999999999999999999999999999999999753211 111222111111100 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.+.. ..++++.+++.+||+.||.+|||+.+|++.|++++++..
T Consensus 241 ----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 ----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0001 122579999999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.37 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=195.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----------------------------ChhHHHHHHHHhh
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----------------------------NTDSFSREVEGLS 115 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------------------------~~~~~~~e~~~l~ 115 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788889999999999999995 468899999986532 1246889999999
Q ss_pred cCCCCcceeeeeEEEe--CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCC
Q 040826 116 RVRHPNLVCLFGCCVE--GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193 (347)
Q Consensus 116 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~ 193 (347)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||.||| +.+++|+||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 568999999999999988653 346999999999999999999999 789999999999
Q ss_pred CEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccCCc---cCCcccHHHHHHHHHHHHhCCCCcCCChh
Q 040826 194 NILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK---LTCASDIYSFGIVALQLLSGQKVIELDFD 270 (347)
Q Consensus 194 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~lltg~~p~~~~~~ 270 (347)
||+++.++.+||+|||++....... .......||..|+|||.+.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999998764322 2234567999999999997654 47789999999999999999999975432
Q ss_pred hhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 271 ARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ....+........ . ... ..+++.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~-----~~~~~~~~~~~~~-----~-~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MC-----LHSKIKSQALEFP-----D-QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HH-----HHHHHHHCCCCCC-----S-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH-----HHHHHhcccCCCC-----C-ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 1111111111110 0 012 2357999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=330.72 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=203.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC-----CCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS-----GQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.... +..||+|.+...... ..+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667889999999999998542 235999999765432 358899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999877677999999999999999999999 789999999999999999999999999999876432
Q ss_pred ccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 218 ESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 218 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +. ...+..+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~----~~~~~~~~~~------ 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EV----MKAINDGFRL------ 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HH----HHHHHTTCCC------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HH----HHHHHCCCcC------
Confidence 2211 222346778999999999899999999999999999999 99998643221 11 1122111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.........+.+++.+||+.||.+|||+.++++.|+++++...
T Consensus 270 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 270 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0111234679999999999999999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=331.21 Aligned_cols=269 Identities=25% Similarity=0.345 Sum_probs=215.8
Q ss_pred ccHHHHHHHhcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceee
Q 040826 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCL 125 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~ 125 (347)
+...++....++|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555678899999999999999999983 35688999999765443 3588999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEeecCCCChHHHhhcCCC---------------CCCHHHHHHHHHHHHHHHHHhhhccCCCceeCC
Q 040826 126 FGCCVEGG-EQYLVYEFCAAGNLAQHLLRKDS---------------VLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189 (347)
Q Consensus 126 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 189 (347)
++++...+ ..+++|||+++++|.+++..... .+++..++.++.|++.||.||| +.|++|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987654 58999999999999999975433 2889999999999999999999 78999999
Q ss_pred CCCCCEEecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCC
Q 040826 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIEL 267 (347)
Q Consensus 190 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~ 267 (347)
|||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643322 22334557889999999998899999999999999999998 9999875
Q ss_pred ChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 268 DFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
................. . .......++.+++.+||+.||.+|||+.++++.|+.++++..
T Consensus 254 ~~~~~~~~~~~~~~~~~---~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRM---R------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSHHHHHHHHHTCCC---C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhHHHHHHhccCccC---C------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 43322222222111110 0 011123579999999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.62 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=207.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
..++|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3567888999999999999999964 78999999987543 23468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC--CCceEEeecccceecCCCc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE--KLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~~~~~~ 218 (347)
|+++|+|.+++......+++..++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999999999776667999999999999999999999 789999999999999974 567999999999876432
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||..|+|||++.+..++.++||||||+++|+|++|..||...... ..+...... .... ++...
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~----~~~~----~~~~~ 274 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRC----DWEF----DEDAF 274 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHC----CCCC----CSSTT
T ss_pred -cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhC----CCCC----Ccccc
Confidence 2233457999999999999999999999999999999999999999754322 222222111 1110 11111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. ...++.+++.+||+.||.+|||+.++++.
T Consensus 275 ~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 12 23579999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=331.09 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=203.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-------CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45688889999999999999995 47899999998532 23567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeeccc
Q 040826 137 LVYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGL 210 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg~ 210 (347)
+||||+++++|.+++.. .+..+++..+..++.|++.||.||| +++++||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988754 2346899999999999999999999 789999999999999987655 99999999
Q ss_pred ceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..... +..+.....
T Consensus 180 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~----i~~~~~~~~ 252 (351)
T 3c0i_A 180 AIQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEG----IIKGKYKMN 252 (351)
T ss_dssp CEECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHH----HHHTCCCCC
T ss_pred eeEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHH----HHcCCCCCC
Confidence 9876532 2223445799999999999999999999999999999999999999975421 11111 111111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. .... ...+++.+|+.+||+.||.+|||+.++++
T Consensus 253 ~----~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 P----RQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H----HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c----cccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000 12357999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=325.35 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=203.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +|+.||+|.+... .....+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888899999999999999964 7899999998653 3456788899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.+|.+||+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999999654 45899999999999999999999 88999999999999999999999999999987532
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......||+.|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+. .......
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~----~~~~~~p-------- 223 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKIL----NAELRFP-------- 223 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH----HCCCCCC--------
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH----hCCCCCC--------
Confidence 123457999999999999999999999999999999999999999754322 1122221 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
.....++.+++.+||+.||.+|| ++.+|++
T Consensus 224 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 ----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11235799999999999999999 8888875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=334.94 Aligned_cols=246 Identities=26% Similarity=0.332 Sum_probs=198.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... +|+.||+|++... .....+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 568888999999999999999954 6899999998653 3445678899999988 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||++.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999998654 45999999999999999999999 78999999999999999999999999999985432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +... .+..+.....
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~----~i~~~~~~~p------- 244 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFE----AILNDEVVYP------- 244 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHHCCCCCC-------
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHH----HHHcCCCCCC-------
Confidence 222344567999999999999989999999999999999999999999754322 2222 2222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTI------DVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~ei~~ 332 (347)
.....++.+++.+||+.||.+||++ .+|++
T Consensus 245 -----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 -----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1123578999999999999999998 66654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=332.41 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=204.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567889999999999999999964 689999999975432 24678999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~dfg~~~~~~ 215 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999988654 45899999999999999999999 78999999999999998654 59999999998764
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..... +..+..... .+
T Consensus 183 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~----i~~~~~~~~---~~ 252 (362)
T 2bdw_A 183 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQ----IKAGAYDYP---SP 252 (362)
T ss_dssp TC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH----HHHTCCCCC---TT
T ss_pred CC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHH----HHhCCCCCC---cc
Confidence 22 2234467999999999999989999999999999999999999999754321 11111 111111111 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. .....++.+|+.+||+.||.+|||+.++++.
T Consensus 253 ~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1223578999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=325.20 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=206.8
Q ss_pred ccCCeeeecCCeeEEEEEeC-----CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLP-----SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLV 138 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 138 (347)
...+.||+|+||.||++.+. +|+.||+|++..... ...+.+|+.++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67788999999999998642 678999999976543 3468899999999999999999999987 4678999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999654 3899999999999999999999 7899999999999999999999999999998765332
Q ss_pred cc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh----------HHHHHHhhhcCCC
Q 040826 219 SK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD----------QLTRKARDVSMGK 286 (347)
Q Consensus 219 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~----------~~~~~~~~~~~~~ 286 (347)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...........+.
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 21 22334578889999999998999999999999999999999999875322111 1111111111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
....+.....++.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus 269 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 269 -----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111222334679999999999999999999999999999976543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=324.74 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=204.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEE-eCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCV-EGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l 137 (347)
.+|...+.||+|+||.||+|...+ +..+|+|.+...... ..+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457777899999999999998542 236899988765443 46889999999999999999999864 4567899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
+|||+++|+|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999877777999999999999999999999 789999999999999999999999999999876432
Q ss_pred cc---ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 218 ES---KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 218 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.......+......... ...
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----~~~----- 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----RLL----- 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----CCC-----
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----CCC-----
Confidence 21 122334577889999999988999999999999999999996554433332222222222211 110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.+......+.+++.+||+.||.+|||+.++++.|++++++.
T Consensus 253 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 ------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 01112357999999999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.50 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=204.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|...+ +..||+|.+..... .+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4577788899999999999998532 33699999876543 3568899999999999999999999764 45789
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999877677999999999999999999999 789999999999999999999999999999876543
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ......... ..+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~~~---~~~-------- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGD---RLP-------- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHHTC---CCC--------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhcCC---CCC--------
Confidence 3333344557889999999998889999999999999999998 999986433221 111111111 000
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.+....+.+.+++.+||+.||.+|||+.++++.|+++++..
T Consensus 235 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 ----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01112357999999999999999999999999999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=322.72 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=205.7
Q ss_pred cccCCeeeecCCeeEEEEEeC-CCC---EEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE-EEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP-SGQ---VVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ-YLVY 139 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~ 139 (347)
|...+.||+|+||.||+|... ++. .+|+|.+...... +.+.+|+.++++++||||+++++++.+.+.. ++++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445578999999999999843 333 7999998765443 4678999999999999999999999876554 9999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+.+++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999877778999999999999999999999 78999999999999999999999999999986543221
Q ss_pred ---ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 ---KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.......++..|+|||.+.+..++.++||||||+++|+|++|..|+.......+...........
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------ 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------------ 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------------
Confidence 12233467889999999999999999999999999999999776665443333322222221110
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+....+.+.+++.+||+.||.+|||+.++++.|++++++-
T Consensus 248 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 ---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 011122357999999999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=330.11 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=208.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe--------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL--------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEG 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||+|.. .++..||+|.+...... ..+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46788889999999999999985 35678999999765443 4578999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999997543 24899999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-HHH
Confidence 99999999999999876533221 2233456788999999998899999999999999999999 99988643221 111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..... +... ........++.+++.+||+.||.+|||+.++++.|++++...
T Consensus 270 ~~~~~----~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 270 KLLKE----GHRM-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHH----TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhc----CCCC-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11111 1110 011123357999999999999999999999999999997643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=321.98 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=193.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. +|+.+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35777889999999999999998 48899999986542 235688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC---ceeCCCCCCCEEecC--------CCceEEee
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC---IVHRDIKLTNILLTE--------KLEPKLSD 207 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~---i~H~dl~p~Nili~~--------~~~~kl~d 207 (347)
|||+++++|.+++. ...+++..++.++.|++.||.||| +.+ ++|+||||+||+++. ++.++|+|
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999884 346899999999999999999999 566 999999999999986 67899999
Q ss_pred cccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
||++...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........... ... ...
T Consensus 160 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~----~~~ 231 (271)
T 3dtc_A 160 FGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-VAM----NKL 231 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-HHT----SCC
T ss_pred CCcccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-hhc----CCC
Confidence 9999865322 12245689999999999988899999999999999999999999975432221111 111 110
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
. ...+....+.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 011122335799999999999999999999999999854
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=334.86 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=202.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCE----EEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQV----VAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|... +|+. |++|.+.... ....+.+|+..+++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46777889999999999999954 4554 7888775432 2346778999999999999999999886 557899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|+||+++|+|.+++......+++..++.++.|++.||.||| +.|++||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876433
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... .+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~---~~~~~------- 236 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLE---KGERL------- 236 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHH---TTCBC-------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHH---cCCCC-------
Confidence 222 2344567889999999998899999999999999999999 999987543221 111111 11110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+..+..++.+++.+||+.||.+|||+.++++.|+.+.++.
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001112235888999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=333.90 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=198.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... +++.||+|++.+.. ....+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467888999999999999999965 68899999987532 234578899999887 89999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++.... .
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-R 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC-C
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc-c
Confidence 99999999999988654 45999999999999999999999 7899999999999999999999999999998632 2
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh----hHHHHHHhhhcCCCCCccccc
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR----DQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.........||+.|+|||++.+..++.++|+||||+++|+|++|+.||....... .........+.......
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---- 281 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---- 281 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC----
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC----
Confidence 2233455679999999999999999999999999999999999999996422111 01111122222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
+.....++.+|+.+||+.||.+||++
T Consensus 282 --------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 --------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11223578999999999999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=330.88 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=209.0
Q ss_pred cCcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEE--eCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCV--EGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 136 (347)
++|...+.||+|+||.||+|.+ .+++.||+|.+..... .+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5677888999999999999983 3688999999876543 245889999999999999999999887 456789
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999765566999999999999999999999 78999999999999999999999999999987643
Q ss_pred Cccc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh----------HHHHHHhhhcC
Q 040826 217 EESK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARD----------QLTRKARDVSM 284 (347)
Q Consensus 217 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~----------~~~~~~~~~~~ 284 (347)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...........
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3222 22334578889999999998999999999999999999999999874332110 11111111111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+. .........+.+.+++.+||+.||.+|||+.++++.|+.++.+.
T Consensus 260 ~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 260 GQ-----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cc-----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11 11122234467999999999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=326.15 Aligned_cols=273 Identities=23% Similarity=0.286 Sum_probs=206.9
Q ss_pred cHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcC--CCCcceeeeeEEEeC--
Q 040826 57 SKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV--RHPNLVCLFGCCVEG-- 132 (347)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~-- 132 (347)
+...-....++|...+.||+|+||.||+|... |+.||+|++.... ......|.+++... +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33334445678999999999999999999984 8999999985443 33445566665554 899999999999887
Q ss_pred --CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC--------CceeCCCCCCCEEecCCCc
Q 040826 133 --GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG--------CIVHRDIKLTNILLTEKLE 202 (347)
Q Consensus 133 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~--------~i~H~dl~p~Nili~~~~~ 202 (347)
...++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +++||||||+||+++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7899999999999999999553 5899999999999999999999 66 9999999999999999999
Q ss_pred eEEeecccceecCCCccce---eecccCCCCccccccccCCccCCc------ccHHHHHHHHHHHHhC----------CC
Q 040826 203 PKLSDFGLAKMLGMEESKV---FTDVRGTIGYMDPEYMTNAKLTCA------SDIYSFGIVALQLLSG----------QK 263 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~slG~il~~lltg----------~~ 263 (347)
+||+|||++.......... .....||..|+|||.+.+...+.. +||||||+++|+|++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998764322211 224568999999999987666554 9999999999999999 55
Q ss_pred CcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 264 VIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG-NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 264 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
||..................... ..+.... ....++.+++.+++.+||+.||.+|||+.+|++.|+++.++..
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKK------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSC------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cHhhhcCCCCchhhhHHHHhhhc------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 55432221111111111111110 0011110 1123677889999999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=329.98 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=200.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788889999999999999995 57899999998642 3345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+ +|+|.+++.... .+++..++.++.|++.||.||| +.|++||||||+||++++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999 679999886543 5899999999999999999999 789999999999999999999999999999865422
Q ss_pred cceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ....+..+..
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~i~~~~~---------- 225 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----LFKKVNSCVY---------- 225 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----CBCCCCSSCC----------
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHcCCC----------
Confidence 22344579999999999998776 689999999999999999999997432110 0011111100
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+.....++.+|+.+||+.||.+|||+.|+++
T Consensus 226 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 --VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112223357899999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=340.38 Aligned_cols=259 Identities=22% Similarity=0.211 Sum_probs=208.1
Q ss_pred HHHHHHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEe
Q 040826 58 KDEIENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVE 131 (347)
Q Consensus 58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 131 (347)
..+.....++|...+.||+|+||.||++... +|+.||+|++.+. .....+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344445788999999999999999999964 7999999998642 233458899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.+..++||||+++|+|.+++.+.+..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999776667999999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCcccccccc-------CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMT-------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
...............||+.|+|||++. +..++.++||||||+++|||++|+.||...... .....+......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~ 288 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEH 288 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC
Confidence 876543333334467999999999987 457899999999999999999999999754322 222222211100
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR---PTIDVVYE 332 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~ei~~ 332 (347)
.. .|..... ...++.+|+.+||. +|.+| |+++||++
T Consensus 289 ~~-------~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 289 LS-------LPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC-------CC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cC-------CCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00 0111112 23579999999998 99998 58888864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=329.67 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=209.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CC-----CEEEEEEcccCCC---hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SG-----QVVAIKHIYKSNN---TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|... ++ ..||+|.+..... ...+.+|+.+++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 567888899999999999999954 23 4799999976543 34688999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 135 QYLVYEFCAAGNLAQHLLRK-------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
.++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence 99999999999999998642 345899999999999999999999 78999999999999999999
Q ss_pred ceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHH
Q 040826 202 EPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 202 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~ 279 (347)
.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHH
Confidence 9999999999865432222 2233456789999999998889999999999999999999 8888865432222 12222
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
....... .+....+.+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 281 ~~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 281 KDGYQMA--------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHTCCCC--------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcCCCCC--------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2111100 01112357999999999999999999999999999987653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=339.26 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=206.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEccc-----CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYK-----SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
..++|...+.||+|+||.||+|... +|+.||+|++.. ......+.+|..+++.++||||+++++++.+.+..++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4678999999999999999999965 688999999864 2344568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++... .+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||++......
T Consensus 147 V~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999988643 5899999999999999999999 789999999999999999999999999999876544
Q ss_pred ccceeecccCCCCccccccccCCc----cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAK----LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... .....+.........+
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~p----- 295 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLTFP----- 295 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHCCCC-----
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccccccCC-----
Confidence 333344668999999999998655 889999999999999999999999754322 2222222211100100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKG--RPTIDVVYEE 333 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~ei~~~ 333 (347)
. ...+ ..++.+|+.+||+.+|.+ ||++.||+++
T Consensus 296 --~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 --D-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --T-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --C-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0012 257999999999999988 9999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=335.34 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=213.7
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCC--eEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGG--EQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46778889999999999999965 5899999998753 33457789999999999999999999988755 789999
Q ss_pred eecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe----cCCCceEEeeccccee
Q 040826 140 EFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----TEKLEPKLSDFGLAKM 213 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----~~~~~~kl~dfg~~~~ 213 (347)
||+++|+|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++..
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996532 34899999999999999999999 7899999999999999 7778899999999987
Q ss_pred cCCCccceeecccCCCCccccccccC--------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh---HHHHHHhhh
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN--------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD---QLTRKARDV 282 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~---~~~~~~~~~ 282 (347)
.... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .+.......
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 6432 23344579999999998864 5678899999999999999999999975332222 222222211
Q ss_pred cCCCC---------CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 283 SMGKR---------PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 283 ~~~~~---------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..... ......+......+.......+.+++.+||+.||++|||+.++++.++++++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11000 000000111122456788889999999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=327.68 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=193.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC-CC---EEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE-
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS-GQ---VVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ- 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 135 (347)
.++|...+.||+|+||.||+|.... +. .||+|.+.... ....+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4578888999999999999999543 32 79999987542 235688999999999999999999999876654
Q ss_pred -----EEEEeecCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 136 -----YLVYEFCAAGNLAQHLLRK-----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 136 -----~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
+++|||+++|+|.+++... ...+++..++.++.|++.||.||| +.|++||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998532 235899999999999999999999 789999999999999999999999
Q ss_pred eecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhc
Q 040826 206 SDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 206 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .........
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~-- 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIYNYLIGG-- 255 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTT--
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHHHHHhcC--
Confidence 99999987543222 12233456788999999999899999999999999999999 88888753322 111111111
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
... .......+++.+++.+||+.||.+|||+.++++.|+++++..
T Consensus 256 --~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 256 --NRL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --CCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --CCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 111123357999999999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=330.65 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=201.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCE----EEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQV----VAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|... +++. |++|.+... .....+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888899999999999999953 4554 577777543 34567889999999999999999999988654 789
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
+++|+++|+|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999877778999999999999999999999 789999999999999999999999999999876432
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... +...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~---~~~~------- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK---GERL------- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT---TCCC-------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc---CCCC-------
Confidence 221 2233456788999999999999999999999999999999 999987543221 1111111 1100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
........++.+++.+||+.||.+|||+.|+++.|+++.++..
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 1111233579999999999999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.01 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=202.5
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 136 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+... .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578888999999999999999964 6899999998653 3455678899999877 8999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999998654 35899999999999999999999 78999999999999999999999999999986432
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
. ........||+.|+|||++.+..++.++|+||||+++|+|++|..||...... .. ...+..+.....
T Consensus 171 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~----~~~i~~~~~~~p------ 238 (345)
T 1xjd_A 171 G-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-EL----FHSIRMDNPFYP------ 238 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHCCCCCC------
T ss_pred C-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HH----HHHHHhCCCCCC------
Confidence 2 22244567999999999999999999999999999999999999999754321 11 122222221111
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTID-VVY 331 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-ei~ 331 (347)
.. ...++.+|+.+||+.||.+||++. +|+
T Consensus 239 --~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 --RW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --cc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 235789999999999999999997 654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=323.77 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=204.4
Q ss_pred hcCcccCC-eeeecCCeeEEEEEe---CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 65 INNDWDRR-FLGRGSAGLVYKGVL---PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 65 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
.++|...+ .||+|+||.||+|.+ .+++.||+|.+..... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34566666 899999999999963 3468899999876432 34688999999999999999999998 567789
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999664 45899999999999999999999 78999999999999999999999999999987653
Q ss_pred Cccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 217 EESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 217 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ..+..+...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~~~~~~----- 239 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT---AMLEKGERM----- 239 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHHHTTCCC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---HHHHcCCCC-----
Confidence 32221 222346788999999998889999999999999999999 99998753321 111 111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+......+.+++.+||+.||.+|||+.++++.|++++.+.-
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 240 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111233579999999999999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=331.78 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=201.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356778899999999999999954 6889999998643 3446788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 9999999999988654 45999999999999999999999 78999999999999999999999999999987642
Q ss_pred cceeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ......+.......
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~------ 239 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFETTVVTY------ 239 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHHHCCCCC------
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhhcccCC------
Confidence 233455679999999999864 4689999999999999999999999975332111 11111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPT-IDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~ei~~ 332 (347)
+.....++.+|+.+||+.||.+||+ +.++.+
T Consensus 240 ------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122357999999999999999999 666553
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=326.18 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=196.7
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCC------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGG------ 133 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 133 (347)
..++|...+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567888899999999999999965 79999999986533 2357889999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCChHHHhhcCC--CCCCH
Q 040826 134 ---------------------------------------------------EQYLVYEFCAAGNLAQHLLRKD--SVLTW 160 (347)
Q Consensus 134 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~~~~ 160 (347)
..++||||+++++|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3799999999999999997543 34567
Q ss_pred HHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-----------ceeecccCCC
Q 040826 161 ERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES-----------KVFTDVRGTI 229 (347)
Q Consensus 161 ~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~ 229 (347)
..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++........ .......||.
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 778999999999999999 78999999999999999999999999999987653321 1223356899
Q ss_pred CccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHH
Q 040826 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESI 309 (347)
Q Consensus 230 ~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 309 (347)
.|+|||.+.+..++.++||||||+++|+|++|..|+.. . ............+ ........++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~---~~~~~~~~~~~~~-----------~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----R---VRIITDVRNLKFP-----------LLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----H---HHHHHHHHTTCCC-----------HHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----H---HHHHHHhhccCCC-----------cccccCChhH
Confidence 99999999999999999999999999999998765421 1 1111111111111 1112334678
Q ss_pred HHHHHHhccCCCCCCCCHHHHHH
Q 040826 310 LKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 310 ~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+++.+||+.||.+|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=316.88 Aligned_cols=249 Identities=18% Similarity=0.272 Sum_probs=202.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC--CeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG--GEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 138 (347)
.++|...+.||+|+||.||+|... |+.+|+|.+..... ...+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 356778889999999999999984 88999999876532 24688999999999999999999999876 788999
Q ss_pred EeecCCCChHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDS-VLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|||+++|+|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.++++|||.+....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999976543 5899999999999999999999 778 9999999999999999999999998765432
Q ss_pred CCccceeecccCCCCccccccccCCccCC---cccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTC---ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
.....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||......... ..... .+..
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~---~~~~----- 229 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MKVAL---EGLR----- 229 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-HHHHH---SCCC-----
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-HHHHh---cCCC-----
Confidence 12346789999999998766554 799999999999999999999754322211 11111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
+ ..+.....++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 230 --~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 --P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 111123357999999999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=332.39 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=194.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||++... +|+.||+|++.... ....+.+|+..++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 357888899999999999999965 78999999997643 3467889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc--eEEeecccceecCCCccc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE--PKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 220 (347)
++|+|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+||+++.++. +||+|||++..... ..
T Consensus 99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~ 172 (361)
T 3uc3_A 99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HS 172 (361)
T ss_dssp CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--cC
Confidence 9999999886543 5899999999999999999999 789999999999999987765 99999999875321 22
Q ss_pred eeecccCCCCccccccccCCccCCc-ccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCA-SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||........ .......+.........
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~-------- 243 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSIPD-------- 243 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCCCCCT--------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCCCCCC--------
Confidence 2344569999999999988777655 8999999999999999999975433222 12222222222111110
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......++.+|+.+||+.||.+|||+.|++++
T Consensus 244 --~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 --DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00122578999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=356.30 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=201.3
Q ss_pred eeeecCCeeEEEEEeC---CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCC
Q 040826 73 FLGRGSAGLVYKGVLP---SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGN 146 (347)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 146 (347)
.||+|+||.||+|.+. ++..||||.+.... ..+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999853 46679999997643 34679999999999999999999999876 56899999999999
Q ss_pred hHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce--eec
Q 040826 147 LAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--FTD 224 (347)
Q Consensus 147 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~ 224 (347)
|.+++......+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++.......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999877777999999999999999999999 7899999999999999999999999999998754322211 222
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..++..|+|||++.+..++.++||||||+++|||++ |+.||...... +... .+..+... ..+.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~----~i~~~~~~-----------~~p~ 562 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA----FIEQGKRM-----------ECPP 562 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHH----HHHTTCCC-----------CCCT
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH----HHHcCCCC-----------CCCC
Confidence 345689999999998899999999999999999998 99998753322 1111 12222111 1122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.++.++.+++.+||+.||.+|||+.+|++.|++++.+.
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 34468999999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=323.10 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=198.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45788889999999999999995 578999999987532 124688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|||+++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998854 3566899999999999999999999 7899999999999999999999999999988654
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. ........++..|+|||.+.+..++.++||||||+++|+|++|..||........... ........+ ..
T Consensus 188 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~--~~--- 258 (310)
T 2wqm_A 188 SK-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KKIEQCDYP--PL--- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH---HHHHTTCSC--CC---
T ss_pred CC-CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH---HHhhcccCC--CC---
Confidence 22 2222345689999999999998999999999999999999999999875432222222 222111111 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
. .....+++.+++.+||+.||.+|||+.+|++.|+++...
T Consensus 259 -~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 259 -P----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -C----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -c----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 012235799999999999999999999999999999654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=335.10 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=194.5
Q ss_pred cccCCeeeecCCeeEEEEEeC--CC--CEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVLP--SG--QVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYLVY 139 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 139 (347)
|...+.||+|+||.||+|... ++ ..||+|.+..... ...+.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 555678999999999999853 22 3689998875433 3468899999999999999999998654 56789999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++......+++..++.++.|+++||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999877777999999999999999999999 78999999999999999999999999999986532221
Q ss_pred c---eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 220 K---VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 220 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.... ..+...... .+...
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~----~~~~~------- 315 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL----QGRRL------- 315 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHH----TTCCC-------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHH----cCCCC-------
Confidence 1 1233457788999999999899999999999999999999 555654322 111111111 11111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+..+...+.+++.+||+.||++|||+.++++.|++++.+.
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 011123357999999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=322.99 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=190.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35778889999999999999995 468999999986543 33578899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 141 FCAAGNLAQHLLRK-----DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 141 ~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
|+++ +|.+++... ...+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9985 999988542 245899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc-----
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI----- 289 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 289 (347)
.. ........+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+..............
T Consensus 160 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhhh
Confidence 22 222344568999999999976 46899999999999999999999999754332 22333322211110000
Q ss_pred -----------------ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 290 -----------------KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 290 -----------------~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+..... ...++.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00001111111 2357999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.48 Aligned_cols=263 Identities=17% Similarity=0.198 Sum_probs=209.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC---------CCEEEEEEcccCCChhHHHHHHHHhhcCCCCccee------------
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS---------GQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC------------ 124 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~------------ 124 (347)
++|...+.||+|+||.||+|.... ++.||+|.+... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 578888999999999999999653 789999998654 46789999999999999987
Q ss_pred ---eeeEEEe-CCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC
Q 040826 125 ---LFGCCVE-GGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE 199 (347)
Q Consensus 125 ---~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~ 199 (347)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.|++.||.||| +.+++||||||+||+++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcC
Confidence 5677766 67899999999 88999999764 356999999999999999999999 789999999999999999
Q ss_pred CC--ceEEeecccceecCCCccc------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh
Q 040826 200 KL--EPKLSDFGLAKMLGMEESK------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA 271 (347)
Q Consensus 200 ~~--~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~ 271 (347)
++ .++|+|||++......... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876432211 123347899999999999989999999999999999999999999865433
Q ss_pred hhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
................ .+..+.... ....+++.+++.+||+.||.+|||+.++++.|++++++.
T Consensus 275 ~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPG---PFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHHHHHHHHHSCC---CEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhccCChh---hhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 3333333332222211 111111110 011257999999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=327.25 Aligned_cols=243 Identities=21% Similarity=0.227 Sum_probs=203.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357888899999999999999964 7899999998643 3445788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999997543 5899999999999999999999 789999999999999999999999999999876432
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.....||+.|+|||++.+..++.++|+||||+++|+|++|..||...... . ....+..+.....
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~----~~~~i~~~~~~~p-------- 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-Q----IYEKIVSGKVRFP-------- 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHHCCCCCC--------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-H----HHHHHHcCCCCCC--------
Confidence 23456899999999999999999999999999999999999999754321 1 1122222221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
.....++.+++.+||+.||.+||+ +.+|++
T Consensus 259 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 ----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122357999999999999999998 777765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=323.64 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=200.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeC-CeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG-GEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||++.. +|+.||+|.+......+.+.+|+.++++++||||+++++++... +..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 46788889999999999999987 58899999998877778899999999999999999999987544 47899999999
Q ss_pred CCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...... .
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~ 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc----c
Confidence 999999996543 23789999999999999999999 789999999999999999999999999998764322 2
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +.... +..+.. + ..
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~----~~~~~~-------~----~~ 235 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPR----VEKGYK-------M----DA 235 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHH----HTTTCC-------C----CC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HhcCCC-------C----CC
Confidence 23357889999999998889999999999999999998 99988643221 11111 111111 0 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.....+.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 112335799999999999999999999999999999654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=332.85 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=209.6
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEE
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCV 130 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~ 130 (347)
+++...++|...+.||+|+||.||+|... +++.||+|.+...... ..+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678889999999999999999853 4678999999765433 35889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL 201 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~ 201 (347)
+.+..++||||+++|+|.+++... ...+++..++.++.|++.||.||| ++|++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence 989999999999999999998642 145799999999999999999999 78999999999999999999
Q ss_pred ceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHH
Q 040826 202 EPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 202 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~ 279 (347)
.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~--- 251 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLR--- 251 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHHH---
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-HHHHH---
Confidence 9999999999865322211 1222346788999999998889999999999999999999 7888764322 11111
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.+..+... .........+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 252 -~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 252 -FVMEGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -HHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -HHHcCCcC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11111110 01112335799999999999999999999999999887543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=324.61 Aligned_cols=260 Identities=24% Similarity=0.285 Sum_probs=199.6
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
...++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+|+..+++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34678999999999999999999964 788999999875422 246889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+++||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999998654 45899999999999999999999 78999999999999999999999999999887643
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... .... ...
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---~~~~-~~~----- 255 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN---QAIP-RPS----- 255 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH---SCCC-CGG-----
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc---cCCC-Ccc-----
Confidence 3333344556899999999999999999999999999999999999999754322 1111111 1111 010
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRP-TIDVVYEEIDKAWKN 340 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~ei~~~l~~~~~~ 340 (347)
......+.++.+++.+||+.||++|| |++++++.|+..+.+
T Consensus 256 ---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 ---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11112234699999999999999999 999999999987644
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=326.54 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=205.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCE--EEEEEcccC---CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQV--VAIKHIYKS---NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... +|.. +++|.+... .....+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57778889999999999999954 5664 489988653 2345788999999999 899999999999999999999
Q ss_pred EeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 139 YEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999996543 46899999999999999999999 7899999999999999999999
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhh
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDV 282 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~ 282 (347)
||+|||++..... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL 254 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHG
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHHHHh
Confidence 9999999874321 112233456889999999998889999999999999999998 99998744321 111222
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+... .........+.+++.+||+.||.+|||+.++++.|+.++++.
T Consensus 255 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 PQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGTCCC-----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcCCCC-----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 221110 111123357999999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=331.92 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=196.5
Q ss_pred CCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 71 RRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
.+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999995 478999999987653 345788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe--cCCCceEEeecccceecCCCccceeecc
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL--TEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
.+++......+++..++.++.|++.||.||| +.+++||||||+|||+ +.++.+||+|||++...... ......
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cccccc
Confidence 9999776667999999999999999999999 7899999999999999 56789999999999876432 223345
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 305 (347)
.||+.|+|||++.+..++.++||||||+++|+|++|..||...... +.+..+..... .... ..... .
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~----~~~~----~~~~~----~ 315 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRW----DLED----EEFQD----I 315 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC----CSCS----GGGTT----S
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccC----CCCh----hhhcc----C
Confidence 6999999999999989999999999999999999999999754322 22222222111 1100 00011 2
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 306 FESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 306 ~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+++.+|+.+||+.||.+|||+.|+++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 357999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=324.15 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=202.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CC-------CEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SG-------QVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
++|...+.||+|+||.||+|... ++ ..||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56778889999999999999854 34 469999986543 345788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc--------eEEee
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE--------PKLSD 207 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~--------~kl~d 207 (347)
++||||+++++|.+++......+++..++.++.|++.||.||| +++++||||||+||+++.++. ++|+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999876666999999999999999999999 789999999999999998887 99999
Q ss_pred cccceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+................
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~----- 234 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR----- 234 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc-----
Confidence 9998754321 22347889999999987 778999999999999999999766655443332222211111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..... .. ..++.+++.+||+.||.+|||+.++++.|++++...
T Consensus 235 ~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 HQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 01110 11 235889999999999999999999999999886543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=331.35 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=208.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-----CCCCEEEEEEcccCCCh--hHHHHHHHHhhcCCCCcceeeeeEEEeCC--eE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-----PSGQVVAIKHIYKSNNT--DSFSREVEGLSRVRHPNLVCLFGCCVEGG--EQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 135 (347)
.++|...+.||+|+||.||+|.+ .+|+.||+|.+...... ..+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35677889999999999999983 36889999998765433 46889999999999999999999886543 78
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999877677999999999999999999999 7899999999999999999999999999998765
Q ss_pred CCccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH-----------HHHHHhhh
Q 040826 216 MEESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ-----------LTRKARDV 282 (347)
Q Consensus 216 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~-----------~~~~~~~~ 282 (347)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+..+...... ........
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 332211 22345677899999999888999999999999999999999988643211000 00111111
Q ss_pred cCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 283 SMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 283 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
..+.. ...+..++.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 277 ~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNGR-----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTCC-----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCC-----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11110 011223346799999999999999999999999999998543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=324.96 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=193.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccCC------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788889999999999999996 478999999987542 23457789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999998654 35899999999999999999999 789999999999999999999999999998754
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. .........||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ .....
T Consensus 172 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~----~~~~~----- 240 (327)
T 3a62_A 172 IH-DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILK----CKLNL----- 240 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH----TCCCC-----
T ss_pred cc-CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh----CCCCC-----
Confidence 32 122234457899999999999989999999999999999999999999754322 11222221 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
+.....++.+++.+||+.||.+|| ++.++++
T Consensus 241 -------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 -------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112235799999999999999999 6777765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=322.95 Aligned_cols=243 Identities=28% Similarity=0.336 Sum_probs=193.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----hHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...++||+|+||.||+|... +|+.||||++...... .....|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357888899999999999999965 7999999988654322 2344555555555 899999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+ +++|.+++...+..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 55999998777777999999999999999999999 789999999999999999999999999998876422
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||..|+|||++.+ .++.++||||||+++|+|++|..|+.... ....... +..+ +.+.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~----~~~~------~~~~ 274 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQ----GYLP------PEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTT----TCCC------HHHH
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhc----cCCC------cccc
Confidence 22334568999999999886 78999999999999999999987765321 1111111 1100 0011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ...+++.+++.+||+.||++|||+.|+++
T Consensus 275 ~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 A----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 12357999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=353.65 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=209.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|.+.++..||||++.... ..+.+.+|+.+|++++||||+++++++.+ +..++||||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45677888999999999999999888889999997643 45679999999999999999999999865 67899999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|+|.+++... +..+++..++.++.|++.||.||| +++++||||||+|||+++++.+||+|||++...........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99999999653 356899999999999999999999 78999999999999999999999999999986543222223
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+....+.. +... ..
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~~~~~i~~----~~~~-----------~~ 485 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER----GYRM-----------PC 485 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HHHHHHHHT----TCCC-----------CC
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc----CCCC-----------CC
Confidence 33456789999999998899999999999999999999 8888864322 122222211 1110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
...+.+++.+|+.+||+.||++|||+.+|++.|++++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 12334679999999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.44 Aligned_cols=276 Identities=23% Similarity=0.269 Sum_probs=213.7
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhc--CCCCcceeeeeEEEeCC----
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSR--VRHPNLVCLFGCCVEGG---- 133 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---- 133 (347)
.-....++|...+.||+|+||.||+|.. +|+.||+|.+... ....+.+|.+++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3345578899999999999999999998 5899999998643 34567788888877 78999999999998765
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCceeCCCCCCCEEecCCCceEEeec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI-----DGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-----~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||... +.+++|+||||+||+++.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 789999999999999999653 5899999999999999999999321 368999999999999999999999999
Q ss_pred ccceecCCCccc---eeecccCCCCccccccccCC------ccCCcccHHHHHHHHHHHHhC----------CCCcCCCh
Q 040826 209 GLAKMLGMEESK---VFTDVRGTIGYMDPEYMTNA------KLTCASDIYSFGIVALQLLSG----------QKVIELDF 269 (347)
Q Consensus 209 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~lltg----------~~p~~~~~ 269 (347)
|++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876433222 22345689999999999765 345789999999999999999 66775432
Q ss_pred hhhhHHHHHHhhhcCCCCCcccccCCCCCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Q 040826 270 DARDQLTRKARDVSMGKRPIKDFEDPRLNG-NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~~ 345 (347)
.................. .+.+.. ....+....+.+|+.+||+.||.+|||+.+|++.|+++.++...+|
T Consensus 272 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~~~ 342 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKL------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 342 (342)
T ss_dssp CSSCCHHHHHHHHTTSCC------CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC---
T ss_pred cCcccHHHHHHHHHHHHh------CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcCCC
Confidence 222222222222211110 111111 1123667889999999999999999999999999999988765543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.35 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=203.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56778889999999999999965 7999999998653 23457889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 999999999998654 45999999999999999999999 889999999999999999999999999999876432
Q ss_pred ceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... . ....+..+.....
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~----~~~~i~~~~~~~p-------- 236 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-T----LFKKICDGIFYTP-------- 236 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-H----HHHHHHTTCCCCC--------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-H----HHHHHhcCCcCCC--------
Confidence 22344579999999999988765 68999999999999999999999754322 1 1122222221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ...++.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 QY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11 2257899999999999999999999987
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.30 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=197.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56778899999999999999964 688999999975421 23577899999888 899999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... .
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-P 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-T
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC-C
Confidence 9999999999998654 35899999999999999999999 78999999999999999999999999999986432 2
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh----hhHHHHHHhhhcCCCCCcccccC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA----RDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
........||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..........+.......
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----- 238 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----- 238 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC-----
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC-----
Confidence 22344567999999999999999999999999999999999999999642111 011111112222121111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
+.....++.+|+.+||+.||.+||++
T Consensus 239 -------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 -------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11223578999999999999999996
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=331.00 Aligned_cols=261 Identities=16% Similarity=0.179 Sum_probs=198.8
Q ss_pred cCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC-------------hhHHHHHHHHhhcCCCCcceeeeeE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN-------------TDSFSREVEGLSRVRHPNLVCLFGC 128 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-------------~~~~~~e~~~l~~l~h~niv~~~~~ 128 (347)
++|...+.||+|+||.||+|... ++..+|+|....... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56788899999999999999965 577899999876532 1236678888999999999999999
Q ss_pred EEe----CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC--c
Q 040826 129 CVE----GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL--E 202 (347)
Q Consensus 129 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~--~ 202 (347)
+.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||.||| +.+++||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 988 67899999999 889999986554 6999999999999999999999 78999999999999999887 9
Q ss_pred eEEeecccceecCCCcc------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHH
Q 040826 203 PKLSDFGLAKMLGMEES------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLT 276 (347)
Q Consensus 203 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~ 276 (347)
+||+|||++........ .......||..|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987642211 111345789999999999999999999999999999999999999964332222222
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
.......... ......... ....++++.+++.+||+.||.+|||+.+|++.|+++
T Consensus 272 ~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 272 TAKTNLLDEL---PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHTT---THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHhhcccc---cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 2222221111 000000000 002235799999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=340.81 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=195.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788899999999999999995 47899999998643 2334677899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| + .|++||||||+|||++.++.+||+|||++.....
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 9999999999988654 45899999999999999999999 5 7999999999999999999999999999975432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... +.......
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~----i~~~~~~~-------- 368 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFEL----ILMEEIRF-------- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH----HHHCCCCC--------
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHH----HHhCCCCC--------
Confidence 222344567999999999999999999999999999999999999999754322 11111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
+.....++.+|+.+||+.||.+|| |+.|+++
T Consensus 369 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 ----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111235799999999999999999 9999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=327.01 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=202.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+... .....+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 567888999999999999999965 5889999998653 3455688899999988 79999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+|||++.+|.+||+|||++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 999999999999986543 5899999999999999999999 78999999999999999999999999999986432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.........||+.|+|||++.+..++.++|+||||+++|+|++|+.||...... ... ..+........
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~~~~~~p------- 241 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELF----QSIMEHNVAYP------- 241 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHHHHCCCCCC-------
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHH----HHHHhCCCCCC-------
Confidence 222344567999999999999999999999999999999999999999754322 111 22222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTI-----DVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~ei~~ 332 (347)
.....++.+|+.+||+.||.+||++ .+|++
T Consensus 242 -----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 -----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1223579999999999999999964 66654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=321.22 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999965 68999999986542 235688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~ 211 (347)
++||||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999654 45899999999999999999999 78999999999999999888 7999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... +.... +.........
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~----i~~~~~~~~~ 239 (321)
T 2a2a_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN----ITSVSYDFDE 239 (321)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH----HHTTCCCCCH
T ss_pred eecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHH----HHhcccccCh
Confidence 876432 2234456899999999999999999999999999999999999999754322 11221 1111111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ...+.+.+++.+||+.||.+|||+.++++
T Consensus 240 ----~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 240 ----EFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----HHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----hhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0001 12357999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.89 Aligned_cols=262 Identities=26% Similarity=0.311 Sum_probs=197.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|... +|+.||+|++...... ..+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367888899999999999999964 6899999998765442 35778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-S 156 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-c
Confidence 999998888877543 45899999999999999999999 789999999999999999999999999999876422 2
Q ss_pred ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----------CCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----------KRP 288 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~ 288 (347)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... +............ ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-DQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhcccccccccccccccc
Confidence 22344568999999999876 67899999999999999999999999754332 2222221111100 000
Q ss_pred ccc--ccCCCCCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 IKD--FEDPRLNGN---INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ~~~--~~~~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... ..++..... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 000000000 00123356899999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=313.31 Aligned_cols=257 Identities=26% Similarity=0.318 Sum_probs=207.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
..++|...+.||+|+||.||+|... ++..+|+|++... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567888899999999999999965 5778999998763 445678999999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 217 (347)
|+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999988654 44899999999999999999999 7899999999999999 78889999999999876432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.......+|..|+|||.+.+. ++.++||||||+++|+|++|..||....... ..... ..+..........
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~-- 232 (277)
T 3f3z_A 163 --KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKI----REGTFTFPEKDWL-- 232 (277)
T ss_dssp --SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH----HHCCCCCCHHHHT--
T ss_pred --cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHH----HhCCCCCCchhhh--
Confidence 233445689999999998764 8999999999999999999999997543321 11111 1111111100000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHHHHh
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE--EIDKAWKN 340 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~--~l~~~~~~ 340 (347)
.....+.+++.+||+.||.+|||+.++++ .+++....
T Consensus 233 ------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 233 ------NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp ------TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred ------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 12357999999999999999999999986 34544433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=315.05 Aligned_cols=245 Identities=28% Similarity=0.397 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... ++..||+|.+... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888899999999999999854 6789999998543 3345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~--- 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC---
Confidence 9999999999988654 35899999999999999999999 8899999999999999999999999999886532
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... .......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~~~~~~--------- 226 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRI----SRVEFTF--------- 226 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH----HHTCCCC---------
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHH----HhCCCCC---------
Confidence 222334568999999999999999999999999999999999999997543221 11111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus 227 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123578999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.59 Aligned_cols=262 Identities=27% Similarity=0.327 Sum_probs=200.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-------ChhHHHHHHHHhhcCC---CCcceeeeeEEEeC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-------NTDSFSREVEGLSRVR---HPNLVCLFGCCVEG 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 132 (347)
..++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999995 578999999986432 1346778888877775 99999999999875
Q ss_pred C-----eEEEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 133 G-----EQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 133 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
. ..+++|||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 57999999985 9999987643 34999999999999999999999 7899999999999999999999999
Q ss_pred ecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 207 DFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 207 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
|||++..... ........+|..|+|||.+.+..++.++||||||+++|+|++|+.||...... +.+...........
T Consensus 163 Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred eCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 9999986532 22234567899999999999999999999999999999999999999754332 22333332221111
Q ss_pred C-Ccccc-------cCCCCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 R-PIKDF-------EDPRLN---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~-~~~~~-------~~~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ..... ..+... .....+..+++.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 00000 000000 0001123367899999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=324.72 Aligned_cols=253 Identities=16% Similarity=0.207 Sum_probs=208.2
Q ss_pred hcCcccCCeeeecCCeeEEEEE------eCCCCEEEEEEcccCCChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGV------LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|. ..+++.||+|++... ....+..|..++++++ |+|++.+++++...+..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 4567888899999999999994 457889999998654 4556788888888886 99999999999999999
Q ss_pred EEEEeecCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-----------C
Q 040826 136 YLVYEFCAAGNLAQHLLR----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-----------K 200 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-----------~ 200 (347)
++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999964 3566999999999999999999999 889999999999999998 8
Q ss_pred CceEEeecccceecCC-CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHH
Q 040826 201 LEPKLSDFGLAKMLGM-EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKA 279 (347)
Q Consensus 201 ~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~ 279 (347)
+.+||+|||++..... ..........||..|+|||++.+..++.++||||||+++|+|+||+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 9999999999976532 2233445567999999999999999999999999999999999999998643221100
Q ss_pred hhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHhhh
Q 040826 280 RDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGR-PTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~ei~~~l~~~~~~~~ 342 (347)
....+.... ..+.+.+++..|++.+|.+| |++.++.+.|++.+....
T Consensus 295 -------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 295 -------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 000111111 23578889999999999998 789999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=322.38 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=196.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC---
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG--- 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 133 (347)
.++|...+.||+|+||.||+|... ++..||+|.+..... ...+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 467888889999999999999853 345899999875432 245889999999999999999999987654
Q ss_pred --eEEEEEeecCCCChHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 134 --EQYLVYEFCAAGNLAQHLLR-----KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 134 --~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
..+++|||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999999842 3456999999999999999999999 8899999999999999999999999
Q ss_pred ecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcC
Q 040826 207 DFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 207 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~---- 264 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDYLLH---- 264 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHT----
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHHc----
Confidence 9999986543221 12233457889999999999999999999999999999999 88888643322 11111111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+... ........++.+++.+||+.||.+|||+.++++.|+++++.
T Consensus 265 ~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 265 GHRL-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp TCCC-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 01112335799999999999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=316.84 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=184.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788889999999999999996 57899999998643 2345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999876677999999999999999999999 7899999999999999999999999999998764222
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......... ...
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~--------~~~- 231 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVVLAD--------YEM- 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSC--------CCC-
T ss_pred -CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHhhcc--------cCC-
Confidence 12233568999999999999889999999999999999999999997432211 011111111 011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.....++.+++.+||+.||.+|||+.++++
T Consensus 232 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 ---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122357899999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=325.04 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=180.9
Q ss_pred CCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 71 RRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
.+.||+|+||.||+|... +|+.||+|.+... ....+.+|+..++.+. ||||+++++++.+....++||||+++|+|.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 478999999999999964 6899999998643 3456778999999997 999999999999999999999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceEEeecccceecCCCccceeecc
Q 040826 149 QHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 149 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++ .++|+|||++...... .......
T Consensus 95 ~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 169 (325)
T 3kn6_A 95 ERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTP 169 (325)
T ss_dssp HHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCccccc
Confidence 999664 46999999999999999999999 78999999999999998766 7999999999865422 2233445
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
.+|..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........+..+...... ....
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~--------~~~~ 241 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG--------EAWK 241 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS--------HHHH
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc--------cccc
Confidence 6899999999999999999999999999999999999999753221 11112223333322211110 0011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+++.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 23467999999999999999999998873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.38 Aligned_cols=245 Identities=28% Similarity=0.377 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.+.|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34578889999999999999995 5789999999865432 23578999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++ +|.+++......+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 999985 898888766677999999999999999999999 78999999999999999999999999999986532
Q ss_pred cceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.....||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... ......... ..+
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~----~~~------- 271 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN----ESP------- 271 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS----CCC-------
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc----CCC-------
Confidence 23356899999999884 567899999999999999999999998754322 112222111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. ......+.+.+++.+||+.||.+|||+.++++.
T Consensus 272 ~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 011223578999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=319.80 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=204.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 3567888899999999999999965 689999999988777788999999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++++|.+++......+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-BSCB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-cccc
Confidence 999999999766677999999999999999999999 789999999999999999999999999999875422 2223
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ...+ .+. ..
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~--~~~-------~~ 248 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-IFMIPT----NPPP--TFR-------KP 248 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH----SCCC--CCS-------SG
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhc----CCCc--ccC-------Cc
Confidence 345689999999999998999999999999999999999999975432211 111111 1100 000 01
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112357999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=314.81 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888899999999999999954 689999999865432 245778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~ 216 (347)
||+++++|.+.+... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988654 45899999999999999999999 789999999999999987655 99999999987642
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...... ............ .. .+.
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~----~~---~~~ 230 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYD----YP---SPE 230 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC----CC---TTT
T ss_pred --CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhcccc----CC---chh
Confidence 22234467899999999999999999999999999999999999999754322 212222211111 10 010
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.....+++.+++.+||+.||.+|||+.++++.
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 -----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01223579999999999999999999999873
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.47 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=194.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh-----hHHHHHHHHhhcCCCCcceeeeeEEEeCC----e
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT-----DSFSREVEGLSRVRHPNLVCLFGCCVEGG----E 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 134 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++...... ..+.+|+..+++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788889999999999999995 57899999999764322 35789999999999999999999987644 3
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998654 35899999999999999999999 789999999999999999999999999999865
Q ss_pred CCCcc--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 215 GMEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 215 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..... .......||..|+|||.+.+..++.++||||||+++|+|++|+.||........... .... ...+ ...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~---~~~~-~~~ 241 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-HVRE---DPIP-PSA 241 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHC---CCCC-HHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhcC---CCCC-ccc
Confidence 43222 223345689999999999999999999999999999999999999975433222111 1111 1100 000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVY-EEIDKA 337 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~-~~l~~~ 337 (347)
. ......++.+++.+||+.||.+||+..+++ ..+...
T Consensus 242 ~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 242 R--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 011235799999999999999999766554 444444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.80 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=201.3
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEee
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+..... ...+|++++.++ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4577888999999999999999964 688999999976543 345788888888 799999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC----CceEEeecccceecCCC
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK----LEPKLSDFGLAKMLGME 217 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~----~~~kl~dfg~~~~~~~~ 217 (347)
+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||++.++ +.+||+|||++......
T Consensus 98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999998654 45999999999999999999999 7899999999999998543 24999999999876432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
. .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ........+..+..... .
T Consensus 174 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~~~----~-- 244 (342)
T 2qr7_A 174 N-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFSLS----G-- 244 (342)
T ss_dssp T-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCCCC----S--
T ss_pred C-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcccC----c--
Confidence 2 2234457899999999999888999999999999999999999999753211 11222222222221111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+++.+|+.+||+.||.+|||+.++++
T Consensus 245 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 --GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111123357999999999999999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=328.07 Aligned_cols=252 Identities=27% Similarity=0.342 Sum_probs=202.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccC------CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKS------NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
.++|...+.||+|+||.||++.. .+|+.||+|++... .....+.+|+.+++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46788899999999999999996 47899999998643 2345677899999999 6999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999996543 5899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.............||..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .....+.......+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~--- 284 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPP--- 284 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccCCC---
Confidence 65433333445679999999999985 3578899999999999999999999975332211 11122222111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
.+......+.+|+.+||+.||.+|| |+.++++.
T Consensus 285 ---------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 285 ---------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1112335789999999999999999 89998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=313.30 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=204.9
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe-----------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE----------- 131 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------- 131 (347)
...+|...+.||+|+||.||+|... +|+.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 3567888899999999999999975 78999999986543 457799999999999999999998864
Q ss_pred -----CCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEE
Q 040826 132 -----GGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKL 205 (347)
Q Consensus 132 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl 205 (347)
....++||||+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEE
Confidence 34579999999999999999653 456999999999999999999999 789999999999999999999999
Q ss_pred eecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 206 SDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+... .. .......+
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~----~~~~~~~~ 234 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SK----FFTDLRDG 234 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HH----HHHHHHTT
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HH----HHHHhhcc
Confidence 9999998764322 233456899999999999999999999999999999999999876421 11 11111111
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
. +...++ ..+.+++.+||+.||.+|||+.++++.|+.+.++
T Consensus 235 ~----------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 I----------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp C----------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c----------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 111222 4688999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.66 Aligned_cols=256 Identities=25% Similarity=0.284 Sum_probs=200.4
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-------CChhHHHHHHHHhhcCCCCcceeeeeEEEeC
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-------NNTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 132 (347)
+..+.++|...+.||+|+||.||+|.. .++..||+|.+... .....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999995 46889999988643 2345788999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRK---------------------------------------DSVLTWERRVKILRDCALA 173 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~ 173 (347)
+..++||||+++|+|.+++... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988420 1123567788999999999
Q ss_pred HHHhhhccCCCceeCCCCCCCEEecCCC--ceEEeecccceecCCCc---cceeecccCCCCccccccccC--CccCCcc
Q 040826 174 LRYLHHYIDGCIVHRDIKLTNILLTEKL--EPKLSDFGLAKMLGMEE---SKVFTDVRGTIGYMDPEYMTN--AKLTCAS 246 (347)
Q Consensus 174 l~~Lh~~~~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~ 246 (347)
|.||| +.+++|+||||+||+++.++ .+||+|||++....... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 78999999999999998776 89999999998753211 112345578999999999875 6789999
Q ss_pred cHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 040826 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPT 326 (347)
Q Consensus 247 Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps 326 (347)
||||||+++|+|++|+.||...... +............. .+. ......++.+++.+||+.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~-------~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFE-------NPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTT-------SGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccC-------Ccc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999754332 22222222111111 010 0112357999999999999999999
Q ss_pred HHHHHH
Q 040826 327 IDVVYE 332 (347)
Q Consensus 327 ~~ei~~ 332 (347)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=323.38 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=205.0
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----------hhHHHHHHHHhhcC-CCCcceeee
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----------TDSFSREVEGLSRV-RHPNLVCLF 126 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l-~h~niv~~~ 126 (347)
.......++|...+.||+|+||.||+|... +|+.||||++..... ...+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999975 799999999865432 23577899999999 799999999
Q ss_pred eEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 127 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999998654 45899999999999999999999 7899999999999999999999999
Q ss_pred ecccceecCCCccceeecccCCCCccccccccC------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHh
Q 040826 207 DFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280 (347)
Q Consensus 207 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~ 280 (347)
|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ........
T Consensus 243 DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~ 319 (365)
T 2y7j_A 243 DFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRMIME 319 (365)
T ss_dssp CCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred ecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh
Confidence 99999876432 22344679999999998863 35889999999999999999999999753221 11111111
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+..... .+.. .. ....+.+++.+||+.||.+|||+.++++
T Consensus 320 ----~~~~~~---~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 ----GQYQFS---SPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----TCCCCC---HHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCCCC---Cccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111100 0000 01 2256999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=322.28 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=197.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHH--hhcCCCCcceeeeeEEEe-----CCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEG--LSRVRHPNLVCLFGCCVE-----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~~~l 137 (347)
.++|...+.||+|+||.||+|.. +|+.||+|++.... ...+..|.++ +..++||||+++++.+.. ....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 45778889999999999999987 68999999986443 3334444444 455899999999986543 236789
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC---------CceeCCCCCCCEEecCCCceEEeec
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG---------CIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~---------~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
||||+++|+|.+++.... .++..+..++.|++.||.||| +. +++||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999996543 588999999999999999999 67 9999999999999999999999999
Q ss_pred ccceecCCCc-------cceeecccCCCCccccccccC-------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh-
Q 040826 209 GLAKMLGMEE-------SKVFTDVRGTIGYMDPEYMTN-------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD- 273 (347)
Q Consensus 209 g~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~- 273 (347)
|++....... ........||..|+|||.+.+ ..++.++||||||+++|+|++|..|+........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998764321 111234569999999999987 4677899999999999999999887753321100
Q ss_pred ------------HHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 274 ------------QLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 274 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
............. .... ..+.+ ........++.+|+.+||+.||.+|||+.|+++.|++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREK-QRPK-FPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSC-CCCC-CCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccc-cCCC-CCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 0000000000000 0000 00001 112345678999999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.44 Aligned_cols=268 Identities=22% Similarity=0.210 Sum_probs=205.0
Q ss_pred ccHHHHHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-ChhHHHHHHHHhhcCC-----CCcceeeeeE
Q 040826 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-NTDSFSREVEGLSRVR-----HPNLVCLFGC 128 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~-----h~niv~~~~~ 128 (347)
++..+.....++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+..|..+++.+. ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33333334567899999999999999999996 478999999986532 2346778999999886 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC--------
Q 040826 129 CVEGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-------- 199 (347)
Q Consensus 129 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-------- 199 (347)
+...+..++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999 889999997543 45899999999999999999999 789999999999999975
Q ss_pred -----------------CCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCC
Q 040826 200 -----------------KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262 (347)
Q Consensus 200 -----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~ 262 (347)
++.+||+|||++..... ......||..|+|||++.+..++.++||||||+++|+|++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 78999999999986432 223456899999999999999999999999999999999999
Q ss_pred CCcCCChhhhhHHHHHHhhhcCCCC---------Cccccc-CCCC----CCCC-C---------------HHHHHHHHHH
Q 040826 263 KVIELDFDARDQLTRKARDVSMGKR---------PIKDFE-DPRL----NGNI-N---------------RADFESILKI 312 (347)
Q Consensus 263 ~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~l----~~~~-~---------------~~~~~~l~~l 312 (347)
.||...... +.+............ ...... ...+ .... . ....+.+.+|
T Consensus 257 ~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 257 LLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp CSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 999754322 222221111110000 000000 0000 0000 0 0011568899
Q ss_pred HHHhccCCCCCCCCHHHHHH
Q 040826 313 AVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 313 ~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.+||+.||.+|||+.|+++
T Consensus 336 i~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCChhhCCCHHHHhc
Confidence 99999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=315.04 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=196.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||++.. .+|..+|+|.+.... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35677889999999999999995 468899999987643 34678899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceec
Q 040826 141 FCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKML 214 (347)
Q Consensus 141 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 214 (347)
|+++|+|.+++.. ....+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998854 3467999999999999999999999 7899999999999999 45678999999999865
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
... .......++..|+|||.+.+ .++.++||||||+++|+|++|+.||......... ............
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~~~~--- 246 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-----QKATYKEPNYAV--- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCCCCCCC---
T ss_pred CCc--ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-----hhhccCCccccc---
Confidence 422 22344568999999998864 6888999999999999999999999754322211 111111111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..... .+++.+++.+||+.||.+|||+.|+++
T Consensus 247 --~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112 257889999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.18 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=205.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999964 7999999998542 3455688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 139 YEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
|||+++|+|.+++...+ ..+++..++.++.|++.||.||| +.||+||||||+|||++.+|.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987643 45999999999999999999999 789999999999999999999999999999876422
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ...+..... ......
T Consensus 340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~---~~~~~~------ 408 (576)
T 2acx_A 340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVPEEY------ 408 (576)
T ss_dssp --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH---HCCCCC------
T ss_pred --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh---cccccC------
Confidence 2234457999999999999999999999999999999999999999764321 112222111 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
+.....++.+|+.+||+.||.+|| ++.||++
T Consensus 409 ------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 ------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112235799999999999999999 6788865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=322.46 Aligned_cols=241 Identities=25% Similarity=0.291 Sum_probs=201.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----------ChhHHHHHHHHhhcCCCCcceeeeeEEEeC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----------NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 132 (347)
..++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 467899999999999999999994 578899999987643 233577899999999999999999999999
Q ss_pred CeEEEEEeecCCC-ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 133 GEQYLVYEFCAAG-NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 133 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
+..++||||+.+| +|.+++... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 999988654 45999999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
...... .......||..|+|||.+.+..+ +.++||||||+++|+|++|..||..... .......
T Consensus 178 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~-- 242 (335)
T 3dls_A 178 AYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVEAAIH-- 242 (335)
T ss_dssp EECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTTTCCC--
T ss_pred eECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHhhccC--
Confidence 876432 22334568999999999988776 7899999999999999999999963211 0000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+ .. ..+++.+|+.+||+.||.+|||+.++++.
T Consensus 243 ---~~---~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 ---PP---YL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CS---SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---CC---cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01 23579999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=322.03 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=198.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888899999999999999965 789999999865432 22455799999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++ +|.+++...+..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKT 156 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccc
Confidence 985 999999877778999999999999999999999 789999999999999999999999999999865322 222
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-CcccccC-----
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PIKDFED----- 294 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----- 294 (347)
.....+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+......+....... .......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 344568999999999876 5689999999999999999999999975432 2333333332211110 0110000
Q ss_pred ----CCCCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 ----PRLNGN----INRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ----~~l~~~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+..... .......++.+|+.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00122357899999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.77 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=199.0
Q ss_pred CeeeecCCeeEEEEEe---CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVL---PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4699999999999964 3567899999975422 3578999999999999999999999864 568899999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc--cee
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVF 222 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 222 (347)
|+|.+++... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........ ...
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999654 45899999999999999999999 78999999999999999999999999999987643222 122
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....+|..|+|||++.+..++.++||||||+++|+|++ |+.||...... +... .+..+... ..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~----~i~~~~~~-----------~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTA----MLEKGERM-----------GC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHTTCCC-----------CC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHcCCCC-----------CC
Confidence 33456788999999999899999999999999999998 99999754322 1111 11111111 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+..++.++.+++.+||+.||++|||+.+|++.|++++.+-
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1233468999999999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=322.03 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=196.0
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
...++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457889999999999999999994 4789999999975432 2357789999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-----CCCceEEeecccce
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-----EKLEPKLSDFGLAK 212 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-----~~~~~kl~dfg~~~ 212 (347)
||||+++ +|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++ .++.+||+|||++.
T Consensus 111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999986 9999886544 4899999999999999999999 78999999999999994 45569999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-cc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IK 290 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 290 (347)
..... ........+|..|+|||.+.+. .++.++||||||+++|+|++|..||...... +.+............. ..
T Consensus 186 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTST
T ss_pred ccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhhh
Confidence 65422 2223445689999999999874 5899999999999999999999999754332 2233333222111100 00
Q ss_pred cc--------cCCCCCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DF--------EDPRLNGNI-----NRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~--------~~~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ..+...... .....+++.+|+.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000000000 0112367899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.09 Aligned_cols=244 Identities=25% Similarity=0.251 Sum_probs=192.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHH-hhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEG-LSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467888899999999999999965 68899999986542 23345666666 577899999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++... ..+++..++.++.|++.||.||| ++|++||||||+|||++.+|.+||+|||++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 99999999999988654 35899999999999999999999 78999999999999999999999999999875322
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||...... .....+. ......
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~----~~~~~~-------- 258 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNIL----NKPLQL-------- 258 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHH----HSCCCC--------
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH----hcccCC--------
Confidence 222344567999999999999999999999999999999999999999754322 1122221 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
...+ ..++.+|+.+||+.||.+||++.+.
T Consensus 259 ~~~~----~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 259 KPNI----TNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CSSS----CHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCC----CHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1122 2578999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.86 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=194.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCCh----hHHHHHHHHhhcCCC--CcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNT----DSFSREVEGLSRVRH--PNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++...+++.||+|++...... ..+.+|+.++++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3567888999999999999999888999999998754322 467899999999976 9999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
||+ .+++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++ ++.+||+|||++.......
T Consensus 88 ~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 577999999764 45899999999999999999999 78999999999999997 5789999999998764322
Q ss_pred cc-eeecccCCCCccccccccC-----------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 219 SK-VFTDVRGTIGYMDPEYMTN-----------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 219 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...................
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-- 239 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 239 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--
Confidence 21 2334579999999999864 678889999999999999999999997543332222222211100
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...+.....++.+|+.+||+.||.+|||+.++++.
T Consensus 240 ------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 ------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 01111122578999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=322.58 Aligned_cols=265 Identities=27% Similarity=0.321 Sum_probs=201.5
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
...++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578888999999999999999964 689999999865321 2467899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++ +|.+++......+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999987 899988777677999999999999999999999 789999999999999999999999999999875
Q ss_pred CCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-C----
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-P---- 288 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~---- 288 (347)
... ........+|..|+|||.+.+ ..++.++||||||+++|+|++|.+||..... .+.+............ .
T Consensus 163 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSST
T ss_pred cCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhhhh
Confidence 422 222344578999999999876 4588999999999999999999998875432 2333333332211110 0
Q ss_pred --cccccCCCCCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 --IKDFEDPRLNGNIN-----RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 --~~~~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.............+ .....++.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000011 1233679999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=328.19 Aligned_cols=265 Identities=18% Similarity=0.198 Sum_probs=200.7
Q ss_pred hcCcccCCeeeec--CCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRG--SAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+| +||.||+|... +|+.||+|++..... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3567788999999 99999999965 799999999975432 2457789999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 138 VYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999998654 356999999999999999999999 78999999999999999999999999998875421
Q ss_pred Ccc------ceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC---
Q 040826 217 EES------KVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG--- 285 (347)
Q Consensus 217 ~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--- 285 (347)
... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCCCcccc
Confidence 111 11122368889999999987 67999999999999999999999999753222111 1110000000
Q ss_pred --CCCcccc-------------------c------CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 286 --KRPIKDF-------------------E------DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 286 --~~~~~~~-------------------~------~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+...+ . ..............++.+|+.+||+.||.+|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 0 0000001222344679999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=333.78 Aligned_cols=262 Identities=18% Similarity=0.183 Sum_probs=211.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCC-CcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-PNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.. .+|+.||||++........+.+|+.+++.++| +++..+..++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46788999999999999999995 57899999998777777778999999999986 55556666667788999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecCCCcc
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
+++|.+++......+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 88999999766677999999999999999999999 7899999999999999 6889999999999987653322
Q ss_pred c------eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhh--hhHHHHHHhhhcCCCCCccc
Q 040826 220 K------VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDA--RDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 220 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (347)
. ......||..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+........... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~--~~~ 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS--IEA 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC--HHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc--HHH
Confidence 1 123567999999999999999999999999999999999999999753221 111222211111100 000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+ ...+..++.+++.+||+.+|++||++.+|++.|++++...
T Consensus 240 l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 L---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp H---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0 0012357999999999999999999999999999997653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.18 Aligned_cols=245 Identities=20% Similarity=0.248 Sum_probs=201.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|++... .....+.+|..++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56777889999999999999964 7999999998643 33457889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
||+++|+|.+++... ...+++..++.++.|++.||.||| +.|++||||||+|||++.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998653 346999999999999999999999 78999999999999999999999999999987643
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||........ .......+.......
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~~~~------- 412 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQAVTY------- 412 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCCCCC-------
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcccCC-------
Confidence 22 223345799999999999999999999999999999999999999975432111 111222222111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
+......+.+|+.+||+.||.+||++
T Consensus 413 -----p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 -----PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11223578999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=328.82 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=191.3
Q ss_pred hcCcccC-CeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhh-cCCCCcceeeeeEEEe----CCeEEE
Q 040826 65 INNDWDR-RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLS-RVRHPNLVCLFGCCVE----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~l 137 (347)
.++|... +.||+|+||.||+|... +|+.||+|++.. ...+.+|+.++. ..+||||+++++++.. .+..++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 4556555 68999999999999954 789999999853 345778888874 4589999999999876 557899
Q ss_pred EEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccccee
Q 040826 138 VYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKM 213 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~ 213 (347)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+|||++. ++.+||+|||++..
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999997643 46999999999999999999999 789999999999999997 78999999999987
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... ........||..|+|||++.+..++.++||||||+++|+|++|..||.......... .....+..+.....
T Consensus 214 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~~~~~~~~--- 287 (400)
T 1nxk_A 214 TTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRMGQYEFP--- 287 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHHHTCCCCC---
T ss_pred cCC--CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHHcCcccCC---
Confidence 542 222345578999999999999999999999999999999999999997543221100 00011111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.. .....++.+|+.+||+.||.+|||+.+++++
T Consensus 288 ~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110 1223579999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.27 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=203.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.. .++..||+|.+..... ...+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788889999999999999983 2577899999975433 34688899999999999999999999998899
Q ss_pred EEEEeecCCCChHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEe
Q 040826 136 YLVYEFCAAGNLAQHLLRKD------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLS 206 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~ 206 (347)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999997543 45899999999999999999999 789999999999999994 4469999
Q ss_pred ecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcC
Q 040826 207 DFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 207 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ..+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~----~~~~~ 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVL----EFVTS 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH----HHHHT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHH----HHHhc
Confidence 9999875432221 22233467889999999988889999999999999999998 88888643221 111 11111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+... .........+.+++.+||+.||.+|||+.++++.|+.+.++.
T Consensus 261 ~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 GGRM-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCC-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1111 011123357999999999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=311.32 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=203.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888899999999999999965 68999999886532 245788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~ 211 (347)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999998654 45899999999999999999999 78999999999999999877 7999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...... .........
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~ 232 (283)
T 3bhy_A 160 HKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNI----SAVNYDFDE 232 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH----HTTCCCCCH
T ss_pred eeccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHh----HhcccCCcc
Confidence 875422 2233456899999999999989999999999999999999999999754322 111111 111111100
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE--EIDKA 337 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~--~l~~~ 337 (347)
.. .....+.+.+++.+||+.||.+|||+.++++ .++.+
T Consensus 233 ----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 233 ----EY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ----HH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----hh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 00 0112357999999999999999999999997 45554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=321.31 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=202.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe--------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE-------- 131 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 131 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788889999999999999996 5789999999865432 3467899999999999999999999887
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.+..++||||+++ +|.+.+......+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999986 888888776677999999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCc---cceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 212 KMLGMEE---SKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 212 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
....... ........||..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ...............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 8764221 122344568999999999876 56899999999999999999999999754332 222222222111111
Q ss_pred C-cccccCCC------CCC---CCCHH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 P-IKDFEDPR------LNG---NINRA------DFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~-~~~~~~~~------l~~---~~~~~------~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ........ ... ....+ ..+.+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 00000000 000 00000 1246889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=325.68 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=195.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCC--CCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVR--HPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 139 (347)
.+|...+.||+|+||.||++...+++.||+|.+..... ...+.+|+.+++++. ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888899999999999999988899999999865432 246889999999996 599999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
| +.+++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++ ++.+||+|||++........
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56779999987654 6899999999999999999999 88999999999999996 57999999999987643222
Q ss_pred c-eeecccCCCCccccccccC-----------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 220 K-VFTDVRGTIGYMDPEYMTN-----------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 220 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........+..... ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~----~~~ 285 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----PNH 285 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----TTS
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----ccc
Confidence 1 2344579999999999865 36888999999999999999999999754332222222221 111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. ..+.....++.+|+.+||+.||.+|||+.|+++.
T Consensus 286 ~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EI----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CC----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC----------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00 0111112578999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=311.69 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888899999999999999965 78999999986543 23578899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
|+++++|.+++.. ...+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998854 345899999999999999999999 78999999999999999999999999999986532221
Q ss_pred ceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......++..|+|||.+.+..+ +.++||||||+++|+|++|..||............+.... ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~-------- 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----TYLN-------- 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----TTST--------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----cccC--------
Confidence 22344568999999999987665 7799999999999999999999976544333333222211 0000
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........+.+++.+||+.||.+|||+.++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00122357899999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=316.13 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=203.6
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+.|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577788999999999999985 478999999986543 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++.. ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 999999998854 46899999999999999999999 7899999999999999999999999999998764322 22
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ...... .... +.+...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~-------~~~~~~~ 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VLFLIP----KNNP-------PTLEGNY 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH----HSCC-------CCCCSSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-HHHHhh----cCCC-------CCCcccc
Confidence 344568999999999999999999999999999999999999987433221 111111 1111 1111222
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...+.+++.+||+.||.+|||+.++++.
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3569999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=348.19 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=206.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC----CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|.+. .+..||+|.+...... ..+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 466788889999999999999864 2457999998754332 56889999999999999999999984 557899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++......+++..++.++.|++.||.||| +.|++||||||+|||++.++.+||+|||++......
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876433
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....... +...
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~~~i~~----~~~~-------- 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIEN----GERL-------- 611 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHH----TCCC--------
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHc----CCCC--------
Confidence 3333334457789999999998899999999999999999997 8888874322 222222211 1110
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
..+..++..+.+++.+||+.||.+|||+.++++.|++++++..
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 1111233679999999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=311.64 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=203.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... +++.||+|.+... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888899999999999999965 6789999998542 2345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++...+ .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999986543 5899999999999999999999 889999999999999999999999999998765322
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ... .+.......
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~----~~~~~~~~~--------- 231 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THR----RIVNVDLKF--------- 231 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHH----HHHTTCCCC---------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHH----HHhccccCC---------
Confidence 2234568999999999999999999999999999999999999997543221 111 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+......+.+++.+||+.||.+|||+.++++.
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11223578999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=322.17 Aligned_cols=263 Identities=27% Similarity=0.368 Sum_probs=198.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|... +|+.||+|++...... ..+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888899999999999999965 5899999998655432 34678999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.++... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-G 178 (331)
T ss_dssp ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-c
Confidence 99999888876643 345999999999999999999999 789999999999999999999999999999865422 2
Q ss_pred ceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----------CCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG----------KRP 288 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~ 288 (347)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ............ ...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhccc
Confidence 223445689999999999875 78999999999999999999999997654322 221111111000 000
Q ss_pred cccccCCCCCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 IKDFEDPRLNGNIN-----RADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 ~~~~~~~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......+....... ....+++.+|+.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01111111111111 1234689999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=330.83 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=192.4
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCC-CCcceeeeeEEEeCC--e
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVR-HPNLVCLFGCCVEGG--E 134 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~ 134 (347)
...++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3567899999999999999999995 4789999999865422 345778999999997 999999999997544 7
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++ +|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 8999999985 89998865 36899999999999999999999 789999999999999999999999999999865
Q ss_pred CCC--------------------ccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhh
Q 040826 215 GME--------------------ESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARD 273 (347)
Q Consensus 215 ~~~--------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~ 273 (347)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-TMN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHH
Confidence 321 1112334579999999999986 678999999999999999999999997543 223
Q ss_pred HHHHHHhhhcCCCCC-ccccc------------------CCCCCCCC------------CHHHHHHHHHHHHHhccCCCC
Q 040826 274 QLTRKARDVSMGKRP-IKDFE------------------DPRLNGNI------------NRADFESILKIAVLCVAKSSK 322 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~-~~~~~------------------~~~l~~~~------------~~~~~~~l~~l~~~cl~~~p~ 322 (347)
.+..+.......... ..... .......+ .....+++.+|+.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 333333222111100 00000 00000000 002235789999999999999
Q ss_pred CCCCHHHHHHH
Q 040826 323 GRPTIDVVYEE 333 (347)
Q Consensus 323 ~Rps~~ei~~~ 333 (347)
+|||+.|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.74 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 137 (347)
.++|...+.||+|+||.||++.. .+|+.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788889999999999999996 578999999886543 23568899999999999999999999873 347899
Q ss_pred EEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 138 VYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
|+||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999998865 4567999999999999999999999 789999999999999999999999999998765
Q ss_pred CCCccc--------eeecccCCCCccccccccCCc---cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 215 GMEESK--------VFTDVRGTIGYMDPEYMTNAK---LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 215 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
...... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||..................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321110 012235799999999987543 788999999999999999999998632211111111111100
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
.. ........++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 265 --~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 265 --SI------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --CC------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 001122357999999999999999999999999998863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=314.66 Aligned_cols=255 Identities=24% Similarity=0.272 Sum_probs=194.7
Q ss_pred cCccc-CCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWD-RRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~-~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 140 (347)
+.|.. .+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45555 36799999999999994 478999999986543 346788999999885 79999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~ 217 (347)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999654 35899999999999999999999 789999999999999998776 999999998765321
Q ss_pred c------cceeecccCCCCccccccccC-----CccCCcccHHHHHHHHHHHHhCCCCcCCChhhh----------hHHH
Q 040826 218 E------SKVFTDVRGTIGYMDPEYMTN-----AKLTCASDIYSFGIVALQLLSGQKVIELDFDAR----------DQLT 276 (347)
Q Consensus 218 ~------~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~----------~~~~ 276 (347)
. ........||..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1 111223458999999999875 568899999999999999999999997542210 0011
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+..+......... . ....++.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~i~~~~~~~~~~~~----~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDW----A----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCCCCHHHH----T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcccCchhc----c----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111222222111110000 0 12357999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=314.56 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=202.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
..++|...+.||+|+||.||++... +|+.||+|.+.... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567888899999999999999964 78999999987543 34568899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecCCC
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 217 (347)
|+++++|.+++...+ .+++..+..++.|++.||.||| +.|++|+||||+||++ ++++.++|+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 999999999886543 5899999999999999999999 7899999999999999 7888999999999875432
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ +..... .
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~----~~~~~~---~--- 228 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKE----GYYEFE---S--- 228 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHH----CCCCCC---T---
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHc----CCCCCC---c---
Confidence 1223346899999999999999999999999999999999999999754321 11222211 111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........++.+++.+||+.||.+|||+.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 --PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111123357999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=325.38 Aligned_cols=269 Identities=23% Similarity=0.273 Sum_probs=201.6
Q ss_pred cHHHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-------------hhHHHHHHHHhhcCCCCcce
Q 040826 57 SKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-------------TDSFSREVEGLSRVRHPNLV 123 (347)
Q Consensus 57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~e~~~l~~l~h~niv 123 (347)
...++....++|...+.||+|+||.||+|...+|+.||+|++..... ...+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 44577788899999999999999999999988899999999865322 15688999999999999999
Q ss_pred eeeeEEEeC-----CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 124 CLFGCCVEG-----GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 124 ~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
++++++... ...++||||+++ +|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 999998542 368999999985 999988877778999999999999999999999 78999999999999999
Q ss_pred CCCceEEeecccceecCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR 277 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~ 277 (347)
.++.++|+|||++..... ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~ 245 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNK 245 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH
T ss_pred CCCCEEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 999999999999975432 222334568999999999876 67899999999999999999999999764322 22222
Q ss_pred HHhhhcCCCCC---------cccccCCCC-------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 278 KARDVSMGKRP---------IKDFEDPRL-------NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 278 ~~~~~~~~~~~---------~~~~~~~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........... ......... .........+.+.+|+.+||+.||.+|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 21111110000 000000000 00011122357999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=314.53 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=203.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356778899999999999999965 68899999986542 234678899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 168 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC-
Confidence 9999999999988654 45899999999999999999999 789999999999999999999999999999876422
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .... +.......
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~~--------- 234 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLR----IKKNEYSI--------- 234 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH----HHTTCCCC---------
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH----HhhccCCC---------
Confidence 222334568999999999999899999999999999999999999997543221 1111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+......+.+++.+||+.||.+|||+.++++.
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 ---PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11222578999999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=320.83 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++... +++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888899999999999999965 58899999986542 234688899999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC-
Confidence 9999999999988654 45899999999999999999999 789999999999999999999999999999876422
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... .....
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~----~~~~~--------- 260 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKK----NEYSI--------- 260 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH----TCCCC---------
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhc----CCCCC---------
Confidence 222344568999999999999999999999999999999999999997543221 1111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+.....++.+++.+||+.||.+|||+.++++.
T Consensus 261 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 ---PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122578999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.11 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=196.2
Q ss_pred cCcccCCeeeecCCeeEEEEEeC--CCC--EEEEEEcccCC-----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP--SGQ--VVAIKHIYKSN-----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|.+. +++ .||+|.+.... ..+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56778889999999999999853 333 68999886542 2346889999999999999999999987654 88
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+|+||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999776667999999999999999999999 78999999999999999999999999999987643
Q ss_pred Cccc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 217 EESK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 217 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~----~~~~~~~~~---- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILH----KIDKEGERL---- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH----HHHTSCCCC----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHH----HHHccCCCC----
Confidence 3222 1223457788999999998889999999999999999999 99998754322 1111 111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
........++.+++.+||+.||.+|||+.++++.|+++......
T Consensus 245 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 245 ------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred ------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 01112336799999999999999999999999999998655443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.04 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=196.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeC------C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEG------G 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 133 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788899999999999999985 468999999997542 234678999999999999999999998654 4
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 67999999987 57666633 3899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-------
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK------- 286 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 286 (347)
... ........||..|+|||++.+..++.++|||||||++|+|++|+.||.... ..+++..+........
T Consensus 214 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHc
Confidence 542 223445679999999999999999999999999999999999999997543 2233333332221110
Q ss_pred -----------CCcc-----cccCCCCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 287 -----------RPIK-----DFEDPRLN---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 287 -----------~~~~-----~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... ......+. .........++.+|+.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000 00111225689999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=322.91 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=205.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC---h----------------hHHHHHHHHhhcCCCCcceee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN---T----------------DSFSREVEGLSRVRHPNLVCL 125 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~----------------~~~~~e~~~l~~l~h~niv~~ 125 (347)
.++|...+.||+|+||.||+|.. +|+.||+|.+..... . ..+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788889999999999999999 899999999864311 1 678999999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccC-CCceeCCCCCCCEEe
Q 040826 126 FGCCVEGGEQYLVYEFCAAGNLAQH------LLRK-DSVLTWERRVKILRDCALALRYLHHYID-GCIVHRDIKLTNILL 197 (347)
Q Consensus 126 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~-~~i~H~dl~p~Nili 197 (347)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.||| + .|++|+||+|+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 5432 567999999999999999999999 6 899999999999999
Q ss_pred cCCCceEEeecccceecCCCccceeecccCCCCccccccccCC-ccCC-cccHHHHHHHHHHHHhCCCCcCCChhhhhHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTC-ASDIYSFGIVALQLLSGQKVIELDFDARDQL 275 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slG~il~~lltg~~p~~~~~~~~~~~ 275 (347)
+.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|+|++|..||..........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999875322 34456789999999999877 6666 9999999999999999999998654322222
Q ss_pred HHHHhhhcCCCCCccc----ccCCCCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 276 TRKARDVSMGKRPIKD----FEDPRLN---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~----~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... .+...... +..+... .........++.+++.+||+.||.+|||+.++++
T Consensus 263 ~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222 22111111 0000000 0011233467999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.66 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=192.2
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----------ChhHHHHHHHHhhcCCCCcceeeeeEEEe
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----------NTDSFSREVEGLSRVRHPNLVCLFGCCVE 131 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 131 (347)
...++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4578899999999999999999995 468999999986431 1235789999999999999999999975
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceEEeec
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPKLSDF 208 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~kl~df 208 (347)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++ .+||+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 55689999999999999988654 45899999999999999999999 78999999999999997544 5999999
Q ss_pred ccceecCCCccceeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
|++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||............... +
T Consensus 287 G~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----~ 360 (419)
T 3i6u_A 287 GHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----G 360 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----T
T ss_pred ccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----C
Confidence 99987542 223345679999999999853 56888999999999999999999999754322221111111 1
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..... +.... ...+.+.+|+.+||+.||.+|||+.++++
T Consensus 361 ~~~~~----~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNFI----PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCC----HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCC----chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11100 00000 12357999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=332.49 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=199.5
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
..++|...+.||+|+||.||+|... ++..+|+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567888999999999999999965 7889999998753 2345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC---CceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK---LEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~ 215 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.. +.+||+|||++....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999988654 35899999999999999999999 7899999999999999764 459999999998764
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. .......||+.|+|||++.+ .++.++||||+|+++|+|++|..||...... .....+. .+..... .+
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~----~~~~~~~---~~ 259 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVE----KGKYTFD---SP 259 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----HTCCCCC---SG
T ss_pred CC--ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----hCCCCCC---ch
Confidence 32 23345679999999998864 6899999999999999999999999754322 2222222 2211111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+ .. ..+.+.+|+.+||+.||.+|||+.++++.
T Consensus 260 ~~-~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 EW-KN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG-TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hc-cc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 11 23578999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.50 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=199.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 137 (347)
.++|...+.||+|+||.||++... +|+.||+|.+..... .+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888899999999999999964 789999999875432 3468899999999999999999998754 568999
Q ss_pred EEeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----ceeCCCCCCCEEecCCCceEEeecc
Q 040826 138 VYEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDGC-----IVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~-----i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.++|+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999864 2345999999999999999999999 556 9999999999999999999999999
Q ss_pred cceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
.+....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... .+..+..+
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~----~i~~~~~~- 234 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAG----KIREGKFR- 234 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHHTCCC-
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-HHHH----HHhhcccc-
Confidence 988654221 1123346899999999999989999999999999999999999998754321 1111 11111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEI 334 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l 334 (347)
..+.....++.+++.+||+.||.+|||+.++++.+
T Consensus 235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 ----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11112335799999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.38 Aligned_cols=262 Identities=21% Similarity=0.212 Sum_probs=198.8
Q ss_pred HHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeC--------
Q 040826 62 ENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG-------- 132 (347)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 132 (347)
+...++|...+.||+|+||.||+|.. .+|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 34467888999999999999999995 57999999998654332 33799999999999999999998543
Q ss_pred ------------------------------CeEEEEEeecCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040826 133 ------------------------------GEQYLVYEFCAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHH 179 (347)
Q Consensus 133 ------------------------------~~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~ 179 (347)
...++||||+++ +|.+.+. ..+..+++..+..++.|++.||.|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH- 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH- 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 348899999985 8877775 34567999999999999999999999
Q ss_pred ccCCCceeCCCCCCCEEec-CCCceEEeecccceecCCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHH
Q 040826 180 YIDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQ 257 (347)
Q Consensus 180 ~~~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~ 257 (347)
+.|++||||||+||+++ .++.+||+|||++...... .......+|..|+|||.+.+. .++.++||||+|+++|+
T Consensus 159 --~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 --SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp --TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred --HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 89999999999999998 6889999999999876422 223345689999999998764 58999999999999999
Q ss_pred HHhCCCCcCCChhhhhHHHHHHhhhcCCC--------CCcccccCCC-----CCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 258 LLSGQKVIELDFDARDQLTRKARDVSMGK--------RPIKDFEDPR-----LNGNINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 258 lltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-----l~~~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
|++|+.||..... .+.+....+...... ........+. +....+.....++.+|+.+||+.||.+|
T Consensus 235 ll~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 235 LILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999975432 233333332211110 0001111111 1111222344679999999999999999
Q ss_pred CCHHHHHH
Q 040826 325 PTIDVVYE 332 (347)
Q Consensus 325 ps~~ei~~ 332 (347)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=310.80 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=194.8
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeEEEE
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQYLV 138 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 138 (347)
|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55667899999999999995 468899999886543 23468899999999999999999999875 3568999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEec-CCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLT-EKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 215 (347)
|||+++++|.+++... ..+++..++.++.|++.||.||| +.+ ++|+||||+||+++ .++.++|+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999654 45899999999999999999999 777 99999999999998 78999999999997543
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. .......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||............. ..+..+.
T Consensus 184 ~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~------ 249 (290)
T 1t4h_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSGVKPA------ 249 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----TTTCCCG------
T ss_pred c---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH----hccCCcc------
Confidence 2 22334568999999998875 58999999999999999999999997544333322222 1111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...... ..++.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011111 246999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=332.98 Aligned_cols=250 Identities=28% Similarity=0.349 Sum_probs=200.7
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---------------ChhHHHHHHHHhhcCCCCcceeeee
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---------------NTDSFSREVEGLSRVRHPNLVCLFG 127 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~~~~ 127 (347)
..++|...++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999964 68899999986532 2356889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC---ceE
Q 040826 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL---EPK 204 (347)
Q Consensus 128 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~---~~k 204 (347)
++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988654 45899999999999999999999 78999999999999999776 699
Q ss_pred EeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 205 LSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 205 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
|+|||++...... .......||+.|+|||++.+ .++.++||||+|+++|+|++|..||...... ..... +..
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~----i~~ 261 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKK----VEK 261 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH----HHH
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH----HHc
Confidence 9999999876432 23345579999999999875 6899999999999999999999999754322 22222 222
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+...... +. ... ...++.+|+.+||+.||.+|||+.|+++.
T Consensus 262 ~~~~~~~---~~-~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYYFDF---ND-WKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCCH---HH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCc---cc-cCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2111100 00 001 23579999999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.19 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=201.0
Q ss_pred HHHhcCcccC-CeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCe
Q 040826 62 ENAINNDWDR-RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGE 134 (347)
Q Consensus 62 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 134 (347)
+...++|... +.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445566665 78999999999999965 68999999987532 2457889999999994 7999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccc
Q 040826 135 QYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGL 210 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~ 210 (347)
.++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.|++||||||+||+++. ++.++|+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999988643 467999999999999999999999 789999999999999998 78999999999
Q ss_pred ceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+...... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........... ..
T Consensus 181 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~----~~ 253 (327)
T 3lm5_A 181 SRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNISQVNVD----YS 253 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC----CC
T ss_pred ccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhcccc----cC
Confidence 9876422 22344579999999999999999999999999999999999999997543322 11111111110 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+ .........+.+++.+||+.||.+|||+.++++.
T Consensus 254 ----~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 ----E----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----T----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----c----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 1111233579999999999999999999999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=331.99 Aligned_cols=250 Identities=28% Similarity=0.370 Sum_probs=201.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEccc----CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYK----SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
..++|...+.||+|+||.||+|... +|+.||+|++.. ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567888899999999999999964 789999999854 34456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec---CCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT---EKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~ 215 (347)
|||+++|+|.+.+... ..+++..+..++.|++.||.||| +.|++||||||+||+++ .++.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988654 35899999999999999999999 78999999999999995 45679999999998653
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...... +.+..+.. +..... .+
T Consensus 176 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~----~~~~~~---~~ 244 (486)
T 3mwu_A 176 Q--NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVET----GKYAFD---LP 244 (486)
T ss_dssp C--C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH----TCCCSC---SG
T ss_pred C--CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----CCCCCC---Cc
Confidence 2 223345579999999999976 5899999999999999999999999754322 22222221 111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+ ....+++.+|+.+||+.||.+|||+.++++.
T Consensus 245 ~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 QW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1223578999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=309.91 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=196.7
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
+|.....||+|+||.||+|.. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999995 4688999999876433 4578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccceecCCCccc
Q 040826 144 AGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 144 ~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~ 220 (347)
+++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NP 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-CC
Confidence 999999997543 35678899999999999999999 789999999999999987 899999999999875422 12
Q ss_pred eeecccCCCCccccccccCCc--cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTNAK--LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||............. ...... +.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~--------~~~- 247 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMFKVH--------PEI- 247 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHHCCC--------CCC-
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--cccccc--------ccc-
Confidence 233456899999999987643 7889999999999999999999986432221111111 111100 111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.....++.+++.+||+.||.+|||+.++++
T Consensus 248 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ---PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1123357999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.20 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=202.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... +|+.||+|++... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888899999999999999965 7899999998543 3345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe---cCCCceEEeecccceecC
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL---TEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~ 215 (347)
|||+.+|+|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999988654 45899999999999999999999 7899999999999999 567899999999998754
Q ss_pred CCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 216 MEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... +....+.. +..... .+
T Consensus 181 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~----~~~~~~---~~ 249 (484)
T 3nyv_A 181 AS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEK----GKYTFE---LP 249 (484)
T ss_dssp CC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH----CCCCCC---SG
T ss_pred cc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHc----CCCCCC---Cc
Confidence 32 22344579999999999877 6899999999999999999999999754322 22222222 211110 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ....+++.+|+.+||+.||.+|||+.++++
T Consensus 250 ~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 QW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 122357999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=312.70 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=202.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEe--CCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVE--GGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.. .....+.+|+.++++++ ||||+++++++.+ ....++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 36788889999999999999985 5789999999864 44567889999999997 9999999999987 667899999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~ 219 (347)
|+++++|.+++.. +++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++......
T Consensus 114 ~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-- 184 (330)
T 3nsz_A 114 HVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 184 (330)
T ss_dssp CCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT--
T ss_pred ccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC--
Confidence 9999999998843 889999999999999999999 78999999999999999776 8999999999876432
Q ss_pred ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC---------C---
Q 040826 220 KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG---------K--- 286 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---------~--- 286 (347)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......+.+.......... .
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 22344568999999999877 6789999999999999999999999965544433333222211100 0
Q ss_pred -------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 -------------RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 -------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....+... ........++.+|+.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHS----ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCT----TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccc----cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011111 111123467999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=320.00 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=196.3
Q ss_pred HHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-CChhHHHHHHHHhhcC-CCCcceeeeeEEEe------CC
Q 040826 63 NAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-NNTDSFSREVEGLSRV-RHPNLVCLFGCCVE------GG 133 (347)
Q Consensus 63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~ 133 (347)
...++|...+.||+|+||.||+|.. .+|+.||+|.+... .....+.+|+..++++ +||||+++++++.. .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3467888899999999999999996 47899999998654 3456788999999999 79999999999987 46
Q ss_pred eEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccce
Q 040826 134 EQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAK 212 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 212 (347)
..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 889999999999999999753 356899999999999999999999 7899999999999999999999999999988
Q ss_pred ecCCCccceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
..... ........++..|+|||.+. +..++.++||||||+++|+|++|..||....... ........ ..
T Consensus 178 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~ 251 (326)
T 2x7f_A 178 QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRN----PA 251 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS----CC
T ss_pred ecCcC-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcC----cc
Confidence 65422 12233456899999999987 5678899999999999999999999996443221 11111111 10
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ...+ ...+.+++.+||+.||.+|||+.++++
T Consensus 252 --~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 --PRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --CCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --ccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0011 1112 357999999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.26 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=194.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888899999999999999965 7899999998643 2345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 99999999999986543 5899999999999999999999 789999999999999999999999999998865422
Q ss_pred cceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...... . ....+..+....
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~~-------- 230 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-T----LFKKIRGGVFYI-------- 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHHCCCCC--------
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-H----HHHHhhcCcccC--------
Confidence 22234568999999999988765 68999999999999999999999754221 1 111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+......+.+++.+||+.||.+|||+.++++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122578999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=323.02 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=201.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 456888899999999999999965 789999999876543 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|+++++|.+++.... .+++..+..++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---
Confidence 999999999986543 5899999999999999999999 54 899999999999999999999999999875421
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC------------
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR------------ 287 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 287 (347)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .........+..
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC-------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccCCCCCCCcccCCC
Confidence 223345789999999999999999999999999999999999999975432221 111100000000
Q ss_pred Cccc-----------------ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 PIKD-----------------FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ~~~~-----------------~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... ................++.+|+.+||+.||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 000000000011123579999999999999999999999873
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=317.62 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=186.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+..+++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46788889999999999999995 478999999886532 34567899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 141 FCAAGNLAQHLLR-------KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 141 ~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
|+++++|.+++.. ....+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 3456899999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCcc----ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC
Q 040826 214 LGMEES----KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP 288 (347)
Q Consensus 214 ~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 288 (347)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ........ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~--~~~ 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTLQNDP--PSL 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHHTSSC--CCT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-HHHhccCC--Ccc
Confidence 532211 11233568999999999875 56889999999999999999999999754332221 11111110 000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.....++.....+ ..++.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0111112222222 357899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=309.63 Aligned_cols=242 Identities=20% Similarity=0.310 Sum_probs=196.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567888899999999999999965 79999999987542 234678899999999 89999999999999999999
Q ss_pred EEeecCCCChHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC--------------
Q 040826 138 VYEFCAAGNLAQHLLRK---DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-------------- 200 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-------------- 200 (347)
||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999653 256899999999999999999999 7899999999999999844
Q ss_pred -----CceEEeecccceecCCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH
Q 040826 201 -----LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274 (347)
Q Consensus 201 -----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~ 274 (347)
..++|+|||.+...... ....++..|+|||.+.+. .++.++||||||+++|+|++|.+++.... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~ 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H
Confidence 47999999999876432 223589999999999865 66789999999999999999998765332 1
Q ss_pred HHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 275 LTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...... +.. +.+...+ ..++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~----~~~-------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 WHEIRQ----GRL-------PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHT----TCC-------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHc----CCC-------CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111111 111 1111122 357999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=314.83 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=198.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888899999999999999965 6899999998654 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+++++|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ....
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-HHHC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc-cccc
Confidence 9999999998776667999999999999999999999 78999999999999999999999999998754321 1112
Q ss_pred eecccCCCCccccccc-----cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 222 FTDVRGTIGYMDPEYM-----TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....++..|+|||.+ .+..++.++||||||+++|+|++|..||....... ........ ..+. .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~~--~---- 242 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS----DPPT--L---- 242 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS----CCCC--C----
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhcc----CCcc--c----
Confidence 2345689999999988 36678899999999999999999999987543221 11111111 1110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.........+.+++.+||+.||.+|||+.++++
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122357999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.58 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=187.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChh----HHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++....... .+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788889999999999999995 578999999997654332 2344455578889999999999999999999999
Q ss_pred eecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 140 EFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 140 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
||+++ +|.+++.. ....+++..++.++.|++.||.||| ++ |++|+||||+||+++.++.++|+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99986 88887753 4567999999999999999999999 66 99999999999999999999999999998654
Q ss_pred CCccceeecccCCCCccccccc----cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 216 MEESKVFTDVRGTIGYMDPEYM----TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 216 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.. .......|+..|+|||.+ .+..++.++||||||+++|+|++|+.||................. ....
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-- 234 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQL-- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC---CCCC--
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC---CCCc--
Confidence 22 222334689999999996 456788999999999999999999999975433333333222221 1110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......++.+++.+||+.||.+|||+.++++
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ---------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00122357999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=311.55 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=194.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEe----------
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVE---------- 131 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 131 (347)
..++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356788889999999999999995 478999999986532 23568899999999999999999998765
Q ss_pred ---CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 132 ---GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 132 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
.+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 35679999999999999999876667889999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCc-------------cceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH
Q 040826 209 GLAKMLGMEE-------------SKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274 (347)
Q Consensus 209 g~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~ 274 (347)
|++....... ........++..|+|||.+.+. .++.++||||||+++|+|++ |+.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9988653211 1122345689999999999864 68999999999999999998 44432222221
Q ss_pred HHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 275 LTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ..+........ + .........+.+++.+||+.||.+|||+.++++
T Consensus 238 ~----~~~~~~~~~~~----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 L----KKLRSVSIEFP----P----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H----HHHHSTTCCCC----T----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HhccccccccC----c----cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 22211111111 1 222233457899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=319.19 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=186.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCC-CCcceeeeeEEEe--------C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVR-HPNLVCLFGCCVE--------G 132 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~--------~ 132 (347)
..+|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+..++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34678889999999999999995 4789999998865432 346889999999996 9999999999852 3
Q ss_pred CeEEEEEeecCCCChHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEecCCCceEEeec
Q 040826 133 GEQYLVYEFCAAGNLAQHLLR--KDSVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~~~~~~kl~df 208 (347)
...++++||+. |+|.+++.. ....+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999997 599998864 4456999999999999999999999 778 999999999999999999999999
Q ss_pred ccceecCCCccc-----------eeecccCCCCccccccc---cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhH
Q 040826 209 GLAKMLGMEESK-----------VFTDVRGTIGYMDPEYM---TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQ 274 (347)
Q Consensus 209 g~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~ 274 (347)
|++......... ......++..|+|||.+ .+..++.++||||||+++|+|++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876432211 11134589999999998 5667889999999999999999999998632211
Q ss_pred HHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 275 LTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
......... .........+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 260 --~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 --RIVNGKYSI--------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------CCC--------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HhhcCcccC--------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111110000 000111235889999999999999999999999999997654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=340.20 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=203.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|... +++.||+|++... .....+..|..++..+ +||+|+.+++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 567888899999999999999954 6889999998642 3455678899999988 69999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999997643 5999999999999999999999 789999999999999999999999999999864322
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...... + ....+........
T Consensus 496 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~----~~~~i~~~~~~~p------- 562 (674)
T 3pfq_A 496 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-E----LFQSIMEHNVAYP------- 562 (674)
T ss_dssp -TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHSSCCCCC-------
T ss_pred -CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-H----HHHHHHhCCCCCC-------
Confidence 22345567999999999999999999999999999999999999999754321 2 2222222222111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTI-----DVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~ei~~ 332 (347)
.....++.+|+.+||+.||.+||++ .+|++
T Consensus 563 -----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 -----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1233579999999999999999998 56553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=325.56 Aligned_cols=263 Identities=24% Similarity=0.294 Sum_probs=184.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC-----Ce
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 134 (347)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999954 789999999865432 24688999999999999999999998543 57
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+. ++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999986 5999988653 56999999999999999999999 789999999999999999999999999999875
Q ss_pred CCCcc--------------------------ceeecccCCCCccccccc-cCCccCCcccHHHHHHHHHHHHh-------
Q 040826 215 GMEES--------------------------KVFTDVRGTIGYMDPEYM-TNAKLTCASDIYSFGIVALQLLS------- 260 (347)
Q Consensus 215 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~llt------- 260 (347)
..... .......||..|+|||++ .+..++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 42211 123445789999999976 56679999999999999999999
Q ss_pred ----CCCCcCCChh-------------------hhhHHHHHHhhhcCCCCC----------------cccccCCCCCCCC
Q 040826 261 ----GQKVIELDFD-------------------ARDQLTRKARDVSMGKRP----------------IKDFEDPRLNGNI 301 (347)
Q Consensus 261 ----g~~p~~~~~~-------------------~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~~ 301 (347)
|+++|..... ..+++..+.......... ........+. ..
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA-ER 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG-GG
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH-HH
Confidence 5555543210 112222222111100000 0000000000 00
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
......++.+|+.+||..||.+|||+.|++++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11224678999999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=312.78 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=196.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC----------ChhHHHHHHHHhhcCCCCcceeeeeEEEeC
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN----------NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 132 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567888999999999999999954 68899999986532 123578999999999999999999998765
Q ss_pred CeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeecc
Q 040826 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFG 209 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg 209 (347)
+ .++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 4 89999999999999988653 46899999999999999999999 789999999999999987665 9999999
Q ss_pred cceecCCCccceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
++...... .......|+..|+|||.+. +..++.++||||||+++|+|++|..||............... +.
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~ 236 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----GK 236 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----TC
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----Cc
Confidence 99876422 2223456899999999874 567889999999999999999999999754322111111111 11
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... +.... ...+.+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~----~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YNFI----PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCC----HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccC----chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00001 12357999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.10 Aligned_cols=238 Identities=16% Similarity=0.130 Sum_probs=185.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHH---HHhhcCCCCcceeee-------eE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREV---EGLSRVRHPNLVCLF-------GC 128 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 128 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++... ...+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677788999999999999995 57999999998643 2235688999 455566899999998 66
Q ss_pred EEeCC-----------------eEEEEEeecCCCChHHHhhcCCC------CCCHHHHHHHHHHHHHHHHHhhhccCCCc
Q 040826 129 CVEGG-----------------EQYLVYEFCAAGNLAQHLLRKDS------VLTWERRVKILRDCALALRYLHHYIDGCI 185 (347)
Q Consensus 129 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 185 (347)
+.+.+ ..+++|||+ +|+|.+++..... .+++..++.++.|++.||.||| +.|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55443 278999999 5699999965322 2335888899999999999999 7899
Q ss_pred eeCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccCC-----------ccCCcccHHHHHHH
Q 040826 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-----------KLTCASDIYSFGIV 254 (347)
Q Consensus 186 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~i 254 (347)
+||||||+|||++.++.+||+|||++.... .......| ..|+|||.+.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998642 23344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 255 ALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 255 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+|+|++|+.||....... ....... .. ..+ .+++.+|+.+||+.||.+|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~-----~~~~~~~-----------~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----GSEWIFR-----------SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----CSGGGGS-----------SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----chhhhhh-----------hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999986322110 0000000 00 122 357999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=324.18 Aligned_cols=258 Identities=25% Similarity=0.281 Sum_probs=196.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeC----C--eEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG----G--EQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~--~~~lv 138 (347)
.+|...+.||+|+||.||+|... +|+.||+|++..... ...+|++++++++||||+++++++... + ..++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 35778899999999999999964 689999999865432 234799999999999999999988542 1 36789
Q ss_pred EeecCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-CceEEeecccceec
Q 040826 139 YEFCAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKML 214 (347)
Q Consensus 139 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 214 (347)
|||+++ +|.+.+. .....+++..+..++.|++.||.||| +.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999987 6766654 34567999999999999999999999 8999999999999999965 57899999999875
Q ss_pred CCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC--------
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG-------- 285 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 285 (347)
... .......+|..|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+..+.+.....
T Consensus 208 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 208 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhh
Confidence 422 223345789999999998764 789999999999999999999999975432 23333333321111
Q ss_pred CCCcccccCCCCCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 KRPIKDFEDPRLNG-----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 ~~~~~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......+..+.+.. .+......++.+|+.+||+.||.+|||+.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00111111111110 011223467999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=318.91 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=194.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC------C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG------G 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 133 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788889999999999999996 4799999999965432 24577999999999999999999998765 3
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 6799998865 45899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC----
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP---- 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 288 (347)
... ......+|..|+|||.+.+ ..++.++||||+||++++|++|+.||..... .+.+..+..........
T Consensus 178 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHT
T ss_pred ccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHH
Confidence 542 2344578999999999887 6799999999999999999999999975432 22222222211110000
Q ss_pred ------------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 ------------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 ------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........+. .........+.+|+.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 111123457999999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.35 Aligned_cols=196 Identities=29% Similarity=0.406 Sum_probs=164.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC-----Ce
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 134 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788889999999999999995 4688999999975432 24688999999999999999999998765 57
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++ +|.+++... ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 8999999975 999988653 45999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCcc---------------------ceeecccCCCCccccccc-cCCccCCcccHHHHHHHHHHHHhCCCCc
Q 040826 215 GMEES---------------------KVFTDVRGTIGYMDPEYM-TNAKLTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 215 ~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
..... .......||..|+|||++ .+..++.++|||||||++|+|++|..|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 43221 123456789999999986 5667999999999999999999865444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=322.32 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=187.1
Q ss_pred cCccc-CCeeeecCCeeEEEEEeC---CCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEEE
Q 040826 66 NNDWD-RRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLVY 139 (347)
Q Consensus 66 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 139 (347)
+.|.. .++||+|+||.||+|... +++.||+|.+........+.+|+.++++++||||+++++++.. ....++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44554 457999999999999954 5789999999877777789999999999999999999999965 66899999
Q ss_pred eecCCCChHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe----cCCCceEEee
Q 040826 140 EFCAAGNLAQHLLR--------KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----TEKLEPKLSD 207 (347)
Q Consensus 140 e~~~~gsL~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----~~~~~~kl~d 207 (347)
||+++ +|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99986 88887742 1235899999999999999999999 7899999999999999 6788999999
Q ss_pred cccceecCCCcc--ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhh--------hhHHH
Q 040826 208 FGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDA--------RDQLT 276 (347)
Q Consensus 208 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~--------~~~~~ 276 (347)
||++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987643211 22344678999999999987 45899999999999999999999999754321 23333
Q ss_pred HHHhhhcCCCCC-ccccc-------------CCCCCCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 277 RKARDVSMGKRP-IKDFE-------------DPRLNGNIN---------RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 277 ~~~~~~~~~~~~-~~~~~-------------~~~l~~~~~---------~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+.......... ..... ..... ... ......+.+|+.+||+.||.+|||+.|+++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 333322111100 00000 00000 000 001346889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=318.21 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=192.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG------ 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 133 (347)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467888899999999999999954 688999999875432 245778999999999999999999987654
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999986 78888742 4899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-------
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK------- 286 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 286 (347)
... ........||..|+|||.+.+..++.++||||||+++|+|++|+.||...... +.+...........
T Consensus 177 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTS
T ss_pred ccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHh
Confidence 532 22234457899999999999999999999999999999999999999754322 22222222111100
Q ss_pred -----------CCcc-----cccCCCC---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 287 -----------RPIK-----DFEDPRL---NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 287 -----------~~~~-----~~~~~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.... ....... ..........++.+|+.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0000000 000112335789999999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.07 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=202.0
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----------hhHHHHHHHHhhcCC-CCcceeeeeEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----------TDSFSREVEGLSRVR-HPNLVCLFGCCV 130 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~-h~niv~~~~~~~ 130 (347)
..++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3567888899999999999999964 689999999865431 235778999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccc
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999998654 45899999999999999999999 78999999999999999999999999999
Q ss_pred ceecCCCccceeecccCCCCcccccccc------CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMT------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
+...... .......++..|+|||.+. ...++.++||||||+++|+|++|..||...... ........
T Consensus 171 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~---- 243 (298)
T 1phk_A 171 SCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMS---- 243 (298)
T ss_dssp CEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH----
T ss_pred hhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhc----
Confidence 9876432 2234456899999999885 456889999999999999999999999754322 11111111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+..... .+ ........+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~---~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQFG---SP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCCC---TT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcccC---cc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111100 01 01123357999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=321.98 Aligned_cols=260 Identities=24% Similarity=0.266 Sum_probs=196.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe------EEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE------QYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~lv 138 (347)
..+|...+.||+|+||.||+|...++..+|+|++...... ..+|+.+++.++||||+++++++...+. .++|
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 3468888999999999999999877777999988654332 2379999999999999999999865433 7899
Q ss_pred EeecCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEEeecccceec
Q 040826 139 YEFCAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKML 214 (347)
Q Consensus 139 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~ 214 (347)
|||+++ ++.+.+. .....+++..+..++.|++.||.||| +.|++||||||+||+++ .++.+||+|||++...
T Consensus 117 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999988 4444432 23567999999999999999999999 78999999999999999 7999999999999876
Q ss_pred CCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC------
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR------ 287 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 287 (347)
... .......+|..|+|||.+.+. .++.++|||||||++|+|++|+.||..... .+.+..+.+.......
T Consensus 193 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhh
Confidence 422 223345689999999998764 589999999999999999999999975432 2333333322111100
Q ss_pred --CcccccCCCC-----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 --PIKDFEDPRL-----NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 --~~~~~~~~~l-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.......+.. ...+.....+++.+|+.+||+.||.+|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000 001111234689999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=315.76 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=199.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|...+ .+++|.+.... ....+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 5678889999999999999999753 48999886532 23457789999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc--
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-- 218 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 218 (347)
|+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++ ++.++|+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999877667999999999999999999999 78999999999999998 6799999999987643211
Q ss_pred --cceeecccCCCCccccccccC---------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 219 --SKVFTDVRGTIGYMDPEYMTN---------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 219 --~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... ....+..
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~----~~~~~~~ 260 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-IIW----QMGTGMK 260 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-HHH----HHHTTCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH----HhccCCC
Confidence 112233458899999999864 357889999999999999999999997543221 111 1111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 288 PIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 288 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+. ... .. ...++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 261 ~~--~~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 261 PN--LSQ----IG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CC--CCC----SS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CC--CCc----CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 10 000 01 124689999999999999999999999999988654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.30 Aligned_cols=262 Identities=24% Similarity=0.289 Sum_probs=201.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe--CCCCEEEEEEcccCC----ChhHHHHHHHHhhcC---CCCcceeeeeEEE----
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL--PSGQVVAIKHIYKSN----NTDSFSREVEGLSRV---RHPNLVCLFGCCV---- 130 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 130 (347)
..++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346788899999999999999996 468899999886432 234677888877776 8999999999987
Q ss_pred -eCCeEEEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeec
Q 040826 131 -EGGEQYLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDF 208 (347)
Q Consensus 131 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~df 208 (347)
.....++||||+++ +|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 45678999999985 9999987543 45899999999999999999999 789999999999999999999999999
Q ss_pred ccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC-C
Q 040826 209 GLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK-R 287 (347)
Q Consensus 209 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 287 (347)
|++..... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... +.+........... .
T Consensus 165 g~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 165 GLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred cccccccC--CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCcc
Confidence 99986542 22234456899999999999989999999999999999999999999754332 22222222211110 0
Q ss_pred Cccc-------ccC---CCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 288 PIKD-------FED---PRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 288 ~~~~-------~~~---~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ... ............+.+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000 00000111223467899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.49 Aligned_cols=259 Identities=21% Similarity=0.231 Sum_probs=200.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcC------CCCcceeeeeEEEeCCeEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRV------RHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~ 136 (347)
..+|...+.||+|+||.||+|... +++.||+|++..... ...+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457888899999999999999854 689999999975432 34567788887776 5789999999999999999
Q ss_pred EEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc--eEEeeccccee
Q 040826 137 LVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE--PKLSDFGLAKM 213 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~ 213 (347)
+||||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99999975 9999887543 45999999999999999999999 779999999999999999887 99999999976
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-----
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP----- 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 288 (347)
... ......+|..|+|||++.+..++.++|||||||++|+|++|.+||..... .+.+..+..........
T Consensus 252 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 252 EHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp TTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTB
T ss_pred cCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHhh
Confidence 432 22345789999999999999999999999999999999999999975432 22232222221111000
Q ss_pred --ccccc--------------------------------CCCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 040826 289 --IKDFE--------------------------------DPRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVV 330 (347)
Q Consensus 289 --~~~~~--------------------------------~~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei 330 (347)
...+. .+.... .......+.+.+|+.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 00000 000000 0001113578999999999999999999999
Q ss_pred HH
Q 040826 331 YE 332 (347)
Q Consensus 331 ~~ 332 (347)
++
T Consensus 407 L~ 408 (429)
T 3kvw_A 407 LR 408 (429)
T ss_dssp HT
T ss_pred hC
Confidence 86
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.34 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=197.2
Q ss_pred HhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC------CChhHHHHHHHHhhcCCCCcceeeeeEEE--eCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS------NNTDSFSREVEGLSRVRHPNLVCLFGCCV--EGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~ 134 (347)
..++|...+.||+|+||.||++.. .+++.+|+|.+... .....+.+|+.++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999996 46889999998653 23457889999999999999999999984 4557
Q ss_pred EEEEEeecCCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 135 QYLVYEFCAAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.++||||++++ |.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999985 7777654 3456999999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCc-cceeecccCCCCccccccccCC--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 214 LGMEE-SKVFTDVRGTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 214 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...... . ....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~i~~~~~~-- 231 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-K----LFENIGKGSYA-- 231 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----HHHHHHHCCCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-H----HHHHHhcCCCC--
Confidence 64321 2223445689999999998764 3477999999999999999999999754321 1 11111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
+.. .....+.+++.+||+.||.+|||+.++++.
T Consensus 232 ------~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ------IPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 223578999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=321.41 Aligned_cols=250 Identities=12% Similarity=0.005 Sum_probs=179.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-----hhHHHHHH---HHhhcCCCCcceeee-------eEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-----TDSFSREV---EGLSRVRHPNLVCLF-------GCC 129 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~e~---~~l~~l~h~niv~~~-------~~~ 129 (347)
.+|...+.||+|+||.||+|... +|+.||+|++..... ...+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 44777889999999999999954 789999999987543 23466774 45555 799988754 444
Q ss_pred EeC-----------------CeEEEEEeecCCCChHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHhhhccCCCce
Q 040826 130 VEG-----------------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERR------VKILRDCALALRYLHHYIDGCIV 186 (347)
Q Consensus 130 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~Lh~~~~~~i~ 186 (347)
... ...++||||++ |+|.+++...+..+.+..+ ..++.|++.||.||| ++|++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 34799999999 7999999764444555556 778899999999999 78999
Q ss_pred eCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCC
Q 040826 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKV 264 (347)
Q Consensus 187 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p 264 (347)
||||||+|||++.++.+||+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987532 1224457799999999987 6799999999999999999999999
Q ss_pred cCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 265 IELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
|.......... ..... ..................+.+.+|+.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS---WKRPS-----LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC---CCBCC-----TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc---hhhhh-----hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97543221100 00000 00000001111111133467999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.19 Aligned_cols=269 Identities=23% Similarity=0.233 Sum_probs=193.7
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCe--
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGE-- 134 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 134 (347)
.......++|...+.||+|+||.||+|... +|+.||+|++.... ......+++..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345566789999999999999999999964 68999999886543 34567788888899999999999999876433
Q ss_pred -----EEEEEeecCCCChHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEE
Q 040826 135 -----QYLVYEFCAAGNLAQHLL---RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKL 205 (347)
Q Consensus 135 -----~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl 205 (347)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.|||.+ +.|++||||||+||+++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999987 6655443 2456789999999999999999999943 578999999999999997 899999
Q ss_pred eecccceecCCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 206 SDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
+|||++...... .......||..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ..+....+....
T Consensus 174 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred eeCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcCC
Confidence 999999876422 223345689999999998654 4899999999999999999999999754322 223333322211
Q ss_pred CCCCcccccCCC----------------CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 285 GKRPIKDFEDPR----------------LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 285 ~~~~~~~~~~~~----------------l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.........++. ...........++.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 110000000000 000111224578999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=302.34 Aligned_cols=251 Identities=28% Similarity=0.370 Sum_probs=201.4
Q ss_pred HHHhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 62 ENAINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
....++|...+.||+|+||.||+|... +++.||+|.+... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999965 7899999998643 34567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC---CceEEeeccccee
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK---LEPKLSDFGLAKM 213 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~ 213 (347)
+|+||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999886543 5899999999999999999999 7899999999999999764 4699999999876
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... .......++..|+|||.+.+. ++.++||||||+++|+|++|..||...... +.... +..+.....
T Consensus 174 ~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~~~~~~--- 242 (287)
T 2wei_A 174 FQQN--TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKR----VETGKYAFD--- 242 (287)
T ss_dssp BCCC--SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH----HHHCCCCCC---
T ss_pred ecCC--CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHH----HHcCCCCCC---
Confidence 5322 122334578899999998764 889999999999999999999999754322 11111 111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+.. . ....++.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LPQW-R----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SGGG-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhh-h----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 1 12357999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=318.99 Aligned_cols=260 Identities=21% Similarity=0.237 Sum_probs=200.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-hhHHHHHHHHhhcCC--------CCcceeeeeEEE----
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-TDSFSREVEGLSRVR--------HPNLVCLFGCCV---- 130 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~--------h~niv~~~~~~~---- 130 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46788899999999999999985 4688999999975432 356788999999885 788999999987
Q ss_pred eCCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCC-------
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKL------- 201 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~------- 201 (347)
+....++||||+. ++|.+.+... ...+++..++.++.|++.||.||| ++ |++||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 4557899999995 4777766543 366999999999999999999999 66 999999999999999775
Q ss_pred ------------------------------------------ceEEeecccceecCCCccceeecccCCCCccccccccC
Q 040826 202 ------------------------------------------EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239 (347)
Q Consensus 202 ------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 239 (347)
.+||+|||++...... .....||..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999875422 334568999999999999
Q ss_pred CccCCcccHHHHHHHHHHHHhCCCCcCCChh-----hhhHHHHHHhhhcCCC-----------------CCcccccCCC-
Q 040826 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFD-----ARDQLTRKARDVSMGK-----------------RPIKDFEDPR- 296 (347)
Q Consensus 240 ~~~~~~~Dv~slG~il~~lltg~~p~~~~~~-----~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~- 296 (347)
..++.++||||||+++|+|++|+.||..... ..+.+........... ..........
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999975321 1222222222111100 0000000000
Q ss_pred --------CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 --------LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 --------l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
-...........+.+|+.+||+.||.+|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001345677789999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=311.72 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=199.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeC-----CeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEG-----GEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 135 (347)
.++|...+.||+|+||.||+|... +++.||+|++...... ..+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888899999999999999954 7889999999754433 4678999999999999999999998754 368
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
++|+||+++ +|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....
T Consensus 106 ~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999986 99998854 35899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCccce--eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-c--
Q 040826 216 MEESKV--FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-I-- 289 (347)
Q Consensus 216 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-- 289 (347)
...... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+............. .
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHH
Confidence 322211 234578999999998754 55899999999999999999999999754322 2222222111110000 0
Q ss_pred ------c----cccCCCCC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 290 ------K----DFEDPRLN--GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 290 ------~----~~~~~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
. ....+... .........++.+|+.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000000 0000122357899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.73 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=193.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----hhHHHHHHHHhhcCC--CCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----TDSFSREVEGLSRVR--HPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||++...+|+.||+|.+..... ...+.+|+.++++++ ||||+++++++.+.+..+++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 456888899999999999999988899999999865432 246789999999997 59999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|| +.+++|.+++... ..+++..++.++.|+++||.||| +.+++|+||||+||++++ +.+||+|||++.......
T Consensus 107 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred Ee-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 99 5577999998754 45899999999999999999999 789999999999999975 899999999998754322
Q ss_pred cc-eeecccCCCCccccccccC-----------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 219 SK-VFTDVRGTIGYMDPEYMTN-----------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 219 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||................ .
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~ 256 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP----N 256 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT----T
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc----c
Confidence 21 2234568999999999875 468889999999999999999999997543332222222111 1
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.. . ..+.....++.+++.+||+.||.+|||+.++++.
T Consensus 257 ~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HE------I----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SC------C----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc------c----CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00 0 1111113579999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.21 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=201.4
Q ss_pred hcCcccCCeeeecCCeeEEEEEe--CCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCC------cceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL--PSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHP------NLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+|+.+++.++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35788889999999999999985 368899999986543 235678899999888655 499999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---------------
Q 040826 136 YLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE--------------- 199 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~--------------- 199 (347)
++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 779999987654 46899999999999999999999 789999999999999987
Q ss_pred ----CCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHH
Q 040826 200 ----KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQL 275 (347)
Q Consensus 200 ----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~ 275 (347)
++.++|+|||++..... ......||..|+|||.+.+..++.++||||||+++|+|++|..||...... +..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-EHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-HHH
T ss_pred ccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence 66899999999986432 223456899999999999999999999999999999999999999754322 222
Q ss_pred HHHHhhhcCCCCCc-------cccc--------------------CCC-CCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 276 TRKARDVSMGKRPI-------KDFE--------------------DPR-LNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 276 ~~~~~~~~~~~~~~-------~~~~--------------------~~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
.............. ..+. .+. -.........+++.+|+.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 22211111000000 0000 000 0001233556789999999999999999999
Q ss_pred HHHHHH
Q 040826 328 DVVYEE 333 (347)
Q Consensus 328 ~ei~~~ 333 (347)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=317.82 Aligned_cols=258 Identities=23% Similarity=0.285 Sum_probs=182.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC------C
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG------G 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 133 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788889999999999999994 5789999999865432 34677999999999999999999998653 5
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++++|++ +++|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 5699888854 46999999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc--
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK-- 290 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 290 (347)
... ......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .+.+..+.+..........
T Consensus 182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 182 TAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHTT
T ss_pred ccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHH
Confidence 432 2334578999999999887 6789999999999999999999999975432 2333333322211100000
Q ss_pred -------cccC--CCCCC-C---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 291 -------DFED--PRLNG-N---INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 291 -------~~~~--~~l~~-~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
.+.. +.... . ......+.+.+|+.+||+.||.+|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 00000 0 001123578999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.43 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=178.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh---hHHHHHHH-HhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT---DSFSREVE-GLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+...... ..+..|.. .++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999964 7899999999765433 24555555 677789999999999999999999999
Q ss_pred eecCCCChHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 140 EFCAAGNLAQHLLR----KDSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 140 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
||+++ +|.+++.. ....+++..+..++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 88887752 3567999999999999999999999 66 9999999999999999999999999999865
Q ss_pred CCCccceeecccCCCCccccccc----cCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYM----TNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
... .......|+..|+|||.+ .+..++.++||||||+++|+|++|+.||.......+ .......+..
T Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~--- 247 (327)
T 3aln_A 177 VDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGDP--- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCC---
T ss_pred ccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCCC---
Confidence 322 222334689999999998 456789999999999999999999999974322111 1111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.+...........+.+|+.+||+.||.+|||+.++++
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111123357999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=309.97 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=171.6
Q ss_pred hcCcccC-CeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHH-HHhhcCCCCcceeeeeEEEe----CCeEEE
Q 040826 65 INNDWDR-RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREV-EGLSRVRHPNLVCLFGCCVE----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~----~~~~~l 137 (347)
.++|... +.||+|+||.||+|... +|+.||+|++... ....+|+ ..++.++||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4567664 46999999999999965 7899999998643 2222333 44667789999999999876 445899
Q ss_pred EEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccccee
Q 040826 138 VYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKM 213 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~ 213 (347)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+||+++. ++.++|+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999997653 46999999999999999999999 789999999999999986 44599999999986
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... .......+|..|+|||.+.+..++.++||||||+++|+|++|..||......... .........+.... .
T Consensus 181 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~---~ 253 (336)
T 3fhr_A 181 TTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKRRIRLGQYGF---P 253 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CC---C
T ss_pred ccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHHhhhcccccc---C
Confidence 532 2233456899999999999989999999999999999999999999743322110 00111111111000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.+ .......++.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 254 NP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01 11123357999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.67 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=194.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE----
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ---- 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888899999999999999954 789999999976433 24677999999999999999999999876654
Q ss_pred --EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 136 --YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 136 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
++||||+.+ +|.+.+. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..
T Consensus 121 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 999999985 8888773 34899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
... ......+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+.................
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHHHH
Confidence 432 2344568999999999887 78999999999999999999999999754322 22222222111110000000
Q ss_pred c------------CCCCCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 293 E------------DPRLNG---NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 293 ~------------~~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
. ...... ........++.+|+.+||+.||.+|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000 0001223679999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.15 Aligned_cols=262 Identities=21% Similarity=0.249 Sum_probs=201.1
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCC-CC-----cceeeeeEEEeCCeE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVR-HP-----NLVCLFGCCVEGGEQ 135 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 135 (347)
..++|...+.||+|+||.||+|... +|+.||+|++..... ...+..|+.+++.++ |+ +++++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4578889999999999999999954 688999999975432 345667888888774 44 499999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--CCCceEEeecccce
Q 040826 136 YLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLEPKLSDFGLAK 212 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~~~kl~dfg~~~ 212 (347)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||.+ ..||+||||||+|||++ .++.+||+|||++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999975 9999987643 5689999999999999999999943 46899999999999995 47789999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-----
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR----- 287 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 287 (347)
..... .....+|..|+|||++.+..++.++||||||+++|+|++|+.||...... +.+............
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 76422 23456899999999999999999999999999999999999999854322 222222221111000
Q ss_pred --Cccc---------------------ccCCC--------------------CCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 040826 288 --PIKD---------------------FEDPR--------------------LNGNINRADFESILKIAVLCVAKSSKGR 324 (347)
Q Consensus 288 --~~~~---------------------~~~~~--------------------l~~~~~~~~~~~l~~l~~~cl~~~p~~R 324 (347)
.... +..+. -.........+++.+|+.+||+.||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 0000 00000 0001223445689999999999999999
Q ss_pred CCHHHHHH
Q 040826 325 PTIDVVYE 332 (347)
Q Consensus 325 ps~~ei~~ 332 (347)
||+.|+++
T Consensus 365 pta~e~L~ 372 (382)
T 2vx3_A 365 IQPYYALQ 372 (382)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=316.82 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=187.8
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCCC
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAAG 145 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 145 (347)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+..++||||+. |
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 344457899999999987776689999999886532 34677899999876 89999999999999999999999996 4
Q ss_pred ChHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC-------------CceEEe
Q 040826 146 NLAQHLLRKDSV------LTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-------------LEPKLS 206 (347)
Q Consensus 146 sL~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~-------------~~~kl~ 206 (347)
+|.+++...... .++..++.++.|++.||.||| +.+++||||||+||+++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999654321 123345789999999999999 7899999999999999754 489999
Q ss_pred ecccceecCCCccc---eeecccCCCCccccccccC-------CccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHH
Q 040826 207 DFGLAKMLGMEESK---VFTDVRGTIGYMDPEYMTN-------AKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQL 275 (347)
Q Consensus 207 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~ 275 (347)
|||++......... ......||..|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 99999876533221 1234579999999999865 568999999999999999999 8999875433221
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
........ . +............++.+++.+||+.||.+|||+.+|++
T Consensus 249 -~i~~~~~~----~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NIIRGIFS----L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHTCCC----C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCCC----c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111 1 11111234566789999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=305.42 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=181.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChh----HHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+....... .+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467788889999999999999965 78999999997654432 2334445678889999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
||+ ++.+..+.......+++..++.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 44565555544567999999999999999999999 54 8999999999999999999999999998765322
Q ss_pred cceeecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 219 SKVFTDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.......++..|+|||.+. +..++.++||||||+++|+|++|+.||................. .+..
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~~--- 250 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE----PPLL--- 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC----CCCC---
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC----CCCC---
Confidence 2233456899999999984 45688899999999999999999999975433333333222221 1100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+. ... ...++.+++.+||+.||.+|||+.++++
T Consensus 251 -~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 -PG-HMG----FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CS-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -Cc-cCC----CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 011 2257999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=306.93 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=197.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeC-----CeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 135 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457888899999999999999964 689999999965443 23577899999999999999999987654 678
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecC
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG 215 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 215 (347)
+++|||+.+ +|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....
T Consensus 90 ~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999999985 99998865 45899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCccc---------eeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 216 MEESK---------VFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 216 ~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
..... ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCC
Confidence 22111 1223468999999998764 67899999999999999999999999754322 2222222111110
Q ss_pred CC--CcccccC----------CCCCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 KR--PIKDFED----------PRLNG----NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 ~~--~~~~~~~----------~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ....... +.... ........++.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0000000 00000 000123357899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.40 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=194.0
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCe------
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGE------ 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 134 (347)
++|...+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5677888999999999999995 4789999999876432 2467789999999999999999999887543
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.+++|||+++ +|.+++. ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 4999999985 8887763 34899999999999999999999 789999999999999999999999999998764
Q ss_pred CCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-----
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP----- 288 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 288 (347)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+.............
T Consensus 177 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 177 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHTTC
T ss_pred CC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHH
Confidence 32 2334568999999999876 67899999999999999999999999754322 2222222211100000
Q ss_pred -----------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 -----------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 -----------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......+.+. ........++.+|+.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 111233467999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=307.48 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=198.0
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--------ChhHHHHHHHHhhcCC--CCcceeeeeEE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVR--HPNLVCLFGCC 129 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~--h~niv~~~~~~ 129 (347)
.+...++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999985 478999999986542 2245678999999996 59999999999
Q ss_pred EeCCeEEEEEeecCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEEee
Q 040826 130 VEGGEQYLVYEFCAA-GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLSD 207 (347)
Q Consensus 130 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl~d 207 (347)
...+..++++|++.+ ++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++ +++.+||+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999999986 7999998654 45899999999999999999999 78999999999999999 788999999
Q ss_pred cccceecCCCccceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCC
Q 040826 208 FGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGK 286 (347)
Q Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 286 (347)
||++...... ......||..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... .... .
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~----~ 259 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRG----Q 259 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHC----C
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcc----c
Confidence 9999876422 2334568999999999886665 6889999999999999999999864211 1111 1
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 RPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.. ....+ .+++.+++.+||+.||.+|||+.++++
T Consensus 260 ~~--------~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 VF--------FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CC--------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc--------ccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 11122 257999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=316.13 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=188.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
.+|...+.||+|+||+|+.....+|+.||||++.... ...+.+|+.+++.+ +||||+++++++.+.+..++||||+.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 3577778999999999765556689999999986533 33467899999999 799999999999999999999999975
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-----CCceEEeecccceecCCCcc
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-----KLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-----~~~~kl~dfg~~~~~~~~~~ 219 (347)
+|.+++........+..+..++.|++.||.||| +.+++||||||+||+++. ...++|+|||++........
T Consensus 103 -~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 103 -TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp -EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred -CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999999876655666677899999999999999 789999999999999953 23578999999987643221
Q ss_pred --ceeecccCCCCcccccccc---CCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 220 --KVFTDVRGTIGYMDPEYMT---NAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 220 --~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.......||..|+|||++. +..++.++|||||||++|+|++ |..||........ .... ...... ..
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~-----~~~~~~-~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILL-----GACSLD-CL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHT-----TCCCCT-TS
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHh-----ccCCcc-cc
Confidence 2234467999999999997 4567889999999999999999 8888864322211 1111 110000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.........+.+|+.+||+.||.+|||+.++++
T Consensus 251 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 ------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111234466889999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.64 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=189.7
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--------ChhHHHHHHHHhhcC----CCCcceeeee
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--------NTDSFSREVEGLSRV----RHPNLVCLFG 127 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l----~h~niv~~~~ 127 (347)
.+...++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+..++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 478899999996543 223456789999888 8999999999
Q ss_pred EEEeCCeEEEEEee-cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEE
Q 040826 128 CCVEGGEQYLVYEF-CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKL 205 (347)
Q Consensus 128 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl 205 (347)
++.+.+..++++|+ +.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++ .++.++|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99998999999999 78899999997643 5899999999999999999999 78999999999999999 8899999
Q ss_pred eecccceecCCCccceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcC
Q 040826 206 SDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284 (347)
Q Consensus 206 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 284 (347)
+|||++...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ....
T Consensus 182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~--- 248 (312)
T 2iwi_A 182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEA--- 248 (312)
T ss_dssp CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHT---
T ss_pred EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhh---
Confidence 999999876432 2334568999999999876665 4589999999999999999999863211 1111
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 285 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
... .......++.+++.+||+.||++|||+.++++
T Consensus 249 -~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 -ELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -CCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11122357899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=306.25 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=190.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEE-----------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCV----------- 130 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 130 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 457888899999999999999965 589999998865432 346889999999999999999998873
Q ss_pred ---eCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec-CCCceEEe
Q 040826 131 ---EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLS 206 (347)
Q Consensus 131 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~-~~~~~kl~ 206 (347)
+....++||||+++ +|.+++.+ ..+++..++.++.|++.||.||| +.|++|+||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCSE-EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccCC-CHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 34678999999985 99998854 45899999999999999999999 78999999999999997 56799999
Q ss_pred ecccceecCCCcc--ceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 207 DFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 207 dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
|||++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC
Confidence 9999987542211 12233457899999998865 67899999999999999999999999754332 22222221111
Q ss_pred CCCC--------CcccccCCCCCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 284 MGKR--------PIKDFEDPRLNG------NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 284 ~~~~--------~~~~~~~~~l~~------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ............ ........++.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 000000000000 000122367999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=302.26 Aligned_cols=259 Identities=18% Similarity=0.201 Sum_probs=198.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CC-CEEEEEEcccCC-ChhHHHHHHHHhhcCCCCc------ceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SG-QVVAIKHIYKSN-NTDSFSREVEGLSRVRHPN------LVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|... ++ +.||+|.+.... ....+.+|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 357888899999999999999964 44 689999986543 2356778999999887655 89999999999999
Q ss_pred EEEEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe-----------------
Q 040826 136 YLVYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL----------------- 197 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili----------------- 197 (347)
++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.|++||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 557777775543 56999999999999999999999 8899999999999999
Q ss_pred --cCCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHH
Q 040826 198 --TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQL 275 (347)
Q Consensus 198 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~ 275 (347)
+.++.+||+|||++...... .....||..|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-EHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 56789999999999864322 23456899999999999999999999999999999999999999754322 222
Q ss_pred HHHHhhhcCCCCC-------cccccCCC---------------------CCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 040826 276 TRKARDVSMGKRP-------IKDFEDPR---------------------LNGNINRADFESILKIAVLCVAKSSKGRPTI 327 (347)
Q Consensus 276 ~~~~~~~~~~~~~-------~~~~~~~~---------------------l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 327 (347)
............. ...+.... ...........++.+|+.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 2111111100000 00000000 0001122445689999999999999999999
Q ss_pred HHHHH
Q 040826 328 DVVYE 332 (347)
Q Consensus 328 ~ei~~ 332 (347)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=309.10 Aligned_cols=259 Identities=20% Similarity=0.260 Sum_probs=198.5
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC-ChhHHHHHHHHhhcCC-----------CCcceeeeeEEEeC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN-NTDSFSREVEGLSRVR-----------HPNLVCLFGCCVEG 132 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~ 132 (347)
++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5678889999999999999995 578999999987543 2356778999988886 88999999998865
Q ss_pred C----eEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCC-CceeCCCCCCCEEec------CC
Q 040826 133 G----EQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDG-CIVHRDIKLTNILLT------EK 200 (347)
Q Consensus 133 ~----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~H~dl~p~Nili~------~~ 200 (347)
+ ..+++||++ +++|.+++... ...+++..+..++.|++.||.||| ++ |++||||||+||+++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence 4 789999999 77999998753 355999999999999999999999 66 999999999999994 44
Q ss_pred CceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh-----hhhHH
Q 040826 201 LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD-----ARDQL 275 (347)
Q Consensus 201 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~-----~~~~~ 275 (347)
+.+||+|||++...... .....+|..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+.+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 47999999999875422 2344689999999999999999999999999999999999999975421 11222
Q ss_pred HHHHhhhcCCC-----------------CCcccccCC---------CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 040826 276 TRKARDVSMGK-----------------RPIKDFEDP---------RLNGNINRADFESILKIAVLCVAKSSKGRPTIDV 329 (347)
Q Consensus 276 ~~~~~~~~~~~-----------------~~~~~~~~~---------~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~e 329 (347)
........... ......... .-....+.....++.+|+.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 22222111000 000000000 0011345677889999999999999999999999
Q ss_pred HHH
Q 040826 330 VYE 332 (347)
Q Consensus 330 i~~ 332 (347)
+++
T Consensus 331 ll~ 333 (373)
T 1q8y_A 331 LVN 333 (373)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.73 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=204.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEe------CCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVE------GGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 134 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46788999999999999999995 4689999999876533 3468889999999999999999998755 667
Q ss_pred EEEEEeecCCCChHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc---eEEeecc
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD--SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE---PKLSDFG 209 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~---~kl~dfg 209 (347)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 36899999999999999999999 789999999999999997765 8999999
Q ss_pred cceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHH---------HHh
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTR---------KAR 280 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~---------~~~ 280 (347)
.+...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||............ ...
T Consensus 170 ~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 99876432 2234467899999999999999999999999999999999999999754322110000 000
Q ss_pred hhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHHHhh
Q 040826 281 DVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDV-----VYEEIDKAWKNT 341 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~e-----i~~~l~~~~~~~ 341 (347)
....+..... ..............+.+.+++.+||+.||.+|||+.+ +.+.++++++..
T Consensus 248 ~~l~g~~~~~--~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFS--SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCC--SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccc--cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000000 0001112344556789999999999999999999988 667777776543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.48 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=195.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC--CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCe-----
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP--SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGE----- 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 134 (347)
.++|...+.||+|+||.||+|... +|+.||+|.+...... ..+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999964 6899999998765432 357899999999999999999999987655
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++++|.+++.. .+++..++.++.|++.||.||| +.||+||||||+|||++.+ .+||+|||++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999887643 6999999999999999999999 7899999999999999986 9999999999875
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccC
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFED 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
... ....||+.|+|||++.+.. +.++||||||+++|+|++|..|+...... . ..
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------~---~~---- 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------G---LP---- 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------S---CC----
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------c---cc----
Confidence 422 3456999999999987654 88999999999999999998887632110 0 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHhh
Q 040826 295 PRLNGNINRADFESILKIAVLCVAKSSKGRP-TIDVVYEEIDKAWKNT 341 (347)
Q Consensus 295 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~ei~~~l~~~~~~~ 341 (347)
...........+.+++.+||+.||.+|| +++++.+.|..++++.
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0001112336799999999999999999 5777778888776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=286.92 Aligned_cols=230 Identities=14% Similarity=0.061 Sum_probs=181.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh-----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT-----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|.+...... ..+.+|+..+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999965 5899999999765432 56889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++... .....+.+++.|++.||.||| +.|++||||||+||+++.++.++|++++
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999998432 356678899999999999999 7899999999999999999999997543
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
|++ +++.++||||||+++|+|++|+.||........ +....+ ...+......
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~~-~~~~~~~~~~-------- 226 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAER-DTAGQPIEPA-------- 226 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECCB-CTTSCBCCHH--------
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHHH-HhccCCCChh--------
Confidence 222 367899999999999999999999975322110 000000 0000000000
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
.......+++.+++.+||+.||.+| |+.|+++.|+++...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0111233579999999999999999 999999999998543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=286.33 Aligned_cols=226 Identities=22% Similarity=0.265 Sum_probs=177.6
Q ss_pred hcCcccC-CeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHh-hcCCCCcceeeeeEEEe----CCeEEE
Q 040826 65 INNDWDR-RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGL-SRVRHPNLVCLFGCCVE----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~l 137 (347)
.++|... +.||+|+||.||++.. .+|+.||+|.+.. ...+.+|+..+ +..+||||+++++++.. ....++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 3456555 6799999999999995 4789999999853 35677888887 56689999999999887 667899
Q ss_pred EEeecCCCChHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccccee
Q 040826 138 VYEFCAAGNLAQHLLRKD-SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKM 213 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~ 213 (347)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999997643 46999999999999999999999 789999999999999998 78899999999875
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.. +..++.++||||||+++|+|++|..||....... ........ ..
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~~~~------~~ 215 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTR------IR 215 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCS------SC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----hhHHHHHH------Hh
Confidence 32 2356789999999999999999999996432111 00000000 00
Q ss_pred CCCCCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNIN----RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.... ..+ .....++.+++.+||+.||.+|||+.|+++
T Consensus 216 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 011 123467999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.43 Aligned_cols=237 Identities=16% Similarity=0.131 Sum_probs=177.5
Q ss_pred cCcccCCeeeecCCeeEEEEE-eCCCCEEEEEEcccCC-----ChhHHHHHHHHhhcCCC-Cccee--------------
Q 040826 66 NNDWDRRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-----NTDSFSREVEGLSRVRH-PNLVC-------------- 124 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~h-~niv~-------------- 124 (347)
.+|...+.||+|+||.||+|. ..+|+.||||++.... ..+.+.+|+.+++.++| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 446667889999999999999 4579999999987432 24568899999999976 22111
Q ss_pred -------eeeEEEe-----CCeEEEEEeecCCCChHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCce
Q 040826 125 -------LFGCCVE-----GGEQYLVYEFCAAGNLAQHLL------RKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186 (347)
Q Consensus 125 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 186 (347)
+..+... ....+++|+++ +++|.+++. ..+..+++..++.++.|+++||.||| +.+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1111111 22457777766 459999884 23445788899999999999999999 78999
Q ss_pred eCCCCCCCEEecCCCceEEeecccceecCCCccceeecccCCCCccccccc----------cCCccCCcccHHHHHHHHH
Q 040826 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM----------TNAKLTCASDIYSFGIVAL 256 (347)
Q Consensus 187 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slG~il~ 256 (347)
||||||+|||++.++.+||+|||++...... .....| ..|+|||.+ .+..++.++||||||+++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865322 344567 999999999 5667889999999999999
Q ss_pred HHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 257 QLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 257 ~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+|++|+.||........ ........ ..+ ++++.+|+.+||+.||.+|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~-----~~~~~~~~------------~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----SEWIFRSC------------KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----SGGGGSSC------------CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-----HHHHHhhc------------ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999974322110 00010000 022 257999999999999999999888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.39 Aligned_cols=241 Identities=15% Similarity=0.102 Sum_probs=182.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----------hhHHHHHHHHhhcCC---------CCcceee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----------TDSFSREVEGLSRVR---------HPNLVCL 125 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~---------h~niv~~ 125 (347)
.++|...+.||+|+||.||+|.. +|+.||+|++..... ...+.+|+.+++.++ |||++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 789999999976432 156889999988885 6666666
Q ss_pred eeEEE-----------------e-------------CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 040826 126 FGCCV-----------------E-------------GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALR 175 (347)
Q Consensus 126 ~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 175 (347)
.+++. + .+..++||||+++|++.+.+.+ ..+++..+..++.|++.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 65532 2 6789999999999987777743 45899999999999999999
Q ss_pred HhhhccCCCceeCCCCCCCEEecCCC--------------------ceEEeecccceecCCCccceeecccCCCCccccc
Q 040826 176 YLHHYIDGCIVHRDIKLTNILLTEKL--------------------EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPE 235 (347)
Q Consensus 176 ~Lh~~~~~~i~H~dl~p~Nili~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 235 (347)
|||+ +.+|+||||||+|||++.++ .+||+|||+++..... ...||..|+|||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE 247 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED 247 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence 9993 35899999999999999887 8999999999875421 236899999999
Q ss_pred cccCCccCCcccHHHHHHH-HHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHH
Q 040826 236 YMTNAKLTCASDIYSFGIV-ALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAV 314 (347)
Q Consensus 236 ~~~~~~~~~~~Dv~slG~i-l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~ 314 (347)
++.+.. +.++||||++++ .+++++|..||...................... ..........+++.+|+.
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK---------CNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC---------CCSHHHHHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc---------cchhhhhhcCHHHHHHHH
Confidence 998766 889999998777 777888988874211001111111111111110 011223456789999999
Q ss_pred HhccCCCCCCCCHHHHH
Q 040826 315 LCVAKSSKGRPTIDVVY 331 (347)
Q Consensus 315 ~cl~~~p~~Rps~~ei~ 331 (347)
+||+.| |+.|++
T Consensus 318 ~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 318 TMLNFS-----SATDLL 329 (336)
T ss_dssp HGGGSS-----SHHHHH
T ss_pred HHhccC-----CHHHHH
Confidence 999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=261.58 Aligned_cols=182 Identities=16% Similarity=0.102 Sum_probs=128.4
Q ss_pred eeecCCeeEEEEE-eCCCCEEEEEEcccCC------------ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEEE
Q 040826 74 LGRGSAGLVYKGV-LPSGQVVAIKHIYKSN------------NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 74 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~------------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 139 (347)
.+.|+.|.+..+. .-.|+.+++|.+.... +.+.+.+|+++|+++ +|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666554 3358899999986542 123588999999999 6999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||++|++|.+++...+ +++.. +|+.|+++||.|+| ++||+||||||+|||++++|.+||+|||+++..... .
T Consensus 322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-C 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-C
Confidence 9999999999997654 45553 58899999999999 899999999999999999999999999999875422 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKV 264 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p 264 (347)
.......||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 234456799999999999864 56689999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=233.40 Aligned_cols=181 Identities=15% Similarity=0.184 Sum_probs=143.9
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC----------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN----------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
..++||+|+||.||+|.. .++.+++|+...... .+.+.+|++++++++||||+.+..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356799999999999965 578888887654321 124789999999999999996666666777889999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++++|.+++.. +..++.|+++||.||| +++++||||||+|||++. .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999999854 5689999999999999 789999999999999999 999999999998753222
Q ss_pred ce------eecccCCCCccccccccC--CccCCcccHHHHHHHHHHHHhCCCCc
Q 040826 220 KV------FTDVRGTIGYMDPEYMTN--AKLTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 220 ~~------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
.. .....||+.|+|||++.. ..|+..+|+|+...-..+-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 234679999999999987 67888999999999888888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=192.30 Aligned_cols=145 Identities=15% Similarity=0.096 Sum_probs=116.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--------------------hhHHHHHHHHhhcCCCCccee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--------------------TDSFSREVEGLSRVRHPNLVC 124 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~e~~~l~~l~h~niv~ 124 (347)
...|...+.||+|+||.||+|...+|+.||+|.+..... ...+.+|+.++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 344556689999999999999997799999999864321 235789999999999 5 66
Q ss_pred eeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceE
Q 040826 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPK 204 (347)
Q Consensus 125 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~k 204 (347)
+.+++.. +..++||||+++++|.+ +.. .....++.|++.||.||| +.|++||||||+|||++ ++.++
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEE
Confidence 6666544 45699999999999988 421 224579999999999999 88999999999999999 99999
Q ss_pred EeecccceecCCCccceeecccCCCCccccccccC
Q 040826 205 LSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239 (347)
Q Consensus 205 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 239 (347)
|+|||++... ..+.|||++..
T Consensus 233 l~DFG~a~~~--------------~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVEV--------------GEEGWREILER 253 (282)
T ss_dssp ECCCTTCEET--------------TSTTHHHHHHH
T ss_pred EEECCCCeEC--------------CCCCHHHHHHH
Confidence 9999998742 34688887743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.1e-21 Score=163.37 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=104.4
Q ss_pred cccCCeeeecCCeeEEEEEe-CCCCE--EEEEEcccCCCh--------------------------hHHHHHHHHhhcCC
Q 040826 68 DWDRRFLGRGSAGLVYKGVL-PSGQV--VAIKHIYKSNNT--------------------------DSFSREVEGLSRVR 118 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~--------------------------~~~~~e~~~l~~l~ 118 (347)
|...+.||+|+||.||+|.. .+|+. ||||.+...... ..+.+|+..+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999997 68888 999986543110 25778999999998
Q ss_pred CCcc--eeeeeEEEeCCeEEEEEeecCC-C----ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCC
Q 040826 119 HPNL--VCLFGCCVEGGEQYLVYEFCAA-G----NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191 (347)
Q Consensus 119 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~ 191 (347)
|+++ ..++.+ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.|||. +.|++|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8764 333332 356899999942 3 67665432 2344677899999999999994 4689999999
Q ss_pred CCCEEecCCCceEEeecccceec
Q 040826 192 LTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 192 p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=155.34 Aligned_cols=135 Identities=15% Similarity=0.076 Sum_probs=98.5
Q ss_pred cccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----------------ChhH--------HHHHHHHhhcCCCCcce
Q 040826 68 DWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----------------NTDS--------FSREVEGLSRVRHPNLV 123 (347)
Q Consensus 68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~--------~~~e~~~l~~l~h~niv 123 (347)
|...++||+|++|.||+|...+|+.||||++.... .... ...|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78889999999999999999899999999875320 0011 12456666666544432
Q ss_pred eeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC--
Q 040826 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-- 201 (347)
Q Consensus 124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-- 201 (347)
-..-+... ..++||||++|++|.++... +....++.|++.+|.+|| ..|++||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 21111122 23799999999888664321 234568899999999999 78999999999999999877
Q ss_pred --------ceEEeecccceec
Q 040826 202 --------EPKLSDFGLAKML 214 (347)
Q Consensus 202 --------~~kl~dfg~~~~~ 214 (347)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=3.5e-13 Score=115.89 Aligned_cols=146 Identities=16% Similarity=0.081 Sum_probs=113.7
Q ss_pred HHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccC--CChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEE
Q 040826 61 IENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS--NNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 137 (347)
+.....+|.....++.|+.+.||++... |+.+++|..... .....+.+|..+++.+. +..+.+++++..+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567877777888888999999864 688999988652 33456889999999885 6678889999888889999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI------------------------------------ 181 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------ 181 (347)
||||++|.+|.+.+. +......++.++++++..||+..
T Consensus 88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999987642 11223467889999999999610
Q ss_pred --------------------CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 182 --------------------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 182 --------------------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998765567999987764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=111.70 Aligned_cols=131 Identities=19% Similarity=0.190 Sum_probs=97.7
Q ss_pred eee-ecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCc--ceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLG-RGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPN--LVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
.++ .|..+.||++...+|..+++|..... ....+.+|..+++.+++.+ +.+++++...++..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 344 45569999998877888999987654 3456788999999886444 455888877777889999999998883
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------------------
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYI------------------------------------------------ 181 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------------------ 181 (347)
... .. ...++.++++.+..||+..
T Consensus 104 -~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 -SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp -TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred -cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 11 2356777888888888531
Q ss_pred -------CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 182 -------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 182 -------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.9e-11 Score=106.70 Aligned_cols=141 Identities=18% Similarity=0.268 Sum_probs=106.4
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcc--cCC---ChhHHHHHHHHhhcCC--CCcceeeeeEEEeC---CeEEEEE
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIY--KSN---NTDSFSREVEGLSRVR--HPNLVCLFGCCVEG---GEQYLVY 139 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~---~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 139 (347)
..+.++.|.++.||+....+ ..+++|+.. ... ....+.+|..+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999998754 678888776 332 2346788999999887 44577888887665 4589999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc--------------------------------------
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI-------------------------------------- 181 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-------------------------------------- 181 (347)
||++|.++.+.. ...++......++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998775422 233678888899999999999999631
Q ss_pred -----------------CCCceeCCCCCCCEEecCCCc--eEEeecccceec
Q 040826 182 -----------------DGCIVHRDIKLTNILLTEKLE--PKLSDFGLAKML 214 (347)
Q Consensus 182 -----------------~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~ 214 (347)
...++|+|++|.||+++.++. +.|+||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256999999999999997753 689999988763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=5e-11 Score=104.67 Aligned_cols=183 Identities=18% Similarity=0.188 Sum_probs=119.7
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCc--ceeeeeEEEeCC---eEEEEEeecCC
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPN--LVCLFGCCVEGG---EQYLVYEFCAA 144 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~ 144 (347)
.+.++.|.++.||+.. ..+++|..........+.+|...++.+. +.. +..++......+ ..++||++++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4568999999999863 5688887654433457889999998874 322 333443332222 34789999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc-------------------------------------------
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI------------------------------------------- 181 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------------- 181 (347)
.+|.+... ..++..+...++.|+++.+..||+..
T Consensus 101 ~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 88865332 23677777888888888888888511
Q ss_pred ------------CCCceeCCCCCCCEEecC--CCceEEeecccceecCCCccceeecccCCCCc---cccccccC-----
Q 040826 182 ------------DGCIVHRDIKLTNILLTE--KLEPKLSDFGLAKMLGMEESKVFTDVRGTIGY---MDPEYMTN----- 239 (347)
Q Consensus 182 ------------~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~----- 239 (347)
...++|+|++|.||++++ +..+.++||+.+....... ... ....+ ..|+....
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~---~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI---SLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH---TTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH---HHHhhccccCHHHHHHHHHHc
Confidence 135799999999999998 4567899999887642211 100 00111 22221110
Q ss_pred C---------ccCCcccHHHHHHHHHHHHhCCCCc
Q 040826 240 A---------KLTCASDIYSFGIVALQLLSGQKVI 265 (347)
Q Consensus 240 ~---------~~~~~~Dv~slG~il~~lltg~~p~ 265 (347)
. ......+.|+++.++|.+.+|..++
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0112368999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.6e-07 Score=82.31 Aligned_cols=136 Identities=15% Similarity=0.153 Sum_probs=92.1
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCC---cceeeeeEEE-eCCeEEEEEeecCCCCh
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHP---NLVCLFGCCV-EGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gsL 147 (347)
+.++.|....||+. |..+++|..........+.+|..+++.+.+. .+..++.+.. ..+..+++||+++|.++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 55788888899988 5678888753332345788999999998642 2455555553 34567899999999888
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------------------
Q 040826 148 AQHLLRKDSVLTWERRVKILRDCALALRYLHHYI---------------------------------------------- 181 (347)
Q Consensus 148 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~---------------------------------------------- 181 (347)
.+.... .++......++.++.+.|..||+..
T Consensus 101 ~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 101 GEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp HHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred chhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 653211 1344444455555555555555321
Q ss_pred -----------CCCceeCCCCCCCEEecC---CCce-EEeecccceec
Q 040826 182 -----------DGCIVHRDIKLTNILLTE---KLEP-KLSDFGLAKML 214 (347)
Q Consensus 182 -----------~~~i~H~dl~p~Nili~~---~~~~-kl~dfg~~~~~ 214 (347)
...++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 335699999999999997 4554 79999987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=2.2e-07 Score=79.71 Aligned_cols=135 Identities=19% Similarity=0.168 Sum_probs=95.6
Q ss_pred eeeecCCe-eEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLGRGSAG-LVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 35556655 68988754 5667889976433 3456788999988885 3336678888888899999999999988776
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------------------
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHYI------------------------------------------------ 181 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------------------ 181 (347)
..... ......+..+++..|..||...
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 54321 1223345566666666666421
Q ss_pred -------CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 182 -------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 182 -------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...++|+|+++.||++++++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01278999999999999877777999988765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.2e-07 Score=84.95 Aligned_cols=77 Identities=9% Similarity=0.009 Sum_probs=54.2
Q ss_pred Cee-eecCCeeEEEEEeC-------CCCEEEEEEcccCC-----ChhHHHHHHHHhhcCC-C--CcceeeeeEEEeC---
Q 040826 72 RFL-GRGSAGLVYKGVLP-------SGQVVAIKHIYKSN-----NTDSFSREVEGLSRVR-H--PNLVCLFGCCVEG--- 132 (347)
Q Consensus 72 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 132 (347)
+.| +.|..+.+|+.... ++..+++|...... ....+.+|..+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999998764 26788999775533 2356788998888884 2 2456677766544
Q ss_pred CeEEEEEeecCCCChH
Q 040826 133 GEQYLVYEFCAAGNLA 148 (347)
Q Consensus 133 ~~~~lv~e~~~~gsL~ 148 (347)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=4.6e-06 Score=73.89 Aligned_cols=139 Identities=17% Similarity=0.203 Sum_probs=80.2
Q ss_pred CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-----CCcceeee-e--EEEeCCeEEEEEeecC
Q 040826 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-----HPNLVCLF-G--CCVEGGEQYLVYEFCA 143 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~~~ 143 (347)
+.|+.|..+.||+....+| .+++|..... ......|..+++.+. .|.++... | +....+..+++++|++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 3455567889999988655 4889988652 334445556555553 24433311 1 1234677899999999
Q ss_pred CCChH-----------H---Hhhc--CC---C--------CCCHHHH-------------------------------HH
Q 040826 144 AGNLA-----------Q---HLLR--KD---S--------VLTWERR-------------------------------VK 165 (347)
Q Consensus 144 ~gsL~-----------~---~l~~--~~---~--------~~~~~~~-------------------------------~~ 165 (347)
|.++. . .++. .. . ...|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1 1111 10 0 0122110 11
Q ss_pred HHHHHHHHHHHhhh----------ccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 166 ILRDCALALRYLHH----------YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 166 i~~qi~~~l~~Lh~----------~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
+..++..++.+|+. .....++|+|+++.||+++.++.+.++||+.+..
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11223345666652 1257899999999999998888999999987754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=8.2e-06 Score=74.04 Aligned_cols=73 Identities=21% Similarity=0.167 Sum_probs=48.5
Q ss_pred CCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---------ChhHHHHHHHHhhcCCC--Ccce-eeeeEEEeCCeEEE
Q 040826 71 RRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---------NTDSFSREVEGLSRVRH--PNLV-CLFGCCVEGGEQYL 137 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~l 137 (347)
.+.+|.|.++.||++... +++.+++|...+.. ....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 56889999764321 22356788888887742 3333 44433 4455689
Q ss_pred EEeecCCC
Q 040826 138 VYEFCAAG 145 (347)
Q Consensus 138 v~e~~~~g 145 (347)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.07 E-value=3e-05 Score=67.74 Aligned_cols=75 Identities=19% Similarity=0.168 Sum_probs=59.1
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC---CCcceeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR---HPNLVCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
.+.|+.|.+..+|+... ++..+++|..... ....+..|...|+.+. ...+.+++.+....+..++||||+++.++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 45688999999999987 4677888876543 3556888988888884 35677888887777889999999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.06 E-value=1.9e-05 Score=69.34 Aligned_cols=158 Identities=13% Similarity=0.113 Sum_probs=89.9
Q ss_pred cccHHHHHHHhcCcccC-----CeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCC-----CCccee
Q 040826 55 RFSKDEIENAINNDWDR-----RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-----HPNLVC 124 (347)
Q Consensus 55 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 124 (347)
.++.+++.....+|... +.|+.|....+|+....+| .+++|..........+..|..+++.+. -|.++.
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 35677777777777542 3456688899999987666 578898876444456667888777764 233332
Q ss_pred ee-e--EEEeCCeEEEEEeecCCCChHH-----------H---hhcC--C--CC----CC---HHHHHH-----------
Q 040826 125 LF-G--CCVEGGEQYLVYEFCAAGNLAQ-----------H---LLRK--D--SV----LT---WERRVK----------- 165 (347)
Q Consensus 125 ~~-~--~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~--~--~~----~~---~~~~~~----------- 165 (347)
.. | +....+..+++++|++|.++.. . ++.. . .. .. |.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 11 1 1123466789999999865311 1 1110 0 00 11 111000
Q ss_pred -HHHHHHHHHHHhhhc----cCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 166 -ILRDCALALRYLHHY----IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 166 -i~~qi~~~l~~Lh~~----~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
+...+.+.+..++.. ...+++|+|+++.||++++++.+.++||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 135799999999999999876568999987764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=5.9e-05 Score=65.12 Aligned_cols=77 Identities=16% Similarity=0.154 Sum_probs=55.2
Q ss_pred CcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC--ChhHHHHHHHHhhcCCCC---cceeeeeEEEeCCeEEEEEee
Q 040826 67 NDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVRHP---NLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~ 141 (347)
.....+.+|.|..+.||+....+|+.+++|+..... ....+..|...|+.+... .+.+++++ + ..+++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 344567799999999999999999999999876543 234678899998888422 23344433 2 24789999
Q ss_pred cCCCCh
Q 040826 142 CAAGNL 147 (347)
Q Consensus 142 ~~~gsL 147 (347)
.+++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00013 Score=66.72 Aligned_cols=77 Identities=9% Similarity=0.057 Sum_probs=46.8
Q ss_pred CCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeeccc--CCCCccccccccCC---ccCCcccHHHHHHHHH
Q 040826 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVR--GTIGYMDPEYMTNA---KLTCASDIYSFGIVAL 256 (347)
Q Consensus 182 ~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~ 256 (347)
...++|+|++|.|||++.++ +.++||+.+...... ....... -...|.+|+..... .-....+..+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 67899999999999999876 999999988764311 1111100 12345555544311 1112344557777777
Q ss_pred HHHhC
Q 040826 257 QLLSG 261 (347)
Q Consensus 257 ~lltg 261 (347)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0001 Score=59.77 Aligned_cols=104 Identities=15% Similarity=0.053 Sum_probs=69.8
Q ss_pred ChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeecc
Q 040826 146 NLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDV 225 (347)
Q Consensus 146 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 225 (347)
||.+.|...+.+++++++|.++.|.+.+|.-+-. .+.-..+=+.|..|++..+|++.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 8999998888899999999999999999887621 11112333457999999999987764 1110
Q ss_pred cCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 226 RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 226 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
.....+.|||... ...+.+.=|||||+++|..+--..|-.
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1223456788763 345567889999999999987665543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00027 Score=62.02 Aligned_cols=157 Identities=14% Similarity=0.089 Sum_probs=90.8
Q ss_pred ccccHHHHHHHhcCccc-----CCeeeecCCeeEEEEEeCCCCEEEEEEcccC-CChhHHHHHHHHhhcCCCCc--ceee
Q 040826 54 YRFSKDEIENAINNDWD-----RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKS-NNTDSFSREVEGLSRVRHPN--LVCL 125 (347)
Q Consensus 54 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~h~n--iv~~ 125 (347)
..++.+.+......|.. ...++ |....||+....+|+.+++|...+. .....+..|..+++.+.... +.++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecce
Confidence 34556666665554432 23466 8888999988777878999998754 34556777888877774211 3333
Q ss_pred eeE-----EEeCCeEEEEEeecCCCChH-----H------H---hhc--C------CCCCCHHHH---------------
Q 040826 126 FGC-----CVEGGEQYLVYEFCAAGNLA-----Q------H---LLR--K------DSVLTWERR--------------- 163 (347)
Q Consensus 126 ~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~--~------~~~~~~~~~--------------- 163 (347)
+.. ....+..++++++++|.++. . . ++. . ....++...
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 332 22355678899999875431 1 1 111 0 011222111
Q ss_pred -------HHHHHHHHHHHHHhhh-ccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 164 -------VKILRDCALALRYLHH-YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 164 -------~~i~~qi~~~l~~Lh~-~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...+.+++..+..+-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0111112222221110 0245689999999999999 4 899999987764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=9.4e-05 Score=64.29 Aligned_cols=136 Identities=13% Similarity=0.055 Sum_probs=74.6
Q ss_pred CCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEeec-CCCCh
Q 040826 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYEFC-AAGNL 147 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL 147 (347)
.+.|+.|....+|+. ..+++|....... .....+|..+++.+...++ .++++. +.+.-++++||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 567888999999999 5588887765321 1234568877777743233 344443 333456899999 65444
Q ss_pred HH--------H----------hhcCCCCC----CH-HHHHHHHHH--------------HHHHHH----Hhhh-ccCCCc
Q 040826 148 AQ--------H----------LLRKDSVL----TW-ERRVKILRD--------------CALALR----YLHH-YIDGCI 185 (347)
Q Consensus 148 ~~--------~----------l~~~~~~~----~~-~~~~~i~~q--------------i~~~l~----~Lh~-~~~~~i 185 (347)
.. . ++.....+ .. .....+..+ +...+. .+.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 0 01111111 11 111111110 111111 1110 113458
Q ss_pred eeCCCCCCCEEecCCCceEEeecccceec
Q 040826 186 VHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 186 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
+|+|+.+.||+ ..++.+.++||..+...
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 99999999999 56678899999887753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.70 E-value=5.7e-05 Score=69.14 Aligned_cols=73 Identities=14% Similarity=0.199 Sum_probs=49.5
Q ss_pred CCeeeecCCeeEEEEEeCC--------CCEEEEEEcccCCChhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEee
Q 040826 71 RRFLGRGSAGLVYKGVLPS--------GQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 141 (347)
.+.|+.|....+|++...+ +..+++|+.........+.+|..+++.+...++ .++++.+. + .+|+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 4567888899999998753 578999988443222566689998888853333 45555432 2 389999
Q ss_pred cCCCCh
Q 040826 142 CAAGNL 147 (347)
Q Consensus 142 ~~~gsL 147 (347)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00017 Score=63.57 Aligned_cols=140 Identities=15% Similarity=0.075 Sum_probs=71.9
Q ss_pred CeeeecCCee-EEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC--CcceeeeeEEEeCCeEEEEEeecCCCChH
Q 040826 72 RFLGRGSAGL-VYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH--PNLVCLFGCCVEGGEQYLVYEFCAAGNLA 148 (347)
Q Consensus 72 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 148 (347)
+.|+.|+... +|+....+|..+++|...+.. ...+..|..+++.+.. -.+.+++.+....+ +++||++.+.++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 4466565554 667766446777777654432 1334566777666642 22445555422222 6899999776664
Q ss_pred HHhhc---------------------CC----CCCCHHHHH-------HHH-------------HHHHHHHHHhhh---c
Q 040826 149 QHLLR---------------------KD----SVLTWERRV-------KIL-------------RDCALALRYLHH---Y 180 (347)
Q Consensus 149 ~~l~~---------------------~~----~~~~~~~~~-------~i~-------------~qi~~~l~~Lh~---~ 180 (347)
+.+.. .. ..+...... .+. ..+...+..+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 43211 00 112111100 000 011112222210 1
Q ss_pred cCCCceeCCCCCCCEEecCC----CceEEeecccceec
Q 040826 181 IDGCIVHRDIKLTNILLTEK----LEPKLSDFGLAKML 214 (347)
Q Consensus 181 ~~~~i~H~dl~p~Nili~~~----~~~kl~dfg~~~~~ 214 (347)
....++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 14679999999999999875 67899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00044 Score=62.00 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=82.3
Q ss_pred CCeeeecCCeeEEEEEeC--------CCCEEEEEEcccC-CChhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEe
Q 040826 71 RRFLGRGSAGLVYKGVLP--------SGQVVAIKHIYKS-NNTDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 140 (347)
.+.+.-|-...+|++... +++.+++|+.... .......+|..+++.+...++ .++++++. + .+|+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 345777888899999875 2478999986432 234556789999888852222 45555443 2 28999
Q ss_pred ecCCCChHH--------------Hh---hcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 040826 141 FCAAGNLAQ--------------HL---LRK----DSVLT--WERRVKILRDCAL-------------------ALRYLH 178 (347)
Q Consensus 141 ~~~~gsL~~--------------~l---~~~----~~~~~--~~~~~~i~~qi~~-------------------~l~~Lh 178 (347)
|++|.+|.. .+ +.. +.... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865431 11 111 11122 3455555554422 122222
Q ss_pred hc-----cCCCceeCCCCCCCEEecCC----CceEEeeccccee
Q 040826 179 HY-----IDGCIVHRDIKLTNILLTEK----LEPKLSDFGLAKM 213 (347)
Q Consensus 179 ~~-----~~~~i~H~dl~p~Nili~~~----~~~kl~dfg~~~~ 213 (347)
.. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 13469999999999999876 7899999988765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0015 Score=60.13 Aligned_cols=72 Identities=14% Similarity=0.033 Sum_probs=46.2
Q ss_pred CeeeecCCeeEEEEEeCC-CCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEeecCCCCh
Q 040826 72 RFLGRGSAGLVYKGVLPS-GQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYEFCAAGNL 147 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 147 (347)
+.|+.|-...+|++...+ +..+++|+...... .-+-.+|..+++.+...++ .++++.+ .+ .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457778889999998765 47888987754321 1123588888888865444 4556554 22 259999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0029 Score=55.87 Aligned_cols=33 Identities=18% Similarity=0.260 Sum_probs=28.7
Q ss_pred CCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 182 DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 182 ~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
...++|+|+.+.||++++++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00089 Score=59.85 Aligned_cols=72 Identities=13% Similarity=0.040 Sum_probs=43.0
Q ss_pred CeeeecCCeeEEEEEeCC---------CCEEEEEEcccCCCh-hHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEe
Q 040826 72 RFLGRGSAGLVYKGVLPS---------GQVVAIKHIYKSNNT-DSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 140 (347)
+.++.|....+|+....+ +..+++|........ .....|..+++.+...++ .++++.. . -++|+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457788889999998654 268888877543211 124578888887753333 3555432 2 268999
Q ss_pred ecCCCCh
Q 040826 141 FCAAGNL 147 (347)
Q Consensus 141 ~~~~gsL 147 (347)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.021 Score=51.84 Aligned_cols=138 Identities=11% Similarity=0.121 Sum_probs=82.6
Q ss_pred CCeeeecCCeeEEEEEeCC--------CCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEe
Q 040826 71 RRFLGRGSAGLVYKGVLPS--------GQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 140 (347)
.+.+..|-...+|+....+ +..+++|+...... .-+-.+|..+++.+...++ .++++. ..+ ++|+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD--FPE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE--ETT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE--cCC--CEEEE
Confidence 3457778888999998753 57899998654321 1234578888888753233 344442 222 68999
Q ss_pred ecCCCChHH--------------Hh---hc--C---------C-CCCCHHHHHHHHHHHHH-------------------
Q 040826 141 FCAAGNLAQ--------------HL---LR--K---------D-SVLTWERRVKILRDCAL------------------- 172 (347)
Q Consensus 141 ~~~~gsL~~--------------~l---~~--~---------~-~~~~~~~~~~i~~qi~~------------------- 172 (347)
|++|.+|.. .+ ++ . . .+..+.++.++..++-.
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 01 10 0 1 11124444444433221
Q ss_pred HHHHhhhc---------------------cCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 173 ALRYLHHY---------------------IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 173 ~l~~Lh~~---------------------~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
.+..|... ....++|+|+.+.|++ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22222211 1346899999999999 7888999999988775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.27 E-value=0.0031 Score=57.07 Aligned_cols=30 Identities=37% Similarity=0.474 Sum_probs=25.4
Q ss_pred CceeCCCCCCCEEe------cCCCceEEeeccccee
Q 040826 184 CIVHRDIKLTNILL------TEKLEPKLSDFGLAKM 213 (347)
Q Consensus 184 ~i~H~dl~p~Nili------~~~~~~kl~dfg~~~~ 213 (347)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566799999988875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.00 E-value=0.29 Score=39.58 Aligned_cols=116 Identities=9% Similarity=0.093 Sum_probs=77.5
Q ss_pred CCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 118 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
.||+.++. .+..+++.+.+.++.-+.+.-...+. ..+...+++++.+++....+++ .-+|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence 57888866 45556666666666554332222232 3678889999999988886666 23788999999999
Q ss_pred cCCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 198 TEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
+.++.+++.-.|+...+ +|. ..+...=.-.+=+++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999887764432 222 11111223356678888999887764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.13 E-value=0.45 Score=38.61 Aligned_cols=115 Identities=13% Similarity=0.088 Sum_probs=77.1
Q ss_pred CCCcceeeeeEEEeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhhccCCCceeCCCCCCCEE
Q 040826 118 RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALR-YLHHYIDGCIVHRDIKLTNIL 196 (347)
Q Consensus 118 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~-~Lh~~~~~~i~H~dl~p~Nil 196 (347)
.||+. -...-.+++.+.+.++.-+++.-...+. ..+...+++++.+++.... +++ .-.|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 3344466777777777765554444442 3678889999999888777 555 3578899999999
Q ss_pred ecCCCceEEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcC
Q 040826 197 LTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIE 266 (347)
Q Consensus 197 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~ 266 (347)
++.++.+++.-.|+... ++|.-+.. .-=.-++=+++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~------------------lpP~e~~e-----e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES------------------LPPDEWDD-----ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT------------------BSSCSCCH-----HHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc------------------CCCCCCCH-----HHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999988876443 22222111 1112355677888888877653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.19 E-value=0.87 Score=26.32 Aligned_cols=11 Identities=18% Similarity=0.259 Sum_probs=4.6
Q ss_pred HHHHHHhhhcc
Q 040826 16 LIKHVAKSKIQ 26 (347)
Q Consensus 16 ~~~~~~~~~~~ 26 (347)
.|.+.|+++.+
T Consensus 30 ~~~~~RRRr~~ 40 (44)
T 2l2t_A 30 FAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHTTCSS
T ss_pred HHHHhhhhhhh
Confidence 34444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.27 E-value=0.99 Score=26.11 Aligned_cols=10 Identities=10% Similarity=0.142 Sum_probs=4.1
Q ss_pred HHHHHHhhhc
Q 040826 16 LIKHVAKSKI 25 (347)
Q Consensus 16 ~~~~~~~~~~ 25 (347)
.|.+.|+++.
T Consensus 31 ~~~~~RRr~~ 40 (44)
T 2ks1_B 31 IGLFMRRRHI 40 (44)
T ss_dssp HHHHHHTTTC
T ss_pred HHHHhhhhHh
Confidence 3444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 347 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-60
Identities = 74/277 (26%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFG 127
+ +G GS G VYKG VA+K + + T F EV L + RH N++ G
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
+ +V ++C +L HL ++ + + I R A + YLH I+H
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLG-MEESKVFTDVRGTIGYMDPEYMTNAK---LT 243
RD+K NI L E L K+ DFGLA + S F + G+I +M PE + +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303
SD+Y+FGIV +L++GQ + + RDQ+ R + ++ N
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMV------GRGYLSPDLSKVRSNCP- 239
Query: 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
+++ ++ C+ K RP + I+ ++
Sbjct: 240 ---KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-59
Identities = 64/264 (24%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEG 132
+G G GLV+ G + VAIK I + + + F E E + ++ HP LV L+G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 133 GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192
LV+EF G L+ +L + + E + + D + + + C++HRD+
Sbjct: 73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRDLAA 129
Query: 193 TNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFG 252
N L+ E K+SDFG+ + + ++ T + + + PE + ++ + SD++SFG
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 189
Query: 253 IVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKI 312
++ ++ S K+ + + + D+S G R PRL + +I
Sbjct: 190 VLMWEVFSEGKIPYENRSNSEVV----EDISTGFRL----YKPRLAS-------THVYQI 234
Query: 313 AVLCVAKSSKGRPTIDVVYEEIDK 336
C + + RP + ++ +
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-59
Identities = 58/267 (21%), Positives = 120/267 (44%), Gaps = 21/267 (7%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCV 130
LG G G V+ G VA+K + + + + D+F E + +++H LV L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSV-LTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
+ Y++ E+ G+L L + LT + + + A + ++ +HRD
Sbjct: 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRD 134
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
++ NIL+++ L K++DFGLA+++ E + I + PE + T SD++
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 250 SFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESI 309
SFGI+ ++++ ++ + + +++ G R ++ P E +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVI----QNLERGYRMVRPDNCP-----------EEL 239
Query: 310 LKIAVLCVAKSSKGRPTIDVVYEEIDK 336
++ LC + + RPT D + ++
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-58
Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 19/264 (7%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+ LG G G+V G VAIK I + + + D F E + + + H LV L+G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
+ +++ E+ A G L +L ++ +++ +D A+ YL +HRD+
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 126
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
N L+ ++ K+SDFGL++ + +E + + + PE + +K + SDI++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 251 FGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESIL 310
FG++ ++ S K+ F + ++ G R + E +
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLAS-----------EKVY 231
Query: 311 KIAVLCVAKSSKGRPTIDVVYEEI 334
I C + + RPT ++ I
Sbjct: 232 TIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-56
Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 11/268 (4%)
Query: 66 NNDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHP 120
++D+++ LG G+ G+V+K PSG V+A K I+ + RE++ L P
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
+V +G GE + E G+L Q L+K + + K+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGLTYLRE- 122
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+HRD+K +NIL+ + E KL DFG++ L + GT YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGT 178
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
+ SDI+S G+ +++ G+ I +L + P +
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 301 INRADFESILKIAVLCVAKSSKGRPTID 328
D + I L ++ P +
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLP 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-56
Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 21/288 (7%)
Query: 56 FSKDEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGL 114
+KD E + LG+G G V+ G VAIK + + ++F +E + +
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 115 SRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDS-VLTWERRVKILRDCALA 173
++RH LV L+ Y+V E+ + G+L L + L + V + A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
+ Y+ VHRD++ NIL+ E L K++DFGLA+++ E + I +
Sbjct: 126 MAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 234 PEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293
PE + T SD++SFGI+ +L + +V R+ L + V G R E
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VERGYRMPCPPE 238
Query: 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341
P ES+ + C K + RPT + + ++ + +T
Sbjct: 239 CP-----------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (448), Expect = 9e-54
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 38/305 (12%)
Query: 56 FSKDEIENAINN-----DWDR----RFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSN 102
F+ ++ A+ D + +G G G V G L VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 103 NTD---SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLT 159
F E + + HPN++ L G + ++ EF G+L L + D T
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 160 WERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219
+ V +LR A ++YL VHRD+ NIL+ L K+SDFGL++ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 220 KV----FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQL 275
+ I + PE + K T ASD++S+GIV +++S + D +D +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 276 TRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEID 335
+ R + P ++ ++ + C K RP + +D
Sbjct: 244 NA----IEQDYRLPPPMDCP-----------SALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 336 KAWKN 340
K +N
Sbjct: 289 KMIRN 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE 131
+ +G+G G V G G VA+K I +F E ++++RH NLV L G VE
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 132 GGEQ-YLVYEFCAAGNLAQHLL-RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
Y+V E+ A G+L +L R SVL + +K D A+ YL VHRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 128
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
+ N+L++E K+SDFGL K S + + + PE + K + SD++
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 250 SFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESI 309
SFGI+ ++ S +V +D + R ++ ++
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPR-----------VEKGYKMDAPDGCP----PAV 229
Query: 310 LKIAVLCVAKSSKGRPTIDVVYEEIDK 336
++ C + RP+ + E+++
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-53
Identities = 62/269 (23%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLF 126
+G GS G K G+++ K + + T++ EV L ++HPN+V +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 127 GCCVEGGEQ--YLVYEFCAAGNLAQHL---LRKDSVLTWERRVKILRDCALALRYLH--H 179
++ Y+V E+C G+LA + ++ L E ++++ LAL+ H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
++HRD+K N+ L K KL DFGLA++L ++ GT YM PE M
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNR 188
Query: 240 AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299
SDI+S G + +L + F ++ + I++ + R+
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGK-----------IREGKFRRIPY 236
Query: 300 NINRADFESILKIAVLCVAKSSKGRPTID 328
+ + + +I + RP+++
Sbjct: 237 RYS----DELNEIITRMLNLKDYHRPSVE 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-53
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 74 LGRGSAGLVYKGVL---PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFG 127
LG G+ G V +GV VAIK + + T+ RE + + ++ +P +V L G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
C + LV E G L + L+ K + ++L ++ ++YL VH
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVH 132
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGMEES--KVFTDVRGTIGYMDPEYMTNAKLTCA 245
RD+ N+LL + K+SDFGL+K LG ++S + + + + PE + K +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305
SD++S+G+ + LS + + + + GKR E P
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGKRMECPPECP---------- 238
Query: 306 FESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
+ + C + RP V + + + +
Sbjct: 239 -PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 5e-52
Identities = 57/274 (20%), Positives = 115/274 (41%), Gaps = 21/274 (7%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVE 131
LG G G VY+GV VA+K + + + F +E + ++HPNLV L G C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 132 GGEQYLVYEFCAAGNLAQHLLRKDS-VLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
Y++ EF GNL +L + ++ + + + A+ YL +HRD+
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 141
Query: 191 KLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYS 250
N L+ E K++DFGL++++ + + I + PE + K + SD+++
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201
Query: 251 FGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESIL 310
FG++ ++ + L++ + R + P E +
Sbjct: 202 FGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRMERPEGCP-----------EKVY 246
Query: 311 KIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344
++ C + RP+ +++ + ++ + +
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-51
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 72 RFLGRGSAGLVYKGVLP----SGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVC 124
+GRG G VY G L A+K + + + F E + HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 125 LFGCCVEG-GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G C+ G +V + G+L + + T + + A +++L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--- 149
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK---VFTDVRGTIGYMDPEYMTNA 240
VHRD+ N +L EK K++DFGLA+ + +E T + + +M E +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
K T SD++SFG++ +L++ D + D + G+R ++ P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGRRLLQPEYCP----- 260
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344
+ + ++ + C ++ RP+ + I + + E
Sbjct: 261 ------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-51
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 24/263 (9%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS---FSREVEGLSRVRHPNLVCLFG 127
+ LG G+ G V V + + VA+K + D +E+ + H N+V +G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 128 CCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVH 187
EG QYL E+C +G + D + + + YLH I H
Sbjct: 71 HRREGNIQYLFLEYC-SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITH 126
Query: 188 RDIKLTNILLTEKLEPKLSDFGLAKMLGM-EESKVFTDVRGTIGYMDPEYMTNAKL-TCA 245
RDIK N+LL E+ K+SDFGLA + ++ + GT+ Y+ PE + +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 246 SDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRAD 305
D++S GIV +L+G+ L +D ++ D K + ++ I+ A
Sbjct: 187 VDVWSCGIVLTAMLAGE----LPWDQPSDSCQEYSDWKEKKTYLNPWK------KIDSAP 236
Query: 306 FESILKIAVLCVAKSSKGRPTID 328
+ K + ++ R TI
Sbjct: 237 LALLHK----ILVENPSARITIP 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-51
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 26/230 (11%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLVCL 125
R LG+G G VY S ++A+K ++K+ + REVE S +RHPN++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+G + YL+ E+ G + + L +K S +R + + A AL Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRV 127
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
+HRDIK N+LL E K++DFG + S T + GT+ Y+ PE +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 246 SDIYSFGIVALQLLSGQ-------------KVIELDFDARDQLTRKARDV 282
D++S G++ + L G+ ++ ++F D +T ARD+
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-50
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 29/284 (10%)
Query: 70 DRRFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNL 122
+ + LG G+ G V KG + VA+K + N D E + ++ +P +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
V + G C E LV E G L ++L + + + ++++ ++ ++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMTNA 240
VHRD+ N+LL + K+SDFGL+K L K T + + + PE +
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 241 KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGN 300
K + SD++SFG++ + S + + + G+R P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKGERMGCPAGCP----- 236
Query: 301 INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344
+ + LC + RP V + + + + E
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-50
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 28/275 (10%)
Query: 72 RFLGRGSAGLVYKGVLPSGQ-----VVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLV 123
+ +G G G VYKG+L + VAIK + F E + + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G + ++ E+ G L + L KD + + V +LR A ++YL +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--- 129
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMTNAK 241
VHRD+ NIL+ L K+SDFGL+++L E + + + I + PE ++ K
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 242 LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301
T ASD++SFGIV ++++ + + + + + ++ G R + P
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAINDGFRLPTPMDCP------ 239
Query: 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+I ++ + C + RP + +DK
Sbjct: 240 -----SAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 3e-50
Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 38/282 (13%)
Query: 65 INNDWDRRF-----LGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEG 113
+D ++ F +G GS G VY + + +VVAIK + S + +EV
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 114 LSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
L ++RHPN + GC + +LV E+C + K L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQG 127
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMD 233
L YLH + ++HRD+K NILL+E KL DFG A ++ GT +M
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMA 179
Query: 234 PEY---MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK 290
PE M + D++S GI ++L + + + +A L I
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYH-----------IA 227
Query: 291 DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332
E P L F + + C+ K + RPT +V+ +
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (428), Expect = 3e-50
Identities = 62/262 (23%), Positives = 113/262 (43%), Gaps = 23/262 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGC 128
LG G+ G+V++ +G A K + + +D + +E++ +S +RHP LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+ E ++YEF + G L + + + + ++ + V+ +R L ++H + VH
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148
Query: 189 DIKLTNILLTEKL--EPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
D+K NI+ T K E KL DFGL L + + GT + PE + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADF 306
D++S G+++ LLSG F + R+V + D ++ D
Sbjct: 207 DMWSVGVLSYILLSGL----SPFGGENDD-ETLRNVKSCDWNMDDSAFSGIS-----EDG 256
Query: 307 ESILKIAVLCVAKSSKGRPTID 328
+ ++ + R TI
Sbjct: 257 KDFIR---KLLLADPNTRMTIH 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-50
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD--SFSREVEGLSRVRHPNLVCLFGC 128
LG G+ G VYK + + A K I + + + E++ L+ HPN+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+++ EFCA G + +L + LT + + + AL YLH D I+HR
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM-----TNAKLT 243
D+K NIL T + KL+DFG++ + GT +M PE + +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 244 CASDIYSFGIVALQLLSGQ 262
+D++S GI +++ +
Sbjct: 194 YKADVWSLGITLIEMAEIE 212
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-50
Identities = 63/290 (21%), Positives = 110/290 (37%), Gaps = 27/290 (9%)
Query: 71 RRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFS-REVEGLSRVRHPNLVCLFGCC 129
+ +G+G G V++G G+ VA+K F E+ +RH N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 130 VEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC- 184
+ +LV ++ G+L +L R +T E +K+ A L +LH I G
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 185 ----IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF---TDVRGTIGYMDPEY- 236
I HRD+K NIL+ + ++D GLA + GT YM PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 237 -----MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR----DQLTRKARDVSMGKR 287
M + + +DIY+ G+V ++ + + D + D + M K
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 288 PIKDFEDPRLNGNINRAD-FESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+ P + + + KI C + R T + + + +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-50
Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS--FSREVEGLSRVRHPNLVCLFGC 128
+G+G++G VY + + +GQ VAI+ + E+ + ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHR 188
+ G E ++V E+ A G+L + + + R+C AL +LH ++HR
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 189 DIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDI 248
DIK NILL KL+DFG + E+SK T V GT +M PE +T DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 249 YSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFES 308
+S GI+A++++ G+ + + L + G +++ E A F
Sbjct: 200 WSLGIMAIEMIEGE----PPYLNENPLRALYLIATNGTPELQNPEKL-------SAIFRD 248
Query: 309 ILKIAVLCVAKSSKGRPTID 328
L C+ + R +
Sbjct: 249 FLN---RCLDMDVEKRGSAK 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 8e-50
Identities = 62/298 (20%), Positives = 116/298 (38%), Gaps = 51/298 (17%)
Query: 72 RFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNL 122
R +G G+ G V++ P +VA+K + + + D F RE ++ +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDS-----------------------VLT 159
V L G C G L++E+ A G+L + L L+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 160 WERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML-GMEE 218
++ I R A + YL VHRD+ N L+ E + K++DFGL++ + +
Sbjct: 139 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRK 278
K + I +M PE + + T SD++++G+V ++ S + +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY- 254
Query: 279 ARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
++D N + + LC +K RP+ ++ + +
Sbjct: 255 ----------VRDGNILACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 64/265 (24%), Positives = 108/265 (40%), Gaps = 30/265 (11%)
Query: 74 LGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGC 128
+GRGS VYKG+ + VA + T S F E E L ++HPN+V +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 129 CVEGGEQ----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
+ LV E +G L + L++ V+ + R L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPP 134
Query: 185 IVHRDIKLTNILLT-EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLT 243
I+HRD+K NI +T K+ D GLA + + V GT +M PE K
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE-KYD 190
Query: 244 CASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303
+ D+Y+FG+ L++ + + + + R V+ G +P ++
Sbjct: 191 ESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPAS----------FDK 236
Query: 304 ADFESILKIAVLCVAKSSKGRPTID 328
+ +I C+ ++ R +I
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIK 261
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-49
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 45/293 (15%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTD---SFSREVEGLSRV-RHPN 121
+ LG G+ G V + + VA+K + S + + E++ LS + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRK-----------------DSVLTWERRV 164
+V L G C GG ++ E+C G+L L RK + L E +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 165 KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF-T 223
A + +L +HRD+ NILLT K+ DFGLA+ + + + V
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283
+ R + +M PE + N T SD++S+GI +L S + + ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE-- 263
Query: 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
G R + P + I C RPT + + I+K
Sbjct: 264 -GFRMLSPEHAP-----------AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-47
Identities = 63/280 (22%), Positives = 106/280 (37%), Gaps = 30/280 (10%)
Query: 68 DWDR----RFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNTD---SFSREVEGLSR 116
+R R +G G G V++G+ S VAIK + F +E + +
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 117 VRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRY 176
HP++V L G E +++ E C G L L + L + + AL Y
Sbjct: 65 FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 177 LHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY 236
L VHRDI N+L++ KL DFGL++ + + + I +M PE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 237 MTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296
+ + T ASD++ FG+ ++L D + R I++ E
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----------IENGERLP 229
Query: 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+ N ++ + C A RP + ++
Sbjct: 230 MPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (410), Expect = 1e-47
Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 11/225 (4%)
Query: 44 EIYSTTWSGLYRFSKDEIENAINNDWD-RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS 101
+ Y W + + ++ + +D LG G+ G+V++ V +G+V K I
Sbjct: 6 KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP 65
Query: 102 NNTD--SFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLT 159
D + E+ ++++ HP L+ L + E L+ EF + G L + +D ++
Sbjct: 66 YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 125
Query: 160 WERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP--KLSDFGLAKMLGME 217
+ +R L+++H + IVH DIK NI+ K K+ DFGLA L
Sbjct: 126 EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--N 180
Query: 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
++ T + PE + + +D+++ G++ LLSG
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-47
Identities = 65/294 (22%), Positives = 117/294 (39%), Gaps = 50/294 (17%)
Query: 72 RFLGRGSAGLVYKGVLPS------GQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPN 121
+ LG G+ G V VA+K + + ++ ++ E++ ++++ H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 122 LVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD----------------------SVLT 159
+V L G C G YL++E+C G+L +L K +VLT
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 160 WERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219
+E + A + +L VHRD+ N+L+T K+ DFGLA+ + + +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 220 -KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRK 278
V + R + +M PE + T SD++S+GI+ ++ S +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 279 ARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332
++ G + + F E I I C A S+ RP+ +
Sbjct: 280 IQN---GFKMDQPFYAT-----------EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-47
Identities = 58/275 (21%), Positives = 107/275 (38%), Gaps = 29/275 (10%)
Query: 74 LGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNTD-----SFSREVEGLSRVRHPNLVC 124
LG GS G+V +G + VA+K + + F REV + + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
L+G + +V E G+L L + + A + YL
Sbjct: 76 LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---R 131
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKML--GMEESKVFTDVRGTIGYMDPEYMTNAKL 242
+HRD+ N+LL + K+ DFGL + L + + + + PE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
+ ASD + FG+ ++ + + + + L + ++ G+R + + P
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GERLPRPEDCP------- 241
Query: 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337
+ I + V C A + RPT + + + +A
Sbjct: 242 ----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-47
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 24/231 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRHPNLVCL 125
+ LG GS V L + + AIK + K + +RE + +SR+ HP V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ + + Y + G L +++ + S + AL YLH I
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGK---GI 129
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTC 244
+HRD+K NILL E + +++DFG AK+L E + GT Y+ PE +T
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 245 ASDIYSFGIVALQLLSG-------------QKVIELDFDARDQLTRKARDV 282
+SD+++ G + QL++G QK+I+L++D ++ KARD+
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-46
Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 46/295 (15%)
Query: 68 DWDR----RFLGRGSAGLVYKGVLPSG---QVVAIKHIYKSNNTD---SFSREVEGLSRV 117
DW+ +G G+ G V K + AIK + + + D F+ E+E L ++
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 118 -RHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWE 161
HPN++ L G C G YL E+ GNL L + S L+ +
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 162 RRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
+ + D A + YL +HRD+ NIL+ E K++DFGL++ + K
Sbjct: 128 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK- 183
Query: 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARD 281
T R + +M E + + T SD++S+G++ +++S + +
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---- 238
Query: 282 VSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+ G R K + + + C + RP+ + +++
Sbjct: 239 LPQGYRLEKPLNCD-----------DEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-45
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 28/278 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQV----VAIKHIYKSNNTDS---FSREVEGLSRVRHPNLV 123
+ LG G+ G VYKG+ +P G+ VAIK + ++ + + E ++ V +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L G C+ L+ + G L ++ + + + A + YL
Sbjct: 75 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 130
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKL 242
+VHRD+ N+L+ K++DFGLAK+LG EE + + I +M E + +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 243 TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302
T SD++S+G+ +L++ A + + + G+R +
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----LEKGERLPQPPICT------- 239
Query: 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
+ I V C + RP + E K ++
Sbjct: 240 ----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-44
Identities = 54/261 (20%), Positives = 102/261 (39%), Gaps = 22/261 (8%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHI-YKSNNTDSFSREVEGLSRVRHPNLVCLFGCC 129
LGRG G+V++ V S + K + K + +E+ L+ RH N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
E +++EF + ++ + + L V + AL++LH I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 190 IKLTNILLTEKLEP--KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASD 247
I+ NI+ + K+ +FG A+ L ++ F + Y PE + ++ A+D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 248 IYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFE 307
++S G + LLSG F A + ++ + + ++ +
Sbjct: 186 MWSLGTLVYVLLSGI----NPFLAETN-QQIIENIMNAEYTFDEEAFKEIS-----IEAM 235
Query: 308 SILKIAVLCVAKSSKGRPTID 328
+ + K K R T
Sbjct: 236 DFVD---RLLVKERKSRMTAS 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 5e-44
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 65 INNDWD-RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRH 119
I + +D R LG G+ V + ++VAIK I K S E+ L +++H
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
PN+V L GG YL+ + + G L ++ K T +++ A++YLH
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHD 125
Query: 180 YIDGCIVHRDIKLTNILLT---EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY 236
IVHRD+K N+L E + +SDFGL+KM + V + GT GY+ PE
Sbjct: 126 L---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEV 180
Query: 237 MTNAKLTCASDIYSFGIVALQLLSGQ 262
+ + A D +S G++A LL G
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (371), Expect = 1e-42
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 65 INNDWD-RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD-----SFSREVEGLSRV 117
+++ ++ LG G V+ L + VA+K + D F RE + + +
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 118 RHPNLVCLFGCCVE----GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALA 173
HP +V ++ G Y+V E+ L + + +T +R ++++ D A
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQA 123
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--FTDVRGTIGY 231
L + H I+HRD+K NI+++ K+ DFG+A+ + + V V GT Y
Sbjct: 124 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 232 MDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
+ PE + SD+YS G V ++L+G+
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (367), Expect = 4e-42
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 38/276 (13%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD-----------SFSREVEGLSRVR- 118
LGRG + +V + + P+ + A+K I + + +EV+ L +V
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 119 HPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
HPN++ L +LV++ G L +L + L+ + KI+R + LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 127
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMT 238
IVHRD+K NILL + + KL+DFG + L + + +V GT Y+ PE +
Sbjct: 128 KL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIE 182
Query: 239 ------NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
+ D++S G++ LL+G F R Q+ R + G
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----PPFWHRKQM-LMLRMIMSGNYQFGSP 237
Query: 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328
E + + ++ + + R T +
Sbjct: 238 EWDDYS-----DTVKDLVS---RFLVVQPQKRYTAE 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-41
Identities = 59/293 (20%), Positives = 114/293 (38%), Gaps = 37/293 (12%)
Query: 72 RFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNL 122
R LG+GS G+VY+GV VAIK + ++ + F E + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHL---------LRKDSVLTWERRVKILRDCALA 173
V L G +G ++ E G+L +L + + + +++ + A
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 174 LRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLG-MEESKVFTDVRGTIGYM 232
+ YL+ VHRD+ N ++ E K+ DFG+ + + + + + +M
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292
PE + + T SD++SFG+V ++ + + L R V G K
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEGGLLDKPD 258
Query: 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVEM 345
P + + ++ +C + K RP+ + I + + E+
Sbjct: 259 NCP-----------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-41
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKS-----NNTDSFSREVEGLSRV-RHPNLVC 124
+ LG+GS G V+ + Q AIK + K ++ + E LS HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 125 LFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
+F + V E+ G+L H+ + R + L L++LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSK---G 123
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTC 244
IV+RD+KL NILL + K++DFG+ K + ++K GT Y+ PE + K
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKYNH 182
Query: 245 ASDIYSFGIVALQLLSGQ 262
+ D +SFG++ ++L GQ
Sbjct: 183 SVDWWSFGVLLYEMLIGQ 200
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 44/292 (15%)
Query: 72 RFLGRGSAGLVYKGV------LPSGQVVAIKHIYKSNNTD---SFSREVEGLSR-VRHPN 121
+ LGRG+ G V + + + VA+K + + + E++ L H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 122 LVCLFGCCVE-GGEQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVK 165
+V L G C + GG ++ EFC GNL+ +L K LT E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 166 ILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF-TD 224
A + +L +HRD+ NILL+EK K+ DFGLA+ + + V D
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSM 284
R + +M PE + + T SD++SFG++ ++ S ++ R+
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------ 249
Query: 285 GKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
+K+ R + + + C RPT + E +
Sbjct: 250 ----LKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-40
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 8/196 (4%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLF 126
+G G+ G+VYK +G+VVA+K I T+ RE+ L + HPN+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
+ YLV+EF + + L L + H + ++
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVL 124
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRD+K N+L+ + KL+DFGLA+ G+ +V + + A
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 247 DIYSFGIVALQLLSGQ 262
DI+S G + ++++ +
Sbjct: 185 DIWSLGCIFAEMVTRR 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-40
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 26/231 (11%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS--------FSREVEGLSRVR--HP 120
LG G G VY G+ + VAIKH+ K +D EV L +V
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
++ L L+ E + + L E A+R+ H+
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 181 IDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
++HRDIK NIL+ + E KL DFG +L + V+TD GT Y PE++
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 240 AKL-TCASDIYSFGIVALQLLSGQ-------KVIELDFDARDQLTRKARDV 282
+ ++ ++S GI+ ++ G ++I R +++ + + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 234
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-40
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-------FSREVEGLSRVRHPNLV 123
FLG G VYK + Q+VAIK I + +++ RE++ L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 124 CLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDG 183
L LV++F +L + VLT + L YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--- 119
Query: 184 CIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKL- 242
I+HRD+K N+LL E KL+DFGLAK G ++ +T T Y PE + A++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 243 TCASDIYSFGIVALQLLSGQ 262
D+++ G + +LL
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 1e-39
Identities = 45/279 (16%), Positives = 84/279 (30%), Gaps = 22/279 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
R +G GS G +Y G + +G+ VAIK E + ++ + C
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 131 EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDI 190
G+ ++ +L + + + + + Y+H +HRD+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129
Query: 191 KLTNILLTEKLEPKL---SDFGLAKMLGMEESKVF------TDVRGTIGYMDPEYMTNAK 241
K N L+ + L DFGLAK + ++ GT Y +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 242 LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301
+ D+ S G V + G + A + L
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----YERISEKKMSTPIEVLCKGY 244
Query: 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
+F + L C + +P + + +
Sbjct: 245 PS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 1e-39
Identities = 48/282 (17%), Positives = 88/282 (31%), Gaps = 26/282 (9%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-PNLVCLFGCC 129
R +G GS G++++G L + Q VAIK + ++ E + + ++
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
EG LV + L + + + ++ +H +V+RD
Sbjct: 71 QEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126
Query: 190 IKLTNILLTEKLEP-----KLSDFGLAKMLGMEESKVF------TDVRGTIGYMDPEYMT 238
IK N L+ + DFG+ K +K ++ GT YM
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
+ + D+ + G V + L G + +K + K+ L
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEKKQSTP---LRELC 241
Query: 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340
E K + P D + K +
Sbjct: 242 AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 2e-39
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD-----SFSREVEGLSRVRHPNLVCL 125
R LG GS G V+ +G+ A+K + K + E LS V HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+G + + +++ ++ G L L + + + LAL YLH I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHSK---DI 125
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
++RD+K NILL + K++DFG AK + V + GT Y+ PE ++ +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 246 SDIYSFGIVALQLLSGQK 263
D +SFGI+ ++L+G
Sbjct: 182 IDWWSFGILIYEMLAGYT 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-39
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 46/293 (15%)
Query: 72 RFLGRGSAGLVYKGVLPS--------GQVVAIKHIYKS---NNTDSFSREVEGLSRV-RH 119
+ LG G+ G V VA+K + + E+E + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHL---------------LRKDSVLTWERRV 164
N++ L G C + G Y++ E+ + GNL ++L + L+ + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 165 KILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224
A + YL +HRD+ N+L+TE K++DFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 225 V-RGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283
R + +M PE + + T SD++SFG++ ++ + + + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF----KLLK 251
Query: 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336
G R K + + C RPT + E++D+
Sbjct: 252 EGHRMDKPSNCT-----------NELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 5e-39
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDS--------FSREVEGLSRVRHPNL 122
R +GRG G VY +G++ A+K + K + +S P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 123 VCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
VC+ + + + G+L HL + V + + L L ++H+
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHN--- 125
Query: 183 GCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEY-MTNAK 241
+V+RD+K NILL E ++SD GLA ++ GT GYM PE
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVA 182
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
++D +S G + +LL G
Sbjct: 183 YDSSADWFSLGCMLFKLLRGH 203
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-39
Identities = 73/290 (25%), Positives = 113/290 (38%), Gaps = 43/290 (14%)
Query: 56 FSKDEIENAINNDWDR----RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS---- 106
F ++ ++ D LG G +V K +G A K I K S
Sbjct: 3 FRQENVD-------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 107 ----FSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWER 162
REV L ++HPN++ L + L+ E A G L L K+S LT E
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEE 114
Query: 163 RVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP----KLSDFGLAKMLGMEE 218
+ L+ + YLH I H D+K NI+L ++ P K+ DFGLA + +
Sbjct: 115 ATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DF 169
Query: 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRK 278
F ++ GT ++ PE + L +D++S G++ LLSG D
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ET 224
Query: 279 ARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328
+VS +D + A + ++ + K K R TI
Sbjct: 225 LANVSAVNYEFEDEYFSNTS-----ALAKDFIR---RLLVKDPKKRMTIQ 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (346), Expect = 6e-39
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 8/193 (4%)
Query: 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLFGCC 129
+G G+ G+VYK G+ A+K I + RE+ L ++H N+V L+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD 189
LV+E +L + L + L L + Y H ++HRD
Sbjct: 70 HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD 125
Query: 190 IKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIY 249
+K N+L+ + E K++DFGLA+ G+ K ++ M + K + DI+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 250 SFGIVALQLLSGQ 262
S G + ++++G
Sbjct: 186 SVGCIFAEMVNGT 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-39
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 62 ENAINNDWD--RRFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSREVEGLSRV- 117
+NAI +D+ + LG G G V + + + A+K + + REVE R
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRAS 62
Query: 118 RHPNLVCLFGCC----VEGGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCAL 172
+ P++V + +V E G L + + D T +I++
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 173 ALRYLHHYIDGCIVHRDIKLTNILLTEKLEP---KLSDFGLAKMLGMEESKVFTDVRGTI 229
A++YLH I HRD+K N+L T K KL+DFG AK S T T
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTP 177
Query: 230 GYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI 289
Y+ PE + K + D++S G++ LL G + MG+
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQYEF 236
Query: 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTID 328
+ E ++ + + +++ + R TI
Sbjct: 237 PNPEWSEVS-----EEVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-39
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 19/205 (9%)
Query: 72 RFLGRGSAGLVYKG--VLPSGQVVAIKHIYKSNNTD----SFSREVE---GLSRVRHPNL 122
+G G+ G V+K + G+ VA+K + + S REV L HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 123 VCLFGCCVEGGEQ-----YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYL 177
V LF C LV+E + + E ++ L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 178 HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM 237
H + +VHRD+K NIL+T + KL+DFGLA++ T V T+ Y PE +
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVL 187
Query: 238 TNAKLTCASDIYSFGIVALQLLSGQ 262
+ D++S G + ++ +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-38
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 72 RFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV 130
+ +G GS G+VY+ L SG++VAIK + + +RE++ + ++ H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 EGGEQ------YLVYEFCAAGNL--AQHLLRKDSVLTWERRVKILRDCALALRYLHHYID 182
GE+ LV ++ A+H R L + +L Y+H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---S 140
Query: 183 GCIVHRDIKLTNILLTEK-LEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAK 241
I HRDIK N+LL KL DFG AK L + + +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIFGATD 199
Query: 242 LTCASDIYSFGIVALQLLSGQ 262
T + D++S G V +LL GQ
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-37
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 67 NDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS-----FSREVEGLSRVRH 119
ND+D + LG+G+ G V +G+ A+K + K E L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 120 PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHH 179
P L L V E+ G L HL ++ V T ER + AL YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 180 YIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTN 239
+V+RDIKL N++L + K++DFGL K + + + T GT Y+ PE + +
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179
Query: 240 AKLTCASDIYSFGIVALQLLSGQ 262
A D + G+V +++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 18/246 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD---SFSREVEGLSRVRHPNLVCLFG 127
++G G+ G+V + VAIK I + RE++ L R RH N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 128 CCVEGGEQYLVYEFC---AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC 184
+ + + G LL+ L+ + L L+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH---SAN 129
Query: 185 IVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK--VFTDVRGTIGYMDPEYMTNAKL 242
++HRD+K +N+LL + K+ DFGLA++ + T+ T Y PE M N+K
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 243 TC-ASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301
+ DI+S G + ++LS + + F + L + + + P ++ + +N
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPI----FPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 302 NRADFE 307
Sbjct: 246 RNYLLS 251
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-35
Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS----REVEGLSRVRHPNLVCLF 126
+G+G+ G V+K +GQ VA+K + N + F RE++ L ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 127 GCCVEG--------GEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLH 178
C G YLV++FC T ++++ L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLY 131
Query: 179 HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES---KVFTDVRGTIGYMDPE 235
+ I+HRD+K N+L+T KL+DFGLA+ + ++ +T+ T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 236 YMTNAKL-TCASDIYSFGIVALQLLSGQ 262
+ + D++ G + ++ +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-35
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 9/211 (4%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD----SFSREVEGLSRVRHPNLVCLF 126
+G G+ G V+K + ++VA+K + ++ + S RE+ L ++H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIV 186
+ LV+EFC + E L L + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 187 HRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCAS 246
HRD+K N+L+ E KL++FGLA+ G+ +V + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 247 DIYSFGIVALQLLSGQKVIELDFDARDQLTR 277
D++S G + +L + + + D DQL R
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (322), Expect = 8e-35
Identities = 48/197 (24%), Positives = 78/197 (39%), Gaps = 14/197 (7%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTD-----SFSREVEGLSRVRHPNLVCL 125
+ LG GS G V SG A+K + K E L V P LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 126 FGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCI 185
+ Y+V E+ A G + HL R + L YLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 186 VHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCA 245
++RD+K N+L+ ++ +++DFG AK + GT + PE + + A
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 246 SDIYSFGIVALQLLSGQ 262
D ++ G++ ++ +G
Sbjct: 219 VDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-34
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 51 SGLYRFSKDEIENAINNDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFS 108
SG YR + + + + +G G+ G V V +G VAIK +Y+ ++ F+
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 109 ----REVEGLSRVRHPNLVCLFGCCVEGG------EQYLVYEFCAAGNLAQHLLRKDSVL 158
RE+ L +RH N++ L + YLV F G L++ + L
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-L 118
Query: 159 TWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218
+R ++ LRY+H I+HRD+K N+ + E E K+ DFGLA+
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD--- 172
Query: 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
S++ V + + T DI+S G + ++++G+
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 3e-32
Identities = 50/235 (21%), Positives = 101/235 (42%), Gaps = 17/235 (7%)
Query: 53 LYRFSKDEIENAINNDWDR-RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDSFSRE 110
+ + +E +D+ R LGRG V++ + + + + V +K + K RE
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKRE 79
Query: 111 VEGLSRVR-HPNLVCLFGCCVEGGEQ--YLVYEFCAAGNLAQHLLRKDSVLTWERRVKIL 167
++ L +R PN++ L + + LV+E + Q LT +
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYM 135
Query: 168 RDCALALRYLHHYIDGCIVHRDIKLTNILLTEK-LEPKLSDFGLAKMLGMEESKVFTDVR 226
+ AL Y H I+HRD+K N+++ + + +L D+GLA+ + +
Sbjct: 136 YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRV 190
Query: 227 GTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKAR 280
+ + PE + + ++ + D++S G + ++ ++ D DQL R A+
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-31
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 20/202 (9%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS----FSREVEGLSRVRHPNLVCLF 126
+ +G G+ G+V + VAIK + + + RE+ + V H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 127 GCCV------EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
E + YLV E A + D ER +L +++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKHLHSA 138
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNA 240
I+HRD+K +NI++ K+ DFGLA+ S + T T Y PE +
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 241 KLTCASDIYSFGIVALQLLSGQ 262
DI+S G + +++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 18/245 (7%)
Query: 72 RFLGRGSAGLVYKGVL----PSGQVVAIKHIYKSN------NTDSFSREVEGLSRVRH-P 120
+ LG G+ G V+ +G++ A+K + K+ T+ E + L +R P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 121 NLVCLFGCCVEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY 180
LV L + +L+ ++ G L L + T + + LAL +LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALEHLH-- 146
Query: 181 IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYM--T 238
I++RDIKL NILL L+DFGL+K +E++ D GTI YM P+ +
Sbjct: 147 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 239 NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298
++ A D +S G++ +LL+G +D ++ +R + + P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 299 GNINR 303
I R
Sbjct: 265 DLIQR 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 9e-28
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 22/221 (9%)
Query: 56 FSKDEIENAINNDWDR----RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSNNTDS---- 106
F + E+ I +R +G G+ G V +G VA+K + + +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 107 FSREVEGLSRVRHPNLVCLFGCCVEG-----GEQYLVYEFCAAGNLAQHLLRKDSVLTWE 161
RE+ L ++H N++ L + +L + K LT +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDD 121
Query: 162 RRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221
++ L+Y+H I+HRD+K +N+ + E E K+ DFGLA+ E +
Sbjct: 122 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-- 176
Query: 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
V + DI+S G + +LL+G+
Sbjct: 177 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 5e-24
Identities = 44/210 (20%), Positives = 76/210 (36%), Gaps = 21/210 (10%)
Query: 72 RFLGRGSAGLVYKGV-LPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCC 129
R LG G V+ + + VA+K + T++ E++ L RV +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 130 VE---------------GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALAL 174
G +V+E LA + + +I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 175 RYLHHYIDGCIVHRDIKLTNILLT-EKLEPKLSDFGLAKM-LGMEESKVFTDVRGTIGYM 232
Y+H I+H DIK N+L+ L +A + + +T+ T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 233 DPEYMTNAKLTCASDIYSFGIVALQLLSGQ 262
PE + A C +DI+S + +L++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 2e-18
Identities = 35/189 (18%), Positives = 59/189 (31%), Gaps = 30/189 (15%)
Query: 72 RFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTD------------SFSREVEGLSRVRH 119
+ +G G V+ +K + + FS +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 120 PNLVCLFGCCV----EGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALR 175
L L G V ++ E A L + E ++L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 176 YLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT--DVRGTIGYMD 233
+H IVH D+ N+L++E+ + DF + +G E + DVR I Y
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 234 PEYMTNAKL 242
Y T +
Sbjct: 174 RTYRTEKDI 182
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 83.13 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=398.06 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=205.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|.+.+++.||||++.... ..+.+.+|++++++++||||++++|++.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 4567778899999999999999888999999997644 456799999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++......+++..++.++.|++.||.||| +++++||||||+|||+++++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999877778999999999999999999999 7899999999999999999999999999998765443344445
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRA 304 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 304 (347)
..||..|+|||++.+..++.++||||||+++|||+|+..|+............+.. +... ..+..
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~----~~~~-----------~~p~~ 226 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRL-----------YKPRL 226 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH----TCCC-----------CCCTT
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh----cCCC-----------CCccc
Confidence 67899999999999999999999999999999999965555433333222222222 2111 11112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 305 DFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 305 ~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
+.+++.+|+.+||+.||++|||+++|++.|+++.++
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 336799999999999999999999999999999654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=392.38 Aligned_cols=257 Identities=22% Similarity=0.370 Sum_probs=213.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecC
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 143 (347)
.++|...+.||+|+||.||+|.+++++.||||++.... ..+.+.+|+.++++++||||+++++++. ++..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 35677788999999999999999888999999997643 4567999999999999999999999875 456799999999
Q ss_pred CCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 144 AGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 144 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
+|+|.+++... ...+++..+++++.|+++||.||| +++++||||||+|||+++++.+||+|||+++..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999987543 345899999999999999999999 78999999999999999999999999999998764444445
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....||+.|+|||++.+..++.++||||||+++|||+||..|+.......+....+. .+..+ ..+
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~----~~~~~-----------~~p 232 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----RGYRM-----------VRP 232 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTCCC-----------CCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCC-----------CCc
Confidence 556789999999999988999999999999999999997776654433333222222 22111 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKN 340 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~ 340 (347)
...++++.+|+.+||+.||++|||+.+|++.|++++.+
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 12335799999999999999999999999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=391.97 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=204.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|+++ ..||||++.... ..+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 457788899999999999999874 359999986532 2357889999999999999999999865 457899999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc-c
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE-S 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 219 (347)
|+++|+|.+++......+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877777999999999999999999999 7899999999999999999999999999998754322 2
Q ss_pred ceeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..............+...... . +
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--~-----~- 232 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--L-----S- 232 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--G-----G-
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--c-----h-
Confidence 23455679999999999864 35889999999999999999999999754332222222222211111 0 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.....+++++.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122334679999999999999999999999999998854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-57 Score=386.30 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=214.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...++||+|+||.||+|.+++++.||||++.... ..+++.+|+.++++++||||++++|++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 5778889999999999999999888899999997643 557899999999999999999999999999999999999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceeec
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFTD 224 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 224 (347)
|+|.+++......+++..+++++.|+++||.||| +.|++||||||+||++++++.+||+|||+++............
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999998777777999999999999999999999 7899999999999999999999999999998765444444445
Q ss_pred ccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 225 VRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 225 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
..+|..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+.. ..+..+.+. ..+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~~~~----~~i~~~~~~-----------~~p~ 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETA----EHIAQGLRL-----------YRPH 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHH----HHHHTTCCC-----------CCCT
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-HHHH----HHHHhCCCC-----------CCcc
Confidence 678999999999999999999999999999999998 7888874432 2222 222222211 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
..++++.+|+.+||+.||++|||+++|++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233679999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-58 Score=397.88 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=216.8
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|.+. +|+.||||++..+. ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 346777889999999999999965 68899999997653 4567999999999999999999999999999999999999
Q ss_pred CCCChHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 143 AAGNLAQHLLR-KDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 143 ~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
++|+|.+++.. ....+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999865 3567999999999999999999999 7899999999999999999999999999998765444444
Q ss_pred eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 222 FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
.....|+..|+|||++.+..++.++||||||+++|||++|..|+................ ..+ ..
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~----~~~-----------~~ 237 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----YRM-----------ER 237 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----CCC-----------CC
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC----CCC-----------CC
Confidence 555668999999999999999999999999999999999887776444333222222111 110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
+...++++.+|+.+||+.||++|||+.+|++.|+.+++++.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 22334679999999999999999999999999999866543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-56 Score=392.60 Aligned_cols=258 Identities=28% Similarity=0.395 Sum_probs=201.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC---EEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ---VVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|.+. +|+ .||||.+...... +.+.+|+++|++++||||++++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999964 332 6899988765443 4688999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++......+++..+..++.|+++||.||| +++++||||||+|||++.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999877778999999999999999999999 7899999999999999999999999999998764322
Q ss_pred cce----eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 219 SKV----FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 219 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+... .+..+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~~~~----~i~~~~~~----- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVIN----AIEQDYRL----- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHH----HHHTTCCC-----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-HHHHH----HHHcCCCC-----
Confidence 211 222457899999999999999999999999999999998 7888864322 12222 22222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
+.+.++++++.+|+.+||+.||++|||+.||++.|++++++..
T Consensus 253 ------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 253 ------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 1122344679999999999999999999999999999987653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=384.35 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=207.9
Q ss_pred CcccCC-eeeecCCeeEEEEEeC---CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 67 NDWDRR-FLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 67 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++...+ +||+|+||.||+|.+. ++..||||.+...... +.+.+|+++|++++||||++++|++.+ +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 344444 4999999999999853 4557999999765443 468899999999999999999999865 5689999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++......+++..++.++.|+++||.||| +++++||||||+||+++.++.+||+|||+++.......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999998777778999999999999999999999 78999999999999999999999999999998754332
Q ss_pred ce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 220 KV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 220 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.. .....||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .+.. ..+..+.++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~----~~i~~~~~~-------- 231 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVM----AFIEQGKRM-------- 231 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHH----HHHHTTCCC--------
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHH----HHHHcCCCC--------
Confidence 22 233568899999999999999999999999999999998 8999875332 1212 222222221
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+..+++++.+|+.+||+.||++|||+.+|.+.|+..+.+-
T Consensus 232 ---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 112233467999999999999999999999999999887553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=382.49 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35688889999999999999996 479999999986543 23468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc-
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 219 (347)
|+++|+|.+++.. ...+++..+..++.|+++||.||| ++||+||||||+|||+++++.+||+|||++........
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999998854 446999999999999999999999 78999999999999999999999999999987643322
Q ss_pred ceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||................... .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~----~--------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----L--------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----S---------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----C---------
Confidence 22445679999999999988775 678999999999999999999997654333322222211100 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+++.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122357889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=378.02 Aligned_cols=243 Identities=27% Similarity=0.389 Sum_probs=205.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEccc-----CCChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYK-----SNNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|... +|+.||+|++.. ......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56888899999999999999964 789999999864 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... ..+++..+..++.|+++||.||| ++|++||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 999999999998654 35899999999999999999999 78999999999999999999999999999986532
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +. ...+.......+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~----~~~i~~~~~~~p--------- 224 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ET----YKRISRVEFTFP--------- 224 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHHHHTTCCCCC---------
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HH----HHHHHcCCCCCC---------
Confidence 2234567999999999999999999999999999999999999999754321 11 222222222111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...++++.+|+.+||+.||++|||++|+++
T Consensus 225 ---~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 ---DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122357899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=382.77 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCC-----CEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSG-----QVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
+.|...++||+|+||.||+|.+.++ ..||||++...... ..+.+|+.++++++||||++++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3466678899999999999996532 36999998765433 368899999999999999999999999999999
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+.++++.+++......+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999988877778999999999999999999999 789999999999999999999999999999876432
Q ss_pred ccc--eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK--VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......||..|+|||++.+..++.++||||||+++|||++|..|+.......+... .+..+.++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~----~i~~~~~~------- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AINDGFRL------- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTTCCC-------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH----HHhccCCC-------
Confidence 221 23345689999999999999999999999999999999998777664443332222 22222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+.+..++.++.+|+.+||+.||++|||+.||++.|+++++..
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 112234467999999999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=380.85 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=202.2
Q ss_pred CeeeecCCeeEEEEEeC---CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 72 RFLGRGSAGLVYKGVLP---SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++||+|+||.||+|.+. +++.||||++..... .+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999853 356899999865432 2468899999999999999999999865 467899999999
Q ss_pred CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce--e
Q 040826 145 GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV--F 222 (347)
Q Consensus 145 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~ 222 (347)
|+|.+++.+. ..+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++......... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999988654 45999999999999999999999 7899999999999999999999999999998765332222 2
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNI 301 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 301 (347)
....||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+ . ...+..+.++ ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~-~---~~~i~~~~~~-----------~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE-V---TAMLEKGERM-----------GC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH-H---HHHHHTTCCC-----------CC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HH-H---HHHHHcCCCC-----------CC
Confidence 33568999999999999999999999999999999998 8999874322 11 1 2222222211 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 040826 302 NRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344 (347)
Q Consensus 302 ~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~ 344 (347)
+..+++++.+|+.+||+.||++|||+++|.+.|+..+.+-+++
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence 1233467999999999999999999999999999988766553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=379.28 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=206.1
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC--CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS--NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
++|...+.||+|+||.||+|.. .+|+.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688889999999999999995 57999999998653 34567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++|+|.+++.++ .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCCB
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-cccc
Confidence 999999987543 5899999999999999999999 789999999999999999999999999999876432 2234
Q ss_pred ecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 223 TDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +.+...... +.... ..+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~---~~~~~----------~~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATN---GTPEL----------QNP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHH---CSCCC----------SSG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhC---CCCCC----------CCc
Confidence 4567999999999999999999999999999999999999999754322 222222221 11111 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123357999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=381.22 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=205.0
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
+.|...+.||+|+||.||+|.. .+|+.||+|++..... .+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3567778899999999999995 4789999999876433 357889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
++|+|.+++.+....+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence 999999998776677999999999999999999999 789999999999999999999999999999865321 2223
Q ss_pred ecccCCCCcccccccc-----CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 223 TDVRGTIGYMDPEYMT-----NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
....||+.|+|||++. +..|+.++|||||||++|+|+||+.||...... +.+...... ..+. +
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~----~~~~--~----- 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKS----EPPT--L----- 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHS----CCCC--C-----
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcC----CCCC--C-----
Confidence 4567999999999984 456889999999999999999999999754322 222222221 1110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+...++++.+|+.+||+.||.+|||+.|+++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111123467999999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=380.56 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=191.6
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe--CCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE--GGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 138 (347)
++|...+.||+|+||.||+|.. .+|+.||+|.+..... .+.+.+|++++++++||||+++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788889999999999999995 4789999999876532 2358899999999999999999999865 4568999
Q ss_pred EeecCCCChHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 139 YEFCAAGNLAQHLLR---KDSVLTWERRVKILRDCALALRYLHHYI--DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
|||+++|+|.+++.+ ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999854 3467999999999999999999999532 13599999999999999999999999999987
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||..... .+.. ..+..+..+
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~~~----~~i~~~~~~----- 232 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELA----GKIREGKFR----- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHH----HHHHHTCCC-----
T ss_pred cccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-HHHH----HHHHcCCCC-----
Confidence 6432 2233456799999999999999999999999999999999999999975322 1211 222222111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.++...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111123357999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=379.32 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=206.4
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|.+.+++.||||++.... ..+.+.+|+.++++++||||+++++++. ++..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 5788889999999999999999888899999997654 4567999999999999999999999985 4568899999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
|+|..++... ...+++..++.++.|+++||+||| +++++||||||+|||+++++++||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999988643 356999999999999999999999 789999999999999999999999999999876544434444
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCH
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNINR 303 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 303 (347)
...||+.|+|||++.+..++.++||||||+++|||++|..|+.......+.+..+.+.... +.+.
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------------~~~~ 237 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------PCPP 237 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------CCCT
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------CCCc
Confidence 5678999999999999999999999999999999999877776554444433333322111 1122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 304 ADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 304 ~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
.+.+++.+++.+||+.||++|||+.+|++.|++.+.
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 334679999999999999999999999999988653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=370.19 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=194.7
Q ss_pred ccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEe----CCeEEEEE
Q 040826 69 WDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVE----GGEQYLVY 139 (347)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 139 (347)
...++||+|+||.||+|... +++.||+|.+..... .+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999954 688999999865432 2468899999999999999999999875 34689999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--ceeCCCCCCCEEec-CCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGC--IVHRDIKLTNILLT-EKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~ 216 (347)
||+++|+|.+++.+. ..+++..++.++.|+++||+||| +++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 999999999999654 45899999999999999999999 666 99999999999997 57899999999998643
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
........||+.|+|||++.+ +++.++|||||||++|+|++|+.||......... .+.+..+..+. .
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~----~~~i~~~~~~~------~ 233 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSGVKPA------S 233 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----HHHHTTTCCCG------G
T ss_pred --CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH----HHHHHcCCCCc------c
Confidence 222345679999999999876 5999999999999999999999999744333222 22222222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+.... .+++.+|+.+||++||++|||+.|+++
T Consensus 234 ~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11122 246899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-54 Score=378.56 Aligned_cols=250 Identities=28% Similarity=0.362 Sum_probs=191.5
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCC---ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSN---NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
+.+.|...+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3466888899999999999999964 78999999987542 2346778999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec---CCCceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT---EKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~ 216 (347)
||++||+|.+++... ..+++..+..++.|++.||.||| +++++||||||+||++. +++.+||+|||++.....
T Consensus 87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999654 46999999999999999999999 78999999999999995 578999999999986532
Q ss_pred CccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ..+..+......
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~----~~i~~~~~~~~~----- 230 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLF----EQILKAEYEFDS----- 230 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH----HHHHTTCCCCCT-----
T ss_pred --CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHH----HHHhccCCCCCC-----
Confidence 22334567999999999999999999999999999999999999999754322 111 222222211111
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+.++++.+|+.+||++||++|||+.|+++
T Consensus 231 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 ---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111123357999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=374.51 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=200.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC----CCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS----GQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
.++|...+.||+|+||.||+|.+.. +..||+|.+...... ..+.+|+.++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3577888999999999999998542 346899988654333 46889999999999999999999985 567899
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
||||+++|+|.+++......+++..++.++.|+++||.||| +++++||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999988777778999999999999999999999 789999999999999999999999999999876544
Q ss_pred ccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCC
Q 040826 218 ESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPR 296 (347)
Q Consensus 218 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.........||+.|+|||.+.+..++.++||||||+++|||+| |.+||..... .+.... +..+...
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~----i~~~~~~-------- 228 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGR----IENGERL-------- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH----HHTTCCC--------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHH----HHcCCCC--------
Confidence 4444455678999999999999999999999999999999998 7888764332 222222 2222211
Q ss_pred CCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 297 LNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 297 l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
+.+..+++++.+|+.+||+.||++|||+.||++.|++++++..
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1122334679999999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=375.54 Aligned_cols=246 Identities=23% Similarity=0.288 Sum_probs=202.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688889999999999999996 47999999998642 34467899999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+++|+|.+++... +.+++..++.++.|++.||.||| ++||+||||||+|||+++++.+||+|||+++.......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988654 45999999999999999999999 78999999999999999999999999999987653322
Q ss_pred -ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 220 -KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 220 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ....+..+.....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~----~~~~i~~~~~~~p-------- 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-L----IFQKIIKLEYDFP-------- 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHTTCCCCC--------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-H----HHHHHHcCCCCCC--------
Confidence 2234567999999999999999999999999999999999999999754321 1 1222222221111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....+++.+|+.+||+.||++|||++|++.
T Consensus 231 ----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 ----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 122357899999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=382.19 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=204.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEeCC-C-----CEEEEEEcccCC---ChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLPS-G-----QVVAIKHIYKSN---NTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|+... + ..||+|.+.... ....+.+|+.++.++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578888999999999999998532 2 268999886542 345788999999998 89999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCC
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD----------------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKL 192 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p 192 (347)
.++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 999999999999999996542 34889999999999999999999 78999999999
Q ss_pred CCEEecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChh
Q 040826 193 TNILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFD 270 (347)
Q Consensus 193 ~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~ 270 (347)
+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999875433222 2334568999999999999999999999999999999998 8999874332
Q ss_pred hhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 040826 271 ARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDK 336 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~ 336 (347)
. ..+...... +.+. +.+..+++++.+|+.+||+.||++|||++||+++|..
T Consensus 273 ~-~~~~~~~~~---~~~~-----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 D-ANFYKLIQN---GFKM-----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp S-HHHHHHHHT---TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHHHhc---CCCC-----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 2 222222221 1110 1122334679999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-53 Score=380.03 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46788899999999999999995 4799999999976533 34688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--CCCceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~~~kl~dfg~~~~~~~~~~ 219 (347)
+++|+|.+++......+++..++.++.|++.||.||| ++|++||||||+|||++ .++.+||+|||++......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 9999999999776677999999999999999999999 78999999999999996 4678999999999876432
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.+..+.. ....... ..
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~----~~~~~~~----~~-- 248 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKS----CDWNMDD----SA-- 248 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH----TCCCSCC----GG--
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHh----CCCCCCc----cc--
Confidence 334456799999999999999999999999999999999999999975432 222222222 1111111 01
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
....++++.+|+.+||+.||++|||++|++++
T Consensus 249 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 --FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223578999999999999999999999873
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=383.07 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=203.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC---hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN---TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788889999999999999995 4789999999875432 3468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+||+||||||+|||+++++.+||+|||+|..... .
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 158 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---H
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---C
Confidence 999999999996543 58999999999999999999994 24899999999999999999999999999986532 2
Q ss_pred eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC---------------
Q 040826 221 VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG--------------- 285 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--------------- 285 (347)
......||+.|+|||++.+.+|+.++||||+||++|||++|+.||........+...........
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 23456899999999999999999999999999999999999999976433222111100000000
Q ss_pred -----CCCcc----------cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 286 -----KRPIK----------DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 286 -----~~~~~----------~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..+.. ....+.+. ......++.+|+.+||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 00000000 01123578999999999999999999999883
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=371.27 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=199.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEEEEeecCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYLVYEFCAA 144 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~ 144 (347)
++|...+.||+|+||.||+|.+ .|..||||++..+...+.+.+|++++++++||||++++|++.+ .+..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4566778899999999999998 5789999999888778889999999999999999999998854 4568999999999
Q ss_pred CChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccceee
Q 040826 145 GNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVFT 223 (347)
Q Consensus 145 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 223 (347)
|+|.+++... ...+++..+++++.|++.||.||| +.+++||||||+||+++.++.+|++|||+++..... ..
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----Cc
Confidence 9999999653 345899999999999999999999 789999999999999999999999999999865322 23
Q ss_pred cccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCCCCC
Q 040826 224 DVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNGNIN 302 (347)
Q Consensus 224 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 302 (347)
...++..|+|||++.+..++.++||||||+++|||+| |+.|+... ...+-... +..+..+ +.+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~----i~~~~~~-----------~~~ 222 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPR----VEKGYKM-----------DAP 222 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHH----HTTTCCC-----------CCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHH----HHcCCCC-----------CCC
Confidence 3457899999999998899999999999999999998 56666532 22222221 2222111 122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 303 RADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 303 ~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
....+++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2333679999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-53 Score=378.90 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=208.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45688889999999999999995 5799999999876432 34678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec--CCCceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT--EKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~--~~~~~kl~dfg~~~~~~~~~~ 219 (347)
+++|+|.+++...+..+++..++.++.|++.||.||| ++||+||||||+|||++ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999988777777999999999999999999999 78999999999999998 6789999999999987532
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ..+..+.+ +..... +
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~----~~~~~~----~---- 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKR----CDWEFD----E---- 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHH----CCCCCC----S----
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----CCCCCC----c----
Confidence 2344567999999999999999999999999999999999999999754322 22222222 211111 1
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......++++.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122357899999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-53 Score=372.89 Aligned_cols=242 Identities=28% Similarity=0.379 Sum_probs=198.6
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh-----hHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT-----DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
.|...+.||+|+||.||+|.. .+|+.||||.+...... +.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477888999999999999995 57899999998764322 358899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
|+++|+|..++.. ...+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999888765543 456999999999999999999999 78999999999999999999999999999986532
Q ss_pred eeecccCCCCccccccccC---CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCC
Q 040826 221 VFTDVRGTIGYMDPEYMTN---AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRL 297 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 297 (347)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...... +.+..... +..+ .+.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~----~~~~--~~~---- 235 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NESP--ALQ---- 235 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHH----SCCC--CCS----
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh----CCCC--CCC----
Confidence 234579999999999864 46899999999999999999999999754322 22222221 1111 000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 298 NGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 298 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+...++++.+|+.+||+.||.+|||+.|+++
T Consensus 236 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122357999999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=367.30 Aligned_cols=249 Identities=27% Similarity=0.339 Sum_probs=204.9
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--------ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35788889999999999999996 579999999986431 235688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC----ceEEeecccc
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL----EPKLSDFGLA 211 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~----~~kl~dfg~~ 211 (347)
++||||+++|+|.+++...+ .+++..++.++.|++.||.||| +.+++||||||+||+++.++ .+|++|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999986543 5999999999999999999999 78999999999999999776 4999999999
Q ss_pred eecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...... +.+. .+.........
T Consensus 165 ~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~----~i~~~~~~~~~ 237 (293)
T d1jksa_ 165 HKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----NVSAVNYEFED 237 (293)
T ss_dssp EECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHTTCCCCCH
T ss_pred hhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHH----HHHhcCCCCCc
Confidence 876432 2334557899999999999999999999999999999999999999754322 2222 22222211111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+ ..+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~--------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 EYFS--------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHT--------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcC--------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 12357899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-53 Score=372.25 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=207.8
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCe
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3567888999999999999999853 3578999999765433 468999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCC
Q 040826 135 QYLVYEFCAAGNLAQHLLRK-----------------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIK 191 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~ 191 (347)
.+++|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence 99999999999999998532 134889999999999999999999 7899999999
Q ss_pred CCCEEecCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCC-CcCCCh
Q 040826 192 LTNILLTEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQK-VIELDF 269 (347)
Q Consensus 192 p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~-p~~~~~ 269 (347)
|+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++|.. ||. ..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~-~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY-GM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT-TS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC-CC
Confidence 9999999999999999999986543222 22344568899999999999999999999999999999999975 454 33
Q ss_pred hhhhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 040826 270 DARDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAW 338 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~ 338 (347)
...+... .+..+..+ ..+..++.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 247 ~~~e~~~----~v~~~~~~-----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIY----YVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHH----HHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHH----HHHcCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3322222 22222211 112233357999999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=368.20 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=205.9
Q ss_pred CCeeeecCCeeEEEEEeCCC----CEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEe-CCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGVLPSG----QVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVE-GGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 142 (347)
.++||+|+||+||+|.+.++ ..||||++...... ..+.+|++++++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996432 26899998754333 468999999999999999999999876 56899999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc--
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK-- 220 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 220 (347)
++|+|.+++.......++..+++++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877777889999999999999999999 789999999999999999999999999999876432221
Q ss_pred -eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 221 -VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 221 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
......||..|+|||.+.+..++.++||||||+++|||+||..||.......+.... +..+.++.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~----i~~g~~~~---------- 254 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGRRLL---------- 254 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH----HHTTCCCC----------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCCCCC----------
Confidence 223356899999999999999999999999999999999998888754433322222 22222211
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhh
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMV 343 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~ 343 (347)
.+..+.+++.+|+.+||+.||++|||+.||++.|+.++++...
T Consensus 255 -~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1112335799999999999999999999999999999876443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=370.65 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=204.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC----EEEEEEcccC---CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ----VVAIKHIYKS---NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYL 137 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 137 (347)
++|...+.||+|+||.||+|.+. +|+ .||+|.+... ...+.+.+|+.++++++||||++++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35788899999999999999854 454 5899988653 2345799999999999999999999998764 5678
Q ss_pred EEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCC
Q 040826 138 VYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 217 (347)
++|++.+|+|.+++......+++..+++++.|++.||.||| +++++||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999887888999999999999999999999 789999999999999999999999999999876533
Q ss_pred ccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 218 ESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 218 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......||..|+|||.+.+..++.++||||||+++|||+| |..||.... ... +...... +.+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-~~~-~~~~i~~---~~~~------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASE-ISSILEK---GERL------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-GGG-HHHHHHH---TCCC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-HHH-HHHHHHc---CCCC-------
Confidence 322 2334568999999999999999999999999999999999 677765432 222 2222211 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
..+..+++++.+|+.+||+.||.+|||+.||++.|+.+.++.
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 112233467999999999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=370.81 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=199.8
Q ss_pred HHHHHhcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEE
Q 040826 60 EIENAINNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCC 129 (347)
Q Consensus 60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~ 129 (347)
+++...++|...+.||+|+||.||+|.+. +++.||||++...... ..+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33333467888999999999999999843 3468999999765433 3567777777776 689999999987
Q ss_pred EeC-CeEEEEEeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCC
Q 040826 130 VEG-GEQYLVYEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLT 193 (347)
Q Consensus 130 ~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~ 193 (347)
... ...++||||+++|+|.+++... ...+++..++.++.|+++||.||| +++|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcc
Confidence 664 4689999999999999998642 235889999999999999999999 789999999999
Q ss_pred CEEecCCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCC-CcCCChhh
Q 040826 194 NILLTEKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQK-VIELDFDA 271 (347)
Q Consensus 194 Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~-p~~~~~~~ 271 (347)
|||+++++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||.. ||.....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~- 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999875433222 2344679999999999999999999999999999999999765 5543222
Q ss_pred hhHHHHHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 272 RDQLTRKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
...+...... +..+ ..+...++++.+++.+||+.||++|||+.||+++|++++++++
T Consensus 243 ~~~~~~~~~~---~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n~ 299 (299)
T d1ywna1 243 DEEFCRRLKE---GTRM-----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299 (299)
T ss_dssp SHHHHHHHHH---TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhc---CCCC-----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCCC
Confidence 2222222222 1111 1111233579999999999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=368.86 Aligned_cols=246 Identities=26% Similarity=0.290 Sum_probs=206.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 138 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|++.+. .....+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35788899999999999999995 57999999998643 3456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++...+ .+++..++.++.|++.||.||| ++|++||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 99999999999886544 5899999999999999999999 789999999999999999999999999999865422
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........||+.|+|||++.+..|+.++|||||||++|+|++|++||...... ...+.+..+....+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~~~~i~~~~~~~p-------- 225 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEIRFP-------- 225 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCC--------
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----HHHHHHhcCCCCCC--------
Confidence 23344567999999999999999999999999999999999999999854322 12222222222111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
.. .++++.+|+.+||++||.+||+ +.|+++
T Consensus 226 ~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12 2356899999999999999995 777776
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=368.25 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=205.3
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCC--EEEEEEcccC---CChhHHHHHHHHhhcC-CCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQ--VVAIKHIYKS---NNTDSFSREVEGLSRV-RHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||.||+|.+. +|. .||||++... ...+.+.+|+++|+++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56777789999999999999964 444 5788887543 2345799999999999 699999999999999999999
Q ss_pred EeecCCCChHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCce
Q 040826 139 YEFCAAGNLAQHLLRK---------------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEP 203 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~ 203 (347)
|||+++|+|.+++... ...+++..+++++.|++.||.||| +++++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998643 357999999999999999999999 7899999999999999999999
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS 283 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 283 (347)
||+|||+++.... ........||..|+|||.+.+..++.++||||||+++|||++|..|+.......+ ....+.
T Consensus 167 kl~DfG~a~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240 (309)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG
T ss_pred EEccccccccccc--cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHH
Confidence 9999999986432 2222345689999999999999999999999999999999998764433322222 222222
Q ss_pred CCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 284 MGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 284 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.+.++ ..+...++++.+|+.+||+.||++|||+.||++.|++++++.
T Consensus 241 ~~~~~-----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 QGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GTCCC-----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcCCC-----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22211 112233468999999999999999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-52 Score=360.39 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=201.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC----e
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG----E 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 134 (347)
.++|...+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46788889999999999999995 5799999999976432 235889999999999999999999987643 4
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++||||+++++|.+++... ..+++..++.++.|++.||.||| ++|++||||||+|||++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 79999999999999988654 35899999999999999999999 789999999999999999999999999998765
Q ss_pred CCCcc--ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 215 GMEES--KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 215 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... ..... ...... ....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~---~~~~~~-~~~~ 236 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQH---VREDPI-PPSA 236 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH---HHCCCC-CGGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHH---HhcCCC-CCch
Confidence 42222 23444679999999999999999999999999999999999999997543221 11111 111111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRP-TIDVVYEEIDKAW 338 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~ei~~~l~~~~ 338 (347)
. ...+ ++++.+++.+||++||.+|| |++++++.|.++.
T Consensus 237 ~----~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 R----HEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp T----SSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred h----ccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 1122 35799999999999999999 8999999998874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=363.08 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=195.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeC--CC--CEEEEEEcccCC---C--hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP--SG--QVVAIKHIYKSN---N--TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|.+. ++ ..||||++.+.. . .+.+.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45777889999999999999853 23 368999886542 1 2468999999999999999999999965 4678
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++|++.+++......+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999988776667999999999999999999999 78999999999999999999999999999998653
Q ss_pred Cccce--eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 217 EESKV--FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 217 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +......+ .+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~---~~~~~----- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK---EGERL----- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT---SCCCC-----
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHh---CCCCC-----
Confidence 32222 233457889999999999999999999999999999998 89998643222 22222211 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKA 337 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~ 337 (347)
+.+...+.++.+|+.+||+.||++|||+.+|.+.|+++
T Consensus 235 ------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112335799999999999999999999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-51 Score=362.95 Aligned_cols=243 Identities=23% Similarity=0.279 Sum_probs=203.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688889999999999999996 47999999998642 34567889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||++||+|..++... ..+++..+..++.|++.||.||| ++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999887654 45789999999999999999999 899999999999999999999999999999876422
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ....+..+.....
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~----~~~~i~~~~~~~p--------- 221 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-K----TYEKILNAELRFP--------- 221 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-H----HHHHHHHCCCCCC---------
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-H----HHHHHHcCCCCCC---------
Confidence 23467999999999999999999999999999999999999999754322 1 1222222221111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRP-----TIDVVYEE 333 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~~ 333 (347)
....+++.+++.+||++||.+|| |+++++++
T Consensus 222 ---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11235789999999999999996 89998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=369.41 Aligned_cols=269 Identities=22% Similarity=0.278 Sum_probs=204.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHH--HHHHhhcCCCCcceeeeeEEEeCC----eEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSR--EVEGLSRVRHPNLVCLFGCCVEGG----EQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 139 (347)
+.|...+.||+|+||.||+|++ +|+.||||++..... ..+.. |+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778899999999999997 689999999865433 33333 455566789999999999998654 679999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHY-----IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-----~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
||+++|+|.+++.+. .+++..+++++.|++.||.|||+. ..+||+||||||+|||+++++.+||+|||++...
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999654 589999999999999999999952 1369999999999999999999999999999876
Q ss_pred CCCccc---eeecccCCCCccccccccCC------ccCCcccHHHHHHHHHHHHhCCCCcCCChhh----------hhHH
Q 040826 215 GMEESK---VFTDVRGTIGYMDPEYMTNA------KLTCASDIYSFGIVALQLLSGQKVIELDFDA----------RDQL 275 (347)
Q Consensus 215 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~~lltg~~p~~~~~~~----------~~~~ 275 (347)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 433222 23446799999999998764 3678999999999999999998877532111 0111
Q ss_pred HHHHhhhcCCCCCcccccCCCCCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 040826 276 TRKARDVSMGKRPIKDFEDPRLNGN-INRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTMVE 344 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~~~ 344 (347)
........... .+|.+... .+.+....+.+|+.+||+.||.+|||+.||++.|+++.++.-++
T Consensus 239 ~~~~~~~~~~~------~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 239 EEMRKVVCEQK------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp HHHHHHHTTSC------CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHhccc------cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 11111111111 11111111 12356678999999999999999999999999999998776544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=365.50 Aligned_cols=251 Identities=20% Similarity=0.235 Sum_probs=207.7
Q ss_pred HhcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCC-hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 64 AINNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNN-TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
+.++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+|+++|+.++||||+++++++.+++..++||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3578888999999999999999964 788999999976543 34678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCC--CceEEeecccceecCCCcc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEK--LEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~--~~~kl~dfg~~~~~~~~~~ 219 (347)
++||+|.+++...+..+++.+++.++.|+++||.||| +.||+||||||+|||++.+ +.++|+|||++..... .
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--G 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--T
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc--C
Confidence 9999999999777667999999999999999999999 7899999999999999854 4899999999987643 2
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.......+++.|+|||...+..++.++||||+||++|+|++|..||...... +.+.. +..+.........+
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~----i~~~~~~~~~~~~~---- 228 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIEN----IMNAEYTFDEEAFK---- 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH----HHHTCCCCCHHHHT----
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHH----HHhCCCCCChhhcc----
Confidence 2334457899999999999999999999999999999999999999754322 22222 22222111111101
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...+++.+|+.+||..||.+|||+.|+++
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12357899999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=366.25 Aligned_cols=261 Identities=26% Similarity=0.364 Sum_probs=213.1
Q ss_pred hcCcccCCeeeecCCeeEEEEEe------CCCCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeCCe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL------PSGQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEGGE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||.||+|++ .+++.||||++...... ..+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35777888999999999999984 24568999999765443 3688999999999 69999999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEe
Q 040826 135 QYLVYEFCAAGNLAQHLLRKD-----------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILL 197 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili 197 (347)
.+++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 999999999999999986432 35899999999999999999999 7899999999999999
Q ss_pred cCCCceEEeecccceecCCCcc-ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHH
Q 040826 198 TEKLEPKLSDFGLAKMLGMEES-KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLT 276 (347)
Q Consensus 198 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~ 276 (347)
+.++.++++|||.++....... .......||+.|+|||.+.+..++.++||||||+++|||+|+..|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987653322 333446789999999999999999999999999999999996555544433333333
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhhh
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNTM 342 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~~ 342 (347)
.....- .++ ..+...++++.+|+.+||+.||++|||+.+|++.|++++.++.
T Consensus 259 ~~i~~~---~~~-----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~ 310 (311)
T d1t46a_ 259 KMIKEG---FRM-----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (311)
T ss_dssp HHHHHT---CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHhcC---CCC-----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence 333221 111 1111233679999999999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-51 Score=355.59 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=204.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh-----------hHHHHHHHHhhcCC-CCcceeeeeEEEe
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT-----------DSFSREVEGLSRVR-HPNLVCLFGCCVE 131 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~-h~niv~~~~~~~~ 131 (347)
.++|...+.||+|+||+||+|+. .+|+.||||++...... +.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36788899999999999999995 57899999998654321 24778999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
++..++||||+++|+|.+++...+ .+++..++.++.|+++||.||| ++|++||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999997544 5999999999999999999999 789999999999999999999999999999
Q ss_pred eecCCCccceeecccCCCCccccccccC------CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 212 KMLGMEESKVFTDVRGTIGYMDPEYMTN------AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
...... .......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+.. +
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~----~ 230 (277)
T d1phka_ 158 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMS----G 230 (277)
T ss_dssp EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH----T
T ss_pred eEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-HHHHHHHh----C
Confidence 886532 22344679999999998853 35788999999999999999999999855322 22222222 1
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...... ......++++.+|+.+||+.||++|||++||++.
T Consensus 231 ~~~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 NYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 1111233579999999999999999999998763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=362.09 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=201.9
Q ss_pred cCcccCCeeeecCCeeEEEEEeCC--------CCEEEEEEcccCCCh---hHHHHHHHHhhcC-CCCcceeeeeEEEeCC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPS--------GQVVAIKHIYKSNNT---DSFSREVEGLSRV-RHPNLVCLFGCCVEGG 133 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 133 (347)
++|...+.||+|+||.||+|...+ +..||||++...... ..+.+|...+.++ +||||+++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567778899999999999998432 247999999776543 4677888888888 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEec
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKD---------------SVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLT 198 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~ 198 (347)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 9999999999999999996432 45899999999999999999999 88999999999999999
Q ss_pred CCCceEEeecccceecCCCccc-eeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHh-CCCCcCCChhhhhHHH
Q 040826 199 EKLEPKLSDFGLAKMLGMEESK-VFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLS-GQKVIELDFDARDQLT 276 (347)
Q Consensus 199 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~llt-g~~p~~~~~~~~~~~~ 276 (347)
.++.+||+|||++......... ......+++.|+|||.+.+..|+.++||||||+++|||++ |..||..... . ...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~-~~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E-ELF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H-HHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-H-HHH
Confidence 9999999999999876433222 2344568999999999999999999999999999999998 5667653322 1 222
Q ss_pred HHHhhhcCCCCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 277 RKARDVSMGKRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
..+..+..+ ..+...++++.+|+.+||+.||.+|||+.||++.|++++.
T Consensus 248 ---~~i~~~~~~-----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 ---KLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHTTCCC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHcCCCC-----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222222211 1111233579999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-51 Score=363.55 Aligned_cols=242 Identities=21% Similarity=0.230 Sum_probs=203.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccC-----CChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKS-----NNTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVY 139 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 139 (347)
++|...+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5688889999999999999996 47999999998642 34457889999999999999999999999999999999
Q ss_pred eecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 140 EFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 140 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
||+.+|+|.+++...+ .+++..++.++.|++.||.||| +++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999986544 5899999999999999999999 789999999999999999999999999999976422
Q ss_pred ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLNG 299 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 299 (347)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .... .+..+..... .
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~----~i~~~~~~~p--------~ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYE----KIVSGKVRFP--------S 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHHCCCCCC--------T
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHH----HHhcCCCCCC--------c
Confidence 23457999999999999999999999999999999999999999754321 2122 2222221111 1
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 040826 300 NINRADFESILKIAVLCVAKSSKGRP-----TIDVVYE 332 (347)
Q Consensus 300 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~ei~~ 332 (347)
. ..+++.+|+.+||+.||.+|+ |++++++
T Consensus 260 ~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 H----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp T----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred c----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2 235799999999999999994 8999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=360.58 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=201.5
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHHHHHhh-cCCCCcceeeeeEEEeCCeEEEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSREVEGLS-RVRHPNLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 138 (347)
++|...+.||+|+||+||+|... +|+.||||++.+. .....+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888899999999999999954 7999999998642 34455667777665 68999999999999999999999
Q ss_pred EeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCc
Q 040826 139 YEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEE 218 (347)
Q Consensus 139 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 218 (347)
|||+++|+|.+++.... .+++..++.++.|++.||.||| +++++||||||+|||+++++.+||+|||++......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence 99999999999986543 5899999999999999999999 789999999999999999999999999999865432
Q ss_pred cceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCCCCC
Q 040826 219 SKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDPRLN 298 (347)
Q Consensus 219 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 298 (347)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . ....+..+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~----~~~~i~~~~~~~p-------- 223 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-E----LFHSIRMDNPFYP-------- 223 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHHCCCCCC--------
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-H----HHHHHHcCCCCCC--------
Confidence 23344567999999999999999999999999999999999999999754322 1 2222222222111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 040826 299 GNINRADFESILKIAVLCVAKSSKGRPTID-VVYE 332 (347)
Q Consensus 299 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-ei~~ 332 (347)
..+ .+++.+|+.+||+.||.+|||+. ++++
T Consensus 224 ~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122 35699999999999999999995 6753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=361.87 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=207.7
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC------CCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCCeE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP------SGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 135 (347)
.++|...+.||+|+||.||+|.+. +++.||||++...... ..+.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357778889999999999999853 3578999999765443 3588999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEe
Q 040826 136 YLVYEFCAAGNLAQHLLRK---------DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLS 206 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~ 206 (347)
++||||+++|+|.+++... ...+++..+.+++.|+++||.||| +++++||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988532 134789999999999999999999 7899999999999999999999999
Q ss_pred ecccceecCCCccce-eecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC
Q 040826 207 DFGLAKMLGMEESKV-FTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG 285 (347)
Q Consensus 207 dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 285 (347)
|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+||..|+.........+..+. .+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~----~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EG 251 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH----TT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----hC
Confidence 999998654322222 2334689999999999999999999999999999999999644433333333232222 22
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 040826 286 KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWK 339 (347)
Q Consensus 286 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~ 339 (347)
... ..+..+++.+.+++.+||+.||++|||+.+|++.|++.++
T Consensus 252 ~~~-----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 211 1112233679999999999999999999999999987644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=362.52 Aligned_cols=251 Identities=24% Similarity=0.265 Sum_probs=198.6
Q ss_pred hcCcccCC-eeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcC-CCCcceeeeeEEEe----CCeEEE
Q 040826 65 INNDWDRR-FLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRV-RHPNLVCLFGCCVE----GGEQYL 137 (347)
Q Consensus 65 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~l 137 (347)
.++|.... .||+|+||.||+|.. .+|+.||||++.. ...+.+|+.++.++ +||||+++++++.+ +...++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 45777654 599999999999995 5799999999853 45677899987655 89999999999876 457899
Q ss_pred EEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeeccccee
Q 040826 138 VYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKM 213 (347)
Q Consensus 138 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~ 213 (347)
|||||+||+|.+++.+. ...+++..++.++.|++.||.||| +.|++||||||+|||+++ ++.+||+|||+++.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeee
Confidence 99999999999999764 356999999999999999999999 889999999999999985 55799999999987
Q ss_pred cCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccccc
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFE 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... .......||+.|+|||++.+..|+.++|||||||++|+|+||+.||....... ........+..+...
T Consensus 164 ~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i~~~~~~----- 235 (335)
T d2ozaa1 164 TTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYE----- 235 (335)
T ss_dssp CCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSS-----
T ss_pred ccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHHHhcCCCC-----
Confidence 6432 23345679999999999999999999999999999999999999997432211 111111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 294 DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 294 ~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+........++++.+|+.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 ---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001111234568999999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-50 Score=362.42 Aligned_cols=246 Identities=23% Similarity=0.280 Sum_probs=198.6
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccC-----CChhHHHHH---HHHhhcCCCCcceeeeeEEEeCCeEE
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS-----NNTDSFSRE---VEGLSRVRHPNLVCLFGCCVEGGEQY 136 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~ 136 (347)
++|...+.||+|+||.||+|... +|+.||+|++... .....+.+| +.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888899999999999999954 7999999998542 223334444 66778888999999999999999999
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
+||||+++|+|.+++.+. ..+++..++.++.|++.||.||| ++|++||||||+|||++.+|.+||+|||++.....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999998654 45899999999999999999999 88999999999999999999999999999987643
Q ss_pred CccceeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccccCC
Q 040826 217 EESKVFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDFEDP 295 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ......||+.|+|||++. +..|+.++|||||||++|+|+||+.||....... .....+.........
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~------ 228 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVEL------ 228 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCCCCC------
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCCCCC------
Confidence 2 234457999999999986 4578999999999999999999999997543221 112222222221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 296 RLNGNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 296 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
...+ ++++.+|+.+||+.||.+||| ++|+++
T Consensus 229 --~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 --PDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1122 357999999999999999999 577765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=352.19 Aligned_cols=256 Identities=27% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-------hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEeec
Q 040826 71 RRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-------TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++||+|+||+||+|.. .+|+.||||++..... ...+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 35799999999999995 4799999999865321 246889999999999999999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcccee
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKVF 222 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 222 (347)
.++++..+. .....+++..+..++.|++.||.||| ++|++||||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAY 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCC
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC-cccc
Confidence 987665544 45566899999999999999999999 789999999999999999999999999999865432 2223
Q ss_pred ecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-cccc------cC
Q 040826 223 TDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IKDF------ED 294 (347)
Q Consensus 223 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~ 294 (347)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .+.+..+.+........ .... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 44579999999998864 5689999999999999999999999875432 23333333322111100 0000 00
Q ss_pred CCCCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 295 PRLNGNIN-----RADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 295 ~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
.......+ ....+++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000001 122357999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=349.84 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=201.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788889999999999999995 579999999986542 24578899999999999999999999999999999999
Q ss_pred ecCCCChHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCcc
Q 040826 141 FCAAGNLAQHL-LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEES 219 (347)
Q Consensus 141 ~~~~gsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 219 (347)
|+.+ ++.+++ ......+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||.+...... .
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-V 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-S
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC-c
Confidence 9987 444444 445667999999999999999999999 789999999999999999999999999999876432 2
Q ss_pred ceeecccCCCCccccccccCCc-cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-cccc-cCCC
Q 040826 220 KVFTDVRGTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IKDF-EDPR 296 (347)
Q Consensus 220 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~ 296 (347)
.......||+.|+|||.+.... ++.++|+||+|+++|+|++|+.||..... .+.+............. .... ..+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhccccccccc
Confidence 2334457999999999877655 57899999999999999999999975432 23333333222111100 0000 0000
Q ss_pred CCCCC-----------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 297 LNGNI-----------NRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 297 l~~~~-----------~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
..... .....+++.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 01223578999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-49 Score=343.39 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=200.1
Q ss_pred cCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 141 (347)
++|...++||+|+||+||+|..++|+.||||++.... ....+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788889999999999999999899999999986542 245788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccce
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESKV 221 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 221 (347)
+.++.+.. +......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||.+...... ...
T Consensus 82 ~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRK 156 (286)
T ss_dssp CSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC-ccc
Confidence 98855544 4455667999999999999999999999 789999999999999999999999999999876432 222
Q ss_pred eecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-cc---cc----
Q 040826 222 FTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP-IK---DF---- 292 (347)
Q Consensus 222 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~---- 292 (347)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.+....+........ .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 344568999999999875 4678999999999999999999999975432 23333332221111000 00 00
Q ss_pred -----cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 293 -----EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 293 -----~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..+............++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111122357899999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=347.17 Aligned_cols=237 Identities=27% Similarity=0.365 Sum_probs=194.3
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC--------ChhHHHHHHHHhhcCC--CCcceeeeeEEEeCCe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN--------NTDSFSREVEGLSRVR--HPNLVCLFGCCVEGGE 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 134 (347)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788889999999999999995 579999999986532 1234678999999986 8999999999999999
Q ss_pred EEEEEeecCC-CChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-CCceEEeecccce
Q 040826 135 QYLVYEFCAA-GNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-KLEPKLSDFGLAK 212 (347)
Q Consensus 135 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~ 212 (347)
.++||||+.+ +++.+++... ..+++..++.++.|+++||.||| ++|++||||||+|||++. ++.+||+|||++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999986 5677776543 45999999999999999999999 789999999999999985 5799999999998
Q ss_pred ecCCCccceeecccCCCCccccccccCCcc-CCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCccc
Q 040826 213 MLGMEESKVFTDVRGTIGYMDPEYMTNAKL-TCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKD 291 (347)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.... ...+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ...+ +...
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~----~~~~--- 222 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR----GQVF--- 222 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH----CCCC---
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhh----cccC---
Confidence 7532 23345679999999999987654 678999999999999999999997421 1111 1111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 292 FEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 292 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
+...+ ++++.+|+.+||+.||++|||++|+++
T Consensus 223 -----~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 -----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122 357899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=344.88 Aligned_cols=263 Identities=23% Similarity=0.262 Sum_probs=200.5
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CC-CCEEEEEEcccC----CChhHHHHHHHHhhcC---CCCcceeeeeEEEe----
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PS-GQVVAIKHIYKS----NNTDSFSREVEGLSRV---RHPNLVCLFGCCVE---- 131 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 131 (347)
.++|...+.||+|+||.||+|.. .+ ++.||||++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36788899999999999999996 34 567999998643 2234577888887766 79999999999863
Q ss_pred -CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccc
Q 040826 132 -GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGL 210 (347)
Q Consensus 132 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 210 (347)
....++++||++++++..........+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 24689999999997776555556677999999999999999999999 78999999999999999999999999999
Q ss_pred ceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC-Cc
Q 040826 211 AKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR-PI 289 (347)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 289 (347)
+.... .........||+.|+|||++.+.+|+.++||||+||++|+|++|+.||.... ..+.+............ ..
T Consensus 163 ~~~~~--~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYS--FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCC--GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhc--ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhcc
Confidence 88653 2233455679999999999999999999999999999999999999997543 23333333322211100 00
Q ss_pred c--------ccc--CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 290 K--------DFE--DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 290 ~--------~~~--~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
. .+. .+...........+.+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000 0000001111223578899999999999999999999763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-48 Score=340.83 Aligned_cols=261 Identities=19% Similarity=0.193 Sum_probs=204.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCccee-eeeEEEeCCeEEEEEeecC
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVC-LFGCCVEGGEQYLVYEFCA 143 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~ 143 (347)
++|...+.||+|+||.||+|.. .+|+.||||.+........+..|+++++.++|+|++. +.++..+.+..++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 5688889999999999999995 5789999999887766778899999999998766554 5556677888999999995
Q ss_pred CCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC---CCceEEeecccceecCCCcc-
Q 040826 144 AGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE---KLEPKLSDFGLAKMLGMEES- 219 (347)
Q Consensus 144 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~~- 219 (347)
+ +|.+.+......+++..+..++.|++.||+||| ++|++||||||+|||++. +..++++|||+++.......
T Consensus 87 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 P-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp C-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred C-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 4 787877776778999999999999999999999 789999999999999864 45799999999998643221
Q ss_pred -----ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHH--HHHHhhhcCCCCCcccc
Q 040826 220 -----KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQL--TRKARDVSMGKRPIKDF 292 (347)
Q Consensus 220 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 292 (347)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......... .......... +.
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~--- 237 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--PI--- 237 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--CH---
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--Ch---
Confidence 22344679999999999999999999999999999999999999997543222111 1111110000 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
+.+.. ..++++.+++.+||+.+|++||++.++.+.|++++...
T Consensus 238 --~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 --EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00111 22357999999999999999999999999999987543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-48 Score=339.95 Aligned_cols=262 Identities=18% Similarity=0.190 Sum_probs=212.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCChhHHHHHHHHhhcCCC-CcceeeeeEEEeCCeEEEEEeec
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-PNLVCLFGCCVEGGEQYLVYEFC 142 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 142 (347)
.++|...+.||+|+||.||+|... +|+.||||.+........+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 357888899999999999999954 7899999998777777778899999999975 89999999999999999999999
Q ss_pred CCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecC-----CCceEEeecccceecCCC
Q 040826 143 AAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTE-----KLEPKLSDFGLAKMLGME 217 (347)
Q Consensus 143 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~-----~~~~kl~dfg~~~~~~~~ 217 (347)
+++|.+++...+..++...+..++.|++.||.||| +.|++||||||+|||++. ++.++|+|||+++.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 56999998877778999999999999999999999 899999999999999974 578999999999876432
Q ss_pred cc------ceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhh--hHHHHHHhhhcCCCCCc
Q 040826 218 ES------KVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDAR--DQLTRKARDVSMGKRPI 289 (347)
Q Consensus 218 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 289 (347)
.. .......||+.|+|||.+.+..++.++||||||+++|+|+||+.||....... ............. +.
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~--~~ 237 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST--PL 237 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--CH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--Ch
Confidence 21 12334579999999999999999999999999999999999999997533221 1111111110000 00
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhh
Q 040826 290 KDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEEIDKAWKNT 341 (347)
Q Consensus 290 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~l~~~~~~~ 341 (347)
.. +... .++++.+++..|++.+|++||+++.+.+.|+++++..
T Consensus 238 ~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00 1112 2357999999999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=336.59 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=196.0
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCC----ChhHHHHHHHHhhcCCCCcceeeeeEEEe--------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSN----NTDSFSREVEGLSRVRHPNLVCLFGCCVE-------- 131 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 131 (347)
.++|...+.||+|+||+||+|.. .+|+.||||++.... ....+.+|+.+|++++|||++++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46788889999999999999995 579999999986542 23468899999999999999999998754
Q ss_pred CCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccc
Q 040826 132 GGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLA 211 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 211 (347)
.+..+++|||+.++.+. ........+++..+..++.|++.||.||| ++||+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 34679999999885544 44455567999999999999999999999 889999999999999999999999999999
Q ss_pred eecCCCcc---ceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCC
Q 040826 212 KMLGMEES---KVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKR 287 (347)
Q Consensus 212 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (347)
........ .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||..... ........+.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCCh
Confidence 87643222 122335689999999998764 689999999999999999999999975432 2222222222211111
Q ss_pred Ccc-cccCCCC-------CC-CC-CH------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 288 PIK-DFEDPRL-------NG-NI-NR------ADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 288 ~~~-~~~~~~l-------~~-~~-~~------~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
... ....... .. .. .. ...+++.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 0000000 00 00 00 112467889999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=340.61 Aligned_cols=258 Identities=24% Similarity=0.245 Sum_probs=193.6
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEEeC------CeEEEEE
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCVEG------GEQYLVY 139 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~ 139 (347)
+|...++||+|+||+||+|.. .+|+.||||++..... ...+|+++|++++||||+++++++... ...++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 456678899999999999996 4799999999976543 234799999999999999999998643 2478999
Q ss_pred eecCCCChHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCC
Q 040826 140 EFCAAGNLAQHLL--RKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGM 216 (347)
Q Consensus 140 e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~ 216 (347)
||++++.+..... .....+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||++.....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9998754333322 34567999999999999999999999 89999999999999999775 899999999987643
Q ss_pred CccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCC----------
Q 040826 217 EESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMG---------- 285 (347)
Q Consensus 217 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 285 (347)
. .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+.+..+.+.....
T Consensus 176 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 176 G--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp T--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred C--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhhhcc
Confidence 2 22344579999999998765 5789999999999999999999999975432 22222222211100
Q ss_pred ---CCCcccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 286 ---KRPIKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 286 ---~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
...........+.........+++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000011112233457899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=331.82 Aligned_cols=262 Identities=22% Similarity=0.257 Sum_probs=205.5
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCCeEEEEEe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGGEQYLVYE 140 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 140 (347)
++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788889999999999999995 5789999999865432 3468899999999999999999999999999999999
Q ss_pred ecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCCCccc
Q 040826 141 FCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 141 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 220 (347)
++.+++|..++. ....+++..+..++.|+++||+||| +++|+||||||+|||++.++.+|++|||.+...... ..
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CS
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC-Cc
Confidence 999988877664 4556899999999999999999999 789999999999999999999999999999876432 22
Q ss_pred eeecccCCCCccccccccCCc-cCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC-----------
Q 040826 221 VFTDVRGTIGYMDPEYMTNAK-LTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP----------- 288 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 288 (347)
......++..|.|||.+.+.. ++.++||||+||++|+|++|+.||.......+...............
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 333446788899999887654 68999999999999999999999865554444444333322211100
Q ss_pred --cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 289 --IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 289 --~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
..................+++.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000011122233467889999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=338.88 Aligned_cols=250 Identities=27% Similarity=0.343 Sum_probs=202.7
Q ss_pred cCcccCCeeeecCCeeEEEEEe----CCCCEEEEEEcccC------CChhHHHHHHHHhhcCCC-CcceeeeeEEEeCCe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL----PSGQVVAIKHIYKS------NNTDSFSREVEGLSRVRH-PNLVCLFGCCVEGGE 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 134 (347)
++|...+.||+|+||.||+|.. .+|+.||+|.+... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688889999999999999984 25889999998643 234568899999999966 899999999999999
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.++++||+.+|+|.+++...+ .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999986544 4788999999999999999999 789999999999999999999999999999887
Q ss_pred CCCccceeecccCCCCccccccccCC--ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcccc
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNA--KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIKDF 292 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
............|++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ......+.......+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~~~~---- 254 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPP---- 254 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCCCC----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccCCCC----
Confidence 65555555567799999999998754 57889999999999999999999997653322 222222222222211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 040826 293 EDPRLNGNINRADFESILKIAVLCVAKSSKGRPT-----IDVVYE 332 (347)
Q Consensus 293 ~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~ei~~ 332 (347)
++....+++.+|+.+||++||.+||| ++|+++
T Consensus 255 --------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 --------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11123468999999999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=334.19 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=198.8
Q ss_pred cCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCChhHHHHHHHHhhcCC-CCcceeeeeEEEe--CCeEEEEEee
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNTDSFSREVEGLSRVR-HPNLVCLFGCCVE--GGEQYLVYEF 141 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~ 141 (347)
++|...++||+|+||+||+|.. .+|+.||+|++... ....+.+|+++|+.++ ||||+++++++.. ....++||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 5788999999999999999995 57999999998643 4567889999999995 9999999999875 3568999999
Q ss_pred cCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCC-ceEEeecccceecCCCccc
Q 040826 142 CAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKL-EPKLSDFGLAKMLGMEESK 220 (347)
Q Consensus 142 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~ 220 (347)
+++++|..+. ..+++..+..++.|++.||.||| ++||+||||||+|||++.++ .++|+|||++...... .
T Consensus 114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~ 184 (328)
T d3bqca1 114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--Q 184 (328)
T ss_dssp CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--C
T ss_pred cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC--C
Confidence 9999987653 35899999999999999999999 88999999999999998655 6999999999876432 2
Q ss_pred eeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc------------C-CC
Q 040826 221 VFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS------------M-GK 286 (347)
Q Consensus 221 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~------------~-~~ 286 (347)
......+|..|+|||.+.+. .++.++|+||+||++++|++|+.||.......+.......... . ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 34456789999999998764 5799999999999999999999999865544333222221110 0 00
Q ss_pred CCccccc--------CCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 287 RPIKDFE--------DPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 287 ~~~~~~~--------~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....... .............+++.+|+.+||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000011111223357899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=333.73 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=193.6
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCCh---hHHHHHHHHhhcCCCCcceeeeeEEEeCC----eEE
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNNT---DSFSREVEGLSRVRHPNLVCLFGCCVEGG----EQY 136 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 136 (347)
.++|...++||+|+||+||+|.. .+|+.||||++...... ..+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688889999999999999985 58999999999765443 36789999999999999999999987543 234
Q ss_pred EEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceecCC
Q 040826 137 LVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKMLGM 216 (347)
Q Consensus 137 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 216 (347)
++++++.+|+|.+++... .+++..++.++.|+++||.||| ++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 455667788999998543 5899999999999999999999 78999999999999999999999999999987643
Q ss_pred Cccc--eeecccCCCCcccccccc-CCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCc----
Q 040826 217 EESK--VFTDVRGTIGYMDPEYMT-NAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPI---- 289 (347)
Q Consensus 217 ~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 289 (347)
.... ......||+.|+|||++. +..++.++||||+|+++|+|++|+.||........ ...............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhhh
Confidence 2221 134456899999999985 45678999999999999999999999975432211 111111111000000
Q ss_pred -----ccc--cCCCCCC-C---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 290 -----KDF--EDPRLNG-N---INRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 290 -----~~~--~~~~l~~-~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
... ..+.... . .......++.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000000 0 000112468899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=334.29 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=191.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeCC------
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEGG------ 133 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 133 (347)
.++|...++||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++|++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788889999999999999995 4799999999975433 236789999999999999999999987654
Q ss_pred eEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 134 EQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
..++||||+ +.+|...... ..+++..++.++.|++.||.||| ++||+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 569999999 4477776643 35999999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCccceeecccCCCCccccccccC-CccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCC----
Q 040826 214 LGMEESKVFTDVRGTIGYMDPEYMTN-AKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRP---- 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 288 (347)
... ..+...+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... .+.+.............
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHT
T ss_pred cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHhh
Confidence 542 2345679999999999876 4578999999999999999999999975432 22222211111100000
Q ss_pred ------------cccccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 289 ------------IKDFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 289 ------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
........+. ........++.+|+.+||..||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0111223468899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=328.50 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=189.0
Q ss_pred cCcccCCeeeecCCeeEEEEEeC-CCCEEEEEEcccCCCh----hHHHHHHHHhhcCCCCcceeeeeEEEe------CCe
Q 040826 66 NNDWDRRFLGRGSAGLVYKGVLP-SGQVVAIKHIYKSNNT----DSFSREVEGLSRVRHPNLVCLFGCCVE------GGE 134 (347)
Q Consensus 66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 134 (347)
++|...++||+|+||+||+|... +|+.||||++...... ..+.+|+.++++++||||+++++++.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888899999999999999954 7999999999765322 357799999999999999999999863 368
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.|+||||+.++ +.+.+. ..+++..++.++.|++.||.||| +.|++||||||+|||++.++.++++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999874 444442 35899999999999999999999 789999999999999999999999999998865
Q ss_pred CCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhc-----------
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVS----------- 283 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~----------- 283 (347)
.. ........+|..|+|||++.+..++.++||||+||++++|++|+.||...... ...........
T Consensus 170 ~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhh
Confidence 32 22334456899999999999999999999999999999999999999754322 11111111110
Q ss_pred -------CCCCCc-----ccccCCCCC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 040826 284 -------MGKRPI-----KDFEDPRLN---GNINRADFESILKIAVLCVAKSSKGRPTIDVVYEE 333 (347)
Q Consensus 284 -------~~~~~~-----~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~~ 333 (347)
...... ......... .........++.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000000000 01123445789999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=324.31 Aligned_cols=257 Identities=22% Similarity=0.251 Sum_probs=192.3
Q ss_pred hcCcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC----hhHHHHHHHHhhcCCCCcceeeeeEEEeC-----Ce
Q 040826 65 INNDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN----TDSFSREVEGLSRVRHPNLVCLFGCCVEG-----GE 134 (347)
Q Consensus 65 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 134 (347)
.++|...++||+|+||+||+|.. .+|+.||||++..... ...+.+|+++|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45788899999999999999995 5799999999976532 23578999999999999999999998642 34
Q ss_pred EEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecccceec
Q 040826 135 QYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKML 214 (347)
Q Consensus 135 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 214 (347)
.+++++++.+|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 4667788889999998844 45999999999999999999999 789999999999999999999999999998764
Q ss_pred CCCccceeecccCCCCccccccccCC-ccCCcccHHHHHHHHHHHHhCCCCcCCChhhhhHHHHHHhhhcCCCCCcc---
Q 040826 215 GMEESKVFTDVRGTIGYMDPEYMTNA-KLTCASDIYSFGIVALQLLSGQKVIELDFDARDQLTRKARDVSMGKRPIK--- 290 (347)
Q Consensus 215 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 290 (347)
. .......|+..|+|||...+. .++.++|||||||++|+|++|+.||...... .......+..........
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTC
T ss_pred C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhc
Confidence 3 223445688999999987765 5688999999999999999999999754322 111222111111100000
Q ss_pred -------------cccCCCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 291 -------------DFEDPRLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 291 -------------~~~~~~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
......+. .......+++.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000 000012356889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-40 Score=294.68 Aligned_cols=261 Identities=20% Similarity=0.216 Sum_probs=190.8
Q ss_pred CcccCCeeeecCCeeEEEEEe-CCCCEEEEEEcccCCC-hhHHHHHHHHhhcCC-----------CCcceeeeeEEEe--
Q 040826 67 NDWDRRFLGRGSAGLVYKGVL-PSGQVVAIKHIYKSNN-TDSFSREVEGLSRVR-----------HPNLVCLFGCCVE-- 131 (347)
Q Consensus 67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-- 131 (347)
+|...++||+|+||+||+|+. .+|+.||||++..... .+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 488889999999999999995 5799999999976532 346778888888775 5789999988764
Q ss_pred CCeEEEEEeecCCCChHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCc------e
Q 040826 132 GGEQYLVYEFCAAGNLAQHL--LRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLE------P 203 (347)
Q Consensus 132 ~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~------~ 203 (347)
....+++++++..+...... ......+++..+..++.|++.||.|||+ ..||+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 45667777777655433322 2345678999999999999999999994 379999999999999986653 9
Q ss_pred EEeecccceecCCCccceeecccCCCCccccccccCCccCCcccHHHHHHHHHHHHhCCCCcCCChh-----hhhHHHHH
Q 040826 204 KLSDFGLAKMLGMEESKVFTDVRGTIGYMDPEYMTNAKLTCASDIYSFGIVALQLLSGQKVIELDFD-----ARDQLTRK 278 (347)
Q Consensus 204 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~lltg~~p~~~~~~-----~~~~~~~~ 278 (347)
+++|||.+..... ......||..|+|||.+.+..++.++|+||+|+++++|++|+.||..... ..+.+...
T Consensus 172 kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 9999999986532 22445799999999999999999999999999999999999999874321 11112211
Q ss_pred HhhhcCC-----------------C---CCcccccCC------CCCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 040826 279 ARDVSMG-----------------K---RPIKDFEDP------RLNGNINRADFESILKIAVLCVAKSSKGRPTIDVVYE 332 (347)
Q Consensus 279 ~~~~~~~-----------------~---~~~~~~~~~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ei~~ 332 (347)
....... . ......... ............++.+|+.+||..||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111000 0 000000000 0011234567789999999999999999999999986
Q ss_pred H
Q 040826 333 E 333 (347)
Q Consensus 333 ~ 333 (347)
+
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.1e-25 Score=181.39 Aligned_cols=161 Identities=16% Similarity=0.143 Sum_probs=117.7
Q ss_pred cCCeeeecCCeeEEEEEeCCCCEEEEEEcccCCC--------------------hhHHHHHHHHhhcCCCCcceeeeeEE
Q 040826 70 DRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSNN--------------------TDSFSREVEGLSRVRHPNLVCLFGCC 129 (347)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~e~~~l~~l~h~niv~~~~~~ 129 (347)
..++||+|+||+||+|...+|+.||||++..... ......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4578999999999999988999999998753210 01244678889999999988877552
Q ss_pred EeCCeEEEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCCCCCCCEEecCCCceEEeecc
Q 040826 130 VEGGEQYLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYIDGCIVHRDIKLTNILLTEKLEPKLSDFG 209 (347)
Q Consensus 130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg 209 (347)
..+++|||+++..+.+ ++......++.|+++++.||| +.|++||||||+|||++++ .++|+|||
T Consensus 84 ----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp ----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence 2379999999865533 334445678999999999999 7899999999999999965 58999999
Q ss_pred cceecCCCccceeecccCCCCcccc--c---cccCCccCCcccHHHHHHHH
Q 040826 210 LAKMLGMEESKVFTDVRGTIGYMDP--E---YMTNAKLTCASDIYSFGIVA 255 (347)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~y~aP--E---~~~~~~~~~~~Dv~slG~il 255 (347)
.+.......... |... + .+....|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~~---------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWRE---------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHH---------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHH---------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 998654221111 1111 0 01235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=5.4e-08 Score=81.08 Aligned_cols=148 Identities=16% Similarity=0.096 Sum_probs=98.7
Q ss_pred HHHHHHhcCcccCCeeeecCCeeEEEEEeCCCCEEEEEEcccCC--ChhHHHHHHHHhhcCC-CCcceeeeeEEEeCCeE
Q 040826 59 DEIENAINNDWDRRFLGRGSAGLVYKGVLPSGQVVAIKHIYKSN--NTDSFSREVEGLSRVR-HPNLVCLFGCCVEGGEQ 135 (347)
Q Consensus 59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 135 (347)
+++......|...+..+-++.+.||+... +++.+++|+..... ....+.+|...++.++ +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35566666776554433344568999875 55667888776542 3445778888887774 33356677777888899
Q ss_pred EEEEeecCCCChHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------
Q 040826 136 YLVYEFCAAGNLAQHLLRKDSVLTWERRVKILRDCALALRYLHHYI---------------------------------- 181 (347)
Q Consensus 136 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~---------------------------------- 181 (347)
++||++.+|.++.+..... ....+++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999998876544211 112234455555555565321
Q ss_pred ----------------------CCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 182 ----------------------DGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 182 ----------------------~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
...++|+|+.|.||++++++..-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999876667999987764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.41 E-value=8.9e-07 Score=73.05 Aligned_cols=131 Identities=19% Similarity=0.195 Sum_probs=85.9
Q ss_pred eeeecCC-eeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC--CcceeeeeEEEeCCeEEEEEeecCCCChHH
Q 040826 73 FLGRGSA-GLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH--PNLVCLFGCCVEGGEQYLVYEFCAAGNLAQ 149 (347)
Q Consensus 73 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 149 (347)
.+..|.. +.||+....++..+++|..... ....+..|...++.+.. -.+.+++.+..+.+..+++|++++|.++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 3445553 6799999888888899976443 44567788888877743 235667777777888999999998866533
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------------
Q 040826 150 HLLRKDSVLTWERRVKILRDCALALRYLHHY------------------------------------------------- 180 (347)
Q Consensus 150 ~l~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~------------------------------------------------- 180 (347)
.. .... ..+.++.+.+.-||+.
T Consensus 96 ~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 96 SH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp SC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 10 1111 1122233333333321
Q ss_pred ------cCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 181 ------IDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 181 ------~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 012379999999999999876677999987664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=4.4e-05 Score=66.86 Aligned_cols=74 Identities=18% Similarity=0.128 Sum_probs=47.1
Q ss_pred CeeeecCCeeEEEEEeC-CCCEEEEEEcccC------C---ChhHHHHHHHHhhcCC--CC-cceeeeeEEEeCCeEEEE
Q 040826 72 RFLGRGSAGLVYKGVLP-SGQVVAIKHIYKS------N---NTDSFSREVEGLSRVR--HP-NLVCLFGCCVEGGEQYLV 138 (347)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~---~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 138 (347)
+.||.|....||+.... +|+.+++|.-.+. . .......|.+.++.+. .| .+.+++. .+....+++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 46899999999999865 4678999965431 1 1234556888887663 23 3444443 345566889
Q ss_pred EeecCCCCh
Q 040826 139 YEFCAAGNL 147 (347)
Q Consensus 139 ~e~~~~gsL 147 (347)
||++++.++
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.83 E-value=7.8e-05 Score=63.13 Aligned_cols=157 Identities=13% Similarity=0.059 Sum_probs=88.0
Q ss_pred ccHHHHHHHhcCcccCCee-----eecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCC-----Ccceee
Q 040826 56 FSKDEIENAINNDWDRRFL-----GRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRH-----PNLVCL 125 (347)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h-----~niv~~ 125 (347)
++.++++....+|...+.. ..|.-.+.|+...++|+ +++|+............|+..+..+.. |..+..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence 5678899999999775554 35556778999987665 899988665555666777777777742 222211
Q ss_pred e-e--EEEeCCeEEEEEeecCCCChHH-----------H---hhc--CC------CCCCH------------------HH
Q 040826 126 F-G--CCVEGGEQYLVYEFCAAGNLAQ-----------H---LLR--KD------SVLTW------------------ER 162 (347)
Q Consensus 126 ~-~--~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~--~~------~~~~~------------------~~ 162 (347)
. | +.........++.+..+..... . ++. .. ..... ..
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 1 0 1223455667777776542211 0 000 00 00000 01
Q ss_pred HHHHHHHHHHHHHHhh-hccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 163 RVKILRDCALALRYLH-HYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 163 ~~~i~~qi~~~l~~Lh-~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
....+......+...+ .....|++|+|+.++|++++++...-+.||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1112222222222222 11256899999999999999887778999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.50 E-value=0.0011 Score=56.00 Aligned_cols=159 Identities=15% Similarity=0.112 Sum_probs=89.4
Q ss_pred cccccHHHHHHHhcCcc---cCCeee-ecCCeeEEEEEeCCCCEEEEEEcccCC-ChhHHHHHHHHhhcCCCCc-----c
Q 040826 53 LYRFSKDEIENAINNDW---DRRFLG-RGSAGLVYKGVLPSGQVVAIKHIYKSN-NTDSFSREVEGLSRVRHPN-----L 122 (347)
Q Consensus 53 ~~~~~~~~~~~~~~~~~---~~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~h~n-----i 122 (347)
+..++.+.+..+.+.+. ..+.+- .+.-..||++...+|+.+++|...+.. ..+++..|...+..|...+ .
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p 84 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAP 84 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 44566666655544331 112221 233568999999999999999987764 3456778888887774211 1
Q ss_pred eeee--eEEEeCCeEEEEEeecCCCChH-----H------Hh---hc----C----CCCCCH------------------
Q 040826 123 VCLF--GCCVEGGEQYLVYEFCAAGNLA-----Q------HL---LR----K----DSVLTW------------------ 160 (347)
Q Consensus 123 v~~~--~~~~~~~~~~lv~e~~~~gsL~-----~------~l---~~----~----~~~~~~------------------ 160 (347)
+..- ......+..+.++++.+|..+. . .+ +. . ....+.
T Consensus 85 ~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~ 164 (325)
T d1zyla1 85 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 164 (325)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCC
Confidence 1111 1234466788899998764321 1 01 10 0 011111
Q ss_pred -H---HHHHHHHHHHHHHHHh-hhccCCCceeCCCCCCCEEecCCCceEEeeccccee
Q 040826 161 -E---RRVKILRDCALALRYL-HHYIDGCIVHRDIKLTNILLTEKLEPKLSDFGLAKM 213 (347)
Q Consensus 161 -~---~~~~i~~qi~~~l~~L-h~~~~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 213 (347)
. .....+.++...+.-. .+....+++|+|+.+.|||++++ ..+.||+-+..
T Consensus 165 ~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 165 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1 1122233333333222 11124579999999999999753 45889987764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00024 Score=62.12 Aligned_cols=73 Identities=12% Similarity=0.157 Sum_probs=49.3
Q ss_pred CCeeeecCCeeEEEEEeCCC--------CEEEEEEcccCCChhHHHHHHHHhhcCCCCcc-eeeeeEEEeCCeEEEEEee
Q 040826 71 RRFLGRGSAGLVYKGVLPSG--------QVVAIKHIYKSNNTDSFSREVEGLSRVRHPNL-VCLFGCCVEGGEQYLVYEF 141 (347)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 141 (347)
.+.|+-|-.-.+|++..+++ +.|++++.......-...+|..+++.++-.++ .++++++.+ .+|+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 45688889999999986543 46777766544444456688888888853344 356665532 578999
Q ss_pred cCCCCh
Q 040826 142 CAAGNL 147 (347)
Q Consensus 142 ~~~gsL 147 (347)
++|.++
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=83.13 E-value=1 Score=36.42 Aligned_cols=134 Identities=13% Similarity=0.035 Sum_probs=73.0
Q ss_pred eeecCCeeEEEEEeCCCCEEEEEEcccCCChhHHHHHHHHhhcCCCCcceeeeeEEE-----------------------
Q 040826 74 LGRGSAGLVYKGVLPSGQVVAIKHIYKSNNTDSFSREVEGLSRVRHPNLVCLFGCCV----------------------- 130 (347)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------------------- 130 (347)
+..+|.+-|+-+..+ +..+++|... ....+.+..++...-.+..|...-+. .+.
T Consensus 76 ~s~~Gs~Gv~FV~~e-~gaiVlK~s~-tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~se 152 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETE-SGVFIVKRST-NIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITTL 152 (342)
T ss_dssp ECCSTTSCEEEEEES-SCEEEEECCT-THHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHHH
T ss_pred EeecCCceEEEEEcC-CceEEEecCC-chHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHHHH
Confidence 345666667767664 4567888532 22234455666655566666644332 110
Q ss_pred eCCeEEEEEeecCCCChHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCceeCC-CCCCCEEecCCC-ceEEee
Q 040826 131 EGGEQYLVYEFCAAGNLAQHLLRK-DSVLTWERRVKILRDCALALRYLHHYIDGCIVHRD-IKLTNILLTEKL-EPKLSD 207 (347)
Q Consensus 131 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d-l~p~Nili~~~~-~~kl~d 207 (347)
-....+++|||.+|.+|.+.-... ...++...+.+ +-.++-.=.++++...-++.+++ =++.|+++++++ .+..+|
T Consensus 153 l~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~-LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~ID 231 (342)
T d1cjaa_ 153 ANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQ-LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPID 231 (342)
T ss_dssp TTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHH-HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECS
T ss_pred HhcccceeeeccCCccccccccccchhhhcHHHHHH-hhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEEec
Confidence 123468999999987775532110 01122222221 11233333456655455667763 289999999877 677777
Q ss_pred cccc
Q 040826 208 FGLA 211 (347)
Q Consensus 208 fg~~ 211 (347)
=+..
T Consensus 232 s~i~ 235 (342)
T d1cjaa_ 232 SKII 235 (342)
T ss_dssp CCCC
T ss_pred CCcc
Confidence 4443
|